data_2k3y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k3y _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 . . . . . 0 C--O 1.236 0.377 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -56.93 134.15 55.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 168.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.77 125.74 44.51 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -10.18 0.93 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -168.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 28.7 1.2 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.02 -175.27 50.94 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.48 157.3 18.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.06 153.49 37.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 168.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.0 mt -122.07 139.38 53.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.66 123.16 28.77 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.229 0.956 . . . . 0.0 109.386 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -101.5 118.38 36.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.752 1.621 . . . . 0.0 107.6 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -95.08 -25.63 16.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.161 0.585 . . . . 0.0 111.439 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.82 -72.29 0.27 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -72.4 -30.51 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.079 1.853 . . . . 0.0 112.485 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -154.27 177.12 11.48 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.929 1.692 . . . . 0.0 109.63 -170.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.415 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -144.07 151.93 40.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.109 1.764 . . . . 0.0 108.175 -168.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -139.19 167.35 22.25 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.552 1.141 . . . . 0.0 110.583 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.34 144.89 29.37 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.34 161.71 37.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.522 1.529 . . . . 0.0 108.998 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -149.11 108.22 3.91 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.124 -0.985 . . . . 0.0 110.366 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.8 151.06 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.229 3.012 . . . . 0.0 111.348 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.01 -30.05 0.08 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 34.4 ttpt -132.62 136.58 46.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.85 159.89 30.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -168.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -143.68 152.85 41.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.547 -168.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -150.91 142.84 15.76 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 126.065 1.746 . . . . 0.0 109.418 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.79 -11.13 31.05 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.971 2.448 . . . . 0.0 113.7 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.3 m -63.81 -32.62 74.19 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.852 1.205 . . . . 0.0 112.021 -171.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 m -125.82 -4.65 6.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.768 1.227 . . . . 0.0 111.421 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 41.45 50.66 3.67 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 125.298 1.439 . . . . 0.0 111.105 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.5 mtm -150.08 163.37 38.35 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 170.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -103.85 175.7 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.747 0.819 . . . . 0.0 112.272 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 p -143.15 153.51 42.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.346 2.259 . . . . 0.0 106.907 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 m -153.23 163.49 39.79 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.6 pt . . . . . 0 CA--C 1.552 1.049 0 C-N-CA 125.794 1.638 . . . . 0.0 108.726 179.836 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt . . . . . 0 CA--C 1.514 -0.439 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 4.79 80.77 0.0 OUTLIER 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.341 2.657 . . . . 0.0 113.532 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mt -73.78 136.23 25.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -169.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -78.58 146.13 68.82 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -52.73 134.34 53.56 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.848 2.365 . . . . 0.0 110.137 172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -144.9 153.74 41.88 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -65.74 135.82 55.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.19 0.995 . . . . 0.0 109.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.22 153.72 33.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.18 1.792 . . . . 0.0 111.631 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.64 21.88 5.27 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 124.131 0.894 . . . . 0.0 112.783 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -75.87 -34.74 60.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.098 0.949 . . . . 0.0 109.207 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -149.37 4.88 0.62 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.677 1.191 . . . . 0.0 111.855 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 7.0 mp0 -114.18 168.47 9.8 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.476 1.51 . . . . 0.0 110.532 -169.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -149.54 138.96 21.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.1 128.9 18.74 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.85 162.38 41.64 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.958 1.772 . . . . 0.0 109.56 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -15.72 9.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.924 0.89 . . . . 0.0 112.316 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.55 -31.18 72.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.824 1.25 . . . . 0.0 112.119 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . 0.254 4.6 pt -121.27 -9.09 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 119.812 1.187 . . . . 0.0 110.447 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.43 -49.28 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 127.6 2.36 . . . . 0.0 106.137 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -79.44 10.24 4.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.774 1.63 . . . . 0.0 112.114 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.34 28.85 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 119.454 1.024 . . . . 0.0 111.399 -173.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -64.39 132.97 51.61 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.5 m -138.27 154.54 49.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.393 1.058 . . . . 0.0 111.844 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 35.9 m-85 -142.11 115.44 8.93 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.764 -169.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.419 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 46.5 t80 -80.82 128.29 33.49 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -138.25 155.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.458 -167.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -100.45 118.23 36.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.59 121.89 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -90.22 150.27 22.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 10.28 52.71 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.616 -169.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 31.8 m95 -136.07 172.04 13.59 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.833 1.253 . . . . 0.0 111.25 -174.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -71.36 163.08 28.37 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.324 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 m -77.64 -12.11 59.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 171.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 m -55.43 -31.15 61.67 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.969 -1.082 . . . . 0.0 111.713 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -82.79 0.02 45.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.974 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -64.61 112.87 3.37 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -157.63 168.71 26.48 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.098 1.759 . . . . 0.0 107.975 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.506 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.9 152.46 20.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.042 0.925 . . . . 0.0 110.479 168.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.42 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.006 171.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.8 158.84 35.62 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 6.83 1.23 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.78 -26.68 25.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.624 1.57 . . . . 0.0 110.974 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -107.76 -40.42 5.29 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.363 1.065 . . . . 0.0 111.093 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 tt -100.61 148.9 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.596 1.089 . . . . 0.0 110.443 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -145.62 151.28 37.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.94 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.54 146.23 52.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.506 1.522 . . . . 0.0 110.403 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.12 114.75 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 119.053 0.842 . . . . 0.0 112.194 -169.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -159.25 164.82 34.64 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.223 1.409 . . . . 0.0 110.126 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.27 -33.9 68.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.594 1.557 . . . . 0.0 113.527 -169.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.24 -42.27 96.59 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.724 0.773 . . . . 0.0 109.572 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -68.75 -34.96 76.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.9 mm -66.91 -36.79 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 118.687 0.676 . . . . 0.0 110.833 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.96 99.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.259 0.936 . . . . 0.0 109.924 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -57.49 -50.85 71.71 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 170.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -57.72 -48.92 78.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.661 0.785 . . . . 0.0 109.757 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -72.36 -38.99 68.4 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.798 0.839 . . . . 0.0 110.718 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -47.28 82.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.835 0.743 . . . . 0.0 109.215 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.8 mt -73.42 -42.77 61.65 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.434 -0.791 . . . . 0.0 111.819 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.31 -20.05 3.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.294 1.438 . . . . 0.0 112.606 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 . . . . . 0 C--N 1.341 0.199 0 CA-C-N 118.921 0.782 . . . . 0.0 111.557 172.342 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 C--O 1.235 0.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 51.0 p90 -59.99 142.65 53.49 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.34 134.44 45.2 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -169.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.73 -3.14 0.45 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -168.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.87 29.21 0.42 Allowed Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 170.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.72 179.59 48.94 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 -82.28 156.75 24.15 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.29 168.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.37 -2.455 . . . . 0.0 104.37 170.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.8 mt -141.85 130.66 22.93 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.98 130.08 51.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -103.71 114.06 28.04 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -171.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -94.29 -12.84 27.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.446 0.698 . . . . 0.0 111.757 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.96 -73.85 0.37 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.983 1.278 . . . . 0.0 109.914 171.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -66.7 -38.32 18.58 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.059 2.506 . . . . 0.0 113.4 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.7 tp -150.88 176.86 10.68 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 125.417 1.487 . . . . 0.0 108.798 -168.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.5 146.27 39.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.86 2.064 . . . . 0.0 107.014 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -131.5 154.04 49.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.883 0.873 . . . . 0.0 108.729 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -81.08 138.57 35.96 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.011 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.03 158.55 40.02 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.605 1.562 . . . . 0.0 109.344 -171.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.76 96.6 2.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.63 0.372 . . . . 0.0 110.269 -169.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.6 mt -62.16 152.29 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 129.65 3.18 . . . . 0.0 112.41 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.26 -25.21 0.05 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.842 -1.075 . . . . 0.0 112.935 167.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 34.9 ttpt -128.77 136.13 50.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.26 163.42 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.754 0.788 . . . . 0.0 109.024 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -140.16 152.03 45.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.37 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -147.37 139.35 13.88 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.6 1.96 . . . . 0.0 108.428 -172.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.61 -10.27 27.35 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.372 2.715 . . . . 0.0 113.426 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 m -67.11 -32.12 73.05 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.116 1.325 . . . . 0.0 111.491 -170.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -121.63 -13.68 8.3 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.641 1.576 . . . . 0.0 110.823 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt 47.47 50.04 15.25 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.419 ' SD ' ' HE3' ' A' ' 60' ' ' LYS . 5.8 mtm -146.93 165.56 29.42 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.999 2.119 . . . . 0.0 106.396 170.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.4 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 49.0 p90 -107.72 175.18 5.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.968 0.907 . . . . 0.0 112.721 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -146.41 151.09 36.89 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 127.206 2.202 . . . . 0.0 107.336 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 t -147.19 160.84 41.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 110.102 -179.256 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.17 103.87 1.32 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mt -69.85 130.96 34.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -67.63 139.22 93.83 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.02 139.39 70.71 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.966 1.778 . . . . 0.0 110.667 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -136.92 158.47 44.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.419 ' HE3' ' SD ' ' A' ' 37' ' ' MET . 4.2 mmpt? -63.44 122.74 17.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.23 147.7 47.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.681 1.192 . . . . 0.0 111.729 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.0 -127.21 1.18 Allowed Glycine 0 N--CA 1.446 -0.661 1 N-CA-C 102.922 -4.071 . . . . 0.0 102.922 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 53.43 30.13 9.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.355 1.062 . . . . 0.0 113.298 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.64 10.45 5.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.764 2.025 . . . . 0.0 114.263 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -73.17 6.83 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.263 1.425 . . . . 0.0 113.586 171.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -22.4 118.47 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 128.63 2.772 . . . . 0.0 114.21 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.5 pt -115.43 128.68 25.75 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.82 159.49 52.55 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.835 1.69 . . . . 0.0 109.388 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.77 -21.69 11.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.719 0.808 . . . . 0.0 111.611 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.7 -37.96 69.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.472 1.909 . . . . 0.0 114.196 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.4 pt -116.12 -14.79 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.041 1.291 . . . . 0.0 110.814 -172.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mm -50.32 -45.96 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 128.007 2.523 . . . . 0.0 108.504 169.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.57 8.2 10.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.963 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.31 178.72 25.71 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 120.209 1.368 . . . . 0.0 111.44 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.48 130.13 45.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.0 m -131.82 143.69 50.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 124.191 0.932 . . . . 0.0 109.588 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CE1' ' CD1' ' A' ' 8' ' ' PHE . 63.3 m-85 -128.76 111.72 13.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.199 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -78.24 126.68 31.15 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.097 1.359 . . . . 0.0 107.564 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -136.65 158.6 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 125.44 1.713 . . . . 0.0 110.973 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -111.57 121.97 46.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -73.32 121.91 21.17 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -66.87 147.87 52.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.422 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.05 14.38 58.95 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.913 -0.937 . . . . 0.0 113.641 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -135.08 171.39 14.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.885 1.342 . . . . 0.0 110.819 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -68.05 157.98 33.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.903 0.481 . . . . 0.0 111.213 -173.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 m -65.08 -21.66 66.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.21 1.004 . . . . 0.0 111.904 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -54.77 -32.11 59.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.06 1.344 . . . . 0.0 112.713 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -88.4 3.67 49.1 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.049 -0.976 . . . . 0.0 112.776 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.54 117.17 7.63 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.252 7.6 tp10 -157.7 167.48 29.97 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.84 -167.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.46 ' CH2' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -98.72 150.45 21.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.886 0.851 . . . . 0.0 110.313 168.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.52 156.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.887 1.275 . . . . 0.0 109.976 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.77 167.46 26.97 Favored Glycine 0 C--O 1.24 0.52 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.072 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -17.34 9.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.395 1.478 . . . . 0.0 113.387 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -56.77 -22.88 39.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.123 1.369 . . . . 0.0 113.172 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -124.54 -39.22 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.228 173.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.2 tt -93.71 153.24 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.23 0.923 . . . . 0.0 111.268 -169.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -149.88 156.97 42.7 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 127.503 2.321 . . . . 0.0 109.203 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.6 27.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.252 1.021 . . . . 0.0 111.107 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -75.23 113.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -155.98 161.67 40.45 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.594 1.558 . . . . 0.0 108.687 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.54 -33.88 56.22 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.766 1.626 . . . . 0.0 114.469 -169.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.74 -44.97 84.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.289 1.519 . . . . 0.0 109.639 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -75.26 -19.28 59.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.8 mm -74.6 -33.48 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 119.061 0.846 . . . . 0.0 110.25 168.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.99 93.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.212 0.915 . . . . 0.0 108.787 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.8 ttp -58.61 -56.63 19.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.55 0.614 . . . . 0.0 109.364 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -50.08 -45.96 52.98 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.776 1.23 . . . . 0.0 110.956 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -79.43 -41.75 26.92 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.803 1.241 . . . . 0.0 111.553 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -39.59 73.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.644 1.111 . . . . 0.0 109.347 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.18 -46.49 20.38 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.73 30.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.991 0.917 . . . . 0.0 111.469 171.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 t30 . . . . . 0 CA--C 1.532 0.256 0 C-N-CA 124.019 0.928 . . . . 0.0 112.071 174.757 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.441 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -59.26 87.83 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.873 2.069 . . . . 0.0 110.461 169.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.89 130.4 37.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.34 -8.08 3.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -169.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.09 30.61 0.98 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 173.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.11 -163.79 28.7 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 106.585 -2.606 . . . . 0.0 106.585 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 156.29 17.45 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.06 154.72 41.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 168.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -125.06 131.6 53.31 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.55 121.55 35.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.649 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.16 125.21 44.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.034 1.334 . . . . 0.0 107.959 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -98.94 -25.73 14.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.886 0.474 . . . . 0.0 111.607 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.11 -71.86 0.34 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.26 -32.67 12.45 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.857 1.705 . . . . 0.0 112.614 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.4 178.83 9.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.194 1.397 . . . . 0.0 109.6 -174.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.07 151.41 40.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.878 2.071 . . . . 0.0 107.95 -168.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -138.0 159.84 40.93 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.76 0.824 . . . . 0.0 111.108 -170.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.42 140.82 43.16 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 160.6 39.21 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.738 1.615 . . . . 0.0 107.582 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -147.54 103.37 3.53 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.239 -0.913 . . . . 0.0 109.699 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.72 150.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.889 2.076 . . . . 0.0 111.854 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.53 -24.43 0.06 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.776 -1.107 . . . . 0.0 113.109 167.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -126.49 138.7 53.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 pt -139.64 160.47 27.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -147.4 151.12 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -169.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -150.57 142.46 15.57 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.995 1.718 . . . . 0.0 108.465 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 -11.38 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.092 2.528 . . . . 0.0 113.644 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.2 m -64.01 -34.84 78.91 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -120.56 -7.09 9.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.178 0.991 . . . . 0.0 111.186 174.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 44.45 49.45 8.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.679 1.192 . . . . 0.0 109.801 -169.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtp -146.0 147.88 32.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -94.85 173.19 7.72 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.661 0.384 . . . . 0.0 110.53 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -143.97 145.45 32.25 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.975 2.11 . . . . 0.0 105.424 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.408 ' HB2' ' CD1' ' A' ' 56' ' ' ILE . 1.5 m -143.39 157.18 44.67 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -171.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.7 pt . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 170.182 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.8 tttm . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -58.69 107.53 0.53 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 40' ' ' SER . 23.4 mt -73.71 139.55 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -169.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -67.93 134.09 92.0 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.126 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.31 130.52 18.79 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 106.181 -2.276 . . . . 0.0 106.181 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -140.3 165.66 26.79 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.55 150.26 44.38 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.43 146.45 40.61 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.519 1.928 . . . . 0.0 110.284 -168.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.11 36.05 1.41 Allowed Glycine 0 CA--C 1.524 0.652 0 O-C-N 124.377 1.048 . . . . 0.0 114.501 169.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -72.13 -33.22 67.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.731 1.266 . . . . 0.0 108.422 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.48 -29.88 0.13 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.372 1.869 . . . . 0.0 111.97 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 35.81 0.44 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.328 2.251 . . . . 0.0 112.78 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -32.73 144.21 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.785 2.434 . . . . 0.0 114.32 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -132.55 136.38 27.8 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 161.02 47.53 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.663 1.576 . . . . 0.0 109.575 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.76 -12.68 2.01 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.638 1.175 . . . . 0.0 112.711 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.84 -29.82 68.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.186 1.394 . . . . 0.0 113.037 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 pt -121.27 -9.91 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.371 1.441 . . . . 0.0 111.338 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mm -53.67 -45.95 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 128.688 2.795 . . . . 0.0 108.011 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.19 8.41 8.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 111.933 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.78 179.02 26.9 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 120.071 1.305 . . . . 0.0 111.33 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -64.41 129.99 42.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -136.86 151.17 48.8 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.155 0.909 . . . . 0.0 111.004 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.5 m-85 -139.88 115.41 10.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.48 1.512 . . . . 0.0 108.711 -169.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.76 129.58 35.0 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 126.168 1.787 . . . . 0.0 106.899 170.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.39 155.68 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.95 -168.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -101.94 119.53 38.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 167.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -71.07 117.15 12.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -83.73 151.08 25.42 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.851 0.46 . . . . 0.0 109.778 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.49 7.98 36.38 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.033 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -138.2 173.89 11.14 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.725 1.21 . . . . 0.0 110.786 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -72.55 165.98 23.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.199 0.523 . . . . 0.0 111.382 -170.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.51 -11.59 59.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.46 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 m -57.66 -32.48 67.35 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.191 -0.943 . . . . 0.0 111.737 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -83.54 4.97 25.77 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.468 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.95 108.6 2.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -153.66 163.81 39.37 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.622 1.569 . . . . 0.0 107.79 -167.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.76 150.15 22.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.648 0.737 . . . . 0.0 109.612 168.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.18 150.06 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.27 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -83.64 160.81 37.98 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 173.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.22 9.02 0.83 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 93' ' ' GLY . 31.3 t70 -87.09 -30.72 20.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.835 1.654 . . . . 0.0 110.703 168.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -102.47 -39.85 6.94 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.496 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.9 tt -101.13 149.64 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.389 0.995 . . . . 0.0 110.762 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -145.48 147.73 32.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.122 1.369 . . . . 0.0 110.225 169.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.81 144.3 54.34 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.134 1.373 . . . . 0.0 110.238 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -60.34 115.49 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.114 0.87 . . . . 0.0 111.87 -169.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -161.27 165.1 29.73 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.432 1.493 . . . . 0.0 110.431 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.15 -33.99 65.73 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.53 1.532 . . . . 0.0 113.715 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.42 -43.96 96.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.174 0.988 . . . . 0.0 109.949 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -68.75 -33.77 74.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.27 -34.07 61.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.507 0.594 . . . . 0.0 110.682 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.35 99.34 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 119.414 1.006 . . . . 0.0 109.625 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -48.32 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -60.68 -45.44 94.16 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.44 0.696 . . . . 0.0 109.681 -173.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -76.07 -44.11 40.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.17 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -57.35 -33.96 68.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.783 0.72 . . . . 0.0 110.569 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.32 -52.23 9.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.73 -27.19 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.928 1.291 . . . . 0.0 111.747 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.8 t30 . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 124.477 1.111 . . . . 0.0 113.448 174.135 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 C--O 1.234 0.24 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -60.06 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 126.875 2.07 . . . . 0.0 109.953 170.045 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.11 130.4 39.72 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -4.07 1.74 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -168.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.66 33.36 0.69 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.4 -161.37 27.11 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 107.346 -2.301 . . . . 0.0 107.346 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' HG2' HE22 ' A' ' 82' ' ' GLN . 56.3 mtt180 -102.96 156.65 17.52 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 168.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.24 156.54 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 168.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 mt -126.03 134.98 51.27 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.16 129.21 47.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.177 0.923 . . . . 0.0 110.038 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -105.98 131.81 52.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 109.638 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -113.68 -19.93 11.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.758 0.823 . . . . 0.0 111.655 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.95 -72.8 0.31 Allowed Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.75 -32.75 29.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.843 1.695 . . . . 0.0 112.26 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.447 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 -179.26 7.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.702 1.601 . . . . 0.0 109.311 -170.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.447 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -140.94 160.61 39.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.779 1.632 . . . . 0.0 107.281 -175.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.07 160.39 39.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.951 0.9 . . . . 0.0 109.508 -170.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -77.24 140.91 40.2 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.67 41.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.671 1.588 . . . . 0.0 108.672 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -148.5 101.52 3.24 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.142 -0.973 . . . . 0.0 110.339 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.0 mt -58.93 150.23 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 127.769 2.428 . . . . 0.0 112.025 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.51 -28.37 0.05 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 116.51 -1.709 . . . . 0.0 112.374 166.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 20.7 mtmt -114.72 144.79 42.9 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 168.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -142.26 161.07 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -149.6 152.7 35.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.386 -169.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.01 138.69 13.12 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.187 2.195 . . . . 0.0 108.453 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.89 -9.95 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.503 2.802 . . . . 0.0 113.57 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 m -66.57 -32.04 73.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.934 1.243 . . . . 0.0 111.538 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.8 p -121.1 -15.32 8.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.863 1.665 . . . . 0.0 110.866 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 48.62 49.01 19.19 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.917 0.887 . . . . 0.0 109.757 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.3 mtp -144.85 154.78 43.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.961 2.104 . . . . 0.0 105.793 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -104.52 170.56 7.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.223 0.609 . . . . 0.0 111.911 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -138.64 152.89 48.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.911 2.085 . . . . 0.0 106.445 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 m -152.2 156.27 39.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 pt . . . . . 0 CA--C 1.55 0.951 0 C-N-CA 124.849 1.259 . . . . 0.0 109.852 -177.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 mttt . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.51 101.43 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mt -76.12 135.27 27.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.35 140.55 87.7 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.63 139.88 38.19 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.051 1.834 . . . . 0.0 107.381 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -143.65 160.0 41.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -62.99 131.79 49.83 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.178 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -80.35 153.89 28.09 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.404 1.482 . . . . 0.0 111.727 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.12 31.63 1.68 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.37 -40.16 27.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.872 1.336 . . . . 0.0 109.216 169.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -160.32 2.65 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.121 0.968 . . . . 0.0 113.286 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.12 47.21 2.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.678 1.591 . . . . 0.0 111.724 -169.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 m -33.05 142.06 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.65 3.18 . . . . 0.0 113.345 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.8 pt -135.19 132.23 20.04 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 168.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.87 158.85 55.44 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.255 1.303 . . . . 0.0 109.302 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.18 -16.36 3.08 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.341 1.456 . . . . 0.0 112.271 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.13 -32.13 73.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.27 1.828 . . . . 0.0 112.955 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 pt -120.45 -13.19 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.528 1.513 . . . . 0.0 110.868 -173.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.74 -46.03 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 128.278 2.631 . . . . 0.0 108.759 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -79.59 9.03 5.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.95 0.9 . . . . 0.0 111.886 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.1 -176.37 27.23 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.922 1.237 . . . . 0.0 111.093 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.08 130.87 48.0 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -134.29 154.39 51.33 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.885 0.741 . . . . 0.0 110.941 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 23.9 m-85 -141.78 113.49 7.83 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.108 1.363 . . . . 0.0 109.265 -169.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.498 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 55.3 t80 -80.01 129.07 34.2 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.33 157.36 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.362 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -105.8 120.09 40.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 167.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -72.73 118.45 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.439 HE22 ' HG2' ' A' ' 13' ' ' ARG . 62.3 mt-30 -77.7 150.2 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.08 10.91 42.91 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.925 -0.93 . . . . 0.0 113.017 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -134.87 171.01 15.0 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 1.233 . . . . 0.0 111.327 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -69.25 158.23 35.39 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.024 0.53 . . . . 0.0 111.338 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 p -63.92 -19.76 65.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.813 0.845 . . . . 0.0 112.127 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.1 m -54.19 -31.94 54.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.424 1.089 . . . . 0.0 112.779 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -84.14 3.23 35.87 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.95 107.01 2.94 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.253 7.5 tp10 -154.31 168.54 26.25 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.623 1.969 . . . . 0.0 107.854 -167.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.61 151.24 22.58 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.823 0.82 . . . . 0.0 111.011 168.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.68 156.38 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.128 174.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.77 161.32 27.0 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.0 1.286 . . . . 0.0 110.11 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.74 7.5 1.49 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -176.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.56 -20.5 27.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.888 1.675 . . . . 0.0 110.752 169.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -119.0 -31.31 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.01 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.9 tt -108.22 155.91 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 120.665 1.575 . . . . 0.0 111.694 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 11.0 mtt85 -149.19 146.84 27.83 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.027 1.331 . . . . 0.0 110.32 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . 0.259 . . -66.99 143.89 56.52 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.339 1.855 . . . . 0.0 111.916 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -59.06 118.67 6.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.461 1.482 . . . . 0.0 111.516 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -169.35 164.78 10.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.06 1.744 . . . . 0.0 110.622 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.97 -27.99 63.95 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.175 -0.953 . . . . 0.0 113.511 -169.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.18 -45.92 72.13 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 119.543 1.065 . . . . 0.0 110.778 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -74.74 -22.35 58.85 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.02 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.18 -37.65 67.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 118.752 0.705 . . . . 0.0 110.127 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.06 99.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.577 1.08 . . . . 0.0 109.742 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.6 ttp -58.13 -53.68 55.48 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -57.75 -46.41 84.54 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.82 -172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -70.74 -45.19 65.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.237 0.926 . . . . 0.0 110.351 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -34.02 60.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.455 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.6 mt -87.63 -47.27 8.82 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.954 0.797 . . . . 0.0 111.996 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.23 14.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.241 1.416 . . . . 0.0 110.936 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t30 . . . . . 0 C--O 1.235 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 112.957 172.119 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -62.71 82.6 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 124.481 2.086 . . . . 0.0 110.293 169.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.07 128.67 34.88 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 103.455 -2.794 . . . . 0.0 103.455 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.86 -2.82 2.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.77 29.41 1.03 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -166.09 34.7 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 168.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -98.28 156.37 16.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.92 156.42 42.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 169.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -127.75 141.27 51.63 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.96 127.09 44.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.171 0.919 . . . . 0.0 109.155 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -86.2 138.07 32.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.383 1.073 . . . . 0.0 108.323 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -120.22 -11.46 9.2 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.19 0.996 . . . . 0.0 112.385 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.67 -72.65 0.48 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.49 -39.11 22.88 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.258 1.972 . . . . 0.0 112.601 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.7 tp -152.27 -171.81 4.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 125.818 1.647 . . . . 0.0 108.919 -169.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.63 150.77 30.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.438 2.295 . . . . 0.0 107.27 -169.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.01 164.19 29.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.985 0.514 . . . . 0.0 111.397 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.0 137.73 37.71 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 125.492 1.517 . . . . 0.0 109.132 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.6 166.24 22.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.999 1.72 . . . . 0.0 108.76 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -152.59 93.46 1.78 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 110.582 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -53.11 152.43 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.09 2.156 . . . . 0.0 111.523 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -154.96 -35.06 0.09 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.935 0.894 . . . . 0.0 111.009 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 37.5 ttpt -128.93 137.09 51.2 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.15 164.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -141.39 152.88 44.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.228 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -135.11 150.38 72.79 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 127.596 2.358 . . . . 0.0 110.726 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.75 -17.42 7.18 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.787 2.991 . . . . 0.0 112.877 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m -62.08 -37.49 85.23 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.944 1.298 . . . . 0.0 111.979 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.2 m -128.62 5.89 5.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.155 1.782 . . . . 0.0 111.341 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 46.03 55.89 6.65 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 125.173 1.389 . . . . 0.0 109.932 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 ptm -150.94 169.27 22.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -114.38 172.67 6.87 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.451 0.701 . . . . 0.0 112.444 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -145.11 151.4 38.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.256 2.222 . . . . 0.0 106.627 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 t -144.58 152.06 39.97 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.801 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 79.1 mttt . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.43 101.18 0.3 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.3 mt -74.54 134.24 29.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -67.7 143.43 96.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.0 134.67 18.08 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 N-CA-C 107.476 -1.779 . . . . 0.0 107.476 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -137.35 167.81 20.87 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -60.99 154.37 22.75 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.88 153.31 23.22 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 111.333 -168.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.83 30.75 3.13 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-O 119.544 -0.587 . . . . 0.0 112.911 170.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.33 -26.26 38.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.221 1.011 . . . . 0.0 110.281 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -152.07 -31.69 0.15 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.209 1.003 . . . . 0.0 112.149 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.41 179.6 5.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.237 1.415 . . . . 0.0 110.621 171.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.4 m -154.8 152.02 29.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.456 2.702 . . . . 0.0 105.827 169.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 pt -136.45 130.6 18.12 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 168.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.18 159.71 51.95 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.999 1.8 . . . . 0.0 109.846 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.01 -20.89 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.266 1.026 . . . . 0.0 112.145 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.59 -36.94 74.77 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.233 1.813 . . . . 0.0 113.677 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 pt -116.99 -9.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.998 0.817 . . . . 0.0 110.901 -170.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.59 -47.98 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.696 2.799 . . . . 0.0 108.627 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.8 12.03 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.414 0.686 . . . . 0.0 112.841 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.61 -175.77 24.49 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -57.1 139.64 51.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.6 t -140.33 155.62 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.572 0.545 . . . . 0.0 110.03 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.422 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 25.3 m-85 -140.16 113.4 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.77 1.228 . . . . 0.0 110.906 -169.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -78.16 124.59 28.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.901 2.08 . . . . 0.0 106.374 169.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -134.97 157.44 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 113.45 -1.704 . . . . 0.0 111.429 -168.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -103.78 118.32 36.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.057 -2.572 . . . . 0.0 104.057 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -73.39 117.84 15.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.61 147.0 27.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.77 -171.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.9 8.51 49.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.639 -170.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -128.63 174.73 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.982 1.391 . . . . 0.0 111.481 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.02 162.49 29.38 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.215 0.606 . . . . 0.0 111.427 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -64.78 -22.07 66.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.002 . . . . 0.0 111.928 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -56.37 -30.99 63.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.113 . . . . 0.0 112.594 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -90.06 6.63 41.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.035 -0.983 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 107.18 1.9 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -155.67 164.82 38.1 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.996 1.718 . . . . 0.0 108.249 -167.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.472 ' CH2' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -94.74 149.76 20.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.136 0.97 . . . . 0.0 110.396 168.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.51 151.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.548 171.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -87.56 158.66 29.98 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.03 8.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 93' ' ' GLY . 35.4 t70 -89.74 -18.8 25.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.914 1.686 . . . . 0.0 111.09 169.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -117.17 -39.01 3.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.856 -1.069 . . . . 0.0 111.392 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 tt -99.75 150.99 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.727 1.149 . . . . 0.0 111.365 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -143.59 146.62 33.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.609 1.564 . . . . 0.0 110.476 168.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 147.51 53.34 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.871 1.269 . . . . 0.0 111.023 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -64.79 116.44 6.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.051 0.841 . . . . 0.0 111.854 -169.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -159.16 161.71 36.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.963 1.705 . . . . 0.0 109.063 -169.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -61.48 -26.34 67.84 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.618 -1.301 . . . . 0.0 113.114 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -71.65 -44.27 64.62 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.248 1.019 . . . . 0.0 110.8 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.288 44.2 p30 -71.22 -22.28 62.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.338 173.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.58 -35.55 51.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 119.032 0.833 . . . . 0.0 110.502 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.48 98.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.724 1.147 . . . . 0.0 109.684 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.3 ttp -58.8 -53.7 55.4 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -54.0 -46.12 71.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.758 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -73.12 -45.23 58.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.844 0.747 . . . . 0.0 110.041 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.87 39.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.873 -0.584 . . . . 0.0 112.15 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.03 -45.09 8.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.298 0.954 . . . . 0.0 112.037 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.71 13.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.025 1.33 . . . . 0.0 111.316 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.6 t30 . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 126.227 1.811 . . . . 0.0 114.15 173.621 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.561 0.696 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.46 126.21 26.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.51 133.91 55.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 -169.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.77 -8.07 1.21 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -168.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.02 31.58 0.55 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.18 -163.1 29.96 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 168.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.94 152.71 20.61 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.4 166.35 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 168.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 mt -136.35 140.51 43.34 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.6 124.51 36.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -74.17 132.47 42.23 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.81 0.12 10.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.781 0.833 . . . . 0.0 111.148 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.45 -86.52 0.23 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.74 -26.24 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.731 2.287 . . . . 0.0 113.641 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.525 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -153.34 -170.6 3.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.265 1.426 . . . . 0.0 109.81 -168.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.525 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -144.08 149.22 36.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.389 1.876 . . . . 0.0 108.773 -168.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.71 173.2 11.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.068 0.547 . . . . 0.0 110.982 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.57 144.83 28.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.704 1.202 . . . . 0.0 108.652 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.26 50.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.844 1.258 . . . . 0.0 108.539 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -145.18 101.27 3.59 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.115 0.966 . . . . 0.0 109.852 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.5 mt -57.17 152.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 129.025 2.93 . . . . 0.0 111.175 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.21 -29.83 0.08 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.641 168.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -132.32 133.84 44.51 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 pt -137.33 161.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -145.64 151.94 38.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.322 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.5 142.6 16.04 Favored Pre-proline 0 C--O 1.241 0.652 0 C-N-CA 126.263 1.825 . . . . 0.0 109.167 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.85 -11.16 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.897 2.398 . . . . 0.0 113.785 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -62.6 -35.59 80.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.095 1.316 . . . . 0.0 112.463 -169.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 m -129.01 4.65 5.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.264 1.026 . . . . 0.0 111.557 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt 41.43 55.7 3.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.748 1.619 . . . . 0.0 111.045 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptm -152.81 160.75 43.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -102.93 169.78 8.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -141.32 146.5 36.8 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 126.863 2.065 . . . . 0.0 105.761 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -148.18 158.51 44.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -169.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.601 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt . . . . . 0 N--CA 1.469 0.478 0 CA-C-O 118.542 -0.742 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.61 119.49 8.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 mt -84.17 141.31 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 127.075 2.15 . . . . 0.0 106.785 -170.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.11 125.48 91.55 Favored Pre-proline 0 C--O 1.239 0.545 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.659 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.34 135.02 23.81 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.218 1.945 . . . . 0.0 109.049 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -137.08 157.3 47.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.766 0.827 . . . . 0.0 109.008 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.1 mmpt? -64.83 -6.87 9.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -168.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 71.92 151.75 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 114.566 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.54 30.29 2.67 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.772 169.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -83.67 -40.37 19.03 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.887 1.344 . . . . 0.0 109.379 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -160.72 -1.3 0.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 47.16 2.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.013 1.725 . . . . 0.0 110.895 -169.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -32.12 139.32 0.04 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 129.73 3.212 . . . . 0.0 113.383 168.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 pt -135.87 133.63 20.04 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.12 162.21 43.1 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.238 1.959 . . . . 0.0 109.811 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.06 -15.22 8.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 112.472 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.17 -30.23 70.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.632 1.173 . . . . 0.0 112.073 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -121.73 -9.53 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 120.219 1.372 . . . . 0.0 110.608 -173.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mm -58.4 -47.74 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 127.391 2.276 . . . . 0.0 106.292 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -79.29 8.92 5.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.398 1.479 . . . . 0.0 112.297 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.8 178.48 27.27 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.763 1.165 . . . . 0.0 111.684 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -64.29 131.3 46.9 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m -137.09 152.49 50.08 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.351 1.032 . . . . 0.0 111.426 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -138.88 114.56 9.89 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.84 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -81.27 126.65 31.81 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.865 2.066 . . . . 0.0 106.761 169.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -138.43 154.97 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.764 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -100.34 123.19 44.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 167.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -70.7 113.0 7.35 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -75.76 148.29 38.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.82 8.16 51.81 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.995 -0.891 . . . . 0.0 112.735 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -133.14 170.26 15.67 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.58 1.19 . . . . 0.0 111.071 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -73.6 159.74 32.65 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.96 0.409 . . . . 0.0 110.364 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -73.55 -14.44 61.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.981 0.512 . . . . 0.0 111.656 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.0 m -55.29 -31.71 61.83 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.739 1.216 . . . . 0.0 112.241 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -91.34 7.0 43.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.06 0.944 . . . . 0.0 112.527 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.43 120.41 12.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.263 7.5 tp10 -157.01 166.58 32.95 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.476 1.11 . . . . 0.0 108.288 -167.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.67 151.31 21.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.157 0.979 . . . . 0.0 109.497 168.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.12 153.73 39.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.36 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.88 168.47 31.55 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -16.79 13.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.764 1.226 . . . . 0.0 113.608 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.79 -24.39 50.13 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.223 1.009 . . . . 0.0 113.072 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -119.14 -45.47 2.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.405 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 tt -86.61 163.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -164.68 156.06 15.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 129.139 2.975 . . . . 0.0 110.108 170.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.92 169.43 13.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.846 1.203 . . . . 0.0 111.493 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -80.09 108.41 13.66 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.837 -1.164 . . . . 0.0 109.183 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -154.48 162.99 40.86 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.035 1.334 . . . . 0.0 109.898 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.71 -35.18 55.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.017 1.727 . . . . 0.0 114.795 -169.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.09 -42.62 99.64 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.478 1.609 . . . . 0.0 110.382 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.18 -24.71 47.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.014 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.87 -32.92 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.383 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.74 99.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.784 1.175 . . . . 0.0 109.196 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.1 ttp -56.24 -54.33 46.59 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -56.58 -48.52 77.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.475 0.71 . . . . 0.0 111.211 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -69.12 -45.58 69.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.655 0.661 . . . . 0.0 109.572 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -25.89 54.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.26 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.04 -45.86 7.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.697 1.135 . . . . 0.0 112.685 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.74 -24.76 9.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 111.305 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 . . . . . 0 CA--C 1.529 0.162 0 C-N-CA 126.013 1.725 . . . . 0.0 113.334 171.49 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -57.45 89.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.944 2.097 . . . . 0.0 110.117 169.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.95 134.86 37.79 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -6.74 1.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -169.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.73 32.13 0.47 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.51 -173.89 45.4 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.79 157.51 17.9 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.32 154.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 169.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -124.25 136.96 54.53 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.0 126.46 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.305 1.003 . . . . 0.0 109.048 -169.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -105.6 123.9 48.67 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.199 1.4 . . . . 0.0 108.244 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.17 -24.88 14.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.195 0.598 . . . . 0.0 111.911 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.27 -70.58 0.31 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.94 -36.97 16.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.143 1.895 . . . . 0.0 112.552 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -153.47 177.78 10.54 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 125.479 1.512 . . . . 0.0 109.268 -168.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 152.12 43.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.384 2.274 . . . . 0.0 107.64 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -137.1 160.9 37.6 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 109.978 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.16 141.82 39.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.91 163.35 32.53 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.861 1.664 . . . . 0.0 108.177 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -153.24 102.28 2.61 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.179 -0.951 . . . . 0.0 110.595 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.1 mt -59.27 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.998 2.519 . . . . 0.0 112.061 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.38 -17.62 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.764 167.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.75 138.36 49.92 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 170.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt -138.77 163.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -168.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -149.12 151.82 35.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.018 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -147.06 140.93 15.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.759 2.424 . . . . 0.0 108.468 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.1 -9.31 25.98 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.704 . . . . 0.0 113.502 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.3 m -67.92 -32.9 73.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.098 1.317 . . . . 0.0 111.646 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 p -117.96 -15.73 9.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.637 1.575 . . . . 0.0 110.646 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt 49.03 48.97 20.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 118.771 0.714 . . . . 0.0 109.39 -169.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.9 mtp -146.48 151.16 36.94 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.781 2.032 . . . . 0.0 105.636 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -101.89 173.68 6.29 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.818 0.447 . . . . 0.0 112.07 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 p -142.84 156.8 45.0 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 126.542 1.937 . . . . 0.0 106.434 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.7 t -148.72 152.02 35.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pp . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -176.331 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -148.63 107.18 3.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 mt -75.28 132.1 33.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.426 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 11.0 mmpt? -66.89 137.57 94.83 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.76 135.79 26.57 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 N-CA-C 106.896 -2.001 . . . . 0.0 106.896 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -137.04 167.04 22.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -62.06 153.03 30.98 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 169.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.4 tt -105.86 147.13 29.06 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.067 1.747 . . . . 0.0 109.676 -169.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.21 16.95 2.79 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.004 0.815 . . . . 0.0 113.104 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -87.05 -33.8 19.41 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.041 0.92 . . . . 0.0 109.977 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.98 8.0 0.23 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.097 0.959 . . . . 0.0 111.772 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.97 164.09 38.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.709 2.004 . . . . 0.0 107.92 -169.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.7 m -145.56 142.44 29.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.771 2.028 . . . . 0.0 107.352 -170.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.7 pt -135.22 132.73 20.22 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.02 161.32 46.3 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.723 1.615 . . . . 0.0 109.445 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -56.16 -15.44 3.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 112.45 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.32 -27.0 64.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.401 1.48 . . . . 0.0 113.139 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 pt -121.18 -8.17 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 120.131 1.332 . . . . 0.0 111.104 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.85 -45.26 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 128.14 2.576 . . . . 0.0 109.088 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.62 9.86 5.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.931 0.892 . . . . 0.0 112.521 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.57 -172.54 25.82 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -57.55 136.45 56.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.9 t -140.66 153.96 46.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.415 0.447 . . . . 0.0 110.105 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.6 m-85 -140.2 112.45 7.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.348 1.459 . . . . 0.0 110.156 -169.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -77.84 128.82 34.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.68 156.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.983 1.313 . . . . 0.0 112.362 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -101.59 121.84 42.75 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -74.58 112.16 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -78.17 150.5 33.56 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.29 7.58 39.66 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.978 -0.901 . . . . 0.0 112.51 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -135.02 172.96 12.27 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.622 1.211 . . . . 0.0 111.38 -174.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -70.89 160.66 32.41 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 122.871 0.468 . . . . 0.0 111.505 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -65.51 -22.29 66.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.137 0.975 . . . . 0.0 111.761 170.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 m -54.97 -32.24 61.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.515 1.126 . . . . 0.0 112.487 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -83.26 -3.31 57.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.497 -1.239 . . . . 0.0 112.957 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -64.6 111.11 2.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -156.67 166.74 32.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.663 1.585 . . . . 0.0 108.673 -167.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -96.32 149.94 21.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.927 0.87 . . . . 0.0 110.693 168.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.35 153.24 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.32 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -89.18 160.54 29.61 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.49 7.23 1.11 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 93' ' ' GLY . 32.5 t70 -83.46 -23.6 32.18 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.312 1.845 . . . . 0.0 110.899 168.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.31 -34.65 3.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.686 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.7 tt -101.68 149.58 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.786 1.175 . . . . 0.0 110.794 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -144.75 149.44 35.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.075 1.35 . . . . 0.0 110.177 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.83 141.96 53.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.13 1.772 . . . . 0.0 110.627 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -59.9 115.47 3.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.541 1.064 . . . . 0.0 111.759 -169.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -160.76 165.62 30.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.148 1.779 . . . . 0.0 110.505 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -57.58 -33.15 67.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.638 1.575 . . . . 0.0 113.392 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -64.59 -43.43 93.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.013 0.911 . . . . 0.0 109.397 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -69.04 -33.01 72.91 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.8 mm -67.83 -34.72 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.448 0.567 . . . . 0.0 110.748 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.881 0.764 . . . . 0.0 110.196 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.63 -49.92 71.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 170.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -59.18 -50.37 74.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.003 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -76.19 -36.15 58.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.425 1.012 . . . . 0.0 109.85 -170.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -40.85 82.29 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 119.103 -0.475 . . . . 0.0 109.977 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.39 -44.08 22.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.568 1.076 . . . . 0.0 112.862 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -49.24 -34.0 13.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.059 1.344 . . . . 0.0 110.83 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t30 . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 124.316 1.046 . . . . 0.0 113.148 174.552 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--O 1.238 0.455 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -56.2 132.71 51.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.94 129.62 45.69 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -3.27 0.38 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.0 28.79 0.53 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.81 -173.73 48.71 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 106.828 -2.509 . . . . 0.0 106.828 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 mtt85 -91.33 159.99 15.73 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.94 161.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -130.03 140.84 50.8 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.7 128.4 32.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -102.51 124.97 49.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 108.573 -169.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -101.6 -23.19 14.31 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.438 0.295 . . . . 0.0 111.194 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.88 -73.76 0.25 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.63 -31.14 27.01 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.55 2.167 . . . . 0.0 112.273 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.38 177.94 10.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.131 1.772 . . . . 0.0 108.287 -169.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.403 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -135.15 162.09 33.49 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.643 1.577 . . . . 0.0 107.208 -173.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -136.59 159.82 40.66 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.248 1.019 . . . . 0.0 108.854 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -76.61 147.27 37.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.537 . . . . 0.0 109.732 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.94 31.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.846 1.258 . . . . 0.0 108.882 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -153.11 111.38 3.65 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.197 -0.939 . . . . 0.0 110.706 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.0 mt -59.03 152.17 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 128.895 2.878 . . . . 0.0 111.688 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pp -157.99 -30.04 0.08 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.913 0.885 . . . . 0.0 112.514 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 31.9 ttpt -131.25 140.99 49.93 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.99 164.88 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -168.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -149.91 152.21 34.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.973 -168.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.29 141.11 14.53 Favored Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 125.137 1.375 . . . . 0.0 109.965 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.45 -0.23 7.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.088 3.192 . . . . 0.0 113.501 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -66.13 -34.46 78.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.032 1.287 . . . . 0.0 110.979 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -130.81 -7.86 4.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.37 1.068 . . . . 0.0 112.164 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 45.16 53.14 8.13 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.221 1.009 . . . . 0.0 110.72 -169.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -148.81 151.87 35.53 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.827 2.051 . . . . 0.0 105.815 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -103.21 168.06 9.42 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.86 0.464 . . . . 0.0 112.043 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 p -136.42 153.54 51.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 107.324 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.5 m -151.62 158.07 42.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.738 0.699 . . . . 0.0 110.1 -168.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 126.151 1.781 . . . . 0.0 108.621 173.788 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.19 108.5 0.61 Allowed 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.296 -0.878 . . . . 0.0 108.675 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.53 141.74 13.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.76 142.95 88.91 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 123.157 0.583 . . . . 0.0 109.613 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.31 142.18 33.2 Favored 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.54 1.493 . . . . 0.0 108.691 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -132.52 166.32 22.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.014 0.926 . . . . 0.0 109.023 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.645 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -64.7 -13.52 54.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -168.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 68.12 151.66 0.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.647 1.979 . . . . 0.0 112.681 -169.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.42 55.38 0.15 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.113 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 51.44 2.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.736 1.214 . . . . 0.0 108.072 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.59 -7.4 0.72 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.126 2.571 . . . . 0.0 113.405 -172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.95 33.02 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.641 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -33.74 140.51 0.05 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 130.502 3.521 . . . . 0.0 112.203 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 pt -135.41 135.17 21.91 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.564 1.146 . . . . 0.0 108.093 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.94 162.76 41.57 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.03 1.82 . . . . 0.0 109.723 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.14 -17.26 10.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.964 0.906 . . . . 0.0 112.571 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.45 -28.66 69.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.607 1.163 . . . . 0.0 112.536 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . 0.253 7.2 pt -122.21 -9.01 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 120.081 1.31 . . . . 0.0 110.844 -174.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mm -61.16 -50.94 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.484 2.313 . . . . 0.0 105.817 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -78.79 9.16 4.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.496 1.518 . . . . 0.0 111.648 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.72 173.79 24.44 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.45 1.023 . . . . 0.0 110.696 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -62.72 132.49 52.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -135.6 152.71 51.52 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 124.11 0.881 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 32.3 m-85 -142.94 116.29 9.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 109.674 -169.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -81.28 125.36 30.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.252 2.221 . . . . 0.0 105.811 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.53 157.44 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.409 -168.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -100.94 118.51 37.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.14 119.73 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.83 149.53 25.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.9 8.57 57.99 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.553 -169.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -133.89 172.66 12.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.493 1.146 . . . . 0.0 111.633 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -71.1 158.6 36.19 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.196 0.598 . . . . 0.0 110.423 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.6 m -70.36 -12.28 61.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.628 0.371 . . . . 0.0 111.843 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.7 m -56.42 -33.31 65.7 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.748 -1.22 . . . . 0.0 112.439 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -80.24 3.38 21.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.973 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.95 108.72 2.68 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.21 167.21 29.31 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.685 1.994 . . . . 0.0 107.441 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.406 ' CH2' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -100.21 149.56 23.44 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.911 0.862 . . . . 0.0 110.378 169.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.92 150.78 31.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.283 173.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -85.74 158.51 32.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.63 8.12 0.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 93' ' ' GLY . 36.5 t70 -88.59 -18.72 27.46 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.047 1.739 . . . . 0.0 111.311 169.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -119.79 -35.68 3.46 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 117.255 -1.355 . . . . 0.0 111.984 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.3 tt -98.9 153.66 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 120.474 1.488 . . . . 0.0 110.883 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -149.83 152.54 35.32 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.842 1.657 . . . . 0.0 110.827 170.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 154.74 41.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.925 1.69 . . . . 0.0 111.863 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.403 ' CE2' HD12 ' A' ' 105' ' ' ILE . 41.3 t80 -60.59 118.17 6.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.577 0.626 . . . . 0.0 109.882 176.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -164.4 160.59 20.87 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.312 1.445 . . . . 0.0 109.084 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -53.15 -35.7 60.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.523 1.529 . . . . 0.0 113.755 -169.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.82 -43.81 97.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.684 0.755 . . . . 0.0 110.726 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -74.15 -26.55 60.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.813 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.403 HD12 ' CE2' ' A' ' 100' ' ' TYR . 4.3 mm -68.52 -39.08 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.931 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.33 98.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.965 0.802 . . . . 0.0 109.47 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -50.88 72.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -60.5 -46.77 88.92 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.281 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -73.77 -40.19 63.64 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 119.067 0.849 . . . . 0.0 111.04 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -48.59 75.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.02 -44.33 61.04 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.954 -1.091 . . . . 0.0 112.231 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.75 -13.96 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.238 1.815 . . . . 0.0 112.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t30 . . . . . 0 N--CA 1.454 -0.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.059 179.282 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 CA--C 1.545 0.763 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -63.22 68.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 130.454 3.502 . . . . 0.0 110.063 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 138.73 54.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 112.121 -2.308 . . . . 0.0 106.145 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.81 -10.9 1.89 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -168.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.27 32.88 0.5 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 170.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.24 -163.04 21.52 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 169.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 mtt85 -102.33 153.83 19.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 168.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.59 169.27 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -135.26 142.41 45.93 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 103.243 -2.873 . . . . 0.0 103.243 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.3 147.1 51.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -115.12 119.53 36.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -102.14 -9.5 20.45 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.243 0.617 . . . . 0.0 112.56 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.03 -77.99 0.3 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -66.46 -38.66 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.439 2.092 . . . . 0.0 113.317 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.2 tp -148.2 177.76 9.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 125.129 1.371 . . . . 0.0 109.294 -168.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.59 149.23 43.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.598 2.359 . . . . 0.0 107.129 -168.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -136.44 154.32 50.81 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.539 0.736 . . . . 0.0 109.765 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.64 141.9 57.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.277 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.62 162.59 29.04 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.137 1.775 . . . . 0.0 108.083 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -148.66 95.72 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.465 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.52 151.35 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.392 2.277 . . . . 0.0 110.743 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -156.73 -32.27 0.09 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.779 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.424 ' HD2' ' CD2' ' A' ' 38' ' ' TYR . 36.8 ttpt -131.53 138.04 48.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.35 165.33 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -144.3 153.37 41.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.331 -169.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.53 143.57 17.49 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.022 1.729 . . . . 0.0 109.243 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.69 -12.48 36.08 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.585 2.857 . . . . 0.0 113.586 176.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.9 m -64.77 -32.74 74.56 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.066 1.303 . . . . 0.0 111.883 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.0 m -121.35 -11.28 8.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.452 1.101 . . . . 0.0 111.077 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 48.29 49.67 17.49 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.156 0.982 . . . . 0.0 109.331 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -145.4 159.09 43.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.144 2.177 . . . . 0.0 105.5 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.424 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 42.1 p90 -104.58 174.97 5.65 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.622 . . . . 0.0 112.573 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -143.47 152.54 41.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.549 2.339 . . . . 0.0 106.132 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 t -147.56 161.17 41.67 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 CA--C 1.547 0.855 0 C-N-CA 123.96 0.904 . . . . 0.0 110.017 -176.15 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.31 109.1 1.46 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mt -73.66 135.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.19 137.49 96.94 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.02 137.9 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 107.165 -1.898 . . . . 0.0 107.165 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -141.19 164.49 30.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -63.62 153.12 36.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.3 tt -107.71 154.3 21.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.524 1.93 . . . . 0.0 110.583 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.01 21.96 5.12 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.137 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -77.78 -33.42 52.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.723 0.762 . . . . 0.0 109.166 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.9 6.35 0.61 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.696 1.198 . . . . 0.0 111.79 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -124.75 172.53 9.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.012 1.325 . . . . 0.0 111.648 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.9 m -149.55 144.03 25.98 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.988 2.115 . . . . 0.0 106.343 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.3 pt -135.54 120.97 13.77 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 169.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.99 154.45 27.37 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.282 1.988 . . . . 0.0 111.181 170.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.43 -24.46 12.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.341 1.056 . . . . 0.0 111.619 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -57.13 -32.64 66.56 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.156 1.783 . . . . 0.0 114.215 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 pt -117.77 -17.13 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.702 1.137 . . . . 0.0 110.508 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.67 -44.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 128.418 2.687 . . . . 0.0 109.16 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.94 11.53 6.02 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.342 -169.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.88 -177.79 29.43 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 119.577 1.08 . . . . 0.0 111.045 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.87 133.36 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 m -135.99 150.72 49.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 123.812 0.695 . . . . 0.0 110.139 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -135.19 113.3 11.21 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.32 1.048 . . . . 0.0 110.111 -169.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -77.62 121.81 24.46 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.296 2.238 . . . . 0.0 106.963 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.04 159.04 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.672 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -106.95 129.04 54.82 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -75.25 110.02 9.25 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.54 149.21 42.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.915 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.84 4.53 34.26 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.756 -1.024 . . . . 0.0 112.364 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -130.2 172.15 12.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.828 1.314 . . . . 0.0 111.832 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -68.22 162.78 24.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.4 m -65.65 -20.59 66.36 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.018 0.927 . . . . 0.0 111.589 169.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -59.44 -31.04 68.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.789 0.836 . . . . 0.0 112.354 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -91.85 17.56 8.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.801 0.84 . . . . 0.0 112.705 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.1 106.87 1.14 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -153.87 158.07 40.23 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 108.036 -168.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.43 150.41 21.07 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.42 1.105 . . . . 0.0 109.326 167.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.89 154.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.328 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.3 168.18 30.79 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -16.42 6.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.51 1.124 . . . . 0.0 113.297 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.48 -23.79 52.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.532 1.533 . . . . 0.0 112.976 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -123.12 -37.64 2.69 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.227 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 tt -95.63 157.5 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.496 1.044 . . . . 0.0 112.822 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -152.81 165.24 36.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.692 3.197 . . . . 0.0 109.117 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.61 155.21 17.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.67 1.588 . . . . 0.0 112.861 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -67.22 109.06 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.345 1.069 . . . . 0.0 112.551 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -157.74 162.45 38.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 125.764 1.625 . . . . 0.0 108.786 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -54.95 -33.98 62.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -168.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.55 -43.24 97.66 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.081 0.855 . . . . 0.0 110.328 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.72 -25.13 60.05 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.633 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.8 mm -73.87 -32.54 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 118.508 0.594 . . . . 0.0 111.382 171.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.59 96.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.209 0.913 . . . . 0.0 109.097 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -51.69 68.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -54.42 -49.36 70.14 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 123.706 0.802 . . . . 0.0 110.462 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -74.21 -44.71 52.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.368 0.531 . . . . 0.0 110.419 -173.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -32.82 55.64 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.966 0.506 . . . . 0.0 111.068 174.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.63 -46.52 9.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.953 0.797 . . . . 0.0 112.426 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.41 -29.95 11.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 111.31 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t30 . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 125.867 1.667 . . . . 0.0 114.292 174.438 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -57.82 128.84 39.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 168.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.67 136.5 54.51 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -169.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.94 -3.62 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -168.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.05 30.41 0.3 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.66 -168.86 44.26 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 169.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -94.87 157.32 15.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.2 166.62 28.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 102.461 -3.162 . . . . 0.0 102.461 168.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.1 139.75 48.59 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.76 135.46 36.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -106.04 111.67 24.39 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -81.56 -35.16 30.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.622 0.646 . . . . 0.0 110.313 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.37 -72.04 0.19 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.11 -28.54 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.188 2.592 . . . . 0.0 113.338 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.464 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -150.92 171.73 16.8 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.308 1.443 . . . . 0.0 108.622 -173.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.464 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -134.14 144.7 48.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.949 2.099 . . . . 0.0 106.605 -169.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -133.27 160.07 38.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.747 0.819 . . . . 0.0 109.178 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.42 145.74 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.29 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.3 159.13 42.8 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.227 1.411 . . . . 0.0 107.952 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 94.55 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.896 -0.503 . . . . 0.0 110.63 -169.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.11 149.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.577 2.751 . . . . 0.0 112.159 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.54 -24.62 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.439 1.087 . . . . 0.0 113.356 167.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -125.86 139.25 53.63 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.08 165.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -149.76 154.7 38.91 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.515 -169.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.73 141.17 15.02 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 109.147 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -67.19 -10.47 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.268 2.645 . . . . 0.0 112.783 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.3 m -65.11 -33.28 75.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.404 1.456 . . . . 0.0 111.295 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -120.24 -16.32 8.51 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.291 1.836 . . . . 0.0 110.734 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm 49.07 53.25 12.92 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.538 0.735 . . . . 0.0 109.095 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 76.7 mtp -149.01 154.03 38.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.462 2.305 . . . . 0.0 105.533 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -100.58 174.41 6.09 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.158 0.583 . . . . 0.0 112.302 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -144.1 151.91 40.24 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.583 2.353 . . . . 0.0 106.34 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.7 t -147.81 161.11 41.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.9 pt . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 125.199 1.4 . . . . 0.0 110.097 -176.483 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.37 101.96 0.81 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mt -73.93 138.32 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.71 138.15 95.3 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.4 132.47 19.23 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 N-CA-C 107.18 -1.892 . . . . 0.0 107.18 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -137.16 165.28 26.48 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.623 1.169 . . . . 0.0 108.345 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.69 153.74 42.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.5 tt -119.83 142.68 48.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.118 1.767 . . . . 0.0 109.044 -169.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.86 30.24 1.06 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-N 114.774 -1.103 . . . . 0.0 114.144 169.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.89 -39.31 76.33 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.107 1.453 . . . . 0.0 109.769 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -152.86 -32.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.561 1.544 . . . . 0.0 111.043 170.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -66.73 21.1 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.357 3.063 . . . . 0.0 114.03 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -33.39 132.1 0.2 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.359 2.264 . . . . 0.0 111.263 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.288 7.0 tt -124.9 141.95 39.68 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -168.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.46 145.62 48.05 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.417 1.411 . . . . 0.0 110.747 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.44 -15.67 4.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.088 1.355 . . . . 0.0 112.901 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.48 -26.67 68.83 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 112.311 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 pt -122.33 -15.07 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.093 0.86 . . . . 0.0 111.223 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mm -50.75 -42.66 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.578 2.351 . . . . 0.0 109.507 170.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -83.21 10.76 7.67 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.708 1.203 . . . . 0.0 112.475 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.9 -175.78 26.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.85 139.52 58.35 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.9 m -133.19 149.22 52.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.891 0.745 . . . . 0.0 109.427 172.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -136.33 112.63 9.86 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.482 1.113 . . . . 0.0 108.616 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.68 126.94 31.58 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 126.399 1.88 . . . . 0.0 107.511 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -136.76 154.85 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 124.919 1.387 . . . . 0.0 112.491 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -100.77 119.57 38.82 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.19 111.62 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -82.05 151.58 27.0 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.92 2.72 58.29 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.48 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -136.75 179.31 6.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.583 1.192 . . . . 0.0 110.991 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -77.84 160.47 28.29 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.858 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 m -72.53 -13.51 61.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.548 0.739 . . . . 0.0 111.834 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -53.55 -31.75 47.86 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.951 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -89.75 7.68 35.63 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.911 -1.042 . . . . 0.0 113.239 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -64.01 115.89 5.35 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.29 165.07 37.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.193 1.397 . . . . 0.0 108.187 -167.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.65 150.06 23.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.277 1.037 . . . . 0.0 110.043 168.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.17 159.99 42.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.612 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.83 173.01 23.22 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.995 1.283 . . . . 0.0 110.021 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -16.85 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 113.382 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.73 -21.42 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.628 1.171 . . . . 0.0 113.0 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -121.54 -39.88 2.61 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.377 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.9 tt -94.83 157.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.822 1.192 . . . . 0.0 113.323 -168.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -155.04 158.05 38.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.465 3.106 . . . . 0.0 108.778 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.29 168.39 19.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.247 1.839 . . . . 0.0 112.971 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.417 ' CE2' HD11 ' A' ' 105' ' ' ILE . 25.0 t80 -67.96 117.53 9.95 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.841 -1.162 . . . . 0.0 109.84 169.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -161.03 164.15 31.12 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.684 1.593 . . . . 0.0 108.893 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -59.5 -30.43 68.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.444 1.098 . . . . 0.0 113.393 -169.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.63 -42.11 91.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.443 1.116 . . . . 0.0 109.848 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -73.39 -27.84 61.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.359 -0.838 . . . . 0.0 109.56 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.417 HD11 ' CE2' ' A' ' 100' ' ' TYR . 7.2 mm -70.05 -32.74 52.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 CA-C-N 118.751 0.705 . . . . 0.0 110.933 169.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.18 99.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.52 1.055 . . . . 0.0 109.724 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -49.0 79.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.86 -47.12 83.64 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.529 0.732 . . . . 0.0 109.966 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -73.52 -44.51 57.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.524 0.602 . . . . 0.0 109.961 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -32.47 50.81 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.5 173.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.6 mt -89.95 -44.33 9.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.282 0.947 . . . . 0.0 112.348 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.89 -28.45 9.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.249 1.42 . . . . 0.0 111.723 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 t30 . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 125.928 1.691 . . . . 0.0 114.263 174.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.877 0.846 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 1 C-N-CA 132.95 4.5 . . . . 0.0 110.948 171.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.44 142.35 58.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.333 -1.758 . . . . 0.0 106.804 -169.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.69 -10.19 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.28 30.9 0.38 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 179.33 53.19 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 171.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.35 153.66 24.46 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 168.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.2 164.68 34.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 169.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.9 mt -140.56 116.35 10.3 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 -170.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.5 138.71 47.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.363 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -120.59 118.57 30.52 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.199 1.4 . . . . 0.0 108.202 -169.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -98.84 -22.01 16.04 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.87 0.468 . . . . 0.0 111.449 -170.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.31 -76.57 0.23 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -68.19 -31.56 29.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.107 1.871 . . . . 0.0 112.457 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.498 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -153.07 176.33 12.02 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.768 1.227 . . . . 0.0 110.743 -171.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.498 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -130.07 154.6 47.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.809 2.444 . . . . 0.0 107.491 -173.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -140.41 149.59 42.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.186 1.394 . . . . 0.0 108.765 -176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.34 145.53 51.12 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.94 161.23 37.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.475 1.51 . . . . 0.0 109.02 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -148.5 104.37 3.49 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.407 -0.808 . . . . 0.0 109.777 -171.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 54.7 mt -64.79 155.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 128.447 2.699 . . . . 0.0 112.904 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.79 -20.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.822 -1.085 . . . . 0.0 113.724 166.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -131.58 138.66 48.95 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.6 161.76 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -168.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -144.68 154.55 42.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.384 -168.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -146.51 140.93 15.73 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.725 2.41 . . . . 0.0 108.881 -174.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.62 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.666 2.911 . . . . 0.0 113.549 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -66.87 -32.22 73.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.068 1.303 . . . . 0.0 111.571 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.9 m -121.56 -11.09 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.647 1.179 . . . . 0.0 111.02 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt 47.09 50.41 14.1 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.058 0.943 . . . . 0.0 109.985 -171.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.3 mtp -150.65 154.0 36.67 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.365 2.266 . . . . 0.0 105.163 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -103.45 175.12 5.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 p -141.56 155.92 45.74 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.009 2.124 . . . . 0.0 106.847 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -154.06 156.66 37.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 pt . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 123.111 0.564 . . . . 0.0 110.58 -176.807 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.887 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -21.25 97.46 0.01 OUTLIER 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 0.0 112.328 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.7 mt -72.81 136.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 111.687 -2.506 . . . . 0.0 107.793 -168.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.93 141.84 96.99 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.98 138.54 31.33 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 N-CA-C 107.352 -1.826 . . . . 0.0 107.352 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -137.37 160.52 38.84 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -68.57 127.43 32.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 122.113 0.959 . . . . 0.0 109.017 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 tt -71.23 146.83 48.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.538 1.935 . . . . 0.0 111.97 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.7 17.83 3.76 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.697 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -81.6 -32.18 32.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.44 1.12 . . . . 0.0 109.845 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.18 10.91 0.9 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.835 1.254 . . . . 0.0 110.893 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.439 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 15.7 mp0 -130.92 174.04 10.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.247 1.819 . . . . 0.0 109.688 -169.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -165.35 122.96 1.55 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 166.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.424 ' CG1' HD11 ' A' ' 71' ' ' ILE 0.317 4.2 tt -123.48 129.3 24.92 Favored Pre-proline 0 N--CA 1.433 -1.277 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -167.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.47 148.86 67.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.64 1.56 . . . . 0.0 111.25 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.32 -21.11 22.18 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.022 1.329 . . . . 0.0 112.679 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -54.86 -33.27 61.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.032 2.133 . . . . 0.0 113.524 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.424 HD11 ' CG1' ' A' ' 67' ' ' ILE . 4.6 pt -118.1 -16.13 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.422 0.689 . . . . 0.0 111.211 -169.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mm -54.14 -42.56 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 127.948 2.499 . . . . 0.0 109.592 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.92 11.41 6.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.016 . . . . 0.0 112.661 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.97 -171.94 25.43 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -59.34 137.41 58.0 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -136.32 153.25 51.21 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.866 0.729 . . . . 0.0 110.936 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -136.73 114.81 11.51 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.514 1.126 . . . . 0.0 109.416 -170.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.12 126.03 31.55 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.666 1.987 . . . . 0.0 107.168 169.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.45 165.95 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.379 -168.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -119.63 126.94 52.38 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 165.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -78.93 125.87 29.94 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -67.38 149.62 50.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.089 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.97 10.19 50.16 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.497 -1.168 . . . . 0.0 113.576 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -128.04 166.28 18.71 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.11 1.455 . . . . 0.0 111.211 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -61.27 168.41 2.66 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.0 112.198 -171.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 m -63.34 -21.89 66.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.556 0.742 . . . . 0.0 111.711 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -60.8 -25.9 66.9 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.335 -0.853 . . . . 0.0 111.925 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.8 m95 -85.54 16.41 3.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 0.0 112.477 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.73 87.71 3.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 167.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -146.3 166.14 27.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.084 1.353 . . . . 0.0 108.341 -167.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -104.29 152.84 21.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.45 1.119 . . . . 0.0 110.511 169.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.36 155.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.829 173.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.11 169.08 31.74 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -18.06 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.714 1.205 . . . . 0.0 113.037 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.84 -19.69 18.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.272 1.429 . . . . 0.0 113.554 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -127.61 -35.48 2.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 117.39 -1.291 . . . . 0.0 111.939 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.9 tt -101.87 152.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.642 1.565 . . . . 0.0 113.288 -169.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.87 160.95 41.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.28 2.632 . . . . 0.0 108.298 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.71 168.66 18.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.381 1.446 . . . . 0.0 112.273 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -77.86 109.26 11.73 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.105 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -156.42 163.33 39.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.998 1.319 . . . . 0.0 109.278 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -53.14 -35.85 60.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.665 1.586 . . . . 0.0 114.31 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.2 -43.86 97.88 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.695 1.236 . . . . 0.0 110.006 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -78.47 -23.68 46.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 mm -69.57 -35.21 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.685 0.675 . . . . 0.0 109.859 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.3 98.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.521 1.055 . . . . 0.0 109.435 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.25 89.83 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 171.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.988 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -72.54 -42.56 64.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.105 0.866 . . . . 0.0 109.504 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -42.89 53.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.269 0.628 . . . . 0.0 110.419 170.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.09 -47.73 17.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 112.398 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.23 -27.63 6.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 111.605 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.9 t30 . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 125.275 1.43 . . . . 0.0 113.386 172.783 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--O 1.233 0.235 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.25 73.91 0.01 OUTLIER 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.935 2.894 . . . . 0.0 110.46 171.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 131.08 44.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -4.75 1.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.42 32.61 0.7 Allowed Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 170.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.48 -157.21 12.15 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 168.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.06 156.02 21.09 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.77 160.73 39.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 169.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.7 mt -139.45 131.37 27.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 -173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.21 136.81 53.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -170.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -115.9 117.24 29.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.661 0.785 . . . . 0.0 109.19 -168.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -95.53 -21.39 18.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.524 0.729 . . . . 0.0 111.854 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.15 -73.52 0.32 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.63 -30.58 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.358 2.038 . . . . 0.0 112.014 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 178.54 10.11 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 125.254 1.422 . . . . 0.0 109.51 -170.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.528 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -133.94 154.16 51.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.522 2.329 . . . . 0.0 106.776 -173.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.71 152.05 48.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.257 1.023 . . . . 0.0 108.645 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -74.68 149.03 40.09 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.493 0.717 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.37 160.48 40.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.081 1.352 . . . . 0.0 109.113 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -149.03 99.76 2.99 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -169.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.3 mt -58.69 152.66 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.669 1.987 . . . . 0.0 110.647 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pp -156.72 -35.45 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.736 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 37.4 ttpt -126.0 140.1 52.88 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.09 166.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -150.47 150.89 31.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.277 -168.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -147.55 142.12 16.43 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.531 2.332 . . . . 0.0 108.82 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.69 -8.75 24.41 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.437 2.758 . . . . 0.0 113.51 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.0 m -65.66 -34.64 78.69 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.452 1.478 . . . . 0.0 111.248 -171.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -117.72 -18.67 9.57 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.521 1.528 . . . . 0.0 110.718 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm 51.33 52.14 15.43 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -169.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.6 mtp -144.72 157.02 44.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.994 2.518 . . . . 0.0 105.093 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.428 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -107.47 168.95 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.629 0.372 . . . . 0.0 111.474 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -141.57 155.0 45.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.41 1.884 . . . . 0.0 106.647 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 t -149.95 164.23 35.99 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.9 pt . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 124.792 1.237 . . . . 0.0 109.657 -177.691 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 107.37 1.79 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.1 mt -73.66 129.24 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.04 139.61 95.51 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.05 142.11 24.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.861 1.707 . . . . 0.0 108.983 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -130.38 164.19 25.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.582 0.753 . . . . 0.0 109.545 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.63 -16.57 49.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -168.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' CD1' ' CZ2' ' A' ' 91' ' ' TRP . 0.5 OUTLIER 70.91 136.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.597 2.359 . . . . 0.0 112.28 -171.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.11 7.35 2.29 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.949 169.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.16 -34.47 56.41 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.894 1.847 . . . . 0.0 111.211 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.74 -40.09 0.09 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.407 1.483 . . . . 0.0 109.593 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 3.9 pm0 -66.96 137.09 56.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 168.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.6 m -140.46 157.38 45.6 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.318 2.6 tt -149.82 136.55 10.9 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -169.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.43 151.96 54.19 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.727 1.618 . . . . 0.0 111.346 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -56.4 -17.11 6.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.044 1.338 . . . . 0.0 112.832 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -67.18 -24.99 65.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.843 1.257 . . . . 0.0 111.968 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.2 pt -124.38 -12.64 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.35 0.977 . . . . 0.0 111.177 -171.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.8 mm -52.65 -44.36 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 128.097 2.559 . . . . 0.0 108.576 169.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.17 9.47 6.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.881 1.272 . . . . 0.0 112.82 -170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.67 -173.07 26.59 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -171.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -60.79 134.91 57.55 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.285 -0.538 . . . . 0.0 110.608 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 m -137.47 154.13 49.95 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.781 0.676 . . . . 0.0 111.278 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -139.12 114.68 9.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.435 1.094 . . . . 0.0 109.836 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -81.23 127.09 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 106.271 169.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -138.48 154.07 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.101 -168.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -99.72 119.61 38.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -73.0 117.68 15.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -86.14 150.65 24.26 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 6.37 63.0 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 119.082 -0.843 . . . . 0.0 111.2 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -132.84 174.03 10.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.252 1.421 . . . . 0.0 109.874 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.68 174.11 3.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.45 1.1 . . . . 0.0 111.708 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.1 m -85.09 -6.35 59.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.237 0.615 . . . . 0.0 112.033 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -57.36 -31.27 65.59 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.396 -0.815 . . . . 0.0 110.979 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -89.59 20.1 4.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.616 1.166 . . . . 0.0 112.726 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.49 99.77 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -151.3 167.51 27.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.972 2.109 . . . . 0.0 108.111 -167.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.419 ' CZ2' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -104.23 155.26 18.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.369 0.986 . . . . 0.0 112.168 169.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.85 157.59 43.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.932 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.29 160.63 25.95 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.732 1.158 . . . . 0.0 110.346 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.02 9.79 0.65 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.92 -12.71 32.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.709 1.603 . . . . 0.0 111.223 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -125.92 -37.09 2.31 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.561 1.145 . . . . 0.0 111.3 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.8 tt -97.35 154.46 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.412 1.005 . . . . 0.0 110.671 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -145.65 158.26 43.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.192 2.197 . . . . 0.0 109.437 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.88 161.41 30.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.247 1.385 . . . . 0.0 111.511 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -69.47 115.77 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -159.9 162.05 34.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.466 1.506 . . . . 0.0 108.43 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.0 -35.71 47.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.833 1.653 . . . . 0.0 114.364 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -63.53 -44.44 94.24 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.554 1.168 . . . . 0.0 109.984 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.31 -23.91 54.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.278 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.7 mm -68.55 -36.17 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 118.781 0.719 . . . . 0.0 109.793 169.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.1 96.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.451 1.023 . . . . 0.0 110.402 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -48.2 79.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.08 -49.53 74.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.329 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -75.03 -33.19 61.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.033 1.288 . . . . 0.0 109.854 -171.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -54.62 -53.57 52.99 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 169.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.802 0.728 . . . . 0.0 111.628 -172.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.7 -15.54 0.74 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.434 1.494 . . . . 0.0 112.557 169.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 124.82 1.248 . . . . 0.0 112.349 177.635 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -56.92 126.35 26.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 168.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.02 135.68 53.52 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -2.91 0.35 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 116.266 1.951 . . . . 0.0 116.266 -168.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.08 0.28 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 169.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.71 -175.16 50.65 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.212 -2.755 . . . . 0.0 106.212 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.43 ' HG2' HE22 ' A' ' 82' ' ' GLN . 54.1 mtt180 -87.99 156.65 19.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.22 165.9 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 168.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.03 144.37 50.01 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.92 125.7 23.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -99.44 115.73 29.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -87.7 -25.4 23.49 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.958 0.503 . . . . 0.0 111.15 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.74 -69.78 0.32 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.71 -41.41 11.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.39 2.06 . . . . 0.0 112.817 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.9 tp -148.27 179.8 7.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.005 1.722 . . . . 0.0 107.881 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -141.5 151.29 43.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.071 1.748 . . . . 0.0 109.178 -167.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -134.06 157.26 46.57 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.611 1.164 . . . . 0.0 108.594 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.28 150.21 30.07 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.75 155.2 46.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.895 0.478 . . . . 0.0 110.805 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -144.11 94.37 2.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.866 0.866 . . . . 0.0 111.397 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.7 mt -61.94 152.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 127.565 2.346 . . . . 0.0 112.492 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.35 -24.8 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.776 166.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -127.58 139.3 52.85 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.82 163.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -168.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.98 152.54 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.634 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.05 139.37 14.53 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.62 1.968 . . . . 0.0 109.122 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 -0.77 8.56 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.24 3.293 . . . . 0.0 113.348 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -67.55 -33.19 74.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.225 1.375 . . . . 0.0 110.956 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 p -129.48 -10.42 4.57 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.13 1.372 . . . . 0.0 111.618 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 50.1 53.14 13.35 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.098 0.951 . . . . 0.0 109.632 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 63.4 mtp -145.61 156.21 43.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.803 2.041 . . . . 0.0 106.51 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -108.88 171.43 7.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 p -139.49 156.71 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.63 1.972 . . . . 0.0 107.259 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -150.76 163.48 38.48 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 pt . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 125.746 1.618 . . . . 0.0 108.841 -179.114 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 119.334 -0.365 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.56 116.11 5.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 172.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mt -81.83 135.52 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 113.478 -1.692 . . . . 0.0 106.843 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.2 136.45 93.84 Favored Pre-proline 0 C--O 1.237 0.433 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.86 145.94 36.99 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.962 1.775 . . . . 0.0 109.568 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -139.67 156.34 46.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.102 0.961 . . . . 0.0 109.778 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 3.6 mmpt? -62.43 -10.53 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -173.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.252 9.3 tt 71.76 151.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 114.3 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.64 4.22 10.79 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 114.779 -1.1 . . . . 0.0 114.283 169.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.61 -22.04 60.13 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.832 1.316 . . . . 0.0 111.359 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.57 -35.11 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.797 1.239 . . . . 0.0 111.059 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.444 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 20.6 mp0 -66.69 165.44 14.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 174.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 m -147.09 141.1 25.96 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.668 1.987 . . . . 0.0 106.115 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.0 pt -136.75 125.44 15.16 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.14 156.88 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.118 1.879 . . . . 0.0 110.676 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -55.59 -15.35 2.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.242 1.017 . . . . 0.0 112.493 171.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -66.69 -31.33 71.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.385 1.474 . . . . 0.0 112.343 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 pt -119.31 -11.76 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.209 1.368 . . . . 0.0 110.757 -173.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -53.38 -45.88 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.909 2.483 . . . . 0.0 108.548 169.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.45 9.49 7.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 111.732 -170.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.21 -178.41 26.87 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 119.881 1.219 . . . . 0.0 110.814 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -60.42 131.81 51.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.1 m -132.09 150.4 52.16 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.926 0.766 . . . . 0.0 110.601 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.14 112.64 10.67 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 109.276 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -79.55 125.0 29.03 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 126.243 1.817 . . . . 0.0 107.348 169.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.55 156.01 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.935 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -102.01 122.63 44.44 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 166.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -71.74 111.18 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.43 HE22 ' HG2' ' A' ' 13' ' ' ARG . 47.9 mt-30 -76.62 148.29 37.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.41 64.05 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.163 -170.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -131.98 169.14 16.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.828 1.314 . . . . 0.0 110.513 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -65.84 171.33 4.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.543 1.537 . . . . 0.0 112.508 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 m -69.94 -17.15 63.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.532 1.133 . . . . 0.0 111.739 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -62.35 -28.82 70.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.686 0.794 . . . . 0.0 111.865 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -97.44 21.15 10.54 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -68.06 104.83 1.86 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -148.74 168.08 23.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.28 1.832 . . . . 0.0 107.866 -167.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.444 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -107.16 152.95 23.38 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 122.3 1.048 . . . . 0.0 110.402 168.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.46 161.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.773 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.53 170.67 22.38 Favored Glycine 0 C--O 1.242 0.602 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.384 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -15.27 11.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.225 1.41 . . . . 0.0 113.648 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.33 -23.98 52.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.125 1.37 . . . . 0.0 112.516 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.18 -38.76 2.28 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 117.52 -1.229 . . . . 0.0 112.027 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.2 tt -89.41 156.49 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.41 1.004 . . . . 0.0 113.441 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -153.82 157.52 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.615 3.166 . . . . 0.0 108.594 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.7 168.88 17.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.562 1.528 . . . . 0.0 111.827 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.419 ' CE2' HD13 ' A' ' 105' ' ' ILE . 21.8 t80 -62.33 127.62 32.18 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.725 -1.234 . . . . 0.0 109.971 169.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -156.36 153.4 28.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.522 1.929 . . . . 0.0 107.866 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.82 -30.23 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.384 0.673 . . . . 0.0 111.184 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.51 -42.12 92.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.905 0.859 . . . . 0.0 110.34 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.63 -23.94 53.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.083 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.419 HD13 ' CE2' ' A' ' 100' ' ' TYR . 3.2 mm -72.51 -35.57 51.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-N 118.552 0.615 . . . . 0.0 109.654 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.436 1.016 . . . . 0.0 109.899 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -51.39 69.57 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -59.57 -43.32 93.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.733 -173.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -74.77 -39.92 61.49 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.029 0.932 . . . . 0.0 110.894 -174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -52.51 -46.33 66.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.818 0.735 . . . . 0.0 110.368 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.6 -42.01 22.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 119.506 -0.283 . . . . 0.0 111.447 -171.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.28 -32.12 47.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.246 1.418 . . . . 0.0 110.921 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 CA--C 1.528 0.122 0 C-N-CA 124.126 0.97 . . . . 0.0 112.293 174.825 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.444 0.64 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -62.63 66.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 130.906 3.682 . . . . 0.0 110.154 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 139.26 57.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 127.098 2.159 . . . . 0.0 106.587 -169.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -6.26 1.66 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -169.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.11 28.63 0.52 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 171.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 -176.6 49.35 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 106.223 -2.751 . . . . 0.0 106.223 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -87.33 151.07 23.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 168.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -132.8 165.8 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 169.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -139.84 128.36 22.92 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.36 124.36 42.2 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.722 1.264 . . . . 0.0 109.641 -170.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -98.6 125.23 43.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.26 1.824 . . . . 0.0 107.383 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -105.06 -17.88 14.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.762 0.825 . . . . 0.0 111.261 -175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.41 -75.17 0.29 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.4 -25.11 21.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.331 2.021 . . . . 0.0 113.104 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -152.85 175.93 12.37 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 125.036 1.334 . . . . 0.0 109.943 -171.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.528 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -143.76 146.44 33.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.35 2.26 . . . . 0.0 106.796 -169.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.82 151.6 51.98 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -171.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.2 139.05 57.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.23 157.79 45.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.758 2.023 . . . . 0.0 107.598 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.76 95.26 2.39 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.231 -0.918 . . . . 0.0 110.404 -169.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.62 148.01 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 128.037 2.535 . . . . 0.0 112.325 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.13 -31.07 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.914 166.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 17.5 mtmt -111.08 149.61 30.55 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 168.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 pt -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -149.28 153.43 37.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.499 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.45 143.77 17.79 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 109.513 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.99 -11.72 32.94 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.291 2.66 . . . . 0.0 113.526 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.6 m -63.99 -33.02 74.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.834 1.197 . . . . 0.0 112.046 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -122.0 -10.62 8.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.464 1.506 . . . . 0.0 111.243 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt 47.29 50.46 14.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 109.533 -169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.8 mtp -146.32 152.59 39.38 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.744 2.018 . . . . 0.0 105.896 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -101.29 173.66 6.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.114 0.566 . . . . 0.0 112.375 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -138.6 161.23 37.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.717 2.007 . . . . 0.0 107.158 170.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.4 t -154.97 162.17 41.17 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 CA--C 1.549 0.933 0 C-N-CA 125.647 1.579 . . . . 0.0 109.765 179.887 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 119.771 -0.157 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.75 103.18 0.14 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.16 135.82 27.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -175.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.12 136.09 93.94 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.41 136.26 30.85 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.041 1.827 . . . . 0.0 107.706 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -140.36 162.41 35.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -170.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 6.2 mmpt? -63.86 152.41 39.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.55 150.67 27.83 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.442 1.897 . . . . 0.0 110.527 -169.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.57 19.95 5.58 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.3 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.56 -31.63 36.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.591 1.195 . . . . 0.0 109.857 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -150.35 17.75 0.83 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.013 1.325 . . . . 0.0 110.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -131.23 163.57 27.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.982 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -149.2 140.56 23.23 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.723 1.209 . . . . 0.0 108.535 169.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 pt -135.91 122.55 14.26 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.99 154.51 17.35 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.245 1.963 . . . . 0.0 110.959 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -53.39 -22.11 7.01 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.81 0.844 . . . . 0.0 111.414 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.9 -27.99 69.53 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.933 1.693 . . . . 0.0 114.003 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.4 pt -119.54 -12.6 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.508 1.503 . . . . 0.0 110.667 -176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.17 -45.71 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 128.141 2.576 . . . . 0.0 108.963 169.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -81.35 10.31 5.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 -169.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.15 23.66 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -61.2 137.63 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -136.48 151.36 49.37 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.268 0.98 . . . . 0.0 110.378 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.17 113.88 9.19 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.828 1.251 . . . . 0.0 109.408 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.465 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 43.8 t80 -80.11 128.7 33.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.382 1.473 . . . . 0.0 107.091 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.56 152.25 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.563 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -97.8 125.24 42.54 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -75.27 115.5 14.98 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -79.73 151.9 30.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 110.023 -172.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 6.51 34.5 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.837 -0.98 . . . . 0.0 111.859 -170.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -133.7 173.31 11.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.712 1.256 . . . . 0.0 112.069 -173.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.69 163.09 24.68 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.522 1.129 . . . . 0.0 112.466 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -67.7 -19.38 65.15 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.154 0.982 . . . . 0.0 111.386 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 m -57.16 -31.04 64.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.156 -0.965 . . . . 0.0 111.915 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -87.92 9.29 22.63 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 117.879 -1.058 . . . . 0.0 112.912 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.78 99.64 0.34 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -152.15 166.1 32.74 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.481 1.912 . . . . 0.0 107.94 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.41 151.78 23.09 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.892 0.853 . . . . 0.0 110.671 169.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.56 163.09 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.564 173.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.39 174.22 20.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.266 . . . . 0.0 110.043 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -15.38 33.4 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 113.948 -176.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -58.07 -24.38 58.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 112.617 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -124.55 -36.92 2.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 117.807 -1.092 . . . . 0.0 112.027 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.4 tt -97.37 152.36 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.611 1.096 . . . . 0.0 112.752 -168.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -155.14 150.15 26.81 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.449 2.3 . . . . 0.0 111.408 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.56 158.81 34.14 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.016 1.28 . . . . 0.0 112.852 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CE1' HD12 ' A' ' 105' ' ' ILE . 4.3 t80 -70.52 107.33 3.81 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.765 0.793 . . . . 0.0 110.581 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.25 160.5 38.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.254 1.422 . . . . 0.0 109.343 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -52.75 -35.96 57.02 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.454 1.502 . . . . 0.0 114.806 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.21 -44.71 95.96 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.792 1.282 . . . . 0.0 109.808 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -77.13 -20.78 55.16 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.028 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.404 HD12 ' CE1' ' A' ' 100' ' ' TYR . 6.1 mm -73.23 -32.91 39.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 CA-C-N 119.117 0.871 . . . . 0.0 110.385 169.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.395 0.998 . . . . 0.0 108.945 171.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.23 74.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -55.48 -48.97 73.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.284 1.034 . . . . 0.0 109.916 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.82 -44.98 38.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.428 -172.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -57.58 -34.49 69.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.744 0.702 . . . . 0.0 110.179 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -78.21 -50.4 11.98 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.36 -29.0 3.54 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.835 1.254 . . . . 0.0 112.275 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.8 t30 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.917 1.287 . . . . 0.0 113.539 173.845 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -57.11 122.62 12.82 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.06 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -1.27 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.41 30.22 0.36 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.76 -174.58 49.9 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 169.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -86.76 151.69 23.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.33 163.43 35.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 168.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.426 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 60.8 mt -139.91 130.4 25.55 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -173.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.55 129.56 50.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.276 0.985 . . . . 0.0 108.518 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.96 118.03 35.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -99.6 -14.44 18.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -169.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.57 -78.9 0.23 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.24 -32.58 12.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.128 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.501 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.77 -177.17 6.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.821 1.648 . . . . 0.0 109.454 -169.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.501 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 11.7 tmm? -128.37 145.24 51.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.84 2.056 . . . . 0.0 108.306 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -130.3 146.27 51.87 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.791 0.805 . . . . 0.0 109.727 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -73.87 148.32 42.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.286 1.434 . . . . 0.0 109.845 -170.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.96 45.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.809 0.844 . . . . 0.0 110.418 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -148.48 95.74 2.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.275 1.03 . . . . 0.0 110.78 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.72 151.25 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 128.294 2.638 . . . . 0.0 112.158 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.301 0.0 OUTLIER -159.71 -28.68 0.07 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 116.802 -1.571 . . . . 0.0 111.96 166.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -113.77 150.13 33.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 168.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.0 166.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.049 0.928 . . . . 0.0 108.693 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -144.18 151.76 39.95 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.514 1.526 . . . . 0.0 109.525 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.11 142.88 16.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.807 1.643 . . . . 0.0 109.563 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 -11.37 31.92 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.158 2.572 . . . . 0.0 113.801 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -62.15 -31.84 72.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.322 1.419 . . . . 0.0 112.312 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.7 p -129.89 0.51 4.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.252 1.421 . . . . 0.0 111.219 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt 44.21 53.78 6.45 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.615 1.566 . . . . 0.0 110.545 -174.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptm -155.26 165.24 37.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.022 1.329 . . . . 0.0 107.703 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -110.67 172.28 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.083 0.953 . . . . 0.0 112.048 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.8 p -141.0 157.3 45.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.67 1.988 . . . . 0.0 106.379 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.7 t -150.85 159.06 44.8 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 124.645 1.178 . . . . 0.0 109.58 -175.706 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.26 109.77 2.0 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mt -76.12 131.62 34.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -173.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.53 138.55 95.68 Favored Pre-proline 0 C--O 1.234 0.288 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.59 137.9 31.2 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.852 1.701 . . . . 0.0 107.931 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -139.05 160.06 40.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 130.16 42.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.79 156.51 34.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.352 1.461 . . . . 0.0 112.31 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.21 29.38 2.15 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.678 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -79.26 -41.08 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.648 1.224 . . . . 0.0 109.041 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -161.96 5.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.347 1.059 . . . . 0.0 113.41 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 48.8 2.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.902 1.281 . . . . 0.0 111.603 -168.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -33.09 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.631 3.172 . . . . 0.0 113.496 168.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.1 pt -136.88 134.47 19.23 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 107.832 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.97 160.1 50.85 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.18 1.92 . . . . 0.0 110.311 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.01 -23.59 20.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 111.829 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.76 -33.97 67.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.336 1.454 . . . . 0.0 113.196 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.2 pt -120.01 -10.06 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 119.487 1.039 . . . . 0.0 110.733 -172.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -59.31 -49.39 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 127.641 2.377 . . . . 0.0 106.661 168.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -77.71 9.42 3.46 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.521 1.528 . . . . 0.0 112.088 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.17 -179.19 27.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.704 1.138 . . . . 0.0 110.881 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -59.31 137.21 58.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 m -136.46 150.65 48.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 124.281 0.988 . . . . 0.0 110.456 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.82 114.66 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.164 -172.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -79.97 124.98 29.18 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.22 1.408 . . . . 0.0 107.374 169.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -137.83 154.06 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 112.433 -168.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -96.46 124.42 40.45 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 166.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -74.03 106.93 5.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -71.99 149.68 44.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.44 3.87 41.99 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.261 -1.299 . . . . 0.0 113.104 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -126.7 168.0 14.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.403 1.602 . . . . 0.0 111.418 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -66.69 171.35 5.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.341 1.056 . . . . 0.0 112.232 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.08 -21.86 66.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.633 1.173 . . . . 0.0 111.585 169.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -63.12 -25.43 68.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.789 0.835 . . . . 0.0 112.144 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -102.23 19.15 19.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 0.0 112.695 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.66 103.52 1.75 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.22 168.39 23.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.382 -167.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.09 152.38 22.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.12 0.962 . . . . 0.0 111.241 168.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.51 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.14 1.376 . . . . 0.0 110.359 173.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 167.2 25.5 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -19.41 21.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.099 1.36 . . . . 0.0 113.733 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.88 -22.88 40.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.676 1.191 . . . . 0.0 112.918 170.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -121.49 -38.54 2.76 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.324 -1.322 . . . . 0.0 111.763 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.4 tt -99.62 154.38 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 120.654 1.57 . . . . 0.0 113.017 -169.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -150.34 156.99 42.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 128.895 2.878 . . . . 0.0 108.921 169.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.39 163.63 27.32 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.602 1.161 . . . . 0.0 112.431 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.93 112.25 9.86 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 120.85 -1.156 . . . . 0.0 109.293 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.979 1.311 . . . . 0.0 109.63 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -52.94 -36.03 59.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.899 1.68 . . . . 0.0 113.733 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -62.7 -43.86 97.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.404 1.097 . . . . 0.0 110.541 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.67 -22.39 50.67 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.253 -0.879 . . . . 0.0 109.519 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mm -70.77 -35.16 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 119.153 0.888 . . . . 0.0 109.926 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.45 99.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.238 0.926 . . . . 0.0 109.319 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -46.8 88.3 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.63 -43.43 96.85 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 118.163 -0.922 . . . . 0.0 109.749 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -72.01 -43.77 64.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.371 0.987 . . . . 0.0 109.677 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -32.16 48.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 118.144 -0.932 . . . . 0.0 111.454 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.85 -45.63 10.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.053 1.297 . . . . 0.0 113.29 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.23 -23.91 9.91 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.157 1.783 . . . . 0.0 111.962 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.1 t30 . . . . . 0 N--CA 1.456 -0.159 0 C-N-CA 126.342 1.857 . . . . 0.0 113.072 172.223 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--O 1.236 0.381 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.434 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -57.05 130.64 46.97 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.124 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.85 125.39 44.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 102.232 -3.247 . . . . 0.0 102.232 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.57 -9.79 0.82 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -168.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.7 34.4 0.81 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.29 -153.03 7.33 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 105.853 -2.899 . . . . 0.0 105.853 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -113.47 155.97 24.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 168.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.22 155.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 169.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 mt -127.74 153.48 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.02 126.91 31.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -173.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -90.57 118.29 29.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -95.25 -14.13 24.28 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.87 0.868 . . . . 0.0 111.624 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.07 -75.67 0.35 Allowed Glycine 0 C--N 1.337 0.609 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.73 -28.63 13.66 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.557 2.171 . . . . 0.0 113.135 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.498 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.01 -177.12 6.3 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 -170.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.498 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -146.22 147.45 31.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.613 1.565 . . . . 0.0 108.302 -168.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.2 170.59 15.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.313 1.045 . . . . 0.0 110.372 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.78 147.54 25.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.778 0.831 . . . . 0.0 109.203 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 165.91 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.759 1.624 . . . . 0.0 108.865 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -153.51 108.52 3.17 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 121.109 -0.994 . . . . 0.0 110.487 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 74.3 mt -55.4 150.09 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 128.454 2.702 . . . . 0.0 110.922 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -157.1 -31.08 0.08 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.773 169.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 24.0 mtmt -119.96 146.93 45.37 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 168.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.51 165.47 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -144.75 150.6 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.612 -170.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.84 142.21 15.27 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.662 1.585 . . . . 0.0 109.242 -173.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.93 -2.87 11.7 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.411 2.74 . . . . 0.0 113.652 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -63.6 -36.67 84.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.579 1.536 . . . . 0.0 111.46 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -134.86 12.37 3.66 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.083 0.953 . . . . 0.0 112.022 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 42.0 55.65 3.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.145 1.378 . . . . 0.0 111.795 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.5 ptm -155.89 164.33 38.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -107.58 169.6 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.412 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 p -136.15 156.17 49.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.755 2.022 . . . . 0.0 106.483 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -154.21 154.63 33.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -169.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 pt . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 123.889 0.876 . . . . 0.0 110.012 -174.275 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.55 112.89 2.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.83 137.04 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.38 141.98 94.05 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.3 138.7 30.75 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 N-CA-C 107.231 -1.873 . . . . 0.0 107.231 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -137.57 159.9 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.779 0.8 . . . . 0.0 108.952 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.44 118.82 11.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.52 153.83 41.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.221 1.408 . . . . 0.0 112.48 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.23 1.55 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-O 118.968 -0.907 . . . . 0.0 115.243 168.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -80.57 -40.66 25.45 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.097 1.449 . . . . 0.0 109.374 169.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.15 -0.41 0.07 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 0.0 113.516 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.69 46.41 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.552 1.541 . . . . 0.0 111.509 -169.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -31.75 139.07 0.04 OUTLIER 'General case' 0 C--O 1.237 0.44 0 C-N-CA 129.776 3.23 . . . . 0.0 113.28 168.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.76 126.66 18.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.15 156.41 20.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.732 2.288 . . . . 0.0 111.128 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.62 -18.48 7.86 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.08 1.352 . . . . 0.0 112.758 173.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -64.04 -30.81 71.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.923 1.289 . . . . 0.0 112.338 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.1 pt -121.03 -9.49 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.835 1.198 . . . . 0.0 110.789 -173.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.19 -49.57 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 127.776 2.43 . . . . 0.0 106.305 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.85 8.94 3.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.411 1.484 . . . . 0.0 111.994 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.96 -178.45 24.9 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.27 0.941 . . . . 0.0 111.315 -174.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -63.4 136.9 57.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.2 m -139.33 152.39 47.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.246 0.966 . . . . 0.0 110.89 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.434 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 37.5 m-85 -140.81 113.21 8.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.293 -170.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.418 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 54.4 t80 -79.15 128.99 33.99 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.19 153.93 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 124.671 1.232 . . . . 0.0 112.28 -168.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -96.38 121.53 38.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 167.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.14 112.7 7.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.73 149.45 31.16 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.86 53.25 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.063 -0.854 . . . . 0.0 111.902 -169.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -132.13 172.59 12.2 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.619 1.21 . . . . 0.0 111.097 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -72.07 158.74 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.331 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.1 m -71.63 -13.09 61.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.636 0.374 . . . . 0.0 111.778 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.9 m -54.75 -34.86 63.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.456 1.102 . . . . 0.0 112.357 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -86.98 7.94 25.37 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.109 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.66 118.24 9.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.278 7.7 tp10 -155.73 168.41 27.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.199 1.8 . . . . 0.0 107.739 -167.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 150.07 23.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.84 0.828 . . . . 0.0 110.652 168.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.65 153.32 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.764 174.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -87.9 157.83 28.81 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.59 8.77 0.76 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 93' ' ' GLY . 35.2 t70 -88.19 -21.03 24.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.355 1.862 . . . . 0.0 111.557 169.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -117.29 -36.7 3.69 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.681 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.07 151.0 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 120.062 1.301 . . . . 0.0 110.592 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -142.62 146.23 34.3 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.596 1.558 . . . . 0.0 110.404 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.91 151.36 46.9 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.229 1.412 . . . . 0.0 109.884 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.51 123.42 16.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.206 1.003 . . . . 0.0 110.823 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -147.85 151.32 35.74 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.107 2.163 . . . . 0.0 106.993 -169.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.66 -28.56 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.913 0.485 . . . . 0.0 110.65 173.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -64.37 -44.21 92.09 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.759 0.824 . . . . 0.0 110.302 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.5 mm -69.67 -33.89 58.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.626 0.648 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.45 99.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.287 0.949 . . . . 0.0 109.68 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -47.43 85.36 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.99 -48.02 83.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.579 -173.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -70.77 -44.51 66.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.32 0.509 . . . . 0.0 109.76 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -27.61 33.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.646 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -94.1 -45.45 7.55 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.441 1.473 . . . . 0.0 112.498 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.15 11.12 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.47 1.508 . . . . 0.0 110.956 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.9 t30 . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 126.215 1.806 . . . . 0.0 113.307 172.522 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -56.65 126.5 26.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 168.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.37 135.76 55.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -169.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -3.62 0.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -168.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.2 28.0 0.26 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.89 -176.31 51.05 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -87.17 153.96 21.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.38 166.93 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 168.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -133.52 145.38 50.1 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.9 134.02 40.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.2 126.62 39.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.693 1.245 . . . . 0.0 107.649 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -103.04 -6.5 22.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.512 0.725 . . . . 0.0 111.109 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -77.63 0.35 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.46 -34.95 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.309 2.006 . . . . 0.0 113.422 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.7 178.36 8.04 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.815 1.646 . . . . 0.0 108.131 -172.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 161.97 33.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.06 163.97 28.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.112 0.965 . . . . 0.0 109.132 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.13 145.59 42.07 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.302 1.041 . . . . 0.0 108.223 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.06 158.47 44.39 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -148.48 94.06 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.927 0.891 . . . . 0.0 109.681 -169.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 54.7 mt -58.48 150.03 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.62 3.168 . . . . 0.0 111.886 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.51 -19.46 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 167.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 35.0 ttpt -131.03 139.77 49.99 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.38 160.09 25.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -168.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -143.67 152.59 41.52 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.288 -168.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -149.63 143.6 16.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.653 1.581 . . . . 0.0 109.618 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.24 -1.97 10.45 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.954 3.103 . . . . 0.0 113.772 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.5 m -63.22 -33.39 75.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.297 1.408 . . . . 0.0 112.014 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -135.74 -0.52 2.58 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.919 1.288 . . . . 0.0 111.669 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 48.17 52.41 13.32 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.159 0.984 . . . . 0.0 110.145 -169.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 77.9 mtp -146.19 156.7 43.59 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.393 1.877 . . . . 0.0 107.034 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -107.25 175.62 5.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.866 0.866 . . . . 0.0 112.365 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -141.71 152.77 44.15 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 127.041 2.136 . . . . 0.0 107.207 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.1 m -152.16 157.12 41.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -169.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 pt . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 110.009 -175.073 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.38 112.0 2.25 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 mt -75.42 139.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 138.34 93.26 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.49 136.55 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 N-CA-C 107.344 -1.829 . . . . 0.0 107.344 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -138.72 159.58 41.76 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -170.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -64.87 131.86 47.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 tt -80.57 155.55 26.88 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.471 1.908 . . . . 0.0 112.199 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.34 20.27 4.79 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.332 0.968 . . . . 0.0 112.129 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.4 -35.48 47.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.942 0.871 . . . . 0.0 109.262 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -150.97 8.94 0.57 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.703 1.201 . . . . 0.0 111.634 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.465 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 6.6 mp0 -126.72 173.5 9.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.523 1.529 . . . . 0.0 110.699 -169.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.7 m -153.85 140.42 18.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 169.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.3 pt -134.54 132.28 20.73 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.12 160.02 50.55 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.363 1.376 . . . . 0.0 109.444 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.02 -14.51 2.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.443 1.097 . . . . 0.0 112.317 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -66.93 -31.95 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.604 1.562 . . . . 0.0 112.773 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.5 pt -119.34 -12.57 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 120.202 1.365 . . . . 0.0 110.686 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -52.41 -46.92 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 128.43 2.692 . . . . 0.0 108.24 169.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.52 8.46 9.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.476 0.711 . . . . 0.0 111.923 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.49 -178.35 25.29 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.881 1.219 . . . . 0.0 111.195 -170.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -64.13 131.84 48.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -136.44 152.98 51.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.288 0.993 . . . . 0.0 111.546 176.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.71 114.68 10.73 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.967 1.307 . . . . 0.0 110.006 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -80.49 126.33 31.08 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 126.206 1.802 . . . . 0.0 106.791 169.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.47 156.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.334 1.454 . . . . 0.0 111.488 -168.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -105.45 120.15 40.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 167.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -72.22 120.59 18.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -72.34 148.41 45.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.582 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 9.6 56.74 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.5 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -130.76 165.01 23.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.95 1.375 . . . . 0.0 112.035 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -75.26 161.62 29.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -62.17 -21.51 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 111.448 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -25.66 39.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.828 1.251 . . . . 0.0 112.695 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -101.57 1.82 38.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.216 1.006 . . . . 0.0 111.726 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.77 115.4 7.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.277 6.8 tp10 -156.91 169.35 24.98 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.759 1.624 . . . . 0.0 108.241 -167.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.465 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.08 150.46 22.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.229 1.014 . . . . 0.0 109.72 168.094 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.44 155.26 40.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.749 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.27 166.52 32.12 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.66 -17.48 15.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.83 1.252 . . . . 0.0 113.232 174.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -22.86 40.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.767 1.227 . . . . 0.0 113.176 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -122.89 -38.98 2.55 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.431 174.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.9 tt -95.85 156.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 119.767 1.167 . . . . 0.0 112.615 -169.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -155.19 155.41 33.85 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.391 2.676 . . . . 0.0 109.862 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.97 163.09 27.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.297 1.439 . . . . 0.0 112.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -66.95 115.84 7.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.15 -0.969 . . . . 0.0 110.392 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -161.69 161.89 29.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.482 1.513 . . . . 0.0 108.785 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.11 -33.25 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.798 1.639 . . . . 0.0 114.089 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -64.64 -43.85 92.36 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.015 0.912 . . . . 0.0 110.266 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -74.3 -27.0 60.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.67 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mm -67.15 -45.53 86.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 117.308 -1.329 . . . . 0.0 109.524 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.6 79.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.796 1.634 . . . . 0.0 109.865 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.23 -51.79 63.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.225 0.61 . . . . 0.0 109.973 171.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.57 -48.86 80.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.369 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -68.26 -40.58 81.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 120.022 1.283 . . . . 0.0 110.276 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -52.47 -54.37 33.26 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt -73.71 -40.72 63.4 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.002 -0.436 . . . . 0.0 110.665 -170.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.12 -9.21 0.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.268 1.827 . . . . 0.0 113.009 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 124.993 1.317 . . . . 0.0 112.284 178.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.84 126.09 26.22 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 168.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.73 128.89 52.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -170.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -2.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -168.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.98 32.57 0.37 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 -157.43 14.14 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -109.48 154.57 22.48 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.18 162.04 37.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.9 mt -139.14 130.39 26.81 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 -175.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.31 139.75 51.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -108.2 115.34 29.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -96.3 -10.54 27.62 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.994 0.918 . . . . 0.0 112.065 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.14 -78.69 0.31 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.62 -30.27 18.53 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.628 2.219 . . . . 0.0 112.887 175.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.455 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.11 -178.43 7.1 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.577 1.551 . . . . 0.0 108.894 -169.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.455 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -139.17 155.14 48.04 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.613 1.565 . . . . 0.0 107.326 -172.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -138.01 167.72 21.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 109.914 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.17 144.57 36.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.532 1.133 . . . . 0.0 109.061 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.9 156.43 48.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.168 1.387 . . . . 0.0 108.456 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -147.55 103.65 3.55 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.576 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.09 148.16 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 129.61 3.164 . . . . 0.0 111.428 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.27 -18.41 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 116.732 -1.604 . . . . 0.0 113.88 167.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 15.2 ttpt -124.54 139.87 53.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 pt -141.01 161.11 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -169.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -149.38 152.35 35.62 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.815 0.697 . . . . 0.0 111.988 -169.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.21 139.51 14.08 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.172 2.189 . . . . 0.0 109.054 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.2 -9.79 26.38 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.907 3.071 . . . . 0.0 113.422 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -68.48 -30.91 69.85 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.021 1.282 . . . . 0.0 111.291 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 m -120.1 -15.69 8.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.054 1.342 . . . . 0.0 110.844 174.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 49.18 47.2 22.32 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 118.865 0.757 . . . . 0.0 109.914 -170.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -145.82 148.69 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.84 174.8 6.2 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.111 0.565 . . . . 0.0 112.323 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.9 p -142.28 160.07 40.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.529 1.932 . . . . 0.0 106.884 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.16 165.16 30.85 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.5 pt . . . . . 0 CA--C 1.547 0.846 0 C-N-CA 124.718 1.207 . . . . 0.0 109.113 178.079 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -23.2 98.49 0.01 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.132 2.173 . . . . 0.0 112.322 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mt -70.69 129.42 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 111.388 -2.642 . . . . 0.0 107.24 -168.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -67.12 137.12 94.21 Favored Pre-proline 0 C--O 1.236 0.344 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -173.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.16 131.02 17.27 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.272 1.981 . . . . 0.0 107.092 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -135.45 167.59 20.79 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.588 1.155 . . . . 0.0 108.085 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -65.16 151.94 44.84 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.401 HD12 ' CZ2' ' A' ' 91' ' ' TRP . 10.1 tt -108.09 147.22 31.51 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.585 1.554 . . . . 0.0 109.996 -169.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.87 42.73 0.77 Allowed Glycine 0 CA--C 1.527 0.787 0 O-C-N 123.906 0.754 . . . . 0.0 112.94 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.17 -8.73 3.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.093 0.957 . . . . 0.0 112.6 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.73 10.81 2.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.144 1.378 . . . . 0.0 110.472 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.16 -177.44 6.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 108.016 -169.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.7 m -161.52 141.92 10.77 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.651 2.78 . . . . 0.0 103.64 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.311 5.3 tt -134.01 119.6 14.74 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -170.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.76 145.98 80.02 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.407 2.738 . . . . 0.0 113.037 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.8 -22.07 22.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.289 1.036 . . . . 0.0 112.509 172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -58.01 -31.3 66.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.792 2.037 . . . . 0.0 113.282 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 pt -117.82 -17.53 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.935 0.894 . . . . 0.0 111.014 -169.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 mm -52.87 -43.29 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 128.561 2.744 . . . . 0.0 109.656 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.91 11.75 4.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.252 -169.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.59 -171.1 26.07 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 121.0 -1.063 . . . . 0.0 110.487 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.01 136.16 56.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.131 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 m -137.91 151.21 47.78 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.927 0.767 . . . . 0.0 111.205 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -138.47 114.76 10.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.895 1.278 . . . . 0.0 110.294 -171.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -81.48 129.23 34.57 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -137.97 149.04 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.017 -168.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -92.83 123.83 36.38 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -71.3 113.41 8.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -73.65 149.49 41.95 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.29 15.71 52.22 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 119.001 -0.888 . . . . 0.0 113.063 -176.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -136.31 172.15 13.43 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.113 1.365 . . . . 0.0 110.173 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -71.21 161.5 31.0 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -175.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -72.57 -13.47 61.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.759 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.9 m -55.09 -32.6 62.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.343 1.057 . . . . 0.0 112.225 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -87.77 2.45 51.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.858 0.863 . . . . 0.0 113.005 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.77 119.42 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 40.9 tt0 -158.81 153.94 25.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.434 ' CH2' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -91.18 149.69 21.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.282 1.039 . . . . 0.0 109.224 168.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.8 149.13 31.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.49 -1.686 . . . . 0.0 110.484 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -84.74 161.93 37.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.552 173.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.06 10.06 0.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.035 1.734 . . . . 0.0 114.95 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 93' ' ' GLY . 28.5 t70 -90.27 -34.98 15.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.947 1.699 . . . . 0.0 110.378 169.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -93.39 -45.11 7.95 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.12 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 tt -98.61 156.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.564 0.62 . . . . 0.0 111.335 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -148.23 155.25 41.13 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.771 2.029 . . . . 0.0 109.743 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 161.72 30.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.16 1.346 . . . . 0.0 111.427 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.12 117.9 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 173.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -162.02 161.32 28.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.131 1.373 . . . . 0.0 108.976 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.92 -36.08 47.85 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.68 1.592 . . . . 0.0 114.476 -169.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.19 -45.22 94.35 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.628 1.204 . . . . 0.0 110.476 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.49 -22.99 53.78 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.834 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.01 -35.67 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.722 0.692 . . . . 0.0 109.772 169.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.9 97.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 118.809 0.731 . . . . 0.0 110.271 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -50.11 74.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -59.14 -48.04 83.08 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.6 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.69 -35.98 38.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.918 1.235 . . . . 0.0 110.276 -171.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -28.19 65.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.243 171.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -45.57 8.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.262 1.392 . . . . 0.0 112.819 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.04 16.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.285 1.434 . . . . 0.0 111.162 171.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.3 t30 . . . . . 0 CA--C 1.534 0.357 0 C-N-CA 125.684 1.594 . . . . 0.0 113.367 170.765 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 121.741 0.782 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.75 63.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 1 C-N-CA 132.094 4.158 . . . . 0.0 111.401 169.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.33 135.81 55.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 127.24 2.216 . . . . 0.0 105.688 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.85 -4.92 1.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -169.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.61 30.43 0.51 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 171.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.44 -165.21 34.32 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.533 -2.627 . . . . 0.0 106.533 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -99.74 154.75 18.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.39 165.88 28.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 168.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.53 140.74 47.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.92 129.8 34.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -104.54 114.2 28.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -87.64 -22.25 24.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.116 0.566 . . . . 0.0 110.98 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.89 -72.08 0.31 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.11 -32.07 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.53 2.153 . . . . 0.0 112.736 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.31 174.65 12.61 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.909 1.684 . . . . 0.0 109.302 -172.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -139.12 150.35 45.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.7 1.6 . . . . 0.0 108.757 -169.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -137.24 159.97 40.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 109.673 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 148.87 39.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 123.612 0.765 . . . . 0.0 109.158 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.56 159.33 42.36 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.207 1.003 . . . . 0.0 109.912 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.92 95.7 2.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.331 0.652 . . . . 0.0 109.457 -170.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.4 mt -54.77 152.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 128.08 2.552 . . . . 0.0 111.632 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.02 -32.08 0.09 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.399 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 34.8 ttpt -132.2 136.81 47.29 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.65 166.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.7 0.762 . . . . 0.0 109.182 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -143.17 153.24 42.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.587 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -148.6 137.48 11.96 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 127.501 2.32 . . . . 0.0 108.152 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -10.93 28.18 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.528 2.819 . . . . 0.0 113.304 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -65.62 -31.85 73.11 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.863 1.21 . . . . 0.0 111.957 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -124.51 -7.44 7.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.013 1.325 . . . . 0.0 111.163 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt 47.05 48.41 15.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.388 1.075 . . . . 0.0 110.65 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtp -147.19 158.18 43.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.642 2.377 . . . . 0.0 105.98 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.418 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -108.99 174.21 5.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.788 0.835 . . . . 0.0 112.321 -174.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 p -147.37 149.38 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.503 1.921 . . . . 0.0 107.035 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.9 t -146.5 165.9 28.05 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 pt . . . . . 0 CA--C 1.544 0.72 0 C-N-CA 125.141 1.377 . . . . 0.0 109.158 -176.875 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.53 113.84 3.2 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.1 mt -79.14 133.15 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.73 135.5 95.57 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.71 137.63 30.35 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.244 1.963 . . . . 0.0 108.024 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -139.69 160.67 39.34 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -170.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -67.02 120.08 13.05 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.618 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.26 150.71 33.88 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.805 2.042 . . . . 0.0 112.132 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.58 25.52 3.39 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.421 -1.21 . . . . 0.0 115.751 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.28 -30.57 17.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.986 1.893 . . . . 0.0 111.023 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.04 -39.9 0.11 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.07 1.748 . . . . 0.0 110.272 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -71.18 159.91 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -153.93 159.31 41.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.432 HG13 ' CD1' ' A' ' 91' ' ' TRP 0.329 2.0 tt -144.63 126.61 8.09 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 -169.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.84 155.0 70.05 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 121.155 1.448 . . . . 0.0 111.142 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -56.96 -17.6 10.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.788 1.235 . . . . 0.0 112.542 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.11 -25.51 67.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.433 1.493 . . . . 0.0 112.332 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 pt -125.27 -14.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.229 0.922 . . . . 0.0 111.3 -170.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -50.73 -42.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 128.587 2.755 . . . . 0.0 109.591 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.14 9.66 6.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.854 1.262 . . . . 0.0 112.768 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.01 -171.52 24.91 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 14.6 mmtt -58.66 140.4 54.63 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.294 -0.533 . . . . 0.0 109.658 174.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 m -138.2 149.35 45.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 123.933 0.771 . . . . 0.0 110.721 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 75' ' ' LYS . 50.0 m-85 -134.94 113.88 11.95 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.041 0.936 . . . . 0.0 110.763 -170.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -78.87 125.25 29.12 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.8 2.04 . . . . 0.0 106.479 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -135.15 151.94 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.069 1.348 . . . . 0.0 111.435 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -101.0 116.05 31.94 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 167.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.93 121.31 15.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.93 157.18 25.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.176 0.512 . . . . 0.0 110.031 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.35 11.11 45.64 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.217 -0.769 . . . . 0.0 111.731 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -135.7 167.65 20.74 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.526 1.13 . . . . 0.0 110.339 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -64.98 169.09 5.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.726 1.21 . . . . 0.0 110.659 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -82.97 -11.53 58.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.566 171.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.3 m -55.78 -33.43 64.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.707 1.203 . . . . 0.0 112.031 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -84.74 4.16 34.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.05 118.97 10.58 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.258 9.1 tt0 -157.23 162.02 39.25 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.589 1.556 . . . . 0.0 107.806 -167.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.432 ' CD1' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -96.68 152.85 18.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.15 0.976 . . . . 0.0 109.497 168.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.11 155.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.441 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.49 167.56 28.76 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -17.58 9.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.247 1.419 . . . . 0.0 113.304 176.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.77 -23.19 41.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 113.143 170.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.97 -38.56 2.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.881 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.2 tt -94.19 155.29 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.728 1.149 . . . . 0.0 112.451 -169.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -153.95 160.23 42.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.275 3.03 . . . . 0.0 108.765 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.78 15.67 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.616 1.553 . . . . 0.0 112.832 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CE2' HD13 ' A' ' 105' ' ' ILE . 32.0 t80 -70.22 115.0 8.91 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.056 -1.027 . . . . 0.0 110.023 169.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -162.02 163.64 28.72 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.622 1.569 . . . . 0.0 109.333 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -54.41 -34.34 61.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.629 1.572 . . . . 0.0 113.815 -169.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -63.9 -42.07 97.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.096 0.95 . . . . 0.0 110.412 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.16 -25.85 55.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.552 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.416 HD13 ' CE2' ' A' ' 100' ' ' TYR . 4.8 mm -69.59 -37.56 74.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.345 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.6 98.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.275 0.943 . . . . 0.0 109.702 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -49.8 74.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.98 -51.07 69.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.759 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.45 -31.98 58.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 117.63 -1.176 . . . . 0.0 110.176 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.99 -45.72 75.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.827 1.194 . . . . 0.0 110.358 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.06 -46.82 22.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.683 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.06 -29.58 30.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.022 1.329 . . . . 0.0 111.421 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 . . . . . 0 N--CA 1.456 -0.174 0 C-N-CA 124.559 1.143 . . . . 0.0 113.062 173.024 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.79 127.76 31.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.67 131.2 56.67 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 102.403 -3.184 . . . . 0.0 102.403 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -11.42 0.3 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -168.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.24 32.48 0.54 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.19 -170.47 36.47 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 169.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -91.16 153.25 20.17 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -135.92 158.35 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 169.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -128.28 154.66 45.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.97 129.24 31.82 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -93.18 129.05 39.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -110.19 -6.13 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.435 1.094 . . . . 0.0 111.991 -173.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.02 -80.68 0.29 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -72.42 -29.32 13.82 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.378 2.052 . . . . 0.0 113.16 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.65 177.83 10.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.782 1.633 . . . . 0.0 110.158 -169.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.75 150.85 40.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.042 1.737 . . . . 0.0 108.887 -168.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.61 175.75 9.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.11 147.13 25.07 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 109.746 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.34 160.29 40.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.199 1.799 . . . . 0.0 108.465 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -148.41 103.47 3.43 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 120.938 -1.101 . . . . 0.0 108.882 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.7 mt -51.64 148.11 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.657 2.383 . . . . 0.0 110.441 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -153.92 -31.89 0.12 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.433 0.693 . . . . 0.0 111.632 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 33.4 ttpt -133.06 135.47 45.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 165.87 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -145.45 154.59 42.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.302 -168.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.24 141.3 14.97 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.844 2.457 . . . . 0.0 108.697 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.82 -8.42 23.38 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.474 2.783 . . . . 0.0 113.356 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 m -66.92 -33.61 75.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.586 1.539 . . . . 0.0 110.961 -172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 p -118.95 -17.39 9.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.733 1.613 . . . . 0.0 110.847 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm 48.81 52.34 14.28 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.01 0.823 . . . . 0.0 109.212 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.9 mtp -148.9 156.94 43.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.476 2.71 . . . . 0.0 104.522 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 53.1 p90 -106.07 170.08 8.12 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.602 0.361 . . . . 0.0 111.666 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 p -142.57 150.58 40.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 126.995 2.118 . . . . 0.0 105.647 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 m -150.79 157.99 43.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -168.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.0 pt . . . . . 0 CA--C 1.553 1.07 0 C-N-CA 123.224 0.609 . . . . 0.0 109.595 -177.662 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt . . . . . 0 C--O 1.231 0.081 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -17.24 91.64 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.472 3.109 . . . . 0.0 111.127 -169.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.03 136.48 25.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.121 -167.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.79 141.68 95.06 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.535 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.34 142.65 27.11 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.931 1.754 . . . . 0.0 108.822 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -129.75 165.91 20.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 108.953 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.603 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -60.37 -25.4 65.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 -168.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.6 tt 73.46 144.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.847 2.059 . . . . 0.0 112.66 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.97 25.16 5.47 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.989 -0.895 . . . . 0.0 115.188 169.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.25 -34.6 55.81 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.062 1.431 . . . . 0.0 109.113 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -153.16 -24.15 0.15 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.435 1.894 . . . . 0.0 112.369 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 34.3 mp0 -55.6 -19.51 10.54 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 129.162 2.985 . . . . 0.0 115.216 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -17.54 108.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.465 2.706 . . . . 0.0 111.962 -169.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.342 4.3 tt -115.26 136.6 22.71 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.509 2.324 . . . . 0.0 106.764 -166.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.97 151.81 56.67 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.107 1.871 . . . . 0.0 111.578 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.61 -16.64 10.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.766 1.227 . . . . 0.0 113.339 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.71 -24.64 67.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.634 1.174 . . . . 0.0 112.367 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 pt -125.16 -15.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.706 0.684 . . . . 0.0 110.688 -170.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.0 mm -54.67 -44.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.342 2.257 . . . . 0.0 107.158 169.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -81.15 11.31 4.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.177 1.791 . . . . 0.0 112.562 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.38 -172.26 26.29 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.636 1.107 . . . . 0.0 111.569 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -60.14 137.13 58.17 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -139.24 150.22 45.24 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.957 0.785 . . . . 0.0 110.465 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -137.04 115.58 11.96 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 110.272 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -82.04 130.87 35.2 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 126.348 1.859 . . . . 0.0 106.44 169.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.05 151.83 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.643 -167.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.62 122.96 36.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.71 115.63 11.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.49 147.99 30.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -173.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.16 46.8 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.336 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -130.73 171.47 13.06 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.597 1.199 . . . . 0.0 111.668 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -73.28 161.16 30.84 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.082 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.7 m -76.72 -13.86 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.229 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -51.1 -36.04 38.3 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.382 1.473 . . . . 0.0 111.979 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -88.06 2.13 52.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.76 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.55 121.64 14.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -172.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.276 7.7 tp10 -159.13 169.19 24.73 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.894 1.278 . . . . 0.0 108.099 -167.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.64 153.34 19.85 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.775 0.797 . . . . 0.0 110.744 168.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.24 156.3 41.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.239 172.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.08 161.12 31.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.8 7.44 0.9 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -87.43 -21.04 25.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.991 1.716 . . . . 0.0 111.115 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm105 -117.91 -35.37 3.9 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.599 1.16 . . . . 0.0 111.813 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.4 tt -101.42 150.24 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.219 0.918 . . . . 0.0 110.094 -176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -147.32 143.8 28.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.094 1.358 . . . . 0.0 112.076 170.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.18 147.81 51.74 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.703 2.001 . . . . 0.0 111.33 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -59.52 114.68 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.197 0.453 . . . . 0.0 111.407 -169.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -160.53 162.23 32.92 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.27 -33.74 67.93 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.58 -42.99 98.27 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.598 0.713 . . . . 0.0 110.082 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -67.91 -36.59 80.45 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.4 mm -67.58 -34.87 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.498 0.59 . . . . 0.0 110.804 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.29 98.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.209 0.913 . . . . 0.0 109.955 174.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -47.67 83.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -60.23 -48.95 79.56 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.732 0.813 . . . . 0.0 109.282 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -71.64 -43.89 65.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.34 0.518 . . . . 0.0 109.804 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -29.06 41.14 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.017 172.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.5 mt -92.96 -45.47 7.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.537 1.517 . . . . 0.0 112.341 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.0 -26.15 10.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.651 1.58 . . . . 0.0 111.491 170.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.9 t30 . . . . . 0 CA--C 1.531 0.233 0 C-N-CA 125.967 1.707 . . . . 0.0 112.969 172.441 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.93 163.59 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.675 1.19 . . . . 0.0 109.965 -175.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.21 -24.79 64.07 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.4 tp -57.02 -29.01 63.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.143 1.777 . . . . 0.0 112.446 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.08 -27.51 68.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.4 1.08 . . . . 0.0 111.299 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.58 -27.33 68.34 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.047 1.739 . . . . 0.0 112.556 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.53 144.88 30.99 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.734 0.697 . . . . 0.0 109.975 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -56.93 134.15 55.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 168.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.77 125.74 44.51 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -10.18 0.93 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -168.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 28.7 1.2 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.02 -175.27 50.94 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.48 157.3 18.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.06 153.49 37.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 168.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.0 mt -122.07 139.38 53.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.66 123.16 28.77 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.229 0.956 . . . . 0.0 109.386 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -101.5 118.38 36.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.752 1.621 . . . . 0.0 107.6 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -95.08 -25.63 16.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.161 0.585 . . . . 0.0 111.439 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.82 -72.29 0.27 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -72.4 -30.51 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.079 1.853 . . . . 0.0 112.485 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -154.27 177.12 11.48 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.929 1.692 . . . . 0.0 109.63 -170.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.415 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -144.07 151.93 40.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.109 1.764 . . . . 0.0 108.175 -168.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -139.19 167.35 22.25 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.552 1.141 . . . . 0.0 110.583 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.34 144.89 29.37 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.34 161.71 37.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.522 1.529 . . . . 0.0 108.998 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -149.11 108.22 3.91 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.124 -0.985 . . . . 0.0 110.366 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.9 mt -53.8 151.06 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.229 3.012 . . . . 0.0 111.348 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.01 -30.05 0.08 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 34.4 ttpt -132.62 136.58 46.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.85 159.89 30.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -168.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -143.68 152.85 41.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.547 -168.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -150.91 142.84 15.76 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 126.065 1.746 . . . . 0.0 109.418 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.79 -11.13 31.05 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.971 2.448 . . . . 0.0 113.7 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.3 m -63.81 -32.62 74.19 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.852 1.205 . . . . 0.0 112.021 -171.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 m -125.82 -4.65 6.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.768 1.227 . . . . 0.0 111.421 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 41.45 50.66 3.67 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 125.298 1.439 . . . . 0.0 111.105 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.5 mtm -150.08 163.37 38.35 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 170.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -103.85 175.7 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.747 0.819 . . . . 0.0 112.272 -173.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 p -143.15 153.51 42.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.346 2.259 . . . . 0.0 106.907 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 m -153.23 163.49 39.79 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.6 pt -146.63 164.73 22.52 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.794 1.638 . . . . 0.0 108.726 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -78.5 46.2 2.07 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 125.096 3.864 . . . . 0.0 112.62 -169.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -10.09 59.4 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.173 -0.954 . . . . 0.0 113.491 -169.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -164.65 -169.17 1.66 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.044 1.338 . . . . 0.0 109.838 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -140.21 92.8 9.34 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 128.085 2.554 . . . . 0.0 105.931 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.19 165.56 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.281 2.654 . . . . 0.0 112.353 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.63 19.89 1.1 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.549 1.547 . . . . 0.0 114.513 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.49 31.25 0.52 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.622 1.582 . . . . 0.0 111.31 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.3 m -139.73 148.24 42.02 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.623 1.169 . . . . 0.0 109.497 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 p -68.37 -42.79 78.62 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -175.38 160.04 2.55 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 129.75 3.22 . . . . 0.0 105.792 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.03 146.95 45.54 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 166.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.1 p -96.84 168.74 10.31 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.049 0.84 . . . . 0.0 110.975 -174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -54.14 150.61 8.05 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.421 1.089 . . . . 0.0 109.257 169.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 4.79 80.77 0.0 OUTLIER 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.341 2.657 . . . . 0.0 113.532 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.2 mt -73.78 136.23 25.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -169.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -78.58 146.13 68.82 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -52.73 134.34 53.56 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.848 2.365 . . . . 0.0 110.137 172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -144.9 153.74 41.88 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -65.74 135.82 55.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.19 0.995 . . . . 0.0 109.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.22 153.72 33.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.18 1.792 . . . . 0.0 111.631 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.64 21.88 5.27 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 124.131 0.894 . . . . 0.0 112.783 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -75.87 -34.74 60.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.098 0.949 . . . . 0.0 109.207 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -149.37 4.88 0.62 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.677 1.191 . . . . 0.0 111.855 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.506 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 7.0 mp0 -114.18 168.47 9.8 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.476 1.51 . . . . 0.0 110.532 -169.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -149.54 138.96 21.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.9 pt -135.1 128.9 18.74 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.85 162.38 41.64 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.958 1.772 . . . . 0.0 109.56 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -15.72 9.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.924 0.89 . . . . 0.0 112.316 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.55 -31.18 72.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.824 1.25 . . . . 0.0 112.119 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . 0.254 4.6 pt -121.27 -9.09 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 119.812 1.187 . . . . 0.0 110.447 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.43 -49.28 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 127.6 2.36 . . . . 0.0 106.137 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -79.44 10.24 4.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.774 1.63 . . . . 0.0 112.114 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.34 28.85 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 119.454 1.024 . . . . 0.0 111.399 -173.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -64.39 132.97 51.61 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.5 m -138.27 154.54 49.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.393 1.058 . . . . 0.0 111.844 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 35.9 m-85 -142.11 115.44 8.93 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.764 -169.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.419 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 46.5 t80 -80.82 128.29 33.49 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -138.25 155.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.458 -167.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -100.45 118.23 36.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.59 121.89 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -90.22 150.27 22.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 10.28 52.71 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.616 -169.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.495 ' CG ' HM2B ' A' ' 128' ' ' M2L . 31.8 m95 -136.07 172.04 13.59 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.833 1.253 . . . . 0.0 111.25 -174.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -71.36 163.08 28.37 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.324 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 m -77.64 -12.11 59.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 171.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 m -55.43 -31.15 61.67 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.969 -1.082 . . . . 0.0 111.713 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -82.79 0.02 45.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.974 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -64.61 112.87 3.37 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -157.63 168.71 26.48 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.098 1.759 . . . . 0.0 107.975 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.506 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.9 152.46 20.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.042 0.925 . . . . 0.0 110.479 168.707 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.42 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.006 171.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.8 158.84 35.62 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 6.83 1.23 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.78 -26.68 25.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.624 1.57 . . . . 0.0 110.974 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -107.76 -40.42 5.29 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.363 1.065 . . . . 0.0 111.093 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.4 tt -100.61 148.9 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.596 1.089 . . . . 0.0 110.443 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -145.62 151.28 37.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.94 168.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.54 146.23 52.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.506 1.522 . . . . 0.0 110.403 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -61.12 114.75 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 119.053 0.842 . . . . 0.0 112.194 -169.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -159.25 164.82 34.64 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.223 1.409 . . . . 0.0 110.126 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.27 -33.9 68.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.594 1.557 . . . . 0.0 113.527 -169.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.24 -42.27 96.59 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.724 0.773 . . . . 0.0 109.572 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -68.75 -34.96 76.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.9 mm -66.91 -36.79 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 118.687 0.676 . . . . 0.0 110.833 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.96 99.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.259 0.936 . . . . 0.0 109.924 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -57.49 -50.85 71.71 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 170.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -57.72 -48.92 78.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.661 0.785 . . . . 0.0 109.757 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -72.36 -38.99 68.4 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.798 0.839 . . . . 0.0 110.718 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -47.28 82.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.835 0.743 . . . . 0.0 109.215 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.8 mt -73.42 -42.77 61.65 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.434 -0.791 . . . . 0.0 111.819 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.31 -20.05 3.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.294 1.438 . . . . 0.0 112.606 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -93.54 -52.24 4.58 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.921 0.782 . . . . 0.0 111.557 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -71.96 -26.57 62.32 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -170.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -138.67 9.35 2.63 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -168.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.0 75.61 0.24 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.715 1.626 . . . . 0.0 112.536 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.1 m -142.76 162.51 35.27 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 128.123 2.569 . . . . 0.0 106.11 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.4 p -74.54 -20.23 60.04 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.54 1.536 . . . . 0.0 113.442 -172.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.92 12.51 68.16 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.261 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 m -74.32 59.93 0.81 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.187 1.795 . . . . 0.0 111.866 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.29 158.61 57.64 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.952 1.301 . . . . 0.0 109.249 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.01 10.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 125.091 3.861 . . . . 0.0 117.113 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -126.16 5.36 7.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.353 1.861 . . . . 0.0 111.962 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.4 m 73.17 -30.97 0.22 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.722 2.009 . . . . 0.0 113.503 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 77.05 -63.98 3.15 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.819 2.152 . . . . 0.0 111.937 171.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 168.13 33.61 0.02 OUTLIER Glycine 0 CA--C 1.522 0.524 0 CA-C-O 118.432 -1.205 . . . . 0.0 110.633 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -144.01 146.9 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -169.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.495 HM2B ' CG ' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp 19.63 94.68 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 131.579 3.952 . . . . 0.0 113.531 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -86.36 -10.45 6.58 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.615 2.21 . . . . 0.0 112.466 -172.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -43.54 -39.4 3.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.35 1.86 . . . . 0.0 113.565 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -155.47 149.63 25.74 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.233 1.413 . . . . 0.0 108.597 169.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -160.51 165.82 30.22 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.545 1.538 . . . . 0.0 108.095 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 . . . . . 0 C--O 1.251 1.135 0 C-N-CA 125.511 1.524 . . . . 0.0 106.986 176.353 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.58 152.7 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.321 1.448 . . . . 0.0 108.682 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -155.79 147.07 22.59 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.401 1.881 . . . . 0.0 106.388 172.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tm? 60.33 -40.76 0.1 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.601 2.76 . . . . 0.0 114.367 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -55.95 -28.04 55.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.298 1.839 . . . . 0.0 111.518 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -50.08 -40.41 45.37 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.439 2.696 . . . . 0.0 113.441 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -79.7 146.41 32.43 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 51.0 p90 -59.99 142.65 53.49 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.34 134.44 45.2 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -169.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.1 tp -59.73 -3.14 0.45 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -168.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.87 29.21 0.42 Allowed Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 170.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.72 179.59 48.94 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 -82.28 156.75 24.15 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.29 168.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.37 -2.455 . . . . 0.0 104.37 170.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.8 mt -141.85 130.66 22.93 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 -172.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.98 130.08 51.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -103.71 114.06 28.04 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -171.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -94.29 -12.84 27.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.446 0.698 . . . . 0.0 111.757 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.96 -73.85 0.37 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.983 1.278 . . . . 0.0 109.914 171.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -66.7 -38.32 18.58 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.059 2.506 . . . . 0.0 113.4 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 18.7 tp -150.88 176.86 10.68 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 125.417 1.487 . . . . 0.0 108.798 -168.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.5 146.27 39.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.86 2.064 . . . . 0.0 107.014 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -131.5 154.04 49.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.883 0.873 . . . . 0.0 108.729 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -81.08 138.57 35.96 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.011 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.03 158.55 40.02 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.605 1.562 . . . . 0.0 109.344 -171.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.76 96.6 2.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.63 0.372 . . . . 0.0 110.269 -169.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.6 mt -62.16 152.29 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 129.65 3.18 . . . . 0.0 112.41 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.26 -25.21 0.05 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.842 -1.075 . . . . 0.0 112.935 167.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 34.9 ttpt -128.77 136.13 50.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.26 163.42 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.754 0.788 . . . . 0.0 109.024 -173.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -140.16 152.03 45.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.37 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -147.37 139.35 13.88 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.6 1.96 . . . . 0.0 108.428 -172.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.61 -10.27 27.35 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.372 2.715 . . . . 0.0 113.426 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 m -67.11 -32.12 73.05 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.116 1.325 . . . . 0.0 111.491 -170.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -121.63 -13.68 8.3 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.641 1.576 . . . . 0.0 110.823 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt 47.47 50.04 15.25 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.419 ' SD ' ' HE3' ' A' ' 60' ' ' LYS . 5.8 mtm -146.93 165.56 29.42 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.999 2.119 . . . . 0.0 106.396 170.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.4 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 49.0 p90 -107.72 175.18 5.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.968 0.907 . . . . 0.0 112.721 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -146.41 151.09 36.89 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 127.206 2.202 . . . . 0.0 107.336 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.6 t -147.19 160.84 41.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt -144.1 158.22 55.74 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 110.102 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.29 44.84 1.09 Allowed 'Trans proline' 0 CA--C 1.544 1.004 1 C-N-CA 125.888 4.392 . . . . 0.0 113.178 -177.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -61.95 -46.14 90.6 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 120.7 -1.25 . . . . 0.0 110.04 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -160.89 -124.23 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.68 158.99 25.56 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 120.088 1.313 . . . . 0.0 111.577 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.3 165.51 28.51 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.971 1.781 . . . . 0.0 107.638 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.07 18.65 1.43 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.735 1.159 . . . . 0.0 114.642 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -138.01 18.84 3.32 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.526 1.536 . . . . 0.0 112.535 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 m -145.28 178.59 7.97 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.185 1.394 . . . . 0.0 109.885 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -114.96 -27.47 7.36 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.055 0.942 . . . . 0.0 112.414 -172.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -169.67 141.91 2.42 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 118.769 0.713 . . . . 0.0 110.102 169.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.31 164.81 12.8 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 165.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.9 p -124.53 91.13 3.38 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.647 -1.283 . . . . 0.0 112.797 -168.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 50.8 -163.53 0.05 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.486 1.915 . . . . 0.0 110.983 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.17 103.87 1.32 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.3 mt -69.85 130.96 34.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -67.63 139.22 93.83 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.02 139.39 70.71 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.966 1.778 . . . . 0.0 110.667 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -136.92 158.47 44.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.419 ' HE3' ' SD ' ' A' ' 37' ' ' MET . 4.2 mmpt? -63.44 122.74 17.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.23 147.7 47.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.681 1.192 . . . . 0.0 111.729 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.0 -127.21 1.18 Allowed Glycine 0 N--CA 1.446 -0.661 1 N-CA-C 102.922 -4.071 . . . . 0.0 102.922 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 53.43 30.13 9.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.355 1.062 . . . . 0.0 113.298 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.64 10.45 5.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.764 2.025 . . . . 0.0 114.263 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -73.17 6.83 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.263 1.425 . . . . 0.0 113.586 171.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -22.4 118.47 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 128.63 2.772 . . . . 0.0 114.21 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.5 pt -115.43 128.68 25.75 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.82 159.49 52.55 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.835 1.69 . . . . 0.0 109.388 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.77 -21.69 11.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.719 0.808 . . . . 0.0 111.611 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.7 -37.96 69.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.472 1.909 . . . . 0.0 114.196 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.4 pt -116.12 -14.79 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.041 1.291 . . . . 0.0 110.814 -172.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mm -50.32 -45.96 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 128.007 2.523 . . . . 0.0 108.504 169.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.57 8.2 10.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.963 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.31 178.72 25.71 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 120.209 1.368 . . . . 0.0 111.44 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.48 130.13 45.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.0 m -131.82 143.69 50.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 124.191 0.932 . . . . 0.0 109.588 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CE1' ' CD1' ' A' ' 8' ' ' PHE . 63.3 m-85 -128.76 111.72 13.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.199 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -78.24 126.68 31.15 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.097 1.359 . . . . 0.0 107.564 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -136.65 158.6 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 125.44 1.713 . . . . 0.0 110.973 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -111.57 121.97 46.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -73.32 121.91 21.17 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -66.87 147.87 52.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.422 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.05 14.38 58.95 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.913 -0.937 . . . . 0.0 113.641 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.475 ' CZ2' ' HD ' ' A' ' 128' ' ' M2L . 96.4 m95 -135.08 171.39 14.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.885 1.342 . . . . 0.0 110.819 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -68.05 157.98 33.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.903 0.481 . . . . 0.0 111.213 -173.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 m -65.08 -21.66 66.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.21 1.004 . . . . 0.0 111.904 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -54.77 -32.11 59.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.06 1.344 . . . . 0.0 112.713 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -88.4 3.67 49.1 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.049 -0.976 . . . . 0.0 112.776 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.54 117.17 7.63 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.252 7.6 tp10 -157.7 167.48 29.97 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.84 -167.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.46 ' CH2' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -98.72 150.45 21.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.886 0.851 . . . . 0.0 110.313 168.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.52 156.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.887 1.275 . . . . 0.0 109.976 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.77 167.46 26.97 Favored Glycine 0 C--O 1.24 0.52 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.072 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -17.34 9.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.395 1.478 . . . . 0.0 113.387 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -56.77 -22.88 39.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.123 1.369 . . . . 0.0 113.172 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -124.54 -39.22 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.228 173.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.2 tt -93.71 153.24 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.23 0.923 . . . . 0.0 111.268 -169.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -149.88 156.97 42.7 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 127.503 2.321 . . . . 0.0 109.203 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.6 27.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.252 1.021 . . . . 0.0 111.107 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -75.23 113.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -155.98 161.67 40.45 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.594 1.558 . . . . 0.0 108.687 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.54 -33.88 56.22 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.766 1.626 . . . . 0.0 114.469 -169.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.74 -44.97 84.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.289 1.519 . . . . 0.0 109.639 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -75.26 -19.28 59.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.8 mm -74.6 -33.48 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 119.061 0.846 . . . . 0.0 110.25 168.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.99 93.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.212 0.915 . . . . 0.0 108.787 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.8 ttp -58.61 -56.63 19.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.55 0.614 . . . . 0.0 109.364 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -50.08 -45.96 52.98 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.776 1.23 . . . . 0.0 110.956 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -79.43 -41.75 26.92 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.803 1.241 . . . . 0.0 111.553 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -39.59 73.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.644 1.111 . . . . 0.0 109.347 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.18 -46.49 20.38 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.73 30.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.991 0.917 . . . . 0.0 111.469 171.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -72.78 -54.38 9.03 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.019 0.928 . . . . 0.0 112.071 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.65 -18.24 36.02 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 118.703 0.683 . . . . 0.0 112.791 -171.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 55.64 3.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 130.786 3.634 . . . . 0.0 117.007 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.6 -144.62 47.8 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.4 m -72.87 1.28 8.98 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -59.6 148.84 32.1 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.782 1.174 . . . . 0.0 109.317 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.57 -155.8 13.49 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.4 m -66.47 77.13 0.1 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.796 1.638 . . . . 0.0 110.556 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.41 161.79 29.52 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 127.315 2.246 . . . . 0.0 107.99 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.65 50.73 2.79 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 124.283 3.322 . . . . 0.0 111.874 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.21 122.33 12.89 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.346 1.458 . . . . 0.0 110.306 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -39.47 62.24 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.122 0.419 . . . . 0.0 110.227 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.7 24.43 0.08 OUTLIER Glycine 0 CA--C 1.531 1.086 0 CA-C-N 118.077 0.398 . . . . 0.0 112.122 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.35 -137.43 4.91 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -169.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.68 -26.26 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -169.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.475 ' HD ' ' CZ2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -151.15 126.61 4.86 Favored Pre-proline 0 N--CA 1.447 -0.625 0 O-C-N 120.44 -1.412 . . . . 0.0 108.015 -168.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -95.99 5.59 1.96 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.215 2.61 . . . . 0.0 111.574 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -38.14 -55.12 1.32 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 128.87 2.868 . . . . 0.0 114.397 -169.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.37 156.06 34.76 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.501 1.12 . . . . 0.0 109.963 -174.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -67.51 168.26 11.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.539 0.735 . . . . 0.0 109.275 169.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.9 ttt85 . . . . . 0 C--O 1.252 1.228 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.833 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 m -137.85 155.0 29.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.123 1.369 . . . . 0.0 107.584 171.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.37 -60.84 0.16 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.695 0.798 . . . . 0.0 109.024 172.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.7 tp -71.39 -44.58 64.68 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 122.843 0.457 . . . . 0.0 110.611 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -59.85 -30.98 69.34 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.93 0.892 . . . . 0.0 110.532 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -68.89 -19.36 64.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.42 1.488 . . . . 0.0 113.316 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -89.12 150.4 22.73 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.903 0.774 . . . . 0.0 109.978 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.441 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -59.26 87.83 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.873 2.069 . . . . 0.0 110.461 169.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.89 130.4 37.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.34 -8.08 3.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -169.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.09 30.61 0.98 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 173.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.11 -163.79 28.7 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 106.585 -2.606 . . . . 0.0 106.585 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 156.29 17.45 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.06 154.72 41.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 168.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 34.8 mt -125.06 131.6 53.31 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.55 121.55 35.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.649 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.16 125.21 44.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.034 1.334 . . . . 0.0 107.959 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -98.94 -25.73 14.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.886 0.474 . . . . 0.0 111.607 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.11 -71.86 0.34 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.26 -32.67 12.45 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.857 1.705 . . . . 0.0 112.614 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.4 178.83 9.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.194 1.397 . . . . 0.0 109.6 -174.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.07 151.41 40.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.878 2.071 . . . . 0.0 107.95 -168.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -138.0 159.84 40.93 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.76 0.824 . . . . 0.0 111.108 -170.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.42 140.82 43.16 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 160.6 39.21 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.738 1.615 . . . . 0.0 107.582 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -147.54 103.37 3.53 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.239 -0.913 . . . . 0.0 109.699 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.9 mt -57.72 150.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.889 2.076 . . . . 0.0 111.854 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.53 -24.43 0.06 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.776 -1.107 . . . . 0.0 113.109 167.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -126.49 138.7 53.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 pt -139.64 160.47 27.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -147.4 151.12 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -169.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -150.57 142.46 15.57 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.995 1.718 . . . . 0.0 108.465 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 -11.38 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.092 2.528 . . . . 0.0 113.644 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.2 m -64.01 -34.84 78.91 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -120.56 -7.09 9.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.178 0.991 . . . . 0.0 111.186 174.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 44.45 49.45 8.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.679 1.192 . . . . 0.0 109.801 -169.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtp -146.0 147.88 32.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -94.85 173.19 7.72 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.661 0.384 . . . . 0.0 110.53 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -143.97 145.45 32.25 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.975 2.11 . . . . 0.0 105.424 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.408 ' HB2' ' CD1' ' A' ' 56' ' ' ILE . 1.5 m -143.39 157.18 44.67 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -171.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.7 pt -130.32 153.6 81.3 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -86.82 41.73 0.8 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.715 2.277 . . . . 0.0 111.354 -168.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.97 -16.0 63.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.463 1.505 . . . . 0.0 111.907 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -147.21 178.79 8.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.933 1.293 . . . . 0.0 108.88 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -125.75 72.38 68.57 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.59 163.76 37.94 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.823 2.349 . . . . 0.0 112.826 -168.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.14 -26.42 61.22 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.698 1.142 . . . . 0.0 113.682 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.88 -19.59 58.91 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 117.888 0.844 . . . . 0.0 113.503 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 m 53.98 17.85 1.49 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.603 1.961 . . . . 0.0 115.496 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m -57.18 -54.71 43.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.224 1.41 . . . . 0.0 111.196 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -174.62 163.93 3.6 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.874 1.67 . . . . 0.0 109.425 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.82 75.54 0.54 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.823 2.049 . . . . 0.0 108.409 168.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.6 p -112.5 -80.14 0.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.515 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -148.14 -139.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -58.69 107.53 0.53 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.408 ' CD1' ' HB2' ' A' ' 40' ' ' SER . 23.4 mt -73.71 139.55 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -169.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -67.93 134.09 92.0 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.126 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.31 130.52 18.79 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 106.181 -2.276 . . . . 0.0 106.181 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -140.3 165.66 26.79 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.55 150.26 44.38 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.43 146.45 40.61 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.519 1.928 . . . . 0.0 110.284 -168.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.11 36.05 1.41 Allowed Glycine 0 CA--C 1.524 0.652 0 O-C-N 124.377 1.048 . . . . 0.0 114.501 169.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -72.13 -33.22 67.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.731 1.266 . . . . 0.0 108.422 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.48 -29.88 0.13 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.372 1.869 . . . . 0.0 111.97 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 35.81 0.44 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.328 2.251 . . . . 0.0 112.78 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -32.73 144.21 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.785 2.434 . . . . 0.0 114.32 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -132.55 136.38 27.8 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 161.02 47.53 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.663 1.576 . . . . 0.0 109.575 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.76 -12.68 2.01 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.638 1.175 . . . . 0.0 112.711 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.84 -29.82 68.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.186 1.394 . . . . 0.0 113.037 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 pt -121.27 -9.91 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.371 1.441 . . . . 0.0 111.338 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mm -53.67 -45.95 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 128.688 2.795 . . . . 0.0 108.011 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.19 8.41 8.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 111.933 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.78 179.02 26.9 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 120.071 1.305 . . . . 0.0 111.33 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -64.41 129.99 42.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -136.86 151.17 48.8 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.155 0.909 . . . . 0.0 111.004 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.5 m-85 -139.88 115.41 10.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.48 1.512 . . . . 0.0 108.711 -169.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.76 129.58 35.0 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 126.168 1.787 . . . . 0.0 106.899 170.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.39 155.68 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.95 -168.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -101.94 119.53 38.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 167.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -71.07 117.15 12.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -83.73 151.08 25.42 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.851 0.46 . . . . 0.0 109.778 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.49 7.98 36.38 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.033 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.512 ' CG ' ' HM2' ' A' ' 128' ' ' M2L . 33.8 m95 -138.2 173.89 11.14 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.725 1.21 . . . . 0.0 110.786 -173.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -72.55 165.98 23.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.199 0.523 . . . . 0.0 111.382 -170.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.51 -11.59 59.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.46 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 m -57.66 -32.48 67.35 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.191 -0.943 . . . . 0.0 111.737 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -83.54 4.97 25.77 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.468 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.95 108.6 2.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -153.66 163.81 39.37 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.622 1.569 . . . . 0.0 107.79 -167.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.76 150.15 22.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.648 0.737 . . . . 0.0 109.612 168.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.18 150.06 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.27 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -83.64 160.81 37.98 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 173.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.22 9.02 0.83 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 93' ' ' GLY . 31.3 t70 -87.09 -30.72 20.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.835 1.654 . . . . 0.0 110.703 168.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -102.47 -39.85 6.94 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.496 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.9 tt -101.13 149.64 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.389 0.995 . . . . 0.0 110.762 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -145.48 147.73 32.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.122 1.369 . . . . 0.0 110.225 169.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.81 144.3 54.34 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.134 1.373 . . . . 0.0 110.238 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -60.34 115.49 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.114 0.87 . . . . 0.0 111.87 -169.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -161.27 165.1 29.73 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.432 1.493 . . . . 0.0 110.431 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.15 -33.99 65.73 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.53 1.532 . . . . 0.0 113.715 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.42 -43.96 96.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.174 0.988 . . . . 0.0 109.949 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -68.75 -33.77 74.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.27 -34.07 61.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.507 0.594 . . . . 0.0 110.682 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.35 99.34 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 119.414 1.006 . . . . 0.0 109.625 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -48.32 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -60.68 -45.44 94.16 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.44 0.696 . . . . 0.0 109.681 -173.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -76.07 -44.11 40.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.17 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -57.35 -33.96 68.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.783 0.72 . . . . 0.0 110.569 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.32 -52.23 9.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.73 -27.19 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.928 1.291 . . . . 0.0 111.747 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -72.25 -45.41 60.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.477 1.111 . . . . 0.0 113.448 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -92.76 -13.22 29.56 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.98 0.809 . . . . 0.0 112.988 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -44.55 116.73 1.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.761 2.425 . . . . 0.0 113.843 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.21 56.01 4.96 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.037 1.303 . . . . 0.0 110.011 169.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -63.1 -18.24 63.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.06 0.944 . . . . 0.0 113.318 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 p -137.57 176.5 8.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.4 1.88 . . . . 0.0 109.171 -172.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.98 30.26 47.92 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 121.817 -0.552 . . . . 0.0 112.207 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m 54.04 40.99 32.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.956 1.302 . . . . 0.0 113.051 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.09 146.02 62.74 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 118.793 -0.623 . . . . 0.0 110.054 172.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.21 157.1 26.93 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.578 2.852 . . . . 0.0 113.198 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.18 -10.24 29.75 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 112.672 -2.058 . . . . 0.0 113.172 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 m -139.92 35.78 1.96 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.243 1.417 . . . . 0.0 109.049 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.93 22.65 0.7 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.957 1.265 . . . . 0.0 112.548 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 172.77 -47.53 0.17 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-O 118.341 -1.255 . . . . 0.0 110.973 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.32 141.02 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 119.439 1.619 . . . . 0.0 108.061 -171.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.512 ' HM2' ' CG ' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp 30.48 94.49 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 130.912 3.685 . . . . 0.0 115.462 168.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -91.71 -4.54 4.0 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.279 2.653 . . . . 0.0 112.731 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -45.21 -25.21 0.34 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 128.654 2.782 . . . . 0.0 115.767 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -78.35 65.4 3.67 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.174 1.39 . . . . 0.0 108.963 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -59.02 156.91 10.89 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.702 1.201 . . . . 0.0 110.849 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? . . . . . 0 C--O 1.254 1.325 0 C-N-CA 123.785 0.834 . . . . 0.0 109.148 175.171 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.31 161.44 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.347 0.659 . . . . 0.0 110.796 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -150.03 -53.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.813 0.845 . . . . 0.0 110.015 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.92 -34.97 77.04 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.355 0.662 . . . . 0.0 111.596 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.94 -28.41 66.22 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.096 0.958 . . . . 0.0 111.749 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -89.32 -6.69 56.49 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.319 1.448 . . . . 0.0 111.88 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -84.53 161.17 20.32 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.963 -1.086 . . . . 0.0 108.295 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -60.06 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 126.875 2.07 . . . . 0.0 109.953 170.045 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.11 130.4 39.72 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -4.07 1.74 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -168.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.66 33.36 0.69 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.4 -161.37 27.11 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 107.346 -2.301 . . . . 0.0 107.346 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' HG2' HE22 ' A' ' 82' ' ' GLN . 56.3 mtt180 -102.96 156.65 17.52 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 168.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.24 156.54 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 168.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 mt -126.03 134.98 51.27 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.16 129.21 47.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.177 0.923 . . . . 0.0 110.038 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -105.98 131.81 52.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 109.638 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -113.68 -19.93 11.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.758 0.823 . . . . 0.0 111.655 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.95 -72.8 0.31 Allowed Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.75 -32.75 29.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.843 1.695 . . . . 0.0 112.26 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.447 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 -179.26 7.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.702 1.601 . . . . 0.0 109.311 -170.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.447 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -140.94 160.61 39.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.779 1.632 . . . . 0.0 107.281 -175.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.07 160.39 39.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.951 0.9 . . . . 0.0 109.508 -170.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -77.24 140.91 40.2 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.67 41.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.671 1.588 . . . . 0.0 108.672 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -148.5 101.52 3.24 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.142 -0.973 . . . . 0.0 110.339 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 64.0 mt -58.93 150.23 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 127.769 2.428 . . . . 0.0 112.025 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.51 -28.37 0.05 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 116.51 -1.709 . . . . 0.0 112.374 166.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 20.7 mtmt -114.72 144.79 42.9 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 168.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -142.26 161.07 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -149.6 152.7 35.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.386 -169.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.01 138.69 13.12 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.187 2.195 . . . . 0.0 108.453 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.89 -9.95 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.503 2.802 . . . . 0.0 113.57 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 m -66.57 -32.04 73.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.934 1.243 . . . . 0.0 111.538 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.8 p -121.1 -15.32 8.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.863 1.665 . . . . 0.0 110.866 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 48.62 49.01 19.19 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.917 0.887 . . . . 0.0 109.757 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.3 mtp -144.85 154.78 43.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.961 2.104 . . . . 0.0 105.793 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -104.52 170.56 7.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.223 0.609 . . . . 0.0 111.911 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -138.64 152.89 48.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.911 2.085 . . . . 0.0 106.445 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.8 m -152.2 156.27 39.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -168.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 pt -147.43 159.92 40.45 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.849 1.259 . . . . 0.0 109.852 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.32 46.15 2.03 Favored 'Trans proline' 0 CA--C 1.549 1.231 0 C-N-CA 124.417 3.411 . . . . 0.0 115.35 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -79.03 -4.13 48.6 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.844 -1.16 . . . . 0.0 112.903 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -151.88 173.69 14.49 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.414 -1.428 . . . . 0.0 113.007 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -134.19 81.68 49.76 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.786 2.435 . . . . 0.0 107.809 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -60.04 166.19 9.24 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.601 2.2 . . . . 0.0 111.794 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.28 -24.41 22.21 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.085 0.85 . . . . 0.0 115.051 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.22 5.95 36.33 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.261 -1.3 . . . . 0.0 114.221 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.1 m -146.01 124.98 12.75 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.713 1.757 . . . . 0.0 110.225 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -54.53 -31.03 55.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.104 1.362 . . . . 0.0 112.235 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -165.28 157.94 15.83 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.117 2.167 . . . . 0.0 107.423 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.64 166.57 23.35 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 166.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 p -92.94 -82.09 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -167.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -151.5 -154.74 0.56 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.525 2.33 . . . . 0.0 106.233 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.51 101.43 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.7 mt -76.12 135.27 27.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.35 140.55 87.7 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.63 139.88 38.19 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.051 1.834 . . . . 0.0 107.381 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -143.65 160.0 41.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -62.99 131.79 49.83 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.178 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -80.35 153.89 28.09 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.404 1.482 . . . . 0.0 111.727 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.12 31.63 1.68 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.37 -40.16 27.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.872 1.336 . . . . 0.0 109.216 169.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -160.32 2.65 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.121 0.968 . . . . 0.0 113.286 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.12 47.21 2.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.678 1.591 . . . . 0.0 111.724 -169.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 m -33.05 142.06 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.65 3.18 . . . . 0.0 113.345 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.8 pt -135.19 132.23 20.04 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 168.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.87 158.85 55.44 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.255 1.303 . . . . 0.0 109.302 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.18 -16.36 3.08 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.341 1.456 . . . . 0.0 112.271 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.13 -32.13 73.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.27 1.828 . . . . 0.0 112.955 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 pt -120.45 -13.19 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.528 1.513 . . . . 0.0 110.868 -173.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.74 -46.03 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 128.278 2.631 . . . . 0.0 108.759 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -79.59 9.03 5.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.95 0.9 . . . . 0.0 111.886 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.1 -176.37 27.23 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.922 1.237 . . . . 0.0 111.093 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.08 130.87 48.0 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -134.29 154.39 51.33 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.885 0.741 . . . . 0.0 110.941 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 23.9 m-85 -141.78 113.49 7.83 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.108 1.363 . . . . 0.0 109.265 -169.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.498 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 55.3 t80 -80.01 129.07 34.2 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.33 157.36 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.362 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -105.8 120.09 40.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 167.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -72.73 118.45 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.439 HE22 ' HG2' ' A' ' 13' ' ' ARG . 62.3 mt-30 -77.7 150.2 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.08 10.91 42.91 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.925 -0.93 . . . . 0.0 113.017 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.444 ' CG ' HM2A ' A' ' 128' ' ' M2L . 48.5 m95 -134.87 171.01 15.0 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 1.233 . . . . 0.0 111.327 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -69.25 158.23 35.39 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.024 0.53 . . . . 0.0 111.338 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 p -63.92 -19.76 65.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.813 0.845 . . . . 0.0 112.127 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.1 m -54.19 -31.94 54.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.424 1.089 . . . . 0.0 112.779 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -84.14 3.23 35.87 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.95 107.01 2.94 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.253 7.5 tp10 -154.31 168.54 26.25 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.623 1.969 . . . . 0.0 107.854 -167.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.61 151.24 22.58 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.823 0.82 . . . . 0.0 111.011 168.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.68 156.38 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.128 174.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.77 161.32 27.0 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.0 1.286 . . . . 0.0 110.11 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.74 7.5 1.49 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -176.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.56 -20.5 27.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.888 1.675 . . . . 0.0 110.752 169.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -119.0 -31.31 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.01 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.9 tt -108.22 155.91 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 120.665 1.575 . . . . 0.0 111.694 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 11.0 mtt85 -149.19 146.84 27.83 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.027 1.331 . . . . 0.0 110.32 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . 0.259 . . -66.99 143.89 56.52 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.339 1.855 . . . . 0.0 111.916 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -59.06 118.67 6.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.461 1.482 . . . . 0.0 111.516 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -169.35 164.78 10.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.06 1.744 . . . . 0.0 110.622 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.97 -27.99 63.95 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.175 -0.953 . . . . 0.0 113.511 -169.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.18 -45.92 72.13 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 119.543 1.065 . . . . 0.0 110.778 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -74.74 -22.35 58.85 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.02 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.18 -37.65 67.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 118.752 0.705 . . . . 0.0 110.127 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.06 99.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.577 1.08 . . . . 0.0 109.742 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.6 ttp -58.13 -53.68 55.48 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -57.75 -46.41 84.54 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.82 -172.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -70.74 -45.19 65.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.237 0.926 . . . . 0.0 110.351 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -34.02 60.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.455 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.6 mt -87.63 -47.27 8.82 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.954 0.797 . . . . 0.0 111.996 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.23 14.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.241 1.416 . . . . 0.0 110.936 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -67.22 -56.98 7.61 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 112.957 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.11 -24.72 35.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.244 0.929 . . . . 0.0 112.694 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.68 118.88 10.86 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.803 0.841 . . . . 0.0 111.107 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.68 -35.73 35.29 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.4 m 54.82 16.55 1.47 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.933 1.693 . . . . 0.0 113.95 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 p -78.33 130.31 36.03 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.559 1.544 . . . . 0.0 108.922 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 121' ' ' ALA . . . 166.41 64.78 0.03 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.0 m -68.43 16.68 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.067 1.347 . . . . 0.0 113.633 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 119' ' ' GLY . . . -144.66 164.66 26.72 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 129.155 2.982 . . . . 0.0 107.707 -169.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.58 82.13 1.47 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.357 2.705 . . . . 0.0 111.88 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.55 148.29 31.01 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.719 1.608 . . . . 0.0 108.139 170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.5 m -80.88 69.22 7.39 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.072 1.349 . . . . 0.0 108.131 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.44 57.27 2.89 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.802 1.668 . . . . 0.0 112.214 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.17 11.13 84.25 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-O 117.886 -1.508 . . . . 0.0 112.252 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.24 143.93 11.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 120.926 2.363 . . . . 0.0 106.289 -168.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.444 HM2A ' CG ' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -163.48 152.48 12.17 Favored Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 125.15 1.38 . . . . 0.0 109.208 169.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -100.36 2.6 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.489 3.459 . . . . 0.0 112.22 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -147.08 158.57 43.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.954 2.502 . . . . 0.0 108.385 -169.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? 126.75 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 1 C-N-CA 133.23 4.612 . . . . 0.0 107.745 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -78.76 163.77 25.1 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.017 0.927 . . . . 0.0 108.899 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 . . . . . 0 C--O 1.254 1.315 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.949 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -68.95 159.66 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.493 1.042 . . . . 0.0 109.818 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.25 142.45 15.83 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.931 1.292 . . . . 0.0 108.141 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 tp 58.32 12.63 2.05 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.135 2.174 . . . . 0.0 114.42 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.13 -53.14 13.65 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.34 111.11 2.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 169.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.94 176.71 6.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.459 -1.7 . . . . 0.0 108.765 169.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -62.71 82.6 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 124.481 2.086 . . . . 0.0 110.293 169.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.07 128.67 34.88 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 103.455 -2.794 . . . . 0.0 103.455 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.86 -2.82 2.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.77 29.41 1.03 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -166.09 34.7 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 168.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -98.28 156.37 16.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.92 156.42 42.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 169.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -127.75 141.27 51.63 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.96 127.09 44.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.171 0.919 . . . . 0.0 109.155 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -86.2 138.07 32.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.383 1.073 . . . . 0.0 108.323 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -120.22 -11.46 9.2 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.19 0.996 . . . . 0.0 112.385 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.67 -72.65 0.48 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.49 -39.11 22.88 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.258 1.972 . . . . 0.0 112.601 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.7 tp -152.27 -171.81 4.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 125.818 1.647 . . . . 0.0 108.919 -169.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.63 150.77 30.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.438 2.295 . . . . 0.0 107.27 -169.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.01 164.19 29.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.985 0.514 . . . . 0.0 111.397 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.0 137.73 37.71 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 125.492 1.517 . . . . 0.0 109.132 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.6 166.24 22.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.999 1.72 . . . . 0.0 108.76 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -152.59 93.46 1.78 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 110.582 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.1 mt -53.11 152.43 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.09 2.156 . . . . 0.0 111.523 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -154.96 -35.06 0.09 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.935 0.894 . . . . 0.0 111.009 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 37.5 ttpt -128.93 137.09 51.2 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.15 164.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -141.39 152.88 44.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.228 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -135.11 150.38 72.79 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 127.596 2.358 . . . . 0.0 110.726 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.75 -17.42 7.18 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.787 2.991 . . . . 0.0 112.877 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m -62.08 -37.49 85.23 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.944 1.298 . . . . 0.0 111.979 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.2 m -128.62 5.89 5.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.155 1.782 . . . . 0.0 111.341 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 46.03 55.89 6.65 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 125.173 1.389 . . . . 0.0 109.932 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 ptm -150.94 169.27 22.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -114.38 172.67 6.87 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.451 0.701 . . . . 0.0 112.444 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -145.11 151.4 38.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.256 2.222 . . . . 0.0 106.627 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.8 t -144.58 152.06 39.97 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pp -141.07 149.17 54.75 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -79.11 67.6 8.54 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.881 3.054 . . . . 0.0 112.992 -169.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -60.49 -51.05 71.13 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -168.89 158.01 8.51 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.052 1.741 . . . . 0.0 107.269 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -67.78 140.8 94.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.903 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.03 170.2 6.52 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.353 2.036 . . . . 0.0 109.105 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.81 5.93 36.3 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 120.999 -1.063 . . . . 0.0 115.069 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.24 29.06 0.46 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.121 1.461 . . . . 0.0 112.289 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 m -141.31 153.7 45.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.057 1.343 . . . . 0.0 108.228 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.5 m -61.8 -57.7 10.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.608 0.763 . . . . 0.0 111.443 -170.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -173.17 159.61 3.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.774 2.029 . . . . 0.0 108.281 170.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.37 154.77 38.7 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 166.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.5 p -129.84 84.96 2.25 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.215 -0.928 . . . . 0.0 111.549 -169.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 79.1 mttt 49.66 -153.41 0.13 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.848 1.659 . . . . 0.0 110.674 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.43 101.18 0.3 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.3 mt -74.54 134.24 29.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -67.7 143.43 96.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.0 134.67 18.08 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 N-CA-C 107.476 -1.779 . . . . 0.0 107.476 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -137.35 167.81 20.87 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -60.99 154.37 22.75 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.88 153.31 23.22 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 111.333 -168.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.83 30.75 3.13 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-O 119.544 -0.587 . . . . 0.0 112.911 170.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.33 -26.26 38.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.221 1.011 . . . . 0.0 110.281 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -152.07 -31.69 0.15 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.209 1.003 . . . . 0.0 112.149 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.41 179.6 5.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.237 1.415 . . . . 0.0 110.621 171.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.4 m -154.8 152.02 29.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.456 2.702 . . . . 0.0 105.827 169.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 pt -136.45 130.6 18.12 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 168.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.18 159.71 51.95 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.999 1.8 . . . . 0.0 109.846 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.01 -20.89 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.266 1.026 . . . . 0.0 112.145 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.59 -36.94 74.77 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.233 1.813 . . . . 0.0 113.677 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.4 pt -116.99 -9.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.998 0.817 . . . . 0.0 110.901 -170.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.59 -47.98 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.696 2.799 . . . . 0.0 108.627 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.8 12.03 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.414 0.686 . . . . 0.0 112.841 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.61 -175.77 24.49 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -57.1 139.64 51.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.6 t -140.33 155.62 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.572 0.545 . . . . 0.0 110.03 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.422 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 25.3 m-85 -140.16 113.4 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.77 1.228 . . . . 0.0 110.906 -169.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -78.16 124.59 28.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.901 2.08 . . . . 0.0 106.374 169.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -134.97 157.44 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 113.45 -1.704 . . . . 0.0 111.429 -168.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -103.78 118.32 36.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.057 -2.572 . . . . 0.0 104.057 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -73.39 117.84 15.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.61 147.0 27.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.77 -171.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.9 8.51 49.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.639 -170.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -128.63 174.73 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.982 1.391 . . . . 0.0 111.481 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.02 162.49 29.38 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.215 0.606 . . . . 0.0 111.427 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -64.78 -22.07 66.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.002 . . . . 0.0 111.928 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -56.37 -30.99 63.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.113 . . . . 0.0 112.594 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -90.06 6.63 41.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.035 -0.983 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 107.18 1.9 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -155.67 164.82 38.1 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.996 1.718 . . . . 0.0 108.249 -167.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.472 ' CH2' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -94.74 149.76 20.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.136 0.97 . . . . 0.0 110.396 168.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.51 151.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.548 171.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.401 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -87.56 158.66 29.98 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.03 8.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 93' ' ' GLY . 35.4 t70 -89.74 -18.8 25.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.914 1.686 . . . . 0.0 111.09 169.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -117.17 -39.01 3.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.856 -1.069 . . . . 0.0 111.392 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.2 tt -99.75 150.99 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.727 1.149 . . . . 0.0 111.365 -175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -143.59 146.62 33.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.609 1.564 . . . . 0.0 110.476 168.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 147.51 53.34 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.871 1.269 . . . . 0.0 111.023 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -64.79 116.44 6.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.051 0.841 . . . . 0.0 111.854 -169.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -159.16 161.71 36.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.963 1.705 . . . . 0.0 109.063 -169.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -61.48 -26.34 67.84 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.618 -1.301 . . . . 0.0 113.114 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -71.65 -44.27 64.62 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.248 1.019 . . . . 0.0 110.8 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.288 44.2 p30 -71.22 -22.28 62.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.338 173.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.1 mm -72.58 -35.55 51.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 119.032 0.833 . . . . 0.0 110.502 169.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.48 98.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.724 1.147 . . . . 0.0 109.684 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.3 ttp -58.8 -53.7 55.4 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -54.0 -46.12 71.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.758 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -73.12 -45.23 58.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.844 0.747 . . . . 0.0 110.041 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.87 39.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.873 -0.584 . . . . 0.0 112.15 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.03 -45.09 8.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.298 0.954 . . . . 0.0 112.037 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.71 13.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.025 1.33 . . . . 0.0 111.316 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -64.73 -34.26 77.89 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.227 1.811 . . . . 0.0 114.15 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -124.0 -16.48 6.54 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.528 1.058 . . . . 0.0 113.826 -170.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 54.8 0.62 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 130.46 3.504 . . . . 0.0 117.094 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.29 -55.98 4.97 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.331 1.443 . . . . 0.0 110.913 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 56.3 m 46.23 48.39 13.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.513 1.525 . . . . 0.0 113.058 171.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.9 49.75 0.55 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.46 1.904 . . . . 0.0 111.857 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.08 -176.42 39.12 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.793 -1.192 . . . . 0.0 111.138 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 m -75.34 10.46 1.6 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 113.886 -175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.79 157.59 35.76 Favored Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 127.219 2.208 . . . . 0.0 107.658 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -54.8 151.26 33.26 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.257 2.638 . . . . 0.0 110.987 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.6 136.74 58.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.658 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 37.8 p -76.27 -26.97 56.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.823 0.449 . . . . 0.0 111.514 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 167.53 -28.46 0.16 Allowed Glycine 0 C--N 1.339 0.703 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.4 166.03 38.17 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 124.609 1.1 . . . . 0.0 110.484 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.74 -3.61 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -167.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp 28.03 97.56 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.361 1 C-N-CA 135.194 5.398 . . . . 0.0 113.493 168.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.42 -11.01 5.24 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.926 2.418 . . . . 0.0 111.572 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -57.44 -26.72 61.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.174 2.59 . . . . 0.0 112.592 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -145.61 -177.07 5.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.804 1.242 . . . . 0.0 109.236 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -130.86 19.49 5.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.864 1.265 . . . . 0.0 111.791 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.812 1.245 . . . . 0.0 108.348 -171.818 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -150.12 137.82 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -162.35 -54.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.13 0.972 . . . . 0.0 109.982 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.98 -42.18 33.61 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.04 0.536 . . . . 0.0 110.546 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -63.74 -22.68 67.03 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.997 0.817 . . . . 0.0 111.5 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -60.28 -37.79 81.59 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.733 1.613 . . . . 0.0 112.116 170.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.35 151.62 26.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.79 0.836 . . . . 0.0 109.227 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.46 126.21 26.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.51 133.91 55.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 -169.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 mt -58.77 -8.07 1.21 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -168.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.02 31.58 0.55 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.18 -163.1 29.96 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 168.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.94 152.71 20.61 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.4 166.35 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 168.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 mt -136.35 140.51 43.34 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.6 124.51 36.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -74.17 132.47 42.23 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.81 0.12 10.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.781 0.833 . . . . 0.0 111.148 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.45 -86.52 0.23 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.74 -26.24 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.731 2.287 . . . . 0.0 113.641 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.525 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -153.34 -170.6 3.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.265 1.426 . . . . 0.0 109.81 -168.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.525 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -144.08 149.22 36.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.389 1.876 . . . . 0.0 108.773 -168.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.71 173.2 11.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.068 0.547 . . . . 0.0 110.982 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.57 144.83 28.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.704 1.202 . . . . 0.0 108.652 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.26 50.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.844 1.258 . . . . 0.0 108.539 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -145.18 101.27 3.59 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.115 0.966 . . . . 0.0 109.852 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.5 mt -57.17 152.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 129.025 2.93 . . . . 0.0 111.175 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.21 -29.83 0.08 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.641 168.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -132.32 133.84 44.51 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 -177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 pt -137.33 161.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -145.64 151.94 38.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.322 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.5 142.6 16.04 Favored Pre-proline 0 C--O 1.241 0.652 0 C-N-CA 126.263 1.825 . . . . 0.0 109.167 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.85 -11.16 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.897 2.398 . . . . 0.0 113.785 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -62.6 -35.59 80.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.095 1.316 . . . . 0.0 112.463 -169.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 m -129.01 4.65 5.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.264 1.026 . . . . 0.0 111.557 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt 41.43 55.7 3.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.748 1.619 . . . . 0.0 111.045 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptm -152.81 160.75 43.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -102.93 169.78 8.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -141.32 146.5 36.8 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 126.863 2.065 . . . . 0.0 105.761 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -148.18 158.51 44.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -169.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.5 pt -131.55 162.82 53.81 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -84.39 42.66 1.21 Allowed 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.334 2.023 . . . . 0.0 111.953 -168.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -68.78 -10.92 59.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.315 1.046 . . . . 0.0 112.22 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -159.6 -177.95 6.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.672 1.589 . . . . 0.0 107.958 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -132.12 87.47 43.69 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.93 -6.2 10.62 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.95 2.433 . . . . 0.0 117.078 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 153.72 -30.73 0.75 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 120.2 1.364 . . . . 0.0 111.725 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.65 -27.54 0.67 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.22 0.914 . . . . 0.0 112.016 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.6 m -62.84 145.54 54.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.984 0.914 . . . . 0.0 109.848 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m 66.61 152.49 0.07 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.171 1.788 . . . . 0.0 111.116 -173.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -56.17 -31.61 63.57 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.84 20.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 m -144.86 103.76 3.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.145 1.778 . . . . 0.0 107.9 -171.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt 52.12 -159.27 0.11 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.953 2.101 . . . . 0.0 111.627 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.61 119.49 8.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.0 mt -84.17 141.31 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 127.075 2.15 . . . . 0.0 106.785 -170.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.11 125.48 91.55 Favored Pre-proline 0 C--O 1.239 0.545 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.659 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.34 135.02 23.81 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.218 1.945 . . . . 0.0 109.049 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -137.08 157.3 47.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.766 0.827 . . . . 0.0 109.008 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.1 mmpt? -64.83 -6.87 9.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -168.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 71.92 151.75 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 114.566 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.54 30.29 2.67 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.772 169.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -83.67 -40.37 19.03 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.887 1.344 . . . . 0.0 109.379 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -160.72 -1.3 0.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 47.16 2.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.013 1.725 . . . . 0.0 110.895 -169.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -32.12 139.32 0.04 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 129.73 3.212 . . . . 0.0 113.383 168.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 pt -135.87 133.63 20.04 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.12 162.21 43.1 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.238 1.959 . . . . 0.0 109.811 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.06 -15.22 8.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 112.472 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.17 -30.23 70.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.632 1.173 . . . . 0.0 112.073 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 7.5 pt -121.73 -9.53 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 120.219 1.372 . . . . 0.0 110.608 -173.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mm -58.4 -47.74 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 127.391 2.276 . . . . 0.0 106.292 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -79.29 8.92 5.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.398 1.479 . . . . 0.0 112.297 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.8 178.48 27.27 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.763 1.165 . . . . 0.0 111.684 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -64.29 131.3 46.9 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m -137.09 152.49 50.08 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.351 1.032 . . . . 0.0 111.426 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -138.88 114.56 9.89 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.84 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -81.27 126.65 31.81 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.865 2.066 . . . . 0.0 106.761 169.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -138.43 154.97 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.764 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -100.34 123.19 44.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 167.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -70.7 113.0 7.35 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -75.76 148.29 38.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.82 8.16 51.81 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.995 -0.891 . . . . 0.0 112.735 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -133.14 170.26 15.67 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.58 1.19 . . . . 0.0 111.071 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -73.6 159.74 32.65 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.96 0.409 . . . . 0.0 110.364 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -73.55 -14.44 61.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.981 0.512 . . . . 0.0 111.656 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.0 m -55.29 -31.71 61.83 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.739 1.216 . . . . 0.0 112.241 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -91.34 7.0 43.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.06 0.944 . . . . 0.0 112.527 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.43 120.41 12.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.263 7.5 tp10 -157.01 166.58 32.95 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.476 1.11 . . . . 0.0 108.288 -167.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.67 151.31 21.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.157 0.979 . . . . 0.0 109.497 168.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.12 153.73 39.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.36 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.88 168.47 31.55 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -16.79 13.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.764 1.226 . . . . 0.0 113.608 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.79 -24.39 50.13 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.223 1.009 . . . . 0.0 113.072 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -119.14 -45.47 2.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.405 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 tt -86.61 163.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -164.68 156.06 15.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 129.139 2.975 . . . . 0.0 110.108 170.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.92 169.43 13.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.846 1.203 . . . . 0.0 111.493 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -80.09 108.41 13.66 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.837 -1.164 . . . . 0.0 109.183 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -154.48 162.99 40.86 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.035 1.334 . . . . 0.0 109.898 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.71 -35.18 55.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.017 1.727 . . . . 0.0 114.795 -169.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.09 -42.62 99.64 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.478 1.609 . . . . 0.0 110.382 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.18 -24.71 47.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.014 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.87 -32.92 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.383 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.74 99.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.784 1.175 . . . . 0.0 109.196 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.1 ttp -56.24 -54.33 46.59 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -56.58 -48.52 77.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.475 0.71 . . . . 0.0 111.211 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -69.12 -45.58 69.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.655 0.661 . . . . 0.0 109.572 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -25.89 54.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.26 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.04 -45.86 7.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.697 1.135 . . . . 0.0 112.685 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.74 -24.76 9.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 111.305 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -68.26 -45.52 72.95 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.013 1.725 . . . . 0.0 113.334 171.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -72.06 -43.09 65.44 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 117.965 0.348 . . . . 0.0 111.15 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.7 173.69 16.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.715 1.245 . . . . 0.0 113.079 -168.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.5 -169.63 29.36 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 127.251 2.357 . . . . 0.0 109.105 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.4 m -70.18 16.82 0.07 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.871 1.669 . . . . 0.0 114.726 -174.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.6 m -135.31 139.54 44.41 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.981 1.312 . . . . 0.0 107.887 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.75 -171.34 43.26 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.0 m -133.01 18.24 4.12 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.286 1.034 . . . . 0.0 111.732 -173.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.06 159.76 68.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 123.48 0.712 . . . . 0.0 109.738 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.56 6.15 1.7 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.346 2.697 . . . . 0.0 114.659 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.56 31.2 2.84 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.143 2.177 . . . . 0.0 109.603 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . 0.285 30.2 p 59.66 -39.72 0.08 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 131.098 3.759 . . . . 0.0 115.815 -173.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.73 -174.14 46.08 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 120.423 1.465 . . . . 0.0 112.072 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.89 53.76 2.55 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 126.079 1.799 . . . . 0.0 112.051 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 49.8 t -145.36 143.74 21.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -169.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.21 156.27 32.45 Favored Pre-proline 0 N--CA 1.444 -0.727 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 169.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -83.13 5.52 6.37 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 122.909 2.406 . . . . 0.0 111.19 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -44.26 -24.85 0.19 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 130.05 3.34 . . . . 0.0 117.761 -173.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -139.1 125.99 20.98 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 120.072 1.305 . . . . 0.0 108.239 -171.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -70.21 -41.42 73.66 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.473 0.709 . . . . 0.0 110.228 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.966 1.707 . . . . 0.0 107.069 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.62 145.59 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.91 -41.5 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.326 1.45 . . . . 0.0 110.231 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.98 -30.1 70.7 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.794 1.238 . . . . 0.0 112.628 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.42 -24.46 55.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.487 0.715 . . . . 0.0 111.27 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -68.17 -22.25 64.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.013 0.925 . . . . 0.0 113.136 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -90.05 152.91 20.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.568 0.747 . . . . 0.0 109.744 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -57.45 89.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.944 2.097 . . . . 0.0 110.117 169.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.95 134.86 37.79 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -6.74 1.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -169.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.73 32.13 0.47 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.51 -173.89 45.4 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.79 157.51 17.9 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.32 154.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 169.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.8 mt -124.25 136.96 54.53 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.0 126.46 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.305 1.003 . . . . 0.0 109.048 -169.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -105.6 123.9 48.67 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.199 1.4 . . . . 0.0 108.244 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.17 -24.88 14.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.195 0.598 . . . . 0.0 111.911 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.27 -70.58 0.31 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.94 -36.97 16.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.143 1.895 . . . . 0.0 112.552 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -153.47 177.78 10.54 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 125.479 1.512 . . . . 0.0 109.268 -168.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 152.12 43.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.384 2.274 . . . . 0.0 107.64 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -137.1 160.9 37.6 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 109.978 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.16 141.82 39.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.91 163.35 32.53 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.861 1.664 . . . . 0.0 108.177 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -153.24 102.28 2.61 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.179 -0.951 . . . . 0.0 110.595 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.1 mt -59.27 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.998 2.519 . . . . 0.0 112.061 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.38 -17.62 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.764 167.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.75 138.36 49.92 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 170.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt -138.77 163.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -168.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -149.12 151.82 35.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.018 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -147.06 140.93 15.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.759 2.424 . . . . 0.0 108.468 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.1 -9.31 25.98 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.704 . . . . 0.0 113.502 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.3 m -67.92 -32.9 73.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.098 1.317 . . . . 0.0 111.646 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 p -117.96 -15.73 9.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.637 1.575 . . . . 0.0 110.646 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt 49.03 48.97 20.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 118.771 0.714 . . . . 0.0 109.39 -169.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.9 mtp -146.48 151.16 36.94 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.781 2.032 . . . . 0.0 105.636 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -101.89 173.68 6.29 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.818 0.447 . . . . 0.0 112.07 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 p -142.84 156.8 45.0 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 126.542 1.937 . . . . 0.0 106.434 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.7 t -148.72 152.02 35.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 pp -142.95 156.23 62.2 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.41 104.98 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.498 3.466 . . . . 0.0 111.085 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -142.76 -3.2 1.01 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.069 0.948 . . . . 0.0 112.169 171.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -152.69 167.99 27.14 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 120.97 -1.081 . . . . 0.0 111.712 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -143.03 85.14 9.99 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 127.56 2.344 . . . . 0.0 105.233 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -63.52 161.03 33.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.949 1.766 . . . . 0.0 110.84 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.68 -22.82 47.99 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.074 1.189 . . . . 0.0 116.074 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.67 5.22 31.02 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.387 -1.229 . . . . 0.0 114.218 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.4 m -145.73 177.44 8.9 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.183 1.491 . . . . 0.0 111.33 -169.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 p -77.69 -169.08 1.37 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.28 1.432 . . . . 0.0 107.634 169.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -66.88 154.22 41.5 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.686 -0.634 . . . . 0.0 110.815 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.16 150.54 48.59 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 167.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -114.42 161.25 18.19 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.93 0.786 . . . . 0.0 112.006 -169.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -22.42 -69.52 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 130.381 3.472 . . . . 0.0 116.163 -169.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -148.63 107.18 3.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 6.1 mt -75.28 132.1 33.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.426 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 11.0 mmpt? -66.89 137.57 94.83 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.76 135.79 26.57 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 N-CA-C 106.896 -2.001 . . . . 0.0 106.896 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -137.04 167.04 22.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -62.06 153.03 30.98 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 169.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.4 tt -105.86 147.13 29.06 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.067 1.747 . . . . 0.0 109.676 -169.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.21 16.95 2.79 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.004 0.815 . . . . 0.0 113.104 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -87.05 -33.8 19.41 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.041 0.92 . . . . 0.0 109.977 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.98 8.0 0.23 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.097 0.959 . . . . 0.0 111.772 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.97 164.09 38.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.709 2.004 . . . . 0.0 107.92 -169.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.7 m -145.56 142.44 29.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.771 2.028 . . . . 0.0 107.352 -170.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.7 pt -135.22 132.73 20.22 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.02 161.32 46.3 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.723 1.615 . . . . 0.0 109.445 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -56.16 -15.44 3.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 112.45 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.32 -27.0 64.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.401 1.48 . . . . 0.0 113.139 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 pt -121.18 -8.17 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 120.131 1.332 . . . . 0.0 111.104 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.85 -45.26 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 128.14 2.576 . . . . 0.0 109.088 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.62 9.86 5.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.931 0.892 . . . . 0.0 112.521 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.57 -172.54 25.82 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -57.55 136.45 56.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.9 t -140.66 153.96 46.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.415 0.447 . . . . 0.0 110.105 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.6 m-85 -140.2 112.45 7.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.348 1.459 . . . . 0.0 110.156 -169.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -77.84 128.82 34.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.68 156.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.983 1.313 . . . . 0.0 112.362 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -101.59 121.84 42.75 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -74.58 112.16 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -78.17 150.5 33.56 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.29 7.58 39.66 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.978 -0.901 . . . . 0.0 112.51 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.495 ' CG ' HM2A ' A' ' 128' ' ' M2L . 42.4 m95 -135.02 172.96 12.27 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.622 1.211 . . . . 0.0 111.38 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -70.89 160.66 32.41 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 122.871 0.468 . . . . 0.0 111.505 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -65.51 -22.29 66.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.137 0.975 . . . . 0.0 111.761 170.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 m -54.97 -32.24 61.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.515 1.126 . . . . 0.0 112.487 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -83.26 -3.31 57.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.497 -1.239 . . . . 0.0 112.957 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -64.6 111.11 2.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -156.67 166.74 32.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.663 1.585 . . . . 0.0 108.673 -167.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -96.32 149.94 21.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.927 0.87 . . . . 0.0 110.693 168.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.35 153.24 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.32 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -89.18 160.54 29.61 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.49 7.23 1.11 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 93' ' ' GLY . 32.5 t70 -83.46 -23.6 32.18 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.312 1.845 . . . . 0.0 110.899 168.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.31 -34.65 3.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.686 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.7 tt -101.68 149.58 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.786 1.175 . . . . 0.0 110.794 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -144.75 149.44 35.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.075 1.35 . . . . 0.0 110.177 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.83 141.96 53.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.13 1.772 . . . . 0.0 110.627 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -59.9 115.47 3.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.541 1.064 . . . . 0.0 111.759 -169.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -160.76 165.62 30.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.148 1.779 . . . . 0.0 110.505 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -57.58 -33.15 67.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.638 1.575 . . . . 0.0 113.392 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -64.59 -43.43 93.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.013 0.911 . . . . 0.0 109.397 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -69.04 -33.01 72.91 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.8 mm -67.83 -34.72 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.448 0.567 . . . . 0.0 110.748 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.881 0.764 . . . . 0.0 110.196 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.63 -49.92 71.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 170.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -59.18 -50.37 74.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.003 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -76.19 -36.15 58.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.425 1.012 . . . . 0.0 109.85 -170.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -40.85 82.29 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 119.103 -0.475 . . . . 0.0 109.977 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.39 -44.08 22.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.568 1.076 . . . . 0.0 112.862 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -49.24 -34.0 13.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.059 1.344 . . . . 0.0 110.83 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -79.51 -54.51 5.84 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.316 1.046 . . . . 0.0 113.148 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -77.38 -26.23 51.67 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.46 4.15 1.76 Allowed 'General case' 0 C--O 1.237 0.395 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -167.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.24 156.55 20.14 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-N 118.815 0.734 . . . . 0.0 112.369 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.1 m -45.86 104.39 0.05 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 128.321 2.648 . . . . 0.0 112.095 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -54.52 122.12 9.85 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.917 1.687 . . . . 0.0 110.039 174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.15 -13.93 82.8 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.35 -0.694 . . . . 0.0 113.72 -171.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.8 p -131.45 15.88 4.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.096 1.358 . . . . 0.0 112.029 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.65 88.49 7.08 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.543 1.537 . . . . 0.0 107.262 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.35 -3.22 11.31 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.903 2.402 . . . . 0.0 114.596 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.24 -30.72 68.46 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.335 1.054 . . . . 0.0 110.655 169.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.1 p 38.29 58.43 1.56 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.828 2.051 . . . . 0.0 111.812 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.95 -28.07 31.3 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.615 1.102 . . . . 0.0 114.319 -172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -84.3 13.62 49.75 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.489 -1.729 . . . . 0.0 113.723 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 80.7 t -135.8 140.25 44.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 121.014 2.407 . . . . 0.0 105.751 -169.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.495 HM2A ' CG ' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -146.04 122.83 5.93 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.506 1.522 . . . . 0.0 108.918 -168.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -84.18 -15.29 6.71 Favored 'Trans proline' 0 CA--C 1.553 1.456 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 167.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' A' ' 132' ' ' ARG . 5.4 t60 -77.76 -167.92 1.09 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 131.126 3.77 . . . . 0.0 108.15 169.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.569 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 82.0 mtt-85 49.15 46.37 22.77 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.657 1.983 . . . . 0.0 112.105 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -57.75 -29.01 64.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.825 0.85 . . . . 0.0 111.172 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.5 1.92 . . . . 0.0 107.589 171.739 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.0 m -138.35 160.6 31.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.368 1.467 . . . . 0.0 108.076 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -153.31 -60.23 0.14 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.525 0.73 . . . . 0.0 109.103 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tt -58.74 -40.98 85.38 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.811 0.844 . . . . 0.0 109.987 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.07 3.39 2.11 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.047 1.339 . . . . 0.0 113.359 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -129.59 -7.24 4.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.816 2.046 . . . . 0.0 110.814 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -86.47 166.19 15.7 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -56.2 132.71 51.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.94 129.62 45.69 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -3.27 0.38 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.0 28.79 0.53 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.81 -173.73 48.71 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 106.828 -2.509 . . . . 0.0 106.828 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 mtt85 -91.33 159.99 15.73 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.94 161.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -130.03 140.84 50.8 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.7 128.4 32.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -102.51 124.97 49.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 108.573 -169.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -101.6 -23.19 14.31 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.438 0.295 . . . . 0.0 111.194 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.88 -73.76 0.25 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.63 -31.14 27.01 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.55 2.167 . . . . 0.0 112.273 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.403 HD23 ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.38 177.94 10.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.131 1.772 . . . . 0.0 108.287 -169.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.403 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -135.15 162.09 33.49 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.643 1.577 . . . . 0.0 107.208 -173.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -136.59 159.82 40.66 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.248 1.019 . . . . 0.0 108.854 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -76.61 147.27 37.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.537 . . . . 0.0 109.732 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.94 31.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.846 1.258 . . . . 0.0 108.882 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -153.11 111.38 3.65 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.197 -0.939 . . . . 0.0 110.706 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.0 mt -59.03 152.17 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 128.895 2.878 . . . . 0.0 111.688 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pp -157.99 -30.04 0.08 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.913 0.885 . . . . 0.0 112.514 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 31.9 ttpt -131.25 140.99 49.93 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.99 164.88 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -168.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -149.91 152.21 34.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.973 -168.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.29 141.11 14.53 Favored Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 125.137 1.375 . . . . 0.0 109.965 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.45 -0.23 7.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.088 3.192 . . . . 0.0 113.501 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -66.13 -34.46 78.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.032 1.287 . . . . 0.0 110.979 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -130.81 -7.86 4.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.37 1.068 . . . . 0.0 112.164 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 45.16 53.14 8.13 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.221 1.009 . . . . 0.0 110.72 -169.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -148.81 151.87 35.53 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.827 2.051 . . . . 0.0 105.815 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -103.21 168.06 9.42 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.86 0.464 . . . . 0.0 112.043 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 p -136.42 153.54 51.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 107.324 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.5 m -151.62 158.07 42.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.738 0.699 . . . . 0.0 110.1 -168.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.9 pt -145.77 156.11 52.13 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 126.151 1.781 . . . . 0.0 108.621 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -83.56 55.32 4.89 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.586 3.524 . . . . 0.0 109.66 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -54.03 -43.0 69.77 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.553 -0.717 . . . . 0.0 111.591 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.69 0.51 23.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.044 0.938 . . . . 0.0 112.439 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 44.47 48.37 4.51 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.645 1.178 . . . . 0.0 108.89 -168.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -60.18 143.13 99.54 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.741 2.961 . . . . 0.0 110.359 -169.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.07 0.9 1.75 Allowed Glycine 0 CA--C 1.539 1.583 0 C-N-CA 123.913 0.768 . . . . 0.0 114.339 -175.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.16 53.03 2.26 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -170.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 m 53.16 16.14 0.74 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.567 1.947 . . . . 0.0 115.312 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 m -92.11 14.06 17.12 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.389 1.876 . . . . 0.0 111.305 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -145.86 165.65 28.26 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.755 2.422 . . . . 0.0 107.256 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 44.77 34.62 1.22 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.178 0.991 . . . . 0.0 113.004 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -39.06 94.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 130.252 3.421 . . . . 0.0 114.9 -168.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? 42.64 -147.61 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.064 2.546 . . . . 0.0 112.104 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.19 108.5 0.61 Allowed 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.296 -0.878 . . . . 0.0 108.675 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.53 141.74 13.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.76 142.95 88.91 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 123.157 0.583 . . . . 0.0 109.613 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.31 142.18 33.2 Favored 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.54 1.493 . . . . 0.0 108.691 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -132.52 166.32 22.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.014 0.926 . . . . 0.0 109.023 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.645 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -64.7 -13.52 54.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -168.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 68.12 151.66 0.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.647 1.979 . . . . 0.0 112.681 -169.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.42 55.38 0.15 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.113 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 51.44 2.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.736 1.214 . . . . 0.0 108.072 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.59 -7.4 0.72 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.126 2.571 . . . . 0.0 113.405 -172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.95 33.02 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.641 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -33.74 140.51 0.05 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 130.502 3.521 . . . . 0.0 112.203 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.2 pt -135.41 135.17 21.91 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.564 1.146 . . . . 0.0 108.093 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.94 162.76 41.57 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.03 1.82 . . . . 0.0 109.723 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.14 -17.26 10.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.964 0.906 . . . . 0.0 112.571 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.45 -28.66 69.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.607 1.163 . . . . 0.0 112.536 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . 0.253 7.2 pt -122.21 -9.01 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 120.081 1.31 . . . . 0.0 110.844 -174.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mm -61.16 -50.94 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.484 2.313 . . . . 0.0 105.817 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -78.79 9.16 4.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.496 1.518 . . . . 0.0 111.648 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.72 173.79 24.44 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.45 1.023 . . . . 0.0 110.696 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -62.72 132.49 52.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -135.6 152.71 51.52 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 124.11 0.881 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 32.3 m-85 -142.94 116.29 9.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 109.674 -169.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -81.28 125.36 30.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.252 2.221 . . . . 0.0 105.811 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.53 157.44 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.409 -168.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -100.94 118.51 37.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.14 119.73 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.83 149.53 25.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.9 8.57 57.99 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.553 -169.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.448 ' CG ' ' HM2' ' A' ' 128' ' ' M2L . 75.4 m95 -133.89 172.66 12.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.493 1.146 . . . . 0.0 111.633 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -71.1 158.6 36.19 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.196 0.598 . . . . 0.0 110.423 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.6 m -70.36 -12.28 61.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.628 0.371 . . . . 0.0 111.843 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.7 m -56.42 -33.31 65.7 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.748 -1.22 . . . . 0.0 112.439 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -80.24 3.38 21.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.973 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.95 108.72 2.68 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.21 167.21 29.31 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.685 1.994 . . . . 0.0 107.441 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.406 ' CH2' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -100.21 149.56 23.44 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.911 0.862 . . . . 0.0 110.378 169.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.92 150.78 31.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.283 173.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -85.74 158.51 32.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.63 8.12 0.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 93' ' ' GLY . 36.5 t70 -88.59 -18.72 27.46 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.047 1.739 . . . . 0.0 111.311 169.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -119.79 -35.68 3.46 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 117.255 -1.355 . . . . 0.0 111.984 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.3 tt -98.9 153.66 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 120.474 1.488 . . . . 0.0 110.883 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -149.83 152.54 35.32 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.842 1.657 . . . . 0.0 110.827 170.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 154.74 41.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.925 1.69 . . . . 0.0 111.863 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.403 ' CE2' HD12 ' A' ' 105' ' ' ILE . 41.3 t80 -60.59 118.17 6.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.577 0.626 . . . . 0.0 109.882 176.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -164.4 160.59 20.87 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.312 1.445 . . . . 0.0 109.084 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -53.15 -35.7 60.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.523 1.529 . . . . 0.0 113.755 -169.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.82 -43.81 97.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.684 0.755 . . . . 0.0 110.726 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -74.15 -26.55 60.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.813 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.403 HD12 ' CE2' ' A' ' 100' ' ' TYR . 4.3 mm -68.52 -39.08 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.931 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.33 98.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.965 0.802 . . . . 0.0 109.47 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -50.88 72.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -60.5 -46.77 88.92 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.281 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -73.77 -40.19 63.64 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 119.067 0.849 . . . . 0.0 111.04 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -48.59 75.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.02 -44.33 61.04 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.954 -1.091 . . . . 0.0 112.231 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.75 -13.96 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.238 1.815 . . . . 0.0 112.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -106.37 -38.84 6.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.059 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.31 -27.2 59.21 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.535 1.061 . . . . 0.0 111.409 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.75 0.18 1.09 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -168.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.02 -144.26 42.85 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 119.873 1.215 . . . . 0.0 110.094 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 p -149.82 -32.15 0.2 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 117.916 0.858 . . . . 0.0 112.224 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.1 p -139.97 167.1 22.9 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.422 1.489 . . . . 0.0 109.083 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.27 -175.32 53.7 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.37 0.509 . . . . 0.0 111.862 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.1 m -64.15 162.35 14.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.784 1.234 . . . . 0.0 111.421 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.68 156.2 44.96 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.593 1.557 . . . . 0.0 108.657 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.01 37.7 0.6 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.424 3.416 . . . . 0.0 112.358 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.44 -177.86 6.09 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.325 1.85 . . . . 0.0 108.894 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.1 m -55.12 -32.8 62.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.846 1.259 . . . . 0.0 111.411 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 170.04 -54.25 0.2 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 62.9 10.57 33.08 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.875 -0.958 . . . . 0.0 113.512 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.9 t -147.51 139.03 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -169.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.448 ' HM2' ' CG ' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -152.85 154.06 30.78 Favored Pre-proline 0 N--CA 1.44 -0.97 0 C-N-CA 129.44 3.096 . . . . 0.0 103.024 168.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.59 -7.76 16.85 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.512 1.475 . . . . 0.0 110.879 169.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -48.95 -48.93 42.61 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.616 2.366 . . . . 0.0 112.706 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -163.76 163.63 23.98 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.598 1.159 . . . . 0.0 109.047 -177.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -152.72 161.48 42.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.044 1.338 . . . . 0.0 108.353 175.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.299 1.439 . . . . 0.0 107.863 174.2 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -138.23 131.86 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -151.22 18.26 0.75 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.826 0.822 . . . . 0.0 111.832 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.4 mt -124.26 14.66 9.02 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.643 1.977 . . . . 0.0 110.232 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.33 -34.76 73.07 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.551 1.54 . . . . 0.0 107.862 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.27 114.67 7.14 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 101.069 -3.678 . . . . 0.0 101.069 169.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.29 174.67 8.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.652 1.981 . . . . 0.0 108.805 169.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -63.22 68.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 130.454 3.502 . . . . 0.0 110.063 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 138.73 54.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 112.121 -2.308 . . . . 0.0 106.145 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.81 -10.9 1.89 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -168.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.27 32.88 0.5 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 170.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.24 -163.04 21.52 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 169.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 mtt85 -102.33 153.83 19.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 168.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.59 169.27 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -135.26 142.41 45.93 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 103.243 -2.873 . . . . 0.0 103.243 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.3 147.1 51.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -115.12 119.53 36.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -102.14 -9.5 20.45 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.243 0.617 . . . . 0.0 112.56 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.03 -77.99 0.3 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -66.46 -38.66 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.439 2.092 . . . . 0.0 113.317 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 21.2 tp -148.2 177.76 9.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 125.129 1.371 . . . . 0.0 109.294 -168.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -139.59 149.23 43.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.598 2.359 . . . . 0.0 107.129 -168.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -136.44 154.32 50.81 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.539 0.736 . . . . 0.0 109.765 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.64 141.9 57.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.277 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.62 162.59 29.04 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.137 1.775 . . . . 0.0 108.083 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -148.66 95.72 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.465 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.0 mt -55.52 151.35 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.392 2.277 . . . . 0.0 110.743 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -156.73 -32.27 0.09 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.779 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.424 ' HD2' ' CD2' ' A' ' 38' ' ' TYR . 36.8 ttpt -131.53 138.04 48.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.35 165.33 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -144.3 153.37 41.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.331 -169.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.53 143.57 17.49 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.022 1.729 . . . . 0.0 109.243 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.69 -12.48 36.08 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.585 2.857 . . . . 0.0 113.586 176.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.9 m -64.77 -32.74 74.56 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.066 1.303 . . . . 0.0 111.883 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.0 m -121.35 -11.28 8.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.452 1.101 . . . . 0.0 111.077 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 48.29 49.67 17.49 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.156 0.982 . . . . 0.0 109.331 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -145.4 159.09 43.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.144 2.177 . . . . 0.0 105.5 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.424 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 42.1 p90 -104.58 174.97 5.65 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.622 . . . . 0.0 112.573 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -143.47 152.54 41.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.549 2.339 . . . . 0.0 106.132 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.7 t -147.56 161.17 41.67 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.2 pt -144.33 159.2 52.83 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.96 0.904 . . . . 0.0 110.017 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.88 32.59 0.23 Allowed 'Trans proline' 0 CA--C 1.547 1.174 1 C-N-CA 125.947 4.432 . . . . 0.0 115.025 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -49.35 -50.44 39.83 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.032 0.933 . . . . 0.0 110.649 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -165.01 -122.92 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -152.14 154.96 33.03 Favored Pre-proline 0 C--O 1.24 0.578 0 CA-C-N 119.492 1.042 . . . . 0.0 110.39 -169.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.39 176.41 4.87 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.315 2.01 . . . . 0.0 106.912 166.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.92 23.36 0.7 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.236 1.398 . . . . 0.0 113.863 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.53 28.31 0.15 Allowed Glycine 0 CA--C 1.533 1.159 0 CA-C-N 118.75 1.275 . . . . 0.0 114.904 -174.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -144.61 169.85 17.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.696 1.748 . . . . 0.0 109.622 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.8 m -79.61 -45.3 19.39 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.082 0.553 . . . . 0.0 111.758 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -168.98 145.24 3.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.433 0.693 . . . . 0.0 109.144 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.99 159.66 11.14 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 167.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -88.88 -71.46 0.59 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -168.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -151.75 -160.91 1.22 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.93 2.892 . . . . 0.0 104.34 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.31 109.1 1.46 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mt -73.66 135.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -173.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.19 137.49 96.94 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.02 137.9 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 107.165 -1.898 . . . . 0.0 107.165 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -141.19 164.49 30.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -63.62 153.12 36.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.3 tt -107.71 154.3 21.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.524 1.93 . . . . 0.0 110.583 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.01 21.96 5.12 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.137 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -77.78 -33.42 52.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.723 0.762 . . . . 0.0 109.166 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.9 6.35 0.61 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.696 1.198 . . . . 0.0 111.79 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -124.75 172.53 9.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.012 1.325 . . . . 0.0 111.648 -169.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.9 m -149.55 144.03 25.98 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.988 2.115 . . . . 0.0 106.343 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.3 pt -135.54 120.97 13.77 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 169.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.99 154.45 27.37 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.282 1.988 . . . . 0.0 111.181 170.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.43 -24.46 12.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.341 1.056 . . . . 0.0 111.619 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -57.13 -32.64 66.56 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.156 1.783 . . . . 0.0 114.215 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 pt -117.77 -17.13 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.702 1.137 . . . . 0.0 110.508 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.67 -44.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 128.418 2.687 . . . . 0.0 109.16 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.94 11.53 6.02 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.342 -169.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.88 -177.79 29.43 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 119.577 1.08 . . . . 0.0 111.045 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.87 133.36 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 m -135.99 150.72 49.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 123.812 0.695 . . . . 0.0 110.139 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -135.19 113.3 11.21 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.32 1.048 . . . . 0.0 110.111 -169.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -77.62 121.81 24.46 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.296 2.238 . . . . 0.0 106.963 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.04 159.04 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.672 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -106.95 129.04 54.82 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -75.25 110.02 9.25 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.54 149.21 42.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.915 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.84 4.53 34.26 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.756 -1.024 . . . . 0.0 112.364 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -130.2 172.15 12.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.828 1.314 . . . . 0.0 111.832 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -68.22 162.78 24.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.4 m -65.65 -20.59 66.36 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.018 0.927 . . . . 0.0 111.589 169.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -59.44 -31.04 68.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.789 0.836 . . . . 0.0 112.354 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -91.85 17.56 8.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.801 0.84 . . . . 0.0 112.705 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.1 106.87 1.14 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -153.87 158.07 40.23 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 108.036 -168.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.43 150.41 21.07 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.42 1.105 . . . . 0.0 109.326 167.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.89 154.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.328 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.3 168.18 30.79 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -16.42 6.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.51 1.124 . . . . 0.0 113.297 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.48 -23.79 52.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.532 1.533 . . . . 0.0 112.976 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -123.12 -37.64 2.69 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.227 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 tt -95.63 157.5 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.496 1.044 . . . . 0.0 112.822 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -152.81 165.24 36.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.692 3.197 . . . . 0.0 109.117 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -99.61 155.21 17.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.67 1.588 . . . . 0.0 112.861 -172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -67.22 109.06 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.345 1.069 . . . . 0.0 112.551 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -157.74 162.45 38.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 125.764 1.625 . . . . 0.0 108.786 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -54.95 -33.98 62.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -168.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.55 -43.24 97.66 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.081 0.855 . . . . 0.0 110.328 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.72 -25.13 60.05 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.633 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.8 mm -73.87 -32.54 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 118.508 0.594 . . . . 0.0 111.382 171.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.59 96.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.209 0.913 . . . . 0.0 109.097 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -51.69 68.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -54.42 -49.36 70.14 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 123.706 0.802 . . . . 0.0 110.462 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -74.21 -44.71 52.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.368 0.531 . . . . 0.0 110.419 -173.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -32.82 55.64 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.966 0.506 . . . . 0.0 111.068 174.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.63 -46.52 9.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.953 0.797 . . . . 0.0 112.426 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.41 -29.95 11.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 111.31 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -65.64 -33.97 77.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.867 1.667 . . . . 0.0 114.292 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.16 -2.72 11.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -48.19 -38.45 18.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.359 2.264 . . . . 0.0 113.417 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.15 -158.87 44.9 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.7 m -147.02 152.31 38.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.491 1.917 . . . . 0.0 106.632 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.6 m -64.26 154.06 36.22 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -160.01 -168.66 22.28 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.5 m -72.5 35.34 0.07 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.752 2.021 . . . . 0.0 113.663 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -138.54 149.03 61.23 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.858 1.663 . . . . 0.0 107.668 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.62 23.23 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.271 3.314 . . . . 0.0 113.804 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.47 149.33 50.21 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.172 0.989 . . . . 0.0 111.433 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.5 p -134.04 -9.36 2.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.761 1.624 . . . . 0.0 111.697 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.87 53.6 3.72 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.991 1.758 . . . . 0.0 112.105 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.7 -40.88 0.04 OUTLIER Glycine 0 C--O 1.219 -0.804 0 CA-C-O 117.84 -1.533 . . . . 0.0 110.96 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.75 134.77 15.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 120.193 1.997 . . . . 0.0 106.378 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -140.79 117.91 7.83 Favored Pre-proline 0 N--CA 1.453 -0.312 0 C-N-CA 124.759 1.224 . . . . 0.0 111.123 -167.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -90.91 -5.25 4.36 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.101 2.534 . . . . 0.0 111.08 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -141.76 137.88 31.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.753 2.821 . . . . 0.0 107.535 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 127.02 153.35 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.369 4.668 . . . . 0.0 107.85 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -145.98 157.6 43.88 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.772 1.229 . . . . 0.0 108.877 -170.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 . . . . . 0 C--O 1.254 1.296 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.024 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 121.072 0.463 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.46 161.4 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.515 1.126 . . . . 0.0 109.455 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -139.21 157.69 45.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.4 1.08 . . . . 0.0 109.763 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 tt 57.94 -52.99 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 131.503 3.921 . . . . 0.0 114.739 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.69 -22.57 64.06 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.807 1.243 . . . . 0.0 110.836 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -57.02 -28.49 62.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 129.903 3.281 . . . . 0.0 114.164 173.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -72.87 154.52 40.56 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.281 -0.887 . . . . 0.0 109.771 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -57.82 128.84 39.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 168.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.67 136.5 54.51 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -169.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.94 -3.62 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -168.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.05 30.41 0.3 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.66 -168.86 44.26 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 169.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -94.87 157.32 15.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.2 166.62 28.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 102.461 -3.162 . . . . 0.0 102.461 168.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -132.1 139.75 48.59 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.76 135.46 36.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -106.04 111.67 24.39 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -81.56 -35.16 30.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.622 0.646 . . . . 0.0 110.313 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.37 -72.04 0.19 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.11 -28.54 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.188 2.592 . . . . 0.0 113.338 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.464 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -150.92 171.73 16.8 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.308 1.443 . . . . 0.0 108.622 -173.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.464 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -134.14 144.7 48.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.949 2.099 . . . . 0.0 106.605 -169.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -133.27 160.07 38.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.747 0.819 . . . . 0.0 109.178 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.42 145.74 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.29 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.3 159.13 42.8 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.227 1.411 . . . . 0.0 107.952 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 94.55 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.896 -0.503 . . . . 0.0 110.63 -169.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.11 149.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.577 2.751 . . . . 0.0 112.159 -177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.54 -24.62 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.439 1.087 . . . . 0.0 113.356 167.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -125.86 139.25 53.63 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.08 165.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -149.76 154.7 38.91 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.515 -169.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.73 141.17 15.02 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 109.147 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -67.19 -10.47 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.268 2.645 . . . . 0.0 112.783 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.3 m -65.11 -33.28 75.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.404 1.456 . . . . 0.0 111.295 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -120.24 -16.32 8.51 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.291 1.836 . . . . 0.0 110.734 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm 49.07 53.25 12.92 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.538 0.735 . . . . 0.0 109.095 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 76.7 mtp -149.01 154.03 38.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.462 2.305 . . . . 0.0 105.533 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -100.58 174.41 6.09 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.158 0.583 . . . . 0.0 112.302 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -144.1 151.91 40.24 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.583 2.353 . . . . 0.0 106.34 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 44.7 t -147.81 161.11 41.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.9 pt -147.78 159.43 40.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.199 1.4 . . . . 0.0 110.097 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.08 94.73 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.426 3.417 . . . . 0.0 110.915 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -141.49 -4.65 1.1 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.479 0.712 . . . . 0.0 112.699 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -152.54 178.47 9.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.394 0.997 . . . . 0.0 111.001 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -144.37 69.7 15.72 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.305 2.242 . . . . 0.0 107.7 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.07 -27.09 53.45 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.755 2.304 . . . . 0.0 116.761 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.75 -41.84 2.1 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 119.673 1.124 . . . . 0.0 110.687 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.89 -16.82 68.79 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 123.815 0.722 . . . . 0.0 112.005 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -141.14 142.22 34.08 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 127.015 2.126 . . . . 0.0 106.534 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 m -63.57 -30.98 72.02 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.08 0.952 . . . . 0.0 111.745 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -158.77 160.43 36.29 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.496 1.918 . . . . 0.0 107.798 169.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.49 137.53 48.25 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 102.942 -2.985 . . . . 0.0 102.942 167.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.3 m -118.5 105.76 11.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.428 1.013 . . . . 0.0 112.154 -168.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt 54.95 -168.29 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.252 2.221 . . . . 0.0 112.266 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.37 101.96 0.81 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.7 mt -73.93 138.32 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.71 138.15 95.3 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.4 132.47 19.23 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 N-CA-C 107.18 -1.892 . . . . 0.0 107.18 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -137.16 165.28 26.48 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.623 1.169 . . . . 0.0 108.345 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.69 153.74 42.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.5 tt -119.83 142.68 48.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.118 1.767 . . . . 0.0 109.044 -169.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.86 30.24 1.06 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-N 114.774 -1.103 . . . . 0.0 114.144 169.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.89 -39.31 76.33 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.107 1.453 . . . . 0.0 109.769 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -152.86 -32.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.561 1.544 . . . . 0.0 111.043 170.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -66.73 21.1 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.357 3.063 . . . . 0.0 114.03 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -33.39 132.1 0.2 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.359 2.264 . . . . 0.0 111.263 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.288 7.0 tt -124.9 141.95 39.68 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -168.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.46 145.62 48.05 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.417 1.411 . . . . 0.0 110.747 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.44 -15.67 4.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.088 1.355 . . . . 0.0 112.901 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.48 -26.67 68.83 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 112.311 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 pt -122.33 -15.07 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.093 0.86 . . . . 0.0 111.223 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mm -50.75 -42.66 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.578 2.351 . . . . 0.0 109.507 170.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -83.21 10.76 7.67 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.708 1.203 . . . . 0.0 112.475 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.9 -175.78 26.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.85 139.52 58.35 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.9 m -133.19 149.22 52.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.891 0.745 . . . . 0.0 109.427 172.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -136.33 112.63 9.86 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.482 1.113 . . . . 0.0 108.616 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.68 126.94 31.58 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 126.399 1.88 . . . . 0.0 107.511 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -136.76 154.85 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 124.919 1.387 . . . . 0.0 112.491 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -100.77 119.57 38.82 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.19 111.62 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -82.05 151.58 27.0 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.92 2.72 58.29 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.48 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.488 ' CH2' ' SG ' ' A' ' 128' ' ' M2L . 94.2 m95 -136.75 179.31 6.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.583 1.192 . . . . 0.0 110.991 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -77.84 160.47 28.29 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.858 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 m -72.53 -13.51 61.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.548 0.739 . . . . 0.0 111.834 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -53.55 -31.75 47.86 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.951 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -89.75 7.68 35.63 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.911 -1.042 . . . . 0.0 113.239 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -64.01 115.89 5.35 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.29 165.07 37.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.193 1.397 . . . . 0.0 108.187 -167.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.65 150.06 23.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.277 1.037 . . . . 0.0 110.043 168.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.17 159.99 42.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.612 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.83 173.01 23.22 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.995 1.283 . . . . 0.0 110.021 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -16.85 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 113.382 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.73 -21.42 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.628 1.171 . . . . 0.0 113.0 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -121.54 -39.88 2.61 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.377 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.9 tt -94.83 157.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.822 1.192 . . . . 0.0 113.323 -168.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -155.04 158.05 38.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.465 3.106 . . . . 0.0 108.778 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.29 168.39 19.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.247 1.839 . . . . 0.0 112.971 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.417 ' CE2' HD11 ' A' ' 105' ' ' ILE . 25.0 t80 -67.96 117.53 9.95 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.841 -1.162 . . . . 0.0 109.84 169.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -161.03 164.15 31.12 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.684 1.593 . . . . 0.0 108.893 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -59.5 -30.43 68.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.444 1.098 . . . . 0.0 113.393 -169.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.63 -42.11 91.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.443 1.116 . . . . 0.0 109.848 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -73.39 -27.84 61.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.359 -0.838 . . . . 0.0 109.56 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.417 HD11 ' CE2' ' A' ' 100' ' ' TYR . 7.2 mm -70.05 -32.74 52.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 CA-C-N 118.751 0.705 . . . . 0.0 110.933 169.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.18 99.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.52 1.055 . . . . 0.0 109.724 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -49.0 79.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.86 -47.12 83.64 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.529 0.732 . . . . 0.0 109.966 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -73.52 -44.51 57.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.524 0.602 . . . . 0.0 109.961 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -32.47 50.81 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.5 173.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.6 mt -89.95 -44.33 9.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.282 0.947 . . . . 0.0 112.348 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.89 -28.45 9.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.249 1.42 . . . . 0.0 111.723 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -66.85 -34.68 78.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.928 1.691 . . . . 0.0 114.263 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -125.19 -11.42 6.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -169.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 51.53 18.27 0.66 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.532 2.733 . . . . 0.0 115.403 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.79 -38.4 2.68 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.996 1.76 . . . . 0.0 111.895 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.3 m 43.79 47.32 6.73 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.333 1.453 . . . . 0.0 112.614 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.0 p -60.38 -24.06 64.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.391 1.076 . . . . 0.0 111.71 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.57 168.87 40.85 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.761 1.648 . . . . 0.0 109.164 169.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.1 m -68.52 102.94 1.55 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.843 0.857 . . . . 0.0 109.215 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.91 157.43 31.35 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.33 1.452 . . . . 0.0 108.907 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.45 32.7 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 124.498 3.465 . . . . 0.0 112.409 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.19 9.83 2.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.798 1.639 . . . . 0.0 112.842 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 p -72.45 60.53 0.46 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.144 2.578 . . . . 0.0 112.02 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.74 -28.62 0.11 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.842 1.21 . . . . 0.0 111.284 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.44 137.11 3.94 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.2 p -117.56 -17.66 7.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.488 ' SG ' ' CH2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.9 mmpp? -153.91 108.57 2.5 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 121.074 -1.017 . . . . 0.0 110.712 -168.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -83.35 -9.3 10.4 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.529 2.153 . . . . 0.0 110.64 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 132' ' ' ARG . 15.3 t60 -124.04 -175.79 3.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.291 3.036 . . . . 0.0 107.098 -169.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . 0.524 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 29.4 mmm180 52.15 34.23 13.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.978 1.711 . . . . 0.0 111.097 -171.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -151.04 155.86 39.89 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.861 1.665 . . . . 0.0 107.861 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.404 1.482 . . . . 0.0 107.083 177.792 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.56 156.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 118.779 0.718 . . . . 0.0 110.057 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -156.18 -46.22 0.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.988 0.915 . . . . 0.0 110.426 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.48 -25.14 67.84 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.387 1.075 . . . . 0.0 112.171 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -55.47 -24.04 28.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.041 1.336 . . . . 0.0 111.768 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -59.08 -33.64 71.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.111 1.364 . . . . 0.0 112.544 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -96.38 161.78 13.78 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 121.877 0.846 . . . . 0.0 110.232 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 1 C-N-CA 132.95 4.5 . . . . 0.0 110.948 171.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.44 142.35 58.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.333 -1.758 . . . . 0.0 106.804 -169.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.69 -10.19 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.28 30.9 0.38 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 179.33 53.19 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 171.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.35 153.66 24.46 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 168.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.2 164.68 34.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 169.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.9 mt -140.56 116.35 10.3 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 -170.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.5 138.71 47.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.363 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -120.59 118.57 30.52 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.199 1.4 . . . . 0.0 108.202 -169.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -98.84 -22.01 16.04 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.87 0.468 . . . . 0.0 111.449 -170.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.31 -76.57 0.23 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -68.19 -31.56 29.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.107 1.871 . . . . 0.0 112.457 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -153.07 176.33 12.02 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.768 1.227 . . . . 0.0 110.743 -171.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.498 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -130.07 154.6 47.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.809 2.444 . . . . 0.0 107.491 -173.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.434 ' CD2' ' HM2' ' A' ' 128' ' ' M2L . 17.3 m-85 -140.41 149.59 42.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.186 1.394 . . . . 0.0 108.765 -176.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.34 145.53 51.12 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.94 161.23 37.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.475 1.51 . . . . 0.0 109.02 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -148.5 104.37 3.49 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.407 -0.808 . . . . 0.0 109.777 -171.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 54.7 mt -64.79 155.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 128.447 2.699 . . . . 0.0 112.904 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.79 -20.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.822 -1.085 . . . . 0.0 113.724 166.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -131.58 138.66 48.95 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.6 161.76 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -168.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -144.68 154.55 42.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.384 -168.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -146.51 140.93 15.73 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.725 2.41 . . . . 0.0 108.881 -174.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.62 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.666 2.911 . . . . 0.0 113.549 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -66.87 -32.22 73.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.068 1.303 . . . . 0.0 111.571 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.9 m -121.56 -11.09 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.647 1.179 . . . . 0.0 111.02 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt 47.09 50.41 14.1 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.058 0.943 . . . . 0.0 109.985 -171.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.3 mtp -150.65 154.0 36.67 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.365 2.266 . . . . 0.0 105.163 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 48.8 p90 -103.45 175.12 5.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 p -141.56 155.92 45.74 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.009 2.124 . . . . 0.0 106.847 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -154.06 156.66 37.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 pt -141.15 162.9 45.42 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.111 0.564 . . . . 0.0 110.58 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.47 45.43 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.991 3.794 . . . . 0.0 111.798 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -57.26 -54.39 47.38 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.631 -0.668 . . . . 0.0 109.826 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -166.59 171.16 11.98 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.544 1.138 . . . . 0.0 108.648 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -64.76 150.33 94.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 127.33 2.252 . . . . 0.0 111.495 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.2 177.84 3.47 Favored 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 122.65 2.233 . . . . 0.0 107.268 166.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.07 -27.42 22.46 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.726 -1.234 . . . . 0.0 115.635 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.51 43.97 0.55 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.52 1.66 . . . . 0.0 113.622 -173.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.8 m -143.08 -178.11 5.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.175 0.99 . . . . 0.0 109.904 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -70.01 -177.76 1.42 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.208 1.403 . . . . 0.0 109.131 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -63.29 153.02 36.16 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.563 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.01 152.04 44.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 167.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -86.7 161.51 18.39 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.754 -0.591 . . . . 0.0 110.353 -174.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.34 150.82 1.66 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.764 1.226 . . . . 0.0 108.887 168.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -21.25 97.46 0.01 OUTLIER 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 0.0 112.328 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.7 mt -72.81 136.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 111.687 -2.506 . . . . 0.0 107.793 -168.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.93 141.84 96.99 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.98 138.54 31.33 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 N-CA-C 107.352 -1.826 . . . . 0.0 107.352 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -137.37 160.52 38.84 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -68.57 127.43 32.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 122.113 0.959 . . . . 0.0 109.017 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 tt -71.23 146.83 48.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.538 1.935 . . . . 0.0 111.97 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.7 17.83 3.76 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.697 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -81.6 -32.18 32.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.44 1.12 . . . . 0.0 109.845 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.18 10.91 0.9 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.835 1.254 . . . . 0.0 110.893 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.439 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 15.7 mp0 -130.92 174.04 10.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.247 1.819 . . . . 0.0 109.688 -169.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -165.35 122.96 1.55 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 166.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.424 ' CG1' HD11 ' A' ' 71' ' ' ILE 0.317 4.2 tt -123.48 129.3 24.92 Favored Pre-proline 0 N--CA 1.433 -1.277 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -167.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.47 148.86 67.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.64 1.56 . . . . 0.0 111.25 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.32 -21.11 22.18 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.022 1.329 . . . . 0.0 112.679 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -54.86 -33.27 61.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.032 2.133 . . . . 0.0 113.524 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.424 HD11 ' CG1' ' A' ' 67' ' ' ILE . 4.6 pt -118.1 -16.13 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.422 0.689 . . . . 0.0 111.211 -169.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mm -54.14 -42.56 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 127.948 2.499 . . . . 0.0 109.592 172.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.92 11.41 6.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.016 . . . . 0.0 112.661 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.97 -171.94 25.43 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -59.34 137.41 58.0 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -136.32 153.25 51.21 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.866 0.729 . . . . 0.0 110.936 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -136.73 114.81 11.51 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.514 1.126 . . . . 0.0 109.416 -170.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.12 126.03 31.55 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.666 1.987 . . . . 0.0 107.168 169.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.45 165.95 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.379 -168.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -119.63 126.94 52.38 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 165.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -78.93 125.87 29.94 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -67.38 149.62 50.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.089 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.97 10.19 50.16 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.497 -1.168 . . . . 0.0 113.576 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.494 ' CE2' ' HE ' ' A' ' 128' ' ' M2L . 81.6 m95 -128.04 166.28 18.71 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.11 1.455 . . . . 0.0 111.211 -176.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -61.27 168.41 2.66 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.0 112.198 -171.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 m -63.34 -21.89 66.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.556 0.742 . . . . 0.0 111.711 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -60.8 -25.9 66.9 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.335 -0.853 . . . . 0.0 111.925 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.8 m95 -85.54 16.41 3.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 0.0 112.477 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.73 87.71 3.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 167.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -146.3 166.14 27.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.084 1.353 . . . . 0.0 108.341 -167.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -104.29 152.84 21.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.45 1.119 . . . . 0.0 110.511 169.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.36 155.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.829 173.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.11 169.08 31.74 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -18.06 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.714 1.205 . . . . 0.0 113.037 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.84 -19.69 18.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.272 1.429 . . . . 0.0 113.554 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -127.61 -35.48 2.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 117.39 -1.291 . . . . 0.0 111.939 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.9 tt -101.87 152.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.642 1.565 . . . . 0.0 113.288 -169.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.87 160.95 41.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.28 2.632 . . . . 0.0 108.298 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.71 168.66 18.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.381 1.446 . . . . 0.0 112.273 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -77.86 109.26 11.73 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.105 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -156.42 163.33 39.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.998 1.319 . . . . 0.0 109.278 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -53.14 -35.85 60.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.665 1.586 . . . . 0.0 114.31 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.2 -43.86 97.88 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.695 1.236 . . . . 0.0 110.006 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -78.47 -23.68 46.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 mm -69.57 -35.21 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.685 0.675 . . . . 0.0 109.859 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.3 98.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.521 1.055 . . . . 0.0 109.435 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.25 89.83 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 171.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.988 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -72.54 -42.56 64.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.105 0.866 . . . . 0.0 109.504 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -42.89 53.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.269 0.628 . . . . 0.0 110.419 170.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.09 -47.73 17.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 112.398 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.23 -27.63 6.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 111.605 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -77.59 -58.07 3.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.275 1.43 . . . . 0.0 113.386 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.88 -23.31 41.95 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.68 1.127 . . . . 0.0 113.6 -170.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.93 131.35 50.61 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.328 0.651 . . . . 0.0 111.252 -169.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.47 30.78 0.26 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.437 1.018 . . . . 0.0 111.373 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 m -61.95 -22.06 65.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.875 1.27 . . . . 0.0 113.6 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 p -73.58 -8.85 57.6 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.4 1.08 . . . . 0.0 112.511 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.69 3.56 80.56 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.292 0.948 . . . . 0.0 111.812 -170.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.3 m -144.21 177.67 8.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.034 2.133 . . . . 0.0 107.897 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.43 138.86 96.52 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.9 63.76 8.16 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 124.602 3.535 . . . . 0.0 109.617 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.16 -21.77 14.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.856 1.662 . . . . 0.0 114.989 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.8 m -55.65 -38.97 70.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.42 1.088 . . . . 0.0 111.019 172.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 133.77 -40.98 1.52 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.08 144.51 9.78 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 104.854 -3.298 . . . . 0.0 104.854 169.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.41 137.18 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.273 0.629 . . . . 0.0 111.316 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.494 ' HE ' ' CE2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.461 ' HE2' ' C ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -161.61 97.95 1.25 Allowed Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 120.522 -1.361 . . . . 0.0 108.999 -172.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.406 ' HD2' ' H ' ' A' ' 131' ' ' HIS . 11.5 Cg_endo -119.12 -18.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.509 2.139 . . . . 0.0 113.82 176.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.406 ' H ' ' HD2' ' A' ' 130' ' ' PRO . 18.9 p-80 -68.82 -10.8 58.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 -168.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -156.12 150.58 25.75 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.027 0.931 . . . . 0.0 108.493 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -60.95 -47.14 87.81 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.493 0.717 . . . . 0.0 111.304 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.249 1.034 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.543 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.3 m -62.56 141.98 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.296 0.638 . . . . 0.0 110.406 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -164.87 -39.04 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.28 1.432 . . . . 0.0 109.788 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.2 tp -52.62 -27.21 16.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.513 2.325 . . . . 0.0 113.124 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -50.8 -38.38 48.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.739 1.216 . . . . 0.0 111.197 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -65.09 -24.96 67.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.391 1.876 . . . . 0.0 113.063 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -97.57 161.34 13.82 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.362 1.065 . . . . 0.0 109.327 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.25 73.91 0.01 OUTLIER 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.935 2.894 . . . . 0.0 110.46 171.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 131.08 44.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -4.75 1.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -169.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.42 32.61 0.7 Allowed Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 170.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.48 -157.21 12.15 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 168.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.06 156.02 21.09 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.77 160.73 39.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 169.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.7 mt -139.45 131.37 27.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 -173.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.21 136.81 53.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -170.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -115.9 117.24 29.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.661 0.785 . . . . 0.0 109.19 -168.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -95.53 -21.39 18.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.524 0.729 . . . . 0.0 111.854 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.15 -73.52 0.32 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.63 -30.58 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.358 2.038 . . . . 0.0 112.014 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 178.54 10.11 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 125.254 1.422 . . . . 0.0 109.51 -170.004 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.528 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -133.94 154.16 51.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.522 2.329 . . . . 0.0 106.776 -173.347 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.71 152.05 48.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.257 1.023 . . . . 0.0 108.645 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -74.68 149.03 40.09 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.493 0.717 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.37 160.48 40.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.081 1.352 . . . . 0.0 109.113 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -149.03 99.76 2.99 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -169.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.3 mt -58.69 152.66 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.669 1.987 . . . . 0.0 110.647 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pp -156.72 -35.45 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.736 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 37.4 ttpt -126.0 140.1 52.88 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.09 166.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -150.47 150.89 31.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.277 -168.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -147.55 142.12 16.43 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.531 2.332 . . . . 0.0 108.82 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.69 -8.75 24.41 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.437 2.758 . . . . 0.0 113.51 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.0 m -65.66 -34.64 78.69 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.452 1.478 . . . . 0.0 111.248 -171.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -117.72 -18.67 9.57 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.521 1.528 . . . . 0.0 110.718 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm 51.33 52.14 15.43 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -169.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.6 mtp -144.72 157.02 44.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.994 2.518 . . . . 0.0 105.093 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.428 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -107.47 168.95 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.629 0.372 . . . . 0.0 111.474 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -141.57 155.0 45.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.41 1.884 . . . . 0.0 106.647 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.5 t -149.95 164.23 35.99 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.9 pt -146.58 159.65 43.78 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.792 1.237 . . . . 0.0 109.657 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.01 89.47 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.645 3.563 . . . . 0.0 110.575 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -130.51 -9.54 4.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.279 1.032 . . . . 0.0 112.692 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -164.45 -173.46 3.08 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.465 0.706 . . . . 0.0 109.73 -173.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 92.46 11.1 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.243 1.817 . . . . 0.0 107.746 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -48.5 164.82 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.317 2.678 . . . . 0.0 113.867 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.73 -12.48 6.75 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.308 1.432 . . . . 0.0 116.067 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -129.99 22.6 4.79 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.006 1.289 . . . . 0.0 112.732 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.4 m -135.88 141.74 44.64 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.57 1.185 . . . . 0.0 110.238 -173.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.6 m -69.77 -40.72 75.88 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.413 0.685 . . . . 0.0 110.531 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -167.25 158.44 11.91 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.161 2.185 . . . . 0.0 107.794 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.41 140.12 51.98 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 166.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.3 m -122.59 105.81 10.43 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.501 1.046 . . . . 0.0 111.315 -168.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 54.09 -170.11 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.771 2.428 . . . . 0.0 111.81 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 107.37 1.79 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.1 mt -73.66 129.24 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.04 139.61 95.51 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.05 142.11 24.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.861 1.707 . . . . 0.0 108.983 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -130.38 164.19 25.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.582 0.753 . . . . 0.0 109.545 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.63 -16.57 49.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -168.386 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' CD1' ' CZ2' ' A' ' 91' ' ' TRP . 0.5 OUTLIER 70.91 136.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.597 2.359 . . . . 0.0 112.28 -171.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.11 7.35 2.29 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.949 169.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.16 -34.47 56.41 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.894 1.847 . . . . 0.0 111.211 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.74 -40.09 0.09 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.407 1.483 . . . . 0.0 109.593 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 3.9 pm0 -66.96 137.09 56.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 168.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.6 m -140.46 157.38 45.6 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.318 2.6 tt -149.82 136.55 10.9 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -169.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.43 151.96 54.19 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.727 1.618 . . . . 0.0 111.346 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -56.4 -17.11 6.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.044 1.338 . . . . 0.0 112.832 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -67.18 -24.99 65.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.843 1.257 . . . . 0.0 111.968 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.2 pt -124.38 -12.64 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.35 0.977 . . . . 0.0 111.177 -171.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.8 mm -52.65 -44.36 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 128.097 2.559 . . . . 0.0 108.576 169.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.17 9.47 6.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.881 1.272 . . . . 0.0 112.82 -170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.67 -173.07 26.59 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -171.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -60.79 134.91 57.55 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.285 -0.538 . . . . 0.0 110.608 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 m -137.47 154.13 49.95 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.781 0.676 . . . . 0.0 111.278 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -139.12 114.68 9.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.435 1.094 . . . . 0.0 109.836 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -81.23 127.09 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 106.271 169.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -138.48 154.07 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.101 -168.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -99.72 119.61 38.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -73.0 117.68 15.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -86.14 150.65 24.26 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 6.37 63.0 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 119.082 -0.843 . . . . 0.0 111.2 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.427 ' CE2' ' HE ' ' A' ' 128' ' ' M2L . 85.2 m95 -132.84 174.03 10.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.252 1.421 . . . . 0.0 109.874 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.68 174.11 3.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.45 1.1 . . . . 0.0 111.708 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.1 m -85.09 -6.35 59.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.237 0.615 . . . . 0.0 112.033 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -57.36 -31.27 65.59 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.396 -0.815 . . . . 0.0 110.979 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -89.59 20.1 4.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.616 1.166 . . . . 0.0 112.726 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.49 99.77 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -151.3 167.51 27.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.972 2.109 . . . . 0.0 108.111 -167.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.419 ' CZ2' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -104.23 155.26 18.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.369 0.986 . . . . 0.0 112.168 169.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.85 157.59 43.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.932 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.29 160.63 25.95 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.732 1.158 . . . . 0.0 110.346 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.02 9.79 0.65 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.92 -12.71 32.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.709 1.603 . . . . 0.0 111.223 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -125.92 -37.09 2.31 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.561 1.145 . . . . 0.0 111.3 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.8 tt -97.35 154.46 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.412 1.005 . . . . 0.0 110.671 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -145.65 158.26 43.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.192 2.197 . . . . 0.0 109.437 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.88 161.41 30.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.247 1.385 . . . . 0.0 111.511 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -69.47 115.77 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -159.9 162.05 34.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.466 1.506 . . . . 0.0 108.43 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.0 -35.71 47.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.833 1.653 . . . . 0.0 114.364 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -63.53 -44.44 94.24 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.554 1.168 . . . . 0.0 109.984 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.31 -23.91 54.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.278 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.7 mm -68.55 -36.17 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 118.781 0.719 . . . . 0.0 109.793 169.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.1 96.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.451 1.023 . . . . 0.0 110.402 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -48.2 79.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.08 -49.53 74.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.329 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -75.03 -33.19 61.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.033 1.288 . . . . 0.0 109.854 -171.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -54.62 -53.57 52.99 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 169.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.802 0.728 . . . . 0.0 111.628 -172.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.7 -15.54 0.74 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.434 1.494 . . . . 0.0 112.557 169.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -107.44 -50.36 3.09 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.82 1.248 . . . . 0.0 112.349 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -75.44 -23.94 56.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.472 1.033 . . . . 0.0 111.871 -175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -136.83 1.92 2.57 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -168.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.19 35.61 1.95 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.45 1.024 . . . . 0.0 112.743 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.1 m -62.85 -27.09 69.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.487 1.515 . . . . 0.0 113.925 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.7 m -147.71 137.95 22.98 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.95 -169.4 42.12 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.1 m -129.63 11.85 5.78 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.117 0.967 . . . . 0.0 112.606 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.58 150.18 21.39 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.748 1.619 . . . . 0.0 107.838 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.94 10.56 1.06 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.573 2.849 . . . . 0.0 114.268 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.98 6.21 2.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.105 1.762 . . . . 0.0 112.119 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 16.8 m -142.07 87.67 2.05 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -89.76 58.32 3.7 Favored Glycine 0 C--O 1.223 -0.575 0 N-CA-C 107.55 -2.22 . . . . 0.0 107.55 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.62 87.49 0.05 OUTLIER Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.152 0.882 . . . . 0.0 114.191 -169.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.9 m -92.79 -2.16 10.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.584 1.153 . . . . 0.0 112.831 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.453 ' SG ' ' CM2' ' A' ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -152.95 106.38 2.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 O-C-N 119.897 -1.752 . . . . 0.0 110.426 -166.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.41 -25.23 7.06 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.44 2.094 . . . . 0.0 111.404 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 171.49 19.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 128.522 2.729 . . . . 0.0 105.582 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 62.81 13.86 6.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.282 1.833 . . . . 0.0 113.604 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -66.88 -18.29 65.31 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.48 -0.762 . . . . 0.0 110.956 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 49.3 tpt85 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 127.376 2.27 . . . . 0.0 106.14 173.185 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.14 166.35 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.153 1.381 . . . . 0.0 109.049 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -150.77 165.86 32.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.012 1.725 . . . . 0.0 107.088 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.9 tp 65.03 -28.04 0.1 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.05 2.54 . . . . 0.0 114.36 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -54.36 -36.03 63.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.746 1.218 . . . . 0.0 111.432 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -53.63 -36.09 61.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.703 2.001 . . . . 0.0 113.137 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.54 144.32 30.46 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -56.92 126.35 26.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 168.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.02 135.68 53.52 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -2.91 0.35 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 116.266 1.951 . . . . 0.0 116.266 -168.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.08 0.28 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 169.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.71 -175.16 50.65 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.212 -2.755 . . . . 0.0 106.212 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.43 ' HG2' HE22 ' A' ' 82' ' ' GLN . 54.1 mtt180 -87.99 156.65 19.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.22 165.9 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 168.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.03 144.37 50.01 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.92 125.7 23.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -99.44 115.73 29.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -87.7 -25.4 23.49 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.958 0.503 . . . . 0.0 111.15 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.74 -69.78 0.32 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.71 -41.41 11.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.39 2.06 . . . . 0.0 112.817 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.9 tp -148.27 179.8 7.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.005 1.722 . . . . 0.0 107.881 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -141.5 151.29 43.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.071 1.748 . . . . 0.0 109.178 -167.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -134.06 157.26 46.57 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.611 1.164 . . . . 0.0 108.594 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.28 150.21 30.07 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.75 155.2 46.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.895 0.478 . . . . 0.0 110.805 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -144.11 94.37 2.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.866 0.866 . . . . 0.0 111.397 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.7 mt -61.94 152.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 127.565 2.346 . . . . 0.0 112.492 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.35 -24.8 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.776 166.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -127.58 139.3 52.85 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.82 163.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -168.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.98 152.54 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.634 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.05 139.37 14.53 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.62 1.968 . . . . 0.0 109.122 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 -0.77 8.56 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.24 3.293 . . . . 0.0 113.348 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -67.55 -33.19 74.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.225 1.375 . . . . 0.0 110.956 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 p -129.48 -10.42 4.57 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.13 1.372 . . . . 0.0 111.618 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 50.1 53.14 13.35 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.098 0.951 . . . . 0.0 109.632 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 63.4 mtp -145.61 156.21 43.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.803 2.041 . . . . 0.0 106.51 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -108.88 171.43 7.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 p -139.49 156.71 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.63 1.972 . . . . 0.0 107.259 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.4 t -150.76 163.48 38.48 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 pt -149.88 157.87 37.62 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.746 1.618 . . . . 0.0 108.841 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -78.36 56.12 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.81 3.673 . . . . 0.0 111.95 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -57.4 -57.67 11.62 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -165.22 158.99 16.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.288 1.835 . . . . 0.0 106.306 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -60.48 149.74 76.51 Favored Pre-proline 0 C--O 1.24 0.566 0 C-N-CA 123.526 0.73 . . . . 0.0 111.311 172.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -65.02 170.64 10.06 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 N-CA-C 107.494 -1.771 . . . . 0.0 107.494 166.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.97 99.81 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 120.753 -1.217 . . . . 0.0 110.188 169.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.59 15.29 60.01 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.319 -169.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.2 m -142.54 159.82 41.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.317 2.058 . . . . 0.0 109.862 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 m -65.22 -53.99 36.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.025 0.93 . . . . 0.0 112.081 -170.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -169.75 159.51 8.13 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.475 1.51 . . . . 0.0 108.761 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.45 157.49 27.5 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 167.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 p -131.21 89.33 2.71 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.135 -0.978 . . . . 0.0 111.275 -169.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 50.9 -163.09 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.258 1.823 . . . . 0.0 110.652 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.56 116.11 5.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 172.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.2 mt -81.83 135.52 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 113.478 -1.692 . . . . 0.0 106.843 -173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.2 136.45 93.84 Favored Pre-proline 0 C--O 1.237 0.433 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.86 145.94 36.99 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.962 1.775 . . . . 0.0 109.568 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -139.67 156.34 46.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.102 0.961 . . . . 0.0 109.778 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 3.6 mmpt? -62.43 -10.53 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -173.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.252 9.3 tt 71.76 151.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 114.3 -177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.64 4.22 10.79 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 114.779 -1.1 . . . . 0.0 114.283 169.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.61 -22.04 60.13 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.832 1.316 . . . . 0.0 111.359 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.57 -35.11 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.797 1.239 . . . . 0.0 111.059 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.444 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 20.6 mp0 -66.69 165.44 14.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 174.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 m -147.09 141.1 25.96 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.668 1.987 . . . . 0.0 106.115 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.0 pt -136.75 125.44 15.16 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.14 156.88 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.118 1.879 . . . . 0.0 110.676 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -55.59 -15.35 2.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.242 1.017 . . . . 0.0 112.493 171.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -66.69 -31.33 71.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.385 1.474 . . . . 0.0 112.343 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 pt -119.31 -11.76 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.209 1.368 . . . . 0.0 110.757 -173.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -53.38 -45.88 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.909 2.483 . . . . 0.0 108.548 169.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.45 9.49 7.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 111.732 -170.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.21 -178.41 26.87 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 119.881 1.219 . . . . 0.0 110.814 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -60.42 131.81 51.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.1 m -132.09 150.4 52.16 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.926 0.766 . . . . 0.0 110.601 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.14 112.64 10.67 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 109.276 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -79.55 125.0 29.03 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 126.243 1.817 . . . . 0.0 107.348 169.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.55 156.01 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.935 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -102.01 122.63 44.44 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 166.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -71.74 111.18 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.43 HE22 ' HG2' ' A' ' 13' ' ' ARG . 47.9 mt-30 -76.62 148.29 37.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.41 64.05 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.163 -170.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.501 ' CE2' ' HE ' ' A' ' 128' ' ' M2L . 54.7 m95 -131.98 169.14 16.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.828 1.314 . . . . 0.0 110.513 176.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -65.84 171.33 4.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.543 1.537 . . . . 0.0 112.508 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 m -69.94 -17.15 63.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.532 1.133 . . . . 0.0 111.739 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -62.35 -28.82 70.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.686 0.794 . . . . 0.0 111.865 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -97.44 21.15 10.54 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -68.06 104.83 1.86 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -148.74 168.08 23.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.28 1.832 . . . . 0.0 107.866 -167.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.444 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -107.16 152.95 23.38 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 122.3 1.048 . . . . 0.0 110.402 168.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.46 161.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.773 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.53 170.67 22.38 Favored Glycine 0 C--O 1.242 0.602 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.384 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -15.27 11.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.225 1.41 . . . . 0.0 113.648 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.33 -23.98 52.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.125 1.37 . . . . 0.0 112.516 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.18 -38.76 2.28 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 117.52 -1.229 . . . . 0.0 112.027 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.2 tt -89.41 156.49 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.41 1.004 . . . . 0.0 113.441 -169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -153.82 157.52 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.615 3.166 . . . . 0.0 108.594 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.7 168.88 17.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.562 1.528 . . . . 0.0 111.827 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.419 ' CE2' HD13 ' A' ' 105' ' ' ILE . 21.8 t80 -62.33 127.62 32.18 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.725 -1.234 . . . . 0.0 109.971 169.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -156.36 153.4 28.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.522 1.929 . . . . 0.0 107.866 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.82 -30.23 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.384 0.673 . . . . 0.0 111.184 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.51 -42.12 92.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.905 0.859 . . . . 0.0 110.34 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.63 -23.94 53.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.083 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.419 HD13 ' CE2' ' A' ' 100' ' ' TYR . 3.2 mm -72.51 -35.57 51.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-N 118.552 0.615 . . . . 0.0 109.654 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.436 1.016 . . . . 0.0 109.899 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -51.39 69.57 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -59.57 -43.32 93.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.733 -173.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -74.77 -39.92 61.49 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.029 0.932 . . . . 0.0 110.894 -174.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -52.51 -46.33 66.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.818 0.735 . . . . 0.0 110.368 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.6 -42.01 22.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 119.506 -0.283 . . . . 0.0 111.447 -171.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.28 -32.12 47.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.246 1.418 . . . . 0.0 110.921 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -76.5 -50.7 13.33 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.126 0.97 . . . . 0.0 112.293 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -66.45 -33.51 75.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.432 0.56 . . . . 0.0 111.655 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.48 98.18 3.3 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 122.734 1.254 . . . . 0.0 110.014 -168.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -177.99 50.14 0.1 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.935 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.7 m -133.53 24.74 4.08 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.66 1.184 . . . . 0.0 111.179 -169.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.0 p -58.97 159.52 7.01 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.324 1.45 . . . . 0.0 112.372 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.12 -172.06 39.03 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.291 1.424 . . . . 0.0 109.673 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.1 m -74.49 16.89 0.23 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.115 1.366 . . . . 0.0 114.123 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.15 157.69 37.15 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.121 1.768 . . . . 0.0 108.639 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -43.98 106.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 1 C-N-CA 126.019 4.479 . . . . 0.0 112.762 172.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -150.2 163.45 38.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.207 1.803 . . . . 0.0 109.303 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.5 m 65.3 -51.6 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.848 2.459 . . . . 0.0 113.566 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 76.32 -40.47 1.51 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.326 1.441 . . . . 0.0 113.348 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.31 46.84 2.25 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.138 1.828 . . . . 0.0 112.667 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 82.0 t -134.52 129.63 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -169.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.501 ' HE ' ' CE2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -158.64 122.62 2.13 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 126.157 1.783 . . . . 0.0 108.593 -168.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -73.42 -20.02 21.34 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 N-CA-C 108.488 -1.389 . . . . 0.0 108.488 168.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -51.45 -32.49 27.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.254 1.822 . . . . 0.0 112.52 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -81.56 -8.09 59.67 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.294 -0.879 . . . . 0.0 112.993 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -63.86 155.03 31.85 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.696 1.135 . . . . 0.0 110.547 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 125.439 1.495 . . . . 0.0 106.968 -179.837 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.55 158.29 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 118.885 0.766 . . . . 0.0 109.721 169.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -146.85 -27.89 0.39 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.625 0.77 . . . . 0.0 112.719 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.1 tp -132.58 -26.22 1.84 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.277 1.031 . . . . 0.0 111.562 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -58.13 -39.09 77.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.94 1.696 . . . . 0.0 111.21 -173.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -68.18 -18.26 64.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.262 1.825 . . . . 0.0 113.497 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.33 157.87 15.92 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.036 0.834 . . . . 0.0 109.775 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -62.63 66.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 130.906 3.682 . . . . 0.0 110.154 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 139.26 57.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 127.098 2.159 . . . . 0.0 106.587 -169.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -6.26 1.66 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -169.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.11 28.63 0.52 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 171.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 -176.6 49.35 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 106.223 -2.751 . . . . 0.0 106.223 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -87.33 151.07 23.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 168.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -132.8 165.8 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 169.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -139.84 128.36 22.92 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.36 124.36 42.2 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.722 1.264 . . . . 0.0 109.641 -170.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -98.6 125.23 43.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.26 1.824 . . . . 0.0 107.383 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -105.06 -17.88 14.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.762 0.825 . . . . 0.0 111.261 -175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.41 -75.17 0.29 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.4 -25.11 21.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.331 2.021 . . . . 0.0 113.104 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.528 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -152.85 175.93 12.37 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 125.036 1.334 . . . . 0.0 109.943 -171.801 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.528 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -143.76 146.44 33.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.35 2.26 . . . . 0.0 106.796 -169.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.82 151.6 51.98 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -171.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.2 139.05 57.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.23 157.79 45.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.758 2.023 . . . . 0.0 107.598 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.76 95.26 2.39 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.231 -0.918 . . . . 0.0 110.404 -169.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.62 148.01 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 128.037 2.535 . . . . 0.0 112.325 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.13 -31.07 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.914 166.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 17.5 mtmt -111.08 149.61 30.55 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 168.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 pt -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -149.28 153.43 37.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.499 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.45 143.77 17.79 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 109.513 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.99 -11.72 32.94 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.291 2.66 . . . . 0.0 113.526 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.6 m -63.99 -33.02 74.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.834 1.197 . . . . 0.0 112.046 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -122.0 -10.62 8.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.464 1.506 . . . . 0.0 111.243 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt 47.29 50.46 14.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 109.533 -169.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.8 mtp -146.32 152.59 39.38 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.744 2.018 . . . . 0.0 105.896 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -101.29 173.66 6.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.114 0.566 . . . . 0.0 112.375 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -138.6 161.23 37.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.717 2.007 . . . . 0.0 107.158 170.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.4 t -154.97 162.17 41.17 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 pt -146.32 155.65 50.06 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.647 1.579 . . . . 0.0 109.765 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.87 83.93 1.87 Allowed 'Trans proline' 0 CA--C 1.536 0.589 1 C-N-CA 125.482 4.121 . . . . 0.0 111.206 -174.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -141.96 13.51 2.06 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -171.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -149.36 -28.23 0.27 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 40.84 66.35 3.59 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.904 1.281 . . . . 0.0 112.735 -172.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.18 164.23 10.8 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.059 2.506 . . . . 0.0 111.94 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.55 -28.34 36.78 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.233 0.921 . . . . 0.0 114.774 -173.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.38 -5.41 65.35 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.489 -1.173 . . . . 0.0 114.066 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 m -145.8 105.97 4.04 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.358 1.579 . . . . 0.0 109.465 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -50.97 -31.87 19.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.33 1.452 . . . . 0.0 112.657 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -167.29 141.19 3.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.409 0.684 . . . . 0.0 109.542 168.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.67 168.46 13.11 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 166.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.8 p -124.96 85.84 2.47 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 120.854 -1.154 . . . . 0.0 112.011 -168.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt 49.67 -156.4 0.09 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.381 1.872 . . . . 0.0 110.653 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.75 103.18 0.14 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.16 135.82 27.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -175.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.12 136.09 93.94 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.41 136.26 30.85 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.041 1.827 . . . . 0.0 107.706 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -140.36 162.41 35.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -170.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.407 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 6.2 mmpt? -63.86 152.41 39.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.55 150.67 27.83 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.442 1.897 . . . . 0.0 110.527 -169.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.57 19.95 5.58 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.3 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.56 -31.63 36.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.591 1.195 . . . . 0.0 109.857 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -150.35 17.75 0.83 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.013 1.325 . . . . 0.0 110.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -131.23 163.57 27.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.982 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -149.2 140.56 23.23 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.723 1.209 . . . . 0.0 108.535 169.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.7 pt -135.91 122.55 14.26 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.99 154.51 17.35 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.245 1.963 . . . . 0.0 110.959 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -53.39 -22.11 7.01 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.81 0.844 . . . . 0.0 111.414 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.9 -27.99 69.53 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.933 1.693 . . . . 0.0 114.003 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.4 pt -119.54 -12.6 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.508 1.503 . . . . 0.0 110.667 -176.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.17 -45.71 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 128.141 2.576 . . . . 0.0 108.963 169.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -81.35 10.31 5.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 -169.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.15 23.66 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -61.2 137.63 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -136.48 151.36 49.37 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.268 0.98 . . . . 0.0 110.378 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.17 113.88 9.19 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.828 1.251 . . . . 0.0 109.408 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.465 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 43.8 t80 -80.11 128.7 33.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.382 1.473 . . . . 0.0 107.091 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.56 152.25 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.563 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -97.8 125.24 42.54 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -75.27 115.5 14.98 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -79.73 151.9 30.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 110.023 -172.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 6.51 34.5 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.837 -0.98 . . . . 0.0 111.859 -170.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.496 ' CG ' HM2B ' A' ' 128' ' ' M2L . 57.5 m95 -133.7 173.31 11.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.712 1.256 . . . . 0.0 112.069 -173.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.69 163.09 24.68 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.522 1.129 . . . . 0.0 112.466 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -67.7 -19.38 65.15 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.154 0.982 . . . . 0.0 111.386 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 m -57.16 -31.04 64.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.156 -0.965 . . . . 0.0 111.915 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -87.92 9.29 22.63 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 117.879 -1.058 . . . . 0.0 112.912 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.78 99.64 0.34 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -152.15 166.1 32.74 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.481 1.912 . . . . 0.0 107.94 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.41 151.78 23.09 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.892 0.853 . . . . 0.0 110.671 169.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.56 163.09 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.564 173.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.39 174.22 20.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.266 . . . . 0.0 110.043 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -15.38 33.4 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 113.948 -176.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -58.07 -24.38 58.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 112.617 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -124.55 -36.92 2.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 117.807 -1.092 . . . . 0.0 112.027 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.4 tt -97.37 152.36 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.611 1.096 . . . . 0.0 112.752 -168.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -155.14 150.15 26.81 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.449 2.3 . . . . 0.0 111.408 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.56 158.81 34.14 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.016 1.28 . . . . 0.0 112.852 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CE1' HD12 ' A' ' 105' ' ' ILE . 4.3 t80 -70.52 107.33 3.81 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.765 0.793 . . . . 0.0 110.581 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.25 160.5 38.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.254 1.422 . . . . 0.0 109.343 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -52.75 -35.96 57.02 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.454 1.502 . . . . 0.0 114.806 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.21 -44.71 95.96 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.792 1.282 . . . . 0.0 109.808 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -77.13 -20.78 55.16 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.028 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.404 HD12 ' CE1' ' A' ' 100' ' ' TYR . 6.1 mm -73.23 -32.91 39.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 CA-C-N 119.117 0.871 . . . . 0.0 110.385 169.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.395 0.998 . . . . 0.0 108.945 171.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.23 74.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -55.48 -48.97 73.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.284 1.034 . . . . 0.0 109.916 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.82 -44.98 38.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.428 -172.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -57.58 -34.49 69.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.744 0.702 . . . . 0.0 110.179 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -78.21 -50.4 11.98 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.36 -29.0 3.54 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.835 1.254 . . . . 0.0 112.275 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -74.15 -52.67 11.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.917 1.287 . . . . 0.0 113.539 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -86.25 -14.62 43.25 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.149 0.886 . . . . 0.0 113.377 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -44.96 122.55 3.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.813 2.045 . . . . 0.0 114.363 -169.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.69 60.9 4.56 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.5 m -65.88 -3.62 5.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.134 1.774 . . . . 0.0 114.627 -174.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.22 139.11 36.88 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.216 1.006 . . . . 0.0 109.387 170.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -153.81 16.35 0.63 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-O 119.579 -0.567 . . . . 0.0 113.565 -170.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 p -144.86 15.33 1.56 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.782 1.233 . . . . 0.0 112.047 -171.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.74 167.66 13.22 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.947 2.099 . . . . 0.0 108.44 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.62 -9.26 3.66 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.911 3.074 . . . . 0.0 116.563 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.25 -2.21 23.95 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.241 1.817 . . . . 0.0 112.84 170.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.1 m -62.72 108.41 1.16 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.538 1.063 . . . . 0.0 108.233 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -159.98 28.13 0.35 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-O 118.995 -0.892 . . . . 0.0 112.866 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.18 7.43 0.18 Allowed Glycine 0 C--N 1.34 0.791 0 CA-C-O 117.062 -1.966 . . . . 0.0 115.561 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -155.42 149.32 11.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 121.782 2.791 . . . . 0.0 107.685 -169.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.496 HM2B ' CG ' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.459 ' HE3' ' HA ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -159.92 108.74 1.43 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.951 2.1 . . . . 0.0 107.275 -168.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -84.58 -31.79 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.887 1.725 . . . . 0.0 111.832 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -57.1 -27.75 62.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 113.179 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -74.22 -3.06 27.65 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.891 0.876 . . . . 0.0 112.638 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.72 28.38 5.38 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.4 1.88 . . . . 0.0 109.752 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.209 1.804 . . . . 0.0 106.334 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.16 151.37 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -151.92 -59.42 0.16 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.565 0.746 . . . . 0.0 109.055 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.4 tp -76.28 -39.95 52.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.317 0.508 . . . . 0.0 110.439 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.26 -32.32 72.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.533 0.733 . . . . 0.0 110.743 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -59.75 -34.55 73.11 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.045 1.738 . . . . 0.0 112.374 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -86.92 151.7 23.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -57.11 122.62 12.82 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.06 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -1.27 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.41 30.22 0.36 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.76 -174.58 49.9 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 169.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -86.76 151.69 23.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.33 163.43 35.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 168.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.426 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 60.8 mt -139.91 130.4 25.55 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -173.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.55 129.56 50.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.276 0.985 . . . . 0.0 108.518 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.96 118.03 35.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -99.6 -14.44 18.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -169.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.57 -78.9 0.23 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.24 -32.58 12.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.128 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.501 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.77 -177.17 6.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.821 1.648 . . . . 0.0 109.454 -169.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.501 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 11.7 tmm? -128.37 145.24 51.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.84 2.056 . . . . 0.0 108.306 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -130.3 146.27 51.87 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.791 0.805 . . . . 0.0 109.727 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -73.87 148.32 42.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.286 1.434 . . . . 0.0 109.845 -170.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.96 45.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.809 0.844 . . . . 0.0 110.418 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -148.48 95.74 2.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.275 1.03 . . . . 0.0 110.78 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.72 151.25 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 128.294 2.638 . . . . 0.0 112.158 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . 0.301 0.0 OUTLIER -159.71 -28.68 0.07 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 116.802 -1.571 . . . . 0.0 111.96 166.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -113.77 150.13 33.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 168.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.0 166.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.049 0.928 . . . . 0.0 108.693 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -144.18 151.76 39.95 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.514 1.526 . . . . 0.0 109.525 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.11 142.88 16.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.807 1.643 . . . . 0.0 109.563 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 -11.37 31.92 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.158 2.572 . . . . 0.0 113.801 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -62.15 -31.84 72.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.322 1.419 . . . . 0.0 112.312 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.7 p -129.89 0.51 4.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.252 1.421 . . . . 0.0 111.219 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt 44.21 53.78 6.45 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.615 1.566 . . . . 0.0 110.545 -174.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptm -155.26 165.24 37.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.022 1.329 . . . . 0.0 107.703 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -110.67 172.28 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.083 0.953 . . . . 0.0 112.048 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.8 p -141.0 157.3 45.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.67 1.988 . . . . 0.0 106.379 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.7 t -150.85 159.06 44.8 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 pt -149.05 157.11 40.32 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.645 1.178 . . . . 0.0 109.58 -175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.85 55.5 1.74 Allowed 'Trans proline' 0 CA--C 1.542 0.88 1 C-N-CA 125.673 4.248 . . . . 0.0 113.594 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -59.71 -53.59 56.21 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -161.9 -112.44 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -162.66 154.8 15.85 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 126.304 1.841 . . . . 0.0 108.592 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.33 170.59 10.55 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.346 2.03 . . . . 0.0 108.004 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.81 4.22 1.2 Allowed Glycine 0 CA--C 1.539 1.559 0 O-C-N 120.791 -1.193 . . . . 0.0 115.138 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.75 -147.1 10.74 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.851 1.691 . . . . 0.0 110.043 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.3 m -126.99 24.06 6.46 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -168.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -141.02 115.5 9.47 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.97 156.12 37.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.821 0.448 . . . . 0.0 111.296 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.98 131.4 45.4 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 103.271 -2.863 . . . . 0.0 103.271 166.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -81.49 -58.58 2.96 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -168.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -147.48 -163.75 1.84 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.501 2.32 . . . . 0.0 106.076 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.26 109.77 2.0 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mt -76.12 131.62 34.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -173.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.53 138.55 95.68 Favored Pre-proline 0 C--O 1.234 0.288 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.59 137.9 31.2 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.852 1.701 . . . . 0.0 107.931 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -139.05 160.06 40.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 130.16 42.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.79 156.51 34.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.352 1.461 . . . . 0.0 112.31 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.21 29.38 2.15 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.678 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -79.26 -41.08 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.648 1.224 . . . . 0.0 109.041 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -161.96 5.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.347 1.059 . . . . 0.0 113.41 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 48.8 2.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.902 1.281 . . . . 0.0 111.603 -168.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -33.09 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.631 3.172 . . . . 0.0 113.496 168.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.1 pt -136.88 134.47 19.23 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 107.832 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.97 160.1 50.85 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.18 1.92 . . . . 0.0 110.311 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.01 -23.59 20.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 111.829 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.76 -33.97 67.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.336 1.454 . . . . 0.0 113.196 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.2 pt -120.01 -10.06 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 119.487 1.039 . . . . 0.0 110.733 -172.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -59.31 -49.39 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 127.641 2.377 . . . . 0.0 106.661 168.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -77.71 9.42 3.46 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.521 1.528 . . . . 0.0 112.088 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.17 -179.19 27.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.704 1.138 . . . . 0.0 110.881 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -59.31 137.21 58.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 m -136.46 150.65 48.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 124.281 0.988 . . . . 0.0 110.456 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.82 114.66 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.164 -172.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -79.97 124.98 29.18 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.22 1.408 . . . . 0.0 107.374 169.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -137.83 154.06 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 112.433 -168.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -96.46 124.42 40.45 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 166.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -74.03 106.93 5.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -71.99 149.68 44.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.44 3.87 41.99 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.261 -1.299 . . . . 0.0 113.104 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.43 ' CE2' ' HE ' ' A' ' 128' ' ' M2L . 63.9 m95 -126.7 168.0 14.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.403 1.602 . . . . 0.0 111.418 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -66.69 171.35 5.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.341 1.056 . . . . 0.0 112.232 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.08 -21.86 66.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.633 1.173 . . . . 0.0 111.585 169.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -63.12 -25.43 68.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.789 0.835 . . . . 0.0 112.144 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -102.23 19.15 19.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 0.0 112.695 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.66 103.52 1.75 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.22 168.39 23.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.382 -167.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.09 152.38 22.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.12 0.962 . . . . 0.0 111.241 168.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.51 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.14 1.376 . . . . 0.0 110.359 173.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 167.2 25.5 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -19.41 21.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.099 1.36 . . . . 0.0 113.733 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.88 -22.88 40.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.676 1.191 . . . . 0.0 112.918 170.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -121.49 -38.54 2.76 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.324 -1.322 . . . . 0.0 111.763 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.4 tt -99.62 154.38 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 120.654 1.57 . . . . 0.0 113.017 -169.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -150.34 156.99 42.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 128.895 2.878 . . . . 0.0 108.921 169.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.39 163.63 27.32 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.602 1.161 . . . . 0.0 112.431 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.93 112.25 9.86 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 120.85 -1.156 . . . . 0.0 109.293 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.979 1.311 . . . . 0.0 109.63 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -52.94 -36.03 59.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.899 1.68 . . . . 0.0 113.733 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -62.7 -43.86 97.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.404 1.097 . . . . 0.0 110.541 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.67 -22.39 50.67 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.253 -0.879 . . . . 0.0 109.519 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mm -70.77 -35.16 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 119.153 0.888 . . . . 0.0 109.926 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.45 99.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.238 0.926 . . . . 0.0 109.319 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -46.8 88.3 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.63 -43.43 96.85 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 118.163 -0.922 . . . . 0.0 109.749 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -72.01 -43.77 64.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.371 0.987 . . . . 0.0 109.677 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -32.16 48.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 118.144 -0.932 . . . . 0.0 111.454 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.85 -45.63 10.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.053 1.297 . . . . 0.0 113.29 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.23 -23.91 9.91 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.157 1.783 . . . . 0.0 111.962 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -70.09 -43.65 70.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.342 1.857 . . . . 0.0 113.072 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -66.99 -45.89 76.22 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.445 0.641 . . . . 0.0 109.586 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -164.4 175.75 9.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.308 -169.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -129.59 152.05 19.45 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.386 0.993 . . . . 0.0 110.822 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 m -64.04 -12.07 35.18 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.965 1.706 . . . . 0.0 113.548 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m -57.31 -26.72 61.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.189 1.796 . . . . 0.0 112.708 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.35 -42.59 2.78 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.088 0.852 . . . . 0.0 111.365 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 m -75.74 14.16 0.7 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.546 1.538 . . . . 0.0 112.873 170.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 123' ' ' ALA . . . -66.05 168.66 8.63 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.209 1.404 . . . . 0.0 110.337 174.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.03 5.94 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.81 3.673 . . . . 0.0 117.328 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 121' ' ' ALA . . . -141.54 116.42 9.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.858 2.063 . . . . 0.0 105.528 170.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.2 p -89.32 56.07 3.5 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.777 1.231 . . . . 0.0 110.553 -170.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.09 -179.2 48.54 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.46 1.505 . . . . 0.0 109.724 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.59 59.0 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.345 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.4 149.4 25.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.43 ' HE ' ' CE2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -161.41 128.62 2.63 Favored Pre-proline 0 N--CA 1.445 -0.7 0 C-N-CA 127.988 2.515 . . . . 0.0 105.165 -169.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -74.19 -17.33 21.87 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.298 1.998 . . . . 0.0 109.561 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 43.89 54.18 5.87 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 127.84 2.456 . . . . 0.0 113.429 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 69.31 0.53 2.91 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.93 1.692 . . . . 0.0 113.875 170.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -69.31 162.3 27.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.989 1.268 . . . . 0.0 109.731 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.049 1.74 . . . . 0.0 106.949 177.651 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p -152.86 154.01 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.717 1.207 . . . . 0.0 108.013 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -155.25 171.96 18.96 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.92 2.088 . . . . 0.0 105.803 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.5 mt 56.03 30.38 16.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.23 1.412 . . . . 0.0 111.155 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.47 -45.07 76.98 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.955 2.102 . . . . 0.0 106.896 172.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -143.94 112.59 6.57 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 100.642 -3.836 . . . . 0.0 100.642 168.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -65.31 165.87 10.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.759 -2.018 . . . . 0.0 108.698 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.434 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -57.05 130.64 46.97 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.124 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.85 125.39 44.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 102.232 -3.247 . . . . 0.0 102.232 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.57 -9.79 0.82 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -168.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.7 34.4 0.81 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.29 -153.03 7.33 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 105.853 -2.899 . . . . 0.0 105.853 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -113.47 155.97 24.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 168.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.22 155.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 169.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 mt -127.74 153.48 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.02 126.91 31.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -173.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -90.57 118.29 29.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -95.25 -14.13 24.28 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.87 0.868 . . . . 0.0 111.624 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.07 -75.67 0.35 Allowed Glycine 0 C--N 1.337 0.609 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.73 -28.63 13.66 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.557 2.171 . . . . 0.0 113.135 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.01 -177.12 6.3 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 -170.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.498 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -146.22 147.45 31.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.613 1.565 . . . . 0.0 108.302 -168.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.2 170.59 15.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.313 1.045 . . . . 0.0 110.372 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.78 147.54 25.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.778 0.831 . . . . 0.0 109.203 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 165.91 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.759 1.624 . . . . 0.0 108.865 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -153.51 108.52 3.17 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 121.109 -0.994 . . . . 0.0 110.487 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 74.3 mt -55.4 150.09 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 128.454 2.702 . . . . 0.0 110.922 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -157.1 -31.08 0.08 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.773 169.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 24.0 mtmt -119.96 146.93 45.37 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 168.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.51 165.47 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -144.75 150.6 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.612 -170.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.84 142.21 15.27 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.662 1.585 . . . . 0.0 109.242 -173.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.93 -2.87 11.7 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.411 2.74 . . . . 0.0 113.652 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -63.6 -36.67 84.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.579 1.536 . . . . 0.0 111.46 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -134.86 12.37 3.66 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.083 0.953 . . . . 0.0 112.022 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 42.0 55.65 3.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.145 1.378 . . . . 0.0 111.795 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.5 ptm -155.89 164.33 38.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -107.58 169.6 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.412 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 p -136.15 156.17 49.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.755 2.022 . . . . 0.0 106.483 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.0 m -154.21 154.63 33.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -169.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.2 pt -148.2 160.84 36.16 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.889 0.876 . . . . 0.0 110.012 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.73 101.57 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.563 2.842 . . . . 0.0 110.658 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -139.76 -4.13 1.42 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.003 0.921 . . . . 0.0 112.326 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -160.46 -175.18 4.86 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.365 1.066 . . . . 0.0 109.519 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -138.9 62.67 28.17 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 127.334 2.254 . . . . 0.0 110.45 -177.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -49.73 -29.04 18.82 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.157 3.238 . . . . 0.0 116.15 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.58 -38.7 3.2 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 119.403 1.001 . . . . 0.0 111.748 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -18.09 69.69 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.823 0.725 . . . . 0.0 112.025 170.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 m -136.95 135.03 37.36 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 127.101 2.16 . . . . 0.0 105.518 172.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.1 m -57.78 -51.0 71.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.776 0.83 . . . . 0.0 111.392 -169.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -147.45 42.34 1.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.991 171.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 43.15 47.37 5.3 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.467 1.603 . . . . 0.0 110.164 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -42.25 103.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 130.29 3.436 . . . . 0.0 115.206 -167.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt 58.15 -174.84 0.08 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.209 2.604 . . . . 0.0 111.827 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.55 112.89 2.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.6 mt -79.83 137.04 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -175.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.38 141.98 94.05 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.3 138.7 30.75 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 N-CA-C 107.231 -1.873 . . . . 0.0 107.231 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -137.57 159.9 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.779 0.8 . . . . 0.0 108.952 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.44 118.82 11.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.52 153.83 41.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.221 1.408 . . . . 0.0 112.48 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.23 1.55 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-O 118.968 -0.907 . . . . 0.0 115.243 168.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -80.57 -40.66 25.45 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.097 1.449 . . . . 0.0 109.374 169.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.15 -0.41 0.07 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 0.0 113.516 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.69 46.41 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.552 1.541 . . . . 0.0 111.509 -169.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -31.75 139.07 0.04 OUTLIER 'General case' 0 C--O 1.237 0.44 0 C-N-CA 129.776 3.23 . . . . 0.0 113.28 168.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.76 126.66 18.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.15 156.41 20.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.732 2.288 . . . . 0.0 111.128 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.62 -18.48 7.86 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.08 1.352 . . . . 0.0 112.758 173.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -64.04 -30.81 71.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.923 1.289 . . . . 0.0 112.338 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.1 pt -121.03 -9.49 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.835 1.198 . . . . 0.0 110.789 -173.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.19 -49.57 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 127.776 2.43 . . . . 0.0 106.305 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.85 8.94 3.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.411 1.484 . . . . 0.0 111.994 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.96 -178.45 24.9 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.27 0.941 . . . . 0.0 111.315 -174.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -63.4 136.9 57.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.2 m -139.33 152.39 47.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.246 0.966 . . . . 0.0 110.89 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.434 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 37.5 m-85 -140.81 113.21 8.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.293 -170.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.418 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 54.4 t80 -79.15 128.99 33.99 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.19 153.93 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 124.671 1.232 . . . . 0.0 112.28 -168.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -96.38 121.53 38.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 167.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.14 112.7 7.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.73 149.45 31.16 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.86 53.25 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.063 -0.854 . . . . 0.0 111.902 -169.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -132.13 172.59 12.2 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.619 1.21 . . . . 0.0 111.097 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -72.07 158.74 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.331 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.1 m -71.63 -13.09 61.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.636 0.374 . . . . 0.0 111.778 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.9 m -54.75 -34.86 63.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.456 1.102 . . . . 0.0 112.357 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -86.98 7.94 25.37 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.109 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.66 118.24 9.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.278 7.7 tp10 -155.73 168.41 27.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.199 1.8 . . . . 0.0 107.739 -167.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 150.07 23.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.84 0.828 . . . . 0.0 110.652 168.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.65 153.32 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.764 174.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -87.9 157.83 28.81 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.59 8.77 0.76 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 93' ' ' GLY . 35.2 t70 -88.19 -21.03 24.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.355 1.862 . . . . 0.0 111.557 169.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -117.29 -36.7 3.69 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.681 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.07 151.0 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 120.062 1.301 . . . . 0.0 110.592 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -142.62 146.23 34.3 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.596 1.558 . . . . 0.0 110.404 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.91 151.36 46.9 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.229 1.412 . . . . 0.0 109.884 174.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.51 123.42 16.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.206 1.003 . . . . 0.0 110.823 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -147.85 151.32 35.74 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.107 2.163 . . . . 0.0 106.993 -169.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.66 -28.56 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.913 0.485 . . . . 0.0 110.65 173.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -64.37 -44.21 92.09 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.759 0.824 . . . . 0.0 110.302 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.5 mm -69.67 -33.89 58.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.626 0.648 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.45 99.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.287 0.949 . . . . 0.0 109.68 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -47.43 85.36 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.99 -48.02 83.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.579 -173.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -70.77 -44.51 66.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.32 0.509 . . . . 0.0 109.76 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -27.61 33.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.646 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -94.1 -45.45 7.55 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.441 1.473 . . . . 0.0 112.498 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.15 11.12 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.47 1.508 . . . . 0.0 110.956 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -58.21 -42.02 85.29 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.215 1.806 . . . . 0.0 113.307 172.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -102.96 -13.8 16.75 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.524 1.056 . . . . 0.0 113.488 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -46.8 119.78 2.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.351 1.86 . . . . 0.0 113.373 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -173.93 163.43 34.44 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.311 1.434 . . . . 0.0 110.245 169.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -79.01 85.3 4.95 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 172.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.7 p -58.35 -37.1 74.49 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.501 1.12 . . . . 0.0 112.736 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.63 -47.66 1.82 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.388 1.471 . . . . 0.0 113.737 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.9 m -78.48 50.95 1.0 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.664 1.986 . . . . 0.0 110.68 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.01 165.22 21.42 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.733 2.013 . . . . 0.0 108.498 -172.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.58 13.0 0.6 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.472 2.782 . . . . 0.0 114.048 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.04 169.07 21.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.358 2.263 . . . . 0.0 107.154 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.0 p -60.11 -29.03 68.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.189 0.595 . . . . 0.0 112.179 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 164.64 -173.82 40.59 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.888 1.232 . . . . 0.0 110.074 175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -78.13 42.01 2.07 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.735 1.16 . . . . 0.0 111.876 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.8 t -141.77 119.85 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -168.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.87 154.82 33.29 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 169.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.11 -5.45 15.81 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 121.245 1.296 . . . . 0.0 110.301 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -55.99 162.22 1.98 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.502 2.721 . . . . 0.0 109.581 169.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.9 mtm105 61.57 -30.32 0.07 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 129.764 3.225 . . . . 0.0 114.406 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -66.67 161.2 23.92 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 120.071 1.305 . . . . 0.0 109.708 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.252 1.194 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.601 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.79 159.95 37.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.03 1.332 . . . . 0.0 108.145 171.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -153.77 -54.84 0.11 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.802 0.841 . . . . 0.0 109.164 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 62.9 tp -66.57 -40.18 88.85 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.485 0.714 . . . . 0.0 111.344 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.0 -30.61 71.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.187 0.595 . . . . 0.0 111.314 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -71.82 -22.96 61.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.445 1.498 . . . . 0.0 113.196 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -80.67 154.93 27.06 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -56.65 126.5 26.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 168.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.37 135.76 55.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -169.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.9 -3.62 0.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -168.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.2 28.0 0.26 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.89 -176.31 51.05 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -87.17 153.96 21.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.38 166.93 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 168.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -133.52 145.38 50.1 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.9 134.02 40.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.2 126.62 39.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.693 1.245 . . . . 0.0 107.649 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -103.04 -6.5 22.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.512 0.725 . . . . 0.0 111.109 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -77.63 0.35 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.46 -34.95 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.309 2.006 . . . . 0.0 113.422 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.7 178.36 8.04 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.815 1.646 . . . . 0.0 108.131 -172.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 161.97 33.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.06 163.97 28.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.112 0.965 . . . . 0.0 109.132 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.13 145.59 42.07 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.302 1.041 . . . . 0.0 108.223 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.06 158.47 44.39 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -148.48 94.06 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.927 0.891 . . . . 0.0 109.681 -169.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 54.7 mt -58.48 150.03 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.62 3.168 . . . . 0.0 111.886 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.51 -19.46 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 167.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 35.0 ttpt -131.03 139.77 49.99 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.38 160.09 25.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -168.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -143.67 152.59 41.52 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.288 -168.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -149.63 143.6 16.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.653 1.581 . . . . 0.0 109.618 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.24 -1.97 10.45 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.954 3.103 . . . . 0.0 113.772 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.5 m -63.22 -33.39 75.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.297 1.408 . . . . 0.0 112.014 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -135.74 -0.52 2.58 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.919 1.288 . . . . 0.0 111.669 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 48.17 52.41 13.32 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.159 0.984 . . . . 0.0 110.145 -169.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 77.9 mtp -146.19 156.7 43.59 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.393 1.877 . . . . 0.0 107.034 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -107.25 175.62 5.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.866 0.866 . . . . 0.0 112.365 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -141.71 152.77 44.15 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 127.041 2.136 . . . . 0.0 107.207 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.1 m -152.16 157.12 41.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -169.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 pt -148.12 160.68 36.74 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 110.009 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.98 49.31 2.93 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.958 3.772 . . . . 0.0 113.141 -176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -61.54 -50.33 73.08 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.11 -0.994 . . . . 0.0 108.727 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -166.84 165.52 16.14 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.333 1.453 . . . . 0.0 108.357 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -69.46 148.15 97.03 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.484 1.514 . . . . 0.0 112.061 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -60.22 -13.88 26.31 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.248 3.299 . . . . 0.0 116.819 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.1 -38.08 3.48 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.91 1.232 . . . . 0.0 111.989 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.72 14.32 38.33 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.357 1.456 . . . . 0.0 113.124 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.7 m -136.79 159.86 40.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.262 1.825 . . . . 0.0 107.799 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.3 m -66.2 -48.35 70.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.959 0.504 . . . . 0.0 110.989 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -169.04 160.17 9.74 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.936 1.694 . . . . 0.0 109.082 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.75 159.68 33.41 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 167.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -128.77 87.31 2.56 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.397 -0.814 . . . . 0.0 111.486 -169.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt 53.81 -162.9 0.11 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.884 1.674 . . . . 0.0 110.305 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.38 112.0 2.25 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.5 mt -75.42 139.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 138.34 93.26 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.49 136.55 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 N-CA-C 107.344 -1.829 . . . . 0.0 107.344 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -138.72 159.58 41.76 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -170.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -64.87 131.86 47.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 tt -80.57 155.55 26.88 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.471 1.908 . . . . 0.0 112.199 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.34 20.27 4.79 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.332 0.968 . . . . 0.0 112.129 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.4 -35.48 47.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.942 0.871 . . . . 0.0 109.262 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -150.97 8.94 0.57 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.703 1.201 . . . . 0.0 111.634 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.465 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 6.6 mp0 -126.72 173.5 9.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.523 1.529 . . . . 0.0 110.699 -169.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.7 m -153.85 140.42 18.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 169.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.3 pt -134.54 132.28 20.73 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.12 160.02 50.55 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.363 1.376 . . . . 0.0 109.444 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.02 -14.51 2.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.443 1.097 . . . . 0.0 112.317 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -66.93 -31.95 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.604 1.562 . . . . 0.0 112.773 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.5 pt -119.34 -12.57 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 120.202 1.365 . . . . 0.0 110.686 -173.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -52.41 -46.92 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 128.43 2.692 . . . . 0.0 108.24 169.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.52 8.46 9.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.476 0.711 . . . . 0.0 111.923 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.49 -178.35 25.29 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.881 1.219 . . . . 0.0 111.195 -170.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -64.13 131.84 48.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -136.44 152.98 51.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.288 0.993 . . . . 0.0 111.546 176.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.71 114.68 10.73 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.967 1.307 . . . . 0.0 110.006 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -80.49 126.33 31.08 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 126.206 1.802 . . . . 0.0 106.791 169.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.47 156.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.334 1.454 . . . . 0.0 111.488 -168.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -105.45 120.15 40.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 167.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -72.22 120.59 18.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -72.34 148.41 45.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.582 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 9.6 56.74 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.5 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.405 ' CZ2' ' HD ' ' A' ' 128' ' ' M2L . 84.4 m95 -130.76 165.01 23.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.95 1.375 . . . . 0.0 112.035 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -75.26 161.62 29.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -62.17 -21.51 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 111.448 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -25.66 39.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.828 1.251 . . . . 0.0 112.695 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -101.57 1.82 38.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.216 1.006 . . . . 0.0 111.726 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.77 115.4 7.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.277 6.8 tp10 -156.91 169.35 24.98 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.759 1.624 . . . . 0.0 108.241 -167.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.465 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.08 150.46 22.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.229 1.014 . . . . 0.0 109.72 168.094 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.44 155.26 40.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.749 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.27 166.52 32.12 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.66 -17.48 15.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.83 1.252 . . . . 0.0 113.232 174.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -22.86 40.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.767 1.227 . . . . 0.0 113.176 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -122.89 -38.98 2.55 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.431 174.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.9 tt -95.85 156.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 119.767 1.167 . . . . 0.0 112.615 -169.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -155.19 155.41 33.85 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.391 2.676 . . . . 0.0 109.862 171.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.97 163.09 27.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.297 1.439 . . . . 0.0 112.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -66.95 115.84 7.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.15 -0.969 . . . . 0.0 110.392 174.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -161.69 161.89 29.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.482 1.513 . . . . 0.0 108.785 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.11 -33.25 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.798 1.639 . . . . 0.0 114.089 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -64.64 -43.85 92.36 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.015 0.912 . . . . 0.0 110.266 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -74.3 -27.0 60.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.67 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mm -67.15 -45.53 86.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 117.308 -1.329 . . . . 0.0 109.524 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.6 79.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.796 1.634 . . . . 0.0 109.865 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.23 -51.79 63.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.225 0.61 . . . . 0.0 109.973 171.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.57 -48.86 80.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.369 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -68.26 -40.58 81.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 120.022 1.283 . . . . 0.0 110.276 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -52.47 -54.37 33.26 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt -73.71 -40.72 63.4 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.002 -0.436 . . . . 0.0 110.665 -170.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.12 -9.21 0.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.268 1.827 . . . . 0.0 113.009 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -114.07 -46.03 3.03 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.993 1.317 . . . . 0.0 112.284 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.51 -32.96 70.65 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.057 0.844 . . . . 0.0 111.632 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.41 130.2 53.45 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 122.125 0.964 . . . . 0.0 111.18 -167.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -178.85 54.82 0.09 OUTLIER Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.042 -1.436 . . . . 0.0 110.086 -174.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.7 m -125.82 39.47 3.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 110.111 -169.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.89 -19.33 0.97 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.921 2.889 . . . . 0.0 116.095 -169.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.64 -172.56 32.26 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 120.912 -1.118 . . . . 0.0 110.725 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 m 56.21 36.94 28.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.727 1.211 . . . . 0.0 112.678 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.77 148.28 45.48 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.301 1.44 . . . . 0.0 108.824 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -79.72 36.41 0.61 Allowed 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 124.516 3.477 . . . . 0.0 112.179 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.07 -177.15 5.51 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.683 1.593 . . . . 0.0 109.238 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.2 p -56.86 -34.53 67.91 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.438 0.695 . . . . 0.0 110.512 171.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.11 13.98 67.73 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -171.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.35 27.36 63.86 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-O 117.856 -1.525 . . . . 0.0 112.387 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.3 m -156.53 153.57 6.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 120.236 2.018 . . . . 0.0 108.964 -169.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.405 ' HD ' ' CZ2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.496 ' HE3' ' HD2' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -164.4 91.7 1.03 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 -167.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.496 ' HD2' ' HE3' ' A' ' 129' ' ' LYS . 93.9 Cg_endo -76.83 -41.31 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.85 1.7 . . . . 0.0 115.115 -168.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -72.06 1.75 6.86 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 115.602 1.705 . . . . 0.0 115.602 -170.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -61.38 160.4 10.91 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.985 1.266 . . . . 0.0 110.432 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -57.85 148.61 24.83 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.125 0.97 . . . . 0.0 110.833 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 C--O 1.249 1.077 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.549 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 m -139.93 158.9 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.498 1.519 . . . . 0.0 108.486 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -158.74 -34.43 0.07 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.254 1.022 . . . . 0.0 111.317 -177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.2 tp -53.64 -27.83 29.49 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.702 1.601 . . . . 0.0 113.337 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -59.02 -27.54 65.56 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -84.43 -17.04 40.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.58 1.552 . . . . 0.0 111.518 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -83.71 164.7 19.46 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.84 126.09 26.22 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 168.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.73 128.89 52.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -170.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -2.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -168.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.98 32.57 0.37 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 -157.43 14.14 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -109.48 154.57 22.48 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.18 162.04 37.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.9 mt -139.14 130.39 26.81 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 -175.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.31 139.75 51.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -108.2 115.34 29.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -96.3 -10.54 27.62 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.994 0.918 . . . . 0.0 112.065 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.14 -78.69 0.31 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.62 -30.27 18.53 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.628 2.219 . . . . 0.0 112.887 175.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.455 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.11 -178.43 7.1 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.577 1.551 . . . . 0.0 108.894 -169.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.455 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -139.17 155.14 48.04 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.613 1.565 . . . . 0.0 107.326 -172.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -138.01 167.72 21.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 109.914 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.17 144.57 36.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.532 1.133 . . . . 0.0 109.061 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.9 156.43 48.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.168 1.387 . . . . 0.0 108.456 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -147.55 103.65 3.55 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.576 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.09 148.16 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 129.61 3.164 . . . . 0.0 111.428 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.27 -18.41 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 116.732 -1.604 . . . . 0.0 113.88 167.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 15.2 ttpt -124.54 139.87 53.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 pt -141.01 161.11 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -169.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.9 t-105 -149.38 152.35 35.62 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.815 0.697 . . . . 0.0 111.988 -169.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.21 139.51 14.08 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.172 2.189 . . . . 0.0 109.054 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.2 -9.79 26.38 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.907 3.071 . . . . 0.0 113.422 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -68.48 -30.91 69.85 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.021 1.282 . . . . 0.0 111.291 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 m -120.1 -15.69 8.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.054 1.342 . . . . 0.0 110.844 174.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 49.18 47.2 22.32 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 118.865 0.757 . . . . 0.0 109.914 -170.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -145.82 148.69 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.84 174.8 6.2 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.111 0.565 . . . . 0.0 112.323 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.9 p -142.28 160.07 40.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.529 1.932 . . . . 0.0 106.884 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.16 165.16 30.85 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.5 pt -145.06 162.14 39.14 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.718 1.207 . . . . 0.0 109.113 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.91 87.8 1.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.834 3.023 . . . . 0.0 110.208 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -133.4 7.16 3.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.416 1.086 . . . . 0.0 111.777 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -147.12 161.2 41.35 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.717 -1.24 . . . . 0.0 113.042 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -135.98 71.08 63.24 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 128.546 2.738 . . . . 0.0 104.963 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -60.7 123.9 13.93 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.558 2.838 . . . . 0.0 110.714 -169.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.74 7.25 7.69 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.218 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.54 9.37 53.14 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.782 1.182 . . . . 0.0 112.368 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m -57.06 164.99 1.42 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.479 1.139 . . . . 0.0 110.88 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.1 m -56.01 -60.2 3.81 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.321 1.048 . . . . 0.0 112.315 -169.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -176.87 149.01 0.7 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.105 0.962 . . . . 0.0 108.683 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.29 166.49 12.04 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -105.52 162.46 13.46 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.275 1.03 . . . . 0.0 111.922 -169.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -51.74 155.21 1.75 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.519 1.528 . . . . 0.0 110.126 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -23.2 98.49 0.01 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.132 2.173 . . . . 0.0 112.322 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.0 mt -70.69 129.42 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 111.388 -2.642 . . . . 0.0 107.24 -168.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -67.12 137.12 94.21 Favored Pre-proline 0 C--O 1.236 0.344 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -173.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.16 131.02 17.27 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.272 1.981 . . . . 0.0 107.092 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -135.45 167.59 20.79 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.588 1.155 . . . . 0.0 108.085 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -65.16 151.94 44.84 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.401 HD12 ' CZ2' ' A' ' 91' ' ' TRP . 10.1 tt -108.09 147.22 31.51 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.585 1.554 . . . . 0.0 109.996 -169.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.87 42.73 0.77 Allowed Glycine 0 CA--C 1.527 0.787 0 O-C-N 123.906 0.754 . . . . 0.0 112.94 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.17 -8.73 3.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.093 0.957 . . . . 0.0 112.6 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.73 10.81 2.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.144 1.378 . . . . 0.0 110.472 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -161.16 -177.44 6.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 108.016 -169.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.7 m -161.52 141.92 10.77 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.651 2.78 . . . . 0.0 103.64 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.311 5.3 tt -134.01 119.6 14.74 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -170.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.76 145.98 80.02 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.407 2.738 . . . . 0.0 113.037 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.8 -22.07 22.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.289 1.036 . . . . 0.0 112.509 172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -58.01 -31.3 66.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.792 2.037 . . . . 0.0 113.282 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 pt -117.82 -17.53 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.935 0.894 . . . . 0.0 111.014 -169.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 mm -52.87 -43.29 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 128.561 2.744 . . . . 0.0 109.656 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.91 11.75 4.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.252 -169.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.59 -171.1 26.07 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 121.0 -1.063 . . . . 0.0 110.487 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.01 136.16 56.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.131 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 m -137.91 151.21 47.78 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.927 0.767 . . . . 0.0 111.205 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -138.47 114.76 10.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.895 1.278 . . . . 0.0 110.294 -171.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -81.48 129.23 34.57 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -137.97 149.04 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.017 -168.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -92.83 123.83 36.38 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -71.3 113.41 8.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -73.65 149.49 41.95 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.29 15.71 52.22 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 119.001 -0.888 . . . . 0.0 113.063 -176.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -136.31 172.15 13.43 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.113 1.365 . . . . 0.0 110.173 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -71.21 161.5 31.0 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -175.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -72.57 -13.47 61.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.759 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.9 m -55.09 -32.6 62.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.343 1.057 . . . . 0.0 112.225 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -87.77 2.45 51.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.858 0.863 . . . . 0.0 113.005 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.77 119.42 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 40.9 tt0 -158.81 153.94 25.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.434 ' CH2' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -91.18 149.69 21.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.282 1.039 . . . . 0.0 109.224 168.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.8 149.13 31.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.49 -1.686 . . . . 0.0 110.484 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.422 ' C ' ' H ' ' A' ' 95' ' ' ASP . . . -84.74 161.93 37.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.552 173.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.06 10.06 0.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.035 1.734 . . . . 0.0 114.95 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 93' ' ' GLY . 28.5 t70 -90.27 -34.98 15.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.947 1.699 . . . . 0.0 110.378 169.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -93.39 -45.11 7.95 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.12 175.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.2 tt -98.61 156.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.564 0.62 . . . . 0.0 111.335 -171.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -148.23 155.25 41.13 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.771 2.029 . . . . 0.0 109.743 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 161.72 30.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.16 1.346 . . . . 0.0 111.427 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -70.12 117.9 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 173.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -162.02 161.32 28.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.131 1.373 . . . . 0.0 108.976 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.92 -36.08 47.85 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.68 1.592 . . . . 0.0 114.476 -169.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.19 -45.22 94.35 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.628 1.204 . . . . 0.0 110.476 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.49 -22.99 53.78 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.834 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.2 mm -69.01 -35.67 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.722 0.692 . . . . 0.0 109.772 169.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.9 97.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 118.809 0.731 . . . . 0.0 110.271 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -50.11 74.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -59.14 -48.04 83.08 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.6 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.69 -35.98 38.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.918 1.235 . . . . 0.0 110.276 -171.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -28.19 65.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.243 171.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -45.57 8.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.262 1.392 . . . . 0.0 112.819 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.04 16.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.285 1.434 . . . . 0.0 111.162 171.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -58.02 -42.32 85.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.684 1.594 . . . . 0.0 113.367 170.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -104.43 -10.01 18.02 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.336 0.971 . . . . 0.0 113.327 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -47.5 -45.16 26.12 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.672 1.989 . . . . 0.0 114.417 -170.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.87 -21.64 1.26 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.843 -0.976 . . . . 0.0 114.135 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.0 m 56.32 29.37 14.91 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.252 1.421 . . . . 0.0 112.37 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.6 p -71.32 -0.38 9.94 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.62 1.568 . . . . 0.0 113.147 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.37 -14.93 29.24 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.352 0.977 . . . . 0.0 113.728 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 p -75.29 4.18 7.59 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.211 1.506 . . . . 0.0 113.848 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.2 170.46 10.9 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.656 2.382 . . . . 0.0 108.281 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.22 13.08 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.426 3.417 . . . . 0.0 116.951 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.83 143.35 47.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.05 0.94 . . . . 0.0 110.481 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.2 p -131.54 4.38 4.27 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.113 1.365 . . . . 0.0 111.67 -175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -60.05 -24.02 60.19 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.144 1.354 . . . . 0.0 114.53 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.7 32.38 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 118.541 1.171 . . . . 0.0 112.196 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 p -153.82 146.12 14.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -169.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -151.42 127.05 4.92 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 126.717 2.007 . . . . 0.0 106.193 -171.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' A' ' 131' ' ' HIS . 23.2 Cg_endo -83.74 -27.92 1.5 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 120.942 1.095 . . . . 0.0 110.205 169.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.525 ' H ' ' HD2' ' A' ' 130' ' ' PRO . 6.8 t-80 63.04 146.71 0.02 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 131.017 3.727 . . . . 0.0 113.678 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -61.19 152.43 28.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.817 1.247 . . . . 0.0 110.851 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -66.85 -27.74 67.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 . . . . . 0 C--O 1.251 1.145 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.882 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.8 m -62.94 157.96 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 169.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -151.17 -50.45 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.128 0.571 . . . . 0.0 111.397 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 59.4 tp -86.2 -36.48 19.44 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.959 0.504 . . . . 0.0 109.876 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.45 -34.96 77.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.031 1.333 . . . . 0.0 110.592 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -75.75 -16.28 60.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.684 1.594 . . . . 0.0 112.622 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -93.73 166.42 12.22 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.989 0.813 . . . . 0.0 109.646 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.75 63.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 1 C-N-CA 132.094 4.158 . . . . 0.0 111.401 169.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.33 135.81 55.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 127.24 2.216 . . . . 0.0 105.688 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.85 -4.92 1.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -169.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.61 30.43 0.51 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 171.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.44 -165.21 34.32 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.533 -2.627 . . . . 0.0 106.533 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -99.74 154.75 18.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.39 165.88 28.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 168.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -133.53 140.74 47.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.92 129.8 34.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -104.54 114.2 28.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -87.64 -22.25 24.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.116 0.566 . . . . 0.0 110.98 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.89 -72.08 0.31 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.11 -32.07 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.53 2.153 . . . . 0.0 112.736 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.31 174.65 12.61 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.909 1.684 . . . . 0.0 109.302 -172.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -139.12 150.35 45.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.7 1.6 . . . . 0.0 108.757 -169.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -137.24 159.97 40.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 109.673 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 148.87 39.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 123.612 0.765 . . . . 0.0 109.158 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.56 159.33 42.36 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.207 1.003 . . . . 0.0 109.912 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.92 95.7 2.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.331 0.652 . . . . 0.0 109.457 -170.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 70.4 mt -54.77 152.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 128.08 2.552 . . . . 0.0 111.632 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.02 -32.08 0.09 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.399 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 34.8 ttpt -132.2 136.81 47.29 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.65 166.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.7 0.762 . . . . 0.0 109.182 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -143.17 153.24 42.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.587 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -148.6 137.48 11.96 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 127.501 2.32 . . . . 0.0 108.152 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -10.93 28.18 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.528 2.819 . . . . 0.0 113.304 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -65.62 -31.85 73.11 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.863 1.21 . . . . 0.0 111.957 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -124.51 -7.44 7.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.013 1.325 . . . . 0.0 111.163 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt 47.05 48.41 15.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.388 1.075 . . . . 0.0 110.65 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtp -147.19 158.18 43.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.642 2.377 . . . . 0.0 105.98 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.418 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -108.99 174.21 5.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.788 0.835 . . . . 0.0 112.321 -174.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 p -147.37 149.38 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.503 1.921 . . . . 0.0 107.035 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.9 t -146.5 165.9 28.05 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 pt -147.92 156.73 44.13 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.141 1.377 . . . . 0.0 109.158 -176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -68.77 110.01 2.25 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.422 2.748 . . . . 0.0 109.363 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -142.66 -15.17 0.73 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -166.43 -167.0 0.94 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.346 1.459 . . . . 0.0 109.811 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -136.28 96.24 12.67 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 128.339 2.655 . . . . 0.0 106.654 -171.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -53.79 -21.46 20.28 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.162 2.574 . . . . 0.0 117.13 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.69 -41.0 2.37 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -173.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.79 -14.87 82.11 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.539 1.066 . . . . 0.0 112.103 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -138.37 140.6 39.5 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.801 1.64 . . . . 0.0 108.077 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.6 m -64.92 -28.37 69.49 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.58 1.152 . . . . 0.0 112.324 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -169.45 158.61 8.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.037 2.135 . . . . 0.0 107.714 169.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.64 148.16 45.08 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 166.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.6 p -96.36 -72.0 0.65 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 118.148 2.647 . . . . 0.0 118.148 -166.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -144.42 -164.55 1.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.87 2.068 . . . . 0.0 105.627 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.53 113.84 3.2 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.1 mt -79.14 133.15 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -171.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.73 135.5 95.57 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.71 137.63 30.35 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.244 1.963 . . . . 0.0 108.024 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -139.69 160.67 39.34 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -170.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -67.02 120.08 13.05 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.618 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.26 150.71 33.88 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.805 2.042 . . . . 0.0 112.132 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.58 25.52 3.39 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.421 -1.21 . . . . 0.0 115.751 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.28 -30.57 17.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.986 1.893 . . . . 0.0 111.023 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.04 -39.9 0.11 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.07 1.748 . . . . 0.0 110.272 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -71.18 159.91 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.134 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -153.93 159.31 41.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.432 HG13 ' CD1' ' A' ' 91' ' ' TRP 0.329 2.0 tt -144.63 126.61 8.09 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 -169.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.84 155.0 70.05 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 121.155 1.448 . . . . 0.0 111.142 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -56.96 -17.6 10.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.788 1.235 . . . . 0.0 112.542 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.11 -25.51 67.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.433 1.493 . . . . 0.0 112.332 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 pt -125.27 -14.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.229 0.922 . . . . 0.0 111.3 -170.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -50.73 -42.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 128.587 2.755 . . . . 0.0 109.591 169.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.14 9.66 6.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.854 1.262 . . . . 0.0 112.768 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.01 -171.52 24.91 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 14.6 mmtt -58.66 140.4 54.63 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.294 -0.533 . . . . 0.0 109.658 174.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 m -138.2 149.35 45.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 123.933 0.771 . . . . 0.0 110.721 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 75' ' ' LYS . 50.0 m-85 -134.94 113.88 11.95 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.041 0.936 . . . . 0.0 110.763 -170.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -78.87 125.25 29.12 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.8 2.04 . . . . 0.0 106.479 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -135.15 151.94 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.069 1.348 . . . . 0.0 111.435 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -101.0 116.05 31.94 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 167.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.93 121.31 15.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.93 157.18 25.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.176 0.512 . . . . 0.0 110.031 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.35 11.11 45.64 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.217 -0.769 . . . . 0.0 111.731 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -135.7 167.65 20.74 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.526 1.13 . . . . 0.0 110.339 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -64.98 169.09 5.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.726 1.21 . . . . 0.0 110.659 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -82.97 -11.53 58.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.566 171.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.3 m -55.78 -33.43 64.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.707 1.203 . . . . 0.0 112.031 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -84.74 4.16 34.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.05 118.97 10.58 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.258 9.1 tt0 -157.23 162.02 39.25 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.589 1.556 . . . . 0.0 107.806 -167.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.432 ' CD1' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -96.68 152.85 18.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.15 0.976 . . . . 0.0 109.497 168.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.11 155.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.441 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.49 167.56 28.76 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -17.58 9.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.247 1.419 . . . . 0.0 113.304 176.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.77 -23.19 41.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 113.143 170.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.97 -38.56 2.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.881 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.2 tt -94.19 155.29 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.728 1.149 . . . . 0.0 112.451 -169.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -153.95 160.23 42.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.275 3.03 . . . . 0.0 108.765 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.78 15.67 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.616 1.553 . . . . 0.0 112.832 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CE2' HD13 ' A' ' 105' ' ' ILE . 32.0 t80 -70.22 115.0 8.91 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.056 -1.027 . . . . 0.0 110.023 169.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -162.02 163.64 28.72 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.622 1.569 . . . . 0.0 109.333 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -54.41 -34.34 61.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.629 1.572 . . . . 0.0 113.815 -169.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -63.9 -42.07 97.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.096 0.95 . . . . 0.0 110.412 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.16 -25.85 55.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.552 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.416 HD13 ' CE2' ' A' ' 100' ' ' TYR . 4.8 mm -69.59 -37.56 74.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.345 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.6 98.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.275 0.943 . . . . 0.0 109.702 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -49.8 74.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.98 -51.07 69.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.759 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.45 -31.98 58.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 117.63 -1.176 . . . . 0.0 110.176 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.99 -45.72 75.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.827 1.194 . . . . 0.0 110.358 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.06 -46.82 22.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.683 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.06 -29.58 30.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.022 1.329 . . . . 0.0 111.421 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -75.83 -48.12 22.87 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.559 1.143 . . . . 0.0 113.062 173.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.43 -41.73 98.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.366 0.53 . . . . 0.0 111.058 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.27 110.15 4.32 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.766 1.626 . . . . 0.0 108.304 -168.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -143.64 7.58 1.98 Allowed Glycine 0 CA--C 1.531 1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.919 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.0 m -153.05 158.05 41.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.2 m -74.78 64.92 1.31 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.4 -23.42 0.05 OUTLIER Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.864 1.697 . . . . 0.0 111.924 -169.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.7 p -116.13 -1.73 12.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.695 1.248 . . . . 0.0 112.929 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.12 151.65 93.23 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.393 1.077 . . . . 0.0 110.428 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.74 163.06 25.93 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.639 2.892 . . . . 0.0 111.764 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.64 -21.28 64.26 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 112.862 -1.972 . . . . 0.0 113.183 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.8 p -65.1 -26.62 68.29 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.717 1.207 . . . . 0.0 111.662 173.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 133.48 -46.26 1.07 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.419 1.962 . . . . 0.0 109.269 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 61.54 4.6 5.47 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.018 1.77 . . . . 0.0 116.016 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.7 t -148.47 131.96 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 119.431 1.615 . . . . 0.0 106.983 -169.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.406 ' CM2' ' SG ' ' A' ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? 24.75 88.8 0.07 OUTLIER Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 130.86 3.664 . . . . 0.0 114.742 167.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -90.38 -27.25 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.744 1.63 . . . . 0.0 111.797 -172.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -34.42 77.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -169.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -61.49 140.22 58.11 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.051 0.387 . . . . 0.0 111.301 -170.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -129.71 4.6 5.03 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.754 1.622 . . . . 0.0 109.861 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 128.337 2.655 . . . . 0.0 104.484 177.115 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.95 162.27 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.987 1.315 . . . . 0.0 108.313 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -153.36 -42.44 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.008 0.923 . . . . 0.0 110.812 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.3 tp -63.12 -32.01 73.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.041 1.337 . . . . 0.0 112.01 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -56.5 -36.06 68.72 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.473 1.109 . . . . 0.0 110.816 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.94 -21.15 64.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.736 2.415 . . . . 0.0 113.802 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.93 148.01 25.53 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.057 0.844 . . . . 0.0 109.833 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.79 127.76 31.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.67 131.2 56.67 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 102.403 -3.184 . . . . 0.0 102.403 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -11.42 0.3 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -168.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.24 32.48 0.54 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.19 -170.47 36.47 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 169.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -91.16 153.25 20.17 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -135.92 158.35 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 169.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -128.28 154.66 45.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.97 129.24 31.82 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -93.18 129.05 39.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -110.19 -6.13 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.435 1.094 . . . . 0.0 111.991 -173.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.02 -80.68 0.29 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -72.42 -29.32 13.82 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.378 2.052 . . . . 0.0 113.16 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.65 177.83 10.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.782 1.633 . . . . 0.0 110.158 -169.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.75 150.85 40.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.042 1.737 . . . . 0.0 108.887 -168.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.61 175.75 9.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.11 147.13 25.07 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 109.746 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.34 160.29 40.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.199 1.799 . . . . 0.0 108.465 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -148.41 103.47 3.43 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 120.938 -1.101 . . . . 0.0 108.882 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.7 mt -51.64 148.11 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.657 2.383 . . . . 0.0 110.441 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -153.92 -31.89 0.12 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.433 0.693 . . . . 0.0 111.632 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 33.4 ttpt -133.06 135.47 45.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 165.87 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -145.45 154.59 42.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.302 -168.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.24 141.3 14.97 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.844 2.457 . . . . 0.0 108.697 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.82 -8.42 23.38 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.474 2.783 . . . . 0.0 113.356 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 m -66.92 -33.61 75.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.586 1.539 . . . . 0.0 110.961 -172.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 p -118.95 -17.39 9.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.733 1.613 . . . . 0.0 110.847 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm 48.81 52.34 14.28 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.01 0.823 . . . . 0.0 109.212 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.9 mtp -148.9 156.94 43.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.476 2.71 . . . . 0.0 104.522 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.415 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 53.1 p90 -106.07 170.08 8.12 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.602 0.361 . . . . 0.0 111.666 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 p -142.57 150.58 40.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 126.995 2.118 . . . . 0.0 105.647 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.5 m -150.79 157.99 43.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -168.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.0 pt -137.67 164.24 42.71 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.224 0.609 . . . . 0.0 109.595 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.79 33.15 0.39 Allowed 'Trans proline' 0 CA--C 1.546 1.118 1 C-N-CA 125.392 4.061 . . . . 0.0 114.415 -169.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -75.04 -1.38 22.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -147.33 169.52 19.27 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.237 -1.54 . . . . 0.0 112.764 -169.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.97 72.28 72.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.783 2.033 . . . . 0.0 106.703 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.65 -25.85 43.68 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.012 2.474 . . . . 0.0 117.012 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.27 -42.4 1.89 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.664 1.12 . . . . 0.0 110.806 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 -18.9 75.21 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.888 0.756 . . . . 0.0 112.122 170.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.7 m -140.73 141.73 34.87 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.427 1.891 . . . . 0.0 107.142 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 m -66.34 -23.73 66.4 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.444 1.098 . . . . 0.0 112.254 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -156.86 158.79 37.38 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.475 1.91 . . . . 0.0 107.153 169.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.38 155.7 33.84 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 168.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 m -78.95 156.98 28.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.733 -0.604 . . . . 0.0 110.966 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -54.7 160.77 1.74 Allowed 'General case' 0 C--N 1.338 0.104 0 C-N-CA 124.462 1.105 . . . . 0.0 108.993 168.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -17.24 91.64 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.472 3.109 . . . . 0.0 111.127 -169.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.03 136.48 25.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.121 -167.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.79 141.68 95.06 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.535 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.34 142.65 27.11 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.931 1.754 . . . . 0.0 108.822 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -129.75 165.91 20.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 108.953 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.603 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -60.37 -25.4 65.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 -168.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.6 tt 73.46 144.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.847 2.059 . . . . 0.0 112.66 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.97 25.16 5.47 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.989 -0.895 . . . . 0.0 115.188 169.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.25 -34.6 55.81 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.062 1.431 . . . . 0.0 109.113 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -153.16 -24.15 0.15 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.435 1.894 . . . . 0.0 112.369 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 34.3 mp0 -55.6 -19.51 10.54 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 129.162 2.985 . . . . 0.0 115.216 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -17.54 108.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.465 2.706 . . . . 0.0 111.962 -169.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . 0.342 4.3 tt -115.26 136.6 22.71 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.509 2.324 . . . . 0.0 106.764 -166.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.97 151.81 56.67 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.107 1.871 . . . . 0.0 111.578 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.61 -16.64 10.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.766 1.227 . . . . 0.0 113.339 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.71 -24.64 67.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.634 1.174 . . . . 0.0 112.367 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 pt -125.16 -15.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.706 0.684 . . . . 0.0 110.688 -170.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.0 mm -54.67 -44.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.342 2.257 . . . . 0.0 107.158 169.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -81.15 11.31 4.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.177 1.791 . . . . 0.0 112.562 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.38 -172.26 26.29 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.636 1.107 . . . . 0.0 111.569 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -60.14 137.13 58.17 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -139.24 150.22 45.24 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.957 0.785 . . . . 0.0 110.465 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -137.04 115.58 11.96 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 110.272 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -82.04 130.87 35.2 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 126.348 1.859 . . . . 0.0 106.44 169.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.05 151.83 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.643 -167.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.62 122.96 36.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.71 115.63 11.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.49 147.99 30.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -173.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.16 46.8 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.336 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.415 ' CD1' HM2B ' A' ' 128' ' ' M2L . 78.9 m95 -130.73 171.47 13.06 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.597 1.199 . . . . 0.0 111.668 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -73.28 161.16 30.84 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.082 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.7 m -76.72 -13.86 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.229 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -51.1 -36.04 38.3 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.382 1.473 . . . . 0.0 111.979 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -88.06 2.13 52.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.76 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.55 121.64 14.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -172.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.276 7.7 tp10 -159.13 169.19 24.73 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.894 1.278 . . . . 0.0 108.099 -167.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.64 153.34 19.85 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.775 0.797 . . . . 0.0 110.744 168.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.24 156.3 41.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.239 172.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.08 161.12 31.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.8 7.44 0.9 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -87.43 -21.04 25.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.991 1.716 . . . . 0.0 111.115 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm105 -117.91 -35.37 3.9 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.599 1.16 . . . . 0.0 111.813 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.4 tt -101.42 150.24 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.219 0.918 . . . . 0.0 110.094 -176.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -147.32 143.8 28.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.094 1.358 . . . . 0.0 112.076 170.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.18 147.81 51.74 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.703 2.001 . . . . 0.0 111.33 -176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -59.52 114.68 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.197 0.453 . . . . 0.0 111.407 -169.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -160.53 162.23 32.92 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.27 -33.74 67.93 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.58 -42.99 98.27 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.598 0.713 . . . . 0.0 110.082 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -67.91 -36.59 80.45 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.4 mm -67.58 -34.87 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.498 0.59 . . . . 0.0 110.804 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.29 98.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.209 0.913 . . . . 0.0 109.955 174.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -47.67 83.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -60.23 -48.95 79.56 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.732 0.813 . . . . 0.0 109.282 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -71.64 -43.89 65.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.34 0.518 . . . . 0.0 109.804 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -29.06 41.14 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.017 172.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.5 mt -92.96 -45.47 7.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.537 1.517 . . . . 0.0 112.341 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.0 -26.15 10.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.651 1.58 . . . . 0.0 111.491 170.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -62.72 -45.78 91.15 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.967 1.707 . . . . 0.0 112.969 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.36 -17.21 24.97 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.943 0.792 . . . . 0.0 112.815 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -49.55 118.07 2.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.955 1.702 . . . . 0.0 111.543 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.34 34.98 0.22 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.956 1.741 . . . . 0.0 109.879 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.51 -36.53 78.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.657 1.183 . . . . 0.0 113.057 -169.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.1 m -141.82 33.27 1.59 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.313 0.506 . . . . 0.0 111.265 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.54 174.55 46.15 Favored Glycine 0 CA--C 1.525 0.682 0 O-C-N 121.197 -0.939 . . . . 0.0 111.486 172.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -83.87 17.99 2.17 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.88 1.672 . . . . 0.0 113.313 -171.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.83 151.24 45.32 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 124.877 1.271 . . . . 0.0 109.495 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.57 15.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 125.24 3.96 . . . . 0.0 117.652 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.31 22.04 3.2 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.337 1.455 . . . . 0.0 111.49 -175.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.4 m -136.55 110.05 7.97 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 162.0 -127.43 1.72 Allowed Glycine 0 C--N 1.332 0.352 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.28 68.37 0.69 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 168.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -146.93 149.15 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -167.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' M2L . . . . . 0.415 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 17.11 93.65 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.826 1 C-N-CA 132.217 4.207 . . . . 0.0 115.06 168.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -95.99 -12.02 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.04 2.494 . . . . 0.0 112.344 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -60.23 -16.95 38.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.887 2.475 . . . . 0.0 114.991 -170.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.32 67.14 1.38 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.137 1.375 . . . . 0.0 112.084 -170.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -151.26 171.22 17.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.263 2.225 . . . . 0.0 108.02 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 . . . . . 0 C--O 1.252 1.203 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.102 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 . . . . . 0 C--O 1.236 0.377 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -56.93 134.15 55.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 168.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.77 125.74 44.51 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -10.18 0.93 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -168.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 28.7 1.2 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.02 -175.27 50.94 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.48 157.3 18.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.06 153.49 37.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 168.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 14' ' ' VAL . 21.0 mt -122.07 139.38 53.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 173.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.66 123.16 28.77 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.229 0.956 . . . . 0.0 109.386 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -101.5 118.38 36.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.752 1.621 . . . . 0.0 107.6 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -95.08 -25.63 16.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.161 0.585 . . . . 0.0 111.439 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.82 -72.29 0.27 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -72.4 -30.51 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.079 1.853 . . . . 0.0 112.485 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -154.27 177.12 11.48 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.929 1.692 . . . . 0.0 109.63 -170.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.409 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -144.07 151.93 40.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.109 1.764 . . . . 0.0 108.175 -168.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -139.19 167.35 22.25 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.552 1.141 . . . . 0.0 110.583 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.34 144.89 29.37 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.34 161.71 37.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.522 1.529 . . . . 0.0 108.998 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -149.11 108.22 3.91 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.124 -0.985 . . . . 0.0 110.366 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.566 HD11 HG11 ' A' ' 14' ' ' VAL . 68.9 mt -53.8 151.06 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.229 3.012 . . . . 0.0 111.348 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.01 -30.05 0.08 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 34.4 ttpt -132.62 136.58 46.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.85 159.89 30.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -168.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -143.68 152.85 41.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.547 -168.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -150.91 142.84 15.76 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 126.065 1.746 . . . . 0.0 109.418 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.79 -11.13 31.05 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.971 2.448 . . . . 0.0 113.7 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.3 m -63.81 -32.62 74.19 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.852 1.205 . . . . 0.0 112.021 -171.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 m -125.82 -4.65 6.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.768 1.227 . . . . 0.0 111.421 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 41.45 50.66 3.67 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 125.298 1.439 . . . . 0.0 111.105 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.405 ' HE3' ' CB ' ' A' ' 58' ' ' PRO . 10.5 mtm -150.08 163.37 38.35 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 170.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.404 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 50.8 p90 -103.85 175.7 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.747 0.819 . . . . 0.0 112.272 -173.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 p -143.15 153.51 42.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.346 2.259 . . . . 0.0 106.907 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.643 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.0 m -153.23 163.49 39.79 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.6 pt . . . . . 0 CA--C 1.552 1.049 0 C-N-CA 125.794 1.638 . . . . 0.0 108.726 179.836 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt . . . . . 0 CA--C 1.514 -0.439 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 4.79 80.77 0.0 OUTLIER 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.341 2.657 . . . . 0.0 113.532 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.643 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.2 mt -73.78 136.23 25.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -169.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -78.58 146.13 68.82 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' CB ' ' HE3' ' A' ' 37' ' ' MET . 38.7 Cg_exo -52.73 134.34 53.56 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.848 2.365 . . . . 0.0 110.137 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -144.9 153.74 41.88 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -65.74 135.82 55.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.19 0.995 . . . . 0.0 109.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.22 153.72 33.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.18 1.792 . . . . 0.0 111.631 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.64 21.88 5.27 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 124.131 0.894 . . . . 0.0 112.783 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -75.87 -34.74 60.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.098 0.949 . . . . 0.0 109.207 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -149.37 4.88 0.62 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.677 1.191 . . . . 0.0 111.855 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.639 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 7.0 mp0 -114.18 168.47 9.8 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.476 1.51 . . . . 0.0 110.532 -169.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -149.54 138.96 21.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 71' ' ' ILE . 12.9 pt -135.1 128.9 18.74 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.85 162.38 41.64 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.958 1.772 . . . . 0.0 109.56 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -15.72 9.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.924 0.89 . . . . 0.0 112.316 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.55 -31.18 72.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.824 1.25 . . . . 0.0 112.119 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 67' ' ' ILE 0.254 4.6 pt -121.27 -9.09 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 119.812 1.187 . . . . 0.0 110.447 -172.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.43 -49.28 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 127.6 2.36 . . . . 0.0 106.137 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -79.44 10.24 4.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.774 1.63 . . . . 0.0 112.114 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.34 28.85 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 119.454 1.024 . . . . 0.0 111.399 -173.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -64.39 132.97 51.61 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.5 m -138.27 154.54 49.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.393 1.058 . . . . 0.0 111.844 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 35.9 m-85 -142.11 115.44 8.93 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.764 -169.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 46.5 t80 -80.82 128.29 33.49 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -138.25 155.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.458 -167.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -100.45 118.23 36.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.59 121.89 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -90.22 150.27 22.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 10.28 52.71 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.616 -169.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 31.8 m95 -136.07 172.04 13.59 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.833 1.253 . . . . 0.0 111.25 -174.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -71.36 163.08 28.37 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.324 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 m -77.64 -12.11 59.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 171.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 m -55.43 -31.15 61.67 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.969 -1.082 . . . . 0.0 111.713 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -82.79 0.02 45.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.974 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -64.61 112.87 3.37 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -157.63 168.71 26.48 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.098 1.759 . . . . 0.0 107.975 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.639 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.9 152.46 20.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.042 0.925 . . . . 0.0 110.479 168.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.42 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.006 171.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.8 158.84 35.62 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.412 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -70.47 6.83 1.23 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.78 -26.68 25.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.624 1.57 . . . . 0.0 110.974 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -107.76 -40.42 5.29 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.363 1.065 . . . . 0.0 111.093 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 14' ' ' VAL . 5.4 tt -100.61 148.9 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.596 1.089 . . . . 0.0 110.443 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.412 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 96.2 mtt180 -145.62 151.28 37.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.94 168.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.54 146.23 52.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.506 1.522 . . . . 0.0 110.403 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.489 ' CE2' HD11 ' A' ' 105' ' ' ILE . 44.8 t80 -61.12 114.75 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 119.053 0.842 . . . . 0.0 112.194 -169.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -159.25 164.82 34.64 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.223 1.409 . . . . 0.0 110.126 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.27 -33.9 68.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.594 1.557 . . . . 0.0 113.527 -169.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.24 -42.27 96.59 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.724 0.773 . . . . 0.0 109.572 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -68.75 -34.96 76.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.489 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.9 mm -66.91 -36.79 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 118.687 0.676 . . . . 0.0 110.833 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.96 99.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.259 0.936 . . . . 0.0 109.924 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -57.49 -50.85 71.71 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 170.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -57.72 -48.92 78.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.661 0.785 . . . . 0.0 109.757 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -72.36 -38.99 68.4 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.798 0.839 . . . . 0.0 110.718 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -47.28 82.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.835 0.743 . . . . 0.0 109.215 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.8 mt -73.42 -42.77 61.65 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.434 -0.791 . . . . 0.0 111.819 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.31 -20.05 3.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.294 1.438 . . . . 0.0 112.606 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 . . . . . 0 C--N 1.341 0.199 0 CA-C-N 118.921 0.782 . . . . 0.0 111.557 172.342 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 C--O 1.235 0.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 51.0 p90 -59.99 142.65 53.49 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.34 134.44 45.2 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -169.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.516 HD13 HD12 ' A' ' 30' ' ' ILE . 10.1 tp -59.73 -3.14 0.45 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -168.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.87 29.21 0.42 Allowed Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 170.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.72 179.59 48.94 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 -82.28 156.75 24.15 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -137.29 168.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.37 -2.455 . . . . 0.0 104.37 170.467 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 14' ' ' VAL . 42.8 mt -141.85 130.66 22.93 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 -172.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.98 130.08 51.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -103.71 114.06 28.04 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -171.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -94.29 -12.84 27.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.446 0.698 . . . . 0.0 111.757 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.96 -73.85 0.37 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.983 1.278 . . . . 0.0 109.914 171.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -66.7 -38.32 18.58 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.059 2.506 . . . . 0.0 113.4 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 22' ' ' MET . 18.7 tp -150.88 176.86 10.68 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 125.417 1.487 . . . . 0.0 108.798 -168.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -139.5 146.27 39.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.86 2.064 . . . . 0.0 107.014 -169.331 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -131.5 154.04 49.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.883 0.873 . . . . 0.0 108.729 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -81.08 138.57 35.96 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.011 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.03 158.55 40.02 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.605 1.562 . . . . 0.0 109.344 -171.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.76 96.6 2.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.63 0.372 . . . . 0.0 110.269 -169.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.618 HD11 HG11 ' A' ' 14' ' ' VAL . 42.6 mt -62.16 152.29 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 129.65 3.18 . . . . 0.0 112.41 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.26 -25.21 0.05 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.842 -1.075 . . . . 0.0 112.935 167.027 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.9 ttpt -128.77 136.13 50.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.516 HD12 HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -137.26 163.42 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.754 0.788 . . . . 0.0 109.024 -173.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -140.16 152.03 45.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.37 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -147.37 139.35 13.88 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.6 1.96 . . . . 0.0 108.428 -172.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.61 -10.27 27.35 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.372 2.715 . . . . 0.0 113.426 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 m -67.11 -32.12 73.05 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.116 1.325 . . . . 0.0 111.491 -170.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -121.63 -13.68 8.3 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.641 1.576 . . . . 0.0 110.823 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt 47.47 50.04 15.25 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.423 ' SD ' ' HE3' ' A' ' 60' ' ' LYS . 5.8 mtm -146.93 165.56 29.42 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.999 2.119 . . . . 0.0 106.396 170.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 49.0 p90 -107.72 175.18 5.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.968 0.907 . . . . 0.0 112.721 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -146.41 151.09 36.89 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 127.206 2.202 . . . . 0.0 107.336 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.455 ' HB3' HD12 ' A' ' 56' ' ' ILE . 47.6 t -147.19 160.84 41.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 110.102 -179.256 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.17 103.87 1.32 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.3 mt -69.85 130.96 34.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -67.63 139.22 93.83 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.02 139.39 70.71 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.966 1.778 . . . . 0.0 110.667 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -136.92 158.47 44.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 4.2 mmpt? -63.44 122.74 17.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.23 147.7 47.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.681 1.192 . . . . 0.0 111.729 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.0 -127.21 1.18 Allowed Glycine 0 N--CA 1.446 -0.661 1 N-CA-C 102.922 -4.071 . . . . 0.0 102.922 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 53.43 30.13 9.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.355 1.062 . . . . 0.0 113.298 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.64 10.45 5.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.764 2.025 . . . . 0.0 114.263 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.502 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 8.6 mm-40 -73.17 6.83 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.263 1.425 . . . . 0.0 113.586 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -22.4 118.47 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 128.63 2.772 . . . . 0.0 114.21 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 71' ' ' ILE . 10.5 pt -115.43 128.68 25.75 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.82 159.49 52.55 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.835 1.69 . . . . 0.0 109.388 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.77 -21.69 11.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.719 0.808 . . . . 0.0 111.611 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.7 -37.96 69.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.472 1.909 . . . . 0.0 114.196 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 67' ' ' ILE . 13.4 pt -116.12 -14.79 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.041 1.291 . . . . 0.0 110.814 -172.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mm -50.32 -45.96 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 128.007 2.523 . . . . 0.0 108.504 169.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.57 8.2 10.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.963 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.31 178.72 25.71 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 120.209 1.368 . . . . 0.0 111.44 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.48 130.13 45.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.0 m -131.82 143.69 50.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 124.191 0.932 . . . . 0.0 109.588 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CE1' ' CD1' ' A' ' 8' ' ' PHE . 63.3 m-85 -128.76 111.72 13.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.199 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -78.24 126.68 31.15 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.097 1.359 . . . . 0.0 107.564 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -136.65 158.6 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 125.44 1.713 . . . . 0.0 110.973 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -111.57 121.97 46.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -73.32 121.91 21.17 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -66.87 147.87 52.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.422 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.05 14.38 58.95 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.913 -0.937 . . . . 0.0 113.641 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -135.08 171.39 14.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.885 1.342 . . . . 0.0 110.819 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -68.05 157.98 33.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.903 0.481 . . . . 0.0 111.213 -173.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 m -65.08 -21.66 66.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.21 1.004 . . . . 0.0 111.904 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -54.77 -32.11 59.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.06 1.344 . . . . 0.0 112.713 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -88.4 3.67 49.1 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.049 -0.976 . . . . 0.0 112.776 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.54 117.17 7.63 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.252 7.6 tp10 -157.7 167.48 29.97 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.84 -167.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.502 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -98.72 150.45 21.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.886 0.851 . . . . 0.0 110.313 168.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.52 156.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.887 1.275 . . . . 0.0 109.976 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.77 167.46 26.97 Favored Glycine 0 C--O 1.24 0.52 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.072 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -17.34 9.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.395 1.478 . . . . 0.0 113.387 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -56.77 -22.88 39.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.123 1.369 . . . . 0.0 113.172 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -124.54 -39.22 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.228 173.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 14' ' ' VAL . 7.2 tt -93.71 153.24 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.23 0.923 . . . . 0.0 111.268 -169.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -149.88 156.97 42.7 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 127.503 2.321 . . . . 0.0 109.203 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.6 27.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.252 1.021 . . . . 0.0 111.107 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 105' ' ' ILE . 15.3 t80 -75.23 113.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -155.98 161.67 40.45 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.594 1.558 . . . . 0.0 108.687 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.54 -33.88 56.22 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.766 1.626 . . . . 0.0 114.469 -169.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.74 -44.97 84.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.289 1.519 . . . . 0.0 109.639 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -75.26 -19.28 59.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.404 HD11 ' CE2' ' A' ' 100' ' ' TYR . 7.8 mm -74.6 -33.48 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 119.061 0.846 . . . . 0.0 110.25 168.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.99 93.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.212 0.915 . . . . 0.0 108.787 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.8 ttp -58.61 -56.63 19.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.55 0.614 . . . . 0.0 109.364 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -50.08 -45.96 52.98 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.776 1.23 . . . . 0.0 110.956 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -79.43 -41.75 26.92 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.803 1.241 . . . . 0.0 111.553 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -39.59 73.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.644 1.111 . . . . 0.0 109.347 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.18 -46.49 20.38 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.73 30.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.991 0.917 . . . . 0.0 111.469 171.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 t30 . . . . . 0 CA--C 1.532 0.256 0 C-N-CA 124.019 0.928 . . . . 0.0 112.071 174.757 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.441 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -59.26 87.83 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.873 2.069 . . . . 0.0 110.461 169.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.89 130.4 37.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.441 HD22 HG12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -61.34 -8.08 3.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -169.41 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.09 30.61 0.98 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 173.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.11 -163.79 28.7 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 106.585 -2.606 . . . . 0.0 106.585 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 156.29 17.45 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -131.06 154.72 41.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 168.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 14' ' ' VAL . 34.8 mt -125.06 131.6 53.31 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 176.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.55 121.55 35.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.649 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.16 125.21 44.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.034 1.334 . . . . 0.0 107.959 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -98.94 -25.73 14.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.886 0.474 . . . . 0.0 111.607 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.11 -71.86 0.34 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.26 -32.67 12.45 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.857 1.705 . . . . 0.0 112.614 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.4 178.83 9.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.194 1.397 . . . . 0.0 109.6 -174.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.07 151.41 40.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.878 2.071 . . . . 0.0 107.95 -168.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -138.0 159.84 40.93 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.76 0.824 . . . . 0.0 111.108 -170.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.42 140.82 43.16 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 160.6 39.21 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.738 1.615 . . . . 0.0 107.582 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -147.54 103.37 3.53 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.239 -0.913 . . . . 0.0 109.699 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 14' ' ' VAL . 67.9 mt -57.72 150.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.889 2.076 . . . . 0.0 111.854 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -160.53 -24.43 0.06 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.776 -1.107 . . . . 0.0 113.109 167.114 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.1 ttpt -126.49 138.7 53.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 pt -139.64 160.47 27.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -147.4 151.12 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -169.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -150.57 142.46 15.57 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.995 1.718 . . . . 0.0 108.465 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 -11.38 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.092 2.528 . . . . 0.0 113.644 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.2 m -64.01 -34.84 78.91 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -120.56 -7.09 9.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.178 0.991 . . . . 0.0 111.186 174.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 44.45 49.45 8.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.679 1.192 . . . . 0.0 109.801 -169.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtp -146.0 147.88 32.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -94.85 173.19 7.72 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.661 0.384 . . . . 0.0 110.53 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -143.97 145.45 32.25 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.975 2.11 . . . . 0.0 105.424 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.682 ' HB2' HD12 ' A' ' 56' ' ' ILE . 1.5 m -143.39 157.18 44.67 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -171.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.441 HG12 HD22 ' A' ' 10' ' ' LEU . 26.7 pt . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.8 tttm . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -58.69 107.53 0.53 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.682 HD12 ' HB2' ' A' ' 40' ' ' SER . 23.4 mt -73.71 139.55 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -169.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -67.93 134.09 92.0 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.126 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.31 130.52 18.79 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 106.181 -2.276 . . . . 0.0 106.181 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -140.3 165.66 26.79 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.55 150.26 44.38 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 62' ' ' GLY . 6.3 tt -114.43 146.45 40.61 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.519 1.928 . . . . 0.0 110.284 -168.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.503 ' N ' HD23 ' A' ' 61' ' ' LEU . . . 114.11 36.05 1.41 Allowed Glycine 0 CA--C 1.524 0.652 0 O-C-N 124.377 1.048 . . . . 0.0 114.501 169.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -72.13 -33.22 67.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.731 1.266 . . . . 0.0 108.422 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.48 -29.88 0.13 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.372 1.869 . . . . 0.0 111.97 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 35.81 0.44 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.328 2.251 . . . . 0.0 112.78 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -32.73 144.21 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.785 2.434 . . . . 0.0 114.32 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -132.55 136.38 27.8 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 161.02 47.53 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.663 1.576 . . . . 0.0 109.575 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.76 -12.68 2.01 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.638 1.175 . . . . 0.0 112.711 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.84 -29.82 68.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.186 1.394 . . . . 0.0 113.037 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 pt -121.27 -9.91 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.371 1.441 . . . . 0.0 111.338 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mm -53.67 -45.95 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 128.688 2.795 . . . . 0.0 108.011 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.19 8.41 8.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 111.933 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.78 179.02 26.9 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 120.071 1.305 . . . . 0.0 111.33 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -64.41 129.99 42.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -136.86 151.17 48.8 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.155 0.909 . . . . 0.0 111.004 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.5 m-85 -139.88 115.41 10.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.48 1.512 . . . . 0.0 108.711 -169.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.76 129.58 35.0 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 126.168 1.787 . . . . 0.0 106.899 170.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.39 155.68 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.95 -168.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -101.94 119.53 38.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 167.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -71.07 117.15 12.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -83.73 151.08 25.42 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.851 0.46 . . . . 0.0 109.778 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.49 7.98 36.38 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.033 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -138.2 173.89 11.14 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.725 1.21 . . . . 0.0 110.786 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -72.55 165.98 23.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.199 0.523 . . . . 0.0 111.382 -170.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.51 -11.59 59.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.46 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 m -57.66 -32.48 67.35 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.191 -0.943 . . . . 0.0 111.737 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -83.54 4.97 25.77 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.468 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.95 108.6 2.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -153.66 163.81 39.37 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.622 1.569 . . . . 0.0 107.79 -167.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.76 150.15 22.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.648 0.737 . . . . 0.0 109.612 168.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.18 150.06 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.27 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.64 160.81 37.98 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 173.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.22 9.02 0.83 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.09 -30.72 20.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.835 1.654 . . . . 0.0 110.703 168.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -102.47 -39.85 6.94 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.496 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 14' ' ' VAL . 4.9 tt -101.13 149.64 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.389 0.995 . . . . 0.0 110.762 -173.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 84.7 mtt180 -145.48 147.73 32.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.122 1.369 . . . . 0.0 110.225 169.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.81 144.3 54.34 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.134 1.373 . . . . 0.0 110.238 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.482 ' CE2' HD11 ' A' ' 105' ' ' ILE . 42.4 t80 -60.34 115.49 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.114 0.87 . . . . 0.0 111.87 -169.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -161.27 165.1 29.73 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.432 1.493 . . . . 0.0 110.431 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.15 -33.99 65.73 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.53 1.532 . . . . 0.0 113.715 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.42 -43.96 96.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.174 0.988 . . . . 0.0 109.949 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -68.75 -33.77 74.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.6 mm -69.27 -34.07 61.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.507 0.594 . . . . 0.0 110.682 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.35 99.34 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 119.414 1.006 . . . . 0.0 109.625 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -48.32 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -60.68 -45.44 94.16 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.44 0.696 . . . . 0.0 109.681 -173.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -76.07 -44.11 40.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.17 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -57.35 -33.96 68.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.783 0.72 . . . . 0.0 110.569 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.32 -52.23 9.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.73 -27.19 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.928 1.291 . . . . 0.0 111.747 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.8 t30 . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 124.477 1.111 . . . . 0.0 113.448 174.135 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 C--O 1.234 0.24 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -60.06 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 126.875 2.07 . . . . 0.0 109.953 170.045 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.11 130.4 39.72 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -4.07 1.74 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -168.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.66 33.36 0.69 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.4 -161.37 27.11 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 107.346 -2.301 . . . . 0.0 107.346 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.426 ' HG2' HE22 ' A' ' 82' ' ' GLN . 56.3 mtt180 -102.96 156.65 17.52 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 168.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.573 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -131.24 156.54 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 168.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 14' ' ' VAL . 43.9 mt -126.03 134.98 51.27 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.16 129.21 47.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.177 0.923 . . . . 0.0 110.038 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -105.98 131.81 52.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 109.638 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -113.68 -19.93 11.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.758 0.823 . . . . 0.0 111.655 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.95 -72.8 0.31 Allowed Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.75 -32.75 29.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.843 1.695 . . . . 0.0 112.26 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 -179.26 7.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.702 1.601 . . . . 0.0 109.311 -170.568 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.439 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -140.94 160.61 39.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.779 1.632 . . . . 0.0 107.281 -175.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.07 160.39 39.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.951 0.9 . . . . 0.0 109.508 -170.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -77.24 140.91 40.2 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.67 41.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.671 1.588 . . . . 0.0 108.672 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -148.5 101.52 3.24 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.142 -0.973 . . . . 0.0 110.339 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.573 HD11 HG11 ' A' ' 14' ' ' VAL . 64.0 mt -58.93 150.23 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 127.769 2.428 . . . . 0.0 112.025 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.484 HD22 ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.51 -28.37 0.05 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 116.51 -1.709 . . . . 0.0 112.374 166.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 20.7 mtmt -114.72 144.79 42.9 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 168.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -142.26 161.07 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -149.6 152.7 35.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.386 -169.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.01 138.69 13.12 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.187 2.195 . . . . 0.0 108.453 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.89 -9.95 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.503 2.802 . . . . 0.0 113.57 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 m -66.57 -32.04 73.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.934 1.243 . . . . 0.0 111.538 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.8 p -121.1 -15.32 8.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.863 1.665 . . . . 0.0 110.866 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 48.62 49.01 19.19 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.917 0.887 . . . . 0.0 109.757 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.3 mtp -144.85 154.78 43.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.961 2.104 . . . . 0.0 105.793 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -104.52 170.56 7.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.223 0.609 . . . . 0.0 111.911 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -138.64 152.89 48.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.911 2.085 . . . . 0.0 106.445 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 56' ' ' ILE . 24.8 m -152.2 156.27 39.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -168.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 pt . . . . . 0 CA--C 1.55 0.951 0 C-N-CA 124.849 1.259 . . . . 0.0 109.852 -177.699 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 mttt . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.51 101.43 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.486 HD12 ' HB2' ' A' ' 40' ' ' SER . 3.7 mt -76.12 135.27 27.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -175.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.35 140.55 87.7 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.63 139.88 38.19 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.051 1.834 . . . . 0.0 107.381 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -143.65 160.0 41.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -62.99 131.79 49.83 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.178 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -80.35 153.89 28.09 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.404 1.482 . . . . 0.0 111.727 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.12 31.63 1.68 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.37 -40.16 27.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.872 1.336 . . . . 0.0 109.216 169.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -160.32 2.65 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.121 0.968 . . . . 0.0 113.286 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.12 47.21 2.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.678 1.591 . . . . 0.0 111.724 -169.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 m -33.05 142.06 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.65 3.18 . . . . 0.0 113.345 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 71' ' ' ILE . 5.8 pt -135.19 132.23 20.04 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 168.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.87 158.85 55.44 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.255 1.303 . . . . 0.0 109.302 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.18 -16.36 3.08 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.341 1.456 . . . . 0.0 112.271 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.13 -32.13 73.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.27 1.828 . . . . 0.0 112.955 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 67' ' ' ILE . 14.9 pt -120.45 -13.19 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.528 1.513 . . . . 0.0 110.868 -173.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.74 -46.03 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 128.278 2.631 . . . . 0.0 108.759 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -79.59 9.03 5.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.95 0.9 . . . . 0.0 111.886 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.1 -176.37 27.23 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.922 1.237 . . . . 0.0 111.093 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.08 130.87 48.0 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -134.29 154.39 51.33 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.885 0.741 . . . . 0.0 110.941 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 23.9 m-85 -141.78 113.49 7.83 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.108 1.363 . . . . 0.0 109.265 -169.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.509 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 55.3 t80 -80.01 129.07 34.2 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.33 157.36 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.362 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -105.8 120.09 40.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 167.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -72.73 118.45 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.426 HE22 ' HG2' ' A' ' 13' ' ' ARG . 62.3 mt-30 -77.7 150.2 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.08 10.91 42.91 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.925 -0.93 . . . . 0.0 113.017 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -134.87 171.01 15.0 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 1.233 . . . . 0.0 111.327 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -69.25 158.23 35.39 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.024 0.53 . . . . 0.0 111.338 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 p -63.92 -19.76 65.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.813 0.845 . . . . 0.0 112.127 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.1 m -54.19 -31.94 54.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.424 1.089 . . . . 0.0 112.779 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -84.14 3.23 35.87 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.95 107.01 2.94 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.253 7.5 tp10 -154.31 168.54 26.25 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.623 1.969 . . . . 0.0 107.854 -167.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.61 151.24 22.58 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.823 0.82 . . . . 0.0 111.011 168.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.68 156.38 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.128 174.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.77 161.32 27.0 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.0 1.286 . . . . 0.0 110.11 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.74 7.5 1.49 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -176.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.56 -20.5 27.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.888 1.675 . . . . 0.0 110.752 169.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -119.0 -31.31 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.01 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 14' ' ' VAL . 4.9 tt -108.22 155.91 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 120.665 1.575 . . . . 0.0 111.694 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.453 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 11.0 mtt85 -149.19 146.84 27.83 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.027 1.331 . . . . 0.0 110.32 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . 0.259 . . -66.99 143.89 56.52 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.339 1.855 . . . . 0.0 111.916 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -59.06 118.67 6.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.461 1.482 . . . . 0.0 111.516 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -169.35 164.78 10.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.06 1.744 . . . . 0.0 110.622 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.97 -27.99 63.95 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.175 -0.953 . . . . 0.0 113.511 -169.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.18 -45.92 72.13 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 119.543 1.065 . . . . 0.0 110.778 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -74.74 -22.35 58.85 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.02 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.18 -37.65 67.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 118.752 0.705 . . . . 0.0 110.127 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.06 99.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.577 1.08 . . . . 0.0 109.742 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.6 ttp -58.13 -53.68 55.48 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -57.75 -46.41 84.54 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.82 -172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -70.74 -45.19 65.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.237 0.926 . . . . 0.0 110.351 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -34.02 60.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.455 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.6 mt -87.63 -47.27 8.82 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.954 0.797 . . . . 0.0 111.996 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.23 14.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.241 1.416 . . . . 0.0 110.936 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t30 . . . . . 0 C--O 1.235 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 112.957 172.119 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -62.71 82.6 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 124.481 2.086 . . . . 0.0 110.293 169.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.07 128.67 34.88 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 103.455 -2.794 . . . . 0.0 103.455 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.86 -2.82 2.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.77 29.41 1.03 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -166.09 34.7 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 168.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -98.28 156.37 16.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.92 156.42 42.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 169.229 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 14' ' ' VAL . 32.7 mt -127.75 141.27 51.63 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.96 127.09 44.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.171 0.919 . . . . 0.0 109.155 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -86.2 138.07 32.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.383 1.073 . . . . 0.0 108.323 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -120.22 -11.46 9.2 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.19 0.996 . . . . 0.0 112.385 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.67 -72.65 0.48 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.49 -39.11 22.88 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.258 1.972 . . . . 0.0 112.601 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 22' ' ' MET . 10.7 tp -152.27 -171.81 4.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 125.818 1.647 . . . . 0.0 108.919 -169.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.422 ' H ' ' HG ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -151.63 150.77 30.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.438 2.295 . . . . 0.0 107.27 -169.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.01 164.19 29.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.985 0.514 . . . . 0.0 111.397 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.0 137.73 37.71 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 125.492 1.517 . . . . 0.0 109.132 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.6 166.24 22.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.999 1.72 . . . . 0.0 108.76 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -152.59 93.46 1.78 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 110.582 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.566 HD11 HG11 ' A' ' 14' ' ' VAL . 66.1 mt -53.11 152.43 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.09 2.156 . . . . 0.0 111.523 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -154.96 -35.06 0.09 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.935 0.894 . . . . 0.0 111.009 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 37.5 ttpt -128.93 137.09 51.2 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.15 164.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -141.39 152.88 44.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.228 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -135.11 150.38 72.79 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 127.596 2.358 . . . . 0.0 110.726 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.75 -17.42 7.18 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.787 2.991 . . . . 0.0 112.877 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m -62.08 -37.49 85.23 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.944 1.298 . . . . 0.0 111.979 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.2 m -128.62 5.89 5.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.155 1.782 . . . . 0.0 111.341 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 46.03 55.89 6.65 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 125.173 1.389 . . . . 0.0 109.932 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 ptm -150.94 169.27 22.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.408 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 49.0 p90 -114.38 172.67 6.87 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.451 0.701 . . . . 0.0 112.444 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -145.11 151.4 38.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.256 2.222 . . . . 0.0 106.627 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.478 ' HB3' HD12 ' A' ' 56' ' ' ILE . 40.8 t -144.58 152.06 39.97 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.801 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 79.1 mttt . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.43 101.18 0.3 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 40' ' ' SER . 4.3 mt -74.54 134.24 29.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -67.7 143.43 96.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.0 134.67 18.08 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 N-CA-C 107.476 -1.779 . . . . 0.0 107.476 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -137.35 167.81 20.87 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -60.99 154.37 22.75 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.003 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.88 153.31 23.22 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 111.333 -168.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.83 30.75 3.13 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-O 119.544 -0.587 . . . . 0.0 112.911 170.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.33 -26.26 38.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.221 1.011 . . . . 0.0 110.281 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -152.07 -31.69 0.15 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.209 1.003 . . . . 0.0 112.149 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HB2' ' HE1' ' A' ' 91' ' ' TRP . 0.7 OUTLIER -76.41 179.6 5.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.237 1.415 . . . . 0.0 110.621 171.141 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.4 m -154.8 152.02 29.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.456 2.702 . . . . 0.0 105.827 169.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 67' ' ' ILE . 6.9 pt -136.45 130.6 18.12 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 168.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.18 159.71 51.95 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.999 1.8 . . . . 0.0 109.846 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.01 -20.89 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.266 1.026 . . . . 0.0 112.145 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.59 -36.94 74.77 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.233 1.813 . . . . 0.0 113.677 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 67' ' ' ILE . 8.4 pt -116.99 -9.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.998 0.817 . . . . 0.0 110.901 -170.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.59 -47.98 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.696 2.799 . . . . 0.0 108.627 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.8 12.03 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.414 0.686 . . . . 0.0 112.841 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.61 -175.77 24.49 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -57.1 139.64 51.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.6 t -140.33 155.62 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.572 0.545 . . . . 0.0 110.03 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.422 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 25.3 m-85 -140.16 113.4 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.77 1.228 . . . . 0.0 110.906 -169.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -78.16 124.59 28.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.901 2.08 . . . . 0.0 106.374 169.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -134.97 157.44 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 113.45 -1.704 . . . . 0.0 111.429 -168.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -103.78 118.32 36.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.057 -2.572 . . . . 0.0 104.057 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -73.39 117.84 15.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.61 147.0 27.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.77 -171.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.9 8.51 49.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.639 -170.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -128.63 174.73 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.982 1.391 . . . . 0.0 111.481 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.02 162.49 29.38 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.215 0.606 . . . . 0.0 111.427 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -64.78 -22.07 66.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.002 . . . . 0.0 111.928 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -56.37 -30.99 63.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.113 . . . . 0.0 112.594 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -90.06 6.63 41.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.035 -0.983 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 107.18 1.9 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -155.67 164.82 38.1 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.996 1.718 . . . . 0.0 108.249 -167.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.476 ' HE1' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -94.74 149.76 20.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.136 0.97 . . . . 0.0 110.396 168.382 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.51 151.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.548 171.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.56 158.66 29.98 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.435 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.03 8.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.476 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.74 -18.8 25.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.914 1.686 . . . . 0.0 111.09 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -117.17 -39.01 3.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.856 -1.069 . . . . 0.0 111.392 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 14' ' ' VAL . 4.2 tt -99.75 150.99 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.727 1.149 . . . . 0.0 111.365 -175.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.435 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 92.7 mtt-85 -143.59 146.62 33.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.609 1.564 . . . . 0.0 110.476 168.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 147.51 53.34 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.871 1.269 . . . . 0.0 111.023 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.486 ' CE2' HD11 ' A' ' 105' ' ' ILE . 33.1 t80 -64.79 116.44 6.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.051 0.841 . . . . 0.0 111.854 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -159.16 161.71 36.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.963 1.705 . . . . 0.0 109.063 -169.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -61.48 -26.34 67.84 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.618 -1.301 . . . . 0.0 113.114 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -71.65 -44.27 64.62 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.248 1.019 . . . . 0.0 110.8 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.288 44.2 p30 -71.22 -22.28 62.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.338 173.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.486 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.1 mm -72.58 -35.55 51.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 119.032 0.833 . . . . 0.0 110.502 169.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.48 98.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.724 1.147 . . . . 0.0 109.684 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.3 ttp -58.8 -53.7 55.4 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -54.0 -46.12 71.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.758 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -73.12 -45.23 58.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.844 0.747 . . . . 0.0 110.041 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.87 39.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.873 -0.584 . . . . 0.0 112.15 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.03 -45.09 8.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.298 0.954 . . . . 0.0 112.037 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.71 13.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.025 1.33 . . . . 0.0 111.316 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.6 t30 . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 126.227 1.811 . . . . 0.0 114.15 173.621 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.561 0.696 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.46 126.21 26.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.51 133.91 55.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 -169.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 HG12 ' A' ' 41' ' ' ILE . 1.1 mt -58.77 -8.07 1.21 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -168.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.02 31.58 0.55 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.18 -163.1 29.96 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 168.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.94 152.71 20.61 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.613 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.4 166.35 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 168.187 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 14' ' ' VAL . 44.5 mt -136.35 140.51 43.34 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.6 124.51 36.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -74.17 132.47 42.23 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.81 0.12 10.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.781 0.833 . . . . 0.0 111.148 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.45 -86.52 0.23 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.74 -26.24 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.731 2.287 . . . . 0.0 113.641 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -153.34 -170.6 3.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.265 1.426 . . . . 0.0 109.81 -168.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.499 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -144.08 149.22 36.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.389 1.876 . . . . 0.0 108.773 -168.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.71 173.2 11.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.068 0.547 . . . . 0.0 110.982 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.57 144.83 28.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.704 1.202 . . . . 0.0 108.652 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.26 50.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.844 1.258 . . . . 0.0 108.539 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -145.18 101.27 3.59 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.115 0.966 . . . . 0.0 109.852 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.613 HD11 HG11 ' A' ' 14' ' ' VAL . 77.5 mt -57.17 152.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 129.025 2.93 . . . . 0.0 111.175 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.21 -29.83 0.08 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.641 168.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 31.9 ttpt -132.32 133.84 44.51 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 pt -137.33 161.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -145.64 151.94 38.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.322 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.5 142.6 16.04 Favored Pre-proline 0 C--O 1.241 0.652 0 C-N-CA 126.263 1.825 . . . . 0.0 109.167 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.85 -11.16 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.897 2.398 . . . . 0.0 113.785 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -62.6 -35.59 80.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.095 1.316 . . . . 0.0 112.463 -169.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 m -129.01 4.65 5.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.264 1.026 . . . . 0.0 111.557 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt 41.43 55.7 3.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.748 1.619 . . . . 0.0 111.045 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptm -152.81 160.75 43.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 50.5 p90 -102.93 169.78 8.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -175.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -141.32 146.5 36.8 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 126.863 2.065 . . . . 0.0 105.761 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.614 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.2 m -148.18 158.51 44.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -169.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.502 HG12 HD22 ' A' ' 10' ' ' LEU . 17.5 pt . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt . . . . . 0 N--CA 1.469 0.478 0 CA-C-O 118.542 -0.742 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.61 119.49 8.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 40' ' ' SER . 14.0 mt -84.17 141.31 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 127.075 2.15 . . . . 0.0 106.785 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.11 125.48 91.55 Favored Pre-proline 0 C--O 1.239 0.545 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.659 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.34 135.02 23.81 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.218 1.945 . . . . 0.0 109.049 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -137.08 157.3 47.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.766 0.827 . . . . 0.0 109.008 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.1 mmpt? -64.83 -6.87 9.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -168.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 71.92 151.75 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 114.566 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.54 30.29 2.67 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.772 169.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -83.67 -40.37 19.03 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.887 1.344 . . . . 0.0 109.379 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -160.72 -1.3 0.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 47.16 2.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.013 1.725 . . . . 0.0 110.895 -169.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -32.12 139.32 0.04 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 129.73 3.212 . . . . 0.0 113.383 168.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 71' ' ' ILE . 7.9 pt -135.87 133.63 20.04 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.12 162.21 43.1 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.238 1.959 . . . . 0.0 109.811 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.06 -15.22 8.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 112.472 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.17 -30.23 70.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.632 1.173 . . . . 0.0 112.073 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 67' ' ' ILE . 7.5 pt -121.73 -9.53 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 120.219 1.372 . . . . 0.0 110.608 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mm -58.4 -47.74 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 127.391 2.276 . . . . 0.0 106.292 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -79.29 8.92 5.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.398 1.479 . . . . 0.0 112.297 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.8 178.48 27.27 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.763 1.165 . . . . 0.0 111.684 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -64.29 131.3 46.9 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m -137.09 152.49 50.08 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.351 1.032 . . . . 0.0 111.426 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -138.88 114.56 9.89 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.84 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 47.6 t80 -81.27 126.65 31.81 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.865 2.066 . . . . 0.0 106.761 169.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -138.43 154.97 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.764 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -100.34 123.19 44.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 167.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -70.7 113.0 7.35 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -75.76 148.29 38.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.82 8.16 51.81 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.995 -0.891 . . . . 0.0 112.735 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -133.14 170.26 15.67 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.58 1.19 . . . . 0.0 111.071 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -73.6 159.74 32.65 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.96 0.409 . . . . 0.0 110.364 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -73.55 -14.44 61.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.981 0.512 . . . . 0.0 111.656 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.0 m -55.29 -31.71 61.83 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.739 1.216 . . . . 0.0 112.241 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -91.34 7.0 43.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.06 0.944 . . . . 0.0 112.527 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.43 120.41 12.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.263 7.5 tp10 -157.01 166.58 32.95 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.476 1.11 . . . . 0.0 108.288 -167.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.67 151.31 21.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.157 0.979 . . . . 0.0 109.497 168.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.12 153.73 39.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.36 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.88 168.47 31.55 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -16.79 13.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.764 1.226 . . . . 0.0 113.608 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.79 -24.39 50.13 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.223 1.009 . . . . 0.0 113.072 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -119.14 -45.47 2.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.405 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 97' ' ' ILE . 7.1 tt -86.61 163.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -164.68 156.06 15.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 129.139 2.975 . . . . 0.0 110.108 170.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.92 169.43 13.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.846 1.203 . . . . 0.0 111.493 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -80.09 108.41 13.66 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.837 -1.164 . . . . 0.0 109.183 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -154.48 162.99 40.86 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.035 1.334 . . . . 0.0 109.898 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.71 -35.18 55.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.017 1.727 . . . . 0.0 114.795 -169.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.09 -42.62 99.64 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.478 1.609 . . . . 0.0 110.382 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.18 -24.71 47.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.014 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.87 -32.92 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.383 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.74 99.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.784 1.175 . . . . 0.0 109.196 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.1 ttp -56.24 -54.33 46.59 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -56.58 -48.52 77.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.475 0.71 . . . . 0.0 111.211 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -69.12 -45.58 69.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.655 0.661 . . . . 0.0 109.572 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -25.89 54.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.26 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.04 -45.86 7.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.697 1.135 . . . . 0.0 112.685 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.74 -24.76 9.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 111.305 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 . . . . . 0 CA--C 1.529 0.162 0 C-N-CA 126.013 1.725 . . . . 0.0 113.334 171.49 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -57.45 89.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.944 2.097 . . . . 0.0 110.117 169.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.95 134.86 37.79 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.61 HD12 HG12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -59.48 -6.74 1.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -169.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.73 32.13 0.47 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.51 -173.89 45.4 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.79 157.51 17.9 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.32 154.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 169.128 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 14' ' ' VAL . 27.8 mt -124.25 136.96 54.53 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.0 126.46 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.305 1.003 . . . . 0.0 109.048 -169.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -105.6 123.9 48.67 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.199 1.4 . . . . 0.0 108.244 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.17 -24.88 14.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.195 0.598 . . . . 0.0 111.911 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.27 -70.58 0.31 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.94 -36.97 16.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.143 1.895 . . . . 0.0 112.552 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -153.47 177.78 10.54 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 125.479 1.512 . . . . 0.0 109.268 -168.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 152.12 43.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.384 2.274 . . . . 0.0 107.64 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -137.1 160.9 37.6 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 109.978 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.16 141.82 39.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.91 163.35 32.53 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.861 1.664 . . . . 0.0 108.177 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -153.24 102.28 2.61 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.179 -0.951 . . . . 0.0 110.595 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.567 HD11 HG11 ' A' ' 14' ' ' VAL . 67.1 mt -59.27 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.998 2.519 . . . . 0.0 112.061 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.38 -17.62 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.764 167.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.75 138.36 49.92 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 170.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt -138.77 163.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -168.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -149.12 151.82 35.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.018 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -147.06 140.93 15.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.759 2.424 . . . . 0.0 108.468 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.1 -9.31 25.98 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.704 . . . . 0.0 113.502 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.3 m -67.92 -32.9 73.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.098 1.317 . . . . 0.0 111.646 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 p -117.96 -15.73 9.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.637 1.575 . . . . 0.0 110.646 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt 49.03 48.97 20.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 118.771 0.714 . . . . 0.0 109.39 -169.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.9 mtp -146.48 151.16 36.94 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.781 2.032 . . . . 0.0 105.636 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -101.89 173.68 6.29 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.818 0.447 . . . . 0.0 112.07 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 p -142.84 156.8 45.0 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 126.542 1.937 . . . . 0.0 106.434 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.538 ' HB3' HD12 ' A' ' 56' ' ' ILE . 34.7 t -148.72 152.02 35.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.61 HG12 HD12 ' A' ' 10' ' ' LEU . 1.1 pp . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -148.63 107.18 3.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 40' ' ' SER . 6.1 mt -75.28 132.1 33.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 11.0 mmpt? -66.89 137.57 94.83 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.76 135.79 26.57 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 N-CA-C 106.896 -2.001 . . . . 0.0 106.896 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -137.04 167.04 22.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 6.0 mmpt? -62.06 153.03 30.98 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 169.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.426 HD11 ' CZ2' ' A' ' 91' ' ' TRP . 6.4 tt -105.86 147.13 29.06 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.067 1.747 . . . . 0.0 109.676 -169.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.21 16.95 2.79 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.004 0.815 . . . . 0.0 113.104 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -87.05 -33.8 19.41 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.041 0.92 . . . . 0.0 109.977 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.98 8.0 0.23 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.097 0.959 . . . . 0.0 111.772 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -152.97 164.09 38.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.709 2.004 . . . . 0.0 107.92 -169.659 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.7 m -145.56 142.44 29.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.771 2.028 . . . . 0.0 107.352 -170.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 71' ' ' ILE . 11.7 pt -135.22 132.73 20.22 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.02 161.32 46.3 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.723 1.615 . . . . 0.0 109.445 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -56.16 -15.44 3.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 112.45 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.32 -27.0 64.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.401 1.48 . . . . 0.0 113.139 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 67' ' ' ILE . 12.5 pt -121.18 -8.17 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 120.131 1.332 . . . . 0.0 111.104 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.85 -45.26 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 128.14 2.576 . . . . 0.0 109.088 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.62 9.86 5.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.931 0.892 . . . . 0.0 112.521 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.57 -172.54 25.82 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -57.55 136.45 56.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.9 t -140.66 153.96 46.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.415 0.447 . . . . 0.0 110.105 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.6 m-85 -140.2 112.45 7.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.348 1.459 . . . . 0.0 110.156 -169.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -77.84 128.82 34.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.68 156.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.983 1.313 . . . . 0.0 112.362 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -101.59 121.84 42.75 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -74.58 112.16 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -78.17 150.5 33.56 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.29 7.58 39.66 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.978 -0.901 . . . . 0.0 112.51 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -135.02 172.96 12.27 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.622 1.211 . . . . 0.0 111.38 -174.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -70.89 160.66 32.41 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 122.871 0.468 . . . . 0.0 111.505 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -65.51 -22.29 66.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.137 0.975 . . . . 0.0 111.761 170.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 m -54.97 -32.24 61.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.515 1.126 . . . . 0.0 112.487 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -83.26 -3.31 57.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.497 -1.239 . . . . 0.0 112.957 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -64.6 111.11 2.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -156.67 166.74 32.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.663 1.585 . . . . 0.0 108.673 -167.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.426 ' CZ2' HD11 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -96.32 149.94 21.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.927 0.87 . . . . 0.0 110.693 168.283 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.35 153.24 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.32 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.18 160.54 29.61 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.49 7.23 1.11 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -83.46 -23.6 32.18 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.312 1.845 . . . . 0.0 110.899 168.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.31 -34.65 3.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.686 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.514 HD11 HG21 ' A' ' 14' ' ' VAL . 4.7 tt -101.68 149.58 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.786 1.175 . . . . 0.0 110.794 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -144.75 149.44 35.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.075 1.35 . . . . 0.0 110.177 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.83 141.96 53.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.13 1.772 . . . . 0.0 110.627 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.402 ' CE2' HD11 ' A' ' 105' ' ' ILE . 38.0 t80 -59.9 115.47 3.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.541 1.064 . . . . 0.0 111.759 -169.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -160.76 165.62 30.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.148 1.779 . . . . 0.0 110.505 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -57.58 -33.15 67.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.638 1.575 . . . . 0.0 113.392 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -64.59 -43.43 93.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.013 0.911 . . . . 0.0 109.397 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -69.04 -33.01 72.91 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.402 HD11 ' CE2' ' A' ' 100' ' ' TYR . 3.8 mm -67.83 -34.72 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.448 0.567 . . . . 0.0 110.748 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.881 0.764 . . . . 0.0 110.196 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.63 -49.92 71.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 170.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -59.18 -50.37 74.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.003 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -76.19 -36.15 58.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.425 1.012 . . . . 0.0 109.85 -170.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -40.85 82.29 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 119.103 -0.475 . . . . 0.0 109.977 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.39 -44.08 22.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.568 1.076 . . . . 0.0 112.862 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -49.24 -34.0 13.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.059 1.344 . . . . 0.0 110.83 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t30 . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 124.316 1.046 . . . . 0.0 113.148 174.552 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--O 1.238 0.455 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -56.2 132.71 51.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.94 129.62 45.69 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -3.27 0.38 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.0 28.79 0.53 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.81 -173.73 48.71 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 106.828 -2.509 . . . . 0.0 106.828 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 mtt85 -91.33 159.99 15.73 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.555 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.94 161.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -130.03 140.84 50.8 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.7 128.4 32.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -102.51 124.97 49.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 108.573 -169.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -101.6 -23.19 14.31 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.438 0.295 . . . . 0.0 111.194 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.88 -73.76 0.25 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.63 -31.14 27.01 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.55 2.167 . . . . 0.0 112.273 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.38 177.94 10.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.131 1.772 . . . . 0.0 108.287 -169.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.432 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -135.15 162.09 33.49 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.643 1.577 . . . . 0.0 107.208 -173.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -136.59 159.82 40.66 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.248 1.019 . . . . 0.0 108.854 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -76.61 147.27 37.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.537 . . . . 0.0 109.732 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.94 31.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.846 1.258 . . . . 0.0 108.882 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 26' ' ' LYS . 29.4 ttpt -153.11 111.38 3.65 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.197 -0.939 . . . . 0.0 110.706 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 HG11 ' A' ' 14' ' ' VAL . 65.0 mt -59.03 152.17 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 128.895 2.878 . . . . 0.0 111.688 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pp -157.99 -30.04 0.08 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.913 0.885 . . . . 0.0 112.514 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -131.25 140.99 49.93 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.99 164.88 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -168.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -149.91 152.21 34.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.973 -168.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.29 141.11 14.53 Favored Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 125.137 1.375 . . . . 0.0 109.965 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.45 -0.23 7.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.088 3.192 . . . . 0.0 113.501 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -66.13 -34.46 78.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.032 1.287 . . . . 0.0 110.979 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -130.81 -7.86 4.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.37 1.068 . . . . 0.0 112.164 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 45.16 53.14 8.13 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.221 1.009 . . . . 0.0 110.72 -169.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -148.81 151.87 35.53 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.827 2.051 . . . . 0.0 105.815 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -103.21 168.06 9.42 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.86 0.464 . . . . 0.0 112.043 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 p -136.42 153.54 51.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 107.324 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.687 ' HB2' HD12 ' A' ' 56' ' ' ILE . 3.5 m -151.62 158.07 42.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.738 0.699 . . . . 0.0 110.1 -168.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 126.151 1.781 . . . . 0.0 108.621 173.788 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.19 108.5 0.61 Allowed 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.296 -0.878 . . . . 0.0 108.675 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.687 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.6 mt -87.53 141.74 13.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.76 142.95 88.91 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 123.157 0.583 . . . . 0.0 109.613 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.31 142.18 33.2 Favored 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.54 1.493 . . . . 0.0 108.691 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -132.52 166.32 22.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.014 0.926 . . . . 0.0 109.023 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.653 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -64.7 -13.52 54.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -168.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 68.12 151.66 0.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.647 1.979 . . . . 0.0 112.681 -169.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.42 55.38 0.15 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.113 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 51.44 2.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.736 1.214 . . . . 0.0 108.072 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.59 -7.4 0.72 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.126 2.571 . . . . 0.0 113.405 -172.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.95 33.02 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.641 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -33.74 140.51 0.05 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 130.502 3.521 . . . . 0.0 112.203 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 71' ' ' ILE . 10.2 pt -135.41 135.17 21.91 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.564 1.146 . . . . 0.0 108.093 169.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.94 162.76 41.57 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.03 1.82 . . . . 0.0 109.723 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.14 -17.26 10.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.964 0.906 . . . . 0.0 112.571 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.45 -28.66 69.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.607 1.163 . . . . 0.0 112.536 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 67' ' ' ILE 0.253 7.2 pt -122.21 -9.01 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 120.081 1.31 . . . . 0.0 110.844 -174.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mm -61.16 -50.94 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.484 2.313 . . . . 0.0 105.817 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -78.79 9.16 4.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.496 1.518 . . . . 0.0 111.648 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.72 173.79 24.44 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.45 1.023 . . . . 0.0 110.696 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -62.72 132.49 52.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -135.6 152.71 51.52 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 124.11 0.881 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 32.3 m-85 -142.94 116.29 9.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 109.674 -169.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -81.28 125.36 30.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.252 2.221 . . . . 0.0 105.811 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.53 157.44 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.409 -168.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -100.94 118.51 37.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.14 119.73 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.83 149.53 25.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.9 8.57 57.99 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.553 -169.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -133.89 172.66 12.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.493 1.146 . . . . 0.0 111.633 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -71.1 158.6 36.19 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.196 0.598 . . . . 0.0 110.423 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.6 m -70.36 -12.28 61.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.628 0.371 . . . . 0.0 111.843 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.7 m -56.42 -33.31 65.7 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.748 -1.22 . . . . 0.0 112.439 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -80.24 3.38 21.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.973 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.95 108.72 2.68 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.21 167.21 29.31 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.685 1.994 . . . . 0.0 107.441 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.21 149.56 23.44 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.911 0.862 . . . . 0.0 110.378 169.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.92 150.78 31.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.283 173.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.74 158.51 32.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.63 8.12 0.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -88.59 -18.72 27.46 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.047 1.739 . . . . 0.0 111.311 169.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -119.79 -35.68 3.46 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 117.255 -1.355 . . . . 0.0 111.984 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 14' ' ' VAL . 6.3 tt -98.9 153.66 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 120.474 1.488 . . . . 0.0 110.883 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.569 ' HB3' HD21 ' A' ' 104' ' ' ASN . 90.4 mtt180 -149.83 152.54 35.32 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.842 1.657 . . . . 0.0 110.827 170.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 154.74 41.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.925 1.69 . . . . 0.0 111.863 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.514 ' CE2' HD11 ' A' ' 105' ' ' ILE . 41.3 t80 -60.59 118.17 6.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.577 0.626 . . . . 0.0 109.882 176.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -164.4 160.59 20.87 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.312 1.445 . . . . 0.0 109.084 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -53.15 -35.7 60.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.523 1.529 . . . . 0.0 113.755 -169.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.82 -43.81 97.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.684 0.755 . . . . 0.0 110.726 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.569 HD21 ' HB3' ' A' ' 98' ' ' ARG . 72.8 m-20 -74.15 -26.55 60.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.813 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.514 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.3 mm -68.52 -39.08 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.931 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.33 98.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.965 0.802 . . . . 0.0 109.47 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -50.88 72.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -60.5 -46.77 88.92 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.281 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -73.77 -40.19 63.64 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 119.067 0.849 . . . . 0.0 111.04 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -48.59 75.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.02 -44.33 61.04 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.954 -1.091 . . . . 0.0 112.231 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.75 -13.96 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.238 1.815 . . . . 0.0 112.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t30 . . . . . 0 N--CA 1.454 -0.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.059 179.282 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 CA--C 1.545 0.763 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -63.22 68.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 130.454 3.502 . . . . 0.0 110.063 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 138.73 54.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 112.121 -2.308 . . . . 0.0 106.145 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.63 HD12 HG12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -57.81 -10.9 1.89 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -168.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.27 32.88 0.5 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 170.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.24 -163.04 21.52 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 169.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 mtt85 -102.33 153.83 19.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 168.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.587 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.59 169.27 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.5 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.0 mm? -135.26 142.41 45.93 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 103.243 -2.873 . . . . 0.0 103.243 176.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.3 147.1 51.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -115.12 119.53 36.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -102.14 -9.5 20.45 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.243 0.617 . . . . 0.0 112.56 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.03 -77.99 0.3 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -66.46 -38.66 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.439 2.092 . . . . 0.0 113.317 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD12 ' H ' ' A' ' 22' ' ' MET . 21.2 tp -148.2 177.76 9.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 125.129 1.371 . . . . 0.0 109.294 -168.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.5 ' CE ' HD12 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -139.59 149.23 43.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.598 2.359 . . . . 0.0 107.129 -168.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -136.44 154.32 50.81 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.539 0.736 . . . . 0.0 109.765 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.64 141.9 57.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.277 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.62 162.59 29.04 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.137 1.775 . . . . 0.0 108.083 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -148.66 95.72 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.465 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.587 HD11 HG11 ' A' ' 14' ' ' VAL . 75.0 mt -55.52 151.35 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.392 2.277 . . . . 0.0 110.743 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -156.73 -32.27 0.09 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.779 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD2' ' CD2' ' A' ' 38' ' ' TYR . 36.8 ttpt -131.53 138.04 48.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.35 165.33 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -144.3 153.37 41.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.331 -169.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.53 143.57 17.49 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.022 1.729 . . . . 0.0 109.243 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.69 -12.48 36.08 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.585 2.857 . . . . 0.0 113.586 176.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.9 m -64.77 -32.74 74.56 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.066 1.303 . . . . 0.0 111.883 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.0 m -121.35 -11.28 8.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.452 1.101 . . . . 0.0 111.077 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 48.29 49.67 17.49 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.156 0.982 . . . . 0.0 109.331 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -145.4 159.09 43.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.144 2.177 . . . . 0.0 105.5 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.449 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 42.1 p90 -104.58 174.97 5.65 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.622 . . . . 0.0 112.573 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -143.47 152.54 41.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.549 2.339 . . . . 0.0 106.132 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB3' HD12 ' A' ' 56' ' ' ILE . 47.7 t -147.56 161.17 41.67 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -175.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.63 HG12 HD12 ' A' ' 10' ' ' LEU . 15.2 pt . . . . . 0 CA--C 1.547 0.855 0 C-N-CA 123.96 0.904 . . . . 0.0 110.017 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.31 109.1 1.46 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.2 mt -73.66 135.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -173.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.19 137.49 96.94 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.02 137.9 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 107.165 -1.898 . . . . 0.0 107.165 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -141.19 164.49 30.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.9 mmpt? -63.62 153.12 36.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.3 tt -107.71 154.3 21.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.524 1.93 . . . . 0.0 110.583 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.01 21.96 5.12 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.137 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -77.78 -33.42 52.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.723 0.762 . . . . 0.0 109.166 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.9 6.35 0.61 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.696 1.198 . . . . 0.0 111.79 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.601 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 4.8 mp0 -124.75 172.53 9.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.012 1.325 . . . . 0.0 111.648 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.9 m -149.55 144.03 25.98 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.988 2.115 . . . . 0.0 106.343 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 71' ' ' ILE . 9.3 pt -135.54 120.97 13.77 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 169.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.99 154.45 27.37 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.282 1.988 . . . . 0.0 111.181 170.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.43 -24.46 12.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.341 1.056 . . . . 0.0 111.619 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -57.13 -32.64 66.56 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.156 1.783 . . . . 0.0 114.215 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 67' ' ' ILE . 14.9 pt -117.77 -17.13 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.702 1.137 . . . . 0.0 110.508 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.67 -44.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 128.418 2.687 . . . . 0.0 109.16 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.94 11.53 6.02 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.342 -169.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.88 -177.79 29.43 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 119.577 1.08 . . . . 0.0 111.045 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.87 133.36 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 m -135.99 150.72 49.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 123.812 0.695 . . . . 0.0 110.139 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -135.19 113.3 11.21 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.32 1.048 . . . . 0.0 110.111 -169.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -77.62 121.81 24.46 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.296 2.238 . . . . 0.0 106.963 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.04 159.04 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.672 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -106.95 129.04 54.82 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -75.25 110.02 9.25 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.54 149.21 42.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.915 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.84 4.53 34.26 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.756 -1.024 . . . . 0.0 112.364 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -130.2 172.15 12.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.828 1.314 . . . . 0.0 111.832 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -68.22 162.78 24.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.4 m -65.65 -20.59 66.36 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.018 0.927 . . . . 0.0 111.589 169.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -59.44 -31.04 68.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.789 0.836 . . . . 0.0 112.354 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -91.85 17.56 8.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.801 0.84 . . . . 0.0 112.705 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.1 106.87 1.14 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -153.87 158.07 40.23 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 108.036 -168.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.601 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -97.43 150.41 21.07 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.42 1.105 . . . . 0.0 109.326 167.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.89 154.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.328 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.3 168.18 30.79 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -16.42 6.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.51 1.124 . . . . 0.0 113.297 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.48 -23.79 52.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.532 1.533 . . . . 0.0 112.976 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -123.12 -37.64 2.69 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.227 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 tt -95.63 157.5 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.496 1.044 . . . . 0.0 112.822 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -152.81 165.24 36.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.692 3.197 . . . . 0.0 109.117 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . . . -99.61 155.21 17.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.67 1.588 . . . . 0.0 112.861 -172.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.534 ' CE2' HD11 ' A' ' 105' ' ' ILE . 29.8 t80 -67.22 109.06 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.345 1.069 . . . . 0.0 112.551 -169.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -157.74 162.45 38.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 125.764 1.625 . . . . 0.0 108.786 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -54.95 -33.98 62.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -168.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.55 -43.24 97.66 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.081 0.855 . . . . 0.0 110.328 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.72 -25.13 60.05 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.633 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.534 HD11 ' CE2' ' A' ' 100' ' ' TYR . 6.8 mm -73.87 -32.54 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 118.508 0.594 . . . . 0.0 111.382 171.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.59 96.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.209 0.913 . . . . 0.0 109.097 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -51.69 68.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -54.42 -49.36 70.14 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 123.706 0.802 . . . . 0.0 110.462 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -74.21 -44.71 52.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.368 0.531 . . . . 0.0 110.419 -173.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -32.82 55.64 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.966 0.506 . . . . 0.0 111.068 174.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.63 -46.52 9.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.953 0.797 . . . . 0.0 112.426 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.41 -29.95 11.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 111.31 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t30 . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 125.867 1.667 . . . . 0.0 114.292 174.438 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -57.82 128.84 39.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 168.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.67 136.5 54.51 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -169.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.431 HD22 HG12 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -59.94 -3.62 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -168.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.05 30.41 0.3 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.66 -168.86 44.26 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 169.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -94.87 157.32 15.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.57 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.2 166.62 28.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 102.461 -3.162 . . . . 0.0 102.461 168.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.501 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.3 mm? -132.1 139.75 48.59 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.76 135.46 36.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -106.04 111.67 24.39 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -81.56 -35.16 30.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.622 0.646 . . . . 0.0 110.313 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.37 -72.04 0.19 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.11 -28.54 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.188 2.592 . . . . 0.0 113.338 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -150.92 171.73 16.8 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.308 1.443 . . . . 0.0 108.622 -173.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.501 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.14 144.7 48.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.949 2.099 . . . . 0.0 106.605 -169.326 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -133.27 160.07 38.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.747 0.819 . . . . 0.0 109.178 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.42 145.74 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.29 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.3 159.13 42.8 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.227 1.411 . . . . 0.0 107.952 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 94.55 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.896 -0.503 . . . . 0.0 110.63 -169.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 HG11 ' A' ' 14' ' ' VAL . 58.3 mt -59.11 149.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.577 2.751 . . . . 0.0 112.159 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.54 -24.62 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.439 1.087 . . . . 0.0 113.356 167.33 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' N ' HD22 ' A' ' 28' ' ' LEU . 35.4 ttpt -125.86 139.25 53.63 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.08 165.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.512 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.3 t-105 -149.76 154.7 38.91 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.515 -169.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.73 141.17 15.02 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 109.147 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -67.19 -10.47 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.268 2.645 . . . . 0.0 112.783 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.3 m -65.11 -33.28 75.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.404 1.456 . . . . 0.0 111.295 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -120.24 -16.32 8.51 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.291 1.836 . . . . 0.0 110.734 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm 49.07 53.25 12.92 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.538 0.735 . . . . 0.0 109.095 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 76.7 mtp -149.01 154.03 38.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.462 2.305 . . . . 0.0 105.533 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -100.58 174.41 6.09 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.158 0.583 . . . . 0.0 112.302 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -144.1 151.91 40.24 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.583 2.353 . . . . 0.0 106.34 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.447 ' HB3' HD12 ' A' ' 56' ' ' ILE . 44.7 t -147.81 161.11 41.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.431 HG12 HD22 ' A' ' 10' ' ' LEU . 6.9 pt . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 125.199 1.4 . . . . 0.0 110.097 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.37 101.96 0.81 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 40' ' ' SER . 2.7 mt -73.93 138.32 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.71 138.15 95.3 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.4 132.47 19.23 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 N-CA-C 107.18 -1.892 . . . . 0.0 107.18 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -137.16 165.28 26.48 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.623 1.169 . . . . 0.0 108.345 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.41 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -66.69 153.74 42.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.374 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 62' ' ' GLY . 5.5 tt -119.83 142.68 48.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.118 1.767 . . . . 0.0 109.044 -169.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.49 ' N ' HD23 ' A' ' 61' ' ' LEU . . . 123.86 30.24 1.06 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-N 114.774 -1.103 . . . . 0.0 114.144 169.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.89 -39.31 76.33 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.107 1.453 . . . . 0.0 109.769 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -152.86 -32.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.561 1.544 . . . . 0.0 111.043 170.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -66.73 21.1 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.357 3.063 . . . . 0.0 114.03 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -33.39 132.1 0.2 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.359 2.264 . . . . 0.0 111.263 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 67' ' ' ILE 0.288 7.0 tt -124.9 141.95 39.68 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -168.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.46 145.62 48.05 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.417 1.411 . . . . 0.0 110.747 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.44 -15.67 4.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.088 1.355 . . . . 0.0 112.901 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.48 -26.67 68.83 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 112.311 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 pt -122.33 -15.07 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.093 0.86 . . . . 0.0 111.223 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.512 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 3.4 mm -50.75 -42.66 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.578 2.351 . . . . 0.0 109.507 170.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -83.21 10.76 7.67 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.708 1.203 . . . . 0.0 112.475 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.9 -175.78 26.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.85 139.52 58.35 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.9 m -133.19 149.22 52.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.891 0.745 . . . . 0.0 109.427 172.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -136.33 112.63 9.86 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.482 1.113 . . . . 0.0 108.616 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.68 126.94 31.58 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 126.399 1.88 . . . . 0.0 107.511 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -136.76 154.85 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 124.919 1.387 . . . . 0.0 112.491 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -100.77 119.57 38.82 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.19 111.62 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -82.05 151.58 27.0 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.92 2.72 58.29 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.48 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -136.75 179.31 6.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.583 1.192 . . . . 0.0 110.991 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -77.84 160.47 28.29 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.858 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 m -72.53 -13.51 61.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.548 0.739 . . . . 0.0 111.834 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -53.55 -31.75 47.86 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.951 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -89.75 7.68 35.63 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.911 -1.042 . . . . 0.0 113.239 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -64.01 115.89 5.35 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.29 165.07 37.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.193 1.397 . . . . 0.0 108.187 -167.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.65 150.06 23.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.277 1.037 . . . . 0.0 110.043 168.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.17 159.99 42.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.612 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.83 173.01 23.22 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.995 1.283 . . . . 0.0 110.021 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -16.85 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 113.382 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.73 -21.42 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.628 1.171 . . . . 0.0 113.0 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -121.54 -39.88 2.61 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.377 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -94.83 157.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.822 1.192 . . . . 0.0 113.323 -168.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -155.04 158.05 38.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.465 3.106 . . . . 0.0 108.778 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.29 168.39 19.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.247 1.839 . . . . 0.0 112.971 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.553 ' CE2' HD11 ' A' ' 105' ' ' ILE . 25.0 t80 -67.96 117.53 9.95 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.841 -1.162 . . . . 0.0 109.84 169.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -161.03 164.15 31.12 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.684 1.593 . . . . 0.0 108.893 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -59.5 -30.43 68.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.444 1.098 . . . . 0.0 113.393 -169.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.63 -42.11 91.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.443 1.116 . . . . 0.0 109.848 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -73.39 -27.84 61.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.359 -0.838 . . . . 0.0 109.56 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.553 HD11 ' CE2' ' A' ' 100' ' ' TYR . 7.2 mm -70.05 -32.74 52.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 CA-C-N 118.751 0.705 . . . . 0.0 110.933 169.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.18 99.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.52 1.055 . . . . 0.0 109.724 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -49.0 79.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.86 -47.12 83.64 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.529 0.732 . . . . 0.0 109.966 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -73.52 -44.51 57.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.524 0.602 . . . . 0.0 109.961 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -32.47 50.81 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.5 173.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.6 mt -89.95 -44.33 9.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.282 0.947 . . . . 0.0 112.348 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.89 -28.45 9.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.249 1.42 . . . . 0.0 111.723 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 t30 . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 125.928 1.691 . . . . 0.0 114.263 174.857 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.877 0.846 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 1 C-N-CA 132.95 4.5 . . . . 0.0 110.948 171.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.44 142.35 58.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.333 -1.758 . . . . 0.0 106.804 -169.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.69 -10.19 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.28 30.9 0.38 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 179.33 53.19 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 171.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.35 153.66 24.46 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 168.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.2 164.68 34.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 169.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.621 HD22 ' CE ' ' A' ' 22' ' ' MET . 65.9 mt -140.56 116.35 10.3 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 -170.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.5 138.71 47.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.363 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -120.59 118.57 30.52 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.199 1.4 . . . . 0.0 108.202 -169.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -98.84 -22.01 16.04 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.87 0.468 . . . . 0.0 111.449 -170.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.31 -76.57 0.23 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -68.19 -31.56 29.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.107 1.871 . . . . 0.0 112.457 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.49 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -153.07 176.33 12.02 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.768 1.227 . . . . 0.0 110.743 -171.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.621 ' CE ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.07 154.6 47.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.809 2.444 . . . . 0.0 107.491 -173.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -140.41 149.59 42.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.186 1.394 . . . . 0.0 108.765 -176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.34 145.53 51.12 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.94 161.23 37.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.475 1.51 . . . . 0.0 109.02 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -148.5 104.37 3.49 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.407 -0.808 . . . . 0.0 109.777 -171.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 14' ' ' VAL . 54.7 mt -64.79 155.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 128.447 2.699 . . . . 0.0 112.904 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -163.79 -20.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.822 -1.085 . . . . 0.0 113.724 166.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.7 ttpt -131.58 138.66 48.95 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.6 161.76 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -168.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.48 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.9 t-105 -144.68 154.55 42.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.384 -168.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -146.51 140.93 15.73 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.725 2.41 . . . . 0.0 108.881 -174.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.62 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.666 2.911 . . . . 0.0 113.549 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -66.87 -32.22 73.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.068 1.303 . . . . 0.0 111.571 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.9 m -121.56 -11.09 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.647 1.179 . . . . 0.0 111.02 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt 47.09 50.41 14.1 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.058 0.943 . . . . 0.0 109.985 -171.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.3 mtp -150.65 154.0 36.67 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.365 2.266 . . . . 0.0 105.163 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.421 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 48.8 p90 -103.45 175.12 5.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 p -141.56 155.92 45.74 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.009 2.124 . . . . 0.0 106.847 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.64 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.2 m -154.06 156.66 37.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 pt . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 123.111 0.564 . . . . 0.0 110.58 -176.807 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.887 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -21.25 97.46 0.01 OUTLIER 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 0.0 112.328 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.7 mt -72.81 136.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 111.687 -2.506 . . . . 0.0 107.793 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.93 141.84 96.99 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.98 138.54 31.33 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 N-CA-C 107.352 -1.826 . . . . 0.0 107.352 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -137.37 160.52 38.84 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -68.57 127.43 32.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 122.113 0.959 . . . . 0.0 109.017 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 tt -71.23 146.83 48.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.538 1.935 . . . . 0.0 111.97 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.7 17.83 3.76 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.697 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -81.6 -32.18 32.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.44 1.12 . . . . 0.0 109.845 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.18 10.91 0.9 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.835 1.254 . . . . 0.0 110.893 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 15.7 mp0 -130.92 174.04 10.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.247 1.819 . . . . 0.0 109.688 -169.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -165.35 122.96 1.55 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 166.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.478 HG12 HD11 ' A' ' 71' ' ' ILE 0.317 4.2 tt -123.48 129.3 24.92 Favored Pre-proline 0 N--CA 1.433 -1.277 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -167.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.47 148.86 67.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.64 1.56 . . . . 0.0 111.25 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.32 -21.11 22.18 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.022 1.329 . . . . 0.0 112.679 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -54.86 -33.27 61.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.032 2.133 . . . . 0.0 113.524 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 67' ' ' ILE . 4.6 pt -118.1 -16.13 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.422 0.689 . . . . 0.0 111.211 -169.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.48 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 2.9 mm -54.14 -42.56 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 127.948 2.499 . . . . 0.0 109.592 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.92 11.41 6.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.016 . . . . 0.0 112.661 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.97 -171.94 25.43 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -59.34 137.41 58.0 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -136.32 153.25 51.21 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.866 0.729 . . . . 0.0 110.936 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -136.73 114.81 11.51 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.514 1.126 . . . . 0.0 109.416 -170.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.12 126.03 31.55 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.666 1.987 . . . . 0.0 107.168 169.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.45 165.95 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.379 -168.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -119.63 126.94 52.38 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 165.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -78.93 125.87 29.94 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -67.38 149.62 50.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.089 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.97 10.19 50.16 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.497 -1.168 . . . . 0.0 113.576 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -128.04 166.28 18.71 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.11 1.455 . . . . 0.0 111.211 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -61.27 168.41 2.66 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.0 112.198 -171.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 m -63.34 -21.89 66.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.556 0.742 . . . . 0.0 111.711 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -60.8 -25.9 66.9 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.335 -0.853 . . . . 0.0 111.925 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.8 m95 -85.54 16.41 3.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 0.0 112.477 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.73 87.71 3.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 167.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -146.3 166.14 27.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.084 1.353 . . . . 0.0 108.341 -167.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.49 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -104.29 152.84 21.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.45 1.119 . . . . 0.0 110.511 169.275 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.36 155.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.829 173.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.11 169.08 31.74 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -18.06 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.714 1.205 . . . . 0.0 113.037 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.84 -19.69 18.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.272 1.429 . . . . 0.0 113.554 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -127.61 -35.48 2.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 117.39 -1.291 . . . . 0.0 111.939 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -101.87 152.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.642 1.565 . . . . 0.0 113.288 -169.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.87 160.95 41.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.28 2.632 . . . . 0.0 108.298 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.71 168.66 18.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.381 1.446 . . . . 0.0 112.273 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -77.86 109.26 11.73 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.105 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -156.42 163.33 39.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.998 1.319 . . . . 0.0 109.278 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -53.14 -35.85 60.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.665 1.586 . . . . 0.0 114.31 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.2 -43.86 97.88 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.695 1.236 . . . . 0.0 110.006 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -78.47 -23.68 46.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 mm -69.57 -35.21 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.685 0.675 . . . . 0.0 109.859 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.3 98.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.521 1.055 . . . . 0.0 109.435 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.25 89.83 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 171.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.988 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -72.54 -42.56 64.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.105 0.866 . . . . 0.0 109.504 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -42.89 53.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.269 0.628 . . . . 0.0 110.419 170.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.09 -47.73 17.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 112.398 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.23 -27.63 6.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 111.605 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.9 t30 . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 125.275 1.43 . . . . 0.0 113.386 172.783 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--O 1.233 0.235 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.25 73.91 0.01 OUTLIER 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.935 2.894 . . . . 0.0 110.46 171.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 131.08 44.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.409 HD22 HG12 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -61.05 -4.75 1.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -169.086 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.42 32.61 0.7 Allowed Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 170.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.48 -157.21 12.15 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 168.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.06 156.02 21.09 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.621 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.77 160.73 39.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 169.236 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.538 HD22 ' CE ' ' A' ' 22' ' ' MET . 42.7 mt -139.45 131.37 27.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 -173.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.21 136.81 53.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -170.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -115.9 117.24 29.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.661 0.785 . . . . 0.0 109.19 -168.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -95.53 -21.39 18.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.524 0.729 . . . . 0.0 111.854 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.15 -73.52 0.32 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.63 -30.58 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.358 2.038 . . . . 0.0 112.014 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.52 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 178.54 10.11 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 125.254 1.422 . . . . 0.0 109.51 -170.004 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.538 ' CE ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -133.94 154.16 51.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.522 2.329 . . . . 0.0 106.776 -173.347 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.71 152.05 48.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.257 1.023 . . . . 0.0 108.645 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -74.68 149.03 40.09 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.493 0.717 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.37 160.48 40.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.081 1.352 . . . . 0.0 109.113 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -149.03 99.76 2.99 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -169.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.621 HD11 HG11 ' A' ' 14' ' ' VAL . 60.3 mt -58.69 152.66 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.669 1.987 . . . . 0.0 110.647 -176.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pp -156.72 -35.45 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.736 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 37.4 ttpt -126.0 140.1 52.88 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.09 166.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.501 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 3.7 t-105 -150.47 150.89 31.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.277 -168.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -147.55 142.12 16.43 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.531 2.332 . . . . 0.0 108.82 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.69 -8.75 24.41 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.437 2.758 . . . . 0.0 113.51 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.0 m -65.66 -34.64 78.69 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.452 1.478 . . . . 0.0 111.248 -171.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -117.72 -18.67 9.57 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.521 1.528 . . . . 0.0 110.718 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm 51.33 52.14 15.43 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -169.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.6 mtp -144.72 157.02 44.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.994 2.518 . . . . 0.0 105.093 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.451 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -107.47 168.95 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.629 0.372 . . . . 0.0 111.474 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -141.57 155.0 45.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.41 1.884 . . . . 0.0 106.647 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.465 ' HB3' HD12 ' A' ' 56' ' ' ILE . 32.5 t -149.95 164.23 35.99 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.409 HG12 HD22 ' A' ' 10' ' ' LEU . 6.9 pt . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 124.792 1.237 . . . . 0.0 109.657 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 107.37 1.79 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.1 mt -73.66 129.24 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -173.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.04 139.61 95.51 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.05 142.11 24.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.861 1.707 . . . . 0.0 108.983 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -130.38 164.19 25.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.582 0.753 . . . . 0.0 109.545 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.596 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.63 -16.57 49.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -168.386 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' CD1' ' CZ2' ' A' ' 91' ' ' TRP . 0.5 OUTLIER 70.91 136.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.597 2.359 . . . . 0.0 112.28 -171.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.11 7.35 2.29 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.949 169.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.16 -34.47 56.41 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.894 1.847 . . . . 0.0 111.211 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.74 -40.09 0.09 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.407 1.483 . . . . 0.0 109.593 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.96 137.09 56.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 168.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.6 m -140.46 157.38 45.6 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.469 HG23 HG12 ' A' ' 72' ' ' ILE 0.318 2.6 tt -149.82 136.55 10.9 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -169.102 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.43 151.96 54.19 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.727 1.618 . . . . 0.0 111.346 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -56.4 -17.11 6.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.044 1.338 . . . . 0.0 112.832 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -67.18 -24.99 65.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.843 1.257 . . . . 0.0 111.968 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.2 pt -124.38 -12.64 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.35 0.977 . . . . 0.0 111.177 -171.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.501 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 1.8 mm -52.65 -44.36 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 128.097 2.559 . . . . 0.0 108.576 169.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.17 9.47 6.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.881 1.272 . . . . 0.0 112.82 -170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.67 -173.07 26.59 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -171.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -60.79 134.91 57.55 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.285 -0.538 . . . . 0.0 110.608 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 m -137.47 154.13 49.95 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.781 0.676 . . . . 0.0 111.278 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -139.12 114.68 9.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.435 1.094 . . . . 0.0 109.836 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -81.23 127.09 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 106.271 169.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -138.48 154.07 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.101 -168.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -99.72 119.61 38.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -73.0 117.68 15.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -86.14 150.65 24.26 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 6.37 63.0 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 119.082 -0.843 . . . . 0.0 111.2 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -132.84 174.03 10.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.252 1.421 . . . . 0.0 109.874 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.68 174.11 3.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.45 1.1 . . . . 0.0 111.708 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.1 m -85.09 -6.35 59.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.237 0.615 . . . . 0.0 112.033 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -57.36 -31.27 65.59 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.396 -0.815 . . . . 0.0 110.979 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -89.59 20.1 4.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.616 1.166 . . . . 0.0 112.726 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.49 99.77 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -151.3 167.51 27.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.972 2.109 . . . . 0.0 108.111 -167.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.419 ' CZ2' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -104.23 155.26 18.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.369 0.986 . . . . 0.0 112.168 169.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.85 157.59 43.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.932 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.29 160.63 25.95 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.732 1.158 . . . . 0.0 110.346 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.425 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -71.02 9.79 0.65 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.92 -12.71 32.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.709 1.603 . . . . 0.0 111.223 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -125.92 -37.09 2.31 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.561 1.145 . . . . 0.0 111.3 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 14' ' ' VAL . 6.8 tt -97.35 154.46 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.412 1.005 . . . . 0.0 110.671 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 98.2 mtt180 -145.65 158.26 43.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.192 2.197 . . . . 0.0 109.437 169.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.88 161.41 30.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.247 1.385 . . . . 0.0 111.511 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.455 ' CE2' HD11 ' A' ' 105' ' ' ILE . 27.6 t80 -69.47 115.77 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -159.9 162.05 34.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.466 1.506 . . . . 0.0 108.43 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.0 -35.71 47.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.833 1.653 . . . . 0.0 114.364 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -63.53 -44.44 94.24 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.554 1.168 . . . . 0.0 109.984 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.31 -23.91 54.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.278 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -68.55 -36.17 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 118.781 0.719 . . . . 0.0 109.793 169.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.1 96.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.451 1.023 . . . . 0.0 110.402 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -48.2 79.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.08 -49.53 74.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.329 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -75.03 -33.19 61.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.033 1.288 . . . . 0.0 109.854 -171.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -54.62 -53.57 52.99 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 169.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.802 0.728 . . . . 0.0 111.628 -172.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.7 -15.54 0.74 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.434 1.494 . . . . 0.0 112.557 169.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 124.82 1.248 . . . . 0.0 112.349 177.635 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -56.92 126.35 26.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 168.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.02 135.68 53.52 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -2.91 0.35 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 116.266 1.951 . . . . 0.0 116.266 -168.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.08 0.28 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 169.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.71 -175.16 50.65 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.212 -2.755 . . . . 0.0 106.212 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.443 ' HG2' HE22 ' A' ' 82' ' ' GLN . 54.1 mtt180 -87.99 156.65 19.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -132.22 165.9 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 168.418 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.412 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.5 mm? -133.03 144.37 50.01 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 177.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.92 125.7 23.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -99.44 115.73 29.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -87.7 -25.4 23.49 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.958 0.503 . . . . 0.0 111.15 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.74 -69.78 0.32 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.71 -41.41 11.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.39 2.06 . . . . 0.0 112.817 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.9 tp -148.27 179.8 7.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.005 1.722 . . . . 0.0 107.881 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.412 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -141.5 151.29 43.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.071 1.748 . . . . 0.0 109.178 -167.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -134.06 157.26 46.57 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.611 1.164 . . . . 0.0 108.594 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.28 150.21 30.07 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.75 155.2 46.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.895 0.478 . . . . 0.0 110.805 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -144.11 94.37 2.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.866 0.866 . . . . 0.0 111.397 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.571 HD11 HG11 ' A' ' 14' ' ' VAL . 42.7 mt -61.94 152.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 127.565 2.346 . . . . 0.0 112.492 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.35 -24.8 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.776 166.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' N ' HD22 ' A' ' 28' ' ' LEU . 38.5 ttpt -127.58 139.3 52.85 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.82 163.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -168.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.98 152.54 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.634 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.05 139.37 14.53 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.62 1.968 . . . . 0.0 109.122 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 -0.77 8.56 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.24 3.293 . . . . 0.0 113.348 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -67.55 -33.19 74.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.225 1.375 . . . . 0.0 110.956 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 p -129.48 -10.42 4.57 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.13 1.372 . . . . 0.0 111.618 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 50.1 53.14 13.35 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.098 0.951 . . . . 0.0 109.632 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 63.4 mtp -145.61 156.21 43.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.803 2.041 . . . . 0.0 106.51 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -108.88 171.43 7.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 p -139.49 156.71 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.63 1.972 . . . . 0.0 107.259 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.469 ' HB3' HD12 ' A' ' 56' ' ' ILE . 43.4 t -150.76 163.48 38.48 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 pt . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 125.746 1.618 . . . . 0.0 108.841 -179.114 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 119.334 -0.365 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.56 116.11 5.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 172.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.2 mt -81.83 135.52 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 113.478 -1.692 . . . . 0.0 106.843 -173.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.2 136.45 93.84 Favored Pre-proline 0 C--O 1.237 0.433 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.86 145.94 36.99 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.962 1.775 . . . . 0.0 109.568 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -139.67 156.34 46.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.102 0.961 . . . . 0.0 109.778 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -62.43 -10.53 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -173.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.433 HD12 ' CZ2' ' A' ' 91' ' ' TRP 0.252 9.3 tt 71.76 151.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 114.3 -177.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.64 4.22 10.79 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 114.779 -1.1 . . . . 0.0 114.283 169.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.61 -22.04 60.13 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.832 1.316 . . . . 0.0 111.359 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.57 -35.11 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.797 1.239 . . . . 0.0 111.059 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.578 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 20.6 mp0 -66.69 165.44 14.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 174.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 m -147.09 141.1 25.96 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.668 1.987 . . . . 0.0 106.115 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.499 HG22 HD11 ' A' ' 71' ' ' ILE . 9.0 pt -136.75 125.44 15.16 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.14 156.88 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.118 1.879 . . . . 0.0 110.676 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -55.59 -15.35 2.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.242 1.017 . . . . 0.0 112.493 171.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -66.69 -31.33 71.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.385 1.474 . . . . 0.0 112.343 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' ILE . 18.3 pt -119.31 -11.76 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.209 1.368 . . . . 0.0 110.757 -173.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -53.38 -45.88 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.909 2.483 . . . . 0.0 108.548 169.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.45 9.49 7.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 111.732 -170.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.21 -178.41 26.87 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 119.881 1.219 . . . . 0.0 110.814 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -60.42 131.81 51.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.1 m -132.09 150.4 52.16 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.926 0.766 . . . . 0.0 110.601 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.14 112.64 10.67 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 109.276 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -79.55 125.0 29.03 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 126.243 1.817 . . . . 0.0 107.348 169.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.55 156.01 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.935 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -102.01 122.63 44.44 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 166.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -71.74 111.18 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.443 HE22 ' HG2' ' A' ' 13' ' ' ARG . 47.9 mt-30 -76.62 148.29 37.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.41 64.05 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.163 -170.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -131.98 169.14 16.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.828 1.314 . . . . 0.0 110.513 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -65.84 171.33 4.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.543 1.537 . . . . 0.0 112.508 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 m -69.94 -17.15 63.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.532 1.133 . . . . 0.0 111.739 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -62.35 -28.82 70.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.686 0.794 . . . . 0.0 111.865 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -97.44 21.15 10.54 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -68.06 104.83 1.86 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -148.74 168.08 23.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.28 1.832 . . . . 0.0 107.866 -167.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.578 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -107.16 152.95 23.38 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 122.3 1.048 . . . . 0.0 110.402 168.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.46 161.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.773 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.53 170.67 22.38 Favored Glycine 0 C--O 1.242 0.602 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.384 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -15.27 11.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.225 1.41 . . . . 0.0 113.648 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.33 -23.98 52.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.125 1.37 . . . . 0.0 112.516 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.18 -38.76 2.28 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 117.52 -1.229 . . . . 0.0 112.027 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.58 HD11 HG21 ' A' ' 14' ' ' VAL . 8.2 tt -89.41 156.49 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.41 1.004 . . . . 0.0 113.441 -169.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -153.82 157.52 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.615 3.166 . . . . 0.0 108.594 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.7 168.88 17.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.562 1.528 . . . . 0.0 111.827 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.515 ' CE2' HD11 ' A' ' 105' ' ' ILE . 21.8 t80 -62.33 127.62 32.18 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.725 -1.234 . . . . 0.0 109.971 169.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -156.36 153.4 28.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.522 1.929 . . . . 0.0 107.866 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.82 -30.23 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.384 0.673 . . . . 0.0 111.184 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.51 -42.12 92.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.905 0.859 . . . . 0.0 110.34 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.63 -23.94 53.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.083 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.515 HD11 ' CE2' ' A' ' 100' ' ' TYR . 3.2 mm -72.51 -35.57 51.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-N 118.552 0.615 . . . . 0.0 109.654 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.436 1.016 . . . . 0.0 109.899 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -51.39 69.57 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -59.57 -43.32 93.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.733 -173.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -74.77 -39.92 61.49 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.029 0.932 . . . . 0.0 110.894 -174.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -52.51 -46.33 66.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.818 0.735 . . . . 0.0 110.368 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.6 -42.01 22.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 119.506 -0.283 . . . . 0.0 111.447 -171.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.28 -32.12 47.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.246 1.418 . . . . 0.0 110.921 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 CA--C 1.528 0.122 0 C-N-CA 124.126 0.97 . . . . 0.0 112.293 174.825 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.444 0.64 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -62.63 66.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 130.906 3.682 . . . . 0.0 110.154 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 139.26 57.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 127.098 2.159 . . . . 0.0 106.587 -169.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -6.26 1.66 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -169.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.11 28.63 0.52 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 171.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 -176.6 49.35 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 106.223 -2.751 . . . . 0.0 106.223 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -87.33 151.07 23.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 168.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.921 HG11 HD11 ' A' ' 97' ' ' ILE . 2.9 p -132.8 165.8 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 169.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -139.84 128.36 22.92 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.36 124.36 42.2 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.722 1.264 . . . . 0.0 109.641 -170.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -98.6 125.23 43.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.26 1.824 . . . . 0.0 107.383 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -105.06 -17.88 14.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.762 0.825 . . . . 0.0 111.261 -175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.41 -75.17 0.29 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.4 -25.11 21.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.331 2.021 . . . . 0.0 113.104 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -152.85 175.93 12.37 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 125.036 1.334 . . . . 0.0 109.943 -171.801 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.515 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -143.76 146.44 33.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.35 2.26 . . . . 0.0 106.796 -169.141 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.82 151.6 51.98 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -171.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.2 139.05 57.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' HB3' HG13 ' A' ' 14' ' ' VAL . . . -136.23 157.79 45.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.758 2.023 . . . . 0.0 107.598 -176.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.76 95.26 2.39 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.231 -0.918 . . . . 0.0 110.404 -169.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.62 148.01 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 128.037 2.535 . . . . 0.0 112.325 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.572 HD22 ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.13 -31.07 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.914 166.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HG2' HD22 ' A' ' 28' ' ' LEU . 17.5 mtmt -111.08 149.61 30.55 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 168.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 pt -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -149.28 153.43 37.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.499 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.45 143.77 17.79 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 109.513 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.99 -11.72 32.94 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.291 2.66 . . . . 0.0 113.526 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.6 m -63.99 -33.02 74.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.834 1.197 . . . . 0.0 112.046 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -122.0 -10.62 8.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.464 1.506 . . . . 0.0 111.243 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt 47.29 50.46 14.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 109.533 -169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.8 mtp -146.32 152.59 39.38 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.744 2.018 . . . . 0.0 105.896 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -101.29 173.66 6.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.114 0.566 . . . . 0.0 112.375 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -138.6 161.23 37.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.717 2.007 . . . . 0.0 107.158 170.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 56' ' ' ILE . 31.4 t -154.97 162.17 41.17 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 CA--C 1.549 0.933 0 C-N-CA 125.647 1.579 . . . . 0.0 109.765 179.887 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 119.771 -0.157 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.75 103.18 0.14 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.6 mt -71.16 135.82 27.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -175.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.12 136.09 93.94 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.41 136.26 30.85 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.041 1.827 . . . . 0.0 107.706 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -140.36 162.41 35.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -170.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 6.2 mmpt? -63.86 152.41 39.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.55 150.67 27.83 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.442 1.897 . . . . 0.0 110.527 -169.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.57 19.95 5.58 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.3 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.56 -31.63 36.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.591 1.195 . . . . 0.0 109.857 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -150.35 17.75 0.83 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.013 1.325 . . . . 0.0 110.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -131.23 163.57 27.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.982 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -149.2 140.56 23.23 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.723 1.209 . . . . 0.0 108.535 169.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 71' ' ' ILE . 10.7 pt -135.91 122.55 14.26 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.99 154.51 17.35 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.245 1.963 . . . . 0.0 110.959 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -53.39 -22.11 7.01 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.81 0.844 . . . . 0.0 111.414 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.9 -27.99 69.53 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.933 1.693 . . . . 0.0 114.003 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 67' ' ' ILE . 18.4 pt -119.54 -12.6 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.508 1.503 . . . . 0.0 110.667 -176.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.17 -45.71 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 128.141 2.576 . . . . 0.0 108.963 169.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -81.35 10.31 5.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 -169.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.15 23.66 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -173.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -61.2 137.63 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -136.48 151.36 49.37 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.268 0.98 . . . . 0.0 110.378 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.17 113.88 9.19 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.828 1.251 . . . . 0.0 109.408 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.474 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 43.8 t80 -80.11 128.7 33.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.382 1.473 . . . . 0.0 107.091 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.56 152.25 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.563 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -97.8 125.24 42.54 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -75.27 115.5 14.98 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -79.73 151.9 30.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 110.023 -172.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 6.51 34.5 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.837 -0.98 . . . . 0.0 111.859 -170.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -133.7 173.31 11.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.712 1.256 . . . . 0.0 112.069 -173.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.69 163.09 24.68 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.522 1.129 . . . . 0.0 112.466 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -67.7 -19.38 65.15 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.154 0.982 . . . . 0.0 111.386 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 m -57.16 -31.04 64.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.156 -0.965 . . . . 0.0 111.915 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -87.92 9.29 22.63 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 117.879 -1.058 . . . . 0.0 112.912 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.78 99.64 0.34 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -152.15 166.1 32.74 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.481 1.912 . . . . 0.0 107.94 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.401 ' CD1' HG23 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -104.41 151.78 23.09 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.892 0.853 . . . . 0.0 110.671 169.023 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.48 HG23 HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -132.56 163.09 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.564 173.102 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.39 174.22 20.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.266 . . . . 0.0 110.043 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -15.38 33.4 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 113.948 -176.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -58.07 -24.38 58.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 112.617 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -124.55 -36.92 2.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 117.807 -1.092 . . . . 0.0 112.027 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.921 HD11 HG11 ' A' ' 14' ' ' VAL . 6.4 tt -97.37 152.36 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.611 1.096 . . . . 0.0 112.752 -168.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -155.14 150.15 26.81 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.449 2.3 . . . . 0.0 111.408 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.56 158.81 34.14 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.016 1.28 . . . . 0.0 112.852 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.484 ' CE1' HD11 ' A' ' 105' ' ' ILE . 4.3 t80 -70.52 107.33 3.81 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.765 0.793 . . . . 0.0 110.581 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.25 160.5 38.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.254 1.422 . . . . 0.0 109.343 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -52.75 -35.96 57.02 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.454 1.502 . . . . 0.0 114.806 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.21 -44.71 95.96 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.792 1.282 . . . . 0.0 109.808 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -77.13 -20.78 55.16 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.028 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.484 HD11 ' CE1' ' A' ' 100' ' ' TYR . 6.1 mm -73.23 -32.91 39.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 CA-C-N 119.117 0.871 . . . . 0.0 110.385 169.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.395 0.998 . . . . 0.0 108.945 171.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.23 74.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -55.48 -48.97 73.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.284 1.034 . . . . 0.0 109.916 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.82 -44.98 38.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.428 -172.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -57.58 -34.49 69.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.744 0.702 . . . . 0.0 110.179 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -78.21 -50.4 11.98 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.36 -29.0 3.54 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.835 1.254 . . . . 0.0 112.275 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.8 t30 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.917 1.287 . . . . 0.0 113.539 173.845 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -57.11 122.62 12.82 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.06 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -1.27 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.41 30.22 0.36 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.76 -174.58 49.9 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 169.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -86.76 151.69 23.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.56 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -130.33 163.43 35.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 168.541 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.433 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 60.8 mt -139.91 130.4 25.55 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -173.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.55 129.56 50.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.276 0.985 . . . . 0.0 108.518 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.96 118.03 35.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -99.6 -14.44 18.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -169.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.57 -78.9 0.23 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.24 -32.58 12.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.128 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.77 -177.17 6.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.821 1.648 . . . . 0.0 109.454 -169.484 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.499 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 11.7 tmm? -128.37 145.24 51.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.84 2.056 . . . . 0.0 108.306 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -130.3 146.27 51.87 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.791 0.805 . . . . 0.0 109.727 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -73.87 148.32 42.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.286 1.434 . . . . 0.0 109.845 -170.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.96 45.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.809 0.844 . . . . 0.0 110.418 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -148.48 95.74 2.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.275 1.03 . . . . 0.0 110.78 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.56 HD11 HG11 ' A' ' 14' ' ' VAL . 46.2 mt -59.72 151.25 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 128.294 2.638 . . . . 0.0 112.158 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 29' ' ' LYS 0.301 0.0 OUTLIER -159.71 -28.68 0.07 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 116.802 -1.571 . . . . 0.0 111.96 166.887 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.473 ' N ' HD22 ' A' ' 28' ' ' LEU . 17.0 mtmt -113.77 150.13 33.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 168.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.0 166.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.049 0.928 . . . . 0.0 108.693 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -144.18 151.76 39.95 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.514 1.526 . . . . 0.0 109.525 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.11 142.88 16.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.807 1.643 . . . . 0.0 109.563 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 -11.37 31.92 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.158 2.572 . . . . 0.0 113.801 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -62.15 -31.84 72.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.322 1.419 . . . . 0.0 112.312 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.7 p -129.89 0.51 4.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.252 1.421 . . . . 0.0 111.219 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt 44.21 53.78 6.45 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.615 1.566 . . . . 0.0 110.545 -174.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptm -155.26 165.24 37.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.022 1.329 . . . . 0.0 107.703 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -110.67 172.28 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.083 0.953 . . . . 0.0 112.048 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.8 p -141.0 157.3 45.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.67 1.988 . . . . 0.0 106.379 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 56' ' ' ILE . 28.7 t -150.85 159.06 44.8 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 124.645 1.178 . . . . 0.0 109.58 -175.706 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.26 109.77 2.0 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.0 mt -76.12 131.62 34.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -173.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.53 138.55 95.68 Favored Pre-proline 0 C--O 1.234 0.288 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.59 137.9 31.2 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.852 1.701 . . . . 0.0 107.931 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -139.05 160.06 40.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 130.16 42.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.79 156.51 34.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.352 1.461 . . . . 0.0 112.31 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.21 29.38 2.15 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.678 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -79.26 -41.08 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.648 1.224 . . . . 0.0 109.041 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -161.96 5.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.347 1.059 . . . . 0.0 113.41 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 48.8 2.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.902 1.281 . . . . 0.0 111.603 -168.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -33.09 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.631 3.172 . . . . 0.0 113.496 168.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 71' ' ' ILE . 8.1 pt -136.88 134.47 19.23 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 107.832 169.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.97 160.1 50.85 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.18 1.92 . . . . 0.0 110.311 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.01 -23.59 20.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 111.829 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.76 -33.97 67.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.336 1.454 . . . . 0.0 113.196 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 67' ' ' ILE . 8.2 pt -120.01 -10.06 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 119.487 1.039 . . . . 0.0 110.733 -172.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -59.31 -49.39 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 127.641 2.377 . . . . 0.0 106.661 168.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -77.71 9.42 3.46 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.521 1.528 . . . . 0.0 112.088 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.17 -179.19 27.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.704 1.138 . . . . 0.0 110.881 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -59.31 137.21 58.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 m -136.46 150.65 48.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 124.281 0.988 . . . . 0.0 110.456 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.82 114.66 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.164 -172.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -79.97 124.98 29.18 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.22 1.408 . . . . 0.0 107.374 169.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -137.83 154.06 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 112.433 -168.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -96.46 124.42 40.45 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 166.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -74.03 106.93 5.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -71.99 149.68 44.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.44 3.87 41.99 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.261 -1.299 . . . . 0.0 113.104 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -126.7 168.0 14.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.403 1.602 . . . . 0.0 111.418 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -66.69 171.35 5.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.341 1.056 . . . . 0.0 112.232 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.08 -21.86 66.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.633 1.173 . . . . 0.0 111.585 169.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -63.12 -25.43 68.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.789 0.835 . . . . 0.0 112.144 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -102.23 19.15 19.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 0.0 112.695 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.66 103.52 1.75 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.22 168.39 23.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.382 -167.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.09 152.38 22.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.12 0.962 . . . . 0.0 111.241 168.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.51 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.14 1.376 . . . . 0.0 110.359 173.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 167.2 25.5 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -19.41 21.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.099 1.36 . . . . 0.0 113.733 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.88 -22.88 40.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.676 1.191 . . . . 0.0 112.918 170.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -121.49 -38.54 2.76 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.324 -1.322 . . . . 0.0 111.763 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.476 HD11 HG21 ' A' ' 14' ' ' VAL . 7.4 tt -99.62 154.38 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 120.654 1.57 . . . . 0.0 113.017 -169.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -150.34 156.99 42.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 128.895 2.878 . . . . 0.0 108.921 169.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.39 163.63 27.32 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.602 1.161 . . . . 0.0 112.431 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.93 112.25 9.86 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 120.85 -1.156 . . . . 0.0 109.293 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.979 1.311 . . . . 0.0 109.63 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -52.94 -36.03 59.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.899 1.68 . . . . 0.0 113.733 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -62.7 -43.86 97.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.404 1.097 . . . . 0.0 110.541 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.67 -22.39 50.67 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.253 -0.879 . . . . 0.0 109.519 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mm -70.77 -35.16 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 119.153 0.888 . . . . 0.0 109.926 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.45 99.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.238 0.926 . . . . 0.0 109.319 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -46.8 88.3 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.63 -43.43 96.85 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 118.163 -0.922 . . . . 0.0 109.749 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -72.01 -43.77 64.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.371 0.987 . . . . 0.0 109.677 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -32.16 48.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 118.144 -0.932 . . . . 0.0 111.454 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.85 -45.63 10.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.053 1.297 . . . . 0.0 113.29 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.23 -23.91 9.91 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.157 1.783 . . . . 0.0 111.962 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.1 t30 . . . . . 0 N--CA 1.456 -0.159 0 C-N-CA 126.342 1.857 . . . . 0.0 113.072 172.223 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--O 1.236 0.381 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.439 ' HA ' ' HB2' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -57.05 130.64 46.97 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.124 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.85 125.39 44.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 102.232 -3.247 . . . . 0.0 102.232 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.433 HD22 HG12 ' A' ' 41' ' ' ILE . 1.7 mt -56.57 -9.79 0.82 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -168.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.7 34.4 0.81 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.29 -153.03 7.33 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 105.853 -2.899 . . . . 0.0 105.853 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -113.47 155.97 24.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 168.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.553 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.22 155.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 169.649 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 14' ' ' VAL . 7.8 mt -127.74 153.48 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.02 126.91 31.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -173.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -90.57 118.29 29.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -95.25 -14.13 24.28 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.87 0.868 . . . . 0.0 111.624 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.07 -75.67 0.35 Allowed Glycine 0 C--N 1.337 0.609 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.73 -28.63 13.66 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.557 2.171 . . . . 0.0 113.135 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.493 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.01 -177.12 6.3 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 -170.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.493 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -146.22 147.45 31.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.613 1.565 . . . . 0.0 108.302 -168.43 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.2 170.59 15.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.313 1.045 . . . . 0.0 110.372 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.78 147.54 25.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.778 0.831 . . . . 0.0 109.203 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 165.91 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.759 1.624 . . . . 0.0 108.865 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -153.51 108.52 3.17 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 121.109 -0.994 . . . . 0.0 110.487 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 14' ' ' VAL . 74.3 mt -55.4 150.09 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 128.454 2.702 . . . . 0.0 110.922 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -157.1 -31.08 0.08 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.773 169.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 24.0 mtmt -119.96 146.93 45.37 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 168.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.51 165.47 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -144.75 150.6 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.612 -170.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.84 142.21 15.27 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.662 1.585 . . . . 0.0 109.242 -173.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.93 -2.87 11.7 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.411 2.74 . . . . 0.0 113.652 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -63.6 -36.67 84.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.579 1.536 . . . . 0.0 111.46 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -134.86 12.37 3.66 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.083 0.953 . . . . 0.0 112.022 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 42.0 55.65 3.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.145 1.378 . . . . 0.0 111.795 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.5 ptm -155.89 164.33 38.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -107.58 169.6 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.412 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 p -136.15 156.17 49.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.755 2.022 . . . . 0.0 106.483 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.566 ' HB2' HD12 ' A' ' 56' ' ' ILE . 20.0 m -154.21 154.63 33.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -169.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.433 HG12 HD22 ' A' ' 10' ' ' LEU . 3.2 pt . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 123.889 0.876 . . . . 0.0 110.012 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.55 112.89 2.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.6 mt -79.83 137.04 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -175.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.38 141.98 94.05 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.3 138.7 30.75 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 N-CA-C 107.231 -1.873 . . . . 0.0 107.231 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -137.57 159.9 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.779 0.8 . . . . 0.0 108.952 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.44 118.82 11.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.52 153.83 41.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.221 1.408 . . . . 0.0 112.48 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.23 1.55 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-O 118.968 -0.907 . . . . 0.0 115.243 168.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -80.57 -40.66 25.45 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.097 1.449 . . . . 0.0 109.374 169.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.15 -0.41 0.07 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 0.0 113.516 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.69 46.41 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.552 1.541 . . . . 0.0 111.509 -169.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -31.75 139.07 0.04 OUTLIER 'General case' 0 C--O 1.237 0.44 0 C-N-CA 129.776 3.23 . . . . 0.0 113.28 168.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 71' ' ' ILE . 7.6 pt -134.76 126.66 18.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.15 156.41 20.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.732 2.288 . . . . 0.0 111.128 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.62 -18.48 7.86 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.08 1.352 . . . . 0.0 112.758 173.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -64.04 -30.81 71.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.923 1.289 . . . . 0.0 112.338 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.447 HD11 HG22 ' A' ' 67' ' ' ILE . 10.1 pt -121.03 -9.49 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.835 1.198 . . . . 0.0 110.789 -173.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.19 -49.57 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 127.776 2.43 . . . . 0.0 106.305 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.85 8.94 3.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.411 1.484 . . . . 0.0 111.994 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.96 -178.45 24.9 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.27 0.941 . . . . 0.0 111.315 -174.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -63.4 136.9 57.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.2 m -139.33 152.39 47.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.246 0.966 . . . . 0.0 110.89 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.434 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 37.5 m-85 -140.81 113.21 8.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.293 -170.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 54.4 t80 -79.15 128.99 33.99 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.19 153.93 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 124.671 1.232 . . . . 0.0 112.28 -168.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -96.38 121.53 38.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 167.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.14 112.7 7.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.73 149.45 31.16 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.86 53.25 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.063 -0.854 . . . . 0.0 111.902 -169.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -132.13 172.59 12.2 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.619 1.21 . . . . 0.0 111.097 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -72.07 158.74 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.331 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.1 m -71.63 -13.09 61.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.636 0.374 . . . . 0.0 111.778 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.9 m -54.75 -34.86 63.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.456 1.102 . . . . 0.0 112.357 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -86.98 7.94 25.37 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.109 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.66 118.24 9.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.278 7.7 tp10 -155.73 168.41 27.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.199 1.8 . . . . 0.0 107.739 -167.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 150.07 23.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.84 0.828 . . . . 0.0 110.652 168.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.65 153.32 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.764 174.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.9 157.83 28.81 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 174.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.59 8.77 0.76 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.19 -21.03 24.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.355 1.862 . . . . 0.0 111.557 169.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -117.29 -36.7 3.69 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.681 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.07 151.0 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 120.062 1.301 . . . . 0.0 110.592 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -142.62 146.23 34.3 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.596 1.558 . . . . 0.0 110.404 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 8' ' ' PHE . . . -65.91 151.36 46.9 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.229 1.412 . . . . 0.0 109.884 174.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.51 123.42 16.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.206 1.003 . . . . 0.0 110.823 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -147.85 151.32 35.74 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.107 2.163 . . . . 0.0 106.993 -169.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.66 -28.56 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.913 0.485 . . . . 0.0 110.65 173.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -64.37 -44.21 92.09 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.759 0.824 . . . . 0.0 110.302 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.5 mm -69.67 -33.89 58.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.626 0.648 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.45 99.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.287 0.949 . . . . 0.0 109.68 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -47.43 85.36 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.99 -48.02 83.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.579 -173.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -70.77 -44.51 66.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.32 0.509 . . . . 0.0 109.76 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -27.61 33.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.646 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -94.1 -45.45 7.55 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.441 1.473 . . . . 0.0 112.498 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.15 11.12 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.47 1.508 . . . . 0.0 110.956 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.9 t30 . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 126.215 1.806 . . . . 0.0 113.307 172.522 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -56.65 126.5 26.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 168.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.37 135.76 55.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -169.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.404 HD22 HG12 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -58.9 -3.62 0.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -168.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.2 28.0 0.26 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.89 -176.31 51.05 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 100' ' ' TYR . 87.4 mtt-85 -87.17 153.96 21.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.563 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.38 166.93 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 168.382 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -133.52 145.38 50.1 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.9 134.02 40.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.2 126.62 39.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.693 1.245 . . . . 0.0 107.649 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -103.04 -6.5 22.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.512 0.725 . . . . 0.0 111.109 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -77.63 0.35 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.46 -34.95 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.309 2.006 . . . . 0.0 113.422 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.7 178.36 8.04 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.815 1.646 . . . . 0.0 108.131 -172.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 161.97 33.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.06 163.97 28.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.112 0.965 . . . . 0.0 109.132 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.13 145.59 42.07 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.302 1.041 . . . . 0.0 108.223 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.06 158.47 44.39 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -148.48 94.06 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.927 0.891 . . . . 0.0 109.681 -169.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.563 HD11 HG11 ' A' ' 14' ' ' VAL . 54.7 mt -58.48 150.03 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.62 3.168 . . . . 0.0 111.886 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.51 -19.46 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 167.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -131.03 139.77 49.99 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.38 160.09 25.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -168.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -143.67 152.59 41.52 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.288 -168.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -149.63 143.6 16.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.653 1.581 . . . . 0.0 109.618 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.24 -1.97 10.45 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.954 3.103 . . . . 0.0 113.772 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.5 m -63.22 -33.39 75.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.297 1.408 . . . . 0.0 112.014 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -135.74 -0.52 2.58 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.919 1.288 . . . . 0.0 111.669 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 48.17 52.41 13.32 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.159 0.984 . . . . 0.0 110.145 -169.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 77.9 mtp -146.19 156.7 43.59 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.393 1.877 . . . . 0.0 107.034 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -107.25 175.62 5.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.866 0.866 . . . . 0.0 112.365 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -141.71 152.77 44.15 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 127.041 2.136 . . . . 0.0 107.207 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.1 m -152.16 157.12 41.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -169.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.404 HG12 HD22 ' A' ' 10' ' ' LEU . 4.8 pt . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 110.009 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.38 112.0 2.25 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.5 mt -75.42 139.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 138.34 93.26 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.49 136.55 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 N-CA-C 107.344 -1.829 . . . . 0.0 107.344 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -138.72 159.58 41.76 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -170.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -64.87 131.86 47.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 tt -80.57 155.55 26.88 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.471 1.908 . . . . 0.0 112.199 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.34 20.27 4.79 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.332 0.968 . . . . 0.0 112.129 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.4 -35.48 47.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.942 0.871 . . . . 0.0 109.262 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -150.97 8.94 0.57 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.703 1.201 . . . . 0.0 111.634 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.628 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 6.6 mp0 -126.72 173.5 9.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.523 1.529 . . . . 0.0 110.699 -169.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.7 m -153.85 140.42 18.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 169.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.499 HG22 HD11 ' A' ' 71' ' ' ILE . 12.3 pt -134.54 132.28 20.73 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.12 160.02 50.55 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.363 1.376 . . . . 0.0 109.444 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.02 -14.51 2.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.443 1.097 . . . . 0.0 112.317 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -66.93 -31.95 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.604 1.562 . . . . 0.0 112.773 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' ILE . 13.5 pt -119.34 -12.57 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 120.202 1.365 . . . . 0.0 110.686 -173.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -52.41 -46.92 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 128.43 2.692 . . . . 0.0 108.24 169.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.52 8.46 9.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.476 0.711 . . . . 0.0 111.923 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.49 -178.35 25.29 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.881 1.219 . . . . 0.0 111.195 -170.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -64.13 131.84 48.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -136.44 152.98 51.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.288 0.993 . . . . 0.0 111.546 176.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.71 114.68 10.73 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.967 1.307 . . . . 0.0 110.006 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -80.49 126.33 31.08 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 126.206 1.802 . . . . 0.0 106.791 169.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.47 156.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.334 1.454 . . . . 0.0 111.488 -168.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -105.45 120.15 40.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 167.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -72.22 120.59 18.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -72.34 148.41 45.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.582 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 9.6 56.74 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.5 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -130.76 165.01 23.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.95 1.375 . . . . 0.0 112.035 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -75.26 161.62 29.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -62.17 -21.51 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 111.448 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -25.66 39.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.828 1.251 . . . . 0.0 112.695 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -101.57 1.82 38.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.216 1.006 . . . . 0.0 111.726 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.77 115.4 7.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.277 6.8 tp10 -156.91 169.35 24.98 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.759 1.624 . . . . 0.0 108.241 -167.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.628 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.08 150.46 22.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.229 1.014 . . . . 0.0 109.72 168.094 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.44 155.26 40.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.749 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.27 166.52 32.12 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.66 -17.48 15.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.83 1.252 . . . . 0.0 113.232 174.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -22.86 40.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.767 1.227 . . . . 0.0 113.176 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -122.89 -38.98 2.55 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.431 174.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -95.85 156.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 119.767 1.167 . . . . 0.0 112.615 -169.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' HB3' HD21 ' A' ' 104' ' ' ASN . 89.0 mtt180 -155.19 155.41 33.85 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.391 2.676 . . . . 0.0 109.862 171.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.97 163.09 27.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.297 1.439 . . . . 0.0 112.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.52 ' CE2' HD11 ' A' ' 105' ' ' ILE . 35.6 t80 -66.95 115.84 7.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.15 -0.969 . . . . 0.0 110.392 174.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -161.69 161.89 29.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.482 1.513 . . . . 0.0 108.785 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.11 -33.25 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.798 1.639 . . . . 0.0 114.089 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -64.64 -43.85 92.36 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.015 0.912 . . . . 0.0 110.266 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 98' ' ' ARG . 79.6 m-20 -74.3 -27.0 60.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.67 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.52 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.8 mm -67.15 -45.53 86.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 117.308 -1.329 . . . . 0.0 109.524 169.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.6 79.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.796 1.634 . . . . 0.0 109.865 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.23 -51.79 63.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.225 0.61 . . . . 0.0 109.973 171.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.57 -48.86 80.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.369 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -68.26 -40.58 81.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 120.022 1.283 . . . . 0.0 110.276 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -52.47 -54.37 33.26 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt -73.71 -40.72 63.4 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.002 -0.436 . . . . 0.0 110.665 -170.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.12 -9.21 0.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.268 1.827 . . . . 0.0 113.009 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 124.993 1.317 . . . . 0.0 112.284 178.995 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.84 126.09 26.22 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 168.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.73 128.89 52.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -170.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.442 HD22 HG12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -59.04 -2.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -168.631 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.98 32.57 0.37 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 -157.43 14.14 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -109.48 154.57 22.48 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -129.18 162.04 37.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 169.189 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 14' ' ' VAL . 35.9 mt -139.14 130.39 26.81 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 -175.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.31 139.75 51.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -108.2 115.34 29.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -96.3 -10.54 27.62 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.994 0.918 . . . . 0.0 112.065 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.14 -78.69 0.31 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.62 -30.27 18.53 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.628 2.219 . . . . 0.0 112.887 175.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.445 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.11 -178.43 7.1 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.577 1.551 . . . . 0.0 108.894 -169.446 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.445 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -139.17 155.14 48.04 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.613 1.565 . . . . 0.0 107.326 -172.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -138.01 167.72 21.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 109.914 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.17 144.57 36.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.532 1.133 . . . . 0.0 109.061 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.9 156.43 48.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.168 1.387 . . . . 0.0 108.456 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -147.55 103.65 3.55 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.576 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.606 HD11 HG11 ' A' ' 14' ' ' VAL . 74.9 mt -60.09 148.16 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 129.61 3.164 . . . . 0.0 111.428 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.27 -18.41 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 116.732 -1.604 . . . . 0.0 113.88 167.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.445 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 15.2 ttpt -124.54 139.87 53.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 pt -141.01 161.11 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -169.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.48 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 2.9 t-105 -149.38 152.35 35.62 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.815 0.697 . . . . 0.0 111.988 -169.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.21 139.51 14.08 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.172 2.189 . . . . 0.0 109.054 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.2 -9.79 26.38 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.907 3.071 . . . . 0.0 113.422 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -68.48 -30.91 69.85 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.021 1.282 . . . . 0.0 111.291 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 m -120.1 -15.69 8.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.054 1.342 . . . . 0.0 110.844 174.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 49.18 47.2 22.32 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 118.865 0.757 . . . . 0.0 109.914 -170.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -145.82 148.69 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.84 174.8 6.2 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.111 0.565 . . . . 0.0 112.323 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.9 p -142.28 160.07 40.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.529 1.932 . . . . 0.0 106.884 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.646 ' HB3' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -147.16 165.16 30.85 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.809 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.442 HG12 HD22 ' A' ' 10' ' ' LEU . 8.5 pt . . . . . 0 CA--C 1.547 0.846 0 C-N-CA 124.718 1.207 . . . . 0.0 109.113 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -23.2 98.49 0.01 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.132 2.173 . . . . 0.0 112.322 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 40' ' ' SER . 4.0 mt -70.69 129.42 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 111.388 -2.642 . . . . 0.0 107.24 -168.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -67.12 137.12 94.21 Favored Pre-proline 0 C--O 1.236 0.344 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -173.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.16 131.02 17.27 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.272 1.981 . . . . 0.0 107.092 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -135.45 167.59 20.79 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.588 1.155 . . . . 0.0 108.085 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -65.16 151.94 44.84 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.697 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD11 ' CZ2' ' A' ' 91' ' ' TRP . 10.1 tt -108.09 147.22 31.51 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.585 1.554 . . . . 0.0 109.996 -169.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.87 42.73 0.77 Allowed Glycine 0 CA--C 1.527 0.787 0 O-C-N 123.906 0.754 . . . . 0.0 112.94 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.17 -8.73 3.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.093 0.957 . . . . 0.0 112.6 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.73 10.81 2.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.144 1.378 . . . . 0.0 110.472 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.448 ' HB2' ' HE1' ' A' ' 91' ' ' TRP . 0.6 OUTLIER -161.16 -177.44 6.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 108.016 -169.721 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.7 m -161.52 141.92 10.77 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.651 2.78 . . . . 0.0 103.64 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 67' ' ' ILE 0.311 5.3 tt -134.01 119.6 14.74 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -170.183 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.76 145.98 80.02 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.407 2.738 . . . . 0.0 113.037 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.8 -22.07 22.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.289 1.036 . . . . 0.0 112.509 172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -58.01 -31.3 66.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.792 2.037 . . . . 0.0 113.282 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 pt -117.82 -17.53 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.935 0.894 . . . . 0.0 111.014 -169.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.48 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 2.5 mm -52.87 -43.29 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 128.561 2.744 . . . . 0.0 109.656 171.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.91 11.75 4.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.252 -169.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.59 -171.1 26.07 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 121.0 -1.063 . . . . 0.0 110.487 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.01 136.16 56.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.131 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 m -137.91 151.21 47.78 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.927 0.767 . . . . 0.0 111.205 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -138.47 114.76 10.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.895 1.278 . . . . 0.0 110.294 -171.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 29' ' ' LYS . 53.5 t80 -81.48 129.23 34.57 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -137.97 149.04 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.017 -168.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -92.83 123.83 36.38 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -71.3 113.41 8.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -73.65 149.49 41.95 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.29 15.71 52.22 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 119.001 -0.888 . . . . 0.0 113.063 -176.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -136.31 172.15 13.43 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.113 1.365 . . . . 0.0 110.173 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -71.21 161.5 31.0 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -175.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -72.57 -13.47 61.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.759 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.9 m -55.09 -32.6 62.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.343 1.057 . . . . 0.0 112.225 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -87.77 2.45 51.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.858 0.863 . . . . 0.0 113.005 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.77 119.42 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 40.9 tt0 -158.81 153.94 25.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.448 ' HE1' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -91.18 149.69 21.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.282 1.039 . . . . 0.0 109.224 168.095 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.44 HG11 ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -132.8 149.13 31.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.49 -1.686 . . . . 0.0 110.484 -177.698 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.74 161.93 37.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.552 173.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.06 10.06 0.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.035 1.734 . . . . 0.0 114.95 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.27 -34.98 15.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.947 1.699 . . . . 0.0 110.378 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.44 ' HD2' HG11 ' A' ' 92' ' ' VAL . 23.6 ttm180 -93.39 -45.11 7.95 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.12 175.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 14' ' ' VAL . 5.2 tt -98.61 156.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.564 0.62 . . . . 0.0 111.335 -171.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.455 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 99.3 mtt180 -148.23 155.25 41.13 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.771 2.029 . . . . 0.0 109.743 169.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 161.72 30.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.16 1.346 . . . . 0.0 111.427 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CE2' HD11 ' A' ' 105' ' ' ILE . 26.4 t80 -70.12 117.9 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -162.02 161.32 28.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.131 1.373 . . . . 0.0 108.976 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.92 -36.08 47.85 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.68 1.592 . . . . 0.0 114.476 -169.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.19 -45.22 94.35 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.628 1.204 . . . . 0.0 110.476 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.49 -22.99 53.78 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.834 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.416 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.2 mm -69.01 -35.67 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.722 0.692 . . . . 0.0 109.772 169.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.9 97.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 118.809 0.731 . . . . 0.0 110.271 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -50.11 74.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -59.14 -48.04 83.08 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.6 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.69 -35.98 38.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.918 1.235 . . . . 0.0 110.276 -171.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -28.19 65.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.243 171.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -45.57 8.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.262 1.392 . . . . 0.0 112.819 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.04 16.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.285 1.434 . . . . 0.0 111.162 171.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.3 t30 . . . . . 0 CA--C 1.534 0.357 0 C-N-CA 125.684 1.594 . . . . 0.0 113.367 170.765 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 121.741 0.782 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.75 63.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 1 C-N-CA 132.094 4.158 . . . . 0.0 111.401 169.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.33 135.81 55.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 127.24 2.216 . . . . 0.0 105.688 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.85 -4.92 1.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -169.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.61 30.43 0.51 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 171.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.44 -165.21 34.32 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.533 -2.627 . . . . 0.0 106.533 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -99.74 154.75 18.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.58 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -129.39 165.88 28.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 168.213 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.411 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.5 mm? -133.53 140.74 47.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.92 129.8 34.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -104.54 114.2 28.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -87.64 -22.25 24.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.116 0.566 . . . . 0.0 110.98 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.89 -72.08 0.31 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.11 -32.07 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.53 2.153 . . . . 0.0 112.736 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.31 174.65 12.61 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.909 1.684 . . . . 0.0 109.302 -172.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.411 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -139.12 150.35 45.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.7 1.6 . . . . 0.0 108.757 -169.143 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -137.24 159.97 40.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 109.673 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 148.87 39.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 123.612 0.765 . . . . 0.0 109.158 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.56 159.33 42.36 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.207 1.003 . . . . 0.0 109.912 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.92 95.7 2.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.331 0.652 . . . . 0.0 109.457 -170.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.58 HD11 HG11 ' A' ' 14' ' ' VAL . 70.4 mt -54.77 152.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 128.08 2.552 . . . . 0.0 111.632 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.02 -32.08 0.09 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.399 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 34.8 ttpt -132.2 136.81 47.29 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.65 166.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.7 0.762 . . . . 0.0 109.182 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.462 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.9 t-105 -143.17 153.24 42.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.587 -169.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -148.6 137.48 11.96 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 127.501 2.32 . . . . 0.0 108.152 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -10.93 28.18 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.528 2.819 . . . . 0.0 113.304 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -65.62 -31.85 73.11 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.863 1.21 . . . . 0.0 111.957 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -124.51 -7.44 7.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.013 1.325 . . . . 0.0 111.163 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt 47.05 48.41 15.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.388 1.075 . . . . 0.0 110.65 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtp -147.19 158.18 43.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.642 2.377 . . . . 0.0 105.98 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.434 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -108.99 174.21 5.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.788 0.835 . . . . 0.0 112.321 -174.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 p -147.37 149.38 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.503 1.921 . . . . 0.0 107.035 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.437 ' HB3' HD12 ' A' ' 56' ' ' ILE . 35.9 t -146.5 165.9 28.05 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 pt . . . . . 0 CA--C 1.544 0.72 0 C-N-CA 125.141 1.377 . . . . 0.0 109.158 -176.875 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.53 113.84 3.2 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.437 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.1 mt -79.14 133.15 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -171.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -65.73 135.5 95.57 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.71 137.63 30.35 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.244 1.963 . . . . 0.0 108.024 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -139.69 160.67 39.34 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -170.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 4.8 mmpt? -67.02 120.08 13.05 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.618 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.26 150.71 33.88 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.805 2.042 . . . . 0.0 112.132 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.58 25.52 3.39 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.421 -1.21 . . . . 0.0 115.751 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.28 -30.57 17.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.986 1.893 . . . . 0.0 111.023 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.04 -39.9 0.11 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.07 1.748 . . . . 0.0 110.272 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -71.18 159.91 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.134 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -153.93 159.31 41.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 72' ' ' ILE 0.329 2.0 tt -144.63 126.61 8.09 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 -169.472 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.84 155.0 70.05 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 121.155 1.448 . . . . 0.0 111.142 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -56.96 -17.6 10.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.788 1.235 . . . . 0.0 112.542 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.11 -25.51 67.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.433 1.493 . . . . 0.0 112.332 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 pt -125.27 -14.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.229 0.922 . . . . 0.0 111.3 -170.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.51 HG12 HG23 ' A' ' 67' ' ' ILE . 1.6 mm -50.73 -42.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 128.587 2.755 . . . . 0.0 109.591 169.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.14 9.66 6.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.854 1.262 . . . . 0.0 112.768 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.01 -171.52 24.91 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 14.6 mmtt -58.66 140.4 54.63 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.294 -0.533 . . . . 0.0 109.658 174.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 m -138.2 149.35 45.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 123.933 0.771 . . . . 0.0 110.721 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 75' ' ' LYS . 50.0 m-85 -134.94 113.88 11.95 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.041 0.936 . . . . 0.0 110.763 -170.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -78.87 125.25 29.12 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.8 2.04 . . . . 0.0 106.479 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -135.15 151.94 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.069 1.348 . . . . 0.0 111.435 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -101.0 116.05 31.94 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 167.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.93 121.31 15.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.93 157.18 25.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.176 0.512 . . . . 0.0 110.031 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.35 11.11 45.64 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.217 -0.769 . . . . 0.0 111.731 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -135.7 167.65 20.74 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.526 1.13 . . . . 0.0 110.339 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -64.98 169.09 5.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.726 1.21 . . . . 0.0 110.659 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -82.97 -11.53 58.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.566 171.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.3 m -55.78 -33.43 64.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.707 1.203 . . . . 0.0 112.031 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -84.74 4.16 34.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.05 118.97 10.58 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.258 9.1 tt0 -157.23 162.02 39.25 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.589 1.556 . . . . 0.0 107.806 -167.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.435 ' CD1' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -96.68 152.85 18.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.15 0.976 . . . . 0.0 109.497 168.512 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.11 155.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.441 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.49 167.56 28.76 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -17.58 9.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.247 1.419 . . . . 0.0 113.304 176.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.77 -23.19 41.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 113.143 170.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.97 -38.56 2.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.881 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 14' ' ' VAL . 7.2 tt -94.19 155.29 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.728 1.149 . . . . 0.0 112.451 -169.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -153.95 160.23 42.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.275 3.03 . . . . 0.0 108.765 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.78 15.67 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.616 1.553 . . . . 0.0 112.832 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.535 ' CE2' HD11 ' A' ' 105' ' ' ILE . 32.0 t80 -70.22 115.0 8.91 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.056 -1.027 . . . . 0.0 110.023 169.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -162.02 163.64 28.72 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.622 1.569 . . . . 0.0 109.333 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -54.41 -34.34 61.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.629 1.572 . . . . 0.0 113.815 -169.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -63.9 -42.07 97.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.096 0.95 . . . . 0.0 110.412 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.16 -25.85 55.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.552 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.535 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.8 mm -69.59 -37.56 74.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.345 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.6 98.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.275 0.943 . . . . 0.0 109.702 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -49.8 74.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.98 -51.07 69.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.759 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.45 -31.98 58.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 117.63 -1.176 . . . . 0.0 110.176 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.99 -45.72 75.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.827 1.194 . . . . 0.0 110.358 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.06 -46.82 22.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.683 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.06 -29.58 30.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.022 1.329 . . . . 0.0 111.421 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 . . . . . 0 N--CA 1.456 -0.174 0 C-N-CA 124.559 1.143 . . . . 0.0 113.062 173.024 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.79 127.76 31.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.67 131.2 56.67 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 102.403 -3.184 . . . . 0.0 102.403 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -11.42 0.3 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -168.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.24 32.48 0.54 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.19 -170.47 36.47 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 169.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -91.16 153.25 20.17 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.874 HG11 HD11 ' A' ' 97' ' ' ILE . 2.9 p -135.92 158.35 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 169.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 14' ' ' VAL . 9.1 mt -128.28 154.66 45.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.97 129.24 31.82 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -93.18 129.05 39.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -110.19 -6.13 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.435 1.094 . . . . 0.0 111.991 -173.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.02 -80.68 0.29 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -72.42 -29.32 13.82 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.378 2.052 . . . . 0.0 113.16 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.65 177.83 10.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.782 1.633 . . . . 0.0 110.158 -169.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.431 ' CE ' HD13 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -142.75 150.85 40.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.042 1.737 . . . . 0.0 108.887 -168.231 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.61 175.75 9.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.11 147.13 25.07 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 109.746 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 14' ' ' VAL . . . -141.34 160.29 40.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.199 1.799 . . . . 0.0 108.465 -174.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -148.41 103.47 3.43 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 120.938 -1.101 . . . . 0.0 108.882 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 14' ' ' VAL . 79.7 mt -51.64 148.11 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.657 2.383 . . . . 0.0 110.441 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -153.92 -31.89 0.12 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.433 0.693 . . . . 0.0 111.632 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 33.4 ttpt -133.06 135.47 45.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 165.87 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.488 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.7 t-105 -145.45 154.59 42.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.302 -168.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.24 141.3 14.97 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.844 2.457 . . . . 0.0 108.697 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.82 -8.42 23.38 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.474 2.783 . . . . 0.0 113.356 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 m -66.92 -33.61 75.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.586 1.539 . . . . 0.0 110.961 -172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 p -118.95 -17.39 9.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.733 1.613 . . . . 0.0 110.847 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm 48.81 52.34 14.28 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.01 0.823 . . . . 0.0 109.212 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.9 mtp -148.9 156.94 43.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.476 2.71 . . . . 0.0 104.522 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 53.1 p90 -106.07 170.08 8.12 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.602 0.361 . . . . 0.0 111.666 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 p -142.57 150.58 40.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 126.995 2.118 . . . . 0.0 105.647 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.64 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.5 m -150.79 157.99 43.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -168.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.0 pt . . . . . 0 CA--C 1.553 1.07 0 C-N-CA 123.224 0.609 . . . . 0.0 109.595 -177.662 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt . . . . . 0 C--O 1.231 0.081 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -17.24 91.64 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.472 3.109 . . . . 0.0 111.127 -169.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 40' ' ' SER . 5.2 mt -72.03 136.48 25.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.121 -167.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.79 141.68 95.06 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.535 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.34 142.65 27.11 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.931 1.754 . . . . 0.0 108.822 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -129.75 165.91 20.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 108.953 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.622 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -60.37 -25.4 65.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 -168.77 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.6 tt 73.46 144.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.847 2.059 . . . . 0.0 112.66 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.97 25.16 5.47 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.989 -0.895 . . . . 0.0 115.188 169.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.25 -34.6 55.81 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.062 1.431 . . . . 0.0 109.113 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -153.16 -24.15 0.15 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.435 1.894 . . . . 0.0 112.369 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 34.3 mp0 -55.6 -19.51 10.54 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 129.162 2.985 . . . . 0.0 115.216 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -17.54 108.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.465 2.706 . . . . 0.0 111.962 -169.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.464 HG12 HD11 ' A' ' 71' ' ' ILE 0.342 4.3 tt -115.26 136.6 22.71 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.509 2.324 . . . . 0.0 106.764 -166.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.97 151.81 56.67 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.107 1.871 . . . . 0.0 111.578 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.61 -16.64 10.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.766 1.227 . . . . 0.0 113.339 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.71 -24.64 67.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.634 1.174 . . . . 0.0 112.367 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 67' ' ' ILE . 3.6 pt -125.16 -15.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.706 0.684 . . . . 0.0 110.688 -170.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.488 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 3.0 mm -54.67 -44.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.342 2.257 . . . . 0.0 107.158 169.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -81.15 11.31 4.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.177 1.791 . . . . 0.0 112.562 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.38 -172.26 26.29 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.636 1.107 . . . . 0.0 111.569 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -60.14 137.13 58.17 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -139.24 150.22 45.24 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.957 0.785 . . . . 0.0 110.465 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -137.04 115.58 11.96 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 110.272 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 41.3 t80 -82.04 130.87 35.2 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 126.348 1.859 . . . . 0.0 106.44 169.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.05 151.83 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.643 -167.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.62 122.96 36.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.71 115.63 11.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.49 147.99 30.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -173.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.16 46.8 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.336 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -130.73 171.47 13.06 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.597 1.199 . . . . 0.0 111.668 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -73.28 161.16 30.84 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.082 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.7 m -76.72 -13.86 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.229 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -51.1 -36.04 38.3 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.382 1.473 . . . . 0.0 111.979 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -88.06 2.13 52.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.76 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.55 121.64 14.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -172.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.276 7.7 tp10 -159.13 169.19 24.73 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.894 1.278 . . . . 0.0 108.099 -167.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.64 153.34 19.85 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.775 0.797 . . . . 0.0 110.744 168.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.434 HG23 HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -129.24 156.3 41.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.239 172.82 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.08 161.12 31.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.408 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.8 7.44 0.9 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -87.43 -21.04 25.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.991 1.716 . . . . 0.0 111.115 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm105 -117.91 -35.37 3.9 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.599 1.16 . . . . 0.0 111.813 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.874 HD11 HG11 ' A' ' 14' ' ' VAL . 4.4 tt -101.42 150.24 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.219 0.918 . . . . 0.0 110.094 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 87.4 mtt180 -147.32 143.8 28.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.094 1.358 . . . . 0.0 112.076 170.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HA ' HG23 ' A' ' 14' ' ' VAL . . . -68.18 147.81 51.74 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.703 2.001 . . . . 0.0 111.33 -176.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE2' HD11 ' A' ' 105' ' ' ILE . 34.4 t80 -59.52 114.68 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.197 0.453 . . . . 0.0 111.407 -169.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -160.53 162.23 32.92 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.27 -33.74 67.93 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.58 -42.99 98.27 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.598 0.713 . . . . 0.0 110.082 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -67.91 -36.59 80.45 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.412 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -67.58 -34.87 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.498 0.59 . . . . 0.0 110.804 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.29 98.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.209 0.913 . . . . 0.0 109.955 174.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -47.67 83.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -60.23 -48.95 79.56 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.732 0.813 . . . . 0.0 109.282 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -71.64 -43.89 65.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.34 0.518 . . . . 0.0 109.804 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -29.06 41.14 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.017 172.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.5 mt -92.96 -45.47 7.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.537 1.517 . . . . 0.0 112.341 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.0 -26.15 10.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.651 1.58 . . . . 0.0 111.491 170.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.9 t30 . . . . . 0 CA--C 1.531 0.233 0 C-N-CA 125.967 1.707 . . . . 0.0 112.969 172.441 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.93 163.59 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.675 1.19 . . . . 0.0 109.965 -175.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.21 -24.79 64.07 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.4 tp -57.02 -29.01 63.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.143 1.777 . . . . 0.0 112.446 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.08 -27.51 68.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.4 1.08 . . . . 0.0 111.299 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.58 -27.33 68.34 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.047 1.739 . . . . 0.0 112.556 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.53 144.88 30.99 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.734 0.697 . . . . 0.0 109.975 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -56.93 134.15 55.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 168.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.77 125.74 44.51 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -10.18 0.93 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -168.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 28.7 1.2 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.02 -175.27 50.94 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.48 157.3 18.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.06 153.49 37.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 168.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 14' ' ' VAL . 21.0 mt -122.07 139.38 53.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 173.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.66 123.16 28.77 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.229 0.956 . . . . 0.0 109.386 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -101.5 118.38 36.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.752 1.621 . . . . 0.0 107.6 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -95.08 -25.63 16.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.161 0.585 . . . . 0.0 111.439 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.82 -72.29 0.27 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -72.4 -30.51 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.079 1.853 . . . . 0.0 112.485 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -154.27 177.12 11.48 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.929 1.692 . . . . 0.0 109.63 -170.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.409 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -144.07 151.93 40.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.109 1.764 . . . . 0.0 108.175 -168.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -139.19 167.35 22.25 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.552 1.141 . . . . 0.0 110.583 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.34 144.89 29.37 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.34 161.71 37.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.522 1.529 . . . . 0.0 108.998 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -149.11 108.22 3.91 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.124 -0.985 . . . . 0.0 110.366 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.566 HD11 HG11 ' A' ' 14' ' ' VAL . 68.9 mt -53.8 151.06 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.229 3.012 . . . . 0.0 111.348 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.01 -30.05 0.08 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 34.4 ttpt -132.62 136.58 46.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.85 159.89 30.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -168.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -143.68 152.85 41.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.547 -168.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -150.91 142.84 15.76 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 126.065 1.746 . . . . 0.0 109.418 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.79 -11.13 31.05 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.971 2.448 . . . . 0.0 113.7 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.3 m -63.81 -32.62 74.19 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.852 1.205 . . . . 0.0 112.021 -171.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 m -125.82 -4.65 6.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.768 1.227 . . . . 0.0 111.421 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 41.45 50.66 3.67 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 125.298 1.439 . . . . 0.0 111.105 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.405 ' HE3' ' CB ' ' A' ' 58' ' ' PRO . 10.5 mtm -150.08 163.37 38.35 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 170.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.404 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 50.8 p90 -103.85 175.7 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.747 0.819 . . . . 0.0 112.272 -173.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 p -143.15 153.51 42.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.346 2.259 . . . . 0.0 106.907 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.643 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.0 m -153.23 163.49 39.79 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.42 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 6.6 pt -146.63 164.73 22.52 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.794 1.638 . . . . 0.0 108.726 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 41' ' ' ILE . 94.9 Cg_endo -78.5 46.2 2.07 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 125.096 3.864 . . . . 0.0 112.62 -169.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -10.09 59.4 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.173 -0.954 . . . . 0.0 113.491 -169.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -164.65 -169.17 1.66 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.044 1.338 . . . . 0.0 109.838 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -140.21 92.8 9.34 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 128.085 2.554 . . . . 0.0 105.931 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.19 165.56 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.281 2.654 . . . . 0.0 112.353 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.63 19.89 1.1 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.549 1.547 . . . . 0.0 114.513 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.49 31.25 0.52 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.622 1.582 . . . . 0.0 111.31 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.3 m -139.73 148.24 42.02 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.623 1.169 . . . . 0.0 109.497 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 p -68.37 -42.79 78.62 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -175.38 160.04 2.55 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 129.75 3.22 . . . . 0.0 105.792 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -73.03 146.95 45.54 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 166.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.403 ' H ' HD11 ' A' ' 56' ' ' ILE . 7.1 p -96.84 168.74 10.31 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.049 0.84 . . . . 0.0 110.975 -174.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -54.14 150.61 8.05 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.421 1.089 . . . . 0.0 109.257 169.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 4.79 80.77 0.0 OUTLIER 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.341 2.657 . . . . 0.0 113.532 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.643 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.2 mt -73.78 136.23 25.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -169.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -78.58 146.13 68.82 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' CB ' ' HE3' ' A' ' 37' ' ' MET . 38.7 Cg_exo -52.73 134.34 53.56 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.848 2.365 . . . . 0.0 110.137 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -144.9 153.74 41.88 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -65.74 135.82 55.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.19 0.995 . . . . 0.0 109.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.22 153.72 33.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.18 1.792 . . . . 0.0 111.631 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.64 21.88 5.27 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 124.131 0.894 . . . . 0.0 112.783 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -75.87 -34.74 60.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.098 0.949 . . . . 0.0 109.207 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -149.37 4.88 0.62 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.677 1.191 . . . . 0.0 111.855 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.639 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 7.0 mp0 -114.18 168.47 9.8 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.476 1.51 . . . . 0.0 110.532 -169.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -149.54 138.96 21.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 71' ' ' ILE . 12.9 pt -135.1 128.9 18.74 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.85 162.38 41.64 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.958 1.772 . . . . 0.0 109.56 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -15.72 9.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.924 0.89 . . . . 0.0 112.316 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.55 -31.18 72.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.824 1.25 . . . . 0.0 112.119 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 67' ' ' ILE 0.254 4.6 pt -121.27 -9.09 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 119.812 1.187 . . . . 0.0 110.447 -172.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.43 -49.28 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 127.6 2.36 . . . . 0.0 106.137 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -79.44 10.24 4.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.774 1.63 . . . . 0.0 112.114 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.34 28.85 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 119.454 1.024 . . . . 0.0 111.399 -173.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -64.39 132.97 51.61 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.5 m -138.27 154.54 49.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.393 1.058 . . . . 0.0 111.844 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 35.9 m-85 -142.11 115.44 8.93 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.764 -169.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 46.5 t80 -80.82 128.29 33.49 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -138.25 155.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.458 -167.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -100.45 118.23 36.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.59 121.89 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -90.22 150.27 22.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 10.28 52.71 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.616 -169.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.649 ' CD1' HM2B ' A' ' 128' ' ' M2L . 31.8 m95 -136.07 172.04 13.59 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.833 1.253 . . . . 0.0 111.25 -174.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -71.36 163.08 28.37 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.324 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 m -77.64 -12.11 59.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 171.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 m -55.43 -31.15 61.67 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.969 -1.082 . . . . 0.0 111.713 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -82.79 0.02 45.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.974 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -64.61 112.87 3.37 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -157.63 168.71 26.48 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.098 1.759 . . . . 0.0 107.975 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.639 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.9 152.46 20.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.042 0.925 . . . . 0.0 110.479 168.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.42 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.006 171.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.8 158.84 35.62 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.412 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -70.47 6.83 1.23 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.78 -26.68 25.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.624 1.57 . . . . 0.0 110.974 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -107.76 -40.42 5.29 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.363 1.065 . . . . 0.0 111.093 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 14' ' ' VAL . 5.4 tt -100.61 148.9 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.596 1.089 . . . . 0.0 110.443 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.412 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 96.2 mtt180 -145.62 151.28 37.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.94 168.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.54 146.23 52.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.506 1.522 . . . . 0.0 110.403 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.489 ' CE2' HD11 ' A' ' 105' ' ' ILE . 44.8 t80 -61.12 114.75 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 119.053 0.842 . . . . 0.0 112.194 -169.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -159.25 164.82 34.64 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.223 1.409 . . . . 0.0 110.126 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.27 -33.9 68.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.594 1.557 . . . . 0.0 113.527 -169.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.24 -42.27 96.59 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.724 0.773 . . . . 0.0 109.572 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -68.75 -34.96 76.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.489 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.9 mm -66.91 -36.79 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 118.687 0.676 . . . . 0.0 110.833 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.96 99.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.259 0.936 . . . . 0.0 109.924 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -57.49 -50.85 71.71 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 170.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -57.72 -48.92 78.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.661 0.785 . . . . 0.0 109.757 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -72.36 -38.99 68.4 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.798 0.839 . . . . 0.0 110.718 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -47.28 82.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.835 0.743 . . . . 0.0 109.215 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.8 mt -73.42 -42.77 61.65 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.434 -0.791 . . . . 0.0 111.819 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.31 -20.05 3.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.294 1.438 . . . . 0.0 112.606 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -93.54 -52.24 4.58 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.921 0.782 . . . . 0.0 111.557 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -71.96 -26.57 62.32 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -170.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -138.67 9.35 2.63 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -168.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.0 75.61 0.24 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.715 1.626 . . . . 0.0 112.536 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.1 m -142.76 162.51 35.27 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 128.123 2.569 . . . . 0.0 106.11 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.4 p -74.54 -20.23 60.04 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.54 1.536 . . . . 0.0 113.442 -172.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.92 12.51 68.16 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.261 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 m -74.32 59.93 0.81 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.187 1.795 . . . . 0.0 111.866 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.29 158.61 57.64 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.952 1.301 . . . . 0.0 109.249 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.01 10.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 125.091 3.861 . . . . 0.0 117.113 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -126.16 5.36 7.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.353 1.861 . . . . 0.0 111.962 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.4 m 73.17 -30.97 0.22 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.722 2.009 . . . . 0.0 113.503 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 77.05 -63.98 3.15 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.819 2.152 . . . . 0.0 111.937 171.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 168.13 33.61 0.02 OUTLIER Glycine 0 CA--C 1.522 0.524 0 CA-C-O 118.432 -1.205 . . . . 0.0 110.633 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -144.01 146.9 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -169.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.649 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp 19.63 94.68 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 131.579 3.952 . . . . 0.0 113.531 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -86.36 -10.45 6.58 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.615 2.21 . . . . 0.0 112.466 -172.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -43.54 -39.4 3.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.35 1.86 . . . . 0.0 113.565 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -155.47 149.63 25.74 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.233 1.413 . . . . 0.0 108.597 169.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -160.51 165.82 30.22 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.545 1.538 . . . . 0.0 108.095 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 . . . . . 0 C--O 1.251 1.135 0 C-N-CA 125.511 1.524 . . . . 0.0 106.986 176.353 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.58 152.7 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.321 1.448 . . . . 0.0 108.682 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -155.79 147.07 22.59 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.401 1.881 . . . . 0.0 106.388 172.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tm? 60.33 -40.76 0.1 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.601 2.76 . . . . 0.0 114.367 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -55.95 -28.04 55.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.298 1.839 . . . . 0.0 111.518 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -50.08 -40.41 45.37 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.439 2.696 . . . . 0.0 113.441 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -79.7 146.41 32.43 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 51.0 p90 -59.99 142.65 53.49 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.34 134.44 45.2 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -169.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.516 HD13 HD12 ' A' ' 30' ' ' ILE . 10.1 tp -59.73 -3.14 0.45 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -168.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.87 29.21 0.42 Allowed Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 170.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.72 179.59 48.94 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 -82.28 156.75 24.15 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -137.29 168.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.37 -2.455 . . . . 0.0 104.37 170.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 14' ' ' VAL . 42.8 mt -141.85 130.66 22.93 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 -172.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.98 130.08 51.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -103.71 114.06 28.04 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -171.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -94.29 -12.84 27.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.446 0.698 . . . . 0.0 111.757 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.96 -73.85 0.37 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.983 1.278 . . . . 0.0 109.914 171.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -66.7 -38.32 18.58 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.059 2.506 . . . . 0.0 113.4 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 22' ' ' MET . 18.7 tp -150.88 176.86 10.68 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 125.417 1.487 . . . . 0.0 108.798 -168.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -139.5 146.27 39.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.86 2.064 . . . . 0.0 107.014 -169.331 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -131.5 154.04 49.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.883 0.873 . . . . 0.0 108.729 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -81.08 138.57 35.96 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.011 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.03 158.55 40.02 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.605 1.562 . . . . 0.0 109.344 -171.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.76 96.6 2.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.63 0.372 . . . . 0.0 110.269 -169.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.618 HD11 HG11 ' A' ' 14' ' ' VAL . 42.6 mt -62.16 152.29 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 129.65 3.18 . . . . 0.0 112.41 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.26 -25.21 0.05 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.842 -1.075 . . . . 0.0 112.935 167.027 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.9 ttpt -128.77 136.13 50.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.516 HD12 HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -137.26 163.42 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.754 0.788 . . . . 0.0 109.024 -173.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -140.16 152.03 45.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.37 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -147.37 139.35 13.88 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.6 1.96 . . . . 0.0 108.428 -172.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.61 -10.27 27.35 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.372 2.715 . . . . 0.0 113.426 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 m -67.11 -32.12 73.05 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.116 1.325 . . . . 0.0 111.491 -170.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -121.63 -13.68 8.3 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.641 1.576 . . . . 0.0 110.823 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt 47.47 50.04 15.25 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.423 ' SD ' ' HE3' ' A' ' 60' ' ' LYS . 5.8 mtm -146.93 165.56 29.42 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.999 2.119 . . . . 0.0 106.396 170.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 49.0 p90 -107.72 175.18 5.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.968 0.907 . . . . 0.0 112.721 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -146.41 151.09 36.89 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 127.206 2.202 . . . . 0.0 107.336 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.455 ' HB3' HD12 ' A' ' 56' ' ' ILE . 47.6 t -147.19 160.84 41.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt -144.1 158.22 55.74 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 110.102 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 90.7 Cg_endo -74.29 44.84 1.09 Allowed 'Trans proline' 0 CA--C 1.544 1.004 1 C-N-CA 125.888 4.392 . . . . 0.0 113.178 -177.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -61.95 -46.14 90.6 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 120.7 -1.25 . . . . 0.0 110.04 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -160.89 -124.23 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.68 158.99 25.56 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 120.088 1.313 . . . . 0.0 111.577 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.3 165.51 28.51 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.971 1.781 . . . . 0.0 107.638 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.07 18.65 1.43 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.735 1.159 . . . . 0.0 114.642 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -138.01 18.84 3.32 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.526 1.536 . . . . 0.0 112.535 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 m -145.28 178.59 7.97 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.185 1.394 . . . . 0.0 109.885 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -114.96 -27.47 7.36 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.055 0.942 . . . . 0.0 112.414 -172.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -169.67 141.91 2.42 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 118.769 0.713 . . . . 0.0 110.102 169.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -65.31 164.81 12.8 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 165.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.9 p -124.53 91.13 3.38 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.647 -1.283 . . . . 0.0 112.797 -168.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 50.8 -163.53 0.05 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.486 1.915 . . . . 0.0 110.983 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.17 103.87 1.32 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.3 mt -69.85 130.96 34.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -67.63 139.22 93.83 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.02 139.39 70.71 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.966 1.778 . . . . 0.0 110.667 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -136.92 158.47 44.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 4.2 mmpt? -63.44 122.74 17.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.23 147.7 47.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.681 1.192 . . . . 0.0 111.729 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.0 -127.21 1.18 Allowed Glycine 0 N--CA 1.446 -0.661 1 N-CA-C 102.922 -4.071 . . . . 0.0 102.922 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 53.43 30.13 9.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.355 1.062 . . . . 0.0 113.298 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.64 10.45 5.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.764 2.025 . . . . 0.0 114.263 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.502 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 8.6 mm-40 -73.17 6.83 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.263 1.425 . . . . 0.0 113.586 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -22.4 118.47 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 128.63 2.772 . . . . 0.0 114.21 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 71' ' ' ILE . 10.5 pt -115.43 128.68 25.75 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.82 159.49 52.55 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.835 1.69 . . . . 0.0 109.388 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.77 -21.69 11.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.719 0.808 . . . . 0.0 111.611 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.7 -37.96 69.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.472 1.909 . . . . 0.0 114.196 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 67' ' ' ILE . 13.4 pt -116.12 -14.79 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.041 1.291 . . . . 0.0 110.814 -172.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mm -50.32 -45.96 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 128.007 2.523 . . . . 0.0 108.504 169.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.57 8.2 10.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.963 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.31 178.72 25.71 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 120.209 1.368 . . . . 0.0 111.44 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.48 130.13 45.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.0 m -131.82 143.69 50.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 124.191 0.932 . . . . 0.0 109.588 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CE1' ' CD1' ' A' ' 8' ' ' PHE . 63.3 m-85 -128.76 111.72 13.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.199 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -78.24 126.68 31.15 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.097 1.359 . . . . 0.0 107.564 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -136.65 158.6 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 125.44 1.713 . . . . 0.0 110.973 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -111.57 121.97 46.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -73.32 121.91 21.17 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -66.87 147.87 52.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.422 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.05 14.38 58.95 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.913 -0.937 . . . . 0.0 113.641 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.51 ' CZ2' ' HDA' ' A' ' 128' ' ' M2L . 96.4 m95 -135.08 171.39 14.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.885 1.342 . . . . 0.0 110.819 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -68.05 157.98 33.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.903 0.481 . . . . 0.0 111.213 -173.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 m -65.08 -21.66 66.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.21 1.004 . . . . 0.0 111.904 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -54.77 -32.11 59.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.06 1.344 . . . . 0.0 112.713 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -88.4 3.67 49.1 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.049 -0.976 . . . . 0.0 112.776 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.54 117.17 7.63 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.252 7.6 tp10 -157.7 167.48 29.97 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.84 -167.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.502 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -98.72 150.45 21.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.886 0.851 . . . . 0.0 110.313 168.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.52 156.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.887 1.275 . . . . 0.0 109.976 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.77 167.46 26.97 Favored Glycine 0 C--O 1.24 0.52 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.072 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -17.34 9.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.395 1.478 . . . . 0.0 113.387 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -56.77 -22.88 39.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.123 1.369 . . . . 0.0 113.172 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -124.54 -39.22 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.228 173.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 14' ' ' VAL . 7.2 tt -93.71 153.24 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.23 0.923 . . . . 0.0 111.268 -169.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -149.88 156.97 42.7 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 127.503 2.321 . . . . 0.0 109.203 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.6 27.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.252 1.021 . . . . 0.0 111.107 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 105' ' ' ILE . 15.3 t80 -75.23 113.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -155.98 161.67 40.45 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.594 1.558 . . . . 0.0 108.687 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.54 -33.88 56.22 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.766 1.626 . . . . 0.0 114.469 -169.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.74 -44.97 84.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.289 1.519 . . . . 0.0 109.639 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -75.26 -19.28 59.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.404 HD11 ' CE2' ' A' ' 100' ' ' TYR . 7.8 mm -74.6 -33.48 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 119.061 0.846 . . . . 0.0 110.25 168.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.99 93.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.212 0.915 . . . . 0.0 108.787 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.8 ttp -58.61 -56.63 19.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.55 0.614 . . . . 0.0 109.364 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -50.08 -45.96 52.98 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.776 1.23 . . . . 0.0 110.956 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -79.43 -41.75 26.92 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.803 1.241 . . . . 0.0 111.553 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -39.59 73.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.644 1.111 . . . . 0.0 109.347 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.18 -46.49 20.38 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.73 30.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.991 0.917 . . . . 0.0 111.469 171.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -72.78 -54.38 9.03 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.019 0.928 . . . . 0.0 112.071 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.65 -18.24 36.02 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 118.703 0.683 . . . . 0.0 112.791 -171.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 55.64 3.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 130.786 3.634 . . . . 0.0 117.007 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.6 -144.62 47.8 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.4 m -72.87 1.28 8.98 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -59.6 148.84 32.1 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.782 1.174 . . . . 0.0 109.317 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.57 -155.8 13.49 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.4 m -66.47 77.13 0.1 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.796 1.638 . . . . 0.0 110.556 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.41 161.79 29.52 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 127.315 2.246 . . . . 0.0 107.99 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.65 50.73 2.79 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 124.283 3.322 . . . . 0.0 111.874 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.21 122.33 12.89 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.346 1.458 . . . . 0.0 110.306 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -39.47 62.24 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.122 0.419 . . . . 0.0 110.227 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.7 24.43 0.08 OUTLIER Glycine 0 CA--C 1.531 1.086 0 CA-C-N 118.077 0.398 . . . . 0.0 112.122 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.35 -137.43 4.91 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -169.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.68 -26.26 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -169.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.51 ' HDA' ' CZ2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -151.15 126.61 4.86 Favored Pre-proline 0 N--CA 1.447 -0.625 0 O-C-N 120.44 -1.412 . . . . 0.0 108.015 -168.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -95.99 5.59 1.96 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.215 2.61 . . . . 0.0 111.574 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -38.14 -55.12 1.32 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 128.87 2.868 . . . . 0.0 114.397 -169.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.37 156.06 34.76 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.501 1.12 . . . . 0.0 109.963 -174.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -67.51 168.26 11.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.539 0.735 . . . . 0.0 109.275 169.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.9 ttt85 . . . . . 0 C--O 1.252 1.228 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.833 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 m -137.85 155.0 29.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.123 1.369 . . . . 0.0 107.584 171.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.37 -60.84 0.16 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.695 0.798 . . . . 0.0 109.024 172.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.7 tp -71.39 -44.58 64.68 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 122.843 0.457 . . . . 0.0 110.611 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -59.85 -30.98 69.34 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.93 0.892 . . . . 0.0 110.532 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -68.89 -19.36 64.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.42 1.488 . . . . 0.0 113.316 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -89.12 150.4 22.73 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.903 0.774 . . . . 0.0 109.978 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.441 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -59.26 87.83 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.873 2.069 . . . . 0.0 110.461 169.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.89 130.4 37.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.441 HD22 HG12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -61.34 -8.08 3.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -169.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.09 30.61 0.98 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 173.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.11 -163.79 28.7 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 106.585 -2.606 . . . . 0.0 106.585 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 156.29 17.45 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -131.06 154.72 41.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 168.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 14' ' ' VAL . 34.8 mt -125.06 131.6 53.31 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 176.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.55 121.55 35.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.649 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.16 125.21 44.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.034 1.334 . . . . 0.0 107.959 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -98.94 -25.73 14.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.886 0.474 . . . . 0.0 111.607 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.11 -71.86 0.34 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.26 -32.67 12.45 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.857 1.705 . . . . 0.0 112.614 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.4 178.83 9.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.194 1.397 . . . . 0.0 109.6 -174.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.07 151.41 40.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.878 2.071 . . . . 0.0 107.95 -168.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -138.0 159.84 40.93 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.76 0.824 . . . . 0.0 111.108 -170.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.42 140.82 43.16 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 160.6 39.21 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.738 1.615 . . . . 0.0 107.582 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -147.54 103.37 3.53 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.239 -0.913 . . . . 0.0 109.699 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 14' ' ' VAL . 67.9 mt -57.72 150.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.889 2.076 . . . . 0.0 111.854 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -160.53 -24.43 0.06 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.776 -1.107 . . . . 0.0 113.109 167.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.1 ttpt -126.49 138.7 53.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 pt -139.64 160.47 27.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -147.4 151.12 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -169.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -150.57 142.46 15.57 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.995 1.718 . . . . 0.0 108.465 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 -11.38 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.092 2.528 . . . . 0.0 113.644 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.2 m -64.01 -34.84 78.91 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -120.56 -7.09 9.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.178 0.991 . . . . 0.0 111.186 174.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 44.45 49.45 8.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.679 1.192 . . . . 0.0 109.801 -169.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtp -146.0 147.88 32.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -94.85 173.19 7.72 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.661 0.384 . . . . 0.0 110.53 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -143.97 145.45 32.25 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.975 2.11 . . . . 0.0 105.424 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.682 ' HB2' HD12 ' A' ' 56' ' ' ILE . 1.5 m -143.39 157.18 44.67 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -171.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.441 HG12 HD22 ' A' ' 10' ' ' LEU . 26.7 pt -130.32 153.6 81.3 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 170.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -86.82 41.73 0.8 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.715 2.277 . . . . 0.0 111.354 -168.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.97 -16.0 63.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.463 1.505 . . . . 0.0 111.907 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -147.21 178.79 8.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.933 1.293 . . . . 0.0 108.88 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -125.75 72.38 68.57 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.59 163.76 37.94 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.823 2.349 . . . . 0.0 112.826 -168.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.14 -26.42 61.22 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.698 1.142 . . . . 0.0 113.682 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.88 -19.59 58.91 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 117.888 0.844 . . . . 0.0 113.503 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 m 53.98 17.85 1.49 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.603 1.961 . . . . 0.0 115.496 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m -57.18 -54.71 43.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.224 1.41 . . . . 0.0 111.196 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -174.62 163.93 3.6 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.874 1.67 . . . . 0.0 109.425 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.82 75.54 0.54 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.823 2.049 . . . . 0.0 108.409 168.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.6 p -112.5 -80.14 0.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.515 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -148.14 -139.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -58.69 107.53 0.53 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.682 HD12 ' HB2' ' A' ' 40' ' ' SER . 23.4 mt -73.71 139.55 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -169.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -67.93 134.09 92.0 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.126 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.31 130.52 18.79 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 106.181 -2.276 . . . . 0.0 106.181 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -140.3 165.66 26.79 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.55 150.26 44.38 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 62' ' ' GLY . 6.3 tt -114.43 146.45 40.61 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.519 1.928 . . . . 0.0 110.284 -168.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.503 ' N ' HD23 ' A' ' 61' ' ' LEU . . . 114.11 36.05 1.41 Allowed Glycine 0 CA--C 1.524 0.652 0 O-C-N 124.377 1.048 . . . . 0.0 114.501 169.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -72.13 -33.22 67.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.731 1.266 . . . . 0.0 108.422 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.48 -29.88 0.13 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.372 1.869 . . . . 0.0 111.97 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 35.81 0.44 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.328 2.251 . . . . 0.0 112.78 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -32.73 144.21 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.785 2.434 . . . . 0.0 114.32 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -132.55 136.38 27.8 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 161.02 47.53 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.663 1.576 . . . . 0.0 109.575 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.76 -12.68 2.01 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.638 1.175 . . . . 0.0 112.711 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.84 -29.82 68.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.186 1.394 . . . . 0.0 113.037 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 pt -121.27 -9.91 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.371 1.441 . . . . 0.0 111.338 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mm -53.67 -45.95 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 128.688 2.795 . . . . 0.0 108.011 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.19 8.41 8.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 111.933 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.78 179.02 26.9 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 120.071 1.305 . . . . 0.0 111.33 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -64.41 129.99 42.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -136.86 151.17 48.8 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.155 0.909 . . . . 0.0 111.004 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.5 m-85 -139.88 115.41 10.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.48 1.512 . . . . 0.0 108.711 -169.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.76 129.58 35.0 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 126.168 1.787 . . . . 0.0 106.899 170.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.39 155.68 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.95 -168.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -101.94 119.53 38.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 167.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -71.07 117.15 12.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -83.73 151.08 25.42 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.851 0.46 . . . . 0.0 109.778 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.49 7.98 36.38 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.033 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.626 ' CD1' HM2B ' A' ' 128' ' ' M2L . 33.8 m95 -138.2 173.89 11.14 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.725 1.21 . . . . 0.0 110.786 -173.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -72.55 165.98 23.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.199 0.523 . . . . 0.0 111.382 -170.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.51 -11.59 59.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.46 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 m -57.66 -32.48 67.35 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.191 -0.943 . . . . 0.0 111.737 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -83.54 4.97 25.77 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.468 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.95 108.6 2.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -153.66 163.81 39.37 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.622 1.569 . . . . 0.0 107.79 -167.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.76 150.15 22.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.648 0.737 . . . . 0.0 109.612 168.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.18 150.06 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.27 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.64 160.81 37.98 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 173.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.22 9.02 0.83 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.09 -30.72 20.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.835 1.654 . . . . 0.0 110.703 168.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -102.47 -39.85 6.94 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.496 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 14' ' ' VAL . 4.9 tt -101.13 149.64 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.389 0.995 . . . . 0.0 110.762 -173.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 84.7 mtt180 -145.48 147.73 32.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.122 1.369 . . . . 0.0 110.225 169.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.81 144.3 54.34 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.134 1.373 . . . . 0.0 110.238 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.482 ' CE2' HD11 ' A' ' 105' ' ' ILE . 42.4 t80 -60.34 115.49 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.114 0.87 . . . . 0.0 111.87 -169.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -161.27 165.1 29.73 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.432 1.493 . . . . 0.0 110.431 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.15 -33.99 65.73 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.53 1.532 . . . . 0.0 113.715 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.42 -43.96 96.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.174 0.988 . . . . 0.0 109.949 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -68.75 -33.77 74.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.6 mm -69.27 -34.07 61.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.507 0.594 . . . . 0.0 110.682 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.35 99.34 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 119.414 1.006 . . . . 0.0 109.625 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -48.32 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -60.68 -45.44 94.16 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.44 0.696 . . . . 0.0 109.681 -173.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -76.07 -44.11 40.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.17 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -57.35 -33.96 68.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.783 0.72 . . . . 0.0 110.569 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.32 -52.23 9.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.73 -27.19 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.928 1.291 . . . . 0.0 111.747 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -72.25 -45.41 60.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.477 1.111 . . . . 0.0 113.448 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -92.76 -13.22 29.56 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.98 0.809 . . . . 0.0 112.988 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -44.55 116.73 1.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.761 2.425 . . . . 0.0 113.843 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.21 56.01 4.96 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.037 1.303 . . . . 0.0 110.011 169.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -63.1 -18.24 63.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.06 0.944 . . . . 0.0 113.318 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 p -137.57 176.5 8.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.4 1.88 . . . . 0.0 109.171 -172.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.98 30.26 47.92 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 121.817 -0.552 . . . . 0.0 112.207 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m 54.04 40.99 32.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.956 1.302 . . . . 0.0 113.051 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.09 146.02 62.74 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 118.793 -0.623 . . . . 0.0 110.054 172.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.21 157.1 26.93 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.578 2.852 . . . . 0.0 113.198 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.18 -10.24 29.75 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 112.672 -2.058 . . . . 0.0 113.172 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 m -139.92 35.78 1.96 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.243 1.417 . . . . 0.0 109.049 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.93 22.65 0.7 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.957 1.265 . . . . 0.0 112.548 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 172.77 -47.53 0.17 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-O 118.341 -1.255 . . . . 0.0 110.973 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.32 141.02 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 119.439 1.619 . . . . 0.0 108.061 -171.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.626 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp 30.48 94.49 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 130.912 3.685 . . . . 0.0 115.462 168.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -91.71 -4.54 4.0 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.279 2.653 . . . . 0.0 112.731 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -45.21 -25.21 0.34 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 128.654 2.782 . . . . 0.0 115.767 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -78.35 65.4 3.67 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.174 1.39 . . . . 0.0 108.963 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -59.02 156.91 10.89 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.702 1.201 . . . . 0.0 110.849 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? . . . . . 0 C--O 1.254 1.325 0 C-N-CA 123.785 0.834 . . . . 0.0 109.148 175.171 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.31 161.44 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.347 0.659 . . . . 0.0 110.796 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -150.03 -53.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.813 0.845 . . . . 0.0 110.015 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.92 -34.97 77.04 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.355 0.662 . . . . 0.0 111.596 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.94 -28.41 66.22 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.096 0.958 . . . . 0.0 111.749 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -89.32 -6.69 56.49 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.319 1.448 . . . . 0.0 111.88 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -84.53 161.17 20.32 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.963 -1.086 . . . . 0.0 108.295 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -60.06 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 126.875 2.07 . . . . 0.0 109.953 170.045 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.11 130.4 39.72 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -4.07 1.74 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -168.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.66 33.36 0.69 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.4 -161.37 27.11 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 107.346 -2.301 . . . . 0.0 107.346 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.426 ' HG2' HE22 ' A' ' 82' ' ' GLN . 56.3 mtt180 -102.96 156.65 17.52 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 168.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.573 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -131.24 156.54 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 168.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 14' ' ' VAL . 43.9 mt -126.03 134.98 51.27 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.16 129.21 47.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.177 0.923 . . . . 0.0 110.038 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -105.98 131.81 52.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 109.638 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -113.68 -19.93 11.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.758 0.823 . . . . 0.0 111.655 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.95 -72.8 0.31 Allowed Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.75 -32.75 29.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.843 1.695 . . . . 0.0 112.26 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 -179.26 7.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.702 1.601 . . . . 0.0 109.311 -170.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.439 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -140.94 160.61 39.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.779 1.632 . . . . 0.0 107.281 -175.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.07 160.39 39.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.951 0.9 . . . . 0.0 109.508 -170.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -77.24 140.91 40.2 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.67 41.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.671 1.588 . . . . 0.0 108.672 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -148.5 101.52 3.24 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.142 -0.973 . . . . 0.0 110.339 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.573 HD11 HG11 ' A' ' 14' ' ' VAL . 64.0 mt -58.93 150.23 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 127.769 2.428 . . . . 0.0 112.025 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.484 HD22 ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.51 -28.37 0.05 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 116.51 -1.709 . . . . 0.0 112.374 166.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 20.7 mtmt -114.72 144.79 42.9 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 168.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -142.26 161.07 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -149.6 152.7 35.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.386 -169.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.01 138.69 13.12 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.187 2.195 . . . . 0.0 108.453 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.89 -9.95 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.503 2.802 . . . . 0.0 113.57 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 m -66.57 -32.04 73.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.934 1.243 . . . . 0.0 111.538 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.8 p -121.1 -15.32 8.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.863 1.665 . . . . 0.0 110.866 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 48.62 49.01 19.19 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.917 0.887 . . . . 0.0 109.757 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.3 mtp -144.85 154.78 43.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.961 2.104 . . . . 0.0 105.793 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -104.52 170.56 7.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.223 0.609 . . . . 0.0 111.911 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -138.64 152.89 48.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.911 2.085 . . . . 0.0 106.445 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 56' ' ' ILE . 24.8 m -152.2 156.27 39.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -168.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 pt -147.43 159.92 40.45 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.849 1.259 . . . . 0.0 109.852 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.682 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 63.5 Cg_endo -78.32 46.15 2.03 Favored 'Trans proline' 0 CA--C 1.549 1.231 0 C-N-CA 124.417 3.411 . . . . 0.0 115.35 -171.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -79.03 -4.13 48.6 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.844 -1.16 . . . . 0.0 112.903 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -151.88 173.69 14.49 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.414 -1.428 . . . . 0.0 113.007 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -134.19 81.68 49.76 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.786 2.435 . . . . 0.0 107.809 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -60.04 166.19 9.24 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.601 2.2 . . . . 0.0 111.794 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.28 -24.41 22.21 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.085 0.85 . . . . 0.0 115.051 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.22 5.95 36.33 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.261 -1.3 . . . . 0.0 114.221 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.1 m -146.01 124.98 12.75 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.713 1.757 . . . . 0.0 110.225 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -54.53 -31.03 55.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.104 1.362 . . . . 0.0 112.235 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -165.28 157.94 15.83 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.117 2.167 . . . . 0.0 107.423 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.682 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -75.64 166.57 23.35 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 p -92.94 -82.09 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -167.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -151.5 -154.74 0.56 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.525 2.33 . . . . 0.0 106.233 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.51 101.43 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.486 HD12 ' HB2' ' A' ' 40' ' ' SER . 3.7 mt -76.12 135.27 27.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -175.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.35 140.55 87.7 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.63 139.88 38.19 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.051 1.834 . . . . 0.0 107.381 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -143.65 160.0 41.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -62.99 131.79 49.83 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.178 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -80.35 153.89 28.09 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.404 1.482 . . . . 0.0 111.727 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.12 31.63 1.68 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.37 -40.16 27.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.872 1.336 . . . . 0.0 109.216 169.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -160.32 2.65 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.121 0.968 . . . . 0.0 113.286 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.12 47.21 2.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.678 1.591 . . . . 0.0 111.724 -169.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 m -33.05 142.06 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.65 3.18 . . . . 0.0 113.345 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 71' ' ' ILE . 5.8 pt -135.19 132.23 20.04 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 168.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.87 158.85 55.44 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.255 1.303 . . . . 0.0 109.302 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.18 -16.36 3.08 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.341 1.456 . . . . 0.0 112.271 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.13 -32.13 73.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.27 1.828 . . . . 0.0 112.955 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 67' ' ' ILE . 14.9 pt -120.45 -13.19 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.528 1.513 . . . . 0.0 110.868 -173.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.74 -46.03 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 128.278 2.631 . . . . 0.0 108.759 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -79.59 9.03 5.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.95 0.9 . . . . 0.0 111.886 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.1 -176.37 27.23 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.922 1.237 . . . . 0.0 111.093 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.08 130.87 48.0 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -134.29 154.39 51.33 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.885 0.741 . . . . 0.0 110.941 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 23.9 m-85 -141.78 113.49 7.83 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.108 1.363 . . . . 0.0 109.265 -169.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.509 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 55.3 t80 -80.01 129.07 34.2 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.33 157.36 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.362 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -105.8 120.09 40.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 167.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CD2' ' HM2' ' A' ' 128' ' ' M2L . 39.0 m-85 -72.73 118.45 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.426 HE22 ' HG2' ' A' ' 13' ' ' ARG . 62.3 mt-30 -77.7 150.2 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.08 10.91 42.91 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.925 -0.93 . . . . 0.0 113.017 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.659 ' CD1' HM2B ' A' ' 128' ' ' M2L . 48.5 m95 -134.87 171.01 15.0 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 1.233 . . . . 0.0 111.327 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -69.25 158.23 35.39 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.024 0.53 . . . . 0.0 111.338 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 p -63.92 -19.76 65.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.813 0.845 . . . . 0.0 112.127 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.1 m -54.19 -31.94 54.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.424 1.089 . . . . 0.0 112.779 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -84.14 3.23 35.87 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.95 107.01 2.94 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.253 7.5 tp10 -154.31 168.54 26.25 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.623 1.969 . . . . 0.0 107.854 -167.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.61 151.24 22.58 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.823 0.82 . . . . 0.0 111.011 168.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.68 156.38 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.128 174.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.77 161.32 27.0 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.0 1.286 . . . . 0.0 110.11 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.74 7.5 1.49 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -176.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.56 -20.5 27.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.888 1.675 . . . . 0.0 110.752 169.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -119.0 -31.31 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.01 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 14' ' ' VAL . 4.9 tt -108.22 155.91 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 120.665 1.575 . . . . 0.0 111.694 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.453 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 11.0 mtt85 -149.19 146.84 27.83 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.027 1.331 . . . . 0.0 110.32 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . 0.259 . . -66.99 143.89 56.52 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.339 1.855 . . . . 0.0 111.916 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -59.06 118.67 6.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.461 1.482 . . . . 0.0 111.516 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -169.35 164.78 10.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.06 1.744 . . . . 0.0 110.622 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.97 -27.99 63.95 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.175 -0.953 . . . . 0.0 113.511 -169.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.18 -45.92 72.13 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 119.543 1.065 . . . . 0.0 110.778 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -74.74 -22.35 58.85 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.02 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.18 -37.65 67.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 118.752 0.705 . . . . 0.0 110.127 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.06 99.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.577 1.08 . . . . 0.0 109.742 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.6 ttp -58.13 -53.68 55.48 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -57.75 -46.41 84.54 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.82 -172.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -70.74 -45.19 65.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.237 0.926 . . . . 0.0 110.351 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -34.02 60.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.455 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.6 mt -87.63 -47.27 8.82 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.954 0.797 . . . . 0.0 111.996 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.23 14.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.241 1.416 . . . . 0.0 110.936 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -67.22 -56.98 7.61 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 112.957 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.11 -24.72 35.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.244 0.929 . . . . 0.0 112.694 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.68 118.88 10.86 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.803 0.841 . . . . 0.0 111.107 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.68 -35.73 35.29 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.4 m 54.82 16.55 1.47 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.933 1.693 . . . . 0.0 113.95 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 p -78.33 130.31 36.03 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.559 1.544 . . . . 0.0 108.922 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 121' ' ' ALA . . . 166.41 64.78 0.03 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.0 m -68.43 16.68 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.067 1.347 . . . . 0.0 113.633 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 119' ' ' GLY . . . -144.66 164.66 26.72 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 129.155 2.982 . . . . 0.0 107.707 -169.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.58 82.13 1.47 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.357 2.705 . . . . 0.0 111.88 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.55 148.29 31.01 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.719 1.608 . . . . 0.0 108.139 170.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.5 m -80.88 69.22 7.39 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.072 1.349 . . . . 0.0 108.131 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.44 57.27 2.89 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.802 1.668 . . . . 0.0 112.214 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.17 11.13 84.25 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-O 117.886 -1.508 . . . . 0.0 112.252 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.24 143.93 11.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 120.926 2.363 . . . . 0.0 106.289 -168.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.659 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -163.48 152.48 12.17 Favored Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 125.15 1.38 . . . . 0.0 109.208 169.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -100.36 2.6 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.489 3.459 . . . . 0.0 112.22 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -147.08 158.57 43.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.954 2.502 . . . . 0.0 108.385 -169.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? 126.75 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 1 C-N-CA 133.23 4.612 . . . . 0.0 107.745 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -78.76 163.77 25.1 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.017 0.927 . . . . 0.0 108.899 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 . . . . . 0 C--O 1.254 1.315 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.949 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -68.95 159.66 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.493 1.042 . . . . 0.0 109.818 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.25 142.45 15.83 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.931 1.292 . . . . 0.0 108.141 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 tp 58.32 12.63 2.05 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.135 2.174 . . . . 0.0 114.42 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.13 -53.14 13.65 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.34 111.11 2.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 169.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.94 176.71 6.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.459 -1.7 . . . . 0.0 108.765 169.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -62.71 82.6 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 124.481 2.086 . . . . 0.0 110.293 169.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.07 128.67 34.88 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 103.455 -2.794 . . . . 0.0 103.455 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.86 -2.82 2.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.77 29.41 1.03 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -166.09 34.7 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 168.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -98.28 156.37 16.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.92 156.42 42.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 169.229 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 14' ' ' VAL . 32.7 mt -127.75 141.27 51.63 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.96 127.09 44.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.171 0.919 . . . . 0.0 109.155 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -86.2 138.07 32.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.383 1.073 . . . . 0.0 108.323 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -120.22 -11.46 9.2 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.19 0.996 . . . . 0.0 112.385 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.67 -72.65 0.48 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.49 -39.11 22.88 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.258 1.972 . . . . 0.0 112.601 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 22' ' ' MET . 10.7 tp -152.27 -171.81 4.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 125.818 1.647 . . . . 0.0 108.919 -169.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.422 ' H ' ' HG ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -151.63 150.77 30.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.438 2.295 . . . . 0.0 107.27 -169.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.01 164.19 29.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.985 0.514 . . . . 0.0 111.397 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.0 137.73 37.71 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 125.492 1.517 . . . . 0.0 109.132 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.6 166.24 22.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.999 1.72 . . . . 0.0 108.76 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -152.59 93.46 1.78 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 110.582 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.566 HD11 HG11 ' A' ' 14' ' ' VAL . 66.1 mt -53.11 152.43 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.09 2.156 . . . . 0.0 111.523 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -154.96 -35.06 0.09 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.935 0.894 . . . . 0.0 111.009 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 37.5 ttpt -128.93 137.09 51.2 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.15 164.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -141.39 152.88 44.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.228 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -135.11 150.38 72.79 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 127.596 2.358 . . . . 0.0 110.726 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.75 -17.42 7.18 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.787 2.991 . . . . 0.0 112.877 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m -62.08 -37.49 85.23 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.944 1.298 . . . . 0.0 111.979 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.2 m -128.62 5.89 5.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.155 1.782 . . . . 0.0 111.341 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 46.03 55.89 6.65 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 125.173 1.389 . . . . 0.0 109.932 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 ptm -150.94 169.27 22.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.408 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 49.0 p90 -114.38 172.67 6.87 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.451 0.701 . . . . 0.0 112.444 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -145.11 151.4 38.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.256 2.222 . . . . 0.0 106.627 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.478 ' HB3' HD12 ' A' ' 56' ' ' ILE . 40.8 t -144.58 152.06 39.97 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pp -141.07 149.17 54.75 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 63.7 Cg_endo -79.11 67.6 8.54 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.881 3.054 . . . . 0.0 112.992 -169.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -60.49 -51.05 71.13 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -168.89 158.01 8.51 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.052 1.741 . . . . 0.0 107.269 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -67.78 140.8 94.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.903 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.03 170.2 6.52 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.353 2.036 . . . . 0.0 109.105 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.81 5.93 36.3 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 120.999 -1.063 . . . . 0.0 115.069 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.24 29.06 0.46 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.121 1.461 . . . . 0.0 112.289 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 m -141.31 153.7 45.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.057 1.343 . . . . 0.0 108.228 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.5 m -61.8 -57.7 10.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.608 0.763 . . . . 0.0 111.443 -170.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -173.17 159.61 3.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.774 2.029 . . . . 0.0 108.281 170.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -74.37 154.77 38.7 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 166.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.5 p -129.84 84.96 2.25 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.215 -0.928 . . . . 0.0 111.549 -169.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 79.1 mttt 49.66 -153.41 0.13 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.848 1.659 . . . . 0.0 110.674 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.43 101.18 0.3 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 40' ' ' SER . 4.3 mt -74.54 134.24 29.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -67.7 143.43 96.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.0 134.67 18.08 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 N-CA-C 107.476 -1.779 . . . . 0.0 107.476 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -137.35 167.81 20.87 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -60.99 154.37 22.75 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.003 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.88 153.31 23.22 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 111.333 -168.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.83 30.75 3.13 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-O 119.544 -0.587 . . . . 0.0 112.911 170.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.33 -26.26 38.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.221 1.011 . . . . 0.0 110.281 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -152.07 -31.69 0.15 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.209 1.003 . . . . 0.0 112.149 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HB2' ' HE1' ' A' ' 91' ' ' TRP . 0.7 OUTLIER -76.41 179.6 5.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.237 1.415 . . . . 0.0 110.621 171.141 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.4 m -154.8 152.02 29.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.456 2.702 . . . . 0.0 105.827 169.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 67' ' ' ILE . 6.9 pt -136.45 130.6 18.12 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 168.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.18 159.71 51.95 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.999 1.8 . . . . 0.0 109.846 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.01 -20.89 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.266 1.026 . . . . 0.0 112.145 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.59 -36.94 74.77 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.233 1.813 . . . . 0.0 113.677 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 67' ' ' ILE . 8.4 pt -116.99 -9.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.998 0.817 . . . . 0.0 110.901 -170.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.59 -47.98 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.696 2.799 . . . . 0.0 108.627 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.8 12.03 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.414 0.686 . . . . 0.0 112.841 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.61 -175.77 24.49 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -57.1 139.64 51.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.6 t -140.33 155.62 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.572 0.545 . . . . 0.0 110.03 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.422 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 25.3 m-85 -140.16 113.4 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.77 1.228 . . . . 0.0 110.906 -169.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -78.16 124.59 28.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.901 2.08 . . . . 0.0 106.374 169.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -134.97 157.44 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 113.45 -1.704 . . . . 0.0 111.429 -168.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -103.78 118.32 36.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.057 -2.572 . . . . 0.0 104.057 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.451 ' CG ' ' HM2' ' A' ' 128' ' ' M2L . 17.9 m-85 -73.39 117.84 15.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.61 147.0 27.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.77 -171.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.9 8.51 49.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.639 -170.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.467 ' CD1' HM2B ' A' ' 128' ' ' M2L . 94.9 m95 -128.63 174.73 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.982 1.391 . . . . 0.0 111.481 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.02 162.49 29.38 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.215 0.606 . . . . 0.0 111.427 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -64.78 -22.07 66.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.002 . . . . 0.0 111.928 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -56.37 -30.99 63.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.113 . . . . 0.0 112.594 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -90.06 6.63 41.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.035 -0.983 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 107.18 1.9 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -155.67 164.82 38.1 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.996 1.718 . . . . 0.0 108.249 -167.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.476 ' HE1' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -94.74 149.76 20.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.136 0.97 . . . . 0.0 110.396 168.382 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.51 151.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.548 171.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.56 158.66 29.98 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.435 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.03 8.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.476 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.74 -18.8 25.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.914 1.686 . . . . 0.0 111.09 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -117.17 -39.01 3.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.856 -1.069 . . . . 0.0 111.392 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 14' ' ' VAL . 4.2 tt -99.75 150.99 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.727 1.149 . . . . 0.0 111.365 -175.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.435 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 92.7 mtt-85 -143.59 146.62 33.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.609 1.564 . . . . 0.0 110.476 168.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 147.51 53.34 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.871 1.269 . . . . 0.0 111.023 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.486 ' CE2' HD11 ' A' ' 105' ' ' ILE . 33.1 t80 -64.79 116.44 6.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.051 0.841 . . . . 0.0 111.854 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -159.16 161.71 36.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.963 1.705 . . . . 0.0 109.063 -169.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -61.48 -26.34 67.84 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.618 -1.301 . . . . 0.0 113.114 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -71.65 -44.27 64.62 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.248 1.019 . . . . 0.0 110.8 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.288 44.2 p30 -71.22 -22.28 62.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.338 173.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.486 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.1 mm -72.58 -35.55 51.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 119.032 0.833 . . . . 0.0 110.502 169.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.48 98.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.724 1.147 . . . . 0.0 109.684 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.3 ttp -58.8 -53.7 55.4 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -54.0 -46.12 71.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.758 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -73.12 -45.23 58.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.844 0.747 . . . . 0.0 110.041 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.87 39.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.873 -0.584 . . . . 0.0 112.15 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.03 -45.09 8.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.298 0.954 . . . . 0.0 112.037 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.71 13.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.025 1.33 . . . . 0.0 111.316 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -64.73 -34.26 77.89 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.227 1.811 . . . . 0.0 114.15 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -124.0 -16.48 6.54 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.528 1.058 . . . . 0.0 113.826 -170.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 54.8 0.62 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 130.46 3.504 . . . . 0.0 117.094 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.29 -55.98 4.97 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.331 1.443 . . . . 0.0 110.913 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 56.3 m 46.23 48.39 13.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.513 1.525 . . . . 0.0 113.058 171.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.9 49.75 0.55 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.46 1.904 . . . . 0.0 111.857 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.08 -176.42 39.12 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.793 -1.192 . . . . 0.0 111.138 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 m -75.34 10.46 1.6 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 113.886 -175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.79 157.59 35.76 Favored Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 127.219 2.208 . . . . 0.0 107.658 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -54.8 151.26 33.26 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.257 2.638 . . . . 0.0 110.987 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.6 136.74 58.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.658 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 37.8 p -76.27 -26.97 56.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.823 0.449 . . . . 0.0 111.514 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 167.53 -28.46 0.16 Allowed Glycine 0 C--N 1.339 0.703 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.4 166.03 38.17 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 124.609 1.1 . . . . 0.0 110.484 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.74 -3.61 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -167.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.467 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp 28.03 97.56 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.361 1 C-N-CA 135.194 5.398 . . . . 0.0 113.493 168.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.42 -11.01 5.24 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.926 2.418 . . . . 0.0 111.572 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -57.44 -26.72 61.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.174 2.59 . . . . 0.0 112.592 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -145.61 -177.07 5.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.804 1.242 . . . . 0.0 109.236 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -130.86 19.49 5.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.864 1.265 . . . . 0.0 111.791 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.812 1.245 . . . . 0.0 108.348 -171.818 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -150.12 137.82 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -162.35 -54.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.13 0.972 . . . . 0.0 109.982 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.98 -42.18 33.61 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.04 0.536 . . . . 0.0 110.546 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -63.74 -22.68 67.03 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.997 0.817 . . . . 0.0 111.5 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -60.28 -37.79 81.59 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.733 1.613 . . . . 0.0 112.116 170.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.35 151.62 26.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.79 0.836 . . . . 0.0 109.227 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.46 126.21 26.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.51 133.91 55.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 -169.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 HG12 ' A' ' 41' ' ' ILE . 1.1 mt -58.77 -8.07 1.21 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -168.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.02 31.58 0.55 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.18 -163.1 29.96 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 168.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.94 152.71 20.61 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.613 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.4 166.35 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 168.187 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 14' ' ' VAL . 44.5 mt -136.35 140.51 43.34 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.6 124.51 36.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -74.17 132.47 42.23 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.81 0.12 10.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.781 0.833 . . . . 0.0 111.148 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.45 -86.52 0.23 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.74 -26.24 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.731 2.287 . . . . 0.0 113.641 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -153.34 -170.6 3.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.265 1.426 . . . . 0.0 109.81 -168.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.499 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -144.08 149.22 36.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.389 1.876 . . . . 0.0 108.773 -168.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.493 ' CD2' HM2B ' A' ' 128' ' ' M2L . 4.6 m-85 -138.71 173.2 11.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.068 0.547 . . . . 0.0 110.982 177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.57 144.83 28.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.704 1.202 . . . . 0.0 108.652 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.26 50.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.844 1.258 . . . . 0.0 108.539 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -145.18 101.27 3.59 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.115 0.966 . . . . 0.0 109.852 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.613 HD11 HG11 ' A' ' 14' ' ' VAL . 77.5 mt -57.17 152.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 129.025 2.93 . . . . 0.0 111.175 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.21 -29.83 0.08 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.641 168.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 31.9 ttpt -132.32 133.84 44.51 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 pt -137.33 161.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -145.64 151.94 38.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.322 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.5 142.6 16.04 Favored Pre-proline 0 C--O 1.241 0.652 0 C-N-CA 126.263 1.825 . . . . 0.0 109.167 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.85 -11.16 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.897 2.398 . . . . 0.0 113.785 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -62.6 -35.59 80.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.095 1.316 . . . . 0.0 112.463 -169.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 m -129.01 4.65 5.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.264 1.026 . . . . 0.0 111.557 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt 41.43 55.7 3.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.748 1.619 . . . . 0.0 111.045 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptm -152.81 160.75 43.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 50.5 p90 -102.93 169.78 8.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -175.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -141.32 146.5 36.8 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 126.863 2.065 . . . . 0.0 105.761 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.614 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.2 m -148.18 158.51 44.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -169.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.502 HG12 HD22 ' A' ' 10' ' ' LEU . 17.5 pt -131.55 162.82 53.81 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -84.39 42.66 1.21 Allowed 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.334 2.023 . . . . 0.0 111.953 -168.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -68.78 -10.92 59.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.315 1.046 . . . . 0.0 112.22 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -159.6 -177.95 6.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.672 1.589 . . . . 0.0 107.958 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -132.12 87.47 43.69 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.93 -6.2 10.62 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.95 2.433 . . . . 0.0 117.078 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 153.72 -30.73 0.75 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 120.2 1.364 . . . . 0.0 111.725 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.65 -27.54 0.67 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.22 0.914 . . . . 0.0 112.016 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.6 m -62.84 145.54 54.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.984 0.914 . . . . 0.0 109.848 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m 66.61 152.49 0.07 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.171 1.788 . . . . 0.0 111.116 -173.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -56.17 -31.61 63.57 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.84 20.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 m -144.86 103.76 3.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.145 1.778 . . . . 0.0 107.9 -171.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt 52.12 -159.27 0.11 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.953 2.101 . . . . 0.0 111.627 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.61 119.49 8.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 40' ' ' SER . 14.0 mt -84.17 141.31 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 127.075 2.15 . . . . 0.0 106.785 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.11 125.48 91.55 Favored Pre-proline 0 C--O 1.239 0.545 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.659 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.34 135.02 23.81 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.218 1.945 . . . . 0.0 109.049 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -137.08 157.3 47.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.766 0.827 . . . . 0.0 109.008 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.1 mmpt? -64.83 -6.87 9.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -168.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 71.92 151.75 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 114.566 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.54 30.29 2.67 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.772 169.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -83.67 -40.37 19.03 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.887 1.344 . . . . 0.0 109.379 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -160.72 -1.3 0.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 47.16 2.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.013 1.725 . . . . 0.0 110.895 -169.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -32.12 139.32 0.04 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 129.73 3.212 . . . . 0.0 113.383 168.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 71' ' ' ILE . 7.9 pt -135.87 133.63 20.04 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.12 162.21 43.1 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.238 1.959 . . . . 0.0 109.811 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.06 -15.22 8.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 112.472 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.17 -30.23 70.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.632 1.173 . . . . 0.0 112.073 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 67' ' ' ILE . 7.5 pt -121.73 -9.53 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 120.219 1.372 . . . . 0.0 110.608 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mm -58.4 -47.74 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 127.391 2.276 . . . . 0.0 106.292 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -79.29 8.92 5.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.398 1.479 . . . . 0.0 112.297 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.8 178.48 27.27 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.763 1.165 . . . . 0.0 111.684 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -64.29 131.3 46.9 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m -137.09 152.49 50.08 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.351 1.032 . . . . 0.0 111.426 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -138.88 114.56 9.89 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.84 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 47.6 t80 -81.27 126.65 31.81 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.865 2.066 . . . . 0.0 106.761 169.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -138.43 154.97 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.764 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -100.34 123.19 44.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 167.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -70.7 113.0 7.35 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -75.76 148.29 38.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.82 8.16 51.81 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.995 -0.891 . . . . 0.0 112.735 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -133.14 170.26 15.67 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.58 1.19 . . . . 0.0 111.071 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -73.6 159.74 32.65 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.96 0.409 . . . . 0.0 110.364 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -73.55 -14.44 61.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.981 0.512 . . . . 0.0 111.656 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.0 m -55.29 -31.71 61.83 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.739 1.216 . . . . 0.0 112.241 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -91.34 7.0 43.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.06 0.944 . . . . 0.0 112.527 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.43 120.41 12.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.263 7.5 tp10 -157.01 166.58 32.95 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.476 1.11 . . . . 0.0 108.288 -167.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.67 151.31 21.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.157 0.979 . . . . 0.0 109.497 168.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.12 153.73 39.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.36 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.88 168.47 31.55 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -16.79 13.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.764 1.226 . . . . 0.0 113.608 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.79 -24.39 50.13 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.223 1.009 . . . . 0.0 113.072 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -119.14 -45.47 2.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.405 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 97' ' ' ILE . 7.1 tt -86.61 163.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -164.68 156.06 15.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 129.139 2.975 . . . . 0.0 110.108 170.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.92 169.43 13.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.846 1.203 . . . . 0.0 111.493 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -80.09 108.41 13.66 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.837 -1.164 . . . . 0.0 109.183 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -154.48 162.99 40.86 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.035 1.334 . . . . 0.0 109.898 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.71 -35.18 55.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.017 1.727 . . . . 0.0 114.795 -169.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.09 -42.62 99.64 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.478 1.609 . . . . 0.0 110.382 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.18 -24.71 47.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.014 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.87 -32.92 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.383 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.74 99.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.784 1.175 . . . . 0.0 109.196 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.1 ttp -56.24 -54.33 46.59 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -56.58 -48.52 77.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.475 0.71 . . . . 0.0 111.211 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -69.12 -45.58 69.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.655 0.661 . . . . 0.0 109.572 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -25.89 54.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.26 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.04 -45.86 7.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.697 1.135 . . . . 0.0 112.685 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.74 -24.76 9.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 111.305 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -68.26 -45.52 72.95 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.013 1.725 . . . . 0.0 113.334 171.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -72.06 -43.09 65.44 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 117.965 0.348 . . . . 0.0 111.15 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.7 173.69 16.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.715 1.245 . . . . 0.0 113.079 -168.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.5 -169.63 29.36 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 127.251 2.357 . . . . 0.0 109.105 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.4 m -70.18 16.82 0.07 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.871 1.669 . . . . 0.0 114.726 -174.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.6 m -135.31 139.54 44.41 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.981 1.312 . . . . 0.0 107.887 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.75 -171.34 43.26 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.0 m -133.01 18.24 4.12 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.286 1.034 . . . . 0.0 111.732 -173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.06 159.76 68.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 123.48 0.712 . . . . 0.0 109.738 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.56 6.15 1.7 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.346 2.697 . . . . 0.0 114.659 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.56 31.2 2.84 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.143 2.177 . . . . 0.0 109.603 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . 0.285 30.2 p 59.66 -39.72 0.08 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 131.098 3.759 . . . . 0.0 115.815 -173.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.73 -174.14 46.08 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 120.423 1.465 . . . . 0.0 112.072 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.89 53.76 2.55 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 126.079 1.799 . . . . 0.0 112.051 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 49.8 t -145.36 143.74 21.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -169.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.493 HM2B ' CD2' ' A' ' 23' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.21 156.27 32.45 Favored Pre-proline 0 N--CA 1.444 -0.727 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 169.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -83.13 5.52 6.37 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 122.909 2.406 . . . . 0.0 111.19 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -44.26 -24.85 0.19 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 130.05 3.34 . . . . 0.0 117.761 -173.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -139.1 125.99 20.98 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 120.072 1.305 . . . . 0.0 108.239 -171.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -70.21 -41.42 73.66 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.473 0.709 . . . . 0.0 110.228 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.966 1.707 . . . . 0.0 107.069 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.62 145.59 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.91 -41.5 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.326 1.45 . . . . 0.0 110.231 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.98 -30.1 70.7 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.794 1.238 . . . . 0.0 112.628 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.42 -24.46 55.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.487 0.715 . . . . 0.0 111.27 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -68.17 -22.25 64.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.013 0.925 . . . . 0.0 113.136 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -90.05 152.91 20.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.568 0.747 . . . . 0.0 109.744 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -57.45 89.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.944 2.097 . . . . 0.0 110.117 169.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.95 134.86 37.79 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.61 HD12 HG12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -59.48 -6.74 1.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -169.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.73 32.13 0.47 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.51 -173.89 45.4 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.79 157.51 17.9 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.32 154.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 169.128 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 14' ' ' VAL . 27.8 mt -124.25 136.96 54.53 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.0 126.46 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.305 1.003 . . . . 0.0 109.048 -169.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -105.6 123.9 48.67 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.199 1.4 . . . . 0.0 108.244 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.17 -24.88 14.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.195 0.598 . . . . 0.0 111.911 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.27 -70.58 0.31 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.94 -36.97 16.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.143 1.895 . . . . 0.0 112.552 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -153.47 177.78 10.54 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 125.479 1.512 . . . . 0.0 109.268 -168.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 152.12 43.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.384 2.274 . . . . 0.0 107.64 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -137.1 160.9 37.6 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 109.978 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.16 141.82 39.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.91 163.35 32.53 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.861 1.664 . . . . 0.0 108.177 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -153.24 102.28 2.61 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.179 -0.951 . . . . 0.0 110.595 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.567 HD11 HG11 ' A' ' 14' ' ' VAL . 67.1 mt -59.27 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.998 2.519 . . . . 0.0 112.061 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.38 -17.62 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.764 167.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.75 138.36 49.92 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 170.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt -138.77 163.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -168.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -149.12 151.82 35.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.018 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -147.06 140.93 15.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.759 2.424 . . . . 0.0 108.468 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.1 -9.31 25.98 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.704 . . . . 0.0 113.502 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.3 m -67.92 -32.9 73.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.098 1.317 . . . . 0.0 111.646 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 p -117.96 -15.73 9.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.637 1.575 . . . . 0.0 110.646 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt 49.03 48.97 20.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 118.771 0.714 . . . . 0.0 109.39 -169.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.9 mtp -146.48 151.16 36.94 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.781 2.032 . . . . 0.0 105.636 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -101.89 173.68 6.29 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.818 0.447 . . . . 0.0 112.07 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 p -142.84 156.8 45.0 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 126.542 1.937 . . . . 0.0 106.434 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.538 ' HB3' HD12 ' A' ' 56' ' ' ILE . 34.7 t -148.72 152.02 35.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.61 HG12 HD12 ' A' ' 10' ' ' LEU . 1.1 pp -142.95 156.23 62.2 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.41 104.98 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.498 3.466 . . . . 0.0 111.085 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -142.76 -3.2 1.01 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.069 0.948 . . . . 0.0 112.169 171.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -152.69 167.99 27.14 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 120.97 -1.081 . . . . 0.0 111.712 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -143.03 85.14 9.99 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 127.56 2.344 . . . . 0.0 105.233 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -63.52 161.03 33.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.949 1.766 . . . . 0.0 110.84 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.68 -22.82 47.99 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.074 1.189 . . . . 0.0 116.074 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.67 5.22 31.02 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.387 -1.229 . . . . 0.0 114.218 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.4 m -145.73 177.44 8.9 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.183 1.491 . . . . 0.0 111.33 -169.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 p -77.69 -169.08 1.37 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.28 1.432 . . . . 0.0 107.634 169.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -66.88 154.22 41.5 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.686 -0.634 . . . . 0.0 110.815 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.16 150.54 48.59 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 167.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.693 ' H ' HD11 ' A' ' 56' ' ' ILE . 3.0 p -114.42 161.25 18.19 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.93 0.786 . . . . 0.0 112.006 -169.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -22.42 -69.52 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 130.381 3.472 . . . . 0.0 116.163 -169.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -148.63 107.18 3.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.693 HD11 ' H ' ' A' ' 53' ' ' THR . 6.1 mt -75.28 132.1 33.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 11.0 mmpt? -66.89 137.57 94.83 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.76 135.79 26.57 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 N-CA-C 106.896 -2.001 . . . . 0.0 106.896 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -137.04 167.04 22.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 6.0 mmpt? -62.06 153.03 30.98 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 169.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.426 HD11 ' CZ2' ' A' ' 91' ' ' TRP . 6.4 tt -105.86 147.13 29.06 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.067 1.747 . . . . 0.0 109.676 -169.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.21 16.95 2.79 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.004 0.815 . . . . 0.0 113.104 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -87.05 -33.8 19.41 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.041 0.92 . . . . 0.0 109.977 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.98 8.0 0.23 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.097 0.959 . . . . 0.0 111.772 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -152.97 164.09 38.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.709 2.004 . . . . 0.0 107.92 -169.659 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.7 m -145.56 142.44 29.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.771 2.028 . . . . 0.0 107.352 -170.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 71' ' ' ILE . 11.7 pt -135.22 132.73 20.22 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.02 161.32 46.3 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.723 1.615 . . . . 0.0 109.445 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -56.16 -15.44 3.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 112.45 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.32 -27.0 64.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.401 1.48 . . . . 0.0 113.139 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 67' ' ' ILE . 12.5 pt -121.18 -8.17 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 120.131 1.332 . . . . 0.0 111.104 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.85 -45.26 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 128.14 2.576 . . . . 0.0 109.088 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.62 9.86 5.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.931 0.892 . . . . 0.0 112.521 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.57 -172.54 25.82 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -57.55 136.45 56.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.9 t -140.66 153.96 46.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.415 0.447 . . . . 0.0 110.105 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.6 m-85 -140.2 112.45 7.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.348 1.459 . . . . 0.0 110.156 -169.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -77.84 128.82 34.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.68 156.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.983 1.313 . . . . 0.0 112.362 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -101.59 121.84 42.75 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -74.58 112.16 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -78.17 150.5 33.56 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.29 7.58 39.66 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.978 -0.901 . . . . 0.0 112.51 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.568 ' CD1' HM2B ' A' ' 128' ' ' M2L . 42.4 m95 -135.02 172.96 12.27 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.622 1.211 . . . . 0.0 111.38 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -70.89 160.66 32.41 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 122.871 0.468 . . . . 0.0 111.505 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -65.51 -22.29 66.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.137 0.975 . . . . 0.0 111.761 170.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 m -54.97 -32.24 61.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.515 1.126 . . . . 0.0 112.487 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -83.26 -3.31 57.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.497 -1.239 . . . . 0.0 112.957 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -64.6 111.11 2.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -156.67 166.74 32.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.663 1.585 . . . . 0.0 108.673 -167.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.426 ' CZ2' HD11 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -96.32 149.94 21.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.927 0.87 . . . . 0.0 110.693 168.283 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.35 153.24 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.32 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.18 160.54 29.61 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.49 7.23 1.11 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -83.46 -23.6 32.18 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.312 1.845 . . . . 0.0 110.899 168.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.31 -34.65 3.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.686 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.514 HD11 HG21 ' A' ' 14' ' ' VAL . 4.7 tt -101.68 149.58 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.786 1.175 . . . . 0.0 110.794 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -144.75 149.44 35.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.075 1.35 . . . . 0.0 110.177 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.83 141.96 53.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.13 1.772 . . . . 0.0 110.627 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.402 ' CE2' HD11 ' A' ' 105' ' ' ILE . 38.0 t80 -59.9 115.47 3.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.541 1.064 . . . . 0.0 111.759 -169.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -160.76 165.62 30.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.148 1.779 . . . . 0.0 110.505 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -57.58 -33.15 67.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.638 1.575 . . . . 0.0 113.392 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -64.59 -43.43 93.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.013 0.911 . . . . 0.0 109.397 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -69.04 -33.01 72.91 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.402 HD11 ' CE2' ' A' ' 100' ' ' TYR . 3.8 mm -67.83 -34.72 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.448 0.567 . . . . 0.0 110.748 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.881 0.764 . . . . 0.0 110.196 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.63 -49.92 71.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 170.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -59.18 -50.37 74.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.003 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -76.19 -36.15 58.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.425 1.012 . . . . 0.0 109.85 -170.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -40.85 82.29 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 119.103 -0.475 . . . . 0.0 109.977 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.39 -44.08 22.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.568 1.076 . . . . 0.0 112.862 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -49.24 -34.0 13.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.059 1.344 . . . . 0.0 110.83 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -79.51 -54.51 5.84 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.316 1.046 . . . . 0.0 113.148 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -77.38 -26.23 51.67 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.46 4.15 1.76 Allowed 'General case' 0 C--O 1.237 0.395 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -167.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.24 156.55 20.14 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-N 118.815 0.734 . . . . 0.0 112.369 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.1 m -45.86 104.39 0.05 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 128.321 2.648 . . . . 0.0 112.095 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -54.52 122.12 9.85 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.917 1.687 . . . . 0.0 110.039 174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.15 -13.93 82.8 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.35 -0.694 . . . . 0.0 113.72 -171.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.8 p -131.45 15.88 4.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.096 1.358 . . . . 0.0 112.029 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.65 88.49 7.08 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.543 1.537 . . . . 0.0 107.262 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.35 -3.22 11.31 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.903 2.402 . . . . 0.0 114.596 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.24 -30.72 68.46 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.335 1.054 . . . . 0.0 110.655 169.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.1 p 38.29 58.43 1.56 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.828 2.051 . . . . 0.0 111.812 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.95 -28.07 31.3 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.615 1.102 . . . . 0.0 114.319 -172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -84.3 13.62 49.75 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.489 -1.729 . . . . 0.0 113.723 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 80.7 t -135.8 140.25 44.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 121.014 2.407 . . . . 0.0 105.751 -169.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.568 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -146.04 122.83 5.93 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.506 1.522 . . . . 0.0 108.918 -168.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -84.18 -15.29 6.71 Favored 'Trans proline' 0 CA--C 1.553 1.456 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 167.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 132' ' ' ARG . 5.4 t60 -77.76 -167.92 1.09 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 131.126 3.77 . . . . 0.0 108.15 169.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.493 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 82.0 mtt-85 49.15 46.37 22.77 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.657 1.983 . . . . 0.0 112.105 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -57.75 -29.01 64.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.825 0.85 . . . . 0.0 111.172 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.5 1.92 . . . . 0.0 107.589 171.739 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.0 m -138.35 160.6 31.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.368 1.467 . . . . 0.0 108.076 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -153.31 -60.23 0.14 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.525 0.73 . . . . 0.0 109.103 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tt -58.74 -40.98 85.38 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.811 0.844 . . . . 0.0 109.987 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.07 3.39 2.11 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.047 1.339 . . . . 0.0 113.359 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -129.59 -7.24 4.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.816 2.046 . . . . 0.0 110.814 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -86.47 166.19 15.7 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -56.2 132.71 51.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.94 129.62 45.69 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -3.27 0.38 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.0 28.79 0.53 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.81 -173.73 48.71 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 106.828 -2.509 . . . . 0.0 106.828 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 mtt85 -91.33 159.99 15.73 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.555 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.94 161.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -130.03 140.84 50.8 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.7 128.4 32.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -102.51 124.97 49.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 108.573 -169.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -101.6 -23.19 14.31 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.438 0.295 . . . . 0.0 111.194 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.88 -73.76 0.25 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.63 -31.14 27.01 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.55 2.167 . . . . 0.0 112.273 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.38 177.94 10.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.131 1.772 . . . . 0.0 108.287 -169.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.432 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -135.15 162.09 33.49 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.643 1.577 . . . . 0.0 107.208 -173.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -136.59 159.82 40.66 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.248 1.019 . . . . 0.0 108.854 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -76.61 147.27 37.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.537 . . . . 0.0 109.732 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.94 31.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.846 1.258 . . . . 0.0 108.882 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 26' ' ' LYS . 29.4 ttpt -153.11 111.38 3.65 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.197 -0.939 . . . . 0.0 110.706 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 HG11 ' A' ' 14' ' ' VAL . 65.0 mt -59.03 152.17 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 128.895 2.878 . . . . 0.0 111.688 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pp -157.99 -30.04 0.08 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.913 0.885 . . . . 0.0 112.514 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -131.25 140.99 49.93 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.99 164.88 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -168.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -149.91 152.21 34.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.973 -168.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.29 141.11 14.53 Favored Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 125.137 1.375 . . . . 0.0 109.965 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.45 -0.23 7.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.088 3.192 . . . . 0.0 113.501 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -66.13 -34.46 78.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.032 1.287 . . . . 0.0 110.979 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -130.81 -7.86 4.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.37 1.068 . . . . 0.0 112.164 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 45.16 53.14 8.13 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.221 1.009 . . . . 0.0 110.72 -169.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -148.81 151.87 35.53 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.827 2.051 . . . . 0.0 105.815 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -103.21 168.06 9.42 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.86 0.464 . . . . 0.0 112.043 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 p -136.42 153.54 51.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 107.324 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.687 ' HB2' HD12 ' A' ' 56' ' ' ILE . 3.5 m -151.62 158.07 42.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.738 0.699 . . . . 0.0 110.1 -168.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.9 pt -145.77 156.11 52.13 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 126.151 1.781 . . . . 0.0 108.621 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -83.56 55.32 4.89 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.586 3.524 . . . . 0.0 109.66 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -54.03 -43.0 69.77 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.553 -0.717 . . . . 0.0 111.591 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.69 0.51 23.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.044 0.938 . . . . 0.0 112.439 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 44.47 48.37 4.51 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.645 1.178 . . . . 0.0 108.89 -168.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -60.18 143.13 99.54 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.741 2.961 . . . . 0.0 110.359 -169.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.07 0.9 1.75 Allowed Glycine 0 CA--C 1.539 1.583 0 C-N-CA 123.913 0.768 . . . . 0.0 114.339 -175.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.16 53.03 2.26 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -170.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 m 53.16 16.14 0.74 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.567 1.947 . . . . 0.0 115.312 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 m -92.11 14.06 17.12 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.389 1.876 . . . . 0.0 111.305 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -145.86 165.65 28.26 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.755 2.422 . . . . 0.0 107.256 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.508 ' HA ' HD11 ' A' ' 56' ' ' ILE . . . 44.77 34.62 1.22 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.178 0.991 . . . . 0.0 113.004 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -39.06 94.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 130.252 3.421 . . . . 0.0 114.9 -168.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? 42.64 -147.61 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.064 2.546 . . . . 0.0 112.104 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.19 108.5 0.61 Allowed 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.296 -0.878 . . . . 0.0 108.675 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.687 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.6 mt -87.53 141.74 13.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.76 142.95 88.91 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 123.157 0.583 . . . . 0.0 109.613 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.31 142.18 33.2 Favored 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.54 1.493 . . . . 0.0 108.691 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -132.52 166.32 22.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.014 0.926 . . . . 0.0 109.023 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.653 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -64.7 -13.52 54.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -168.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 68.12 151.66 0.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.647 1.979 . . . . 0.0 112.681 -169.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.42 55.38 0.15 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.113 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 51.44 2.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.736 1.214 . . . . 0.0 108.072 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.59 -7.4 0.72 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.126 2.571 . . . . 0.0 113.405 -172.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.95 33.02 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.641 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -33.74 140.51 0.05 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 130.502 3.521 . . . . 0.0 112.203 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 71' ' ' ILE . 10.2 pt -135.41 135.17 21.91 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.564 1.146 . . . . 0.0 108.093 169.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.94 162.76 41.57 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.03 1.82 . . . . 0.0 109.723 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.14 -17.26 10.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.964 0.906 . . . . 0.0 112.571 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.45 -28.66 69.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.607 1.163 . . . . 0.0 112.536 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 67' ' ' ILE 0.253 7.2 pt -122.21 -9.01 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 120.081 1.31 . . . . 0.0 110.844 -174.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mm -61.16 -50.94 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.484 2.313 . . . . 0.0 105.817 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -78.79 9.16 4.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.496 1.518 . . . . 0.0 111.648 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.72 173.79 24.44 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.45 1.023 . . . . 0.0 110.696 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -62.72 132.49 52.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -135.6 152.71 51.52 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 124.11 0.881 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 32.3 m-85 -142.94 116.29 9.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 109.674 -169.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -81.28 125.36 30.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.252 2.221 . . . . 0.0 105.811 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.53 157.44 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.409 -168.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -100.94 118.51 37.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.405 ' CD1' ' HM2' ' A' ' 128' ' ' M2L . 49.5 m-85 -70.14 119.73 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.83 149.53 25.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.9 8.57 57.99 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.553 -169.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.566 ' CD1' HM2B ' A' ' 128' ' ' M2L . 75.4 m95 -133.89 172.66 12.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.493 1.146 . . . . 0.0 111.633 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -71.1 158.6 36.19 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.196 0.598 . . . . 0.0 110.423 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.6 m -70.36 -12.28 61.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.628 0.371 . . . . 0.0 111.843 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.7 m -56.42 -33.31 65.7 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.748 -1.22 . . . . 0.0 112.439 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -80.24 3.38 21.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.973 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.95 108.72 2.68 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.21 167.21 29.31 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.685 1.994 . . . . 0.0 107.441 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.21 149.56 23.44 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.911 0.862 . . . . 0.0 110.378 169.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.92 150.78 31.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.283 173.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.74 158.51 32.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.63 8.12 0.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -88.59 -18.72 27.46 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.047 1.739 . . . . 0.0 111.311 169.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -119.79 -35.68 3.46 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 117.255 -1.355 . . . . 0.0 111.984 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 14' ' ' VAL . 6.3 tt -98.9 153.66 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 120.474 1.488 . . . . 0.0 110.883 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.569 ' HB3' HD21 ' A' ' 104' ' ' ASN . 90.4 mtt180 -149.83 152.54 35.32 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.842 1.657 . . . . 0.0 110.827 170.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 154.74 41.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.925 1.69 . . . . 0.0 111.863 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.514 ' CE2' HD11 ' A' ' 105' ' ' ILE . 41.3 t80 -60.59 118.17 6.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.577 0.626 . . . . 0.0 109.882 176.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -164.4 160.59 20.87 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.312 1.445 . . . . 0.0 109.084 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -53.15 -35.7 60.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.523 1.529 . . . . 0.0 113.755 -169.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.82 -43.81 97.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.684 0.755 . . . . 0.0 110.726 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.569 HD21 ' HB3' ' A' ' 98' ' ' ARG . 72.8 m-20 -74.15 -26.55 60.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.813 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.514 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.3 mm -68.52 -39.08 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.931 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.33 98.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.965 0.802 . . . . 0.0 109.47 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -50.88 72.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -60.5 -46.77 88.92 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.281 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -73.77 -40.19 63.64 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 119.067 0.849 . . . . 0.0 111.04 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -48.59 75.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.02 -44.33 61.04 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.954 -1.091 . . . . 0.0 112.231 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.75 -13.96 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.238 1.815 . . . . 0.0 112.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -106.37 -38.84 6.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.059 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.31 -27.2 59.21 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.535 1.061 . . . . 0.0 111.409 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.75 0.18 1.09 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -168.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.02 -144.26 42.85 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 119.873 1.215 . . . . 0.0 110.094 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 p -149.82 -32.15 0.2 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 117.916 0.858 . . . . 0.0 112.224 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.1 p -139.97 167.1 22.9 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.422 1.489 . . . . 0.0 109.083 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.27 -175.32 53.7 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.37 0.509 . . . . 0.0 111.862 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.1 m -64.15 162.35 14.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.784 1.234 . . . . 0.0 111.421 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.68 156.2 44.96 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.593 1.557 . . . . 0.0 108.657 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.01 37.7 0.6 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.424 3.416 . . . . 0.0 112.358 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.44 -177.86 6.09 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.325 1.85 . . . . 0.0 108.894 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.1 m -55.12 -32.8 62.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.846 1.259 . . . . 0.0 111.411 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 170.04 -54.25 0.2 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 62.9 10.57 33.08 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.875 -0.958 . . . . 0.0 113.512 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.9 t -147.51 139.03 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -169.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.566 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -152.85 154.06 30.78 Favored Pre-proline 0 N--CA 1.44 -0.97 0 C-N-CA 129.44 3.096 . . . . 0.0 103.024 168.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.59 -7.76 16.85 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.512 1.475 . . . . 0.0 110.879 169.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -48.95 -48.93 42.61 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.616 2.366 . . . . 0.0 112.706 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -163.76 163.63 23.98 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.598 1.159 . . . . 0.0 109.047 -177.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -152.72 161.48 42.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.044 1.338 . . . . 0.0 108.353 175.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.299 1.439 . . . . 0.0 107.863 174.2 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -138.23 131.86 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -151.22 18.26 0.75 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.826 0.822 . . . . 0.0 111.832 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.4 mt -124.26 14.66 9.02 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.643 1.977 . . . . 0.0 110.232 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.33 -34.76 73.07 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.551 1.54 . . . . 0.0 107.862 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -145.27 114.67 7.14 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 101.069 -3.678 . . . . 0.0 101.069 169.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.29 174.67 8.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.652 1.981 . . . . 0.0 108.805 169.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -63.22 68.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 130.454 3.502 . . . . 0.0 110.063 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 138.73 54.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 112.121 -2.308 . . . . 0.0 106.145 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.63 HD12 HG12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -57.81 -10.9 1.89 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -168.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.27 32.88 0.5 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 170.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.24 -163.04 21.52 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 169.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 mtt85 -102.33 153.83 19.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 168.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.587 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.59 169.27 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.5 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.0 mm? -135.26 142.41 45.93 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 103.243 -2.873 . . . . 0.0 103.243 176.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.3 147.1 51.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -115.12 119.53 36.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -102.14 -9.5 20.45 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.243 0.617 . . . . 0.0 112.56 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.03 -77.99 0.3 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -66.46 -38.66 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.439 2.092 . . . . 0.0 113.317 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD12 ' H ' ' A' ' 22' ' ' MET . 21.2 tp -148.2 177.76 9.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 125.129 1.371 . . . . 0.0 109.294 -168.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.5 ' CE ' HD12 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -139.59 149.23 43.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.598 2.359 . . . . 0.0 107.129 -168.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -136.44 154.32 50.81 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.539 0.736 . . . . 0.0 109.765 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.64 141.9 57.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.277 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.62 162.59 29.04 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.137 1.775 . . . . 0.0 108.083 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -148.66 95.72 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.465 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.587 HD11 HG11 ' A' ' 14' ' ' VAL . 75.0 mt -55.52 151.35 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.392 2.277 . . . . 0.0 110.743 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -156.73 -32.27 0.09 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.779 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD2' ' CD2' ' A' ' 38' ' ' TYR . 36.8 ttpt -131.53 138.04 48.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.35 165.33 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -144.3 153.37 41.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.331 -169.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.53 143.57 17.49 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.022 1.729 . . . . 0.0 109.243 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.69 -12.48 36.08 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.585 2.857 . . . . 0.0 113.586 176.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.9 m -64.77 -32.74 74.56 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.066 1.303 . . . . 0.0 111.883 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.0 m -121.35 -11.28 8.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.452 1.101 . . . . 0.0 111.077 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 48.29 49.67 17.49 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.156 0.982 . . . . 0.0 109.331 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -145.4 159.09 43.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.144 2.177 . . . . 0.0 105.5 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.449 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 42.1 p90 -104.58 174.97 5.65 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.622 . . . . 0.0 112.573 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -143.47 152.54 41.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.549 2.339 . . . . 0.0 106.132 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB3' HD12 ' A' ' 56' ' ' ILE . 47.7 t -147.56 161.17 41.67 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -175.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.63 HG12 HD12 ' A' ' 10' ' ' LEU . 15.2 pt -144.33 159.2 52.83 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.96 0.904 . . . . 0.0 110.017 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 65.6 Cg_endo -70.88 32.59 0.23 Allowed 'Trans proline' 0 CA--C 1.547 1.174 1 C-N-CA 125.947 4.432 . . . . 0.0 115.025 -177.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -49.35 -50.44 39.83 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.032 0.933 . . . . 0.0 110.649 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -165.01 -122.92 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -152.14 154.96 33.03 Favored Pre-proline 0 C--O 1.24 0.578 0 CA-C-N 119.492 1.042 . . . . 0.0 110.39 -169.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.39 176.41 4.87 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.315 2.01 . . . . 0.0 106.912 166.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.92 23.36 0.7 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.236 1.398 . . . . 0.0 113.863 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.53 28.31 0.15 Allowed Glycine 0 CA--C 1.533 1.159 0 CA-C-N 118.75 1.275 . . . . 0.0 114.904 -174.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -144.61 169.85 17.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.696 1.748 . . . . 0.0 109.622 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.8 m -79.61 -45.3 19.39 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.082 0.553 . . . . 0.0 111.758 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -168.98 145.24 3.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.433 0.693 . . . . 0.0 109.144 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -60.99 159.66 11.14 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 167.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -88.88 -71.46 0.59 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -168.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -151.75 -160.91 1.22 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.93 2.892 . . . . 0.0 104.34 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.31 109.1 1.46 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.2 mt -73.66 135.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -173.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.19 137.49 96.94 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.02 137.9 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 107.165 -1.898 . . . . 0.0 107.165 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -141.19 164.49 30.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.9 mmpt? -63.62 153.12 36.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.3 tt -107.71 154.3 21.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.524 1.93 . . . . 0.0 110.583 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.01 21.96 5.12 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.137 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -77.78 -33.42 52.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.723 0.762 . . . . 0.0 109.166 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.9 6.35 0.61 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.696 1.198 . . . . 0.0 111.79 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.601 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 4.8 mp0 -124.75 172.53 9.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.012 1.325 . . . . 0.0 111.648 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.9 m -149.55 144.03 25.98 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.988 2.115 . . . . 0.0 106.343 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 71' ' ' ILE . 9.3 pt -135.54 120.97 13.77 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 169.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.99 154.45 27.37 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.282 1.988 . . . . 0.0 111.181 170.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.43 -24.46 12.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.341 1.056 . . . . 0.0 111.619 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -57.13 -32.64 66.56 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.156 1.783 . . . . 0.0 114.215 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 67' ' ' ILE . 14.9 pt -117.77 -17.13 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.702 1.137 . . . . 0.0 110.508 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.67 -44.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 128.418 2.687 . . . . 0.0 109.16 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.94 11.53 6.02 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.342 -169.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.88 -177.79 29.43 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 119.577 1.08 . . . . 0.0 111.045 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.87 133.36 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 m -135.99 150.72 49.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 123.812 0.695 . . . . 0.0 110.139 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -135.19 113.3 11.21 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.32 1.048 . . . . 0.0 110.111 -169.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -77.62 121.81 24.46 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.296 2.238 . . . . 0.0 106.963 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.04 159.04 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.672 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -106.95 129.04 54.82 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -75.25 110.02 9.25 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.54 149.21 42.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.915 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.84 4.53 34.26 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.756 -1.024 . . . . 0.0 112.364 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -130.2 172.15 12.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.828 1.314 . . . . 0.0 111.832 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -68.22 162.78 24.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.4 m -65.65 -20.59 66.36 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.018 0.927 . . . . 0.0 111.589 169.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -59.44 -31.04 68.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.789 0.836 . . . . 0.0 112.354 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -91.85 17.56 8.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.801 0.84 . . . . 0.0 112.705 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.1 106.87 1.14 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -153.87 158.07 40.23 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 108.036 -168.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.601 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -97.43 150.41 21.07 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.42 1.105 . . . . 0.0 109.326 167.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.89 154.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.328 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.3 168.18 30.79 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -16.42 6.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.51 1.124 . . . . 0.0 113.297 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.48 -23.79 52.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.532 1.533 . . . . 0.0 112.976 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -123.12 -37.64 2.69 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.227 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 tt -95.63 157.5 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.496 1.044 . . . . 0.0 112.822 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -152.81 165.24 36.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.692 3.197 . . . . 0.0 109.117 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . . . -99.61 155.21 17.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.67 1.588 . . . . 0.0 112.861 -172.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.534 ' CE2' HD11 ' A' ' 105' ' ' ILE . 29.8 t80 -67.22 109.06 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.345 1.069 . . . . 0.0 112.551 -169.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -157.74 162.45 38.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 125.764 1.625 . . . . 0.0 108.786 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -54.95 -33.98 62.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -168.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.55 -43.24 97.66 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.081 0.855 . . . . 0.0 110.328 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.72 -25.13 60.05 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.633 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.534 HD11 ' CE2' ' A' ' 100' ' ' TYR . 6.8 mm -73.87 -32.54 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 118.508 0.594 . . . . 0.0 111.382 171.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.59 96.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.209 0.913 . . . . 0.0 109.097 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -51.69 68.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -54.42 -49.36 70.14 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 123.706 0.802 . . . . 0.0 110.462 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -74.21 -44.71 52.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.368 0.531 . . . . 0.0 110.419 -173.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -32.82 55.64 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.966 0.506 . . . . 0.0 111.068 174.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.63 -46.52 9.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.953 0.797 . . . . 0.0 112.426 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.41 -29.95 11.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 111.31 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -65.64 -33.97 77.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.867 1.667 . . . . 0.0 114.292 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.16 -2.72 11.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -48.19 -38.45 18.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.359 2.264 . . . . 0.0 113.417 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.15 -158.87 44.9 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.7 m -147.02 152.31 38.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.491 1.917 . . . . 0.0 106.632 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.6 m -64.26 154.06 36.22 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -160.01 -168.66 22.28 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.5 m -72.5 35.34 0.07 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.752 2.021 . . . . 0.0 113.663 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -138.54 149.03 61.23 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.858 1.663 . . . . 0.0 107.668 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.62 23.23 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.271 3.314 . . . . 0.0 113.804 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.47 149.33 50.21 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.172 0.989 . . . . 0.0 111.433 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.5 p -134.04 -9.36 2.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.761 1.624 . . . . 0.0 111.697 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.87 53.6 3.72 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.991 1.758 . . . . 0.0 112.105 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.7 -40.88 0.04 OUTLIER Glycine 0 C--O 1.219 -0.804 0 CA-C-O 117.84 -1.533 . . . . 0.0 110.96 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.75 134.77 15.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 120.193 1.997 . . . . 0.0 106.378 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -140.79 117.91 7.83 Favored Pre-proline 0 N--CA 1.453 -0.312 0 C-N-CA 124.759 1.224 . . . . 0.0 111.123 -167.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -90.91 -5.25 4.36 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.101 2.534 . . . . 0.0 111.08 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -141.76 137.88 31.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.753 2.821 . . . . 0.0 107.535 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 127.02 153.35 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.369 4.668 . . . . 0.0 107.85 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -145.98 157.6 43.88 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.772 1.229 . . . . 0.0 108.877 -170.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 . . . . . 0 C--O 1.254 1.296 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.024 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 121.072 0.463 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.46 161.4 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.515 1.126 . . . . 0.0 109.455 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -139.21 157.69 45.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.4 1.08 . . . . 0.0 109.763 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 tt 57.94 -52.99 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 131.503 3.921 . . . . 0.0 114.739 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.69 -22.57 64.06 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.807 1.243 . . . . 0.0 110.836 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -57.02 -28.49 62.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 129.903 3.281 . . . . 0.0 114.164 173.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -72.87 154.52 40.56 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.281 -0.887 . . . . 0.0 109.771 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -57.82 128.84 39.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 168.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.67 136.5 54.51 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -169.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.431 HD22 HG12 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -59.94 -3.62 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -168.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.05 30.41 0.3 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.66 -168.86 44.26 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 169.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -94.87 157.32 15.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.57 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.2 166.62 28.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 102.461 -3.162 . . . . 0.0 102.461 168.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.501 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.3 mm? -132.1 139.75 48.59 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.76 135.46 36.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -106.04 111.67 24.39 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -81.56 -35.16 30.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.622 0.646 . . . . 0.0 110.313 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.37 -72.04 0.19 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.11 -28.54 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.188 2.592 . . . . 0.0 113.338 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -150.92 171.73 16.8 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.308 1.443 . . . . 0.0 108.622 -173.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.501 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.14 144.7 48.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.949 2.099 . . . . 0.0 106.605 -169.326 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -133.27 160.07 38.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.747 0.819 . . . . 0.0 109.178 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.42 145.74 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.29 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.3 159.13 42.8 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.227 1.411 . . . . 0.0 107.952 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 94.55 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.896 -0.503 . . . . 0.0 110.63 -169.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 HG11 ' A' ' 14' ' ' VAL . 58.3 mt -59.11 149.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.577 2.751 . . . . 0.0 112.159 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.54 -24.62 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.439 1.087 . . . . 0.0 113.356 167.33 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' N ' HD22 ' A' ' 28' ' ' LEU . 35.4 ttpt -125.86 139.25 53.63 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.08 165.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.512 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.3 t-105 -149.76 154.7 38.91 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.515 -169.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.73 141.17 15.02 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 109.147 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -67.19 -10.47 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.268 2.645 . . . . 0.0 112.783 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.3 m -65.11 -33.28 75.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.404 1.456 . . . . 0.0 111.295 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -120.24 -16.32 8.51 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.291 1.836 . . . . 0.0 110.734 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm 49.07 53.25 12.92 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.538 0.735 . . . . 0.0 109.095 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 76.7 mtp -149.01 154.03 38.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.462 2.305 . . . . 0.0 105.533 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -100.58 174.41 6.09 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.158 0.583 . . . . 0.0 112.302 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -144.1 151.91 40.24 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.583 2.353 . . . . 0.0 106.34 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.447 ' HB3' HD12 ' A' ' 56' ' ' ILE . 44.7 t -147.81 161.11 41.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.431 HG12 HD22 ' A' ' 10' ' ' LEU . 6.9 pt -147.78 159.43 40.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.199 1.4 . . . . 0.0 110.097 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.08 94.73 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.426 3.417 . . . . 0.0 110.915 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -141.49 -4.65 1.1 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.479 0.712 . . . . 0.0 112.699 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -152.54 178.47 9.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.394 0.997 . . . . 0.0 111.001 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -144.37 69.7 15.72 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.305 2.242 . . . . 0.0 107.7 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.07 -27.09 53.45 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.755 2.304 . . . . 0.0 116.761 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.75 -41.84 2.1 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 119.673 1.124 . . . . 0.0 110.687 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.89 -16.82 68.79 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 123.815 0.722 . . . . 0.0 112.005 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -141.14 142.22 34.08 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 127.015 2.126 . . . . 0.0 106.534 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 m -63.57 -30.98 72.02 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.08 0.952 . . . . 0.0 111.745 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -158.77 160.43 36.29 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.496 1.918 . . . . 0.0 107.798 169.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.49 137.53 48.25 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 102.942 -2.985 . . . . 0.0 102.942 167.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.3 m -118.5 105.76 11.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.428 1.013 . . . . 0.0 112.154 -168.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt 54.95 -168.29 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.252 2.221 . . . . 0.0 112.266 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.37 101.96 0.81 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 40' ' ' SER . 2.7 mt -73.93 138.32 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.71 138.15 95.3 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.4 132.47 19.23 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 N-CA-C 107.18 -1.892 . . . . 0.0 107.18 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -137.16 165.28 26.48 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.623 1.169 . . . . 0.0 108.345 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.41 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -66.69 153.74 42.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 62' ' ' GLY . 5.5 tt -119.83 142.68 48.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.118 1.767 . . . . 0.0 109.044 -169.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.49 ' N ' HD23 ' A' ' 61' ' ' LEU . . . 123.86 30.24 1.06 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-N 114.774 -1.103 . . . . 0.0 114.144 169.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.89 -39.31 76.33 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.107 1.453 . . . . 0.0 109.769 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -152.86 -32.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.561 1.544 . . . . 0.0 111.043 170.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -66.73 21.1 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.357 3.063 . . . . 0.0 114.03 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -33.39 132.1 0.2 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.359 2.264 . . . . 0.0 111.263 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 67' ' ' ILE 0.288 7.0 tt -124.9 141.95 39.68 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -168.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.46 145.62 48.05 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.417 1.411 . . . . 0.0 110.747 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.44 -15.67 4.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.088 1.355 . . . . 0.0 112.901 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.48 -26.67 68.83 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 112.311 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 pt -122.33 -15.07 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.093 0.86 . . . . 0.0 111.223 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.512 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 3.4 mm -50.75 -42.66 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.578 2.351 . . . . 0.0 109.507 170.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -83.21 10.76 7.67 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.708 1.203 . . . . 0.0 112.475 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.9 -175.78 26.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.85 139.52 58.35 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.9 m -133.19 149.22 52.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.891 0.745 . . . . 0.0 109.427 172.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -136.33 112.63 9.86 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.482 1.113 . . . . 0.0 108.616 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.68 126.94 31.58 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 126.399 1.88 . . . . 0.0 107.511 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -136.76 154.85 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 124.919 1.387 . . . . 0.0 112.491 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -100.77 119.57 38.82 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.19 111.62 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -82.05 151.58 27.0 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.92 2.72 58.29 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.48 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.488 ' CH2' ' SG ' ' A' ' 128' ' ' M2L . 94.2 m95 -136.75 179.31 6.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.583 1.192 . . . . 0.0 110.991 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -77.84 160.47 28.29 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.858 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 m -72.53 -13.51 61.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.548 0.739 . . . . 0.0 111.834 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -53.55 -31.75 47.86 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.951 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.455 ' CE2' ' HE ' ' A' ' 128' ' ' M2L . 41.1 m95 -89.75 7.68 35.63 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.911 -1.042 . . . . 0.0 113.239 -176.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -64.01 115.89 5.35 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.29 165.07 37.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.193 1.397 . . . . 0.0 108.187 -167.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.65 150.06 23.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.277 1.037 . . . . 0.0 110.043 168.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.17 159.99 42.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.612 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.83 173.01 23.22 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.995 1.283 . . . . 0.0 110.021 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -16.85 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 113.382 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.73 -21.42 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.628 1.171 . . . . 0.0 113.0 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -121.54 -39.88 2.61 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.377 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -94.83 157.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.822 1.192 . . . . 0.0 113.323 -168.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -155.04 158.05 38.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.465 3.106 . . . . 0.0 108.778 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.29 168.39 19.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.247 1.839 . . . . 0.0 112.971 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.553 ' CE2' HD11 ' A' ' 105' ' ' ILE . 25.0 t80 -67.96 117.53 9.95 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.841 -1.162 . . . . 0.0 109.84 169.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -161.03 164.15 31.12 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.684 1.593 . . . . 0.0 108.893 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -59.5 -30.43 68.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.444 1.098 . . . . 0.0 113.393 -169.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.63 -42.11 91.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.443 1.116 . . . . 0.0 109.848 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -73.39 -27.84 61.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.359 -0.838 . . . . 0.0 109.56 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.553 HD11 ' CE2' ' A' ' 100' ' ' TYR . 7.2 mm -70.05 -32.74 52.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 CA-C-N 118.751 0.705 . . . . 0.0 110.933 169.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.18 99.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.52 1.055 . . . . 0.0 109.724 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -49.0 79.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.86 -47.12 83.64 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.529 0.732 . . . . 0.0 109.966 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -73.52 -44.51 57.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.524 0.602 . . . . 0.0 109.961 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -32.47 50.81 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.5 173.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.6 mt -89.95 -44.33 9.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.282 0.947 . . . . 0.0 112.348 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.89 -28.45 9.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.249 1.42 . . . . 0.0 111.723 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -66.85 -34.68 78.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.928 1.691 . . . . 0.0 114.263 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -125.19 -11.42 6.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -169.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 51.53 18.27 0.66 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.532 2.733 . . . . 0.0 115.403 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.79 -38.4 2.68 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.996 1.76 . . . . 0.0 111.895 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.3 m 43.79 47.32 6.73 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.333 1.453 . . . . 0.0 112.614 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.0 p -60.38 -24.06 64.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.391 1.076 . . . . 0.0 111.71 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.57 168.87 40.85 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.761 1.648 . . . . 0.0 109.164 169.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.1 m -68.52 102.94 1.55 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.843 0.857 . . . . 0.0 109.215 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.91 157.43 31.35 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.33 1.452 . . . . 0.0 108.907 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.45 32.7 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 124.498 3.465 . . . . 0.0 112.409 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.19 9.83 2.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.798 1.639 . . . . 0.0 112.842 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 p -72.45 60.53 0.46 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.144 2.578 . . . . 0.0 112.02 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.74 -28.62 0.11 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.842 1.21 . . . . 0.0 111.284 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.44 137.11 3.94 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.2 p -117.56 -17.66 7.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.488 ' SG ' ' CH2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.9 mmpp? -153.91 108.57 2.5 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 121.074 -1.017 . . . . 0.0 110.712 -168.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -83.35 -9.3 10.4 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.529 2.153 . . . . 0.0 110.64 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.479 ' CG ' ' H ' ' A' ' 132' ' ' ARG . 15.3 t60 -124.04 -175.79 3.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.291 3.036 . . . . 0.0 107.098 -169.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.479 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 29.4 mmm180 52.15 34.23 13.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.978 1.711 . . . . 0.0 111.097 -171.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -151.04 155.86 39.89 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.861 1.665 . . . . 0.0 107.861 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.404 1.482 . . . . 0.0 107.083 177.792 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.56 156.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 118.779 0.718 . . . . 0.0 110.057 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -156.18 -46.22 0.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.988 0.915 . . . . 0.0 110.426 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.48 -25.14 67.84 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.387 1.075 . . . . 0.0 112.171 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -55.47 -24.04 28.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.041 1.336 . . . . 0.0 111.768 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -59.08 -33.64 71.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.111 1.364 . . . . 0.0 112.544 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -96.38 161.78 13.78 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 121.877 0.846 . . . . 0.0 110.232 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 1 C-N-CA 132.95 4.5 . . . . 0.0 110.948 171.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.44 142.35 58.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.333 -1.758 . . . . 0.0 106.804 -169.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.69 -10.19 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.28 30.9 0.38 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 179.33 53.19 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 171.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.35 153.66 24.46 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 168.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.2 164.68 34.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 169.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.621 HD22 ' CE ' ' A' ' 22' ' ' MET . 65.9 mt -140.56 116.35 10.3 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 -170.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.5 138.71 47.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.363 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -120.59 118.57 30.52 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.199 1.4 . . . . 0.0 108.202 -169.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -98.84 -22.01 16.04 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.87 0.468 . . . . 0.0 111.449 -170.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.31 -76.57 0.23 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -68.19 -31.56 29.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.107 1.871 . . . . 0.0 112.457 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.49 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -153.07 176.33 12.02 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.768 1.227 . . . . 0.0 110.743 -171.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.621 ' CE ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.07 154.6 47.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.809 2.444 . . . . 0.0 107.491 -173.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CD2' HM2A ' A' ' 128' ' ' M2L . 17.3 m-85 -140.41 149.59 42.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.186 1.394 . . . . 0.0 108.765 -176.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.34 145.53 51.12 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.94 161.23 37.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.475 1.51 . . . . 0.0 109.02 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -148.5 104.37 3.49 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.407 -0.808 . . . . 0.0 109.777 -171.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 14' ' ' VAL . 54.7 mt -64.79 155.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 128.447 2.699 . . . . 0.0 112.904 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -163.79 -20.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.822 -1.085 . . . . 0.0 113.724 166.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.7 ttpt -131.58 138.66 48.95 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.6 161.76 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -168.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.48 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.9 t-105 -144.68 154.55 42.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.384 -168.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -146.51 140.93 15.73 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.725 2.41 . . . . 0.0 108.881 -174.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.62 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.666 2.911 . . . . 0.0 113.549 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -66.87 -32.22 73.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.068 1.303 . . . . 0.0 111.571 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.9 m -121.56 -11.09 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.647 1.179 . . . . 0.0 111.02 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt 47.09 50.41 14.1 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.058 0.943 . . . . 0.0 109.985 -171.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.3 mtp -150.65 154.0 36.67 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.365 2.266 . . . . 0.0 105.163 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.421 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 48.8 p90 -103.45 175.12 5.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 p -141.56 155.92 45.74 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.009 2.124 . . . . 0.0 106.847 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.64 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.2 m -154.06 156.66 37.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 pt -141.15 162.9 45.42 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.111 0.564 . . . . 0.0 110.58 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.47 45.43 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.991 3.794 . . . . 0.0 111.798 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -57.26 -54.39 47.38 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.631 -0.668 . . . . 0.0 109.826 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -166.59 171.16 11.98 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.544 1.138 . . . . 0.0 108.648 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -64.76 150.33 94.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 127.33 2.252 . . . . 0.0 111.495 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.2 177.84 3.47 Favored 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 122.65 2.233 . . . . 0.0 107.268 166.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.07 -27.42 22.46 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.726 -1.234 . . . . 0.0 115.635 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.51 43.97 0.55 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.52 1.66 . . . . 0.0 113.622 -173.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.8 m -143.08 -178.11 5.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.175 0.99 . . . . 0.0 109.904 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -70.01 -177.76 1.42 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.208 1.403 . . . . 0.0 109.131 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -63.29 153.02 36.16 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.563 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.01 152.04 44.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 167.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -86.7 161.51 18.39 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.754 -0.591 . . . . 0.0 110.353 -174.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.34 150.82 1.66 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.764 1.226 . . . . 0.0 108.887 168.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -21.25 97.46 0.01 OUTLIER 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 0.0 112.328 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.7 mt -72.81 136.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 111.687 -2.506 . . . . 0.0 107.793 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.93 141.84 96.99 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.98 138.54 31.33 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 N-CA-C 107.352 -1.826 . . . . 0.0 107.352 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -137.37 160.52 38.84 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -68.57 127.43 32.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 122.113 0.959 . . . . 0.0 109.017 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 tt -71.23 146.83 48.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.538 1.935 . . . . 0.0 111.97 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.7 17.83 3.76 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.697 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -81.6 -32.18 32.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.44 1.12 . . . . 0.0 109.845 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.18 10.91 0.9 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.835 1.254 . . . . 0.0 110.893 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 15.7 mp0 -130.92 174.04 10.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.247 1.819 . . . . 0.0 109.688 -169.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -165.35 122.96 1.55 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 166.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.478 HG12 HD11 ' A' ' 71' ' ' ILE 0.317 4.2 tt -123.48 129.3 24.92 Favored Pre-proline 0 N--CA 1.433 -1.277 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -167.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.47 148.86 67.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.64 1.56 . . . . 0.0 111.25 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.32 -21.11 22.18 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.022 1.329 . . . . 0.0 112.679 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -54.86 -33.27 61.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.032 2.133 . . . . 0.0 113.524 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 67' ' ' ILE . 4.6 pt -118.1 -16.13 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.422 0.689 . . . . 0.0 111.211 -169.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.48 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 2.9 mm -54.14 -42.56 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 127.948 2.499 . . . . 0.0 109.592 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.92 11.41 6.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.016 . . . . 0.0 112.661 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.97 -171.94 25.43 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -59.34 137.41 58.0 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -136.32 153.25 51.21 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.866 0.729 . . . . 0.0 110.936 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -136.73 114.81 11.51 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.514 1.126 . . . . 0.0 109.416 -170.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.12 126.03 31.55 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.666 1.987 . . . . 0.0 107.168 169.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.45 165.95 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.379 -168.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -119.63 126.94 52.38 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 165.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -78.93 125.87 29.94 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -67.38 149.62 50.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.089 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.97 10.19 50.16 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.497 -1.168 . . . . 0.0 113.576 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.544 ' CE2' ' HEA' ' A' ' 128' ' ' M2L . 81.6 m95 -128.04 166.28 18.71 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.11 1.455 . . . . 0.0 111.211 -176.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -61.27 168.41 2.66 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.0 112.198 -171.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 m -63.34 -21.89 66.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.556 0.742 . . . . 0.0 111.711 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -60.8 -25.9 66.9 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.335 -0.853 . . . . 0.0 111.925 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.567 ' CG ' HM1A ' A' ' 128' ' ' M2L . 41.8 m95 -85.54 16.41 3.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 0.0 112.477 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.73 87.71 3.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 167.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -146.3 166.14 27.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.084 1.353 . . . . 0.0 108.341 -167.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.49 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -104.29 152.84 21.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.45 1.119 . . . . 0.0 110.511 169.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.36 155.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.829 173.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.11 169.08 31.74 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -18.06 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.714 1.205 . . . . 0.0 113.037 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.84 -19.69 18.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.272 1.429 . . . . 0.0 113.554 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -127.61 -35.48 2.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 117.39 -1.291 . . . . 0.0 111.939 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -101.87 152.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.642 1.565 . . . . 0.0 113.288 -169.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.87 160.95 41.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.28 2.632 . . . . 0.0 108.298 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.71 168.66 18.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.381 1.446 . . . . 0.0 112.273 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -77.86 109.26 11.73 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.105 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -156.42 163.33 39.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.998 1.319 . . . . 0.0 109.278 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -53.14 -35.85 60.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.665 1.586 . . . . 0.0 114.31 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.2 -43.86 97.88 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.695 1.236 . . . . 0.0 110.006 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -78.47 -23.68 46.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 mm -69.57 -35.21 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.685 0.675 . . . . 0.0 109.859 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.3 98.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.521 1.055 . . . . 0.0 109.435 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.25 89.83 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 171.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.988 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -72.54 -42.56 64.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.105 0.866 . . . . 0.0 109.504 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -42.89 53.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.269 0.628 . . . . 0.0 110.419 170.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.09 -47.73 17.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 112.398 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.23 -27.63 6.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 111.605 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -77.59 -58.07 3.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.275 1.43 . . . . 0.0 113.386 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.88 -23.31 41.95 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.68 1.127 . . . . 0.0 113.6 -170.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.93 131.35 50.61 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.328 0.651 . . . . 0.0 111.252 -169.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.47 30.78 0.26 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.437 1.018 . . . . 0.0 111.373 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 m -61.95 -22.06 65.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.875 1.27 . . . . 0.0 113.6 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 p -73.58 -8.85 57.6 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.4 1.08 . . . . 0.0 112.511 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.69 3.56 80.56 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.292 0.948 . . . . 0.0 111.812 -170.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.3 m -144.21 177.67 8.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.034 2.133 . . . . 0.0 107.897 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.43 138.86 96.52 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.9 63.76 8.16 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 124.602 3.535 . . . . 0.0 109.617 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.16 -21.77 14.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.856 1.662 . . . . 0.0 114.989 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.8 m -55.65 -38.97 70.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.42 1.088 . . . . 0.0 111.019 172.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 133.77 -40.98 1.52 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.08 144.51 9.78 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 104.854 -3.298 . . . . 0.0 104.854 169.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.41 137.18 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.273 0.629 . . . . 0.0 111.316 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.567 HM1A ' CG ' ' A' ' 88' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.459 ' HE2' ' C ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -161.61 97.95 1.25 Allowed Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 120.522 -1.361 . . . . 0.0 108.999 -172.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -119.12 -18.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.509 2.139 . . . . 0.0 113.82 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -68.82 -10.8 58.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 -168.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -156.12 150.58 25.75 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.027 0.931 . . . . 0.0 108.493 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -60.95 -47.14 87.81 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.493 0.717 . . . . 0.0 111.304 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.249 1.034 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.543 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.3 m -62.56 141.98 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.296 0.638 . . . . 0.0 110.406 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -164.87 -39.04 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.28 1.432 . . . . 0.0 109.788 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.2 tp -52.62 -27.21 16.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.513 2.325 . . . . 0.0 113.124 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -50.8 -38.38 48.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.739 1.216 . . . . 0.0 111.197 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -65.09 -24.96 67.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.391 1.876 . . . . 0.0 113.063 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -97.57 161.34 13.82 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.362 1.065 . . . . 0.0 109.327 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.25 73.91 0.01 OUTLIER 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.935 2.894 . . . . 0.0 110.46 171.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 131.08 44.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.409 HD22 HG12 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -61.05 -4.75 1.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -169.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.42 32.61 0.7 Allowed Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 170.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.48 -157.21 12.15 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 168.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.06 156.02 21.09 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.621 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.77 160.73 39.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 169.236 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD22 ' CE ' ' A' ' 22' ' ' MET . 42.7 mt -139.45 131.37 27.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 -173.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.21 136.81 53.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -170.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -115.9 117.24 29.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.661 0.785 . . . . 0.0 109.19 -168.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -95.53 -21.39 18.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.524 0.729 . . . . 0.0 111.854 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.15 -73.52 0.32 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.63 -30.58 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.358 2.038 . . . . 0.0 112.014 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.52 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 178.54 10.11 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 125.254 1.422 . . . . 0.0 109.51 -170.004 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.538 ' CE ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -133.94 154.16 51.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.522 2.329 . . . . 0.0 106.776 -173.347 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.71 152.05 48.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.257 1.023 . . . . 0.0 108.645 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -74.68 149.03 40.09 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.493 0.717 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.37 160.48 40.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.081 1.352 . . . . 0.0 109.113 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -149.03 99.76 2.99 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -169.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.621 HD11 HG11 ' A' ' 14' ' ' VAL . 60.3 mt -58.69 152.66 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.669 1.987 . . . . 0.0 110.647 -176.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pp -156.72 -35.45 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.736 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 37.4 ttpt -126.0 140.1 52.88 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.09 166.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.501 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 3.7 t-105 -150.47 150.89 31.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.277 -168.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -147.55 142.12 16.43 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.531 2.332 . . . . 0.0 108.82 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.69 -8.75 24.41 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.437 2.758 . . . . 0.0 113.51 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.0 m -65.66 -34.64 78.69 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.452 1.478 . . . . 0.0 111.248 -171.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -117.72 -18.67 9.57 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.521 1.528 . . . . 0.0 110.718 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm 51.33 52.14 15.43 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -169.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.6 mtp -144.72 157.02 44.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.994 2.518 . . . . 0.0 105.093 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.451 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -107.47 168.95 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.629 0.372 . . . . 0.0 111.474 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -141.57 155.0 45.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.41 1.884 . . . . 0.0 106.647 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.465 ' HB3' HD12 ' A' ' 56' ' ' ILE . 32.5 t -149.95 164.23 35.99 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.409 HG12 HD22 ' A' ' 10' ' ' LEU . 6.9 pt -146.58 159.65 43.78 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.792 1.237 . . . . 0.0 109.657 -177.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.01 89.47 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.645 3.563 . . . . 0.0 110.575 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -130.51 -9.54 4.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.279 1.032 . . . . 0.0 112.692 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -164.45 -173.46 3.08 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.465 0.706 . . . . 0.0 109.73 -173.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 92.46 11.1 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.243 1.817 . . . . 0.0 107.746 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -48.5 164.82 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.317 2.678 . . . . 0.0 113.867 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.73 -12.48 6.75 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.308 1.432 . . . . 0.0 116.067 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -129.99 22.6 4.79 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.006 1.289 . . . . 0.0 112.732 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.4 m -135.88 141.74 44.64 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.57 1.185 . . . . 0.0 110.238 -173.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.6 m -69.77 -40.72 75.88 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.413 0.685 . . . . 0.0 110.531 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -167.25 158.44 11.91 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.161 2.185 . . . . 0.0 107.794 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.41 140.12 51.98 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 166.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.3 m -122.59 105.81 10.43 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.501 1.046 . . . . 0.0 111.315 -168.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 54.09 -170.11 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.771 2.428 . . . . 0.0 111.81 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 107.37 1.79 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.1 mt -73.66 129.24 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -173.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.04 139.61 95.51 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.05 142.11 24.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.861 1.707 . . . . 0.0 108.983 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -130.38 164.19 25.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.582 0.753 . . . . 0.0 109.545 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.596 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.63 -16.57 49.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -168.386 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' CD1' ' CZ2' ' A' ' 91' ' ' TRP . 0.5 OUTLIER 70.91 136.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.597 2.359 . . . . 0.0 112.28 -171.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.11 7.35 2.29 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.949 169.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.16 -34.47 56.41 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.894 1.847 . . . . 0.0 111.211 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.74 -40.09 0.09 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.407 1.483 . . . . 0.0 109.593 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.96 137.09 56.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 168.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.6 m -140.46 157.38 45.6 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.469 HG23 HG12 ' A' ' 72' ' ' ILE 0.318 2.6 tt -149.82 136.55 10.9 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -169.102 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.43 151.96 54.19 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.727 1.618 . . . . 0.0 111.346 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -56.4 -17.11 6.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.044 1.338 . . . . 0.0 112.832 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -67.18 -24.99 65.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.843 1.257 . . . . 0.0 111.968 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.2 pt -124.38 -12.64 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.35 0.977 . . . . 0.0 111.177 -171.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.501 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 1.8 mm -52.65 -44.36 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 128.097 2.559 . . . . 0.0 108.576 169.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.17 9.47 6.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.881 1.272 . . . . 0.0 112.82 -170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.67 -173.07 26.59 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -171.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -60.79 134.91 57.55 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.285 -0.538 . . . . 0.0 110.608 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 m -137.47 154.13 49.95 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.781 0.676 . . . . 0.0 111.278 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -139.12 114.68 9.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.435 1.094 . . . . 0.0 109.836 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -81.23 127.09 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 106.271 169.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -138.48 154.07 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.101 -168.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -99.72 119.61 38.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -73.0 117.68 15.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -86.14 150.65 24.26 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 6.37 63.0 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 119.082 -0.843 . . . . 0.0 111.2 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.476 ' CE2' ' HEA' ' A' ' 128' ' ' M2L . 85.2 m95 -132.84 174.03 10.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.252 1.421 . . . . 0.0 109.874 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.68 174.11 3.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.45 1.1 . . . . 0.0 111.708 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.1 m -85.09 -6.35 59.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.237 0.615 . . . . 0.0 112.033 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -57.36 -31.27 65.59 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.396 -0.815 . . . . 0.0 110.979 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -89.59 20.1 4.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.616 1.166 . . . . 0.0 112.726 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.49 99.77 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -151.3 167.51 27.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.972 2.109 . . . . 0.0 108.111 -167.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.419 ' CZ2' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -104.23 155.26 18.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.369 0.986 . . . . 0.0 112.168 169.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.85 157.59 43.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.932 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.29 160.63 25.95 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.732 1.158 . . . . 0.0 110.346 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -71.02 9.79 0.65 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.92 -12.71 32.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.709 1.603 . . . . 0.0 111.223 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -125.92 -37.09 2.31 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.561 1.145 . . . . 0.0 111.3 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 14' ' ' VAL . 6.8 tt -97.35 154.46 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.412 1.005 . . . . 0.0 110.671 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 98.2 mtt180 -145.65 158.26 43.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.192 2.197 . . . . 0.0 109.437 169.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.88 161.41 30.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.247 1.385 . . . . 0.0 111.511 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.455 ' CE2' HD11 ' A' ' 105' ' ' ILE . 27.6 t80 -69.47 115.77 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -159.9 162.05 34.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.466 1.506 . . . . 0.0 108.43 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.0 -35.71 47.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.833 1.653 . . . . 0.0 114.364 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -63.53 -44.44 94.24 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.554 1.168 . . . . 0.0 109.984 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.31 -23.91 54.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.278 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -68.55 -36.17 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 118.781 0.719 . . . . 0.0 109.793 169.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.1 96.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.451 1.023 . . . . 0.0 110.402 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -48.2 79.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.08 -49.53 74.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.329 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -75.03 -33.19 61.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.033 1.288 . . . . 0.0 109.854 -171.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -54.62 -53.57 52.99 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 169.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.802 0.728 . . . . 0.0 111.628 -172.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.7 -15.54 0.74 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.434 1.494 . . . . 0.0 112.557 169.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -107.44 -50.36 3.09 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.82 1.248 . . . . 0.0 112.349 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -75.44 -23.94 56.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.472 1.033 . . . . 0.0 111.871 -175.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -136.83 1.92 2.57 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -168.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.19 35.61 1.95 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.45 1.024 . . . . 0.0 112.743 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.1 m -62.85 -27.09 69.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.487 1.515 . . . . 0.0 113.925 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.7 m -147.71 137.95 22.98 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.95 -169.4 42.12 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.1 m -129.63 11.85 5.78 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.117 0.967 . . . . 0.0 112.606 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.58 150.18 21.39 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.748 1.619 . . . . 0.0 107.838 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.94 10.56 1.06 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.573 2.849 . . . . 0.0 114.268 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.98 6.21 2.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.105 1.762 . . . . 0.0 112.119 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 16.8 m -142.07 87.67 2.05 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -89.76 58.32 3.7 Favored Glycine 0 C--O 1.223 -0.575 0 N-CA-C 107.55 -2.22 . . . . 0.0 107.55 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.62 87.49 0.05 OUTLIER Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.152 0.882 . . . . 0.0 114.191 -169.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.9 m -92.79 -2.16 10.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.584 1.153 . . . . 0.0 112.831 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.699 HM2B ' SG ' ' A' ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -152.95 106.38 2.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 O-C-N 119.897 -1.752 . . . . 0.0 110.426 -166.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.41 -25.23 7.06 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.44 2.094 . . . . 0.0 111.404 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 171.49 19.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 128.522 2.729 . . . . 0.0 105.582 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 62.81 13.86 6.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.282 1.833 . . . . 0.0 113.604 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -66.88 -18.29 65.31 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.48 -0.762 . . . . 0.0 110.956 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 49.3 tpt85 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 127.376 2.27 . . . . 0.0 106.14 173.185 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.14 166.35 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.153 1.381 . . . . 0.0 109.049 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -150.77 165.86 32.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.012 1.725 . . . . 0.0 107.088 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.9 tp 65.03 -28.04 0.1 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.05 2.54 . . . . 0.0 114.36 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -54.36 -36.03 63.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.746 1.218 . . . . 0.0 111.432 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -53.63 -36.09 61.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.703 2.001 . . . . 0.0 113.137 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.54 144.32 30.46 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -56.92 126.35 26.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 168.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.02 135.68 53.52 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -2.91 0.35 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 116.266 1.951 . . . . 0.0 116.266 -168.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.08 0.28 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 169.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.71 -175.16 50.65 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.212 -2.755 . . . . 0.0 106.212 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.443 ' HG2' HE22 ' A' ' 82' ' ' GLN . 54.1 mtt180 -87.99 156.65 19.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -132.22 165.9 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 168.418 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.412 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.5 mm? -133.03 144.37 50.01 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 177.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.92 125.7 23.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -99.44 115.73 29.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -87.7 -25.4 23.49 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.958 0.503 . . . . 0.0 111.15 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.74 -69.78 0.32 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.71 -41.41 11.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.39 2.06 . . . . 0.0 112.817 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.9 tp -148.27 179.8 7.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.005 1.722 . . . . 0.0 107.881 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.412 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -141.5 151.29 43.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.071 1.748 . . . . 0.0 109.178 -167.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -134.06 157.26 46.57 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.611 1.164 . . . . 0.0 108.594 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.28 150.21 30.07 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.75 155.2 46.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.895 0.478 . . . . 0.0 110.805 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -144.11 94.37 2.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.866 0.866 . . . . 0.0 111.397 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.571 HD11 HG11 ' A' ' 14' ' ' VAL . 42.7 mt -61.94 152.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 127.565 2.346 . . . . 0.0 112.492 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.35 -24.8 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.776 166.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' N ' HD22 ' A' ' 28' ' ' LEU . 38.5 ttpt -127.58 139.3 52.85 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.82 163.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -168.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.98 152.54 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.634 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.05 139.37 14.53 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.62 1.968 . . . . 0.0 109.122 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 -0.77 8.56 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.24 3.293 . . . . 0.0 113.348 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -67.55 -33.19 74.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.225 1.375 . . . . 0.0 110.956 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 p -129.48 -10.42 4.57 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.13 1.372 . . . . 0.0 111.618 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 50.1 53.14 13.35 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.098 0.951 . . . . 0.0 109.632 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 63.4 mtp -145.61 156.21 43.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.803 2.041 . . . . 0.0 106.51 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -108.88 171.43 7.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 p -139.49 156.71 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.63 1.972 . . . . 0.0 107.259 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.469 ' HB3' HD12 ' A' ' 56' ' ' ILE . 43.4 t -150.76 163.48 38.48 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 pt -149.88 157.87 37.62 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.746 1.618 . . . . 0.0 108.841 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 54.6 Cg_endo -78.36 56.12 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.81 3.673 . . . . 0.0 111.95 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -57.4 -57.67 11.62 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -165.22 158.99 16.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.288 1.835 . . . . 0.0 106.306 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -60.48 149.74 76.51 Favored Pre-proline 0 C--O 1.24 0.566 0 C-N-CA 123.526 0.73 . . . . 0.0 111.311 172.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -65.02 170.64 10.06 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 N-CA-C 107.494 -1.771 . . . . 0.0 107.494 166.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.97 99.81 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 120.753 -1.217 . . . . 0.0 110.188 169.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.59 15.29 60.01 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.319 -169.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.2 m -142.54 159.82 41.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.317 2.058 . . . . 0.0 109.862 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 m -65.22 -53.99 36.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.025 0.93 . . . . 0.0 112.081 -170.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -169.75 159.51 8.13 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.475 1.51 . . . . 0.0 108.761 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -79.45 157.49 27.5 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 167.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 p -131.21 89.33 2.71 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.135 -0.978 . . . . 0.0 111.275 -169.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 50.9 -163.09 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.258 1.823 . . . . 0.0 110.652 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.56 116.11 5.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 172.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.2 mt -81.83 135.52 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 113.478 -1.692 . . . . 0.0 106.843 -173.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.2 136.45 93.84 Favored Pre-proline 0 C--O 1.237 0.433 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.86 145.94 36.99 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.962 1.775 . . . . 0.0 109.568 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -139.67 156.34 46.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.102 0.961 . . . . 0.0 109.778 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -62.43 -10.53 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -173.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.433 HD12 ' CZ2' ' A' ' 91' ' ' TRP 0.252 9.3 tt 71.76 151.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 114.3 -177.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.64 4.22 10.79 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 114.779 -1.1 . . . . 0.0 114.283 169.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.61 -22.04 60.13 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.832 1.316 . . . . 0.0 111.359 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.57 -35.11 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.797 1.239 . . . . 0.0 111.059 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.578 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 20.6 mp0 -66.69 165.44 14.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 174.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 m -147.09 141.1 25.96 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.668 1.987 . . . . 0.0 106.115 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.499 HG22 HD11 ' A' ' 71' ' ' ILE . 9.0 pt -136.75 125.44 15.16 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.14 156.88 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.118 1.879 . . . . 0.0 110.676 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -55.59 -15.35 2.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.242 1.017 . . . . 0.0 112.493 171.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -66.69 -31.33 71.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.385 1.474 . . . . 0.0 112.343 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' ILE . 18.3 pt -119.31 -11.76 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.209 1.368 . . . . 0.0 110.757 -173.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -53.38 -45.88 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.909 2.483 . . . . 0.0 108.548 169.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.45 9.49 7.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 111.732 -170.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.21 -178.41 26.87 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 119.881 1.219 . . . . 0.0 110.814 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -60.42 131.81 51.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.1 m -132.09 150.4 52.16 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.926 0.766 . . . . 0.0 110.601 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.14 112.64 10.67 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 109.276 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -79.55 125.0 29.03 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 126.243 1.817 . . . . 0.0 107.348 169.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.55 156.01 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.935 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -102.01 122.63 44.44 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 166.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -71.74 111.18 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.443 HE22 ' HG2' ' A' ' 13' ' ' ARG . 47.9 mt-30 -76.62 148.29 37.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.41 64.05 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.163 -170.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.556 ' CE2' ' HEA' ' A' ' 128' ' ' M2L . 54.7 m95 -131.98 169.14 16.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.828 1.314 . . . . 0.0 110.513 176.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -65.84 171.33 4.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.543 1.537 . . . . 0.0 112.508 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 m -69.94 -17.15 63.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.532 1.133 . . . . 0.0 111.739 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -62.35 -28.82 70.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.686 0.794 . . . . 0.0 111.865 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -97.44 21.15 10.54 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -68.06 104.83 1.86 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -148.74 168.08 23.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.28 1.832 . . . . 0.0 107.866 -167.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.578 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -107.16 152.95 23.38 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 122.3 1.048 . . . . 0.0 110.402 168.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.46 161.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.773 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.53 170.67 22.38 Favored Glycine 0 C--O 1.242 0.602 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.384 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -15.27 11.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.225 1.41 . . . . 0.0 113.648 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.33 -23.98 52.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.125 1.37 . . . . 0.0 112.516 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.18 -38.76 2.28 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 117.52 -1.229 . . . . 0.0 112.027 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.58 HD11 HG21 ' A' ' 14' ' ' VAL . 8.2 tt -89.41 156.49 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.41 1.004 . . . . 0.0 113.441 -169.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -153.82 157.52 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.615 3.166 . . . . 0.0 108.594 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.7 168.88 17.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.562 1.528 . . . . 0.0 111.827 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.515 ' CE2' HD11 ' A' ' 105' ' ' ILE . 21.8 t80 -62.33 127.62 32.18 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.725 -1.234 . . . . 0.0 109.971 169.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -156.36 153.4 28.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.522 1.929 . . . . 0.0 107.866 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.82 -30.23 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.384 0.673 . . . . 0.0 111.184 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.51 -42.12 92.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.905 0.859 . . . . 0.0 110.34 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.63 -23.94 53.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.083 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.515 HD11 ' CE2' ' A' ' 100' ' ' TYR . 3.2 mm -72.51 -35.57 51.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-N 118.552 0.615 . . . . 0.0 109.654 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.436 1.016 . . . . 0.0 109.899 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -51.39 69.57 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -59.57 -43.32 93.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.733 -173.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -74.77 -39.92 61.49 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.029 0.932 . . . . 0.0 110.894 -174.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -52.51 -46.33 66.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.818 0.735 . . . . 0.0 110.368 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.6 -42.01 22.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 119.506 -0.283 . . . . 0.0 111.447 -171.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.28 -32.12 47.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.246 1.418 . . . . 0.0 110.921 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -76.5 -50.7 13.33 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.126 0.97 . . . . 0.0 112.293 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -66.45 -33.51 75.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.432 0.56 . . . . 0.0 111.655 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.48 98.18 3.3 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 122.734 1.254 . . . . 0.0 110.014 -168.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -177.99 50.14 0.1 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.935 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.7 m -133.53 24.74 4.08 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.66 1.184 . . . . 0.0 111.179 -169.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.0 p -58.97 159.52 7.01 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.324 1.45 . . . . 0.0 112.372 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.12 -172.06 39.03 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.291 1.424 . . . . 0.0 109.673 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.1 m -74.49 16.89 0.23 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.115 1.366 . . . . 0.0 114.123 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.15 157.69 37.15 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.121 1.768 . . . . 0.0 108.639 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -43.98 106.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 1 C-N-CA 126.019 4.479 . . . . 0.0 112.762 172.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -150.2 163.45 38.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.207 1.803 . . . . 0.0 109.303 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.5 m 65.3 -51.6 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.848 2.459 . . . . 0.0 113.566 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 76.32 -40.47 1.51 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.326 1.441 . . . . 0.0 113.348 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.31 46.84 2.25 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.138 1.828 . . . . 0.0 112.667 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 82.0 t -134.52 129.63 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -169.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.556 ' HEA' ' CE2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -158.64 122.62 2.13 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 126.157 1.783 . . . . 0.0 108.593 -168.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -73.42 -20.02 21.34 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 N-CA-C 108.488 -1.389 . . . . 0.0 108.488 168.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -51.45 -32.49 27.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.254 1.822 . . . . 0.0 112.52 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -81.56 -8.09 59.67 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.294 -0.879 . . . . 0.0 112.993 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -63.86 155.03 31.85 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.696 1.135 . . . . 0.0 110.547 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 125.439 1.495 . . . . 0.0 106.968 -179.837 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.55 158.29 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 118.885 0.766 . . . . 0.0 109.721 169.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -146.85 -27.89 0.39 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.625 0.77 . . . . 0.0 112.719 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.1 tp -132.58 -26.22 1.84 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.277 1.031 . . . . 0.0 111.562 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -58.13 -39.09 77.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.94 1.696 . . . . 0.0 111.21 -173.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -68.18 -18.26 64.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.262 1.825 . . . . 0.0 113.497 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.33 157.87 15.92 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.036 0.834 . . . . 0.0 109.775 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -62.63 66.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 130.906 3.682 . . . . 0.0 110.154 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 139.26 57.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 127.098 2.159 . . . . 0.0 106.587 -169.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -6.26 1.66 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -169.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.11 28.63 0.52 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 171.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 -176.6 49.35 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 106.223 -2.751 . . . . 0.0 106.223 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 39.6 mtt85 -87.33 151.07 23.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 168.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.921 HG11 HD11 ' A' ' 97' ' ' ILE . 2.9 p -132.8 165.8 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 169.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -139.84 128.36 22.92 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.36 124.36 42.2 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.722 1.264 . . . . 0.0 109.641 -170.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -98.6 125.23 43.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.26 1.824 . . . . 0.0 107.383 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -105.06 -17.88 14.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.762 0.825 . . . . 0.0 111.261 -175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.41 -75.17 0.29 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.4 -25.11 21.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.331 2.021 . . . . 0.0 113.104 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -152.85 175.93 12.37 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 125.036 1.334 . . . . 0.0 109.943 -171.801 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.515 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -143.76 146.44 33.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.35 2.26 . . . . 0.0 106.796 -169.141 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.82 151.6 51.98 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -171.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.2 139.05 57.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' HB3' HG13 ' A' ' 14' ' ' VAL . . . -136.23 157.79 45.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.758 2.023 . . . . 0.0 107.598 -176.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.76 95.26 2.39 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.231 -0.918 . . . . 0.0 110.404 -169.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.62 148.01 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 128.037 2.535 . . . . 0.0 112.325 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.572 HD22 ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.13 -31.07 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.914 166.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HG2' HD22 ' A' ' 28' ' ' LEU . 17.5 mtmt -111.08 149.61 30.55 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 168.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 pt -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -149.28 153.43 37.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.499 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.45 143.77 17.79 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 109.513 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.99 -11.72 32.94 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.291 2.66 . . . . 0.0 113.526 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.6 m -63.99 -33.02 74.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.834 1.197 . . . . 0.0 112.046 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -122.0 -10.62 8.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.464 1.506 . . . . 0.0 111.243 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt 47.29 50.46 14.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 109.533 -169.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.8 mtp -146.32 152.59 39.38 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.744 2.018 . . . . 0.0 105.896 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -101.29 173.66 6.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.114 0.566 . . . . 0.0 112.375 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -138.6 161.23 37.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.717 2.007 . . . . 0.0 107.158 170.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 56' ' ' ILE . 31.4 t -154.97 162.17 41.17 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 pt -146.32 155.65 50.06 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.647 1.579 . . . . 0.0 109.765 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 92.5 Cg_endo -75.87 83.93 1.87 Allowed 'Trans proline' 0 CA--C 1.536 0.589 1 C-N-CA 125.482 4.121 . . . . 0.0 111.206 -174.595 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -141.96 13.51 2.06 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -171.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -149.36 -28.23 0.27 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 40.84 66.35 3.59 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.904 1.281 . . . . 0.0 112.735 -172.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.18 164.23 10.8 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.059 2.506 . . . . 0.0 111.94 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.55 -28.34 36.78 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.233 0.921 . . . . 0.0 114.774 -173.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.38 -5.41 65.35 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.489 -1.173 . . . . 0.0 114.066 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 m -145.8 105.97 4.04 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.358 1.579 . . . . 0.0 109.465 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -50.97 -31.87 19.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.33 1.452 . . . . 0.0 112.657 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -167.29 141.19 3.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.409 0.684 . . . . 0.0 109.542 168.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.592 ' HB1' HD11 ' A' ' 56' ' ' ILE . . . -68.67 168.46 13.11 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 166.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.8 p -124.96 85.84 2.47 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 120.854 -1.154 . . . . 0.0 112.011 -168.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt 49.67 -156.4 0.09 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.381 1.872 . . . . 0.0 110.653 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.75 103.18 0.14 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.592 HD11 ' HB1' ' A' ' 52' ' ' ALA . 3.6 mt -71.16 135.82 27.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -175.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.12 136.09 93.94 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.41 136.26 30.85 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.041 1.827 . . . . 0.0 107.706 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -140.36 162.41 35.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -170.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 6.2 mmpt? -63.86 152.41 39.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.55 150.67 27.83 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.442 1.897 . . . . 0.0 110.527 -169.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.57 19.95 5.58 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.3 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.56 -31.63 36.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.591 1.195 . . . . 0.0 109.857 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -150.35 17.75 0.83 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.013 1.325 . . . . 0.0 110.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -131.23 163.57 27.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.982 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -149.2 140.56 23.23 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.723 1.209 . . . . 0.0 108.535 169.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 71' ' ' ILE . 10.7 pt -135.91 122.55 14.26 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.99 154.51 17.35 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.245 1.963 . . . . 0.0 110.959 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -53.39 -22.11 7.01 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.81 0.844 . . . . 0.0 111.414 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.9 -27.99 69.53 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.933 1.693 . . . . 0.0 114.003 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 67' ' ' ILE . 18.4 pt -119.54 -12.6 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.508 1.503 . . . . 0.0 110.667 -176.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.17 -45.71 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 128.141 2.576 . . . . 0.0 108.963 169.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -81.35 10.31 5.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 -169.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.15 23.66 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -173.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -61.2 137.63 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -136.48 151.36 49.37 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.268 0.98 . . . . 0.0 110.378 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.17 113.88 9.19 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.828 1.251 . . . . 0.0 109.408 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.474 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 43.8 t80 -80.11 128.7 33.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.382 1.473 . . . . 0.0 107.091 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.56 152.25 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.563 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -97.8 125.24 42.54 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.414 ' CD2' ' HM2' ' A' ' 128' ' ' M2L . 36.5 m-85 -75.27 115.5 14.98 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 171.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -79.73 151.9 30.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 110.023 -172.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 6.51 34.5 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.837 -0.98 . . . . 0.0 111.859 -170.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.585 ' CD1' HM2B ' A' ' 128' ' ' M2L . 57.5 m95 -133.7 173.31 11.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.712 1.256 . . . . 0.0 112.069 -173.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.69 163.09 24.68 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.522 1.129 . . . . 0.0 112.466 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -67.7 -19.38 65.15 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.154 0.982 . . . . 0.0 111.386 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 m -57.16 -31.04 64.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.156 -0.965 . . . . 0.0 111.915 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -87.92 9.29 22.63 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 117.879 -1.058 . . . . 0.0 112.912 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.78 99.64 0.34 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -152.15 166.1 32.74 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.481 1.912 . . . . 0.0 107.94 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.401 ' CD1' HG23 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -104.41 151.78 23.09 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.892 0.853 . . . . 0.0 110.671 169.023 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.48 HG23 HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -132.56 163.09 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.564 173.102 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.39 174.22 20.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.266 . . . . 0.0 110.043 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -15.38 33.4 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 113.948 -176.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -58.07 -24.38 58.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 112.617 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -124.55 -36.92 2.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 117.807 -1.092 . . . . 0.0 112.027 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.921 HD11 HG11 ' A' ' 14' ' ' VAL . 6.4 tt -97.37 152.36 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.611 1.096 . . . . 0.0 112.752 -168.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -155.14 150.15 26.81 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.449 2.3 . . . . 0.0 111.408 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.56 158.81 34.14 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.016 1.28 . . . . 0.0 112.852 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.484 ' CE1' HD11 ' A' ' 105' ' ' ILE . 4.3 t80 -70.52 107.33 3.81 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.765 0.793 . . . . 0.0 110.581 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.25 160.5 38.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.254 1.422 . . . . 0.0 109.343 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -52.75 -35.96 57.02 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.454 1.502 . . . . 0.0 114.806 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.21 -44.71 95.96 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.792 1.282 . . . . 0.0 109.808 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -77.13 -20.78 55.16 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.028 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.484 HD11 ' CE1' ' A' ' 100' ' ' TYR . 6.1 mm -73.23 -32.91 39.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 CA-C-N 119.117 0.871 . . . . 0.0 110.385 169.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.395 0.998 . . . . 0.0 108.945 171.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.23 74.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -55.48 -48.97 73.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.284 1.034 . . . . 0.0 109.916 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.82 -44.98 38.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.428 -172.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -57.58 -34.49 69.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.744 0.702 . . . . 0.0 110.179 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -78.21 -50.4 11.98 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.36 -29.0 3.54 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.835 1.254 . . . . 0.0 112.275 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -74.15 -52.67 11.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.917 1.287 . . . . 0.0 113.539 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -86.25 -14.62 43.25 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.149 0.886 . . . . 0.0 113.377 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -44.96 122.55 3.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.813 2.045 . . . . 0.0 114.363 -169.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.69 60.9 4.56 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.5 m -65.88 -3.62 5.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.134 1.774 . . . . 0.0 114.627 -174.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.22 139.11 36.88 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.216 1.006 . . . . 0.0 109.387 170.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -153.81 16.35 0.63 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-O 119.579 -0.567 . . . . 0.0 113.565 -170.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 p -144.86 15.33 1.56 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.782 1.233 . . . . 0.0 112.047 -171.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.74 167.66 13.22 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.947 2.099 . . . . 0.0 108.44 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.62 -9.26 3.66 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.911 3.074 . . . . 0.0 116.563 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.25 -2.21 23.95 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.241 1.817 . . . . 0.0 112.84 170.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.1 m -62.72 108.41 1.16 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.538 1.063 . . . . 0.0 108.233 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -159.98 28.13 0.35 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-O 118.995 -0.892 . . . . 0.0 112.866 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.18 7.43 0.18 Allowed Glycine 0 C--N 1.34 0.791 0 CA-C-O 117.062 -1.966 . . . . 0.0 115.561 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -155.42 149.32 11.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 121.782 2.791 . . . . 0.0 107.685 -169.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.585 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HA ' ' HE3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -159.92 108.74 1.43 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.951 2.1 . . . . 0.0 107.275 -168.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -84.58 -31.79 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.887 1.725 . . . . 0.0 111.832 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -57.1 -27.75 62.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 113.179 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -74.22 -3.06 27.65 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.891 0.876 . . . . 0.0 112.638 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.72 28.38 5.38 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.4 1.88 . . . . 0.0 109.752 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.209 1.804 . . . . 0.0 106.334 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.16 151.37 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -151.92 -59.42 0.16 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.565 0.746 . . . . 0.0 109.055 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.4 tp -76.28 -39.95 52.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.317 0.508 . . . . 0.0 110.439 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.26 -32.32 72.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.533 0.733 . . . . 0.0 110.743 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -59.75 -34.55 73.11 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.045 1.738 . . . . 0.0 112.374 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -86.92 151.7 23.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -57.11 122.62 12.82 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.06 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -1.27 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.41 30.22 0.36 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.76 -174.58 49.9 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 169.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -86.76 151.69 23.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.56 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -130.33 163.43 35.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 168.541 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.433 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 60.8 mt -139.91 130.4 25.55 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -173.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.55 129.56 50.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.276 0.985 . . . . 0.0 108.518 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.96 118.03 35.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -99.6 -14.44 18.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -169.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.57 -78.9 0.23 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.24 -32.58 12.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.128 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.77 -177.17 6.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.821 1.648 . . . . 0.0 109.454 -169.484 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.499 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 11.7 tmm? -128.37 145.24 51.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.84 2.056 . . . . 0.0 108.306 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -130.3 146.27 51.87 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.791 0.805 . . . . 0.0 109.727 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -73.87 148.32 42.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.286 1.434 . . . . 0.0 109.845 -170.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.96 45.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.809 0.844 . . . . 0.0 110.418 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -148.48 95.74 2.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.275 1.03 . . . . 0.0 110.78 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.56 HD11 HG11 ' A' ' 14' ' ' VAL . 46.2 mt -59.72 151.25 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 128.294 2.638 . . . . 0.0 112.158 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 29' ' ' LYS 0.301 0.0 OUTLIER -159.71 -28.68 0.07 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 116.802 -1.571 . . . . 0.0 111.96 166.887 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.473 ' N ' HD22 ' A' ' 28' ' ' LEU . 17.0 mtmt -113.77 150.13 33.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 168.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.0 166.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.049 0.928 . . . . 0.0 108.693 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -144.18 151.76 39.95 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.514 1.526 . . . . 0.0 109.525 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.11 142.88 16.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.807 1.643 . . . . 0.0 109.563 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 -11.37 31.92 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.158 2.572 . . . . 0.0 113.801 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -62.15 -31.84 72.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.322 1.419 . . . . 0.0 112.312 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.7 p -129.89 0.51 4.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.252 1.421 . . . . 0.0 111.219 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt 44.21 53.78 6.45 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.615 1.566 . . . . 0.0 110.545 -174.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptm -155.26 165.24 37.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.022 1.329 . . . . 0.0 107.703 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -110.67 172.28 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.083 0.953 . . . . 0.0 112.048 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.8 p -141.0 157.3 45.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.67 1.988 . . . . 0.0 106.379 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 56' ' ' ILE . 28.7 t -150.85 159.06 44.8 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 pt -149.05 157.11 40.32 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.645 1.178 . . . . 0.0 109.58 -175.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.85 55.5 1.74 Allowed 'Trans proline' 0 CA--C 1.542 0.88 1 C-N-CA 125.673 4.248 . . . . 0.0 113.594 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -59.71 -53.59 56.21 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -161.9 -112.44 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -162.66 154.8 15.85 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 126.304 1.841 . . . . 0.0 108.592 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.33 170.59 10.55 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.346 2.03 . . . . 0.0 108.004 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.81 4.22 1.2 Allowed Glycine 0 CA--C 1.539 1.559 0 O-C-N 120.791 -1.193 . . . . 0.0 115.138 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.75 -147.1 10.74 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.851 1.691 . . . . 0.0 110.043 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.3 m -126.99 24.06 6.46 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -168.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -141.02 115.5 9.47 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.97 156.12 37.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.821 0.448 . . . . 0.0 111.296 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.98 131.4 45.4 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 103.271 -2.863 . . . . 0.0 103.271 166.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -81.49 -58.58 2.96 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -168.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -147.48 -163.75 1.84 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.501 2.32 . . . . 0.0 106.076 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.26 109.77 2.0 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.0 mt -76.12 131.62 34.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -173.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.53 138.55 95.68 Favored Pre-proline 0 C--O 1.234 0.288 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.59 137.9 31.2 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.852 1.701 . . . . 0.0 107.931 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -139.05 160.06 40.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 130.16 42.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.79 156.51 34.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.352 1.461 . . . . 0.0 112.31 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.21 29.38 2.15 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.678 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -79.26 -41.08 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.648 1.224 . . . . 0.0 109.041 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -161.96 5.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.347 1.059 . . . . 0.0 113.41 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 48.8 2.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.902 1.281 . . . . 0.0 111.603 -168.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -33.09 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.631 3.172 . . . . 0.0 113.496 168.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 71' ' ' ILE . 8.1 pt -136.88 134.47 19.23 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 107.832 169.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.97 160.1 50.85 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.18 1.92 . . . . 0.0 110.311 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.01 -23.59 20.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 111.829 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.76 -33.97 67.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.336 1.454 . . . . 0.0 113.196 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 67' ' ' ILE . 8.2 pt -120.01 -10.06 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 119.487 1.039 . . . . 0.0 110.733 -172.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -59.31 -49.39 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 127.641 2.377 . . . . 0.0 106.661 168.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -77.71 9.42 3.46 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.521 1.528 . . . . 0.0 112.088 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.17 -179.19 27.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.704 1.138 . . . . 0.0 110.881 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -59.31 137.21 58.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 m -136.46 150.65 48.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 124.281 0.988 . . . . 0.0 110.456 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.82 114.66 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.164 -172.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -79.97 124.98 29.18 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.22 1.408 . . . . 0.0 107.374 169.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -137.83 154.06 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 112.433 -168.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -96.46 124.42 40.45 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 166.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.471 ' CD2' ' HM1' ' A' ' 128' ' ' M2L . 16.7 m-85 -74.03 106.93 5.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -71.99 149.68 44.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.44 3.87 41.99 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.261 -1.299 . . . . 0.0 113.104 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.5 ' CE2' ' HEA' ' A' ' 128' ' ' M2L . 63.9 m95 -126.7 168.0 14.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.403 1.602 . . . . 0.0 111.418 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -66.69 171.35 5.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.341 1.056 . . . . 0.0 112.232 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.08 -21.86 66.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.633 1.173 . . . . 0.0 111.585 169.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -63.12 -25.43 68.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.789 0.835 . . . . 0.0 112.144 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -102.23 19.15 19.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 0.0 112.695 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.66 103.52 1.75 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.22 168.39 23.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.382 -167.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.09 152.38 22.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.12 0.962 . . . . 0.0 111.241 168.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.51 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.14 1.376 . . . . 0.0 110.359 173.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 167.2 25.5 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -19.41 21.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.099 1.36 . . . . 0.0 113.733 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.88 -22.88 40.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.676 1.191 . . . . 0.0 112.918 170.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -121.49 -38.54 2.76 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.324 -1.322 . . . . 0.0 111.763 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.476 HD11 HG21 ' A' ' 14' ' ' VAL . 7.4 tt -99.62 154.38 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 120.654 1.57 . . . . 0.0 113.017 -169.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -150.34 156.99 42.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 128.895 2.878 . . . . 0.0 108.921 169.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.39 163.63 27.32 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.602 1.161 . . . . 0.0 112.431 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.93 112.25 9.86 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 120.85 -1.156 . . . . 0.0 109.293 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.979 1.311 . . . . 0.0 109.63 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -52.94 -36.03 59.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.899 1.68 . . . . 0.0 113.733 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -62.7 -43.86 97.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.404 1.097 . . . . 0.0 110.541 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.67 -22.39 50.67 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.253 -0.879 . . . . 0.0 109.519 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mm -70.77 -35.16 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 119.153 0.888 . . . . 0.0 109.926 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.45 99.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.238 0.926 . . . . 0.0 109.319 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -46.8 88.3 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.63 -43.43 96.85 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 118.163 -0.922 . . . . 0.0 109.749 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -72.01 -43.77 64.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.371 0.987 . . . . 0.0 109.677 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -32.16 48.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 118.144 -0.932 . . . . 0.0 111.454 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.85 -45.63 10.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.053 1.297 . . . . 0.0 113.29 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.23 -23.91 9.91 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.157 1.783 . . . . 0.0 111.962 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -70.09 -43.65 70.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.342 1.857 . . . . 0.0 113.072 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -66.99 -45.89 76.22 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.445 0.641 . . . . 0.0 109.586 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -164.4 175.75 9.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.308 -169.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -129.59 152.05 19.45 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.386 0.993 . . . . 0.0 110.822 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 m -64.04 -12.07 35.18 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.965 1.706 . . . . 0.0 113.548 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m -57.31 -26.72 61.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.189 1.796 . . . . 0.0 112.708 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.35 -42.59 2.78 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.088 0.852 . . . . 0.0 111.365 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 m -75.74 14.16 0.7 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.546 1.538 . . . . 0.0 112.873 170.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.05 168.66 8.63 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.209 1.404 . . . . 0.0 110.337 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.03 5.94 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.81 3.673 . . . . 0.0 117.328 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -141.54 116.42 9.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.858 2.063 . . . . 0.0 105.528 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.2 p -89.32 56.07 3.5 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.777 1.231 . . . . 0.0 110.553 -170.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.09 -179.2 48.54 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.46 1.505 . . . . 0.0 109.724 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.59 59.0 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.345 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.4 149.4 25.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.5 ' HEA' ' CE2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -161.41 128.62 2.63 Favored Pre-proline 0 N--CA 1.445 -0.7 0 C-N-CA 127.988 2.515 . . . . 0.0 105.165 -169.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -74.19 -17.33 21.87 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.298 1.998 . . . . 0.0 109.561 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 43.89 54.18 5.87 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 127.84 2.456 . . . . 0.0 113.429 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 69.31 0.53 2.91 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.93 1.692 . . . . 0.0 113.875 170.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -69.31 162.3 27.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.989 1.268 . . . . 0.0 109.731 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.049 1.74 . . . . 0.0 106.949 177.651 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p -152.86 154.01 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.717 1.207 . . . . 0.0 108.013 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -155.25 171.96 18.96 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.92 2.088 . . . . 0.0 105.803 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.5 mt 56.03 30.38 16.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.23 1.412 . . . . 0.0 111.155 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.47 -45.07 76.98 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.955 2.102 . . . . 0.0 106.896 172.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -143.94 112.59 6.57 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 100.642 -3.836 . . . . 0.0 100.642 168.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -65.31 165.87 10.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.759 -2.018 . . . . 0.0 108.698 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.439 ' HA ' ' HB2' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -57.05 130.64 46.97 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.124 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.85 125.39 44.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 102.232 -3.247 . . . . 0.0 102.232 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.433 HD22 HG12 ' A' ' 41' ' ' ILE . 1.7 mt -56.57 -9.79 0.82 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -168.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.7 34.4 0.81 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.29 -153.03 7.33 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 105.853 -2.899 . . . . 0.0 105.853 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -113.47 155.97 24.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 168.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.553 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.22 155.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 169.649 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 14' ' ' VAL . 7.8 mt -127.74 153.48 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.02 126.91 31.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -173.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -90.57 118.29 29.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -95.25 -14.13 24.28 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.87 0.868 . . . . 0.0 111.624 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.07 -75.67 0.35 Allowed Glycine 0 C--N 1.337 0.609 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.73 -28.63 13.66 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.557 2.171 . . . . 0.0 113.135 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.493 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.01 -177.12 6.3 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 -170.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.493 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -146.22 147.45 31.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.613 1.565 . . . . 0.0 108.302 -168.43 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.2 170.59 15.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.313 1.045 . . . . 0.0 110.372 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.78 147.54 25.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.778 0.831 . . . . 0.0 109.203 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 165.91 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.759 1.624 . . . . 0.0 108.865 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -153.51 108.52 3.17 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 121.109 -0.994 . . . . 0.0 110.487 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 14' ' ' VAL . 74.3 mt -55.4 150.09 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 128.454 2.702 . . . . 0.0 110.922 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -157.1 -31.08 0.08 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.773 169.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 24.0 mtmt -119.96 146.93 45.37 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 168.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.51 165.47 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -144.75 150.6 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.612 -170.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.84 142.21 15.27 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.662 1.585 . . . . 0.0 109.242 -173.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.93 -2.87 11.7 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.411 2.74 . . . . 0.0 113.652 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -63.6 -36.67 84.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.579 1.536 . . . . 0.0 111.46 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -134.86 12.37 3.66 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.083 0.953 . . . . 0.0 112.022 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 42.0 55.65 3.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.145 1.378 . . . . 0.0 111.795 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.5 ptm -155.89 164.33 38.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -107.58 169.6 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.412 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 p -136.15 156.17 49.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.755 2.022 . . . . 0.0 106.483 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.566 ' HB2' HD12 ' A' ' 56' ' ' ILE . 20.0 m -154.21 154.63 33.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -169.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.433 HG12 HD22 ' A' ' 10' ' ' LEU . 3.2 pt -148.2 160.84 36.16 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.889 0.876 . . . . 0.0 110.012 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.73 101.57 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.563 2.842 . . . . 0.0 110.658 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -139.76 -4.13 1.42 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.003 0.921 . . . . 0.0 112.326 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -160.46 -175.18 4.86 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.365 1.066 . . . . 0.0 109.519 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -138.9 62.67 28.17 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 127.334 2.254 . . . . 0.0 110.45 -177.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -49.73 -29.04 18.82 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.157 3.238 . . . . 0.0 116.15 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.58 -38.7 3.2 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 119.403 1.001 . . . . 0.0 111.748 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -18.09 69.69 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.823 0.725 . . . . 0.0 112.025 170.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 m -136.95 135.03 37.36 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 127.101 2.16 . . . . 0.0 105.518 172.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.1 m -57.78 -51.0 71.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.776 0.83 . . . . 0.0 111.392 -169.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -147.45 42.34 1.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.991 171.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 43.15 47.37 5.3 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.467 1.603 . . . . 0.0 110.164 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -42.25 103.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 130.29 3.436 . . . . 0.0 115.206 -167.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt 58.15 -174.84 0.08 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.209 2.604 . . . . 0.0 111.827 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.55 112.89 2.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.6 mt -79.83 137.04 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -175.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.38 141.98 94.05 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.3 138.7 30.75 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 N-CA-C 107.231 -1.873 . . . . 0.0 107.231 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -137.57 159.9 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.779 0.8 . . . . 0.0 108.952 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.44 118.82 11.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.52 153.83 41.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.221 1.408 . . . . 0.0 112.48 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.23 1.55 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-O 118.968 -0.907 . . . . 0.0 115.243 168.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -80.57 -40.66 25.45 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.097 1.449 . . . . 0.0 109.374 169.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.15 -0.41 0.07 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 0.0 113.516 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.69 46.41 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.552 1.541 . . . . 0.0 111.509 -169.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -31.75 139.07 0.04 OUTLIER 'General case' 0 C--O 1.237 0.44 0 C-N-CA 129.776 3.23 . . . . 0.0 113.28 168.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 71' ' ' ILE . 7.6 pt -134.76 126.66 18.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.15 156.41 20.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.732 2.288 . . . . 0.0 111.128 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.62 -18.48 7.86 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.08 1.352 . . . . 0.0 112.758 173.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -64.04 -30.81 71.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.923 1.289 . . . . 0.0 112.338 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.447 HD11 HG22 ' A' ' 67' ' ' ILE . 10.1 pt -121.03 -9.49 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.835 1.198 . . . . 0.0 110.789 -173.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.19 -49.57 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 127.776 2.43 . . . . 0.0 106.305 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.85 8.94 3.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.411 1.484 . . . . 0.0 111.994 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.96 -178.45 24.9 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.27 0.941 . . . . 0.0 111.315 -174.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -63.4 136.9 57.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.2 m -139.33 152.39 47.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.246 0.966 . . . . 0.0 110.89 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.434 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 37.5 m-85 -140.81 113.21 8.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.293 -170.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 54.4 t80 -79.15 128.99 33.99 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.19 153.93 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 124.671 1.232 . . . . 0.0 112.28 -168.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -96.38 121.53 38.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 167.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.14 112.7 7.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.73 149.45 31.16 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.86 53.25 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.063 -0.854 . . . . 0.0 111.902 -169.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.426 ' CD1' HM2B ' A' ' 128' ' ' M2L . 89.5 m95 -132.13 172.59 12.2 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.619 1.21 . . . . 0.0 111.097 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -72.07 158.74 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.331 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.1 m -71.63 -13.09 61.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.636 0.374 . . . . 0.0 111.778 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.9 m -54.75 -34.86 63.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.456 1.102 . . . . 0.0 112.357 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -86.98 7.94 25.37 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.109 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.66 118.24 9.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.278 7.7 tp10 -155.73 168.41 27.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.199 1.8 . . . . 0.0 107.739 -167.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 150.07 23.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.84 0.828 . . . . 0.0 110.652 168.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.65 153.32 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.764 174.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.9 157.83 28.81 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 174.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.59 8.77 0.76 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.19 -21.03 24.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.355 1.862 . . . . 0.0 111.557 169.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -117.29 -36.7 3.69 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.681 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.07 151.0 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 120.062 1.301 . . . . 0.0 110.592 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -142.62 146.23 34.3 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.596 1.558 . . . . 0.0 110.404 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 8' ' ' PHE . . . -65.91 151.36 46.9 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.229 1.412 . . . . 0.0 109.884 174.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.51 123.42 16.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.206 1.003 . . . . 0.0 110.823 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -147.85 151.32 35.74 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.107 2.163 . . . . 0.0 106.993 -169.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.66 -28.56 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.913 0.485 . . . . 0.0 110.65 173.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -64.37 -44.21 92.09 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.759 0.824 . . . . 0.0 110.302 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.5 mm -69.67 -33.89 58.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.626 0.648 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.45 99.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.287 0.949 . . . . 0.0 109.68 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -47.43 85.36 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.99 -48.02 83.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.579 -173.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -70.77 -44.51 66.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.32 0.509 . . . . 0.0 109.76 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -27.61 33.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.646 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -94.1 -45.45 7.55 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.441 1.473 . . . . 0.0 112.498 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.15 11.12 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.47 1.508 . . . . 0.0 110.956 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -58.21 -42.02 85.29 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.215 1.806 . . . . 0.0 113.307 172.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -102.96 -13.8 16.75 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.524 1.056 . . . . 0.0 113.488 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -46.8 119.78 2.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.351 1.86 . . . . 0.0 113.373 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -173.93 163.43 34.44 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.311 1.434 . . . . 0.0 110.245 169.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -79.01 85.3 4.95 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 172.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.7 p -58.35 -37.1 74.49 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.501 1.12 . . . . 0.0 112.736 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.63 -47.66 1.82 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.388 1.471 . . . . 0.0 113.737 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.9 m -78.48 50.95 1.0 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.664 1.986 . . . . 0.0 110.68 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.01 165.22 21.42 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.733 2.013 . . . . 0.0 108.498 -172.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.58 13.0 0.6 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.472 2.782 . . . . 0.0 114.048 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.04 169.07 21.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.358 2.263 . . . . 0.0 107.154 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.0 p -60.11 -29.03 68.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.189 0.595 . . . . 0.0 112.179 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 164.64 -173.82 40.59 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.888 1.232 . . . . 0.0 110.074 175.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -78.13 42.01 2.07 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.735 1.16 . . . . 0.0 111.876 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.8 t -141.77 119.85 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -168.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.426 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.87 154.82 33.29 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 169.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.11 -5.45 15.81 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 121.245 1.296 . . . . 0.0 110.301 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -55.99 162.22 1.98 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.502 2.721 . . . . 0.0 109.581 169.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.9 mtm105 61.57 -30.32 0.07 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 129.764 3.225 . . . . 0.0 114.406 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -66.67 161.2 23.92 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 120.071 1.305 . . . . 0.0 109.708 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.252 1.194 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.601 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.79 159.95 37.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.03 1.332 . . . . 0.0 108.145 171.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -153.77 -54.84 0.11 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.802 0.841 . . . . 0.0 109.164 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 62.9 tp -66.57 -40.18 88.85 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.485 0.714 . . . . 0.0 111.344 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.0 -30.61 71.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.187 0.595 . . . . 0.0 111.314 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -71.82 -22.96 61.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.445 1.498 . . . . 0.0 113.196 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -80.67 154.93 27.06 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -56.65 126.5 26.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 168.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.37 135.76 55.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -169.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.404 HD22 HG12 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -58.9 -3.62 0.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -168.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.2 28.0 0.26 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.89 -176.31 51.05 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 100' ' ' TYR . 87.4 mtt-85 -87.17 153.96 21.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.563 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.38 166.93 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 168.382 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -133.52 145.38 50.1 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.9 134.02 40.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.2 126.62 39.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.693 1.245 . . . . 0.0 107.649 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -103.04 -6.5 22.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.512 0.725 . . . . 0.0 111.109 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -77.63 0.35 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.46 -34.95 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.309 2.006 . . . . 0.0 113.422 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.7 178.36 8.04 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.815 1.646 . . . . 0.0 108.131 -172.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 161.97 33.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.06 163.97 28.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.112 0.965 . . . . 0.0 109.132 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.13 145.59 42.07 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.302 1.041 . . . . 0.0 108.223 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.06 158.47 44.39 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -148.48 94.06 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.927 0.891 . . . . 0.0 109.681 -169.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.563 HD11 HG11 ' A' ' 14' ' ' VAL . 54.7 mt -58.48 150.03 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.62 3.168 . . . . 0.0 111.886 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.51 -19.46 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 167.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -131.03 139.77 49.99 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.38 160.09 25.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -168.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -143.67 152.59 41.52 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.288 -168.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -149.63 143.6 16.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.653 1.581 . . . . 0.0 109.618 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.24 -1.97 10.45 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.954 3.103 . . . . 0.0 113.772 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.5 m -63.22 -33.39 75.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.297 1.408 . . . . 0.0 112.014 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -135.74 -0.52 2.58 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.919 1.288 . . . . 0.0 111.669 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 48.17 52.41 13.32 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.159 0.984 . . . . 0.0 110.145 -169.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 77.9 mtp -146.19 156.7 43.59 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.393 1.877 . . . . 0.0 107.034 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -107.25 175.62 5.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.866 0.866 . . . . 0.0 112.365 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -141.71 152.77 44.15 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 127.041 2.136 . . . . 0.0 107.207 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.1 m -152.16 157.12 41.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -169.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.404 HG12 HD22 ' A' ' 10' ' ' LEU . 4.8 pt -148.12 160.68 36.74 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 110.009 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.641 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 60.2 Cg_endo -77.98 49.31 2.93 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.958 3.772 . . . . 0.0 113.141 -176.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -61.54 -50.33 73.08 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.11 -0.994 . . . . 0.0 108.727 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -166.84 165.52 16.14 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.333 1.453 . . . . 0.0 108.357 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -69.46 148.15 97.03 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.484 1.514 . . . . 0.0 112.061 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -60.22 -13.88 26.31 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.248 3.299 . . . . 0.0 116.819 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.1 -38.08 3.48 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.91 1.232 . . . . 0.0 111.989 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.72 14.32 38.33 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.357 1.456 . . . . 0.0 113.124 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.7 m -136.79 159.86 40.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.262 1.825 . . . . 0.0 107.799 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.3 m -66.2 -48.35 70.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.959 0.504 . . . . 0.0 110.989 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -169.04 160.17 9.74 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.936 1.694 . . . . 0.0 109.082 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.641 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -72.75 159.68 33.41 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 167.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -128.77 87.31 2.56 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.397 -0.814 . . . . 0.0 111.486 -169.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt 53.81 -162.9 0.11 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.884 1.674 . . . . 0.0 110.305 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.38 112.0 2.25 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.5 mt -75.42 139.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 138.34 93.26 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.49 136.55 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 N-CA-C 107.344 -1.829 . . . . 0.0 107.344 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -138.72 159.58 41.76 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -170.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -64.87 131.86 47.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 tt -80.57 155.55 26.88 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.471 1.908 . . . . 0.0 112.199 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.34 20.27 4.79 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.332 0.968 . . . . 0.0 112.129 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.4 -35.48 47.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.942 0.871 . . . . 0.0 109.262 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -150.97 8.94 0.57 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.703 1.201 . . . . 0.0 111.634 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.628 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 6.6 mp0 -126.72 173.5 9.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.523 1.529 . . . . 0.0 110.699 -169.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.7 m -153.85 140.42 18.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 169.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.499 HG22 HD11 ' A' ' 71' ' ' ILE . 12.3 pt -134.54 132.28 20.73 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.12 160.02 50.55 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.363 1.376 . . . . 0.0 109.444 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.02 -14.51 2.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.443 1.097 . . . . 0.0 112.317 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -66.93 -31.95 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.604 1.562 . . . . 0.0 112.773 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' ILE . 13.5 pt -119.34 -12.57 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 120.202 1.365 . . . . 0.0 110.686 -173.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -52.41 -46.92 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 128.43 2.692 . . . . 0.0 108.24 169.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.52 8.46 9.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.476 0.711 . . . . 0.0 111.923 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.49 -178.35 25.29 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.881 1.219 . . . . 0.0 111.195 -170.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -64.13 131.84 48.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -136.44 152.98 51.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.288 0.993 . . . . 0.0 111.546 176.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.71 114.68 10.73 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.967 1.307 . . . . 0.0 110.006 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -80.49 126.33 31.08 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 126.206 1.802 . . . . 0.0 106.791 169.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.47 156.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.334 1.454 . . . . 0.0 111.488 -168.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -105.45 120.15 40.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 167.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -72.22 120.59 18.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -72.34 148.41 45.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.582 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 9.6 56.74 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.5 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.423 ' CZ2' ' HDA' ' A' ' 128' ' ' M2L . 84.4 m95 -130.76 165.01 23.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.95 1.375 . . . . 0.0 112.035 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -75.26 161.62 29.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -62.17 -21.51 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 111.448 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -25.66 39.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.828 1.251 . . . . 0.0 112.695 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -101.57 1.82 38.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.216 1.006 . . . . 0.0 111.726 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.77 115.4 7.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.277 6.8 tp10 -156.91 169.35 24.98 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.759 1.624 . . . . 0.0 108.241 -167.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.628 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.08 150.46 22.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.229 1.014 . . . . 0.0 109.72 168.094 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.44 155.26 40.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.749 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.27 166.52 32.12 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.66 -17.48 15.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.83 1.252 . . . . 0.0 113.232 174.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -22.86 40.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.767 1.227 . . . . 0.0 113.176 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -122.89 -38.98 2.55 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.431 174.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -95.85 156.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 119.767 1.167 . . . . 0.0 112.615 -169.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' HB3' HD21 ' A' ' 104' ' ' ASN . 89.0 mtt180 -155.19 155.41 33.85 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.391 2.676 . . . . 0.0 109.862 171.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.97 163.09 27.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.297 1.439 . . . . 0.0 112.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.52 ' CE2' HD11 ' A' ' 105' ' ' ILE . 35.6 t80 -66.95 115.84 7.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.15 -0.969 . . . . 0.0 110.392 174.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -161.69 161.89 29.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.482 1.513 . . . . 0.0 108.785 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.11 -33.25 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.798 1.639 . . . . 0.0 114.089 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -64.64 -43.85 92.36 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.015 0.912 . . . . 0.0 110.266 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 98' ' ' ARG . 79.6 m-20 -74.3 -27.0 60.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.67 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.52 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.8 mm -67.15 -45.53 86.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 117.308 -1.329 . . . . 0.0 109.524 169.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.6 79.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.796 1.634 . . . . 0.0 109.865 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.23 -51.79 63.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.225 0.61 . . . . 0.0 109.973 171.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.57 -48.86 80.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.369 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -68.26 -40.58 81.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 120.022 1.283 . . . . 0.0 110.276 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -52.47 -54.37 33.26 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt -73.71 -40.72 63.4 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.002 -0.436 . . . . 0.0 110.665 -170.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.12 -9.21 0.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.268 1.827 . . . . 0.0 113.009 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -114.07 -46.03 3.03 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.993 1.317 . . . . 0.0 112.284 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.51 -32.96 70.65 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.057 0.844 . . . . 0.0 111.632 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.41 130.2 53.45 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 122.125 0.964 . . . . 0.0 111.18 -167.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -178.85 54.82 0.09 OUTLIER Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.042 -1.436 . . . . 0.0 110.086 -174.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.7 m -125.82 39.47 3.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 110.111 -169.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.89 -19.33 0.97 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.921 2.889 . . . . 0.0 116.095 -169.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.64 -172.56 32.26 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 120.912 -1.118 . . . . 0.0 110.725 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 m 56.21 36.94 28.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.727 1.211 . . . . 0.0 112.678 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.77 148.28 45.48 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.301 1.44 . . . . 0.0 108.824 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -79.72 36.41 0.61 Allowed 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 124.516 3.477 . . . . 0.0 112.179 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.07 -177.15 5.51 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.683 1.593 . . . . 0.0 109.238 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.2 p -56.86 -34.53 67.91 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.438 0.695 . . . . 0.0 110.512 171.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.11 13.98 67.73 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -171.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.35 27.36 63.86 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-O 117.856 -1.525 . . . . 0.0 112.387 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.3 m -156.53 153.57 6.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 120.236 2.018 . . . . 0.0 108.964 -169.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.423 ' HDA' ' CZ2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.522 ' HE3' ' HD2' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -164.4 91.7 1.03 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 -167.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.522 ' HD2' ' HE3' ' A' ' 129' ' ' LYS . 93.9 Cg_endo -76.83 -41.31 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.85 1.7 . . . . 0.0 115.115 -168.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -72.06 1.75 6.86 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 115.602 1.705 . . . . 0.0 115.602 -170.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -61.38 160.4 10.91 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.985 1.266 . . . . 0.0 110.432 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -57.85 148.61 24.83 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.125 0.97 . . . . 0.0 110.833 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 C--O 1.249 1.077 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.549 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 m -139.93 158.9 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.498 1.519 . . . . 0.0 108.486 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -158.74 -34.43 0.07 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.254 1.022 . . . . 0.0 111.317 -177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.2 tp -53.64 -27.83 29.49 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.702 1.601 . . . . 0.0 113.337 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -59.02 -27.54 65.56 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -84.43 -17.04 40.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.58 1.552 . . . . 0.0 111.518 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -83.71 164.7 19.46 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.84 126.09 26.22 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 168.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.73 128.89 52.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -170.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.442 HD22 HG12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -59.04 -2.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -168.631 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.98 32.57 0.37 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 -157.43 14.14 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -109.48 154.57 22.48 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -129.18 162.04 37.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 169.189 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 14' ' ' VAL . 35.9 mt -139.14 130.39 26.81 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 -175.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.31 139.75 51.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -108.2 115.34 29.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -96.3 -10.54 27.62 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.994 0.918 . . . . 0.0 112.065 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.14 -78.69 0.31 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.62 -30.27 18.53 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.628 2.219 . . . . 0.0 112.887 175.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.445 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.11 -178.43 7.1 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.577 1.551 . . . . 0.0 108.894 -169.446 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.445 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -139.17 155.14 48.04 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.613 1.565 . . . . 0.0 107.326 -172.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -138.01 167.72 21.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 109.914 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.17 144.57 36.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.532 1.133 . . . . 0.0 109.061 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.9 156.43 48.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.168 1.387 . . . . 0.0 108.456 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -147.55 103.65 3.55 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.576 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.606 HD11 HG11 ' A' ' 14' ' ' VAL . 74.9 mt -60.09 148.16 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 129.61 3.164 . . . . 0.0 111.428 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.27 -18.41 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 116.732 -1.604 . . . . 0.0 113.88 167.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.445 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 15.2 ttpt -124.54 139.87 53.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 pt -141.01 161.11 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -169.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.48 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 2.9 t-105 -149.38 152.35 35.62 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.815 0.697 . . . . 0.0 111.988 -169.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.21 139.51 14.08 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.172 2.189 . . . . 0.0 109.054 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.2 -9.79 26.38 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.907 3.071 . . . . 0.0 113.422 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -68.48 -30.91 69.85 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.021 1.282 . . . . 0.0 111.291 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 m -120.1 -15.69 8.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.054 1.342 . . . . 0.0 110.844 174.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 49.18 47.2 22.32 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 118.865 0.757 . . . . 0.0 109.914 -170.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -145.82 148.69 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.84 174.8 6.2 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.111 0.565 . . . . 0.0 112.323 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.9 p -142.28 160.07 40.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.529 1.932 . . . . 0.0 106.884 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.646 ' HB3' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -147.16 165.16 30.85 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.442 HG12 HD22 ' A' ' 10' ' ' LEU . 8.5 pt -145.06 162.14 39.14 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.718 1.207 . . . . 0.0 109.113 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.91 87.8 1.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.834 3.023 . . . . 0.0 110.208 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -133.4 7.16 3.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.416 1.086 . . . . 0.0 111.777 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -147.12 161.2 41.35 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.717 -1.24 . . . . 0.0 113.042 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -135.98 71.08 63.24 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 128.546 2.738 . . . . 0.0 104.963 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -60.7 123.9 13.93 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.558 2.838 . . . . 0.0 110.714 -169.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.74 7.25 7.69 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.218 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.54 9.37 53.14 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.782 1.182 . . . . 0.0 112.368 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m -57.06 164.99 1.42 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.479 1.139 . . . . 0.0 110.88 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.1 m -56.01 -60.2 3.81 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.321 1.048 . . . . 0.0 112.315 -169.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -176.87 149.01 0.7 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.105 0.962 . . . . 0.0 108.683 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.29 166.49 12.04 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -105.52 162.46 13.46 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.275 1.03 . . . . 0.0 111.922 -169.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -51.74 155.21 1.75 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.519 1.528 . . . . 0.0 110.126 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -23.2 98.49 0.01 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.132 2.173 . . . . 0.0 112.322 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 40' ' ' SER . 4.0 mt -70.69 129.42 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 111.388 -2.642 . . . . 0.0 107.24 -168.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -67.12 137.12 94.21 Favored Pre-proline 0 C--O 1.236 0.344 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -173.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.16 131.02 17.27 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.272 1.981 . . . . 0.0 107.092 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -135.45 167.59 20.79 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.588 1.155 . . . . 0.0 108.085 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -65.16 151.94 44.84 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD11 ' CZ2' ' A' ' 91' ' ' TRP . 10.1 tt -108.09 147.22 31.51 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.585 1.554 . . . . 0.0 109.996 -169.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.87 42.73 0.77 Allowed Glycine 0 CA--C 1.527 0.787 0 O-C-N 123.906 0.754 . . . . 0.0 112.94 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.17 -8.73 3.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.093 0.957 . . . . 0.0 112.6 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.73 10.81 2.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.144 1.378 . . . . 0.0 110.472 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.448 ' HB2' ' HE1' ' A' ' 91' ' ' TRP . 0.6 OUTLIER -161.16 -177.44 6.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 108.016 -169.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.7 m -161.52 141.92 10.77 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.651 2.78 . . . . 0.0 103.64 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 67' ' ' ILE 0.311 5.3 tt -134.01 119.6 14.74 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -170.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.76 145.98 80.02 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.407 2.738 . . . . 0.0 113.037 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.8 -22.07 22.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.289 1.036 . . . . 0.0 112.509 172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -58.01 -31.3 66.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.792 2.037 . . . . 0.0 113.282 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 pt -117.82 -17.53 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.935 0.894 . . . . 0.0 111.014 -169.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.48 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 2.5 mm -52.87 -43.29 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 128.561 2.744 . . . . 0.0 109.656 171.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.91 11.75 4.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.252 -169.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.59 -171.1 26.07 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 121.0 -1.063 . . . . 0.0 110.487 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.01 136.16 56.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.131 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 m -137.91 151.21 47.78 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.927 0.767 . . . . 0.0 111.205 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -138.47 114.76 10.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.895 1.278 . . . . 0.0 110.294 -171.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 29' ' ' LYS . 53.5 t80 -81.48 129.23 34.57 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -137.97 149.04 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.017 -168.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -92.83 123.83 36.38 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -71.3 113.41 8.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -73.65 149.49 41.95 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.29 15.71 52.22 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 119.001 -0.888 . . . . 0.0 113.063 -176.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -136.31 172.15 13.43 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.113 1.365 . . . . 0.0 110.173 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -71.21 161.5 31.0 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -175.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -72.57 -13.47 61.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.759 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.9 m -55.09 -32.6 62.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.343 1.057 . . . . 0.0 112.225 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -87.77 2.45 51.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.858 0.863 . . . . 0.0 113.005 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.77 119.42 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 40.9 tt0 -158.81 153.94 25.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.448 ' HE1' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -91.18 149.69 21.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.282 1.039 . . . . 0.0 109.224 168.095 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.44 HG11 ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -132.8 149.13 31.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.49 -1.686 . . . . 0.0 110.484 -177.698 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.74 161.93 37.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.552 173.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.06 10.06 0.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.035 1.734 . . . . 0.0 114.95 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.27 -34.98 15.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.947 1.699 . . . . 0.0 110.378 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.44 ' HD2' HG11 ' A' ' 92' ' ' VAL . 23.6 ttm180 -93.39 -45.11 7.95 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.12 175.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 14' ' ' VAL . 5.2 tt -98.61 156.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.564 0.62 . . . . 0.0 111.335 -171.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.455 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 99.3 mtt180 -148.23 155.25 41.13 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.771 2.029 . . . . 0.0 109.743 169.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 161.72 30.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.16 1.346 . . . . 0.0 111.427 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CE2' HD11 ' A' ' 105' ' ' ILE . 26.4 t80 -70.12 117.9 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -162.02 161.32 28.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.131 1.373 . . . . 0.0 108.976 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.92 -36.08 47.85 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.68 1.592 . . . . 0.0 114.476 -169.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.19 -45.22 94.35 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.628 1.204 . . . . 0.0 110.476 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.49 -22.99 53.78 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.834 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.416 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.2 mm -69.01 -35.67 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.722 0.692 . . . . 0.0 109.772 169.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.9 97.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 118.809 0.731 . . . . 0.0 110.271 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -50.11 74.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -59.14 -48.04 83.08 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.6 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.69 -35.98 38.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.918 1.235 . . . . 0.0 110.276 -171.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -28.19 65.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.243 171.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -45.57 8.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.262 1.392 . . . . 0.0 112.819 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.04 16.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.285 1.434 . . . . 0.0 111.162 171.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -58.02 -42.32 85.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.684 1.594 . . . . 0.0 113.367 170.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -104.43 -10.01 18.02 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.336 0.971 . . . . 0.0 113.327 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -47.5 -45.16 26.12 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.672 1.989 . . . . 0.0 114.417 -170.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.87 -21.64 1.26 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.843 -0.976 . . . . 0.0 114.135 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.0 m 56.32 29.37 14.91 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.252 1.421 . . . . 0.0 112.37 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.6 p -71.32 -0.38 9.94 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.62 1.568 . . . . 0.0 113.147 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.37 -14.93 29.24 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.352 0.977 . . . . 0.0 113.728 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 p -75.29 4.18 7.59 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.211 1.506 . . . . 0.0 113.848 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.2 170.46 10.9 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.656 2.382 . . . . 0.0 108.281 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.22 13.08 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.426 3.417 . . . . 0.0 116.951 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.83 143.35 47.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.05 0.94 . . . . 0.0 110.481 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.2 p -131.54 4.38 4.27 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.113 1.365 . . . . 0.0 111.67 -175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -60.05 -24.02 60.19 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.144 1.354 . . . . 0.0 114.53 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.7 32.38 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 118.541 1.171 . . . . 0.0 112.196 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 p -153.82 146.12 14.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -169.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -151.42 127.05 4.92 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 126.717 2.007 . . . . 0.0 106.193 -171.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.442 ' HD2' ' H ' ' A' ' 131' ' ' HIS . 23.2 Cg_endo -83.74 -27.92 1.5 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 120.942 1.095 . . . . 0.0 110.205 169.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.442 ' H ' ' HD2' ' A' ' 130' ' ' PRO . 6.8 t-80 63.04 146.71 0.02 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 131.017 3.727 . . . . 0.0 113.678 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -61.19 152.43 28.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.817 1.247 . . . . 0.0 110.851 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -66.85 -27.74 67.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 . . . . . 0 C--O 1.251 1.145 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.882 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.8 m -62.94 157.96 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 169.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -151.17 -50.45 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.128 0.571 . . . . 0.0 111.397 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 59.4 tp -86.2 -36.48 19.44 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.959 0.504 . . . . 0.0 109.876 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.45 -34.96 77.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.031 1.333 . . . . 0.0 110.592 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -75.75 -16.28 60.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.684 1.594 . . . . 0.0 112.622 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -93.73 166.42 12.22 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.989 0.813 . . . . 0.0 109.646 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.75 63.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 1 C-N-CA 132.094 4.158 . . . . 0.0 111.401 169.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.33 135.81 55.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 127.24 2.216 . . . . 0.0 105.688 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.85 -4.92 1.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -169.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.61 30.43 0.51 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 171.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.44 -165.21 34.32 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.533 -2.627 . . . . 0.0 106.533 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -99.74 154.75 18.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.58 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -129.39 165.88 28.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 168.213 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.411 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.5 mm? -133.53 140.74 47.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.92 129.8 34.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -104.54 114.2 28.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -87.64 -22.25 24.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.116 0.566 . . . . 0.0 110.98 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.89 -72.08 0.31 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.11 -32.07 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.53 2.153 . . . . 0.0 112.736 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.31 174.65 12.61 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.909 1.684 . . . . 0.0 109.302 -172.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.411 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -139.12 150.35 45.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.7 1.6 . . . . 0.0 108.757 -169.143 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -137.24 159.97 40.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 109.673 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 148.87 39.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 123.612 0.765 . . . . 0.0 109.158 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.56 159.33 42.36 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.207 1.003 . . . . 0.0 109.912 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.92 95.7 2.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.331 0.652 . . . . 0.0 109.457 -170.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.58 HD11 HG11 ' A' ' 14' ' ' VAL . 70.4 mt -54.77 152.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 128.08 2.552 . . . . 0.0 111.632 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.02 -32.08 0.09 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.399 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 34.8 ttpt -132.2 136.81 47.29 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.65 166.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.7 0.762 . . . . 0.0 109.182 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.462 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.9 t-105 -143.17 153.24 42.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.587 -169.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -148.6 137.48 11.96 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 127.501 2.32 . . . . 0.0 108.152 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -10.93 28.18 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.528 2.819 . . . . 0.0 113.304 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -65.62 -31.85 73.11 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.863 1.21 . . . . 0.0 111.957 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -124.51 -7.44 7.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.013 1.325 . . . . 0.0 111.163 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt 47.05 48.41 15.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.388 1.075 . . . . 0.0 110.65 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtp -147.19 158.18 43.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.642 2.377 . . . . 0.0 105.98 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.434 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -108.99 174.21 5.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.788 0.835 . . . . 0.0 112.321 -174.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 p -147.37 149.38 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.503 1.921 . . . . 0.0 107.035 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.437 ' HB3' HD12 ' A' ' 56' ' ' ILE . 35.9 t -146.5 165.9 28.05 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 pt -147.92 156.73 44.13 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.141 1.377 . . . . 0.0 109.158 -176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 65.3 Cg_endo -68.77 110.01 2.25 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.422 2.748 . . . . 0.0 109.363 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -142.66 -15.17 0.73 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -166.43 -167.0 0.94 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.346 1.459 . . . . 0.0 109.811 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -136.28 96.24 12.67 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 128.339 2.655 . . . . 0.0 106.654 -171.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -53.79 -21.46 20.28 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.162 2.574 . . . . 0.0 117.13 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.69 -41.0 2.37 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -173.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.79 -14.87 82.11 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.539 1.066 . . . . 0.0 112.103 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -138.37 140.6 39.5 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.801 1.64 . . . . 0.0 108.077 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.6 m -64.92 -28.37 69.49 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.58 1.152 . . . . 0.0 112.324 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -169.45 158.61 8.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.037 2.135 . . . . 0.0 107.714 169.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -72.64 148.16 45.08 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 166.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.6 p -96.36 -72.0 0.65 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 118.148 2.647 . . . . 0.0 118.148 -166.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -144.42 -164.55 1.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.87 2.068 . . . . 0.0 105.627 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.53 113.84 3.2 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.437 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.1 mt -79.14 133.15 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -171.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -65.73 135.5 95.57 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.71 137.63 30.35 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.244 1.963 . . . . 0.0 108.024 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -139.69 160.67 39.34 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -170.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 4.8 mmpt? -67.02 120.08 13.05 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.618 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.26 150.71 33.88 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.805 2.042 . . . . 0.0 112.132 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.58 25.52 3.39 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.421 -1.21 . . . . 0.0 115.751 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.28 -30.57 17.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.986 1.893 . . . . 0.0 111.023 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.04 -39.9 0.11 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.07 1.748 . . . . 0.0 110.272 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -71.18 159.91 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.134 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -153.93 159.31 41.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 72' ' ' ILE 0.329 2.0 tt -144.63 126.61 8.09 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 -169.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.84 155.0 70.05 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 121.155 1.448 . . . . 0.0 111.142 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -56.96 -17.6 10.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.788 1.235 . . . . 0.0 112.542 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.11 -25.51 67.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.433 1.493 . . . . 0.0 112.332 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 pt -125.27 -14.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.229 0.922 . . . . 0.0 111.3 -170.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.51 HG12 HG23 ' A' ' 67' ' ' ILE . 1.6 mm -50.73 -42.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 128.587 2.755 . . . . 0.0 109.591 169.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.14 9.66 6.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.854 1.262 . . . . 0.0 112.768 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.01 -171.52 24.91 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 14.6 mmtt -58.66 140.4 54.63 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.294 -0.533 . . . . 0.0 109.658 174.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 m -138.2 149.35 45.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 123.933 0.771 . . . . 0.0 110.721 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 75' ' ' LYS . 50.0 m-85 -134.94 113.88 11.95 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.041 0.936 . . . . 0.0 110.763 -170.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -78.87 125.25 29.12 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.8 2.04 . . . . 0.0 106.479 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -135.15 151.94 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.069 1.348 . . . . 0.0 111.435 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -101.0 116.05 31.94 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 167.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.93 121.31 15.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.93 157.18 25.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.176 0.512 . . . . 0.0 110.031 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.35 11.11 45.64 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.217 -0.769 . . . . 0.0 111.731 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -135.7 167.65 20.74 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.526 1.13 . . . . 0.0 110.339 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -64.98 169.09 5.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.726 1.21 . . . . 0.0 110.659 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -82.97 -11.53 58.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.566 171.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.3 m -55.78 -33.43 64.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.707 1.203 . . . . 0.0 112.031 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.444 ' CH2' ' HD ' ' A' ' 128' ' ' M2L . 38.8 m95 -84.74 4.16 34.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.05 118.97 10.58 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.258 9.1 tt0 -157.23 162.02 39.25 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.589 1.556 . . . . 0.0 107.806 -167.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.435 ' CD1' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -96.68 152.85 18.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.15 0.976 . . . . 0.0 109.497 168.512 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.11 155.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.441 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.49 167.56 28.76 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -17.58 9.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.247 1.419 . . . . 0.0 113.304 176.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.77 -23.19 41.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 113.143 170.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.97 -38.56 2.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.881 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 14' ' ' VAL . 7.2 tt -94.19 155.29 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.728 1.149 . . . . 0.0 112.451 -169.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -153.95 160.23 42.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.275 3.03 . . . . 0.0 108.765 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.78 15.67 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.616 1.553 . . . . 0.0 112.832 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.535 ' CE2' HD11 ' A' ' 105' ' ' ILE . 32.0 t80 -70.22 115.0 8.91 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.056 -1.027 . . . . 0.0 110.023 169.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -162.02 163.64 28.72 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.622 1.569 . . . . 0.0 109.333 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -54.41 -34.34 61.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.629 1.572 . . . . 0.0 113.815 -169.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -63.9 -42.07 97.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.096 0.95 . . . . 0.0 110.412 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.16 -25.85 55.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.552 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.535 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.8 mm -69.59 -37.56 74.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.345 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.6 98.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.275 0.943 . . . . 0.0 109.702 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -49.8 74.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.98 -51.07 69.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.759 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.45 -31.98 58.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 117.63 -1.176 . . . . 0.0 110.176 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.99 -45.72 75.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.827 1.194 . . . . 0.0 110.358 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.06 -46.82 22.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.683 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.06 -29.58 30.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.022 1.329 . . . . 0.0 111.421 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -75.83 -48.12 22.87 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.559 1.143 . . . . 0.0 113.062 173.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.43 -41.73 98.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.366 0.53 . . . . 0.0 111.058 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.27 110.15 4.32 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.766 1.626 . . . . 0.0 108.304 -168.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -143.64 7.58 1.98 Allowed Glycine 0 CA--C 1.531 1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.919 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.0 m -153.05 158.05 41.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.2 m -74.78 64.92 1.31 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.4 -23.42 0.05 OUTLIER Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.864 1.697 . . . . 0.0 111.924 -169.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.7 p -116.13 -1.73 12.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.695 1.248 . . . . 0.0 112.929 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.12 151.65 93.23 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.393 1.077 . . . . 0.0 110.428 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.74 163.06 25.93 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.639 2.892 . . . . 0.0 111.764 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.64 -21.28 64.26 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 112.862 -1.972 . . . . 0.0 113.183 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.8 p -65.1 -26.62 68.29 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.717 1.207 . . . . 0.0 111.662 173.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 133.48 -46.26 1.07 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.419 1.962 . . . . 0.0 109.269 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 61.54 4.6 5.47 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.018 1.77 . . . . 0.0 116.016 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.7 t -148.47 131.96 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 119.431 1.615 . . . . 0.0 106.983 -169.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.603 ' SG ' HM2B ' A' ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? 24.75 88.8 0.07 OUTLIER Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 130.86 3.664 . . . . 0.0 114.742 167.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -90.38 -27.25 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.744 1.63 . . . . 0.0 111.797 -172.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -34.42 77.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -169.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -61.49 140.22 58.11 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.051 0.387 . . . . 0.0 111.301 -170.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -129.71 4.6 5.03 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.754 1.622 . . . . 0.0 109.861 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 128.337 2.655 . . . . 0.0 104.484 177.115 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.95 162.27 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.987 1.315 . . . . 0.0 108.313 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -153.36 -42.44 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.008 0.923 . . . . 0.0 110.812 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.3 tp -63.12 -32.01 73.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.041 1.337 . . . . 0.0 112.01 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -56.5 -36.06 68.72 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.473 1.109 . . . . 0.0 110.816 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.94 -21.15 64.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.736 2.415 . . . . 0.0 113.802 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.93 148.01 25.53 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.057 0.844 . . . . 0.0 109.833 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.79 127.76 31.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.67 131.2 56.67 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 102.403 -3.184 . . . . 0.0 102.403 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -11.42 0.3 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -168.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.24 32.48 0.54 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.19 -170.47 36.47 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 169.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -91.16 153.25 20.17 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.874 HG11 HD11 ' A' ' 97' ' ' ILE . 2.9 p -135.92 158.35 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 169.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 14' ' ' VAL . 9.1 mt -128.28 154.66 45.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.97 129.24 31.82 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -93.18 129.05 39.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -110.19 -6.13 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.435 1.094 . . . . 0.0 111.991 -173.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.02 -80.68 0.29 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -72.42 -29.32 13.82 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.378 2.052 . . . . 0.0 113.16 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.65 177.83 10.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.782 1.633 . . . . 0.0 110.158 -169.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.431 ' CE ' HD13 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -142.75 150.85 40.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.042 1.737 . . . . 0.0 108.887 -168.231 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.61 175.75 9.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.11 147.13 25.07 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 109.746 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 14' ' ' VAL . . . -141.34 160.29 40.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.199 1.799 . . . . 0.0 108.465 -174.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -148.41 103.47 3.43 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 120.938 -1.101 . . . . 0.0 108.882 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 14' ' ' VAL . 79.7 mt -51.64 148.11 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.657 2.383 . . . . 0.0 110.441 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -153.92 -31.89 0.12 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.433 0.693 . . . . 0.0 111.632 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 33.4 ttpt -133.06 135.47 45.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 165.87 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.488 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.7 t-105 -145.45 154.59 42.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.302 -168.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.24 141.3 14.97 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.844 2.457 . . . . 0.0 108.697 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.82 -8.42 23.38 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.474 2.783 . . . . 0.0 113.356 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 m -66.92 -33.61 75.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.586 1.539 . . . . 0.0 110.961 -172.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 p -118.95 -17.39 9.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.733 1.613 . . . . 0.0 110.847 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm 48.81 52.34 14.28 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.01 0.823 . . . . 0.0 109.212 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.9 mtp -148.9 156.94 43.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.476 2.71 . . . . 0.0 104.522 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 53.1 p90 -106.07 170.08 8.12 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.602 0.361 . . . . 0.0 111.666 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 p -142.57 150.58 40.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 126.995 2.118 . . . . 0.0 105.647 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.64 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.5 m -150.79 157.99 43.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -168.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.424 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 8.0 pt -137.67 164.24 42.71 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.224 0.609 . . . . 0.0 109.595 -177.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 94.5 Cg_endo -75.79 33.15 0.39 Allowed 'Trans proline' 0 CA--C 1.546 1.118 1 C-N-CA 125.392 4.061 . . . . 0.0 114.415 -169.225 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -75.04 -1.38 22.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -147.33 169.52 19.27 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.237 -1.54 . . . . 0.0 112.764 -169.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.97 72.28 72.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.783 2.033 . . . . 0.0 106.703 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.65 -25.85 43.68 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.012 2.474 . . . . 0.0 117.012 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.27 -42.4 1.89 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.664 1.12 . . . . 0.0 110.806 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 -18.9 75.21 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.888 0.756 . . . . 0.0 112.122 170.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.7 m -140.73 141.73 34.87 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.427 1.891 . . . . 0.0 107.142 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 m -66.34 -23.73 66.4 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.444 1.098 . . . . 0.0 112.254 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -156.86 158.79 37.38 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.475 1.91 . . . . 0.0 107.153 169.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -76.38 155.7 33.84 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 168.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 m -78.95 156.98 28.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.733 -0.604 . . . . 0.0 110.966 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -54.7 160.77 1.74 Allowed 'General case' 0 C--N 1.338 0.104 0 C-N-CA 124.462 1.105 . . . . 0.0 108.993 168.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -17.24 91.64 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.472 3.109 . . . . 0.0 111.127 -169.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 40' ' ' SER . 5.2 mt -72.03 136.48 25.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.121 -167.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.79 141.68 95.06 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.535 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.34 142.65 27.11 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.931 1.754 . . . . 0.0 108.822 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -129.75 165.91 20.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 108.953 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.622 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -60.37 -25.4 65.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 -168.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.6 tt 73.46 144.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.847 2.059 . . . . 0.0 112.66 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.97 25.16 5.47 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.989 -0.895 . . . . 0.0 115.188 169.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.25 -34.6 55.81 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.062 1.431 . . . . 0.0 109.113 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -153.16 -24.15 0.15 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.435 1.894 . . . . 0.0 112.369 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 34.3 mp0 -55.6 -19.51 10.54 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 129.162 2.985 . . . . 0.0 115.216 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -17.54 108.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.465 2.706 . . . . 0.0 111.962 -169.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.464 HG12 HD11 ' A' ' 71' ' ' ILE 0.342 4.3 tt -115.26 136.6 22.71 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.509 2.324 . . . . 0.0 106.764 -166.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.97 151.81 56.67 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.107 1.871 . . . . 0.0 111.578 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.61 -16.64 10.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.766 1.227 . . . . 0.0 113.339 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.71 -24.64 67.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.634 1.174 . . . . 0.0 112.367 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 67' ' ' ILE . 3.6 pt -125.16 -15.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.706 0.684 . . . . 0.0 110.688 -170.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.488 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 3.0 mm -54.67 -44.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.342 2.257 . . . . 0.0 107.158 169.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -81.15 11.31 4.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.177 1.791 . . . . 0.0 112.562 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.38 -172.26 26.29 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.636 1.107 . . . . 0.0 111.569 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -60.14 137.13 58.17 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -139.24 150.22 45.24 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.957 0.785 . . . . 0.0 110.465 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -137.04 115.58 11.96 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 110.272 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 41.3 t80 -82.04 130.87 35.2 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 126.348 1.859 . . . . 0.0 106.44 169.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.05 151.83 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.643 -167.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.62 122.96 36.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.71 115.63 11.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.49 147.99 30.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -173.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.16 46.8 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.336 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.491 ' CD1' HM2B ' A' ' 128' ' ' M2L . 78.9 m95 -130.73 171.47 13.06 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.597 1.199 . . . . 0.0 111.668 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -73.28 161.16 30.84 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.082 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.7 m -76.72 -13.86 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.229 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -51.1 -36.04 38.3 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.382 1.473 . . . . 0.0 111.979 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -88.06 2.13 52.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.76 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.55 121.64 14.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -172.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.276 7.7 tp10 -159.13 169.19 24.73 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.894 1.278 . . . . 0.0 108.099 -167.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.64 153.34 19.85 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.775 0.797 . . . . 0.0 110.744 168.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.434 HG23 HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -129.24 156.3 41.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.239 172.82 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.08 161.12 31.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.408 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.8 7.44 0.9 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -87.43 -21.04 25.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.991 1.716 . . . . 0.0 111.115 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm105 -117.91 -35.37 3.9 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.599 1.16 . . . . 0.0 111.813 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.874 HD11 HG11 ' A' ' 14' ' ' VAL . 4.4 tt -101.42 150.24 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.219 0.918 . . . . 0.0 110.094 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 87.4 mtt180 -147.32 143.8 28.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.094 1.358 . . . . 0.0 112.076 170.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HA ' HG23 ' A' ' 14' ' ' VAL . . . -68.18 147.81 51.74 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.703 2.001 . . . . 0.0 111.33 -176.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE2' HD11 ' A' ' 105' ' ' ILE . 34.4 t80 -59.52 114.68 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.197 0.453 . . . . 0.0 111.407 -169.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -160.53 162.23 32.92 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.27 -33.74 67.93 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.58 -42.99 98.27 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.598 0.713 . . . . 0.0 110.082 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -67.91 -36.59 80.45 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.412 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -67.58 -34.87 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.498 0.59 . . . . 0.0 110.804 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.29 98.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.209 0.913 . . . . 0.0 109.955 174.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -47.67 83.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -60.23 -48.95 79.56 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.732 0.813 . . . . 0.0 109.282 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -71.64 -43.89 65.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.34 0.518 . . . . 0.0 109.804 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -29.06 41.14 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.017 172.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.5 mt -92.96 -45.47 7.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.537 1.517 . . . . 0.0 112.341 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.0 -26.15 10.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.651 1.58 . . . . 0.0 111.491 170.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -62.72 -45.78 91.15 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.967 1.707 . . . . 0.0 112.969 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.36 -17.21 24.97 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.943 0.792 . . . . 0.0 112.815 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -49.55 118.07 2.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.955 1.702 . . . . 0.0 111.543 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.34 34.98 0.22 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.956 1.741 . . . . 0.0 109.879 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.51 -36.53 78.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.657 1.183 . . . . 0.0 113.057 -169.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.1 m -141.82 33.27 1.59 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.313 0.506 . . . . 0.0 111.265 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.54 174.55 46.15 Favored Glycine 0 CA--C 1.525 0.682 0 O-C-N 121.197 -0.939 . . . . 0.0 111.486 172.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -83.87 17.99 2.17 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.88 1.672 . . . . 0.0 113.313 -171.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.83 151.24 45.32 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 124.877 1.271 . . . . 0.0 109.495 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.57 15.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 125.24 3.96 . . . . 0.0 117.652 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.31 22.04 3.2 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.337 1.455 . . . . 0.0 111.49 -175.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.4 m -136.55 110.05 7.97 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 162.0 -127.43 1.72 Allowed Glycine 0 C--N 1.332 0.352 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.28 68.37 0.69 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 168.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -146.93 149.15 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -167.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' M2L . . . . . 0.491 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 17.11 93.65 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.826 1 C-N-CA 132.217 4.207 . . . . 0.0 115.06 168.504 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -95.99 -12.02 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.04 2.494 . . . . 0.0 112.344 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -60.23 -16.95 38.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.887 2.475 . . . . 0.0 114.991 -170.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.32 67.14 1.38 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.137 1.375 . . . . 0.0 112.084 -170.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -151.26 171.22 17.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.263 2.225 . . . . 0.0 108.02 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 . . . . . 0 C--O 1.252 1.203 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.102 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 . . . . . 0 C--O 1.236 0.377 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -56.93 134.15 55.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 168.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.77 125.74 44.51 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -10.18 0.93 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -168.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 28.7 1.2 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.02 -175.27 50.94 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.48 157.3 18.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.06 153.49 37.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 168.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 14' ' ' VAL . 21.0 mt -122.07 139.38 53.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 173.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.66 123.16 28.77 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.229 0.956 . . . . 0.0 109.386 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -101.5 118.38 36.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.752 1.621 . . . . 0.0 107.6 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -95.08 -25.63 16.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.161 0.585 . . . . 0.0 111.439 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.82 -72.29 0.27 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -72.4 -30.51 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.079 1.853 . . . . 0.0 112.485 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -154.27 177.12 11.48 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.929 1.692 . . . . 0.0 109.63 -170.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.409 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -144.07 151.93 40.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.109 1.764 . . . . 0.0 108.175 -168.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -139.19 167.35 22.25 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.552 1.141 . . . . 0.0 110.583 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.34 144.89 29.37 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.34 161.71 37.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.522 1.529 . . . . 0.0 108.998 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -149.11 108.22 3.91 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.124 -0.985 . . . . 0.0 110.366 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.566 HD11 HG11 ' A' ' 14' ' ' VAL . 68.9 mt -53.8 151.06 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.229 3.012 . . . . 0.0 111.348 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.01 -30.05 0.08 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 34.4 ttpt -132.62 136.58 46.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.85 159.89 30.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -168.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -143.68 152.85 41.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.547 -168.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -150.91 142.84 15.76 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 126.065 1.746 . . . . 0.0 109.418 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.79 -11.13 31.05 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.971 2.448 . . . . 0.0 113.7 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.3 m -63.81 -32.62 74.19 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.852 1.205 . . . . 0.0 112.021 -171.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 m -125.82 -4.65 6.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.768 1.227 . . . . 0.0 111.421 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 41.45 50.66 3.67 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 125.298 1.439 . . . . 0.0 111.105 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.405 ' HE3' ' CB ' ' A' ' 58' ' ' PRO . 10.5 mtm -150.08 163.37 38.35 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 170.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.404 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 50.8 p90 -103.85 175.7 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.747 0.819 . . . . 0.0 112.272 -173.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 p -143.15 153.51 42.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.346 2.259 . . . . 0.0 106.907 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.643 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.0 m -153.23 163.49 39.79 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 6.6 pt . . . . . 0 CA--C 1.552 1.049 0 C-N-CA 125.794 1.638 . . . . 0.0 108.726 179.836 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt . . . . . 0 CA--C 1.514 -0.439 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 4.79 80.77 0.0 OUTLIER 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.341 2.657 . . . . 0.0 113.532 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.643 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.2 mt -73.78 136.23 25.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -169.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -78.58 146.13 68.82 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' CB ' ' HE3' ' A' ' 37' ' ' MET . 38.7 Cg_exo -52.73 134.34 53.56 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.848 2.365 . . . . 0.0 110.137 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -144.9 153.74 41.88 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -65.74 135.82 55.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.19 0.995 . . . . 0.0 109.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.22 153.72 33.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.18 1.792 . . . . 0.0 111.631 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.64 21.88 5.27 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 124.131 0.894 . . . . 0.0 112.783 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -75.87 -34.74 60.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.098 0.949 . . . . 0.0 109.207 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -149.37 4.88 0.62 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.677 1.191 . . . . 0.0 111.855 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.639 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 7.0 mp0 -114.18 168.47 9.8 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.476 1.51 . . . . 0.0 110.532 -169.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -149.54 138.96 21.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 71' ' ' ILE . 12.9 pt -135.1 128.9 18.74 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.85 162.38 41.64 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.958 1.772 . . . . 0.0 109.56 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -15.72 9.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.924 0.89 . . . . 0.0 112.316 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.55 -31.18 72.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.824 1.25 . . . . 0.0 112.119 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 67' ' ' ILE 0.254 4.6 pt -121.27 -9.09 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 119.812 1.187 . . . . 0.0 110.447 -172.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.43 -49.28 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 127.6 2.36 . . . . 0.0 106.137 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -79.44 10.24 4.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.774 1.63 . . . . 0.0 112.114 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.34 28.85 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 119.454 1.024 . . . . 0.0 111.399 -173.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -64.39 132.97 51.61 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.5 m -138.27 154.54 49.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.393 1.058 . . . . 0.0 111.844 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 35.9 m-85 -142.11 115.44 8.93 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.764 -169.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 46.5 t80 -80.82 128.29 33.49 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -138.25 155.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.458 -167.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -100.45 118.23 36.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.59 121.89 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -90.22 150.27 22.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 10.28 52.71 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.616 -169.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 31.8 m95 -136.07 172.04 13.59 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.833 1.253 . . . . 0.0 111.25 -174.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -71.36 163.08 28.37 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.324 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 m -77.64 -12.11 59.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 171.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 m -55.43 -31.15 61.67 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.969 -1.082 . . . . 0.0 111.713 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -82.79 0.02 45.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.974 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -64.61 112.87 3.37 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -157.63 168.71 26.48 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.098 1.759 . . . . 0.0 107.975 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.639 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.9 152.46 20.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.042 0.925 . . . . 0.0 110.479 168.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.42 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.006 171.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.8 158.84 35.62 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.412 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -70.47 6.83 1.23 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.78 -26.68 25.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.624 1.57 . . . . 0.0 110.974 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -107.76 -40.42 5.29 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.363 1.065 . . . . 0.0 111.093 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 14' ' ' VAL . 5.4 tt -100.61 148.9 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.596 1.089 . . . . 0.0 110.443 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.412 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 96.2 mtt180 -145.62 151.28 37.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.94 168.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.54 146.23 52.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.506 1.522 . . . . 0.0 110.403 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.489 ' CE2' HD11 ' A' ' 105' ' ' ILE . 44.8 t80 -61.12 114.75 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 119.053 0.842 . . . . 0.0 112.194 -169.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -159.25 164.82 34.64 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.223 1.409 . . . . 0.0 110.126 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.27 -33.9 68.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.594 1.557 . . . . 0.0 113.527 -169.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.24 -42.27 96.59 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.724 0.773 . . . . 0.0 109.572 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -68.75 -34.96 76.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.489 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.9 mm -66.91 -36.79 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 118.687 0.676 . . . . 0.0 110.833 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.96 99.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.259 0.936 . . . . 0.0 109.924 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -57.49 -50.85 71.71 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 170.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -57.72 -48.92 78.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.661 0.785 . . . . 0.0 109.757 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -72.36 -38.99 68.4 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.798 0.839 . . . . 0.0 110.718 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -47.28 82.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.835 0.743 . . . . 0.0 109.215 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.8 mt -73.42 -42.77 61.65 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.434 -0.791 . . . . 0.0 111.819 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.31 -20.05 3.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.294 1.438 . . . . 0.0 112.606 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 . . . . . 0 C--N 1.341 0.199 0 CA-C-N 118.921 0.782 . . . . 0.0 111.557 172.342 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 . . . . . 0 C--O 1.235 0.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 51.0 p90 -59.99 142.65 53.49 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.34 134.44 45.2 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -169.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.516 HD13 HD12 ' A' ' 30' ' ' ILE . 10.1 tp -59.73 -3.14 0.45 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -168.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.87 29.21 0.42 Allowed Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 170.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.72 179.59 48.94 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 -82.28 156.75 24.15 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -137.29 168.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.37 -2.455 . . . . 0.0 104.37 170.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 14' ' ' VAL . 42.8 mt -141.85 130.66 22.93 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 -172.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.98 130.08 51.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -103.71 114.06 28.04 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -171.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -94.29 -12.84 27.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.446 0.698 . . . . 0.0 111.757 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.96 -73.85 0.37 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.983 1.278 . . . . 0.0 109.914 171.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -66.7 -38.32 18.58 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.059 2.506 . . . . 0.0 113.4 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 22' ' ' MET . 18.7 tp -150.88 176.86 10.68 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 125.417 1.487 . . . . 0.0 108.798 -168.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -139.5 146.27 39.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.86 2.064 . . . . 0.0 107.014 -169.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -131.5 154.04 49.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.883 0.873 . . . . 0.0 108.729 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -81.08 138.57 35.96 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.011 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.03 158.55 40.02 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.605 1.562 . . . . 0.0 109.344 -171.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.76 96.6 2.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.63 0.372 . . . . 0.0 110.269 -169.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.618 HD11 HG11 ' A' ' 14' ' ' VAL . 42.6 mt -62.16 152.29 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 129.65 3.18 . . . . 0.0 112.41 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.26 -25.21 0.05 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.842 -1.075 . . . . 0.0 112.935 167.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.9 ttpt -128.77 136.13 50.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.516 HD12 HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -137.26 163.42 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.754 0.788 . . . . 0.0 109.024 -173.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -140.16 152.03 45.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.37 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -147.37 139.35 13.88 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.6 1.96 . . . . 0.0 108.428 -172.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.61 -10.27 27.35 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.372 2.715 . . . . 0.0 113.426 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 m -67.11 -32.12 73.05 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.116 1.325 . . . . 0.0 111.491 -170.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -121.63 -13.68 8.3 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.641 1.576 . . . . 0.0 110.823 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt 47.47 50.04 15.25 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.423 ' SD ' ' HE3' ' A' ' 60' ' ' LYS . 5.8 mtm -146.93 165.56 29.42 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.999 2.119 . . . . 0.0 106.396 170.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 49.0 p90 -107.72 175.18 5.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.968 0.907 . . . . 0.0 112.721 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -146.41 151.09 36.89 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 127.206 2.202 . . . . 0.0 107.336 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.455 ' HB3' HD12 ' A' ' 56' ' ' ILE . 47.6 t -147.19 160.84 41.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 110.102 -179.256 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.17 103.87 1.32 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.3 mt -69.85 130.96 34.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -67.63 139.22 93.83 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.02 139.39 70.71 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.966 1.778 . . . . 0.0 110.667 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -136.92 158.47 44.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 4.2 mmpt? -63.44 122.74 17.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.23 147.7 47.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.681 1.192 . . . . 0.0 111.729 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.0 -127.21 1.18 Allowed Glycine 0 N--CA 1.446 -0.661 1 N-CA-C 102.922 -4.071 . . . . 0.0 102.922 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 53.43 30.13 9.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.355 1.062 . . . . 0.0 113.298 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.64 10.45 5.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.764 2.025 . . . . 0.0 114.263 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.502 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 8.6 mm-40 -73.17 6.83 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.263 1.425 . . . . 0.0 113.586 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -22.4 118.47 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 128.63 2.772 . . . . 0.0 114.21 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 71' ' ' ILE . 10.5 pt -115.43 128.68 25.75 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.82 159.49 52.55 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.835 1.69 . . . . 0.0 109.388 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.77 -21.69 11.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.719 0.808 . . . . 0.0 111.611 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.7 -37.96 69.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.472 1.909 . . . . 0.0 114.196 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 67' ' ' ILE . 13.4 pt -116.12 -14.79 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.041 1.291 . . . . 0.0 110.814 -172.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mm -50.32 -45.96 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 128.007 2.523 . . . . 0.0 108.504 169.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.57 8.2 10.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.963 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.31 178.72 25.71 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 120.209 1.368 . . . . 0.0 111.44 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.48 130.13 45.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.0 m -131.82 143.69 50.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 124.191 0.932 . . . . 0.0 109.588 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CE1' ' CD1' ' A' ' 8' ' ' PHE . 63.3 m-85 -128.76 111.72 13.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.199 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -78.24 126.68 31.15 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.097 1.359 . . . . 0.0 107.564 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -136.65 158.6 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 125.44 1.713 . . . . 0.0 110.973 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -111.57 121.97 46.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -73.32 121.91 21.17 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -66.87 147.87 52.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.422 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.05 14.38 58.95 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.913 -0.937 . . . . 0.0 113.641 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -135.08 171.39 14.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.885 1.342 . . . . 0.0 110.819 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -68.05 157.98 33.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.903 0.481 . . . . 0.0 111.213 -173.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 m -65.08 -21.66 66.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.21 1.004 . . . . 0.0 111.904 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -54.77 -32.11 59.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.06 1.344 . . . . 0.0 112.713 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -88.4 3.67 49.1 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.049 -0.976 . . . . 0.0 112.776 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.54 117.17 7.63 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.252 7.6 tp10 -157.7 167.48 29.97 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.84 -167.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.502 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -98.72 150.45 21.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.886 0.851 . . . . 0.0 110.313 168.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.52 156.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.887 1.275 . . . . 0.0 109.976 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.77 167.46 26.97 Favored Glycine 0 C--O 1.24 0.52 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.072 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -17.34 9.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.395 1.478 . . . . 0.0 113.387 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -56.77 -22.88 39.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.123 1.369 . . . . 0.0 113.172 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -124.54 -39.22 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.228 173.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 14' ' ' VAL . 7.2 tt -93.71 153.24 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.23 0.923 . . . . 0.0 111.268 -169.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -149.88 156.97 42.7 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 127.503 2.321 . . . . 0.0 109.203 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.6 27.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.252 1.021 . . . . 0.0 111.107 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 105' ' ' ILE . 15.3 t80 -75.23 113.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -155.98 161.67 40.45 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.594 1.558 . . . . 0.0 108.687 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.54 -33.88 56.22 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.766 1.626 . . . . 0.0 114.469 -169.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.74 -44.97 84.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.289 1.519 . . . . 0.0 109.639 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -75.26 -19.28 59.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.404 HD11 ' CE2' ' A' ' 100' ' ' TYR . 7.8 mm -74.6 -33.48 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 119.061 0.846 . . . . 0.0 110.25 168.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.99 93.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.212 0.915 . . . . 0.0 108.787 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.8 ttp -58.61 -56.63 19.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.55 0.614 . . . . 0.0 109.364 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -50.08 -45.96 52.98 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.776 1.23 . . . . 0.0 110.956 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -79.43 -41.75 26.92 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.803 1.241 . . . . 0.0 111.553 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -39.59 73.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.644 1.111 . . . . 0.0 109.347 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.18 -46.49 20.38 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.73 30.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.991 0.917 . . . . 0.0 111.469 171.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 t30 . . . . . 0 CA--C 1.532 0.256 0 C-N-CA 124.019 0.928 . . . . 0.0 112.071 174.757 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--O 1.233 0.201 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.441 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -59.26 87.83 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.873 2.069 . . . . 0.0 110.461 169.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.89 130.4 37.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.441 HD22 HG12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -61.34 -8.08 3.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -169.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.09 30.61 0.98 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 173.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.11 -163.79 28.7 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 106.585 -2.606 . . . . 0.0 106.585 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 156.29 17.45 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -131.06 154.72 41.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 168.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 14' ' ' VAL . 34.8 mt -125.06 131.6 53.31 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 176.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.55 121.55 35.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.649 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.16 125.21 44.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.034 1.334 . . . . 0.0 107.959 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -98.94 -25.73 14.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.886 0.474 . . . . 0.0 111.607 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.11 -71.86 0.34 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.26 -32.67 12.45 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.857 1.705 . . . . 0.0 112.614 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.4 178.83 9.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.194 1.397 . . . . 0.0 109.6 -174.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.07 151.41 40.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.878 2.071 . . . . 0.0 107.95 -168.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -138.0 159.84 40.93 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.76 0.824 . . . . 0.0 111.108 -170.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.42 140.82 43.16 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 160.6 39.21 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.738 1.615 . . . . 0.0 107.582 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -147.54 103.37 3.53 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.239 -0.913 . . . . 0.0 109.699 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 14' ' ' VAL . 67.9 mt -57.72 150.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.889 2.076 . . . . 0.0 111.854 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -160.53 -24.43 0.06 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.776 -1.107 . . . . 0.0 113.109 167.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.1 ttpt -126.49 138.7 53.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 pt -139.64 160.47 27.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -147.4 151.12 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -169.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -150.57 142.46 15.57 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.995 1.718 . . . . 0.0 108.465 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 -11.38 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.092 2.528 . . . . 0.0 113.644 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.2 m -64.01 -34.84 78.91 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -120.56 -7.09 9.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.178 0.991 . . . . 0.0 111.186 174.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 44.45 49.45 8.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.679 1.192 . . . . 0.0 109.801 -169.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtp -146.0 147.88 32.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -94.85 173.19 7.72 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.661 0.384 . . . . 0.0 110.53 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -143.97 145.45 32.25 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.975 2.11 . . . . 0.0 105.424 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.682 ' HB2' HD12 ' A' ' 56' ' ' ILE . 1.5 m -143.39 157.18 44.67 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -171.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.441 HG12 HD22 ' A' ' 10' ' ' LEU . 26.7 pt . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 170.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.8 tttm . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -58.69 107.53 0.53 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.682 HD12 ' HB2' ' A' ' 40' ' ' SER . 23.4 mt -73.71 139.55 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -169.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -67.93 134.09 92.0 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.126 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.31 130.52 18.79 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 106.181 -2.276 . . . . 0.0 106.181 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -140.3 165.66 26.79 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.55 150.26 44.38 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 62' ' ' GLY . 6.3 tt -114.43 146.45 40.61 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.519 1.928 . . . . 0.0 110.284 -168.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.503 ' N ' HD23 ' A' ' 61' ' ' LEU . . . 114.11 36.05 1.41 Allowed Glycine 0 CA--C 1.524 0.652 0 O-C-N 124.377 1.048 . . . . 0.0 114.501 169.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -72.13 -33.22 67.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.731 1.266 . . . . 0.0 108.422 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.48 -29.88 0.13 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.372 1.869 . . . . 0.0 111.97 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 35.81 0.44 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.328 2.251 . . . . 0.0 112.78 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -32.73 144.21 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.785 2.434 . . . . 0.0 114.32 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -132.55 136.38 27.8 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 161.02 47.53 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.663 1.576 . . . . 0.0 109.575 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.76 -12.68 2.01 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.638 1.175 . . . . 0.0 112.711 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.84 -29.82 68.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.186 1.394 . . . . 0.0 113.037 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 pt -121.27 -9.91 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.371 1.441 . . . . 0.0 111.338 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mm -53.67 -45.95 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 128.688 2.795 . . . . 0.0 108.011 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.19 8.41 8.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 111.933 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.78 179.02 26.9 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 120.071 1.305 . . . . 0.0 111.33 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -64.41 129.99 42.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -136.86 151.17 48.8 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.155 0.909 . . . . 0.0 111.004 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.5 m-85 -139.88 115.41 10.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.48 1.512 . . . . 0.0 108.711 -169.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.76 129.58 35.0 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 126.168 1.787 . . . . 0.0 106.899 170.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.39 155.68 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.95 -168.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -101.94 119.53 38.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 167.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -71.07 117.15 12.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -83.73 151.08 25.42 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.851 0.46 . . . . 0.0 109.778 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.49 7.98 36.38 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.033 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -138.2 173.89 11.14 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.725 1.21 . . . . 0.0 110.786 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -72.55 165.98 23.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.199 0.523 . . . . 0.0 111.382 -170.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.51 -11.59 59.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.46 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 m -57.66 -32.48 67.35 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.191 -0.943 . . . . 0.0 111.737 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -83.54 4.97 25.77 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.468 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.95 108.6 2.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -153.66 163.81 39.37 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.622 1.569 . . . . 0.0 107.79 -167.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.76 150.15 22.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.648 0.737 . . . . 0.0 109.612 168.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.18 150.06 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.27 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.64 160.81 37.98 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 173.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.22 9.02 0.83 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.09 -30.72 20.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.835 1.654 . . . . 0.0 110.703 168.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -102.47 -39.85 6.94 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.496 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 14' ' ' VAL . 4.9 tt -101.13 149.64 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.389 0.995 . . . . 0.0 110.762 -173.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 84.7 mtt180 -145.48 147.73 32.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.122 1.369 . . . . 0.0 110.225 169.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.81 144.3 54.34 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.134 1.373 . . . . 0.0 110.238 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.482 ' CE2' HD11 ' A' ' 105' ' ' ILE . 42.4 t80 -60.34 115.49 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.114 0.87 . . . . 0.0 111.87 -169.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -161.27 165.1 29.73 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.432 1.493 . . . . 0.0 110.431 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.15 -33.99 65.73 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.53 1.532 . . . . 0.0 113.715 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.42 -43.96 96.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.174 0.988 . . . . 0.0 109.949 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -68.75 -33.77 74.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.6 mm -69.27 -34.07 61.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.507 0.594 . . . . 0.0 110.682 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.35 99.34 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 119.414 1.006 . . . . 0.0 109.625 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -48.32 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -60.68 -45.44 94.16 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.44 0.696 . . . . 0.0 109.681 -173.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -76.07 -44.11 40.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.17 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -57.35 -33.96 68.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.783 0.72 . . . . 0.0 110.569 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.32 -52.23 9.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.73 -27.19 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.928 1.291 . . . . 0.0 111.747 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.8 t30 . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 124.477 1.111 . . . . 0.0 113.448 174.135 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 C--O 1.234 0.24 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -60.06 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 126.875 2.07 . . . . 0.0 109.953 170.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.11 130.4 39.72 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -4.07 1.74 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -168.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.66 33.36 0.69 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.4 -161.37 27.11 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 107.346 -2.301 . . . . 0.0 107.346 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.426 ' HG2' HE22 ' A' ' 82' ' ' GLN . 56.3 mtt180 -102.96 156.65 17.52 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 168.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.573 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -131.24 156.54 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 168.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 14' ' ' VAL . 43.9 mt -126.03 134.98 51.27 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.16 129.21 47.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.177 0.923 . . . . 0.0 110.038 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -105.98 131.81 52.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 109.638 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -113.68 -19.93 11.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.758 0.823 . . . . 0.0 111.655 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.95 -72.8 0.31 Allowed Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.75 -32.75 29.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.843 1.695 . . . . 0.0 112.26 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 -179.26 7.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.702 1.601 . . . . 0.0 109.311 -170.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.439 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -140.94 160.61 39.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.779 1.632 . . . . 0.0 107.281 -175.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.07 160.39 39.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.951 0.9 . . . . 0.0 109.508 -170.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -77.24 140.91 40.2 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.67 41.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.671 1.588 . . . . 0.0 108.672 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -148.5 101.52 3.24 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.142 -0.973 . . . . 0.0 110.339 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.573 HD11 HG11 ' A' ' 14' ' ' VAL . 64.0 mt -58.93 150.23 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 127.769 2.428 . . . . 0.0 112.025 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.484 HD22 ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.51 -28.37 0.05 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 116.51 -1.709 . . . . 0.0 112.374 166.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 20.7 mtmt -114.72 144.79 42.9 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 168.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -142.26 161.07 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -149.6 152.7 35.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.386 -169.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.01 138.69 13.12 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.187 2.195 . . . . 0.0 108.453 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.89 -9.95 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.503 2.802 . . . . 0.0 113.57 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 m -66.57 -32.04 73.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.934 1.243 . . . . 0.0 111.538 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.8 p -121.1 -15.32 8.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.863 1.665 . . . . 0.0 110.866 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 48.62 49.01 19.19 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.917 0.887 . . . . 0.0 109.757 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.3 mtp -144.85 154.78 43.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.961 2.104 . . . . 0.0 105.793 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -104.52 170.56 7.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.223 0.609 . . . . 0.0 111.911 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -138.64 152.89 48.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.911 2.085 . . . . 0.0 106.445 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 56' ' ' ILE . 24.8 m -152.2 156.27 39.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -168.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 pt . . . . . 0 CA--C 1.55 0.951 0 C-N-CA 124.849 1.259 . . . . 0.0 109.852 -177.699 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 mttt . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 106.233 -1.765 . . . . 0.0 106.233 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.51 101.43 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.486 HD12 ' HB2' ' A' ' 40' ' ' SER . 3.7 mt -76.12 135.27 27.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -175.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.35 140.55 87.7 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.63 139.88 38.19 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.051 1.834 . . . . 0.0 107.381 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -143.65 160.0 41.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -62.99 131.79 49.83 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -80.35 153.89 28.09 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.404 1.482 . . . . 0.0 111.727 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.12 31.63 1.68 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.37 -40.16 27.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.872 1.336 . . . . 0.0 109.216 169.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -160.32 2.65 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.121 0.968 . . . . 0.0 113.286 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.12 47.21 2.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.678 1.591 . . . . 0.0 111.724 -169.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 m -33.05 142.06 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.65 3.18 . . . . 0.0 113.345 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 71' ' ' ILE . 5.8 pt -135.19 132.23 20.04 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 168.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.87 158.85 55.44 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.255 1.303 . . . . 0.0 109.302 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.18 -16.36 3.08 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.341 1.456 . . . . 0.0 112.271 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.13 -32.13 73.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.27 1.828 . . . . 0.0 112.955 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 67' ' ' ILE . 14.9 pt -120.45 -13.19 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.528 1.513 . . . . 0.0 110.868 -173.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.74 -46.03 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 128.278 2.631 . . . . 0.0 108.759 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -79.59 9.03 5.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.95 0.9 . . . . 0.0 111.886 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.1 -176.37 27.23 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.922 1.237 . . . . 0.0 111.093 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.08 130.87 48.0 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -134.29 154.39 51.33 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.885 0.741 . . . . 0.0 110.941 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 23.9 m-85 -141.78 113.49 7.83 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.108 1.363 . . . . 0.0 109.265 -169.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.509 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 55.3 t80 -80.01 129.07 34.2 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.33 157.36 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.362 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -105.8 120.09 40.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 167.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -72.73 118.45 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.426 HE22 ' HG2' ' A' ' 13' ' ' ARG . 62.3 mt-30 -77.7 150.2 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.08 10.91 42.91 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.925 -0.93 . . . . 0.0 113.017 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -134.87 171.01 15.0 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 1.233 . . . . 0.0 111.327 -174.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -69.25 158.23 35.39 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.024 0.53 . . . . 0.0 111.338 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 p -63.92 -19.76 65.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.813 0.845 . . . . 0.0 112.127 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.1 m -54.19 -31.94 54.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.424 1.089 . . . . 0.0 112.779 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -84.14 3.23 35.87 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.95 107.01 2.94 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.253 7.5 tp10 -154.31 168.54 26.25 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.623 1.969 . . . . 0.0 107.854 -167.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.61 151.24 22.58 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.823 0.82 . . . . 0.0 111.011 168.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.68 156.38 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.128 174.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.77 161.32 27.0 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.0 1.286 . . . . 0.0 110.11 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.74 7.5 1.49 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -176.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.56 -20.5 27.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.888 1.675 . . . . 0.0 110.752 169.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -119.0 -31.31 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.01 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 14' ' ' VAL . 4.9 tt -108.22 155.91 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 120.665 1.575 . . . . 0.0 111.694 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.453 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 11.0 mtt85 -149.19 146.84 27.83 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.027 1.331 . . . . 0.0 110.32 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . 0.259 . . -66.99 143.89 56.52 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.339 1.855 . . . . 0.0 111.916 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -59.06 118.67 6.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.461 1.482 . . . . 0.0 111.516 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -169.35 164.78 10.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.06 1.744 . . . . 0.0 110.622 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.97 -27.99 63.95 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.175 -0.953 . . . . 0.0 113.511 -169.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.18 -45.92 72.13 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 119.543 1.065 . . . . 0.0 110.778 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -74.74 -22.35 58.85 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.02 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.18 -37.65 67.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 118.752 0.705 . . . . 0.0 110.127 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.06 99.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.577 1.08 . . . . 0.0 109.742 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.6 ttp -58.13 -53.68 55.48 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -57.75 -46.41 84.54 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.82 -172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -70.74 -45.19 65.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.237 0.926 . . . . 0.0 110.351 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -34.02 60.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.455 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.6 mt -87.63 -47.27 8.82 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.954 0.797 . . . . 0.0 111.996 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.23 14.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.241 1.416 . . . . 0.0 110.936 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t30 . . . . . 0 C--O 1.235 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 112.957 172.119 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -62.71 82.6 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 124.481 2.086 . . . . 0.0 110.293 169.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.07 128.67 34.88 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 103.455 -2.794 . . . . 0.0 103.455 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.86 -2.82 2.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.77 29.41 1.03 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -166.09 34.7 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 168.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -98.28 156.37 16.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.92 156.42 42.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 169.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 14' ' ' VAL . 32.7 mt -127.75 141.27 51.63 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.96 127.09 44.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.171 0.919 . . . . 0.0 109.155 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -86.2 138.07 32.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.383 1.073 . . . . 0.0 108.323 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -120.22 -11.46 9.2 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.19 0.996 . . . . 0.0 112.385 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.67 -72.65 0.48 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.49 -39.11 22.88 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.258 1.972 . . . . 0.0 112.601 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 22' ' ' MET . 10.7 tp -152.27 -171.81 4.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 125.818 1.647 . . . . 0.0 108.919 -169.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.422 ' H ' ' HG ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -151.63 150.77 30.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.438 2.295 . . . . 0.0 107.27 -169.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.01 164.19 29.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.985 0.514 . . . . 0.0 111.397 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.0 137.73 37.71 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 125.492 1.517 . . . . 0.0 109.132 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.6 166.24 22.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.999 1.72 . . . . 0.0 108.76 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -152.59 93.46 1.78 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 110.582 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.566 HD11 HG11 ' A' ' 14' ' ' VAL . 66.1 mt -53.11 152.43 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.09 2.156 . . . . 0.0 111.523 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -154.96 -35.06 0.09 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.935 0.894 . . . . 0.0 111.009 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 37.5 ttpt -128.93 137.09 51.2 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.15 164.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -141.39 152.88 44.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.228 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -135.11 150.38 72.79 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 127.596 2.358 . . . . 0.0 110.726 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.75 -17.42 7.18 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.787 2.991 . . . . 0.0 112.877 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m -62.08 -37.49 85.23 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.944 1.298 . . . . 0.0 111.979 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.2 m -128.62 5.89 5.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.155 1.782 . . . . 0.0 111.341 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 46.03 55.89 6.65 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 125.173 1.389 . . . . 0.0 109.932 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 ptm -150.94 169.27 22.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.408 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 49.0 p90 -114.38 172.67 6.87 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.451 0.701 . . . . 0.0 112.444 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -145.11 151.4 38.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.256 2.222 . . . . 0.0 106.627 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.478 ' HB3' HD12 ' A' ' 56' ' ' ILE . 40.8 t -144.58 152.06 39.97 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pp . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.801 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 79.1 mttt . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.43 101.18 0.3 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 40' ' ' SER . 4.3 mt -74.54 134.24 29.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -67.7 143.43 96.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.0 134.67 18.08 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 N-CA-C 107.476 -1.779 . . . . 0.0 107.476 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -137.35 167.81 20.87 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -60.99 154.37 22.75 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.88 153.31 23.22 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 111.333 -168.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.83 30.75 3.13 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-O 119.544 -0.587 . . . . 0.0 112.911 170.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.33 -26.26 38.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.221 1.011 . . . . 0.0 110.281 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -152.07 -31.69 0.15 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.209 1.003 . . . . 0.0 112.149 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HB2' ' HE1' ' A' ' 91' ' ' TRP . 0.7 OUTLIER -76.41 179.6 5.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.237 1.415 . . . . 0.0 110.621 171.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.4 m -154.8 152.02 29.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.456 2.702 . . . . 0.0 105.827 169.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 67' ' ' ILE . 6.9 pt -136.45 130.6 18.12 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 168.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.18 159.71 51.95 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.999 1.8 . . . . 0.0 109.846 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.01 -20.89 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.266 1.026 . . . . 0.0 112.145 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.59 -36.94 74.77 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.233 1.813 . . . . 0.0 113.677 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 67' ' ' ILE . 8.4 pt -116.99 -9.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.998 0.817 . . . . 0.0 110.901 -170.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.59 -47.98 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.696 2.799 . . . . 0.0 108.627 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.8 12.03 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.414 0.686 . . . . 0.0 112.841 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.61 -175.77 24.49 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -57.1 139.64 51.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.6 t -140.33 155.62 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.572 0.545 . . . . 0.0 110.03 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.422 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 25.3 m-85 -140.16 113.4 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.77 1.228 . . . . 0.0 110.906 -169.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -78.16 124.59 28.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.901 2.08 . . . . 0.0 106.374 169.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -134.97 157.44 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 113.45 -1.704 . . . . 0.0 111.429 -168.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -103.78 118.32 36.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.057 -2.572 . . . . 0.0 104.057 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -73.39 117.84 15.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.61 147.0 27.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.77 -171.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.9 8.51 49.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.639 -170.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -128.63 174.73 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.982 1.391 . . . . 0.0 111.481 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.02 162.49 29.38 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.215 0.606 . . . . 0.0 111.427 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -64.78 -22.07 66.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.002 . . . . 0.0 111.928 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -56.37 -30.99 63.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.113 . . . . 0.0 112.594 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -90.06 6.63 41.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.035 -0.983 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 107.18 1.9 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -155.67 164.82 38.1 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.996 1.718 . . . . 0.0 108.249 -167.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.476 ' HE1' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -94.74 149.76 20.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.136 0.97 . . . . 0.0 110.396 168.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.51 151.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.548 171.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.56 158.66 29.98 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.435 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.03 8.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.74 -18.8 25.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.914 1.686 . . . . 0.0 111.09 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -117.17 -39.01 3.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.856 -1.069 . . . . 0.0 111.392 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 14' ' ' VAL . 4.2 tt -99.75 150.99 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.727 1.149 . . . . 0.0 111.365 -175.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.435 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 92.7 mtt-85 -143.59 146.62 33.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.609 1.564 . . . . 0.0 110.476 168.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 147.51 53.34 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.871 1.269 . . . . 0.0 111.023 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.486 ' CE2' HD11 ' A' ' 105' ' ' ILE . 33.1 t80 -64.79 116.44 6.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.051 0.841 . . . . 0.0 111.854 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -159.16 161.71 36.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.963 1.705 . . . . 0.0 109.063 -169.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -61.48 -26.34 67.84 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.618 -1.301 . . . . 0.0 113.114 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -71.65 -44.27 64.62 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.248 1.019 . . . . 0.0 110.8 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.288 44.2 p30 -71.22 -22.28 62.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.338 173.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.486 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.1 mm -72.58 -35.55 51.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 119.032 0.833 . . . . 0.0 110.502 169.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.48 98.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.724 1.147 . . . . 0.0 109.684 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.3 ttp -58.8 -53.7 55.4 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -54.0 -46.12 71.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.758 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -73.12 -45.23 58.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.844 0.747 . . . . 0.0 110.041 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.87 39.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.873 -0.584 . . . . 0.0 112.15 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.03 -45.09 8.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.298 0.954 . . . . 0.0 112.037 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.71 13.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.025 1.33 . . . . 0.0 111.316 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.6 t30 . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 126.227 1.811 . . . . 0.0 114.15 173.621 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.561 0.696 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.46 126.21 26.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.51 133.91 55.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 -169.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 HG12 ' A' ' 41' ' ' ILE . 1.1 mt -58.77 -8.07 1.21 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -168.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.02 31.58 0.55 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.18 -163.1 29.96 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 168.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.94 152.71 20.61 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.613 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.4 166.35 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 168.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 14' ' ' VAL . 44.5 mt -136.35 140.51 43.34 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.6 124.51 36.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -74.17 132.47 42.23 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.81 0.12 10.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.781 0.833 . . . . 0.0 111.148 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.45 -86.52 0.23 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.74 -26.24 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.731 2.287 . . . . 0.0 113.641 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -153.34 -170.6 3.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.265 1.426 . . . . 0.0 109.81 -168.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.499 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -144.08 149.22 36.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.389 1.876 . . . . 0.0 108.773 -168.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -138.71 173.2 11.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.068 0.547 . . . . 0.0 110.982 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.57 144.83 28.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.704 1.202 . . . . 0.0 108.652 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.26 50.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.844 1.258 . . . . 0.0 108.539 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -145.18 101.27 3.59 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.115 0.966 . . . . 0.0 109.852 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.613 HD11 HG11 ' A' ' 14' ' ' VAL . 77.5 mt -57.17 152.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 129.025 2.93 . . . . 0.0 111.175 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.21 -29.83 0.08 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.641 168.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 31.9 ttpt -132.32 133.84 44.51 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 pt -137.33 161.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -145.64 151.94 38.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.322 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.5 142.6 16.04 Favored Pre-proline 0 C--O 1.241 0.652 0 C-N-CA 126.263 1.825 . . . . 0.0 109.167 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.85 -11.16 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.897 2.398 . . . . 0.0 113.785 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -62.6 -35.59 80.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.095 1.316 . . . . 0.0 112.463 -169.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 m -129.01 4.65 5.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.264 1.026 . . . . 0.0 111.557 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt 41.43 55.7 3.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.748 1.619 . . . . 0.0 111.045 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptm -152.81 160.75 43.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 50.5 p90 -102.93 169.78 8.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -175.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -141.32 146.5 36.8 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 126.863 2.065 . . . . 0.0 105.761 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.614 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.2 m -148.18 158.51 44.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -169.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.502 HG12 HD22 ' A' ' 10' ' ' LEU . 17.5 pt . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt . . . . . 0 N--CA 1.469 0.478 0 CA-C-O 118.542 -0.742 . . . . 0.0 111.627 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.61 119.49 8.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 40' ' ' SER . 14.0 mt -84.17 141.31 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 127.075 2.15 . . . . 0.0 106.785 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.11 125.48 91.55 Favored Pre-proline 0 C--O 1.239 0.545 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.659 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.34 135.02 23.81 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.218 1.945 . . . . 0.0 109.049 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -137.08 157.3 47.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.766 0.827 . . . . 0.0 109.008 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.1 mmpt? -64.83 -6.87 9.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -168.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 71.92 151.75 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 114.566 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.54 30.29 2.67 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.772 169.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -83.67 -40.37 19.03 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.887 1.344 . . . . 0.0 109.379 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -160.72 -1.3 0.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 47.16 2.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.013 1.725 . . . . 0.0 110.895 -169.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -32.12 139.32 0.04 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 129.73 3.212 . . . . 0.0 113.383 168.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 71' ' ' ILE . 7.9 pt -135.87 133.63 20.04 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.12 162.21 43.1 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.238 1.959 . . . . 0.0 109.811 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.06 -15.22 8.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 112.472 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.17 -30.23 70.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.632 1.173 . . . . 0.0 112.073 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 67' ' ' ILE . 7.5 pt -121.73 -9.53 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 120.219 1.372 . . . . 0.0 110.608 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mm -58.4 -47.74 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 127.391 2.276 . . . . 0.0 106.292 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -79.29 8.92 5.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.398 1.479 . . . . 0.0 112.297 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.8 178.48 27.27 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.763 1.165 . . . . 0.0 111.684 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -64.29 131.3 46.9 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m -137.09 152.49 50.08 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.351 1.032 . . . . 0.0 111.426 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -138.88 114.56 9.89 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.84 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 47.6 t80 -81.27 126.65 31.81 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.865 2.066 . . . . 0.0 106.761 169.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -138.43 154.97 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.764 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -100.34 123.19 44.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 167.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -70.7 113.0 7.35 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -75.76 148.29 38.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.82 8.16 51.81 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.995 -0.891 . . . . 0.0 112.735 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -133.14 170.26 15.67 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.58 1.19 . . . . 0.0 111.071 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -73.6 159.74 32.65 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.96 0.409 . . . . 0.0 110.364 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -73.55 -14.44 61.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.981 0.512 . . . . 0.0 111.656 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.0 m -55.29 -31.71 61.83 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.739 1.216 . . . . 0.0 112.241 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -91.34 7.0 43.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.06 0.944 . . . . 0.0 112.527 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.43 120.41 12.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.263 7.5 tp10 -157.01 166.58 32.95 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.476 1.11 . . . . 0.0 108.288 -167.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.67 151.31 21.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.157 0.979 . . . . 0.0 109.497 168.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.12 153.73 39.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.36 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.88 168.47 31.55 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -16.79 13.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.764 1.226 . . . . 0.0 113.608 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.79 -24.39 50.13 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.223 1.009 . . . . 0.0 113.072 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -119.14 -45.47 2.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.405 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 97' ' ' ILE . 7.1 tt -86.61 163.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -164.68 156.06 15.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 129.139 2.975 . . . . 0.0 110.108 170.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.92 169.43 13.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.846 1.203 . . . . 0.0 111.493 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -80.09 108.41 13.66 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.837 -1.164 . . . . 0.0 109.183 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -154.48 162.99 40.86 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.035 1.334 . . . . 0.0 109.898 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.71 -35.18 55.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.017 1.727 . . . . 0.0 114.795 -169.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.09 -42.62 99.64 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.478 1.609 . . . . 0.0 110.382 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.18 -24.71 47.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.014 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.87 -32.92 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.383 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.74 99.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.784 1.175 . . . . 0.0 109.196 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.1 ttp -56.24 -54.33 46.59 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -56.58 -48.52 77.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.475 0.71 . . . . 0.0 111.211 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -69.12 -45.58 69.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.655 0.661 . . . . 0.0 109.572 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -25.89 54.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.26 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.04 -45.86 7.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.697 1.135 . . . . 0.0 112.685 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.74 -24.76 9.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 111.305 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 . . . . . 0 CA--C 1.529 0.162 0 C-N-CA 126.013 1.725 . . . . 0.0 113.334 171.49 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -57.45 89.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.944 2.097 . . . . 0.0 110.117 169.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.95 134.86 37.79 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.61 HD12 HG12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -59.48 -6.74 1.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -169.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.73 32.13 0.47 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.51 -173.89 45.4 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.79 157.51 17.9 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.32 154.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 169.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 14' ' ' VAL . 27.8 mt -124.25 136.96 54.53 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.0 126.46 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.305 1.003 . . . . 0.0 109.048 -169.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -105.6 123.9 48.67 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.199 1.4 . . . . 0.0 108.244 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.17 -24.88 14.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.195 0.598 . . . . 0.0 111.911 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.27 -70.58 0.31 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.94 -36.97 16.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.143 1.895 . . . . 0.0 112.552 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -153.47 177.78 10.54 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 125.479 1.512 . . . . 0.0 109.268 -168.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 152.12 43.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.384 2.274 . . . . 0.0 107.64 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -137.1 160.9 37.6 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 109.978 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.16 141.82 39.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.91 163.35 32.53 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.861 1.664 . . . . 0.0 108.177 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -153.24 102.28 2.61 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.179 -0.951 . . . . 0.0 110.595 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.567 HD11 HG11 ' A' ' 14' ' ' VAL . 67.1 mt -59.27 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.998 2.519 . . . . 0.0 112.061 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.38 -17.62 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.764 167.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.75 138.36 49.92 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 170.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt -138.77 163.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -168.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -149.12 151.82 35.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.018 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -147.06 140.93 15.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.759 2.424 . . . . 0.0 108.468 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.1 -9.31 25.98 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.704 . . . . 0.0 113.502 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.3 m -67.92 -32.9 73.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.098 1.317 . . . . 0.0 111.646 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 p -117.96 -15.73 9.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.637 1.575 . . . . 0.0 110.646 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt 49.03 48.97 20.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 118.771 0.714 . . . . 0.0 109.39 -169.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.9 mtp -146.48 151.16 36.94 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.781 2.032 . . . . 0.0 105.636 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -101.89 173.68 6.29 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.818 0.447 . . . . 0.0 112.07 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 p -142.84 156.8 45.0 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 126.542 1.937 . . . . 0.0 106.434 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.538 ' HB3' HD12 ' A' ' 56' ' ' ILE . 34.7 t -148.72 152.02 35.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.61 HG12 HD12 ' A' ' 10' ' ' LEU . 1.1 pp . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -148.63 107.18 3.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 40' ' ' SER . 6.1 mt -75.28 132.1 33.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 11.0 mmpt? -66.89 137.57 94.83 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.76 135.79 26.57 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 N-CA-C 106.896 -2.001 . . . . 0.0 106.896 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -137.04 167.04 22.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 6.0 mmpt? -62.06 153.03 30.98 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 169.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.426 HD11 ' CZ2' ' A' ' 91' ' ' TRP . 6.4 tt -105.86 147.13 29.06 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.067 1.747 . . . . 0.0 109.676 -169.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.21 16.95 2.79 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.004 0.815 . . . . 0.0 113.104 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -87.05 -33.8 19.41 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.041 0.92 . . . . 0.0 109.977 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.98 8.0 0.23 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.097 0.959 . . . . 0.0 111.772 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -152.97 164.09 38.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.709 2.004 . . . . 0.0 107.92 -169.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.7 m -145.56 142.44 29.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.771 2.028 . . . . 0.0 107.352 -170.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 71' ' ' ILE . 11.7 pt -135.22 132.73 20.22 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.02 161.32 46.3 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.723 1.615 . . . . 0.0 109.445 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -56.16 -15.44 3.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 112.45 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.32 -27.0 64.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.401 1.48 . . . . 0.0 113.139 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 67' ' ' ILE . 12.5 pt -121.18 -8.17 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 120.131 1.332 . . . . 0.0 111.104 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.85 -45.26 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 128.14 2.576 . . . . 0.0 109.088 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.62 9.86 5.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.931 0.892 . . . . 0.0 112.521 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.57 -172.54 25.82 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -57.55 136.45 56.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.9 t -140.66 153.96 46.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.415 0.447 . . . . 0.0 110.105 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.6 m-85 -140.2 112.45 7.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.348 1.459 . . . . 0.0 110.156 -169.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -77.84 128.82 34.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.68 156.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.983 1.313 . . . . 0.0 112.362 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -101.59 121.84 42.75 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -74.58 112.16 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -78.17 150.5 33.56 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.29 7.58 39.66 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.978 -0.901 . . . . 0.0 112.51 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 42.4 m95 -135.02 172.96 12.27 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.622 1.211 . . . . 0.0 111.38 -174.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -70.89 160.66 32.41 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 122.871 0.468 . . . . 0.0 111.505 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -65.51 -22.29 66.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.137 0.975 . . . . 0.0 111.761 170.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 m -54.97 -32.24 61.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.515 1.126 . . . . 0.0 112.487 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -83.26 -3.31 57.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.497 -1.239 . . . . 0.0 112.957 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -64.6 111.11 2.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -156.67 166.74 32.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.663 1.585 . . . . 0.0 108.673 -167.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.426 ' CZ2' HD11 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -96.32 149.94 21.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.927 0.87 . . . . 0.0 110.693 168.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.35 153.24 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.32 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.18 160.54 29.61 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.49 7.23 1.11 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -83.46 -23.6 32.18 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.312 1.845 . . . . 0.0 110.899 168.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.31 -34.65 3.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.686 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.514 HD11 HG21 ' A' ' 14' ' ' VAL . 4.7 tt -101.68 149.58 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.786 1.175 . . . . 0.0 110.794 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -144.75 149.44 35.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.075 1.35 . . . . 0.0 110.177 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.83 141.96 53.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.13 1.772 . . . . 0.0 110.627 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.402 ' CE2' HD11 ' A' ' 105' ' ' ILE . 38.0 t80 -59.9 115.47 3.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.541 1.064 . . . . 0.0 111.759 -169.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -160.76 165.62 30.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.148 1.779 . . . . 0.0 110.505 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -57.58 -33.15 67.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.638 1.575 . . . . 0.0 113.392 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -64.59 -43.43 93.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.013 0.911 . . . . 0.0 109.397 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -69.04 -33.01 72.91 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.402 HD11 ' CE2' ' A' ' 100' ' ' TYR . 3.8 mm -67.83 -34.72 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.448 0.567 . . . . 0.0 110.748 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.881 0.764 . . . . 0.0 110.196 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.63 -49.92 71.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 170.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -59.18 -50.37 74.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.003 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -76.19 -36.15 58.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.425 1.012 . . . . 0.0 109.85 -170.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -40.85 82.29 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 119.103 -0.475 . . . . 0.0 109.977 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.39 -44.08 22.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.568 1.076 . . . . 0.0 112.862 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -49.24 -34.0 13.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.059 1.344 . . . . 0.0 110.83 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t30 . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 124.316 1.046 . . . . 0.0 113.148 174.552 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 C--O 1.238 0.455 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -56.2 132.71 51.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.94 129.62 45.69 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -3.27 0.38 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.0 28.79 0.53 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.81 -173.73 48.71 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 106.828 -2.509 . . . . 0.0 106.828 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 mtt85 -91.33 159.99 15.73 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.555 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.94 161.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -130.03 140.84 50.8 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.7 128.4 32.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -102.51 124.97 49.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 108.573 -169.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -101.6 -23.19 14.31 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.438 0.295 . . . . 0.0 111.194 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.88 -73.76 0.25 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.63 -31.14 27.01 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.55 2.167 . . . . 0.0 112.273 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.38 177.94 10.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.131 1.772 . . . . 0.0 108.287 -169.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.432 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -135.15 162.09 33.49 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.643 1.577 . . . . 0.0 107.208 -173.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -136.59 159.82 40.66 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.248 1.019 . . . . 0.0 108.854 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -76.61 147.27 37.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.537 . . . . 0.0 109.732 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.94 31.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.846 1.258 . . . . 0.0 108.882 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 26' ' ' LYS . 29.4 ttpt -153.11 111.38 3.65 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.197 -0.939 . . . . 0.0 110.706 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 HG11 ' A' ' 14' ' ' VAL . 65.0 mt -59.03 152.17 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 128.895 2.878 . . . . 0.0 111.688 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pp -157.99 -30.04 0.08 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.913 0.885 . . . . 0.0 112.514 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -131.25 140.99 49.93 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.99 164.88 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -168.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -149.91 152.21 34.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.973 -168.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.29 141.11 14.53 Favored Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 125.137 1.375 . . . . 0.0 109.965 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.45 -0.23 7.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.088 3.192 . . . . 0.0 113.501 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -66.13 -34.46 78.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.032 1.287 . . . . 0.0 110.979 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -130.81 -7.86 4.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.37 1.068 . . . . 0.0 112.164 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 45.16 53.14 8.13 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.221 1.009 . . . . 0.0 110.72 -169.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -148.81 151.87 35.53 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.827 2.051 . . . . 0.0 105.815 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -103.21 168.06 9.42 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.86 0.464 . . . . 0.0 112.043 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 p -136.42 153.54 51.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 107.324 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.687 ' HB2' HD12 ' A' ' 56' ' ' ILE . 3.5 m -151.62 158.07 42.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.738 0.699 . . . . 0.0 110.1 -168.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.9 pt . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 126.151 1.781 . . . . 0.0 108.621 173.788 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.19 108.5 0.61 Allowed 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.296 -0.878 . . . . 0.0 108.675 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.687 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.6 mt -87.53 141.74 13.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.76 142.95 88.91 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 123.157 0.583 . . . . 0.0 109.613 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.31 142.18 33.2 Favored 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.54 1.493 . . . . 0.0 108.691 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -132.52 166.32 22.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.014 0.926 . . . . 0.0 109.023 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.653 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -64.7 -13.52 54.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -168.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 68.12 151.66 0.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.647 1.979 . . . . 0.0 112.681 -169.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.42 55.38 0.15 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.113 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 51.44 2.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.736 1.214 . . . . 0.0 108.072 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.59 -7.4 0.72 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.126 2.571 . . . . 0.0 113.405 -172.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.95 33.02 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.641 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -33.74 140.51 0.05 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 130.502 3.521 . . . . 0.0 112.203 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 71' ' ' ILE . 10.2 pt -135.41 135.17 21.91 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.564 1.146 . . . . 0.0 108.093 169.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.94 162.76 41.57 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.03 1.82 . . . . 0.0 109.723 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.14 -17.26 10.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.964 0.906 . . . . 0.0 112.571 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.45 -28.66 69.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.607 1.163 . . . . 0.0 112.536 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 67' ' ' ILE 0.253 7.2 pt -122.21 -9.01 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 120.081 1.31 . . . . 0.0 110.844 -174.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mm -61.16 -50.94 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.484 2.313 . . . . 0.0 105.817 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -78.79 9.16 4.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.496 1.518 . . . . 0.0 111.648 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.72 173.79 24.44 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.45 1.023 . . . . 0.0 110.696 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -62.72 132.49 52.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -135.6 152.71 51.52 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 124.11 0.881 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 32.3 m-85 -142.94 116.29 9.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 109.674 -169.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -81.28 125.36 30.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.252 2.221 . . . . 0.0 105.811 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.53 157.44 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.409 -168.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -100.94 118.51 37.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -70.14 119.73 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.83 149.53 25.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.9 8.57 57.99 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.553 -169.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -133.89 172.66 12.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.493 1.146 . . . . 0.0 111.633 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -71.1 158.6 36.19 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.196 0.598 . . . . 0.0 110.423 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.6 m -70.36 -12.28 61.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.628 0.371 . . . . 0.0 111.843 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.7 m -56.42 -33.31 65.7 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.748 -1.22 . . . . 0.0 112.439 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -80.24 3.38 21.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.973 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.95 108.72 2.68 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.21 167.21 29.31 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.685 1.994 . . . . 0.0 107.441 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.21 149.56 23.44 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.911 0.862 . . . . 0.0 110.378 169.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.92 150.78 31.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.283 173.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.74 158.51 32.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.63 8.12 0.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -88.59 -18.72 27.46 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.047 1.739 . . . . 0.0 111.311 169.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -119.79 -35.68 3.46 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 117.255 -1.355 . . . . 0.0 111.984 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 14' ' ' VAL . 6.3 tt -98.9 153.66 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 120.474 1.488 . . . . 0.0 110.883 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.569 ' HB3' HD21 ' A' ' 104' ' ' ASN . 90.4 mtt180 -149.83 152.54 35.32 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.842 1.657 . . . . 0.0 110.827 170.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 154.74 41.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.925 1.69 . . . . 0.0 111.863 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.514 ' CE2' HD11 ' A' ' 105' ' ' ILE . 41.3 t80 -60.59 118.17 6.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.577 0.626 . . . . 0.0 109.882 176.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -164.4 160.59 20.87 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.312 1.445 . . . . 0.0 109.084 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -53.15 -35.7 60.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.523 1.529 . . . . 0.0 113.755 -169.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.82 -43.81 97.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.684 0.755 . . . . 0.0 110.726 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.569 HD21 ' HB3' ' A' ' 98' ' ' ARG . 72.8 m-20 -74.15 -26.55 60.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.813 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.514 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.3 mm -68.52 -39.08 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.931 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.33 98.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.965 0.802 . . . . 0.0 109.47 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -50.88 72.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -60.5 -46.77 88.92 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.281 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -73.77 -40.19 63.64 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 119.067 0.849 . . . . 0.0 111.04 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -48.59 75.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.02 -44.33 61.04 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.954 -1.091 . . . . 0.0 112.231 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.75 -13.96 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.238 1.815 . . . . 0.0 112.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t30 . . . . . 0 N--CA 1.454 -0.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.059 179.282 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 CA--C 1.545 0.763 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -63.22 68.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 130.454 3.502 . . . . 0.0 110.063 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 138.73 54.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 112.121 -2.308 . . . . 0.0 106.145 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.63 HD12 HG12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -57.81 -10.9 1.89 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -168.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.27 32.88 0.5 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 170.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.24 -163.04 21.52 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 169.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 mtt85 -102.33 153.83 19.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 168.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.587 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.59 169.27 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.5 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.0 mm? -135.26 142.41 45.93 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 103.243 -2.873 . . . . 0.0 103.243 176.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.3 147.1 51.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -115.12 119.53 36.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -102.14 -9.5 20.45 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.243 0.617 . . . . 0.0 112.56 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.03 -77.99 0.3 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -66.46 -38.66 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.439 2.092 . . . . 0.0 113.317 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD12 ' H ' ' A' ' 22' ' ' MET . 21.2 tp -148.2 177.76 9.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 125.129 1.371 . . . . 0.0 109.294 -168.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.5 ' CE ' HD12 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -139.59 149.23 43.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.598 2.359 . . . . 0.0 107.129 -168.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -136.44 154.32 50.81 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.539 0.736 . . . . 0.0 109.765 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.64 141.9 57.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.277 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.62 162.59 29.04 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.137 1.775 . . . . 0.0 108.083 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -148.66 95.72 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.465 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.587 HD11 HG11 ' A' ' 14' ' ' VAL . 75.0 mt -55.52 151.35 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.392 2.277 . . . . 0.0 110.743 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -156.73 -32.27 0.09 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.779 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD2' ' CD2' ' A' ' 38' ' ' TYR . 36.8 ttpt -131.53 138.04 48.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.35 165.33 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -144.3 153.37 41.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.331 -169.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.53 143.57 17.49 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.022 1.729 . . . . 0.0 109.243 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.69 -12.48 36.08 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.585 2.857 . . . . 0.0 113.586 176.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.9 m -64.77 -32.74 74.56 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.066 1.303 . . . . 0.0 111.883 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.0 m -121.35 -11.28 8.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.452 1.101 . . . . 0.0 111.077 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 48.29 49.67 17.49 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.156 0.982 . . . . 0.0 109.331 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -145.4 159.09 43.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.144 2.177 . . . . 0.0 105.5 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.449 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 42.1 p90 -104.58 174.97 5.65 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.622 . . . . 0.0 112.573 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -143.47 152.54 41.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.549 2.339 . . . . 0.0 106.132 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB3' HD12 ' A' ' 56' ' ' ILE . 47.7 t -147.56 161.17 41.67 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -175.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.63 HG12 HD12 ' A' ' 10' ' ' LEU . 15.2 pt . . . . . 0 CA--C 1.547 0.855 0 C-N-CA 123.96 0.904 . . . . 0.0 110.017 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.31 109.1 1.46 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.2 mt -73.66 135.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -173.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.19 137.49 96.94 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.02 137.9 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 107.165 -1.898 . . . . 0.0 107.165 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -141.19 164.49 30.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.9 mmpt? -63.62 153.12 36.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.3 tt -107.71 154.3 21.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.524 1.93 . . . . 0.0 110.583 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.01 21.96 5.12 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.137 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -77.78 -33.42 52.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.723 0.762 . . . . 0.0 109.166 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.9 6.35 0.61 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.696 1.198 . . . . 0.0 111.79 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.601 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 4.8 mp0 -124.75 172.53 9.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.012 1.325 . . . . 0.0 111.648 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.9 m -149.55 144.03 25.98 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.988 2.115 . . . . 0.0 106.343 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 71' ' ' ILE . 9.3 pt -135.54 120.97 13.77 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 169.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.99 154.45 27.37 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.282 1.988 . . . . 0.0 111.181 170.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.43 -24.46 12.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.341 1.056 . . . . 0.0 111.619 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -57.13 -32.64 66.56 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.156 1.783 . . . . 0.0 114.215 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 67' ' ' ILE . 14.9 pt -117.77 -17.13 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.702 1.137 . . . . 0.0 110.508 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.67 -44.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 128.418 2.687 . . . . 0.0 109.16 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.94 11.53 6.02 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.342 -169.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.88 -177.79 29.43 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 119.577 1.08 . . . . 0.0 111.045 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.87 133.36 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 m -135.99 150.72 49.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 123.812 0.695 . . . . 0.0 110.139 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -135.19 113.3 11.21 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.32 1.048 . . . . 0.0 110.111 -169.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -77.62 121.81 24.46 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.296 2.238 . . . . 0.0 106.963 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.04 159.04 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.672 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.415 ' HD2' ' OD1' ' A' ' 89' ' ' ASP . 21.6 t-80 -106.95 129.04 54.82 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -75.25 110.02 9.25 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.54 149.21 42.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.915 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.84 4.53 34.26 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.756 -1.024 . . . . 0.0 112.364 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -130.2 172.15 12.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.828 1.314 . . . . 0.0 111.832 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -68.22 162.78 24.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.4 m -65.65 -20.59 66.36 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.018 0.927 . . . . 0.0 111.589 169.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -59.44 -31.04 68.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.789 0.836 . . . . 0.0 112.354 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -91.85 17.56 8.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.801 0.84 . . . . 0.0 112.705 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.415 ' OD1' ' HD2' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -64.1 106.87 1.14 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -153.87 158.07 40.23 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 108.036 -168.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.601 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -97.43 150.41 21.07 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.42 1.105 . . . . 0.0 109.326 167.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.89 154.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.328 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.3 168.18 30.79 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -16.42 6.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.51 1.124 . . . . 0.0 113.297 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.48 -23.79 52.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.532 1.533 . . . . 0.0 112.976 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -123.12 -37.64 2.69 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.227 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 tt -95.63 157.5 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.496 1.044 . . . . 0.0 112.822 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -152.81 165.24 36.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.692 3.197 . . . . 0.0 109.117 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . . . -99.61 155.21 17.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.67 1.588 . . . . 0.0 112.861 -172.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.534 ' CE2' HD11 ' A' ' 105' ' ' ILE . 29.8 t80 -67.22 109.06 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.345 1.069 . . . . 0.0 112.551 -169.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -157.74 162.45 38.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 125.764 1.625 . . . . 0.0 108.786 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -54.95 -33.98 62.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -168.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.55 -43.24 97.66 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.081 0.855 . . . . 0.0 110.328 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.72 -25.13 60.05 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.633 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.534 HD11 ' CE2' ' A' ' 100' ' ' TYR . 6.8 mm -73.87 -32.54 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 118.508 0.594 . . . . 0.0 111.382 171.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.59 96.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.209 0.913 . . . . 0.0 109.097 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -51.69 68.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -54.42 -49.36 70.14 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 123.706 0.802 . . . . 0.0 110.462 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -74.21 -44.71 52.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.368 0.531 . . . . 0.0 110.419 -173.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -32.82 55.64 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.966 0.506 . . . . 0.0 111.068 174.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.63 -46.52 9.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.953 0.797 . . . . 0.0 112.426 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.41 -29.95 11.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 111.31 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t30 . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 125.867 1.667 . . . . 0.0 114.292 174.438 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -57.82 128.84 39.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 168.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.67 136.5 54.51 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -169.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.431 HD22 HG12 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -59.94 -3.62 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -168.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.05 30.41 0.3 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.66 -168.86 44.26 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 169.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -94.87 157.32 15.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.57 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.2 166.62 28.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 102.461 -3.162 . . . . 0.0 102.461 168.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.501 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.3 mm? -132.1 139.75 48.59 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.76 135.46 36.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -106.04 111.67 24.39 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -81.56 -35.16 30.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.622 0.646 . . . . 0.0 110.313 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.37 -72.04 0.19 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.11 -28.54 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.188 2.592 . . . . 0.0 113.338 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -150.92 171.73 16.8 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.308 1.443 . . . . 0.0 108.622 -173.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.501 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.14 144.7 48.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.949 2.099 . . . . 0.0 106.605 -169.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -133.27 160.07 38.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.747 0.819 . . . . 0.0 109.178 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.42 145.74 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.29 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.3 159.13 42.8 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.227 1.411 . . . . 0.0 107.952 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 94.55 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.896 -0.503 . . . . 0.0 110.63 -169.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 HG11 ' A' ' 14' ' ' VAL . 58.3 mt -59.11 149.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.577 2.751 . . . . 0.0 112.159 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.54 -24.62 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.439 1.087 . . . . 0.0 113.356 167.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' N ' HD22 ' A' ' 28' ' ' LEU . 35.4 ttpt -125.86 139.25 53.63 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.08 165.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.512 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.3 t-105 -149.76 154.7 38.91 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.515 -169.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.73 141.17 15.02 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 109.147 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -67.19 -10.47 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.268 2.645 . . . . 0.0 112.783 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.3 m -65.11 -33.28 75.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.404 1.456 . . . . 0.0 111.295 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -120.24 -16.32 8.51 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.291 1.836 . . . . 0.0 110.734 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm 49.07 53.25 12.92 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.538 0.735 . . . . 0.0 109.095 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 76.7 mtp -149.01 154.03 38.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.462 2.305 . . . . 0.0 105.533 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -100.58 174.41 6.09 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.158 0.583 . . . . 0.0 112.302 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -144.1 151.91 40.24 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.583 2.353 . . . . 0.0 106.34 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.447 ' HB3' HD12 ' A' ' 56' ' ' ILE . 44.7 t -147.81 161.11 41.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.431 HG12 HD22 ' A' ' 10' ' ' LEU . 6.9 pt . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 125.199 1.4 . . . . 0.0 110.097 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.37 101.96 0.81 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 40' ' ' SER . 2.7 mt -73.93 138.32 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.71 138.15 95.3 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.4 132.47 19.23 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 N-CA-C 107.18 -1.892 . . . . 0.0 107.18 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -137.16 165.28 26.48 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.623 1.169 . . . . 0.0 108.345 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.41 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -66.69 153.74 42.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 62' ' ' GLY . 5.5 tt -119.83 142.68 48.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.118 1.767 . . . . 0.0 109.044 -169.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.49 ' N ' HD23 ' A' ' 61' ' ' LEU . . . 123.86 30.24 1.06 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-N 114.774 -1.103 . . . . 0.0 114.144 169.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.89 -39.31 76.33 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.107 1.453 . . . . 0.0 109.769 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -152.86 -32.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.561 1.544 . . . . 0.0 111.043 170.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -66.73 21.1 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.357 3.063 . . . . 0.0 114.03 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -33.39 132.1 0.2 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.359 2.264 . . . . 0.0 111.263 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 67' ' ' ILE 0.288 7.0 tt -124.9 141.95 39.68 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -168.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.46 145.62 48.05 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.417 1.411 . . . . 0.0 110.747 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.44 -15.67 4.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.088 1.355 . . . . 0.0 112.901 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.48 -26.67 68.83 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 112.311 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 pt -122.33 -15.07 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.093 0.86 . . . . 0.0 111.223 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.512 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 3.4 mm -50.75 -42.66 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.578 2.351 . . . . 0.0 109.507 170.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -83.21 10.76 7.67 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.708 1.203 . . . . 0.0 112.475 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.9 -175.78 26.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.85 139.52 58.35 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.9 m -133.19 149.22 52.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.891 0.745 . . . . 0.0 109.427 172.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -136.33 112.63 9.86 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.482 1.113 . . . . 0.0 108.616 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.68 126.94 31.58 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 126.399 1.88 . . . . 0.0 107.511 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -136.76 154.85 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 124.919 1.387 . . . . 0.0 112.491 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -100.77 119.57 38.82 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.19 111.62 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -82.05 151.58 27.0 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.92 2.72 58.29 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.48 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -136.75 179.31 6.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.583 1.192 . . . . 0.0 110.991 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -77.84 160.47 28.29 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.858 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 m -72.53 -13.51 61.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.548 0.739 . . . . 0.0 111.834 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -53.55 -31.75 47.86 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.951 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -89.75 7.68 35.63 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.911 -1.042 . . . . 0.0 113.239 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -64.01 115.89 5.35 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.29 165.07 37.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.193 1.397 . . . . 0.0 108.187 -167.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.65 150.06 23.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.277 1.037 . . . . 0.0 110.043 168.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.17 159.99 42.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.612 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.83 173.01 23.22 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.995 1.283 . . . . 0.0 110.021 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -16.85 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 113.382 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.73 -21.42 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.628 1.171 . . . . 0.0 113.0 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -121.54 -39.88 2.61 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.377 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -94.83 157.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.822 1.192 . . . . 0.0 113.323 -168.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -155.04 158.05 38.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.465 3.106 . . . . 0.0 108.778 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.29 168.39 19.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.247 1.839 . . . . 0.0 112.971 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.553 ' CE2' HD11 ' A' ' 105' ' ' ILE . 25.0 t80 -67.96 117.53 9.95 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.841 -1.162 . . . . 0.0 109.84 169.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -161.03 164.15 31.12 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.684 1.593 . . . . 0.0 108.893 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -59.5 -30.43 68.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.444 1.098 . . . . 0.0 113.393 -169.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.63 -42.11 91.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.443 1.116 . . . . 0.0 109.848 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -73.39 -27.84 61.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.359 -0.838 . . . . 0.0 109.56 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.553 HD11 ' CE2' ' A' ' 100' ' ' TYR . 7.2 mm -70.05 -32.74 52.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 CA-C-N 118.751 0.705 . . . . 0.0 110.933 169.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.18 99.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.52 1.055 . . . . 0.0 109.724 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -49.0 79.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.86 -47.12 83.64 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.529 0.732 . . . . 0.0 109.966 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -73.52 -44.51 57.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.524 0.602 . . . . 0.0 109.961 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -32.47 50.81 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.5 173.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.6 mt -89.95 -44.33 9.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.282 0.947 . . . . 0.0 112.348 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.89 -28.45 9.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.249 1.42 . . . . 0.0 111.723 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 t30 . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 125.928 1.691 . . . . 0.0 114.263 174.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 121.877 0.846 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 1 C-N-CA 132.95 4.5 . . . . 0.0 110.948 171.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.44 142.35 58.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.333 -1.758 . . . . 0.0 106.804 -169.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.69 -10.19 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.28 30.9 0.38 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 179.33 53.19 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 171.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.35 153.66 24.46 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 168.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.2 164.68 34.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 169.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.621 HD22 ' CE ' ' A' ' 22' ' ' MET . 65.9 mt -140.56 116.35 10.3 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 -170.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.5 138.71 47.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.363 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -120.59 118.57 30.52 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.199 1.4 . . . . 0.0 108.202 -169.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -98.84 -22.01 16.04 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.87 0.468 . . . . 0.0 111.449 -170.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.31 -76.57 0.23 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -68.19 -31.56 29.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.107 1.871 . . . . 0.0 112.457 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.49 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -153.07 176.33 12.02 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.768 1.227 . . . . 0.0 110.743 -171.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.621 ' CE ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.07 154.6 47.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.809 2.444 . . . . 0.0 107.491 -173.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -140.41 149.59 42.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.186 1.394 . . . . 0.0 108.765 -176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.34 145.53 51.12 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.94 161.23 37.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.475 1.51 . . . . 0.0 109.02 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -148.5 104.37 3.49 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.407 -0.808 . . . . 0.0 109.777 -171.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 14' ' ' VAL . 54.7 mt -64.79 155.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 128.447 2.699 . . . . 0.0 112.904 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -163.79 -20.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.822 -1.085 . . . . 0.0 113.724 166.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.7 ttpt -131.58 138.66 48.95 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.6 161.76 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -168.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.48 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.9 t-105 -144.68 154.55 42.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.384 -168.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -146.51 140.93 15.73 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.725 2.41 . . . . 0.0 108.881 -174.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.62 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.666 2.911 . . . . 0.0 113.549 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -66.87 -32.22 73.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.068 1.303 . . . . 0.0 111.571 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.9 m -121.56 -11.09 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.647 1.179 . . . . 0.0 111.02 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt 47.09 50.41 14.1 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.058 0.943 . . . . 0.0 109.985 -171.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.3 mtp -150.65 154.0 36.67 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.365 2.266 . . . . 0.0 105.163 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.421 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 48.8 p90 -103.45 175.12 5.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 p -141.56 155.92 45.74 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.009 2.124 . . . . 0.0 106.847 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.64 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.2 m -154.06 156.66 37.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 pt . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 123.111 0.564 . . . . 0.0 110.58 -176.807 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.621 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.887 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -21.25 97.46 0.01 OUTLIER 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 0.0 112.328 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.7 mt -72.81 136.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 111.687 -2.506 . . . . 0.0 107.793 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.93 141.84 96.99 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.98 138.54 31.33 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 N-CA-C 107.352 -1.826 . . . . 0.0 107.352 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -137.37 160.52 38.84 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -68.57 127.43 32.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 122.113 0.959 . . . . 0.0 109.017 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 tt -71.23 146.83 48.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.538 1.935 . . . . 0.0 111.97 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.7 17.83 3.76 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.697 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -81.6 -32.18 32.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.44 1.12 . . . . 0.0 109.845 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.18 10.91 0.9 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.835 1.254 . . . . 0.0 110.893 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 15.7 mp0 -130.92 174.04 10.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.247 1.819 . . . . 0.0 109.688 -169.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -165.35 122.96 1.55 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 166.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.478 HG12 HD11 ' A' ' 71' ' ' ILE 0.317 4.2 tt -123.48 129.3 24.92 Favored Pre-proline 0 N--CA 1.433 -1.277 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -167.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.47 148.86 67.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.64 1.56 . . . . 0.0 111.25 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.32 -21.11 22.18 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.022 1.329 . . . . 0.0 112.679 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -54.86 -33.27 61.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.032 2.133 . . . . 0.0 113.524 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 67' ' ' ILE . 4.6 pt -118.1 -16.13 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.422 0.689 . . . . 0.0 111.211 -169.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.48 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 2.9 mm -54.14 -42.56 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 127.948 2.499 . . . . 0.0 109.592 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.92 11.41 6.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.016 . . . . 0.0 112.661 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.97 -171.94 25.43 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -59.34 137.41 58.0 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -136.32 153.25 51.21 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.866 0.729 . . . . 0.0 110.936 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -136.73 114.81 11.51 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.514 1.126 . . . . 0.0 109.416 -170.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.12 126.03 31.55 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.666 1.987 . . . . 0.0 107.168 169.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.45 165.95 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.379 -168.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -119.63 126.94 52.38 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 165.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -78.93 125.87 29.94 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -67.38 149.62 50.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.089 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.97 10.19 50.16 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.497 -1.168 . . . . 0.0 113.576 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -128.04 166.28 18.71 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.11 1.455 . . . . 0.0 111.211 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -61.27 168.41 2.66 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.0 112.198 -171.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 m -63.34 -21.89 66.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.556 0.742 . . . . 0.0 111.711 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -60.8 -25.9 66.9 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.335 -0.853 . . . . 0.0 111.925 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.8 m95 -85.54 16.41 3.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 0.0 112.477 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.73 87.71 3.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 167.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -146.3 166.14 27.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.084 1.353 . . . . 0.0 108.341 -167.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.49 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -104.29 152.84 21.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.45 1.119 . . . . 0.0 110.511 169.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.36 155.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.829 173.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.11 169.08 31.74 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -18.06 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.714 1.205 . . . . 0.0 113.037 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.84 -19.69 18.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.272 1.429 . . . . 0.0 113.554 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -127.61 -35.48 2.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 117.39 -1.291 . . . . 0.0 111.939 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -101.87 152.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.642 1.565 . . . . 0.0 113.288 -169.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.87 160.95 41.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.28 2.632 . . . . 0.0 108.298 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.71 168.66 18.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.381 1.446 . . . . 0.0 112.273 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -77.86 109.26 11.73 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.105 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -156.42 163.33 39.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.998 1.319 . . . . 0.0 109.278 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -53.14 -35.85 60.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.665 1.586 . . . . 0.0 114.31 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.2 -43.86 97.88 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.695 1.236 . . . . 0.0 110.006 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -78.47 -23.68 46.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 mm -69.57 -35.21 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.685 0.675 . . . . 0.0 109.859 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.3 98.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.521 1.055 . . . . 0.0 109.435 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.25 89.83 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 171.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.988 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -72.54 -42.56 64.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.105 0.866 . . . . 0.0 109.504 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -42.89 53.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.269 0.628 . . . . 0.0 110.419 170.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.09 -47.73 17.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 112.398 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.23 -27.63 6.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 111.605 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.9 t30 . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 125.275 1.43 . . . . 0.0 113.386 172.783 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 . . . . . 0 C--O 1.233 0.235 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.25 73.91 0.01 OUTLIER 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.935 2.894 . . . . 0.0 110.46 171.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 131.08 44.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.409 HD22 HG12 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -61.05 -4.75 1.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -169.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.42 32.61 0.7 Allowed Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 170.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.48 -157.21 12.15 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 168.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.06 156.02 21.09 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.621 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.77 160.73 39.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 169.236 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.538 HD22 ' CE ' ' A' ' 22' ' ' MET . 42.7 mt -139.45 131.37 27.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 -173.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.21 136.81 53.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -170.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -115.9 117.24 29.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.661 0.785 . . . . 0.0 109.19 -168.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -95.53 -21.39 18.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.524 0.729 . . . . 0.0 111.854 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.15 -73.52 0.32 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.63 -30.58 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.358 2.038 . . . . 0.0 112.014 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.52 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 178.54 10.11 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 125.254 1.422 . . . . 0.0 109.51 -170.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.538 ' CE ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -133.94 154.16 51.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.522 2.329 . . . . 0.0 106.776 -173.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.71 152.05 48.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.257 1.023 . . . . 0.0 108.645 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -74.68 149.03 40.09 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.493 0.717 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.37 160.48 40.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.081 1.352 . . . . 0.0 109.113 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -149.03 99.76 2.99 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -169.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.621 HD11 HG11 ' A' ' 14' ' ' VAL . 60.3 mt -58.69 152.66 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.669 1.987 . . . . 0.0 110.647 -176.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pp -156.72 -35.45 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.736 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 37.4 ttpt -126.0 140.1 52.88 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.09 166.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.501 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 3.7 t-105 -150.47 150.89 31.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.277 -168.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -147.55 142.12 16.43 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.531 2.332 . . . . 0.0 108.82 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.69 -8.75 24.41 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.437 2.758 . . . . 0.0 113.51 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.0 m -65.66 -34.64 78.69 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.452 1.478 . . . . 0.0 111.248 -171.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -117.72 -18.67 9.57 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.521 1.528 . . . . 0.0 110.718 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm 51.33 52.14 15.43 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -169.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.6 mtp -144.72 157.02 44.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.994 2.518 . . . . 0.0 105.093 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.451 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -107.47 168.95 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.629 0.372 . . . . 0.0 111.474 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -141.57 155.0 45.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.41 1.884 . . . . 0.0 106.647 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.465 ' HB3' HD12 ' A' ' 56' ' ' ILE . 32.5 t -149.95 164.23 35.99 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.409 HG12 HD22 ' A' ' 10' ' ' LEU . 6.9 pt . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 124.792 1.237 . . . . 0.0 109.657 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt . . . . . 0 N--CA 1.469 0.483 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 107.37 1.79 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.1 mt -73.66 129.24 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -173.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.04 139.61 95.51 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.05 142.11 24.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.861 1.707 . . . . 0.0 108.983 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -130.38 164.19 25.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.582 0.753 . . . . 0.0 109.545 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.596 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.63 -16.57 49.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -168.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' CD1' ' CZ2' ' A' ' 91' ' ' TRP . 0.5 OUTLIER 70.91 136.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.597 2.359 . . . . 0.0 112.28 -171.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.11 7.35 2.29 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.949 169.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.16 -34.47 56.41 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.894 1.847 . . . . 0.0 111.211 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.74 -40.09 0.09 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.407 1.483 . . . . 0.0 109.593 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.96 137.09 56.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 168.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.6 m -140.46 157.38 45.6 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.469 HG23 HG12 ' A' ' 72' ' ' ILE 0.318 2.6 tt -149.82 136.55 10.9 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -169.102 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.43 151.96 54.19 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.727 1.618 . . . . 0.0 111.346 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -56.4 -17.11 6.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.044 1.338 . . . . 0.0 112.832 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -67.18 -24.99 65.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.843 1.257 . . . . 0.0 111.968 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.2 pt -124.38 -12.64 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.35 0.977 . . . . 0.0 111.177 -171.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.501 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 1.8 mm -52.65 -44.36 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 128.097 2.559 . . . . 0.0 108.576 169.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.17 9.47 6.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.881 1.272 . . . . 0.0 112.82 -170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.67 -173.07 26.59 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -171.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -60.79 134.91 57.55 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.285 -0.538 . . . . 0.0 110.608 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 m -137.47 154.13 49.95 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.781 0.676 . . . . 0.0 111.278 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -139.12 114.68 9.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.435 1.094 . . . . 0.0 109.836 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -81.23 127.09 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 106.271 169.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -138.48 154.07 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.101 -168.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -99.72 119.61 38.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -73.0 117.68 15.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -86.14 150.65 24.26 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 6.37 63.0 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 119.082 -0.843 . . . . 0.0 111.2 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -132.84 174.03 10.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.252 1.421 . . . . 0.0 109.874 177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.68 174.11 3.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.45 1.1 . . . . 0.0 111.708 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.1 m -85.09 -6.35 59.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.237 0.615 . . . . 0.0 112.033 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -57.36 -31.27 65.59 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.396 -0.815 . . . . 0.0 110.979 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -89.59 20.1 4.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.616 1.166 . . . . 0.0 112.726 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.49 99.77 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -151.3 167.51 27.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.972 2.109 . . . . 0.0 108.111 -167.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.419 ' CZ2' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -104.23 155.26 18.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.369 0.986 . . . . 0.0 112.168 169.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.85 157.59 43.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.932 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.29 160.63 25.95 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.732 1.158 . . . . 0.0 110.346 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.425 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -71.02 9.79 0.65 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.92 -12.71 32.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.709 1.603 . . . . 0.0 111.223 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -125.92 -37.09 2.31 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.561 1.145 . . . . 0.0 111.3 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 14' ' ' VAL . 6.8 tt -97.35 154.46 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.412 1.005 . . . . 0.0 110.671 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 98.2 mtt180 -145.65 158.26 43.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.192 2.197 . . . . 0.0 109.437 169.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.88 161.41 30.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.247 1.385 . . . . 0.0 111.511 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.455 ' CE2' HD11 ' A' ' 105' ' ' ILE . 27.6 t80 -69.47 115.77 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -159.9 162.05 34.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.466 1.506 . . . . 0.0 108.43 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.0 -35.71 47.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.833 1.653 . . . . 0.0 114.364 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -63.53 -44.44 94.24 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.554 1.168 . . . . 0.0 109.984 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.31 -23.91 54.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.278 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -68.55 -36.17 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 118.781 0.719 . . . . 0.0 109.793 169.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.1 96.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.451 1.023 . . . . 0.0 110.402 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -48.2 79.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.08 -49.53 74.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.329 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -75.03 -33.19 61.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.033 1.288 . . . . 0.0 109.854 -171.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -54.62 -53.57 52.99 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 169.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.802 0.728 . . . . 0.0 111.628 -172.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.7 -15.54 0.74 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.434 1.494 . . . . 0.0 112.557 169.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 124.82 1.248 . . . . 0.0 112.349 177.635 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -56.92 126.35 26.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 168.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.02 135.68 53.52 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -2.91 0.35 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 116.266 1.951 . . . . 0.0 116.266 -168.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.08 0.28 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 169.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.71 -175.16 50.65 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.212 -2.755 . . . . 0.0 106.212 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.443 ' HG2' HE22 ' A' ' 82' ' ' GLN . 54.1 mtt180 -87.99 156.65 19.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -132.22 165.9 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 168.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.412 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.5 mm? -133.03 144.37 50.01 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 177.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.92 125.7 23.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -99.44 115.73 29.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -87.7 -25.4 23.49 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.958 0.503 . . . . 0.0 111.15 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.74 -69.78 0.32 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.71 -41.41 11.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.39 2.06 . . . . 0.0 112.817 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.9 tp -148.27 179.8 7.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.005 1.722 . . . . 0.0 107.881 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.412 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -141.5 151.29 43.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.071 1.748 . . . . 0.0 109.178 -167.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -134.06 157.26 46.57 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.611 1.164 . . . . 0.0 108.594 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.28 150.21 30.07 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.75 155.2 46.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.895 0.478 . . . . 0.0 110.805 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -144.11 94.37 2.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.866 0.866 . . . . 0.0 111.397 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.571 HD11 HG11 ' A' ' 14' ' ' VAL . 42.7 mt -61.94 152.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 127.565 2.346 . . . . 0.0 112.492 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.35 -24.8 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.776 166.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' N ' HD22 ' A' ' 28' ' ' LEU . 38.5 ttpt -127.58 139.3 52.85 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.82 163.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -168.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.98 152.54 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.634 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.05 139.37 14.53 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.62 1.968 . . . . 0.0 109.122 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 -0.77 8.56 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.24 3.293 . . . . 0.0 113.348 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -67.55 -33.19 74.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.225 1.375 . . . . 0.0 110.956 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 p -129.48 -10.42 4.57 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.13 1.372 . . . . 0.0 111.618 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 50.1 53.14 13.35 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.098 0.951 . . . . 0.0 109.632 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 63.4 mtp -145.61 156.21 43.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.803 2.041 . . . . 0.0 106.51 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -108.88 171.43 7.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 p -139.49 156.71 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.63 1.972 . . . . 0.0 107.259 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.469 ' HB3' HD12 ' A' ' 56' ' ' ILE . 43.4 t -150.76 163.48 38.48 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 pt . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 125.746 1.618 . . . . 0.0 108.841 -179.114 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 119.334 -0.365 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.56 116.11 5.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 172.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.2 mt -81.83 135.52 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 113.478 -1.692 . . . . 0.0 106.843 -173.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.2 136.45 93.84 Favored Pre-proline 0 C--O 1.237 0.433 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.86 145.94 36.99 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.962 1.775 . . . . 0.0 109.568 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -139.67 156.34 46.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.102 0.961 . . . . 0.0 109.778 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -62.43 -10.53 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -173.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.433 HD12 ' CZ2' ' A' ' 91' ' ' TRP 0.252 9.3 tt 71.76 151.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 114.3 -177.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.64 4.22 10.79 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 114.779 -1.1 . . . . 0.0 114.283 169.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.61 -22.04 60.13 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.832 1.316 . . . . 0.0 111.359 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.57 -35.11 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.797 1.239 . . . . 0.0 111.059 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.578 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 20.6 mp0 -66.69 165.44 14.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 174.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 m -147.09 141.1 25.96 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.668 1.987 . . . . 0.0 106.115 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.499 HG22 HD11 ' A' ' 71' ' ' ILE . 9.0 pt -136.75 125.44 15.16 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.14 156.88 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.118 1.879 . . . . 0.0 110.676 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -55.59 -15.35 2.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.242 1.017 . . . . 0.0 112.493 171.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -66.69 -31.33 71.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.385 1.474 . . . . 0.0 112.343 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' ILE . 18.3 pt -119.31 -11.76 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.209 1.368 . . . . 0.0 110.757 -173.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -53.38 -45.88 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.909 2.483 . . . . 0.0 108.548 169.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.45 9.49 7.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 111.732 -170.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.21 -178.41 26.87 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 119.881 1.219 . . . . 0.0 110.814 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -60.42 131.81 51.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.1 m -132.09 150.4 52.16 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.926 0.766 . . . . 0.0 110.601 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.14 112.64 10.67 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 109.276 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -79.55 125.0 29.03 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 126.243 1.817 . . . . 0.0 107.348 169.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.55 156.01 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.935 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -102.01 122.63 44.44 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 166.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -71.74 111.18 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.443 HE22 ' HG2' ' A' ' 13' ' ' ARG . 47.9 mt-30 -76.62 148.29 37.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.41 64.05 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.163 -170.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -131.98 169.14 16.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.828 1.314 . . . . 0.0 110.513 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -65.84 171.33 4.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.543 1.537 . . . . 0.0 112.508 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 m -69.94 -17.15 63.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.532 1.133 . . . . 0.0 111.739 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -62.35 -28.82 70.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.686 0.794 . . . . 0.0 111.865 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -97.44 21.15 10.54 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -68.06 104.83 1.86 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -148.74 168.08 23.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.28 1.832 . . . . 0.0 107.866 -167.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.578 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -107.16 152.95 23.38 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 122.3 1.048 . . . . 0.0 110.402 168.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.46 161.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.773 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.53 170.67 22.38 Favored Glycine 0 C--O 1.242 0.602 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.384 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -15.27 11.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.225 1.41 . . . . 0.0 113.648 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.33 -23.98 52.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.125 1.37 . . . . 0.0 112.516 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.18 -38.76 2.28 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 117.52 -1.229 . . . . 0.0 112.027 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.58 HD11 HG21 ' A' ' 14' ' ' VAL . 8.2 tt -89.41 156.49 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.41 1.004 . . . . 0.0 113.441 -169.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -153.82 157.52 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.615 3.166 . . . . 0.0 108.594 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.7 168.88 17.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.562 1.528 . . . . 0.0 111.827 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.515 ' CE2' HD11 ' A' ' 105' ' ' ILE . 21.8 t80 -62.33 127.62 32.18 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.725 -1.234 . . . . 0.0 109.971 169.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -156.36 153.4 28.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.522 1.929 . . . . 0.0 107.866 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.82 -30.23 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.384 0.673 . . . . 0.0 111.184 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.51 -42.12 92.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.905 0.859 . . . . 0.0 110.34 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.63 -23.94 53.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.083 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.515 HD11 ' CE2' ' A' ' 100' ' ' TYR . 3.2 mm -72.51 -35.57 51.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-N 118.552 0.615 . . . . 0.0 109.654 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.436 1.016 . . . . 0.0 109.899 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -51.39 69.57 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -59.57 -43.32 93.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.733 -173.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -74.77 -39.92 61.49 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.029 0.932 . . . . 0.0 110.894 -174.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -52.51 -46.33 66.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.818 0.735 . . . . 0.0 110.368 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.6 -42.01 22.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 119.506 -0.283 . . . . 0.0 111.447 -171.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.28 -32.12 47.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.246 1.418 . . . . 0.0 110.921 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 CA--C 1.528 0.122 0 C-N-CA 124.126 0.97 . . . . 0.0 112.293 174.825 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.444 0.64 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -62.63 66.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 130.906 3.682 . . . . 0.0 110.154 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 139.26 57.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 127.098 2.159 . . . . 0.0 106.587 -169.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -6.26 1.66 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -169.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.11 28.63 0.52 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 171.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 -176.6 49.35 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 106.223 -2.751 . . . . 0.0 106.223 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.42 ' HG2' HE22 ' A' ' 82' ' ' GLN . 39.6 mtt85 -87.33 151.07 23.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 168.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.921 HG11 HD11 ' A' ' 97' ' ' ILE . 2.9 p -132.8 165.8 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 169.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -139.84 128.36 22.92 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.36 124.36 42.2 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.722 1.264 . . . . 0.0 109.641 -170.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -98.6 125.23 43.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.26 1.824 . . . . 0.0 107.383 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -105.06 -17.88 14.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.762 0.825 . . . . 0.0 111.261 -175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.41 -75.17 0.29 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.4 -25.11 21.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.331 2.021 . . . . 0.0 113.104 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -152.85 175.93 12.37 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 125.036 1.334 . . . . 0.0 109.943 -171.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.515 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -143.76 146.44 33.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.35 2.26 . . . . 0.0 106.796 -169.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.82 151.6 51.98 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -171.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.2 139.05 57.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' HB3' HG13 ' A' ' 14' ' ' VAL . . . -136.23 157.79 45.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.758 2.023 . . . . 0.0 107.598 -176.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.76 95.26 2.39 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.231 -0.918 . . . . 0.0 110.404 -169.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.62 148.01 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 128.037 2.535 . . . . 0.0 112.325 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.572 HD22 ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.13 -31.07 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.914 166.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HG2' HD22 ' A' ' 28' ' ' LEU . 17.5 mtmt -111.08 149.61 30.55 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 168.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 pt -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -149.28 153.43 37.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.499 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.45 143.77 17.79 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 109.513 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.99 -11.72 32.94 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.291 2.66 . . . . 0.0 113.526 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.6 m -63.99 -33.02 74.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.834 1.197 . . . . 0.0 112.046 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -122.0 -10.62 8.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.464 1.506 . . . . 0.0 111.243 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt 47.29 50.46 14.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 109.533 -169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.8 mtp -146.32 152.59 39.38 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.744 2.018 . . . . 0.0 105.896 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -101.29 173.66 6.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.114 0.566 . . . . 0.0 112.375 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -138.6 161.23 37.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.717 2.007 . . . . 0.0 107.158 170.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 56' ' ' ILE . 31.4 t -154.97 162.17 41.17 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 CA--C 1.549 0.933 0 C-N-CA 125.647 1.579 . . . . 0.0 109.765 179.887 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 119.771 -0.157 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.75 103.18 0.14 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.6 mt -71.16 135.82 27.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -175.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.12 136.09 93.94 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.41 136.26 30.85 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.041 1.827 . . . . 0.0 107.706 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -140.36 162.41 35.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -170.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 6.2 mmpt? -63.86 152.41 39.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.55 150.67 27.83 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.442 1.897 . . . . 0.0 110.527 -169.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.57 19.95 5.58 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.3 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.56 -31.63 36.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.591 1.195 . . . . 0.0 109.857 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -150.35 17.75 0.83 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.013 1.325 . . . . 0.0 110.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -131.23 163.57 27.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.982 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -149.2 140.56 23.23 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.723 1.209 . . . . 0.0 108.535 169.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 71' ' ' ILE . 10.7 pt -135.91 122.55 14.26 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.99 154.51 17.35 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.245 1.963 . . . . 0.0 110.959 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -53.39 -22.11 7.01 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.81 0.844 . . . . 0.0 111.414 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.9 -27.99 69.53 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.933 1.693 . . . . 0.0 114.003 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 67' ' ' ILE . 18.4 pt -119.54 -12.6 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.508 1.503 . . . . 0.0 110.667 -176.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.17 -45.71 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 128.141 2.576 . . . . 0.0 108.963 169.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -81.35 10.31 5.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 -169.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.15 23.66 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -173.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -61.2 137.63 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -136.48 151.36 49.37 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.268 0.98 . . . . 0.0 110.378 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.17 113.88 9.19 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.828 1.251 . . . . 0.0 109.408 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.474 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 43.8 t80 -80.11 128.7 33.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.382 1.473 . . . . 0.0 107.091 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.56 152.25 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.563 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -97.8 125.24 42.54 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -75.27 115.5 14.98 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.42 HE22 ' HG2' ' A' ' 13' ' ' ARG . 56.6 mt-30 -79.73 151.9 30.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 110.023 -172.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 6.51 34.5 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.837 -0.98 . . . . 0.0 111.859 -170.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 57.5 m95 -133.7 173.31 11.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.712 1.256 . . . . 0.0 112.069 -173.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.69 163.09 24.68 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.522 1.129 . . . . 0.0 112.466 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -67.7 -19.38 65.15 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.154 0.982 . . . . 0.0 111.386 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 m -57.16 -31.04 64.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.156 -0.965 . . . . 0.0 111.915 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -87.92 9.29 22.63 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 117.879 -1.058 . . . . 0.0 112.912 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.78 99.64 0.34 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -152.15 166.1 32.74 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.481 1.912 . . . . 0.0 107.94 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.401 ' CD1' HG23 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -104.41 151.78 23.09 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.892 0.853 . . . . 0.0 110.671 169.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.48 HG23 HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -132.56 163.09 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.564 173.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.39 174.22 20.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.266 . . . . 0.0 110.043 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -15.38 33.4 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 113.948 -176.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -58.07 -24.38 58.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 112.617 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -124.55 -36.92 2.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 117.807 -1.092 . . . . 0.0 112.027 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.921 HD11 HG11 ' A' ' 14' ' ' VAL . 6.4 tt -97.37 152.36 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.611 1.096 . . . . 0.0 112.752 -168.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -155.14 150.15 26.81 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.449 2.3 . . . . 0.0 111.408 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.56 158.81 34.14 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.016 1.28 . . . . 0.0 112.852 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.484 ' CE1' HD11 ' A' ' 105' ' ' ILE . 4.3 t80 -70.52 107.33 3.81 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.765 0.793 . . . . 0.0 110.581 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.25 160.5 38.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.254 1.422 . . . . 0.0 109.343 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -52.75 -35.96 57.02 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.454 1.502 . . . . 0.0 114.806 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.21 -44.71 95.96 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.792 1.282 . . . . 0.0 109.808 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -77.13 -20.78 55.16 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.028 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.484 HD11 ' CE1' ' A' ' 100' ' ' TYR . 6.1 mm -73.23 -32.91 39.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 CA-C-N 119.117 0.871 . . . . 0.0 110.385 169.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.395 0.998 . . . . 0.0 108.945 171.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.23 74.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -55.48 -48.97 73.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.284 1.034 . . . . 0.0 109.916 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.82 -44.98 38.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.428 -172.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -57.58 -34.49 69.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.744 0.702 . . . . 0.0 110.179 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -78.21 -50.4 11.98 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.36 -29.0 3.54 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.835 1.254 . . . . 0.0 112.275 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.8 t30 . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 124.917 1.287 . . . . 0.0 113.539 173.845 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -57.11 122.62 12.82 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.06 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -1.27 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.41 30.22 0.36 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.76 -174.58 49.9 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 169.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -86.76 151.69 23.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.56 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -130.33 163.43 35.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 168.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.433 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 60.8 mt -139.91 130.4 25.55 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -173.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.55 129.56 50.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.276 0.985 . . . . 0.0 108.518 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.96 118.03 35.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -99.6 -14.44 18.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -169.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.57 -78.9 0.23 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.24 -32.58 12.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.128 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.77 -177.17 6.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.821 1.648 . . . . 0.0 109.454 -169.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.499 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 11.7 tmm? -128.37 145.24 51.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.84 2.056 . . . . 0.0 108.306 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -130.3 146.27 51.87 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.791 0.805 . . . . 0.0 109.727 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -73.87 148.32 42.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.286 1.434 . . . . 0.0 109.845 -170.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.96 45.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.809 0.844 . . . . 0.0 110.418 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -148.48 95.74 2.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.275 1.03 . . . . 0.0 110.78 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.56 HD11 HG11 ' A' ' 14' ' ' VAL . 46.2 mt -59.72 151.25 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 128.294 2.638 . . . . 0.0 112.158 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 29' ' ' LYS 0.301 0.0 OUTLIER -159.71 -28.68 0.07 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 116.802 -1.571 . . . . 0.0 111.96 166.887 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.473 ' N ' HD22 ' A' ' 28' ' ' LEU . 17.0 mtmt -113.77 150.13 33.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 168.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.0 166.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.049 0.928 . . . . 0.0 108.693 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -144.18 151.76 39.95 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.514 1.526 . . . . 0.0 109.525 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.11 142.88 16.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.807 1.643 . . . . 0.0 109.563 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 -11.37 31.92 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.158 2.572 . . . . 0.0 113.801 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -62.15 -31.84 72.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.322 1.419 . . . . 0.0 112.312 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.7 p -129.89 0.51 4.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.252 1.421 . . . . 0.0 111.219 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt 44.21 53.78 6.45 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.615 1.566 . . . . 0.0 110.545 -174.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptm -155.26 165.24 37.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.022 1.329 . . . . 0.0 107.703 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -110.67 172.28 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.083 0.953 . . . . 0.0 112.048 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.8 p -141.0 157.3 45.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.67 1.988 . . . . 0.0 106.379 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 56' ' ' ILE . 28.7 t -150.85 159.06 44.8 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 pt . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 124.645 1.178 . . . . 0.0 109.58 -175.706 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt . . . . . 0 N--CA 1.467 0.393 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.26 109.77 2.0 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.0 mt -76.12 131.62 34.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -173.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.53 138.55 95.68 Favored Pre-proline 0 C--O 1.234 0.288 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.59 137.9 31.2 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.852 1.701 . . . . 0.0 107.931 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -139.05 160.06 40.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 130.16 42.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.79 156.51 34.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.352 1.461 . . . . 0.0 112.31 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.21 29.38 2.15 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.678 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -79.26 -41.08 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.648 1.224 . . . . 0.0 109.041 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -161.96 5.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.347 1.059 . . . . 0.0 113.41 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 48.8 2.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.902 1.281 . . . . 0.0 111.603 -168.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -33.09 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.631 3.172 . . . . 0.0 113.496 168.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 71' ' ' ILE . 8.1 pt -136.88 134.47 19.23 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 107.832 169.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.97 160.1 50.85 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.18 1.92 . . . . 0.0 110.311 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.01 -23.59 20.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 111.829 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.76 -33.97 67.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.336 1.454 . . . . 0.0 113.196 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 67' ' ' ILE . 8.2 pt -120.01 -10.06 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 119.487 1.039 . . . . 0.0 110.733 -172.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -59.31 -49.39 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 127.641 2.377 . . . . 0.0 106.661 168.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -77.71 9.42 3.46 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.521 1.528 . . . . 0.0 112.088 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.17 -179.19 27.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.704 1.138 . . . . 0.0 110.881 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -59.31 137.21 58.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 m -136.46 150.65 48.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 124.281 0.988 . . . . 0.0 110.456 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.82 114.66 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.164 -172.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -79.97 124.98 29.18 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.22 1.408 . . . . 0.0 107.374 169.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -137.83 154.06 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 112.433 -168.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -96.46 124.42 40.45 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 166.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -74.03 106.93 5.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -71.99 149.68 44.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.44 3.87 41.99 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.261 -1.299 . . . . 0.0 113.104 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 63.9 m95 -126.7 168.0 14.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.403 1.602 . . . . 0.0 111.418 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -66.69 171.35 5.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.341 1.056 . . . . 0.0 112.232 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.08 -21.86 66.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.633 1.173 . . . . 0.0 111.585 169.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -63.12 -25.43 68.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.789 0.835 . . . . 0.0 112.144 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -102.23 19.15 19.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 0.0 112.695 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.66 103.52 1.75 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.22 168.39 23.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.382 -167.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.09 152.38 22.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.12 0.962 . . . . 0.0 111.241 168.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.51 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.14 1.376 . . . . 0.0 110.359 173.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 167.2 25.5 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -19.41 21.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.099 1.36 . . . . 0.0 113.733 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.88 -22.88 40.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.676 1.191 . . . . 0.0 112.918 170.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -121.49 -38.54 2.76 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.324 -1.322 . . . . 0.0 111.763 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.476 HD11 HG21 ' A' ' 14' ' ' VAL . 7.4 tt -99.62 154.38 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 120.654 1.57 . . . . 0.0 113.017 -169.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -150.34 156.99 42.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 128.895 2.878 . . . . 0.0 108.921 169.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.39 163.63 27.32 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.602 1.161 . . . . 0.0 112.431 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.93 112.25 9.86 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 120.85 -1.156 . . . . 0.0 109.293 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.979 1.311 . . . . 0.0 109.63 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -52.94 -36.03 59.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.899 1.68 . . . . 0.0 113.733 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -62.7 -43.86 97.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.404 1.097 . . . . 0.0 110.541 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.67 -22.39 50.67 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.253 -0.879 . . . . 0.0 109.519 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mm -70.77 -35.16 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 119.153 0.888 . . . . 0.0 109.926 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.45 99.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.238 0.926 . . . . 0.0 109.319 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -46.8 88.3 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.63 -43.43 96.85 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 118.163 -0.922 . . . . 0.0 109.749 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -72.01 -43.77 64.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.371 0.987 . . . . 0.0 109.677 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -32.16 48.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 118.144 -0.932 . . . . 0.0 111.454 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.85 -45.63 10.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.053 1.297 . . . . 0.0 113.29 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.23 -23.91 9.91 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.157 1.783 . . . . 0.0 111.962 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.1 t30 . . . . . 0 N--CA 1.456 -0.159 0 C-N-CA 126.342 1.857 . . . . 0.0 113.072 172.223 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--O 1.236 0.381 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.439 ' HA ' ' HB2' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -57.05 130.64 46.97 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.85 125.39 44.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 102.232 -3.247 . . . . 0.0 102.232 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.433 HD22 HG12 ' A' ' 41' ' ' ILE . 1.7 mt -56.57 -9.79 0.82 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -168.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.7 34.4 0.81 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.29 -153.03 7.33 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 105.853 -2.899 . . . . 0.0 105.853 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -113.47 155.97 24.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 168.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.553 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.22 155.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 169.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 14' ' ' VAL . 7.8 mt -127.74 153.48 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.02 126.91 31.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -173.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -90.57 118.29 29.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -95.25 -14.13 24.28 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.87 0.868 . . . . 0.0 111.624 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.07 -75.67 0.35 Allowed Glycine 0 C--N 1.337 0.609 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.73 -28.63 13.66 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.557 2.171 . . . . 0.0 113.135 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.493 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.01 -177.12 6.3 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 -170.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.493 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -146.22 147.45 31.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.613 1.565 . . . . 0.0 108.302 -168.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.2 170.59 15.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.313 1.045 . . . . 0.0 110.372 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.78 147.54 25.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.778 0.831 . . . . 0.0 109.203 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 165.91 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.759 1.624 . . . . 0.0 108.865 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -153.51 108.52 3.17 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 121.109 -0.994 . . . . 0.0 110.487 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 14' ' ' VAL . 74.3 mt -55.4 150.09 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 128.454 2.702 . . . . 0.0 110.922 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -157.1 -31.08 0.08 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.773 169.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 24.0 mtmt -119.96 146.93 45.37 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 168.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.51 165.47 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -144.75 150.6 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.612 -170.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.84 142.21 15.27 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.662 1.585 . . . . 0.0 109.242 -173.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.93 -2.87 11.7 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.411 2.74 . . . . 0.0 113.652 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -63.6 -36.67 84.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.579 1.536 . . . . 0.0 111.46 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -134.86 12.37 3.66 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.083 0.953 . . . . 0.0 112.022 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 42.0 55.65 3.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.145 1.378 . . . . 0.0 111.795 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.5 ptm -155.89 164.33 38.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -107.58 169.6 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.412 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 p -136.15 156.17 49.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.755 2.022 . . . . 0.0 106.483 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.566 ' HB2' HD12 ' A' ' 56' ' ' ILE . 20.0 m -154.21 154.63 33.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -169.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.433 HG12 HD22 ' A' ' 10' ' ' LEU . 3.2 pt . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 123.889 0.876 . . . . 0.0 110.012 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.55 112.89 2.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.6 mt -79.83 137.04 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -175.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.38 141.98 94.05 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.3 138.7 30.75 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 N-CA-C 107.231 -1.873 . . . . 0.0 107.231 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -137.57 159.9 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.779 0.8 . . . . 0.0 108.952 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.44 118.82 11.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.52 153.83 41.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.221 1.408 . . . . 0.0 112.48 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.23 1.55 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-O 118.968 -0.907 . . . . 0.0 115.243 168.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -80.57 -40.66 25.45 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.097 1.449 . . . . 0.0 109.374 169.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.15 -0.41 0.07 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 0.0 113.516 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.69 46.41 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.552 1.541 . . . . 0.0 111.509 -169.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -31.75 139.07 0.04 OUTLIER 'General case' 0 C--O 1.237 0.44 0 C-N-CA 129.776 3.23 . . . . 0.0 113.28 168.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 71' ' ' ILE . 7.6 pt -134.76 126.66 18.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.15 156.41 20.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.732 2.288 . . . . 0.0 111.128 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.62 -18.48 7.86 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.08 1.352 . . . . 0.0 112.758 173.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -64.04 -30.81 71.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.923 1.289 . . . . 0.0 112.338 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.447 HD11 HG22 ' A' ' 67' ' ' ILE . 10.1 pt -121.03 -9.49 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.835 1.198 . . . . 0.0 110.789 -173.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.19 -49.57 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 127.776 2.43 . . . . 0.0 106.305 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.85 8.94 3.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.411 1.484 . . . . 0.0 111.994 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.96 -178.45 24.9 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.27 0.941 . . . . 0.0 111.315 -174.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -63.4 136.9 57.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.2 m -139.33 152.39 47.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.246 0.966 . . . . 0.0 110.89 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.434 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 37.5 m-85 -140.81 113.21 8.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.293 -170.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 54.4 t80 -79.15 128.99 33.99 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.19 153.93 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 124.671 1.232 . . . . 0.0 112.28 -168.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -96.38 121.53 38.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 167.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.14 112.7 7.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.73 149.45 31.16 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.86 53.25 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.063 -0.854 . . . . 0.0 111.902 -169.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -132.13 172.59 12.2 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.619 1.21 . . . . 0.0 111.097 -177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -72.07 158.74 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.331 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.1 m -71.63 -13.09 61.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.636 0.374 . . . . 0.0 111.778 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.9 m -54.75 -34.86 63.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.456 1.102 . . . . 0.0 112.357 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -86.98 7.94 25.37 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.109 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.66 118.24 9.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.278 7.7 tp10 -155.73 168.41 27.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.199 1.8 . . . . 0.0 107.739 -167.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 150.07 23.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.84 0.828 . . . . 0.0 110.652 168.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.65 153.32 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.764 174.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.9 157.83 28.81 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 174.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.59 8.77 0.76 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.19 -21.03 24.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.355 1.862 . . . . 0.0 111.557 169.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -117.29 -36.7 3.69 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.681 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.07 151.0 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 120.062 1.301 . . . . 0.0 110.592 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -142.62 146.23 34.3 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.596 1.558 . . . . 0.0 110.404 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 8' ' ' PHE . . . -65.91 151.36 46.9 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.229 1.412 . . . . 0.0 109.884 174.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.51 123.42 16.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.206 1.003 . . . . 0.0 110.823 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -147.85 151.32 35.74 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.107 2.163 . . . . 0.0 106.993 -169.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.66 -28.56 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.913 0.485 . . . . 0.0 110.65 173.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -64.37 -44.21 92.09 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.759 0.824 . . . . 0.0 110.302 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.5 mm -69.67 -33.89 58.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.626 0.648 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.45 99.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.287 0.949 . . . . 0.0 109.68 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -47.43 85.36 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.99 -48.02 83.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.579 -173.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -70.77 -44.51 66.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.32 0.509 . . . . 0.0 109.76 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -27.61 33.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.646 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -94.1 -45.45 7.55 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.441 1.473 . . . . 0.0 112.498 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.15 11.12 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.47 1.508 . . . . 0.0 110.956 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.9 t30 . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 126.215 1.806 . . . . 0.0 113.307 172.522 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -56.65 126.5 26.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 168.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.37 135.76 55.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -169.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.404 HD22 HG12 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -58.9 -3.62 0.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -168.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.2 28.0 0.26 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.89 -176.31 51.05 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 100' ' ' TYR . 87.4 mtt-85 -87.17 153.96 21.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.563 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.38 166.93 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 168.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -133.52 145.38 50.1 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.9 134.02 40.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.2 126.62 39.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.693 1.245 . . . . 0.0 107.649 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -103.04 -6.5 22.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.512 0.725 . . . . 0.0 111.109 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -77.63 0.35 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.46 -34.95 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.309 2.006 . . . . 0.0 113.422 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.7 178.36 8.04 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.815 1.646 . . . . 0.0 108.131 -172.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 161.97 33.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.06 163.97 28.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.112 0.965 . . . . 0.0 109.132 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.13 145.59 42.07 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.302 1.041 . . . . 0.0 108.223 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.06 158.47 44.39 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -148.48 94.06 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.927 0.891 . . . . 0.0 109.681 -169.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.563 HD11 HG11 ' A' ' 14' ' ' VAL . 54.7 mt -58.48 150.03 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.62 3.168 . . . . 0.0 111.886 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.51 -19.46 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 167.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -131.03 139.77 49.99 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.38 160.09 25.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -168.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -143.67 152.59 41.52 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.288 -168.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -149.63 143.6 16.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.653 1.581 . . . . 0.0 109.618 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.24 -1.97 10.45 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.954 3.103 . . . . 0.0 113.772 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.5 m -63.22 -33.39 75.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.297 1.408 . . . . 0.0 112.014 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -135.74 -0.52 2.58 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.919 1.288 . . . . 0.0 111.669 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 48.17 52.41 13.32 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.159 0.984 . . . . 0.0 110.145 -169.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 77.9 mtp -146.19 156.7 43.59 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.393 1.877 . . . . 0.0 107.034 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -107.25 175.62 5.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.866 0.866 . . . . 0.0 112.365 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -141.71 152.77 44.15 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 127.041 2.136 . . . . 0.0 107.207 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.1 m -152.16 157.12 41.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -169.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.404 HG12 HD22 ' A' ' 10' ' ' LEU . 4.8 pt . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 110.009 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt . . . . . 0 N--CA 1.467 0.417 0 CA-C-O 119.34 -0.362 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.38 112.0 2.25 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.5 mt -75.42 139.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 138.34 93.26 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.49 136.55 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 N-CA-C 107.344 -1.829 . . . . 0.0 107.344 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -138.72 159.58 41.76 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -170.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -64.87 131.86 47.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 tt -80.57 155.55 26.88 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.471 1.908 . . . . 0.0 112.199 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.34 20.27 4.79 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.332 0.968 . . . . 0.0 112.129 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.4 -35.48 47.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.942 0.871 . . . . 0.0 109.262 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -150.97 8.94 0.57 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.703 1.201 . . . . 0.0 111.634 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.628 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 6.6 mp0 -126.72 173.5 9.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.523 1.529 . . . . 0.0 110.699 -169.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.7 m -153.85 140.42 18.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 169.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.499 HG22 HD11 ' A' ' 71' ' ' ILE . 12.3 pt -134.54 132.28 20.73 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.12 160.02 50.55 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.363 1.376 . . . . 0.0 109.444 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.02 -14.51 2.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.443 1.097 . . . . 0.0 112.317 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -66.93 -31.95 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.604 1.562 . . . . 0.0 112.773 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' ILE . 13.5 pt -119.34 -12.57 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 120.202 1.365 . . . . 0.0 110.686 -173.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -52.41 -46.92 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 128.43 2.692 . . . . 0.0 108.24 169.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.52 8.46 9.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.476 0.711 . . . . 0.0 111.923 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.49 -178.35 25.29 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.881 1.219 . . . . 0.0 111.195 -170.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -64.13 131.84 48.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -136.44 152.98 51.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.288 0.993 . . . . 0.0 111.546 176.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.71 114.68 10.73 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.967 1.307 . . . . 0.0 110.006 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -80.49 126.33 31.08 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 126.206 1.802 . . . . 0.0 106.791 169.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.47 156.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.334 1.454 . . . . 0.0 111.488 -168.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -105.45 120.15 40.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 167.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -72.22 120.59 18.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -72.34 148.41 45.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.582 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 9.6 56.74 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.5 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -130.76 165.01 23.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.95 1.375 . . . . 0.0 112.035 -175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -75.26 161.62 29.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -62.17 -21.51 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 111.448 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -25.66 39.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.828 1.251 . . . . 0.0 112.695 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -101.57 1.82 38.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.216 1.006 . . . . 0.0 111.726 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.77 115.4 7.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.277 6.8 tp10 -156.91 169.35 24.98 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.759 1.624 . . . . 0.0 108.241 -167.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.628 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.08 150.46 22.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.229 1.014 . . . . 0.0 109.72 168.094 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.44 155.26 40.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.749 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.27 166.52 32.12 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.66 -17.48 15.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.83 1.252 . . . . 0.0 113.232 174.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -22.86 40.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.767 1.227 . . . . 0.0 113.176 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -122.89 -38.98 2.55 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.431 174.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -95.85 156.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 119.767 1.167 . . . . 0.0 112.615 -169.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' HB3' HD21 ' A' ' 104' ' ' ASN . 89.0 mtt180 -155.19 155.41 33.85 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.391 2.676 . . . . 0.0 109.862 171.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.97 163.09 27.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.297 1.439 . . . . 0.0 112.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.52 ' CE2' HD11 ' A' ' 105' ' ' ILE . 35.6 t80 -66.95 115.84 7.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.15 -0.969 . . . . 0.0 110.392 174.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -161.69 161.89 29.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.482 1.513 . . . . 0.0 108.785 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.11 -33.25 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.798 1.639 . . . . 0.0 114.089 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -64.64 -43.85 92.36 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.015 0.912 . . . . 0.0 110.266 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 98' ' ' ARG . 79.6 m-20 -74.3 -27.0 60.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.67 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.52 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.8 mm -67.15 -45.53 86.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 117.308 -1.329 . . . . 0.0 109.524 169.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.6 79.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.796 1.634 . . . . 0.0 109.865 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.23 -51.79 63.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.225 0.61 . . . . 0.0 109.973 171.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.57 -48.86 80.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.369 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -68.26 -40.58 81.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 120.022 1.283 . . . . 0.0 110.276 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -52.47 -54.37 33.26 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt -73.71 -40.72 63.4 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.002 -0.436 . . . . 0.0 110.665 -170.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.12 -9.21 0.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.268 1.827 . . . . 0.0 113.009 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 CA--C 1.535 0.388 0 C-N-CA 124.993 1.317 . . . . 0.0 112.284 178.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.84 126.09 26.22 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 168.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.73 128.89 52.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -170.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.442 HD22 HG12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -59.04 -2.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -168.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.98 32.57 0.37 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 -157.43 14.14 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -109.48 154.57 22.48 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -129.18 162.04 37.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 169.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 14' ' ' VAL . 35.9 mt -139.14 130.39 26.81 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 -175.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.31 139.75 51.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -108.2 115.34 29.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -96.3 -10.54 27.62 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.994 0.918 . . . . 0.0 112.065 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.14 -78.69 0.31 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.62 -30.27 18.53 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.628 2.219 . . . . 0.0 112.887 175.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.445 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.11 -178.43 7.1 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.577 1.551 . . . . 0.0 108.894 -169.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.445 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -139.17 155.14 48.04 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.613 1.565 . . . . 0.0 107.326 -172.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -138.01 167.72 21.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 109.914 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.17 144.57 36.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.532 1.133 . . . . 0.0 109.061 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.9 156.43 48.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.168 1.387 . . . . 0.0 108.456 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -147.55 103.65 3.55 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.576 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.606 HD11 HG11 ' A' ' 14' ' ' VAL . 74.9 mt -60.09 148.16 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 129.61 3.164 . . . . 0.0 111.428 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.27 -18.41 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 116.732 -1.604 . . . . 0.0 113.88 167.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.445 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 15.2 ttpt -124.54 139.87 53.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 pt -141.01 161.11 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -169.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.48 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 2.9 t-105 -149.38 152.35 35.62 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.815 0.697 . . . . 0.0 111.988 -169.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.21 139.51 14.08 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.172 2.189 . . . . 0.0 109.054 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.2 -9.79 26.38 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.907 3.071 . . . . 0.0 113.422 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -68.48 -30.91 69.85 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.021 1.282 . . . . 0.0 111.291 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 m -120.1 -15.69 8.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.054 1.342 . . . . 0.0 110.844 174.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 49.18 47.2 22.32 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 118.865 0.757 . . . . 0.0 109.914 -170.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -145.82 148.69 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.84 174.8 6.2 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.111 0.565 . . . . 0.0 112.323 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.9 p -142.28 160.07 40.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.529 1.932 . . . . 0.0 106.884 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.646 ' HB3' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -147.16 165.16 30.85 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.442 HG12 HD22 ' A' ' 10' ' ' LEU . 8.5 pt . . . . . 0 CA--C 1.547 0.846 0 C-N-CA 124.718 1.207 . . . . 0.0 109.113 178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -23.2 98.49 0.01 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.132 2.173 . . . . 0.0 112.322 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 40' ' ' SER . 4.0 mt -70.69 129.42 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 111.388 -2.642 . . . . 0.0 107.24 -168.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -67.12 137.12 94.21 Favored Pre-proline 0 C--O 1.236 0.344 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -173.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.16 131.02 17.27 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.272 1.981 . . . . 0.0 107.092 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -135.45 167.59 20.79 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.588 1.155 . . . . 0.0 108.085 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -65.16 151.94 44.84 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD11 ' CZ2' ' A' ' 91' ' ' TRP . 10.1 tt -108.09 147.22 31.51 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.585 1.554 . . . . 0.0 109.996 -169.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.87 42.73 0.77 Allowed Glycine 0 CA--C 1.527 0.787 0 O-C-N 123.906 0.754 . . . . 0.0 112.94 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.17 -8.73 3.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.093 0.957 . . . . 0.0 112.6 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.73 10.81 2.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.144 1.378 . . . . 0.0 110.472 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.448 ' HB2' ' HE1' ' A' ' 91' ' ' TRP . 0.6 OUTLIER -161.16 -177.44 6.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 108.016 -169.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.7 m -161.52 141.92 10.77 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.651 2.78 . . . . 0.0 103.64 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 67' ' ' ILE 0.311 5.3 tt -134.01 119.6 14.74 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -170.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.76 145.98 80.02 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.407 2.738 . . . . 0.0 113.037 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.8 -22.07 22.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.289 1.036 . . . . 0.0 112.509 172.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -58.01 -31.3 66.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.792 2.037 . . . . 0.0 113.282 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 pt -117.82 -17.53 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.935 0.894 . . . . 0.0 111.014 -169.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.48 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 2.5 mm -52.87 -43.29 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 128.561 2.744 . . . . 0.0 109.656 171.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.91 11.75 4.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.252 -169.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.59 -171.1 26.07 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 121.0 -1.063 . . . . 0.0 110.487 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.01 136.16 56.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.131 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 m -137.91 151.21 47.78 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.927 0.767 . . . . 0.0 111.205 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -138.47 114.76 10.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.895 1.278 . . . . 0.0 110.294 -171.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 29' ' ' LYS . 53.5 t80 -81.48 129.23 34.57 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -137.97 149.04 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.017 -168.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -92.83 123.83 36.38 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -71.3 113.41 8.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -73.65 149.49 41.95 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.29 15.71 52.22 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 119.001 -0.888 . . . . 0.0 113.063 -176.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -136.31 172.15 13.43 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.113 1.365 . . . . 0.0 110.173 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -71.21 161.5 31.0 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -175.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -72.57 -13.47 61.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.759 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.9 m -55.09 -32.6 62.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.343 1.057 . . . . 0.0 112.225 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -87.77 2.45 51.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.858 0.863 . . . . 0.0 113.005 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.77 119.42 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 40.9 tt0 -158.81 153.94 25.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.448 ' HE1' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -91.18 149.69 21.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.282 1.039 . . . . 0.0 109.224 168.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.44 HG11 ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -132.8 149.13 31.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.49 -1.686 . . . . 0.0 110.484 -177.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.74 161.93 37.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.552 173.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.06 10.06 0.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.035 1.734 . . . . 0.0 114.95 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.27 -34.98 15.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.947 1.699 . . . . 0.0 110.378 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.44 ' HD2' HG11 ' A' ' 92' ' ' VAL . 23.6 ttm180 -93.39 -45.11 7.95 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.12 175.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 14' ' ' VAL . 5.2 tt -98.61 156.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.564 0.62 . . . . 0.0 111.335 -171.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.455 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 99.3 mtt180 -148.23 155.25 41.13 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.771 2.029 . . . . 0.0 109.743 169.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 161.72 30.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.16 1.346 . . . . 0.0 111.427 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CE2' HD11 ' A' ' 105' ' ' ILE . 26.4 t80 -70.12 117.9 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -162.02 161.32 28.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.131 1.373 . . . . 0.0 108.976 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.92 -36.08 47.85 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.68 1.592 . . . . 0.0 114.476 -169.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.19 -45.22 94.35 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.628 1.204 . . . . 0.0 110.476 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.49 -22.99 53.78 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.834 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.416 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.2 mm -69.01 -35.67 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.722 0.692 . . . . 0.0 109.772 169.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.9 97.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 118.809 0.731 . . . . 0.0 110.271 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -50.11 74.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -59.14 -48.04 83.08 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.6 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.69 -35.98 38.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.918 1.235 . . . . 0.0 110.276 -171.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -28.19 65.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.243 171.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -45.57 8.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.262 1.392 . . . . 0.0 112.819 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.04 16.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.285 1.434 . . . . 0.0 111.162 171.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.3 t30 . . . . . 0 CA--C 1.534 0.357 0 C-N-CA 125.684 1.594 . . . . 0.0 113.367 170.765 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 121.741 0.782 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.75 63.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 1 C-N-CA 132.094 4.158 . . . . 0.0 111.401 169.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.33 135.81 55.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 127.24 2.216 . . . . 0.0 105.688 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.85 -4.92 1.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -169.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.61 30.43 0.51 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 171.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.44 -165.21 34.32 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.533 -2.627 . . . . 0.0 106.533 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -99.74 154.75 18.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.58 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -129.39 165.88 28.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 168.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.411 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.5 mm? -133.53 140.74 47.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.92 129.8 34.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -104.54 114.2 28.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -87.64 -22.25 24.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.116 0.566 . . . . 0.0 110.98 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.89 -72.08 0.31 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.11 -32.07 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.53 2.153 . . . . 0.0 112.736 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.31 174.65 12.61 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.909 1.684 . . . . 0.0 109.302 -172.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.411 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -139.12 150.35 45.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.7 1.6 . . . . 0.0 108.757 -169.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -137.24 159.97 40.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 109.673 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 148.87 39.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 123.612 0.765 . . . . 0.0 109.158 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.56 159.33 42.36 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.207 1.003 . . . . 0.0 109.912 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.92 95.7 2.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.331 0.652 . . . . 0.0 109.457 -170.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.58 HD11 HG11 ' A' ' 14' ' ' VAL . 70.4 mt -54.77 152.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 128.08 2.552 . . . . 0.0 111.632 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.02 -32.08 0.09 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.399 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 34.8 ttpt -132.2 136.81 47.29 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.65 166.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.7 0.762 . . . . 0.0 109.182 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.462 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.9 t-105 -143.17 153.24 42.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.587 -169.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -148.6 137.48 11.96 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 127.501 2.32 . . . . 0.0 108.152 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -10.93 28.18 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.528 2.819 . . . . 0.0 113.304 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -65.62 -31.85 73.11 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.863 1.21 . . . . 0.0 111.957 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -124.51 -7.44 7.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.013 1.325 . . . . 0.0 111.163 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt 47.05 48.41 15.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.388 1.075 . . . . 0.0 110.65 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtp -147.19 158.18 43.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.642 2.377 . . . . 0.0 105.98 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.434 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -108.99 174.21 5.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.788 0.835 . . . . 0.0 112.321 -174.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 p -147.37 149.38 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.503 1.921 . . . . 0.0 107.035 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.437 ' HB3' HD12 ' A' ' 56' ' ' ILE . 35.9 t -146.5 165.9 28.05 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 pt . . . . . 0 CA--C 1.544 0.72 0 C-N-CA 125.141 1.377 . . . . 0.0 109.158 -176.875 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.53 113.84 3.2 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.437 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.1 mt -79.14 133.15 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -171.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -65.73 135.5 95.57 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.71 137.63 30.35 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.244 1.963 . . . . 0.0 108.024 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -139.69 160.67 39.34 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -170.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 4.8 mmpt? -67.02 120.08 13.05 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.618 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.26 150.71 33.88 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.805 2.042 . . . . 0.0 112.132 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.58 25.52 3.39 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.421 -1.21 . . . . 0.0 115.751 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.28 -30.57 17.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.986 1.893 . . . . 0.0 111.023 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.04 -39.9 0.11 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.07 1.748 . . . . 0.0 110.272 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -71.18 159.91 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -153.93 159.31 41.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 72' ' ' ILE 0.329 2.0 tt -144.63 126.61 8.09 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 -169.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.84 155.0 70.05 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 121.155 1.448 . . . . 0.0 111.142 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -56.96 -17.6 10.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.788 1.235 . . . . 0.0 112.542 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.11 -25.51 67.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.433 1.493 . . . . 0.0 112.332 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 pt -125.27 -14.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.229 0.922 . . . . 0.0 111.3 -170.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.51 HG12 HG23 ' A' ' 67' ' ' ILE . 1.6 mm -50.73 -42.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 128.587 2.755 . . . . 0.0 109.591 169.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.14 9.66 6.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.854 1.262 . . . . 0.0 112.768 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.01 -171.52 24.91 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 14.6 mmtt -58.66 140.4 54.63 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.294 -0.533 . . . . 0.0 109.658 174.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 m -138.2 149.35 45.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 123.933 0.771 . . . . 0.0 110.721 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 75' ' ' LYS . 50.0 m-85 -134.94 113.88 11.95 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.041 0.936 . . . . 0.0 110.763 -170.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -78.87 125.25 29.12 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.8 2.04 . . . . 0.0 106.479 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -135.15 151.94 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.069 1.348 . . . . 0.0 111.435 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -101.0 116.05 31.94 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 167.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.93 121.31 15.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.93 157.18 25.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.176 0.512 . . . . 0.0 110.031 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.35 11.11 45.64 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.217 -0.769 . . . . 0.0 111.731 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -135.7 167.65 20.74 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.526 1.13 . . . . 0.0 110.339 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -64.98 169.09 5.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.726 1.21 . . . . 0.0 110.659 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -82.97 -11.53 58.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.566 171.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.3 m -55.78 -33.43 64.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.707 1.203 . . . . 0.0 112.031 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -84.74 4.16 34.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.05 118.97 10.58 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.258 9.1 tt0 -157.23 162.02 39.25 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.589 1.556 . . . . 0.0 107.806 -167.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.435 ' CD1' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -96.68 152.85 18.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.15 0.976 . . . . 0.0 109.497 168.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.11 155.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.441 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.49 167.56 28.76 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -17.58 9.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.247 1.419 . . . . 0.0 113.304 176.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.77 -23.19 41.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 113.143 170.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.97 -38.56 2.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.881 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 14' ' ' VAL . 7.2 tt -94.19 155.29 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.728 1.149 . . . . 0.0 112.451 -169.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -153.95 160.23 42.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.275 3.03 . . . . 0.0 108.765 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.78 15.67 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.616 1.553 . . . . 0.0 112.832 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.535 ' CE2' HD11 ' A' ' 105' ' ' ILE . 32.0 t80 -70.22 115.0 8.91 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.056 -1.027 . . . . 0.0 110.023 169.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -162.02 163.64 28.72 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.622 1.569 . . . . 0.0 109.333 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -54.41 -34.34 61.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.629 1.572 . . . . 0.0 113.815 -169.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -63.9 -42.07 97.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.096 0.95 . . . . 0.0 110.412 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.16 -25.85 55.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.552 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.535 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.8 mm -69.59 -37.56 74.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.345 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.6 98.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.275 0.943 . . . . 0.0 109.702 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -49.8 74.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.98 -51.07 69.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.759 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.45 -31.98 58.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 117.63 -1.176 . . . . 0.0 110.176 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.99 -45.72 75.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.827 1.194 . . . . 0.0 110.358 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.06 -46.82 22.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.683 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.06 -29.58 30.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.022 1.329 . . . . 0.0 111.421 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 . . . . . 0 N--CA 1.456 -0.174 0 C-N-CA 124.559 1.143 . . . . 0.0 113.062 173.024 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.79 127.76 31.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.67 131.2 56.67 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 102.403 -3.184 . . . . 0.0 102.403 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -11.42 0.3 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -168.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.24 32.48 0.54 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.19 -170.47 36.47 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 169.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -91.16 153.25 20.17 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.874 HG11 HD11 ' A' ' 97' ' ' ILE . 2.9 p -135.92 158.35 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 169.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 14' ' ' VAL . 9.1 mt -128.28 154.66 45.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.97 129.24 31.82 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -93.18 129.05 39.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -110.19 -6.13 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.435 1.094 . . . . 0.0 111.991 -173.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.02 -80.68 0.29 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -72.42 -29.32 13.82 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.378 2.052 . . . . 0.0 113.16 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.65 177.83 10.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.782 1.633 . . . . 0.0 110.158 -169.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.431 ' CE ' HD13 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -142.75 150.85 40.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.042 1.737 . . . . 0.0 108.887 -168.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.61 175.75 9.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.11 147.13 25.07 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 109.746 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 14' ' ' VAL . . . -141.34 160.29 40.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.199 1.799 . . . . 0.0 108.465 -174.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -148.41 103.47 3.43 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 120.938 -1.101 . . . . 0.0 108.882 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 14' ' ' VAL . 79.7 mt -51.64 148.11 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.657 2.383 . . . . 0.0 110.441 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -153.92 -31.89 0.12 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.433 0.693 . . . . 0.0 111.632 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 33.4 ttpt -133.06 135.47 45.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 165.87 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.488 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.7 t-105 -145.45 154.59 42.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.302 -168.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.24 141.3 14.97 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.844 2.457 . . . . 0.0 108.697 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.82 -8.42 23.38 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.474 2.783 . . . . 0.0 113.356 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 m -66.92 -33.61 75.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.586 1.539 . . . . 0.0 110.961 -172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 p -118.95 -17.39 9.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.733 1.613 . . . . 0.0 110.847 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm 48.81 52.34 14.28 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.01 0.823 . . . . 0.0 109.212 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.9 mtp -148.9 156.94 43.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.476 2.71 . . . . 0.0 104.522 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 53.1 p90 -106.07 170.08 8.12 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.602 0.361 . . . . 0.0 111.666 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 p -142.57 150.58 40.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 126.995 2.118 . . . . 0.0 105.647 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.64 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.5 m -150.79 157.99 43.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -168.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.0 pt . . . . . 0 CA--C 1.553 1.07 0 C-N-CA 123.224 0.609 . . . . 0.0 109.595 -177.662 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt . . . . . 0 C--O 1.231 0.081 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -17.24 91.64 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.472 3.109 . . . . 0.0 111.127 -169.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 40' ' ' SER . 5.2 mt -72.03 136.48 25.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.121 -167.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.79 141.68 95.06 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.535 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.34 142.65 27.11 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.931 1.754 . . . . 0.0 108.822 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -129.75 165.91 20.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 108.953 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.622 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -60.37 -25.4 65.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 -168.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.6 tt 73.46 144.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.847 2.059 . . . . 0.0 112.66 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.97 25.16 5.47 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.989 -0.895 . . . . 0.0 115.188 169.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.25 -34.6 55.81 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.062 1.431 . . . . 0.0 109.113 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -153.16 -24.15 0.15 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.435 1.894 . . . . 0.0 112.369 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 34.3 mp0 -55.6 -19.51 10.54 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 129.162 2.985 . . . . 0.0 115.216 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -17.54 108.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.465 2.706 . . . . 0.0 111.962 -169.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.464 HG12 HD11 ' A' ' 71' ' ' ILE 0.342 4.3 tt -115.26 136.6 22.71 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.509 2.324 . . . . 0.0 106.764 -166.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.97 151.81 56.67 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.107 1.871 . . . . 0.0 111.578 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.61 -16.64 10.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.766 1.227 . . . . 0.0 113.339 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.71 -24.64 67.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.634 1.174 . . . . 0.0 112.367 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 67' ' ' ILE . 3.6 pt -125.16 -15.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.706 0.684 . . . . 0.0 110.688 -170.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.488 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 3.0 mm -54.67 -44.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.342 2.257 . . . . 0.0 107.158 169.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -81.15 11.31 4.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.177 1.791 . . . . 0.0 112.562 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.38 -172.26 26.29 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.636 1.107 . . . . 0.0 111.569 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -60.14 137.13 58.17 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -139.24 150.22 45.24 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.957 0.785 . . . . 0.0 110.465 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -137.04 115.58 11.96 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 110.272 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 41.3 t80 -82.04 130.87 35.2 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 126.348 1.859 . . . . 0.0 106.44 169.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.05 151.83 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.643 -167.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.62 122.96 36.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.71 115.63 11.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.49 147.99 30.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -173.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.16 46.8 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.336 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -130.73 171.47 13.06 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.597 1.199 . . . . 0.0 111.668 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -73.28 161.16 30.84 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.082 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.7 m -76.72 -13.86 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.229 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -51.1 -36.04 38.3 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.382 1.473 . . . . 0.0 111.979 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -88.06 2.13 52.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.76 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.55 121.64 14.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -172.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.276 7.7 tp10 -159.13 169.19 24.73 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.894 1.278 . . . . 0.0 108.099 -167.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.64 153.34 19.85 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.775 0.797 . . . . 0.0 110.744 168.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.434 HG23 HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -129.24 156.3 41.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.239 172.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.08 161.12 31.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.408 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.8 7.44 0.9 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -87.43 -21.04 25.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.991 1.716 . . . . 0.0 111.115 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm105 -117.91 -35.37 3.9 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.599 1.16 . . . . 0.0 111.813 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.874 HD11 HG11 ' A' ' 14' ' ' VAL . 4.4 tt -101.42 150.24 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.219 0.918 . . . . 0.0 110.094 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 87.4 mtt180 -147.32 143.8 28.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.094 1.358 . . . . 0.0 112.076 170.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HA ' HG23 ' A' ' 14' ' ' VAL . . . -68.18 147.81 51.74 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.703 2.001 . . . . 0.0 111.33 -176.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE2' HD11 ' A' ' 105' ' ' ILE . 34.4 t80 -59.52 114.68 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.197 0.453 . . . . 0.0 111.407 -169.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -160.53 162.23 32.92 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.27 -33.74 67.93 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.58 -42.99 98.27 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.598 0.713 . . . . 0.0 110.082 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -67.91 -36.59 80.45 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.412 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -67.58 -34.87 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.498 0.59 . . . . 0.0 110.804 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.29 98.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.209 0.913 . . . . 0.0 109.955 174.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -47.67 83.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -60.23 -48.95 79.56 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.732 0.813 . . . . 0.0 109.282 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -71.64 -43.89 65.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.34 0.518 . . . . 0.0 109.804 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -29.06 41.14 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.017 172.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.5 mt -92.96 -45.47 7.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.537 1.517 . . . . 0.0 112.341 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.0 -26.15 10.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.651 1.58 . . . . 0.0 111.491 170.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.9 t30 . . . . . 0 CA--C 1.531 0.233 0 C-N-CA 125.967 1.707 . . . . 0.0 112.969 172.441 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.93 163.59 26.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.675 1.19 . . . . 0.0 109.965 -175.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.21 -24.79 64.07 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.4 tp -57.02 -29.01 63.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.143 1.777 . . . . 0.0 112.446 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.08 -27.51 68.41 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.4 1.08 . . . . 0.0 111.299 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.58 -27.33 68.34 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.047 1.739 . . . . 0.0 112.556 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.53 144.88 30.99 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.734 0.697 . . . . 0.0 109.975 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -56.93 134.15 55.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 168.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -124.77 125.74 44.51 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 102.015 -3.328 . . . . 0.0 102.015 -177.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -10.18 0.93 Allowed 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -168.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.44 28.7 1.2 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.02 -175.27 50.94 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 106.629 -2.588 . . . . 0.0 106.629 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -89.48 157.3 18.16 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.06 153.49 37.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 168.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.444 HD23 ' O ' ' A' ' 14' ' ' VAL . 21.0 mt -122.07 139.38 53.79 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 173.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.66 123.16 28.77 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.229 0.956 . . . . 0.0 109.386 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -101.5 118.38 36.83 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.752 1.621 . . . . 0.0 107.6 -171.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -95.08 -25.63 16.37 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.161 0.585 . . . . 0.0 111.439 -172.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.82 -72.29 0.27 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -72.4 -30.51 12.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.079 1.853 . . . . 0.0 112.485 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -154.27 177.12 11.48 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 125.929 1.692 . . . . 0.0 109.63 -170.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.409 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -144.07 151.93 40.29 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.109 1.764 . . . . 0.0 108.175 -168.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -139.19 167.35 22.25 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.552 1.141 . . . . 0.0 110.583 -170.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -83.34 144.89 29.37 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.34 161.71 37.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.522 1.529 . . . . 0.0 108.998 -176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -149.11 108.22 3.91 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.124 -0.985 . . . . 0.0 110.366 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.566 HD11 HG11 ' A' ' 14' ' ' VAL . 68.9 mt -53.8 151.06 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.229 3.012 . . . . 0.0 111.348 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.01 -30.05 0.08 Allowed 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 169.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 34.4 ttpt -132.62 136.58 46.6 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.7 pt -138.85 159.89 30.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -168.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -143.68 152.85 41.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.547 -168.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -150.91 142.84 15.76 Favored Pre-proline 0 C--O 1.238 0.491 0 C-N-CA 126.065 1.746 . . . . 0.0 109.418 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.79 -11.13 31.05 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.971 2.448 . . . . 0.0 113.7 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.3 m -63.81 -32.62 74.19 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.852 1.205 . . . . 0.0 112.021 -171.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 m -125.82 -4.65 6.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.768 1.227 . . . . 0.0 111.421 176.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt 41.45 50.66 3.67 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 125.298 1.439 . . . . 0.0 111.105 -170.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.405 ' HE3' ' CB ' ' A' ' 58' ' ' PRO . 10.5 mtm -150.08 163.37 38.35 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 170.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.404 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 50.8 p90 -103.85 175.7 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.747 0.819 . . . . 0.0 112.272 -173.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 p -143.15 153.51 42.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 127.346 2.259 . . . . 0.0 106.907 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.643 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.0 m -153.23 163.49 39.79 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -169.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.42 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 6.6 pt -146.63 164.73 22.52 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.794 1.638 . . . . 0.0 108.726 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 41' ' ' ILE . 94.9 Cg_endo -78.5 46.2 2.07 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 125.096 3.864 . . . . 0.0 112.62 -169.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.87 -10.09 59.4 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.173 -0.954 . . . . 0.0 113.491 -169.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -164.65 -169.17 1.66 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.044 1.338 . . . . 0.0 109.838 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -140.21 92.8 9.34 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 128.085 2.554 . . . . 0.0 105.931 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -53.19 165.56 1.34 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.281 2.654 . . . . 0.0 112.353 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.63 19.89 1.1 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.549 1.547 . . . . 0.0 114.513 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.49 31.25 0.52 Allowed Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.622 1.582 . . . . 0.0 111.31 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.3 m -139.73 148.24 42.02 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.623 1.169 . . . . 0.0 109.497 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 p -68.37 -42.79 78.62 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 169.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -175.38 160.04 2.55 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 129.75 3.22 . . . . 0.0 105.792 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -73.03 146.95 45.54 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 166.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.403 ' H ' HD11 ' A' ' 56' ' ' ILE . 7.1 p -96.84 168.74 10.31 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.049 0.84 . . . . 0.0 110.975 -174.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -54.14 150.61 8.05 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.421 1.089 . . . . 0.0 109.257 169.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 4.79 80.77 0.0 OUTLIER 'General case' 0 C--O 1.236 0.344 0 C-N-CA 128.341 2.657 . . . . 0.0 113.532 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.643 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.2 mt -73.78 136.23 25.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 -169.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -78.58 146.13 68.82 Favored Pre-proline 0 N--CA 1.447 -0.587 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' CB ' ' HE3' ' A' ' 37' ' ' MET . 38.7 Cg_exo -52.73 134.34 53.56 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 C-N-CA 122.848 2.365 . . . . 0.0 110.137 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -144.9 153.74 41.88 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -65.74 135.82 55.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.19 0.995 . . . . 0.0 109.083 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.22 153.72 33.77 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.18 1.792 . . . . 0.0 111.631 -175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.64 21.88 5.27 Favored Glycine 0 CA--C 1.528 0.869 0 O-C-N 124.131 0.894 . . . . 0.0 112.783 176.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -75.87 -34.74 60.03 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.098 0.949 . . . . 0.0 109.207 173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -149.37 4.88 0.62 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.677 1.191 . . . . 0.0 111.855 175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.639 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 7.0 mp0 -114.18 168.47 9.8 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.476 1.51 . . . . 0.0 110.532 -169.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.9 m -149.54 138.96 21.51 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 169.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 71' ' ' ILE . 12.9 pt -135.1 128.9 18.74 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -68.85 162.38 41.64 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.958 1.772 . . . . 0.0 109.56 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.87 -15.72 9.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.924 0.89 . . . . 0.0 112.316 176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -65.55 -31.18 72.1 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.824 1.25 . . . . 0.0 112.119 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 67' ' ' ILE 0.254 4.6 pt -121.27 -9.09 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 119.812 1.187 . . . . 0.0 110.447 -172.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.43 -49.28 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 127.6 2.36 . . . . 0.0 106.137 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -79.44 10.24 4.01 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.774 1.63 . . . . 0.0 112.114 -171.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.34 28.85 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 119.454 1.024 . . . . 0.0 111.399 -173.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.5 mmtm -64.39 132.97 51.61 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 40.5 m -138.27 154.54 49.05 Favored 'General case' 0 C--N 1.331 -0.225 0 O-C-N 124.393 1.058 . . . . 0.0 111.844 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.44 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 35.9 m-85 -142.11 115.44 8.93 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.764 -169.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 46.5 t80 -80.82 128.29 33.49 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 169.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 pt -138.25 155.52 29.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.277 -1.329 . . . . 0.0 112.458 -167.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -100.45 118.23 36.25 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 167.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.59 121.89 18.71 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -90.22 150.27 22.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 10.28 52.71 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.396 -0.669 . . . . 0.0 111.616 -169.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.649 ' CD1' HM2B ' A' ' 128' ' ' M2L . 31.8 m95 -136.07 172.04 13.59 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.833 1.253 . . . . 0.0 111.25 -174.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -71.36 163.08 28.37 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.324 -173.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.7 m -77.64 -12.11 59.93 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.161 171.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 5.7 m -55.43 -31.15 61.67 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.969 -1.082 . . . . 0.0 111.713 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -82.79 0.02 45.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 117.599 -1.191 . . . . 0.0 112.974 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -64.61 112.87 3.37 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -157.63 168.71 26.48 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.098 1.759 . . . . 0.0 107.975 -167.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.639 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.9 152.46 20.51 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 122.042 0.925 . . . . 0.0 110.479 168.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.59 151.42 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.006 171.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.8 158.84 35.62 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 174.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.412 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -70.47 6.83 1.23 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -85.78 -26.68 25.66 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.624 1.57 . . . . 0.0 110.974 169.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -107.76 -40.42 5.29 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.363 1.065 . . . . 0.0 111.093 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 14' ' ' VAL . 5.4 tt -100.61 148.9 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 119.596 1.089 . . . . 0.0 110.443 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.412 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 96.2 mtt180 -145.62 151.28 37.83 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.52 1.128 . . . . 0.0 109.94 168.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.54 146.23 52.0 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.506 1.522 . . . . 0.0 110.403 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.489 ' CE2' HD11 ' A' ' 105' ' ' ILE . 44.8 t80 -61.12 114.75 3.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 119.053 0.842 . . . . 0.0 112.194 -169.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -159.25 164.82 34.64 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.223 1.409 . . . . 0.0 110.126 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -57.27 -33.9 68.09 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.594 1.557 . . . . 0.0 113.527 -169.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -64.24 -42.27 96.59 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.724 0.773 . . . . 0.0 109.572 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -68.75 -34.96 76.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.489 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.9 mm -66.91 -36.79 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 CA-C-N 118.687 0.676 . . . . 0.0 110.833 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.92 -40.96 99.19 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 119.259 0.936 . . . . 0.0 109.924 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -57.49 -50.85 71.71 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 170.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -57.72 -48.92 78.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.661 0.785 . . . . 0.0 109.757 -173.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -72.36 -38.99 68.4 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.798 0.839 . . . . 0.0 110.718 -173.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -47.28 82.02 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.835 0.743 . . . . 0.0 109.215 173.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.8 mt -73.42 -42.77 61.65 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.434 -0.791 . . . . 0.0 111.819 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.31 -20.05 3.93 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.294 1.438 . . . . 0.0 112.606 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -93.54 -52.24 4.58 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.921 0.782 . . . . 0.0 111.557 172.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -71.96 -26.57 62.32 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -170.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -138.67 9.35 2.63 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -168.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.0 75.61 0.24 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.715 1.626 . . . . 0.0 112.536 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 71.1 m -142.76 162.51 35.27 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 128.123 2.569 . . . . 0.0 106.11 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.4 p -74.54 -20.23 60.04 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.54 1.536 . . . . 0.0 113.442 -172.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 69.92 12.51 68.16 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.261 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 m -74.32 59.93 0.81 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.187 1.795 . . . . 0.0 111.866 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.29 158.61 57.64 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.952 1.301 . . . . 0.0 109.249 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -61.01 10.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 125.091 3.861 . . . . 0.0 117.113 176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -126.16 5.36 7.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.353 1.861 . . . . 0.0 111.962 -177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.4 m 73.17 -30.97 0.22 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.722 2.009 . . . . 0.0 113.503 171.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 77.05 -63.98 3.15 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.819 2.152 . . . . 0.0 111.937 171.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 168.13 33.61 0.02 OUTLIER Glycine 0 CA--C 1.522 0.524 0 CA-C-O 118.432 -1.205 . . . . 0.0 110.633 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -144.01 146.9 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 -169.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.649 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp 19.63 94.68 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 131.579 3.952 . . . . 0.0 113.531 168.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -86.36 -10.45 6.58 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.615 2.21 . . . . 0.0 112.466 -172.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -43.54 -39.4 3.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.35 1.86 . . . . 0.0 113.565 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -155.47 149.63 25.74 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.233 1.413 . . . . 0.0 108.597 169.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -160.51 165.82 30.22 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.545 1.538 . . . . 0.0 108.095 176.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.8 ttp-105 . . . . . 0 C--O 1.251 1.135 0 C-N-CA 125.511 1.524 . . . . 0.0 106.986 176.353 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.58 152.7 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.321 1.448 . . . . 0.0 108.682 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -155.79 147.07 22.59 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.401 1.881 . . . . 0.0 106.388 172.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tm? 60.33 -40.76 0.1 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 128.601 2.76 . . . . 0.0 114.367 -170.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -55.95 -28.04 55.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.298 1.839 . . . . 0.0 111.518 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -50.08 -40.41 45.37 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 128.439 2.696 . . . . 0.0 113.441 169.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -79.7 146.41 32.43 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 77' ' ' PHE . 51.0 p90 -59.99 142.65 53.49 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 169.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -132.34 134.44 45.2 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 -169.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.516 HD13 HD12 ' A' ' 30' ' ' ILE . 10.1 tp -59.73 -3.14 0.45 Allowed 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -168.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.87 29.21 0.42 Allowed Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 170.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.72 179.59 48.94 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 -82.28 156.75 24.15 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 168.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -137.29 168.19 21.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 104.37 -2.455 . . . . 0.0 104.37 170.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 14' ' ' VAL . 42.8 mt -141.85 130.66 22.93 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 103.895 -2.632 . . . . 0.0 103.895 -172.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.98 130.08 51.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -103.71 114.06 28.04 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -171.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -94.29 -12.84 27.27 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.446 0.698 . . . . 0.0 111.757 -170.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.96 -73.85 0.37 Allowed Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.983 1.278 . . . . 0.0 109.914 171.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -66.7 -38.32 18.58 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.059 2.506 . . . . 0.0 113.4 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 22' ' ' MET . 18.7 tp -150.88 176.86 10.68 Favored 'General case' 0 N--CA 1.434 -1.262 0 C-N-CA 125.417 1.487 . . . . 0.0 108.798 -168.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -139.5 146.27 39.77 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.86 2.064 . . . . 0.0 107.014 -169.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -131.5 154.04 49.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.883 0.873 . . . . 0.0 108.729 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -81.08 138.57 35.96 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.011 -176.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.03 158.55 40.02 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 125.605 1.562 . . . . 0.0 109.344 -171.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.76 96.6 2.69 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.63 0.372 . . . . 0.0 110.269 -169.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.618 HD11 HG11 ' A' ' 14' ' ' VAL . 42.6 mt -62.16 152.29 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 129.65 3.18 . . . . 0.0 112.41 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.26 -25.21 0.05 Allowed 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 117.842 -1.075 . . . . 0.0 112.935 167.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.9 ttpt -128.77 136.13 50.13 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.516 HD12 HD13 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -137.26 163.42 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.754 0.788 . . . . 0.0 109.024 -173.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -140.16 152.03 45.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.872 -1.513 . . . . 0.0 109.37 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -147.37 139.35 13.88 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.6 1.96 . . . . 0.0 108.428 -172.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.61 -10.27 27.35 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.372 2.715 . . . . 0.0 113.426 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.3 m -67.11 -32.12 73.05 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 120.116 1.325 . . . . 0.0 111.491 -170.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.1 p -121.63 -13.68 8.3 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.641 1.576 . . . . 0.0 110.823 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt 47.47 50.04 15.25 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.595 0.758 . . . . 0.0 109.826 -169.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.423 ' SD ' ' HE3' ' A' ' 60' ' ' LYS . 5.8 mtm -146.93 165.56 29.42 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.999 2.119 . . . . 0.0 106.396 170.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 49.0 p90 -107.72 175.18 5.57 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.968 0.907 . . . . 0.0 112.721 -175.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -146.41 151.09 36.89 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 127.206 2.202 . . . . 0.0 107.336 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.455 ' HB3' HD12 ' A' ' 56' ' ' ILE . 47.6 t -147.19 160.84 41.98 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -174.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.2 pt -144.1 158.22 55.74 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 123.925 0.89 . . . . 0.0 110.102 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 90.7 Cg_endo -74.29 44.84 1.09 Allowed 'Trans proline' 0 CA--C 1.544 1.004 1 C-N-CA 125.888 4.392 . . . . 0.0 113.178 -177.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -61.95 -46.14 90.6 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 120.7 -1.25 . . . . 0.0 110.04 172.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -160.89 -124.23 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.68 158.99 25.56 Favored Pre-proline 0 C--O 1.235 0.294 0 CA-C-N 120.088 1.313 . . . . 0.0 111.577 -175.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -68.3 165.51 28.51 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.971 1.781 . . . . 0.0 107.638 167.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.07 18.65 1.43 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.735 1.159 . . . . 0.0 114.642 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -138.01 18.84 3.32 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.526 1.536 . . . . 0.0 112.535 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.6 m -145.28 178.59 7.97 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.185 1.394 . . . . 0.0 109.885 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 m -114.96 -27.47 7.36 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.055 0.942 . . . . 0.0 112.414 -172.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -169.67 141.91 2.42 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 118.769 0.713 . . . . 0.0 110.102 169.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -65.31 164.81 12.8 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 165.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.9 p -124.53 91.13 3.38 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 120.647 -1.283 . . . . 0.0 112.797 -168.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 50.8 -163.53 0.05 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.486 1.915 . . . . 0.0 110.983 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -67.17 103.87 1.32 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.3 mt -69.85 130.96 34.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -173.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -67.63 139.22 93.83 Favored Pre-proline 0 N--CA 1.444 -0.73 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -176.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -54.02 139.39 70.71 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 121.966 1.778 . . . . 0.0 110.667 173.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -136.92 158.47 44.39 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 170.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 4.2 mmpt? -63.44 122.74 17.0 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.0 tt -62.23 147.7 47.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 124.681 1.192 . . . . 0.0 111.729 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.0 -127.21 1.18 Allowed Glycine 0 N--CA 1.446 -0.661 1 N-CA-C 102.922 -4.071 . . . . 0.0 102.922 -176.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 53.43 30.13 9.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.355 1.062 . . . . 0.0 113.298 169.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 63.64 10.45 5.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.764 2.025 . . . . 0.0 114.263 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.502 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 8.6 mm-40 -73.17 6.83 2.5 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.263 1.425 . . . . 0.0 113.586 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -22.4 118.47 0.03 OUTLIER 'General case' 0 C--O 1.237 0.446 0 C-N-CA 128.63 2.772 . . . . 0.0 114.21 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 71' ' ' ILE . 10.5 pt -115.43 128.68 25.75 Favored Pre-proline 0 N--CA 1.447 -0.581 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.82 159.49 52.55 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 121.835 1.69 . . . . 0.0 109.388 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -54.77 -21.69 11.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.719 0.808 . . . . 0.0 111.611 177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -55.7 -37.96 69.07 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.472 1.909 . . . . 0.0 114.196 173.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 67' ' ' ILE . 13.4 pt -116.12 -14.79 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 120.041 1.291 . . . . 0.0 110.814 -172.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.0 mm -50.32 -45.96 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 128.007 2.523 . . . . 0.0 108.504 169.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.57 8.2 10.25 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 118.519 -0.753 . . . . 0.0 111.963 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.31 178.72 25.71 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 120.209 1.368 . . . . 0.0 111.44 -172.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.48 130.13 45.37 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.0 m -131.82 143.69 50.37 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 124.191 0.932 . . . . 0.0 109.588 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CE1' ' CD1' ' A' ' 8' ' ' PHE . 63.3 m-85 -128.76 111.72 13.42 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.516 1.127 . . . . 0.0 110.199 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -78.24 126.68 31.15 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 125.097 1.359 . . . . 0.0 107.564 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 pt -136.65 158.6 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 O-C-N 125.44 1.713 . . . . 0.0 110.973 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -111.57 121.97 46.56 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 168.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -73.32 121.91 21.17 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -66.87 147.87 52.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.422 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.05 14.38 58.95 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.913 -0.937 . . . . 0.0 113.641 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.51 ' CZ2' ' HDA' ' A' ' 128' ' ' M2L . 96.4 m95 -135.08 171.39 14.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.885 1.342 . . . . 0.0 110.819 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -68.05 157.98 33.98 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.903 0.481 . . . . 0.0 111.213 -173.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.2 m -65.08 -21.66 66.84 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.21 1.004 . . . . 0.0 111.904 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.2 m -54.77 -32.11 59.56 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.06 1.344 . . . . 0.0 112.713 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.5 m95 -88.4 3.67 49.1 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.049 -0.976 . . . . 0.0 112.776 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -65.54 117.17 7.63 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.252 7.6 tp10 -157.7 167.48 29.97 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.188 0.995 . . . . 0.0 108.84 -167.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.502 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -98.72 150.45 21.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.886 0.851 . . . . 0.0 110.313 168.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.52 156.62 42.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.887 1.275 . . . . 0.0 109.976 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.77 167.46 26.97 Favored Glycine 0 C--O 1.24 0.52 0 CA-C-N 114.429 -1.259 . . . . 0.0 110.072 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -17.34 9.76 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.395 1.478 . . . . 0.0 113.387 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -56.77 -22.88 39.11 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.123 1.369 . . . . 0.0 113.172 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -124.54 -39.22 2.32 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.228 173.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 14' ' ' VAL . 7.2 tt -93.71 153.24 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.23 0.923 . . . . 0.0 111.268 -169.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -149.88 156.97 42.7 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 127.503 2.321 . . . . 0.0 109.203 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.66 162.6 27.35 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.252 1.021 . . . . 0.0 111.107 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 105' ' ' ILE . 15.3 t80 -75.23 113.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -155.98 161.67 40.45 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.594 1.558 . . . . 0.0 108.687 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.54 -33.88 56.22 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.766 1.626 . . . . 0.0 114.469 -169.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -65.74 -44.97 84.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 123.289 1.519 . . . . 0.0 109.639 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -75.26 -19.28 59.81 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 121.202 -0.936 . . . . 0.0 109.189 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.404 HD11 ' CE2' ' A' ' 100' ' ' TYR . 7.8 mm -74.6 -33.48 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.479 0 CA-C-N 119.061 0.846 . . . . 0.0 110.25 168.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.99 93.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.212 0.915 . . . . 0.0 108.787 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.8 ttp -58.61 -56.63 19.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.55 0.614 . . . . 0.0 109.364 169.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -50.08 -45.96 52.98 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.776 1.23 . . . . 0.0 110.956 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -79.43 -41.75 26.92 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.803 1.241 . . . . 0.0 111.553 -173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -39.59 73.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.644 1.111 . . . . 0.0 109.347 174.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.18 -46.49 20.38 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -29.73 30.06 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.991 0.917 . . . . 0.0 111.469 171.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -72.78 -54.38 9.03 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.019 0.928 . . . . 0.0 112.071 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.65 -18.24 36.02 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 118.703 0.683 . . . . 0.0 112.791 -171.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 55.64 3.63 0.09 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 130.786 3.634 . . . . 0.0 117.007 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.6 -144.62 47.8 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.4 m -72.87 1.28 8.98 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.4 m -59.6 148.84 32.1 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.782 1.174 . . . . 0.0 109.317 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -175.57 -155.8 13.49 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -174.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.4 m -66.47 77.13 0.1 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.796 1.638 . . . . 0.0 110.556 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.41 161.79 29.52 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 127.315 2.246 . . . . 0.0 107.99 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -75.65 50.73 2.79 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 124.283 3.322 . . . . 0.0 111.874 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.21 122.33 12.89 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.346 1.458 . . . . 0.0 110.306 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -39.47 62.24 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 118.122 0.419 . . . . 0.0 110.227 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -172.7 24.43 0.08 OUTLIER Glycine 0 CA--C 1.531 1.086 0 CA-C-N 118.077 0.398 . . . . 0.0 112.122 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 161.35 -137.43 4.91 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 108.417 -1.873 . . . . 0.0 108.417 -169.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.68 -26.26 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 -169.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.51 ' HDA' ' CZ2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -151.15 126.61 4.86 Favored Pre-proline 0 N--CA 1.447 -0.625 0 O-C-N 120.44 -1.412 . . . . 0.0 108.015 -168.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -95.99 5.59 1.96 Allowed 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.215 2.61 . . . . 0.0 111.574 172.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -38.14 -55.12 1.32 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 128.87 2.868 . . . . 0.0 114.397 -169.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.37 156.06 34.76 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.501 1.12 . . . . 0.0 109.963 -174.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -67.51 168.26 11.28 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.539 0.735 . . . . 0.0 109.275 169.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.9 ttt85 . . . . . 0 C--O 1.252 1.228 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.833 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 m -137.85 155.0 29.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 125.123 1.369 . . . . 0.0 107.584 171.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -152.37 -60.84 0.16 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.695 0.798 . . . . 0.0 109.024 172.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 60.7 tp -71.39 -44.58 64.68 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 122.843 0.457 . . . . 0.0 110.611 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -59.85 -30.98 69.34 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.93 0.892 . . . . 0.0 110.532 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -68.89 -19.36 64.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.42 1.488 . . . . 0.0 113.316 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -89.12 150.4 22.73 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 118.903 0.774 . . . . 0.0 109.978 176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.441 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -59.26 87.83 0.01 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.873 2.069 . . . . 0.0 110.461 169.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.89 130.4 37.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.441 HD22 HG12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -61.34 -8.08 3.56 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -169.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.09 30.61 0.98 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 173.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.11 -163.79 28.7 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 106.585 -2.606 . . . . 0.0 106.585 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -100.86 156.29 17.45 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 168.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -131.06 154.72 41.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 168.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 14' ' ' VAL . 34.8 mt -125.06 131.6 53.31 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 176.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -123.55 121.55 35.92 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.649 -169.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -99.16 125.21 44.68 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.034 1.334 . . . . 0.0 107.959 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -98.94 -25.73 14.5 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.886 0.474 . . . . 0.0 111.607 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.11 -71.86 0.34 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -71.26 -32.67 12.45 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.857 1.705 . . . . 0.0 112.614 173.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.4 178.83 9.13 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 125.194 1.397 . . . . 0.0 109.6 -174.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -143.07 151.41 40.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.878 2.071 . . . . 0.0 107.95 -168.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -138.0 159.84 40.93 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.76 0.824 . . . . 0.0 111.108 -170.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.42 140.82 43.16 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 160.6 39.21 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 125.738 1.615 . . . . 0.0 107.582 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -147.54 103.37 3.53 Favored 'General case' 0 C--O 1.231 0.118 0 O-C-N 121.239 -0.913 . . . . 0.0 109.699 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 14' ' ' VAL . 67.9 mt -57.72 150.27 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 126.889 2.076 . . . . 0.0 111.854 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -160.53 -24.43 0.06 Allowed 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.776 -1.107 . . . . 0.0 113.109 167.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.1 ttpt -126.49 138.7 53.53 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.5 pt -139.64 160.47 27.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -169.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.1 t-105 -147.4 151.12 35.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.979 -169.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -150.57 142.46 15.57 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 125.995 1.718 . . . . 0.0 108.465 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -66.89 -11.38 31.91 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.092 2.528 . . . . 0.0 113.644 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.2 m -64.01 -34.84 78.91 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 120.562 1.528 . . . . 0.0 112.26 -170.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -120.56 -7.09 9.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.178 0.991 . . . . 0.0 111.186 174.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.7 mtmm 44.45 49.45 8.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.679 1.192 . . . . 0.0 109.801 -169.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtp -146.0 147.88 32.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -94.85 173.19 7.72 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.661 0.384 . . . . 0.0 110.53 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 p -143.97 145.45 32.25 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 126.975 2.11 . . . . 0.0 105.424 175.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.682 ' HB2' HD12 ' A' ' 56' ' ' ILE . 1.5 m -143.39 157.18 44.67 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -171.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.441 HG12 HD22 ' A' ' 10' ' ' LEU . 26.7 pt -130.32 153.6 81.3 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 170.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -86.82 41.73 0.8 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.715 2.277 . . . . 0.0 111.354 -168.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.97 -16.0 63.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.463 1.505 . . . . 0.0 111.907 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -147.21 178.79 8.11 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.933 1.293 . . . . 0.0 108.88 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -125.75 72.38 68.57 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 169.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.59 163.76 37.94 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.823 2.349 . . . . 0.0 112.826 -168.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.14 -26.42 61.22 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.698 1.142 . . . . 0.0 113.682 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.88 -19.59 58.91 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 117.888 0.844 . . . . 0.0 113.503 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.2 m 53.98 17.85 1.49 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.603 1.961 . . . . 0.0 115.496 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.4 m -57.18 -54.71 43.73 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.224 1.41 . . . . 0.0 111.196 -172.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -174.62 163.93 3.6 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 125.874 1.67 . . . . 0.0 109.425 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.82 75.54 0.54 Allowed 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 126.823 2.049 . . . . 0.0 108.409 168.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.6 p -112.5 -80.14 0.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 113.776 -1.556 . . . . 0.0 111.515 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -148.14 -139.18 0.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -58.69 107.53 0.53 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 169.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.682 HD12 ' HB2' ' A' ' 40' ' ' SER . 23.4 mt -73.71 139.55 19.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -169.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -67.93 134.09 92.0 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 118.395 -0.812 . . . . 0.0 109.126 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.31 130.52 18.79 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 106.181 -2.276 . . . . 0.0 106.181 174.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -140.3 165.66 26.79 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.55 150.26 44.38 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 169.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 62' ' ' GLY . 6.3 tt -114.43 146.45 40.61 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 126.519 1.928 . . . . 0.0 110.284 -168.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.503 ' N ' HD23 ' A' ' 61' ' ' LEU . . . 114.11 36.05 1.41 Allowed Glycine 0 CA--C 1.524 0.652 0 O-C-N 124.377 1.048 . . . . 0.0 114.501 169.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -72.13 -33.22 67.61 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.731 1.266 . . . . 0.0 108.422 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -153.48 -29.88 0.13 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.372 1.869 . . . . 0.0 111.97 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 35.81 0.44 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 127.328 2.251 . . . . 0.0 112.78 -175.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -32.73 144.21 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.785 2.434 . . . . 0.0 114.32 169.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -132.55 136.38 27.8 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 169.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.99 161.02 47.53 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.663 1.576 . . . . 0.0 109.575 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.76 -12.68 2.01 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.638 1.175 . . . . 0.0 112.711 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -68.84 -29.82 68.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.186 1.394 . . . . 0.0 113.037 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 pt -121.27 -9.91 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.371 1.441 . . . . 0.0 111.338 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mm -53.67 -45.95 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 128.688 2.795 . . . . 0.0 108.011 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.19 8.41 8.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.819 0.848 . . . . 0.0 111.933 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.78 179.02 26.9 Favored Glycine 0 C--N 1.34 0.786 0 CA-C-N 120.071 1.305 . . . . 0.0 111.33 -170.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -64.41 129.99 42.03 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -136.86 151.17 48.8 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 124.155 0.909 . . . . 0.0 111.004 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.441 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.5 m-85 -139.88 115.41 10.01 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 125.48 1.512 . . . . 0.0 108.711 -169.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -82.76 129.58 35.0 Favored 'General case' 0 C--O 1.246 0.892 0 C-N-CA 126.168 1.787 . . . . 0.0 106.899 170.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.3 pt -137.39 155.68 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.95 -168.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -101.94 119.53 38.94 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 167.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -71.07 117.15 12.21 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 172.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -83.73 151.08 25.42 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 122.851 0.46 . . . . 0.0 109.778 -172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.49 7.98 36.38 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 119.433 -0.648 . . . . 0.0 112.033 -170.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.626 ' CD1' HM2B ' A' ' 128' ' ' M2L . 33.8 m95 -138.2 173.89 11.14 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.725 1.21 . . . . 0.0 110.786 -173.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -72.55 165.98 23.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.199 0.523 . . . . 0.0 111.382 -170.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -77.51 -11.59 59.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.46 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.9 m -57.66 -32.48 67.35 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.191 -0.943 . . . . 0.0 111.737 174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -83.54 4.97 25.77 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 112.468 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -66.95 108.6 2.64 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -153.66 163.81 39.37 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.622 1.569 . . . . 0.0 107.79 -167.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.76 150.15 22.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.648 0.737 . . . . 0.0 109.612 168.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.18 150.06 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.27 176.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -83.64 160.81 37.98 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 173.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.22 9.02 0.83 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -176.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -87.09 -30.72 20.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.835 1.654 . . . . 0.0 110.703 168.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -102.47 -39.85 6.94 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 117.995 -1.003 . . . . 0.0 111.496 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 14' ' ' VAL . 4.9 tt -101.13 149.64 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 119.389 0.995 . . . . 0.0 110.762 -173.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 84.7 mtt180 -145.48 147.73 32.48 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.122 1.369 . . . . 0.0 110.225 169.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.81 144.3 54.34 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.134 1.373 . . . . 0.0 110.238 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.482 ' CE2' HD11 ' A' ' 105' ' ' ILE . 42.4 t80 -60.34 115.49 3.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.114 0.87 . . . . 0.0 111.87 -169.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -161.27 165.1 29.73 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.432 1.493 . . . . 0.0 110.431 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -56.15 -33.99 65.73 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.53 1.532 . . . . 0.0 113.715 -169.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -63.42 -43.96 96.0 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.174 0.988 . . . . 0.0 109.949 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -68.75 -33.77 74.47 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.482 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.6 mm -69.27 -34.07 61.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.179 0 CA-C-N 118.507 0.594 . . . . 0.0 110.682 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.35 99.34 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 119.414 1.006 . . . . 0.0 109.625 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -48.32 81.31 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 170.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.9 tttp -60.68 -45.44 94.16 Favored 'General case' 0 CA--C 1.506 -0.747 0 C-N-CA 123.44 0.696 . . . . 0.0 109.681 -173.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -76.07 -44.11 40.46 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.17 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -57.35 -33.96 68.3 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.783 0.72 . . . . 0.0 110.569 175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.4 mt -77.32 -52.23 9.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.73 -27.19 6.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.928 1.291 . . . . 0.0 111.747 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -72.25 -45.41 60.27 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.477 1.111 . . . . 0.0 113.448 174.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -92.76 -13.22 29.56 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.98 0.809 . . . . 0.0 112.988 -174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -44.55 116.73 1.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 127.761 2.425 . . . . 0.0 113.843 -171.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.21 56.01 4.96 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 125.037 1.303 . . . . 0.0 110.011 169.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -63.1 -18.24 63.19 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.06 0.944 . . . . 0.0 113.318 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.3 p -137.57 176.5 8.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.4 1.88 . . . . 0.0 109.171 -172.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.98 30.26 47.92 Favored Glycine 0 CA--C 1.532 1.124 0 O-C-N 121.817 -0.552 . . . . 0.0 112.207 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.6 m 54.04 40.99 32.19 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.956 1.302 . . . . 0.0 113.051 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.09 146.02 62.74 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 118.793 -0.623 . . . . 0.0 110.054 172.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.21 157.1 26.93 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.578 2.852 . . . . 0.0 113.198 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.18 -10.24 29.75 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 112.672 -2.058 . . . . 0.0 113.172 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 m -139.92 35.78 1.96 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.243 1.417 . . . . 0.0 109.049 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -153.93 22.65 0.7 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 124.957 1.265 . . . . 0.0 112.548 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 172.77 -47.53 0.17 Allowed Glycine 0 C--N 1.334 0.435 0 CA-C-O 118.341 -1.255 . . . . 0.0 110.973 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 21.7 t -149.32 141.02 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 119.439 1.619 . . . . 0.0 108.061 -171.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.626 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.6 mmtp 30.48 94.49 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 130.912 3.685 . . . . 0.0 115.462 168.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -91.71 -4.54 4.0 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.279 2.653 . . . . 0.0 112.731 -177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -45.21 -25.21 0.34 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 128.654 2.782 . . . . 0.0 115.767 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -78.35 65.4 3.67 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.174 1.39 . . . . 0.0 108.963 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -59.02 156.91 10.89 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.702 1.201 . . . . 0.0 110.849 175.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.2 mmp_? . . . . . 0 C--O 1.254 1.325 0 C-N-CA 123.785 0.834 . . . . 0.0 109.148 175.171 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.31 161.44 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 123.347 0.659 . . . . 0.0 110.796 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -150.03 -53.03 0.15 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.813 0.845 . . . . 0.0 110.015 172.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.92 -34.97 77.04 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.355 0.662 . . . . 0.0 111.596 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.94 -28.41 66.22 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.096 0.958 . . . . 0.0 111.749 -177.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -89.32 -6.69 56.49 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.319 1.448 . . . . 0.0 111.88 -174.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -84.53 161.17 20.32 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.963 -1.086 . . . . 0.0 108.295 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.455 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -60.06 83.51 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 126.875 2.07 . . . . 0.0 109.953 170.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.11 130.4 39.72 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.5 -4.07 1.74 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 -168.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.66 33.36 0.69 Allowed Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.4 -161.37 27.11 Favored Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 107.346 -2.301 . . . . 0.0 107.346 169.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.426 ' HG2' HE22 ' A' ' 82' ' ' GLN . 56.3 mtt180 -102.96 156.65 17.52 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 168.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.573 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -131.24 156.54 42.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 168.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 14' ' ' VAL . 43.9 mt -126.03 134.98 51.27 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 175.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -127.16 129.21 47.45 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.177 0.923 . . . . 0.0 110.038 -169.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -105.98 131.81 52.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 109.638 -169.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.1 m-70 -113.68 -19.93 11.38 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.758 0.823 . . . . 0.0 111.655 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.95 -72.8 0.31 Allowed Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 171.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -67.75 -32.75 29.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 121.843 1.695 . . . . 0.0 112.26 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 -179.26 7.92 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.702 1.601 . . . . 0.0 109.311 -170.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.439 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -140.94 160.61 39.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.779 1.632 . . . . 0.0 107.281 -175.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -139.07 160.39 39.89 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.951 0.9 . . . . 0.0 109.508 -170.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -77.24 140.91 40.2 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 159.67 41.71 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.671 1.588 . . . . 0.0 108.672 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttpt -148.5 101.52 3.24 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.142 -0.973 . . . . 0.0 110.339 -170.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.573 HD11 HG11 ' A' ' 14' ' ' VAL . 64.0 mt -58.93 150.23 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 127.769 2.428 . . . . 0.0 112.025 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.484 HD22 ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.51 -28.37 0.05 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 116.51 -1.709 . . . . 0.0 112.374 166.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 20.7 mtmt -114.72 144.79 42.9 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 168.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.1 pt -142.26 161.07 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -149.6 152.7 35.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.386 -169.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.01 138.69 13.12 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 127.187 2.195 . . . . 0.0 108.453 -173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -66.89 -9.95 26.65 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.503 2.802 . . . . 0.0 113.57 176.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.1 m -66.57 -32.04 73.12 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 119.934 1.243 . . . . 0.0 111.538 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.8 p -121.1 -15.32 8.24 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.863 1.665 . . . . 0.0 110.866 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 48.62 49.01 19.19 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 123.917 0.887 . . . . 0.0 109.757 -169.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.3 mtp -144.85 154.78 43.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.961 2.104 . . . . 0.0 105.793 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -104.52 170.56 7.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.223 0.609 . . . . 0.0 111.911 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.6 p -138.64 152.89 48.48 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 126.911 2.085 . . . . 0.0 106.445 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 56' ' ' ILE . 24.8 m -152.2 156.27 39.43 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -168.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.6 pt -147.43 159.92 40.45 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.849 1.259 . . . . 0.0 109.852 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.682 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 63.5 Cg_endo -78.32 46.15 2.03 Favored 'Trans proline' 0 CA--C 1.549 1.231 0 C-N-CA 124.417 3.411 . . . . 0.0 115.35 -171.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -79.03 -4.13 48.6 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 120.844 -1.16 . . . . 0.0 112.903 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -151.88 173.69 14.49 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.414 -1.428 . . . . 0.0 113.007 -171.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -134.19 81.68 49.76 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 127.786 2.435 . . . . 0.0 107.809 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -60.04 166.19 9.24 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.601 2.2 . . . . 0.0 111.794 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.28 -24.41 22.21 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.085 0.85 . . . . 0.0 115.051 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.22 5.95 36.33 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.261 -1.3 . . . . 0.0 114.221 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.1 m -146.01 124.98 12.75 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.713 1.757 . . . . 0.0 110.225 -174.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.3 m -54.53 -31.03 55.49 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.104 1.362 . . . . 0.0 112.235 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -165.28 157.94 15.83 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.117 2.167 . . . . 0.0 107.423 169.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.682 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -75.64 166.57 23.35 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.1 p -92.94 -82.09 0.34 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 -167.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -151.5 -154.74 0.56 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.525 2.33 . . . . 0.0 106.233 -174.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -62.51 101.43 0.24 Allowed 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 169.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.486 HD12 ' HB2' ' A' ' 40' ' ' SER . 3.7 mt -76.12 135.27 27.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -175.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.35 140.55 87.7 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -70.63 139.88 38.19 Favored 'Trans proline' 0 N--CA 1.439 -1.681 0 C-N-CA 122.051 1.834 . . . . 0.0 107.381 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -143.65 160.0 41.47 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 -173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -62.99 131.79 49.83 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.5 tt -80.35 153.89 28.09 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.404 1.482 . . . . 0.0 111.727 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.12 31.63 1.68 Allowed Glycine 0 C--N 1.339 0.75 0 N-CA-C 115.429 0.932 . . . . 0.0 115.429 169.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.37 -40.16 27.09 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.872 1.336 . . . . 0.0 109.216 169.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -160.32 2.65 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.121 0.968 . . . . 0.0 113.286 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.12 47.21 2.29 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.678 1.591 . . . . 0.0 111.724 -169.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 m -33.05 142.06 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.65 3.18 . . . . 0.0 113.345 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 71' ' ' ILE . 5.8 pt -135.19 132.23 20.04 Favored Pre-proline 0 C--O 1.238 0.481 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 168.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.87 158.85 55.44 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.255 1.303 . . . . 0.0 109.302 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.18 -16.36 3.08 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.341 1.456 . . . . 0.0 112.271 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.13 -32.13 73.67 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.27 1.828 . . . . 0.0 112.955 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 67' ' ' ILE . 14.9 pt -120.45 -13.19 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 120.528 1.513 . . . . 0.0 110.868 -173.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -50.74 -46.03 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 128.278 2.631 . . . . 0.0 108.759 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -79.59 9.03 5.41 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.95 0.9 . . . . 0.0 111.886 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.1 -176.37 27.23 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.922 1.237 . . . . 0.0 111.093 -172.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.08 130.87 48.0 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.9 m -134.29 154.39 51.33 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 123.885 0.741 . . . . 0.0 110.941 171.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.455 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 23.9 m-85 -141.78 113.49 7.83 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.108 1.363 . . . . 0.0 109.265 -169.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.509 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 55.3 t80 -80.01 129.07 34.2 Favored 'General case' 0 C--O 1.244 0.776 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.33 157.36 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.362 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -105.8 120.09 40.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 167.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CD2' ' HM2' ' A' ' 128' ' ' M2L . 39.0 m-85 -72.73 118.45 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.426 HE22 ' HG2' ' A' ' 13' ' ' ARG . 62.3 mt-30 -77.7 150.2 34.51 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.08 10.91 42.91 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.925 -0.93 . . . . 0.0 113.017 -173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.659 ' CD1' HM2B ' A' ' 128' ' ' M2L . 48.5 m95 -134.87 171.01 15.0 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 1.233 . . . . 0.0 111.327 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -69.25 158.23 35.39 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.024 0.53 . . . . 0.0 111.338 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.2 p -63.92 -19.76 65.35 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.813 0.845 . . . . 0.0 112.127 169.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.1 m -54.19 -31.94 54.26 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.424 1.089 . . . . 0.0 112.779 175.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -84.14 3.23 35.87 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.889 -1.053 . . . . 0.0 112.379 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -68.95 107.01 2.94 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.253 7.5 tp10 -154.31 168.54 26.25 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 126.623 1.969 . . . . 0.0 107.854 -167.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.61 151.24 22.58 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.823 0.82 . . . . 0.0 111.011 168.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.68 156.38 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.128 174.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.77 161.32 27.0 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 125.0 1.286 . . . . 0.0 110.11 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.74 7.5 1.49 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -176.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -86.56 -20.5 27.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.888 1.675 . . . . 0.0 110.752 169.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 mtm180 -119.0 -31.31 4.78 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 117.324 -1.322 . . . . 0.0 112.01 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 14' ' ' VAL . 4.9 tt -108.22 155.91 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 120.665 1.575 . . . . 0.0 111.694 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.453 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 11.0 mtt85 -149.19 146.84 27.83 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.027 1.331 . . . . 0.0 110.32 168.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . 0.259 . . -66.99 143.89 56.52 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.339 1.855 . . . . 0.0 111.916 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -59.06 118.67 6.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 120.461 1.482 . . . . 0.0 111.516 -170.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -169.35 164.78 10.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.06 1.744 . . . . 0.0 110.622 -171.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -57.97 -27.99 63.95 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.175 -0.953 . . . . 0.0 113.511 -169.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -68.18 -45.92 72.13 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 119.543 1.065 . . . . 0.0 110.778 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -74.74 -22.35 58.85 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.02 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.9 mm -71.18 -37.65 67.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 118.752 0.705 . . . . 0.0 110.127 170.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.29 -42.06 99.03 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 119.577 1.08 . . . . 0.0 109.742 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.6 ttp -58.13 -53.68 55.48 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 171.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -57.75 -46.41 84.54 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 118.336 -0.84 . . . . 0.0 109.82 -172.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -70.74 -45.19 65.31 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 119.237 0.926 . . . . 0.0 110.351 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -34.02 60.88 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.455 175.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.6 mt -87.63 -47.27 8.82 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.954 0.797 . . . . 0.0 111.996 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.23 14.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.241 1.416 . . . . 0.0 110.936 172.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -67.22 -56.98 7.61 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 112.957 172.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.11 -24.72 35.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 119.244 0.929 . . . . 0.0 112.694 -171.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.68 118.88 10.86 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.803 0.841 . . . . 0.0 111.107 -173.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.68 -35.73 35.29 Favored Glycine 0 CA--C 1.531 1.092 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 169.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.4 m 54.82 16.55 1.47 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.933 1.693 . . . . 0.0 113.95 -176.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 p -78.33 130.31 36.03 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.559 1.544 . . . . 0.0 108.922 -178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 121' ' ' ALA . . . 166.41 64.78 0.03 OUTLIER Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.0 m -68.43 16.68 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.067 1.347 . . . . 0.0 113.633 175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 119' ' ' GLY . . . -144.66 164.66 26.72 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 129.155 2.982 . . . . 0.0 107.707 -169.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -72.58 82.13 1.47 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.357 2.705 . . . . 0.0 111.88 -177.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.55 148.29 31.01 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 125.719 1.608 . . . . 0.0 108.139 170.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.5 m -80.88 69.22 7.39 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.072 1.349 . . . . 0.0 108.131 175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -75.44 57.27 2.89 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.802 1.668 . . . . 0.0 112.214 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.17 11.13 84.25 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-O 117.886 -1.508 . . . . 0.0 112.252 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.24 143.93 11.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-N 120.926 2.363 . . . . 0.0 106.289 -168.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.659 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -163.48 152.48 12.17 Favored Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 125.15 1.38 . . . . 0.0 109.208 169.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -100.36 2.6 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 124.489 3.459 . . . . 0.0 112.22 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -147.08 158.57 43.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.954 2.502 . . . . 0.0 108.385 -169.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? 126.75 -38.35 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.791 1 C-N-CA 133.23 4.612 . . . . 0.0 107.745 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -78.76 163.77 25.1 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.017 0.927 . . . . 0.0 108.899 169.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 . . . . . 0 C--O 1.254 1.315 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 174.949 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.8 m -68.95 159.66 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 119.493 1.042 . . . . 0.0 109.818 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -158.25 142.45 15.83 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.931 1.292 . . . . 0.0 108.141 177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 14.2 tp 58.32 12.63 2.05 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.135 2.174 . . . . 0.0 114.42 177.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -72.13 -53.14 13.65 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.34 111.11 2.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 169.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -73.94 176.71 6.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.459 -1.7 . . . . 0.0 108.765 169.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.422 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -62.71 82.6 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 124.481 2.086 . . . . 0.0 110.293 169.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.07 128.67 34.88 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 103.455 -2.794 . . . . 0.0 103.455 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 mp -63.86 -2.82 2.03 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -169.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.77 29.41 1.03 Allowed Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 169.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.79 -166.09 34.7 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 106.458 -2.657 . . . . 0.0 106.458 168.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -98.28 156.37 16.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 168.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.566 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.92 156.42 42.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 169.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 14' ' ' VAL . 32.7 mt -127.75 141.27 51.63 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 173.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.96 127.09 44.3 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.171 0.919 . . . . 0.0 109.155 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -86.2 138.07 32.16 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.383 1.073 . . . . 0.0 108.323 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -120.22 -11.46 9.2 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.19 0.996 . . . . 0.0 112.385 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.67 -72.65 0.48 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 171.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.49 -39.11 22.88 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.258 1.972 . . . . 0.0 112.601 171.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 22' ' ' MET . 10.7 tp -152.27 -171.81 4.04 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 125.818 1.647 . . . . 0.0 108.919 -169.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.422 ' H ' ' HG ' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -151.63 150.77 30.65 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 127.438 2.295 . . . . 0.0 107.27 -169.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -138.01 164.19 29.68 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.985 0.514 . . . . 0.0 111.397 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.0 137.73 37.71 Favored 'General case' 0 CA--C 1.514 -0.407 0 C-N-CA 125.492 1.517 . . . . 0.0 109.132 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.6 166.24 22.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 125.999 1.72 . . . . 0.0 108.76 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.5 ttpt -152.59 93.46 1.78 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.783 0.833 . . . . 0.0 110.582 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.566 HD11 HG11 ' A' ' 14' ' ' VAL . 66.1 mt -53.11 152.43 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.09 2.156 . . . . 0.0 111.523 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -154.96 -35.06 0.09 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 123.935 0.894 . . . . 0.0 111.009 168.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.473 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 37.5 ttpt -128.93 137.09 51.2 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.15 164.65 32.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -141.39 152.88 44.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.228 -169.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -135.11 150.38 72.79 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 127.596 2.358 . . . . 0.0 110.726 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -82.75 -17.42 7.18 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.787 2.991 . . . . 0.0 112.877 172.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 m -62.08 -37.49 85.23 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.944 1.298 . . . . 0.0 111.979 -169.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.2 m -128.62 5.89 5.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.155 1.782 . . . . 0.0 111.341 174.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt 46.03 55.89 6.65 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 125.173 1.389 . . . . 0.0 109.932 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.1 ptm -150.94 169.27 22.17 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 175.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.408 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 49.0 p90 -114.38 172.67 6.87 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.451 0.701 . . . . 0.0 112.444 -177.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.7 p -145.11 151.4 38.43 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 127.256 2.222 . . . . 0.0 106.627 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.478 ' HB3' HD12 ' A' ' 56' ' ' ILE . 40.8 t -144.58 152.06 39.97 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 pp -141.07 149.17 54.75 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 63.7 Cg_endo -79.11 67.6 8.54 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.881 3.054 . . . . 0.0 112.992 -169.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -60.49 -51.05 71.13 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 169.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -168.89 158.01 8.51 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 126.052 1.741 . . . . 0.0 107.269 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -67.78 140.8 94.37 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.903 171.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.03 170.2 6.52 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.353 2.036 . . . . 0.0 109.105 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.81 5.93 36.3 Favored Glycine 0 CA--C 1.535 1.323 0 O-C-N 120.999 -1.063 . . . . 0.0 115.069 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.24 29.06 0.46 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.121 1.461 . . . . 0.0 112.289 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.4 m -141.31 153.7 45.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.057 1.343 . . . . 0.0 108.228 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.5 m -61.8 -57.7 10.83 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.608 0.763 . . . . 0.0 111.443 -170.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -173.17 159.61 3.91 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.774 2.029 . . . . 0.0 108.281 170.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -74.37 154.77 38.7 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 166.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.5 p -129.84 84.96 2.25 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.215 -0.928 . . . . 0.0 111.549 -169.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 79.1 mttt 49.66 -153.41 0.13 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.848 1.659 . . . . 0.0 110.674 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.43 101.18 0.3 Allowed 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.478 HD12 ' HB3' ' A' ' 40' ' ' SER . 4.3 mt -74.54 134.24 29.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -67.7 143.43 96.72 Favored Pre-proline 0 C--O 1.236 0.389 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -75.0 134.67 18.08 Favored 'Trans proline' 0 N--CA 1.438 -1.744 0 N-CA-C 107.476 -1.779 . . . . 0.0 107.476 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -137.35 167.81 20.87 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -60.99 154.37 22.75 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 170.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 tt -107.88 153.31 23.22 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 111.333 -168.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 110.83 30.75 3.13 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-O 119.544 -0.587 . . . . 0.0 112.911 170.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.33 -26.26 38.83 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.221 1.011 . . . . 0.0 110.281 175.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -152.07 -31.69 0.15 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.209 1.003 . . . . 0.0 112.149 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HB2' ' HE1' ' A' ' 91' ' ' TRP . 0.7 OUTLIER -76.41 179.6 5.76 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.237 1.415 . . . . 0.0 110.621 171.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 69.4 m -154.8 152.02 29.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 128.456 2.702 . . . . 0.0 105.827 169.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.423 HD13 HG21 ' A' ' 67' ' ' ILE . 6.9 pt -136.45 130.6 18.12 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 168.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.18 159.71 51.95 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.999 1.8 . . . . 0.0 109.846 172.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -55.01 -20.89 10.27 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.266 1.026 . . . . 0.0 112.145 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -58.59 -36.94 74.77 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 126.233 1.813 . . . . 0.0 113.677 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 67' ' ' ILE . 8.4 pt -116.99 -9.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 118.998 0.817 . . . . 0.0 110.901 -170.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -58.59 -47.98 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 128.696 2.799 . . . . 0.0 108.627 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -83.8 12.03 6.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.414 0.686 . . . . 0.0 112.841 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.61 -175.77 24.49 Favored Glycine 0 C--N 1.333 0.401 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -57.1 139.64 51.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.6 t -140.33 155.62 46.74 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.572 0.545 . . . . 0.0 110.03 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.422 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 25.3 m-85 -140.16 113.4 8.4 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.77 1.228 . . . . 0.0 110.906 -169.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -78.16 124.59 28.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 126.901 2.08 . . . . 0.0 106.374 169.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.5 pt -134.97 157.44 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 113.45 -1.704 . . . . 0.0 111.429 -168.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -103.78 118.32 36.44 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 104.057 -2.572 . . . . 0.0 104.057 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.451 ' CG ' ' HM2' ' A' ' 128' ' ' M2L . 17.9 m-85 -73.39 117.84 15.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 172.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.61 147.0 27.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.77 -171.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.9 8.51 49.03 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.636 -1.091 . . . . 0.0 112.639 -170.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.467 ' CD1' HM2B ' A' ' 128' ' ' M2L . 94.9 m95 -128.63 174.73 9.15 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.982 1.391 . . . . 0.0 111.481 -177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -72.02 162.49 29.38 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.215 0.606 . . . . 0.0 111.427 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -64.78 -22.07 66.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.002 . . . . 0.0 111.928 171.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.9 m -56.37 -30.99 63.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.113 . . . . 0.0 112.594 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -90.06 6.63 41.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 118.035 -0.983 . . . . 0.0 112.527 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 107.18 1.9 Allowed 'General case' 0 C--O 1.236 0.393 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -155.67 164.82 38.1 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.996 1.718 . . . . 0.0 108.249 -167.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.476 ' HE1' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -94.74 149.76 20.91 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.136 0.97 . . . . 0.0 110.396 168.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -126.51 151.86 33.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.548 171.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.56 158.66 29.98 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.435 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -71.03 8.94 0.8 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.74 -18.8 25.68 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.914 1.686 . . . . 0.0 111.09 169.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 -117.17 -39.01 3.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 117.856 -1.069 . . . . 0.0 111.392 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.445 HD11 HG21 ' A' ' 14' ' ' VAL . 4.2 tt -99.75 150.99 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.727 1.149 . . . . 0.0 111.365 -175.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.435 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 92.7 mtt-85 -143.59 146.62 33.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.609 1.564 . . . . 0.0 110.476 168.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.01 147.51 53.34 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.871 1.269 . . . . 0.0 111.023 175.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.486 ' CE2' HD11 ' A' ' 105' ' ' ILE . 33.1 t80 -64.79 116.44 6.31 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.051 0.841 . . . . 0.0 111.854 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.9 p30 -159.16 161.71 36.27 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.963 1.705 . . . . 0.0 109.063 -169.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -61.48 -26.34 67.84 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.618 -1.301 . . . . 0.0 113.114 -169.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -71.65 -44.27 64.62 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.248 1.019 . . . . 0.0 110.8 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . 0.288 44.2 p30 -71.22 -22.28 62.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.338 173.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.486 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.1 mm -72.58 -35.55 51.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 119.032 0.833 . . . . 0.0 110.502 169.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.48 98.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.724 1.147 . . . . 0.0 109.684 175.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 20.3 ttp -58.8 -53.7 55.4 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.4 tttp -54.0 -46.12 71.68 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.758 -173.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -73.12 -45.23 58.1 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 118.844 0.747 . . . . 0.0 110.041 -175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -28.87 39.41 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 118.873 -0.584 . . . . 0.0 112.15 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.1 mt -92.03 -45.09 8.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 119.298 0.954 . . . . 0.0 112.037 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.9 -27.71 13.83 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.025 1.33 . . . . 0.0 111.316 170.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -64.73 -34.26 77.89 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.227 1.811 . . . . 0.0 114.15 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -124.0 -16.48 6.54 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.528 1.058 . . . . 0.0 113.826 -170.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 54.8 0.62 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 130.46 3.504 . . . . 0.0 117.094 174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.29 -55.98 4.97 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.331 1.443 . . . . 0.0 110.913 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 56.3 m 46.23 48.39 13.15 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.513 1.525 . . . . 0.0 113.058 171.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.9 49.75 0.55 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.46 1.904 . . . . 0.0 111.857 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -169.08 -176.42 39.12 Favored Glycine 0 CA--C 1.529 0.922 0 O-C-N 120.793 -1.192 . . . . 0.0 111.138 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 m -75.34 10.46 1.6 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 113.886 -175.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.79 157.59 35.76 Favored Pre-proline 0 C--O 1.24 0.553 0 C-N-CA 127.219 2.208 . . . . 0.0 107.658 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -54.8 151.26 33.26 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.257 2.638 . . . . 0.0 110.987 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.6 136.74 58.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.22 -1.354 . . . . 0.0 108.658 169.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 37.8 p -76.27 -26.97 56.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.823 0.449 . . . . 0.0 111.514 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 167.53 -28.46 0.16 Allowed Glycine 0 C--N 1.339 0.703 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -165.4 166.03 38.17 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 124.609 1.1 . . . . 0.0 110.484 169.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.74 -3.61 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 -167.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.467 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp 28.03 97.56 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.361 1 C-N-CA 135.194 5.398 . . . . 0.0 113.493 168.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -87.42 -11.01 5.24 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.926 2.418 . . . . 0.0 111.572 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -57.44 -26.72 61.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.174 2.59 . . . . 0.0 112.592 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -145.61 -177.07 5.39 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.804 1.242 . . . . 0.0 109.236 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -130.86 19.49 5.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.864 1.265 . . . . 0.0 111.791 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 77.7 mtp85 . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.812 1.245 . . . . 0.0 108.348 -171.818 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -150.12 137.82 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 173.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -162.35 -54.63 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.13 0.972 . . . . 0.0 109.982 172.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.98 -42.18 33.61 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.04 0.536 . . . . 0.0 110.546 -176.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -63.74 -22.68 67.03 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.997 0.817 . . . . 0.0 111.5 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -60.28 -37.79 81.59 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.733 1.613 . . . . 0.0 112.116 170.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.35 151.62 26.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.79 0.836 . . . . 0.0 109.227 176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.46 126.21 26.29 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.51 133.91 55.04 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 -169.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.502 HD22 HG12 ' A' ' 41' ' ' ILE . 1.1 mt -58.77 -8.07 1.21 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -168.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.02 31.58 0.55 Allowed Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 170.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.18 -163.1 29.96 Favored Glycine 0 N--CA 1.437 -1.253 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 168.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -101.94 152.71 20.61 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.613 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.4 166.35 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 101.928 -3.36 . . . . 0.0 101.928 168.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 14' ' ' VAL . 44.5 mt -136.35 140.51 43.34 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.6 124.51 36.05 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -74.17 132.47 42.23 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.81 0.12 10.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.781 0.833 . . . . 0.0 111.148 -170.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.45 -86.52 0.23 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -71.74 -26.24 19.52 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.731 2.287 . . . . 0.0 113.641 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -153.34 -170.6 3.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 125.265 1.426 . . . . 0.0 109.81 -168.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.499 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -144.08 149.22 36.25 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.389 1.876 . . . . 0.0 108.773 -168.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.493 ' CD2' HM2B ' A' ' 128' ' ' M2L . 4.6 m-85 -138.71 173.2 11.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.068 0.547 . . . . 0.0 110.982 177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -84.57 144.83 28.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.704 1.202 . . . . 0.0 108.652 -173.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.26 50.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 124.844 1.258 . . . . 0.0 108.539 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.4 ttpt -145.18 101.27 3.59 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.115 0.966 . . . . 0.0 109.852 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.613 HD11 HG11 ' A' ' 14' ' ' VAL . 77.5 mt -57.17 152.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 129.025 2.93 . . . . 0.0 111.175 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -158.21 -29.83 0.08 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.641 168.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 78' ' ' PHE . 31.9 ttpt -132.32 133.84 44.51 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 -177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.0 pt -137.33 161.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 -169.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.6 t-105 -145.64 151.94 38.86 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.322 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -149.5 142.6 16.04 Favored Pre-proline 0 C--O 1.241 0.652 0 C-N-CA 126.263 1.825 . . . . 0.0 109.167 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.85 -11.16 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.897 2.398 . . . . 0.0 113.785 176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -62.6 -35.59 80.02 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.095 1.316 . . . . 0.0 112.463 -169.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.2 m -129.01 4.65 5.33 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.264 1.026 . . . . 0.0 111.557 175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt 41.43 55.7 3.36 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.748 1.619 . . . . 0.0 111.045 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.4 ptm -152.81 160.75 43.11 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.407 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 50.5 p90 -102.93 169.78 8.38 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.963 -175.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -141.32 146.5 36.8 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 126.863 2.065 . . . . 0.0 105.761 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.614 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.2 m -148.18 158.51 44.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -169.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.502 HG12 HD22 ' A' ' 10' ' ' LEU . 17.5 pt -131.55 162.82 53.81 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 174.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -84.39 42.66 1.21 Allowed 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.334 2.023 . . . . 0.0 111.953 -168.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -68.78 -10.92 59.45 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.315 1.046 . . . . 0.0 112.22 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -159.6 -177.95 6.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.672 1.589 . . . . 0.0 107.958 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -132.12 87.47 43.69 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.93 -6.2 10.62 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.95 2.433 . . . . 0.0 117.078 -169.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 153.72 -30.73 0.75 Allowed Glycine 0 CA--C 1.529 0.924 0 CA-C-N 120.2 1.364 . . . . 0.0 111.725 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.65 -27.54 0.67 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.22 0.914 . . . . 0.0 112.016 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.6 m -62.84 145.54 54.79 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.984 0.914 . . . . 0.0 109.848 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m 66.61 152.49 0.07 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.171 1.788 . . . . 0.0 111.116 -173.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -56.17 -31.61 63.57 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.84 20.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 m -144.86 103.76 3.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.145 1.778 . . . . 0.0 107.9 -171.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt 52.12 -159.27 0.11 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.953 2.101 . . . . 0.0 111.627 178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -61.61 119.49 8.75 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 175.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 40' ' ' SER . 14.0 mt -84.17 141.31 14.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 C-N-CA 127.075 2.15 . . . . 0.0 106.785 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.11 125.48 91.55 Favored Pre-proline 0 C--O 1.239 0.545 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.659 -176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.34 135.02 23.81 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.218 1.945 . . . . 0.0 109.049 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -137.08 157.3 47.0 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.766 0.827 . . . . 0.0 109.008 -174.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.1 mmpt? -64.83 -6.87 9.14 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -168.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 71.92 151.75 0.11 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.847 2.059 . . . . 0.0 114.566 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.54 30.29 2.67 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 118.818 -0.99 . . . . 0.0 114.772 169.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -83.67 -40.37 19.03 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.887 1.344 . . . . 0.0 109.379 170.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -160.72 -1.3 0.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.85 47.16 2.01 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.013 1.725 . . . . 0.0 110.895 -169.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.7 m -32.12 139.32 0.04 OUTLIER 'General case' 0 C--O 1.236 0.349 0 C-N-CA 129.73 3.212 . . . . 0.0 113.383 168.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.449 HG22 HD11 ' A' ' 71' ' ' ILE . 7.9 pt -135.87 133.63 20.04 Favored Pre-proline 0 C--O 1.238 0.476 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 169.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.12 162.21 43.1 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.238 1.959 . . . . 0.0 109.811 174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.06 -15.22 8.54 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.166 0.986 . . . . 0.0 112.472 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -66.17 -30.23 70.67 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.632 1.173 . . . . 0.0 112.073 175.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 67' ' ' ILE . 7.5 pt -121.73 -9.53 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 120.219 1.372 . . . . 0.0 110.608 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mm -58.4 -47.74 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 127.391 2.276 . . . . 0.0 106.292 168.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -79.29 8.92 5.21 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.398 1.479 . . . . 0.0 112.297 -171.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.8 178.48 27.27 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 119.763 1.165 . . . . 0.0 111.684 -173.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.4 mmtm -64.29 131.3 46.9 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 173.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.3 m -137.09 152.49 50.08 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.351 1.032 . . . . 0.0 111.426 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -138.88 114.56 9.89 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.84 -169.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 47.6 t80 -81.27 126.65 31.81 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 126.865 2.066 . . . . 0.0 106.761 169.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 pt -138.43 154.97 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.151 -1.386 . . . . 0.0 112.764 -168.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -100.34 123.19 44.26 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 167.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -70.7 113.0 7.35 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -75.76 148.29 38.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.82 8.16 51.81 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-O 118.995 -0.891 . . . . 0.0 112.735 -170.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -133.14 170.26 15.67 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 118.58 1.19 . . . . 0.0 111.071 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -73.6 159.74 32.65 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 120.96 0.409 . . . . 0.0 110.364 -171.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.5 m -73.55 -14.44 61.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.981 0.512 . . . . 0.0 111.656 172.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.0 m -55.29 -31.71 61.83 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.739 1.216 . . . . 0.0 112.241 174.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -91.34 7.0 43.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.06 0.944 . . . . 0.0 112.527 -176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.43 120.41 12.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.263 7.5 tp10 -157.01 166.58 32.95 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.476 1.11 . . . . 0.0 108.288 -167.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.67 151.31 21.35 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 122.157 0.979 . . . . 0.0 109.497 168.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.12 153.73 39.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.36 175.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.88 168.47 31.55 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.96 -16.79 13.51 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.764 1.226 . . . . 0.0 113.608 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -56.79 -24.39 50.13 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.223 1.009 . . . . 0.0 113.072 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -119.14 -45.47 2.55 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.405 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 97' ' ' ILE . 7.1 tt -86.61 163.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -168.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -164.68 156.06 15.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 129.139 2.975 . . . . 0.0 110.108 170.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.92 169.43 13.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.846 1.203 . . . . 0.0 111.493 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -80.09 108.41 13.66 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.837 -1.164 . . . . 0.0 109.183 170.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -154.48 162.99 40.86 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.035 1.334 . . . . 0.0 109.898 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -52.71 -35.18 55.21 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.017 1.727 . . . . 0.0 114.795 -169.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -63.09 -42.62 99.64 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 123.478 1.609 . . . . 0.0 110.382 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -78.18 -24.71 47.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.226 -0.921 . . . . 0.0 109.014 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.87 -32.92 53.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.174 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.383 169.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.74 99.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 119.784 1.175 . . . . 0.0 109.196 173.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.1 ttp -56.24 -54.33 46.59 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 169.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -56.58 -48.52 77.21 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.475 0.71 . . . . 0.0 111.211 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -69.12 -45.58 69.8 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.655 0.661 . . . . 0.0 109.572 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -25.89 54.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.368 -0.825 . . . . 0.0 112.26 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.5 mt -93.04 -45.86 7.72 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.697 1.135 . . . . 0.0 112.685 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.74 -24.76 9.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.618 1.567 . . . . 0.0 111.305 169.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -68.26 -45.52 72.95 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.013 1.725 . . . . 0.0 113.334 171.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -72.06 -43.09 65.44 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 117.965 0.348 . . . . 0.0 111.15 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -154.7 173.69 16.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.715 1.245 . . . . 0.0 113.079 -168.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -165.5 -169.63 29.36 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 127.251 2.357 . . . . 0.0 109.105 175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.4 m -70.18 16.82 0.07 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.871 1.669 . . . . 0.0 114.726 -174.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.6 m -135.31 139.54 44.41 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.981 1.312 . . . . 0.0 107.887 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.75 -171.34 43.26 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.0 m -133.01 18.24 4.12 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.286 1.034 . . . . 0.0 111.732 -173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.06 159.76 68.46 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 123.48 0.712 . . . . 0.0 109.738 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.56 6.15 1.7 Allowed 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.346 2.697 . . . . 0.0 114.659 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.56 31.2 2.84 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.143 2.177 . . . . 0.0 109.603 172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . 0.285 30.2 p 59.66 -39.72 0.08 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 131.098 3.759 . . . . 0.0 115.815 -173.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.73 -174.14 46.08 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 120.423 1.465 . . . . 0.0 112.072 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.89 53.76 2.55 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 126.079 1.799 . . . . 0.0 112.051 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 49.8 t -145.36 143.74 21.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -169.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.493 HM2B ' CD2' ' A' ' 23' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.21 156.27 32.45 Favored Pre-proline 0 N--CA 1.444 -0.727 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 169.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -83.13 5.52 6.37 Favored 'Trans proline' 0 CA--C 1.549 1.247 0 C-N-CA 122.909 2.406 . . . . 0.0 111.19 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -44.26 -24.85 0.19 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 130.05 3.34 . . . . 0.0 117.761 -173.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -139.1 125.99 20.98 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 120.072 1.305 . . . . 0.0 108.239 -171.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -70.21 -41.42 73.66 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.473 0.709 . . . . 0.0 110.228 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 C-N-CA 125.966 1.707 . . . . 0.0 107.069 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -150.62 145.59 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -165.91 -41.5 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.326 1.45 . . . . 0.0 110.231 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.98 -30.1 70.7 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.794 1.238 . . . . 0.0 112.628 -172.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -57.42 -24.46 55.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.487 0.715 . . . . 0.0 111.27 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -68.17 -22.25 64.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.013 0.925 . . . . 0.0 113.136 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -90.05 152.91 20.94 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.568 0.747 . . . . 0.0 109.744 173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.466 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.1 OUTLIER -57.45 89.2 0.01 OUTLIER 'General case' 0 C--O 1.234 0.239 0 C-N-CA 126.944 2.097 . . . . 0.0 110.117 169.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.95 134.86 37.79 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.61 HD12 HG12 ' A' ' 41' ' ' ILE . 0.3 OUTLIER -59.48 -6.74 1.14 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -169.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.73 32.13 0.47 Allowed Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 171.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.51 -173.89 45.4 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 169.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -89.79 157.51 17.9 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.567 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.32 154.26 38.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 103.639 -2.726 . . . . 0.0 103.639 169.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 14' ' ' VAL . 27.8 mt -124.25 136.96 54.53 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 176.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.0 126.46 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.305 1.003 . . . . 0.0 109.048 -169.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -105.6 123.9 48.67 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.199 1.4 . . . . 0.0 108.244 -169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -101.17 -24.88 14.19 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.195 0.598 . . . . 0.0 111.911 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 150.27 -70.58 0.31 Allowed Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -67.94 -36.97 16.37 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.143 1.895 . . . . 0.0 112.552 172.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 22.1 tp -153.47 177.78 10.54 Favored 'General case' 0 N--CA 1.434 -1.258 0 C-N-CA 125.479 1.512 . . . . 0.0 109.268 -168.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.86 152.12 43.35 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 127.384 2.274 . . . . 0.0 107.64 -168.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -137.1 160.9 37.6 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.372 1.069 . . . . 0.0 109.978 -171.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -77.16 141.82 39.95 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.91 163.35 32.53 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 125.861 1.664 . . . . 0.0 108.177 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -153.24 102.28 2.61 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.179 -0.951 . . . . 0.0 110.595 -172.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.567 HD11 HG11 ' A' ' 14' ' ' VAL . 67.1 mt -59.27 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 127.998 2.519 . . . . 0.0 112.061 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.38 -17.62 0.04 OUTLIER 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 117.599 -1.191 . . . . 0.0 113.764 167.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.75 138.36 49.92 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 170.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 pt -138.77 163.24 27.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -168.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.8 t-105 -149.12 151.82 35.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.018 -168.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -147.06 140.93 15.4 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 127.759 2.424 . . . . 0.0 108.468 -173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.1 -9.31 25.98 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.357 2.704 . . . . 0.0 113.502 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.3 m -67.92 -32.9 73.68 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.098 1.317 . . . . 0.0 111.646 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 p -117.96 -15.73 9.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.637 1.575 . . . . 0.0 110.646 174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mtmt 49.03 48.97 20.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 118.771 0.714 . . . . 0.0 109.39 -169.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.9 mtp -146.48 151.16 36.94 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 126.781 2.032 . . . . 0.0 105.636 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -101.89 173.68 6.29 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 122.818 0.447 . . . . 0.0 112.07 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 p -142.84 156.8 45.0 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 126.542 1.937 . . . . 0.0 106.434 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.538 ' HB3' HD12 ' A' ' 56' ' ' ILE . 34.7 t -148.72 152.02 35.9 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 -176.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.61 HG12 HD12 ' A' ' 10' ' ' LEU . 1.1 pp -142.95 156.23 62.2 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.41 104.98 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 124.498 3.466 . . . . 0.0 111.085 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -142.76 -3.2 1.01 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.069 0.948 . . . . 0.0 112.169 171.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -152.69 167.99 27.14 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 120.97 -1.081 . . . . 0.0 111.712 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -143.03 85.14 9.99 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 127.56 2.344 . . . . 0.0 105.233 175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -63.52 161.03 33.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.949 1.766 . . . . 0.0 110.84 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.68 -22.82 47.99 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 116.074 1.189 . . . . 0.0 116.074 -169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -109.67 5.22 31.02 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 118.387 -1.229 . . . . 0.0 114.218 -174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.4 m -145.73 177.44 8.9 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 119.183 1.491 . . . . 0.0 111.33 -169.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 p -77.69 -169.08 1.37 Allowed 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.28 1.432 . . . . 0.0 107.634 169.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -66.88 154.22 41.5 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.686 -0.634 . . . . 0.0 110.815 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.16 150.54 48.59 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 167.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.693 ' H ' HD11 ' A' ' 56' ' ' ILE . 3.0 p -114.42 161.25 18.19 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.93 0.786 . . . . 0.0 112.006 -169.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -22.42 -69.52 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 130.381 3.472 . . . . 0.0 116.163 -169.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -148.63 107.18 3.79 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 169.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.693 HD11 ' H ' ' A' ' 53' ' ' THR . 6.1 mt -75.28 132.1 33.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' A' ' 57' ' ' LYS . 11.0 mmpt? -66.89 137.57 94.83 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -71.76 135.79 26.57 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 N-CA-C 106.896 -2.001 . . . . 0.0 106.896 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -137.04 167.04 22.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 6.0 mmpt? -62.06 153.03 30.98 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 169.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.426 HD11 ' CZ2' ' A' ' 91' ' ' TRP . 6.4 tt -105.86 147.13 29.06 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.067 1.747 . . . . 0.0 109.676 -169.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 125.21 16.95 2.79 Favored Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.004 0.815 . . . . 0.0 113.104 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -87.05 -33.8 19.41 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.041 0.92 . . . . 0.0 109.977 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.98 8.0 0.23 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.097 0.959 . . . . 0.0 111.772 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -152.97 164.09 38.59 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.709 2.004 . . . . 0.0 107.92 -169.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.7 m -145.56 142.44 29.16 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.771 2.028 . . . . 0.0 107.352 -170.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 71' ' ' ILE . 11.7 pt -135.22 132.73 20.22 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 169.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.02 161.32 46.3 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.723 1.615 . . . . 0.0 109.445 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -56.16 -15.44 3.74 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.66 1.184 . . . . 0.0 112.45 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -70.32 -27.0 64.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.401 1.48 . . . . 0.0 113.139 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 67' ' ' ILE . 12.5 pt -121.18 -8.17 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-N 120.131 1.332 . . . . 0.0 111.104 -176.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.85 -45.26 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 128.14 2.576 . . . . 0.0 109.088 169.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -80.62 9.86 5.57 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.931 0.892 . . . . 0.0 112.521 -169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.57 -172.54 25.82 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 -173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -57.55 136.45 56.75 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.9 t -140.66 153.96 46.21 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.415 0.447 . . . . 0.0 110.105 169.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 33.6 m-85 -140.2 112.45 7.75 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.348 1.459 . . . . 0.0 110.156 -169.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -77.84 128.82 34.59 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.68 156.47 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 124.983 1.313 . . . . 0.0 112.362 -169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -101.59 121.84 42.75 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 167.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -74.58 112.16 10.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -78.17 150.5 33.56 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -172.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.29 7.58 39.66 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-O 118.978 -0.901 . . . . 0.0 112.51 -171.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.568 ' CD1' HM2B ' A' ' 128' ' ' M2L . 42.4 m95 -135.02 172.96 12.27 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.622 1.211 . . . . 0.0 111.38 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 mtmt -70.89 160.66 32.41 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 122.871 0.468 . . . . 0.0 111.505 -169.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 p -65.51 -22.29 66.71 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.137 0.975 . . . . 0.0 111.761 170.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.1 m -54.97 -32.24 61.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.515 1.126 . . . . 0.0 112.487 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -83.26 -3.31 57.3 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 117.497 -1.239 . . . . 0.0 112.957 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -64.6 111.11 2.58 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 -175.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -156.67 166.74 32.54 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.663 1.585 . . . . 0.0 108.673 -167.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.426 ' CZ2' HD11 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -96.32 149.94 21.12 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.927 0.87 . . . . 0.0 110.693 168.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.35 153.24 36.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.32 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.18 160.54 29.61 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -70.49 7.23 1.11 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -83.46 -23.6 32.18 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.312 1.845 . . . . 0.0 110.899 168.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.31 -34.65 3.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 117.757 -1.116 . . . . 0.0 111.686 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.514 HD11 HG21 ' A' ' 14' ' ' VAL . 4.7 tt -101.68 149.58 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.786 1.175 . . . . 0.0 110.794 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.8 mtt85 -144.75 149.44 35.54 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.075 1.35 . . . . 0.0 110.177 168.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.83 141.96 53.18 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 126.13 1.772 . . . . 0.0 110.627 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.402 ' CE2' HD11 ' A' ' 105' ' ' ILE . 38.0 t80 -59.9 115.47 3.43 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 119.541 1.064 . . . . 0.0 111.759 -169.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -160.76 165.62 30.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.148 1.779 . . . . 0.0 110.505 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -57.58 -33.15 67.87 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.638 1.575 . . . . 0.0 113.392 -169.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -64.59 -43.43 93.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 122.013 0.911 . . . . 0.0 109.397 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -69.04 -33.01 72.91 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.402 HD11 ' CE2' ' A' ' 100' ' ' TYR . 3.8 mm -67.83 -34.72 69.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.448 0.567 . . . . 0.0 110.748 176.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.98 -44.9 94.77 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 118.881 0.764 . . . . 0.0 110.196 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -55.63 -49.92 71.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 170.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -59.18 -50.37 74.27 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.003 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -76.19 -36.15 58.79 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.425 1.012 . . . . 0.0 109.85 -170.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.12 -40.85 82.29 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 119.103 -0.475 . . . . 0.0 109.977 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.9 mt -79.39 -44.08 22.18 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.568 1.076 . . . . 0.0 112.862 -177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -49.24 -34.0 13.99 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.059 1.344 . . . . 0.0 110.83 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -79.51 -54.51 5.84 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.316 1.046 . . . . 0.0 113.148 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -77.38 -26.23 51.67 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -169.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.46 4.15 1.76 Allowed 'General case' 0 C--O 1.237 0.395 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -167.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.24 156.55 20.14 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-N 118.815 0.734 . . . . 0.0 112.369 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.1 m -45.86 104.39 0.05 OUTLIER 'General case' 0 C--O 1.235 0.324 0 C-N-CA 128.321 2.648 . . . . 0.0 112.095 -177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -54.52 122.12 9.85 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.917 1.687 . . . . 0.0 110.039 174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.15 -13.93 82.8 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.35 -0.694 . . . . 0.0 113.72 -171.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.8 p -131.45 15.88 4.96 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.096 1.358 . . . . 0.0 112.029 -172.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.65 88.49 7.08 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 125.543 1.537 . . . . 0.0 107.262 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.35 -3.22 11.31 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.903 2.402 . . . . 0.0 114.596 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.24 -30.72 68.46 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.335 1.054 . . . . 0.0 110.655 169.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.1 p 38.29 58.43 1.56 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.828 2.051 . . . . 0.0 111.812 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.95 -28.07 31.3 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.615 1.102 . . . . 0.0 114.319 -172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -84.3 13.62 49.75 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.489 -1.729 . . . . 0.0 113.723 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 80.7 t -135.8 140.25 44.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 121.014 2.407 . . . . 0.0 105.751 -169.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.568 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -146.04 122.83 5.93 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 125.506 1.522 . . . . 0.0 108.918 -168.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -84.18 -15.29 6.71 Favored 'Trans proline' 0 CA--C 1.553 1.456 0 N-CA-C 108.133 -1.526 . . . . 0.0 108.133 167.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 132' ' ' ARG . 5.4 t60 -77.76 -167.92 1.09 Allowed 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 131.126 3.77 . . . . 0.0 108.15 169.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.493 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 82.0 mtt-85 49.15 46.37 22.77 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.657 1.983 . . . . 0.0 112.105 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -57.75 -29.01 64.45 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.825 0.85 . . . . 0.0 111.172 170.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.5 1.92 . . . . 0.0 107.589 171.739 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 ttp . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.0 m -138.35 160.6 31.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.368 1.467 . . . . 0.0 108.076 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -153.31 -60.23 0.14 Allowed 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.525 0.73 . . . . 0.0 109.103 171.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tt -58.74 -40.98 85.38 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.811 0.844 . . . . 0.0 109.987 -177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -69.07 3.39 2.11 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.047 1.339 . . . . 0.0 113.359 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -129.59 -7.24 4.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.816 2.046 . . . . 0.0 110.814 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -86.47 166.19 15.7 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 169.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.414 ' CD2' ' CZ ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -56.2 132.71 51.27 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 168.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.94 129.62 45.69 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 102.72 -3.067 . . . . 0.0 102.72 -172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.25 -3.27 0.38 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -168.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.0 28.79 0.53 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 110.099 -1.201 . . . . 0.0 110.099 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.81 -173.73 48.71 Favored Glycine 0 N--CA 1.436 -1.359 0 N-CA-C 106.828 -2.509 . . . . 0.0 106.828 168.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.2 mtt85 -91.33 159.99 15.73 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.555 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -133.94 161.23 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 103.635 -2.728 . . . . 0.0 103.635 168.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -130.03 140.84 50.8 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.7 128.4 32.91 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -169.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -102.51 124.97 49.04 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.898 1.279 . . . . 0.0 108.573 -169.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -101.6 -23.19 14.31 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.438 0.295 . . . . 0.0 111.194 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.88 -73.76 0.25 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.63 -31.14 27.01 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.55 2.167 . . . . 0.0 112.273 174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.38 177.94 10.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.131 1.772 . . . . 0.0 108.287 -169.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.432 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -135.15 162.09 33.49 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.643 1.577 . . . . 0.0 107.208 -173.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -136.59 159.82 40.66 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.248 1.019 . . . . 0.0 108.854 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -76.61 147.27 37.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.229 0.537 . . . . 0.0 109.732 176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.94 31.5 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 124.846 1.258 . . . . 0.0 108.882 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 26' ' ' LYS . 29.4 ttpt -153.11 111.38 3.65 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.197 -0.939 . . . . 0.0 110.706 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.555 HD11 HG11 ' A' ' 14' ' ' VAL . 65.0 mt -59.03 152.17 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 128.895 2.878 . . . . 0.0 111.688 -178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 pp -157.99 -30.04 0.08 Allowed 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.913 0.885 . . . . 0.0 112.514 169.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -131.25 140.99 49.93 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.99 164.88 20.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -168.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.0 t-105 -149.91 152.21 34.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.973 -168.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.29 141.11 14.53 Favored Pre-proline 0 C--O 1.239 0.55 0 C-N-CA 125.137 1.375 . . . . 0.0 109.965 -171.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -71.45 -0.23 7.87 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.088 3.192 . . . . 0.0 113.501 177.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.3 m -66.13 -34.46 78.09 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.032 1.287 . . . . 0.0 110.979 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.9 m -130.81 -7.86 4.0 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.37 1.068 . . . . 0.0 112.164 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 45.16 53.14 8.13 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.221 1.009 . . . . 0.0 110.72 -169.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -148.81 151.87 35.53 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.827 2.051 . . . . 0.0 105.815 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -103.21 168.06 9.42 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 122.86 0.464 . . . . 0.0 112.043 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.6 p -136.42 153.54 51.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.435 1.894 . . . . 0.0 107.324 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.687 ' HB2' HD12 ' A' ' 56' ' ' ILE . 3.5 m -151.62 158.07 42.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 118.738 0.699 . . . . 0.0 110.1 -168.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.9 pt -145.77 156.11 52.13 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 126.151 1.781 . . . . 0.0 108.621 173.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -83.56 55.32 4.89 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.586 3.524 . . . . 0.0 109.66 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -54.03 -43.0 69.77 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.553 -0.717 . . . . 0.0 111.591 -176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.69 0.51 23.16 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.044 0.938 . . . . 0.0 112.439 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 44.47 48.37 4.51 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.645 1.178 . . . . 0.0 108.89 -168.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -60.18 143.13 99.54 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.741 2.961 . . . . 0.0 110.359 -169.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 61.07 0.9 1.75 Allowed Glycine 0 CA--C 1.539 1.583 0 C-N-CA 123.913 0.768 . . . . 0.0 114.339 -175.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.16 53.03 2.26 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -170.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.2 m 53.16 16.14 0.74 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.567 1.947 . . . . 0.0 115.312 -172.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 54.0 m -92.11 14.06 17.12 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.389 1.876 . . . . 0.0 111.305 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -145.86 165.65 28.26 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 127.755 2.422 . . . . 0.0 107.256 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.508 ' HA ' HD11 ' A' ' 56' ' ' ILE . . . 44.77 34.62 1.22 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.178 0.991 . . . . 0.0 113.004 -177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -39.06 94.8 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 130.252 3.421 . . . . 0.0 114.9 -168.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? 42.64 -147.61 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.064 2.546 . . . . 0.0 112.104 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -58.19 108.5 0.61 Allowed 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.296 -0.878 . . . . 0.0 108.675 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.687 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.6 mt -87.53 141.74 13.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.76 142.95 88.91 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 123.157 0.583 . . . . 0.0 109.613 172.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.31 142.18 33.2 Favored 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.54 1.493 . . . . 0.0 108.691 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -132.52 166.32 22.33 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.014 0.926 . . . . 0.0 109.023 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.653 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -64.7 -13.52 54.83 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 -168.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.3 tt 68.12 151.66 0.08 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.647 1.979 . . . . 0.0 112.681 -169.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 126.42 55.38 0.15 Allowed Glycine 0 C--N 1.342 0.887 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.113 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.79 51.44 2.15 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.736 1.214 . . . . 0.0 108.072 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.9 t70 68.59 -7.4 0.72 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.126 2.571 . . . . 0.0 113.405 -172.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -82.95 33.02 0.43 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.054 2.142 . . . . 0.0 111.641 169.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m -33.74 140.51 0.05 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 130.502 3.521 . . . . 0.0 112.203 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 71' ' ' ILE . 10.2 pt -135.41 135.17 21.91 Favored Pre-proline 0 N--CA 1.451 -0.395 0 C-N-CA 124.564 1.146 . . . . 0.0 108.093 169.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.94 162.76 41.57 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.03 1.82 . . . . 0.0 109.723 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -57.14 -17.26 10.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.964 0.906 . . . . 0.0 112.571 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.45 -28.66 69.38 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.607 1.163 . . . . 0.0 112.536 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.456 HD11 HG22 ' A' ' 67' ' ' ILE 0.253 7.2 pt -122.21 -9.01 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 120.081 1.31 . . . . 0.0 110.844 -174.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.9 mm -61.16 -50.94 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.484 2.313 . . . . 0.0 105.817 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -78.79 9.16 4.42 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.496 1.518 . . . . 0.0 111.648 -173.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.72 173.79 24.44 Favored Glycine 0 C--N 1.337 0.637 0 CA-C-N 119.45 1.023 . . . . 0.0 110.696 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -62.72 132.49 52.44 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.4 m -135.6 152.71 51.52 Favored 'General case' 0 CA--C 1.518 -0.274 0 O-C-N 124.11 0.881 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.414 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 32.3 m-85 -142.94 116.29 9.04 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.284 1.434 . . . . 0.0 109.674 -169.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -81.28 125.36 30.24 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 127.252 2.221 . . . . 0.0 105.811 169.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -136.53 157.44 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.409 -168.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -100.94 118.51 37.12 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.405 ' CD1' ' HM2' ' A' ' 128' ' ' M2L . 49.5 m-85 -70.14 119.73 14.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 170.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -85.83 149.53 25.18 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -172.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.9 8.57 57.99 Favored Glycine 0 CA--C 1.535 1.331 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.553 -169.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.566 ' CD1' HM2B ' A' ' 128' ' ' M2L . 75.4 m95 -133.89 172.66 12.49 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.493 1.146 . . . . 0.0 111.633 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -71.1 158.6 36.19 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.196 0.598 . . . . 0.0 110.423 -174.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.6 m -70.36 -12.28 61.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 122.628 0.371 . . . . 0.0 111.843 170.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 23.7 m -56.42 -33.31 65.7 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.748 -1.22 . . . . 0.0 112.439 173.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -80.24 3.38 21.01 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 117.706 -1.14 . . . . 0.0 112.973 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -66.95 108.72 2.68 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.21 167.21 29.31 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.685 1.994 . . . . 0.0 107.441 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.21 149.56 23.44 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 121.911 0.862 . . . . 0.0 110.378 169.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.92 150.78 31.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 114.451 -1.249 . . . . 0.0 109.283 173.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -85.74 158.51 32.22 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.63 8.12 0.72 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -179.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -88.59 -18.72 27.46 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.047 1.739 . . . . 0.0 111.311 169.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -119.79 -35.68 3.46 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 117.255 -1.355 . . . . 0.0 111.984 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.526 HD11 HG21 ' A' ' 14' ' ' VAL . 6.3 tt -98.9 153.66 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 120.474 1.488 . . . . 0.0 110.883 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.569 ' HB3' HD21 ' A' ' 104' ' ' ASN . 90.4 mtt180 -149.83 152.54 35.32 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.842 1.657 . . . . 0.0 110.827 170.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.28 154.74 41.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.925 1.69 . . . . 0.0 111.863 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.514 ' CE2' HD11 ' A' ' 105' ' ' ILE . 41.3 t80 -60.59 118.17 6.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 118.577 0.626 . . . . 0.0 109.882 176.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -164.4 160.59 20.87 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.312 1.445 . . . . 0.0 109.084 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -53.15 -35.7 60.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.523 1.529 . . . . 0.0 113.755 -169.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -62.82 -43.81 97.81 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.684 0.755 . . . . 0.0 110.726 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.569 HD21 ' HB3' ' A' ' 98' ' ' ARG . 72.8 m-20 -74.15 -26.55 60.38 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.813 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.514 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.3 mm -68.52 -39.08 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.931 172.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.33 98.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.965 0.802 . . . . 0.0 109.47 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -50.88 72.41 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 173.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -60.5 -46.77 88.92 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 118.588 -0.72 . . . . 0.0 109.281 -173.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -73.77 -40.19 63.64 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 119.067 0.849 . . . . 0.0 111.04 -173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -48.59 75.5 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.02 -44.33 61.04 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.954 -1.091 . . . . 0.0 112.231 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.75 -13.96 0.82 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.238 1.815 . . . . 0.0 112.834 169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -106.37 -38.84 6.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.795 1.238 . . . . 0.0 112.059 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.31 -27.2 59.21 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.535 1.061 . . . . 0.0 111.409 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.75 0.18 1.09 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -168.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.02 -144.26 42.85 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 119.873 1.215 . . . . 0.0 110.094 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.6 p -149.82 -32.15 0.2 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 117.916 0.858 . . . . 0.0 112.224 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.1 p -139.97 167.1 22.9 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 125.422 1.489 . . . . 0.0 109.083 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 82.27 -175.32 53.7 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.37 0.509 . . . . 0.0 111.862 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.1 m -64.15 162.35 14.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.784 1.234 . . . . 0.0 111.421 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.68 156.2 44.96 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.593 1.557 . . . . 0.0 108.657 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.01 37.7 0.6 Allowed 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 124.424 3.416 . . . . 0.0 112.358 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.44 -177.86 6.09 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.325 1.85 . . . . 0.0 108.894 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.1 m -55.12 -32.8 62.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.846 1.259 . . . . 0.0 111.411 177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 170.04 -54.25 0.2 Allowed Glycine 0 C--N 1.339 0.7 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 62.9 10.57 33.08 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 118.875 -0.958 . . . . 0.0 113.512 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.9 t -147.51 139.03 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -169.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.566 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 7.7 mtmt -152.85 154.06 30.78 Favored Pre-proline 0 N--CA 1.44 -0.97 0 C-N-CA 129.44 3.096 . . . . 0.0 103.024 168.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -77.59 -7.76 16.85 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.512 1.475 . . . . 0.0 110.879 169.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -48.95 -48.93 42.61 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.616 2.366 . . . . 0.0 112.706 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 17.1 ptm180 -163.76 163.63 23.98 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.598 1.159 . . . . 0.0 109.047 -177.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -152.72 161.48 42.51 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.044 1.338 . . . . 0.0 108.353 175.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.299 1.439 . . . . 0.0 107.863 174.2 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -138.23 131.86 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -151.22 18.26 0.75 Allowed 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.826 0.822 . . . . 0.0 111.832 -174.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 95.4 mt -124.26 14.66 9.02 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.643 1.977 . . . . 0.0 110.232 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -70.33 -34.76 73.07 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.551 1.54 . . . . 0.0 107.862 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.27 114.67 7.14 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 101.069 -3.678 . . . . 0.0 101.069 169.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -74.29 174.67 8.48 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.652 1.981 . . . . 0.0 108.805 169.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -63.22 68.63 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 130.454 3.502 . . . . 0.0 110.063 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 138.73 54.64 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 112.121 -2.308 . . . . 0.0 106.145 -169.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.63 HD12 HG12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -57.81 -10.9 1.89 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -168.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.27 32.88 0.5 Allowed Glycine 0 N--CA 1.446 -0.646 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 170.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.24 -163.04 21.52 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 169.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.6 mtt85 -102.33 153.83 19.63 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 103.892 -2.633 . . . . 0.0 103.892 168.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.587 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.59 169.27 20.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 103.518 -2.771 . . . . 0.0 103.518 168.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.5 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.0 mm? -135.26 142.41 45.93 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 103.243 -2.873 . . . . 0.0 103.243 176.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.3 147.1 51.98 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -115.12 119.53 36.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -169.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -102.14 -9.5 20.45 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.243 0.617 . . . . 0.0 112.56 -169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.03 -77.99 0.3 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 172.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -66.46 -38.66 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.439 2.092 . . . . 0.0 113.317 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD12 ' H ' ' A' ' 22' ' ' MET . 21.2 tp -148.2 177.76 9.13 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 125.129 1.371 . . . . 0.0 109.294 -168.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.5 ' CE ' HD12 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -139.59 149.23 43.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 127.598 2.359 . . . . 0.0 107.129 -168.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -136.44 154.32 50.81 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.539 0.736 . . . . 0.0 109.765 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -66.64 141.9 57.64 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.277 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.62 162.59 29.04 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 126.137 1.775 . . . . 0.0 108.083 -176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -148.66 95.72 2.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.465 -172.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.587 HD11 HG11 ' A' ' 14' ' ' VAL . 75.0 mt -55.52 151.35 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 127.392 2.277 . . . . 0.0 110.743 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pp -156.73 -32.27 0.09 Allowed 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.779 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.449 ' HD2' ' CD2' ' A' ' 38' ' ' TYR . 36.8 ttpt -131.53 138.04 48.76 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.35 165.33 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -144.3 153.37 41.94 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.331 -169.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.53 143.57 17.49 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.022 1.729 . . . . 0.0 109.243 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -66.69 -12.48 36.08 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.585 2.857 . . . . 0.0 113.586 176.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.9 m -64.77 -32.74 74.56 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.066 1.303 . . . . 0.0 111.883 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.0 m -121.35 -11.28 8.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.452 1.101 . . . . 0.0 111.077 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt 48.29 49.67 17.49 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 124.156 0.982 . . . . 0.0 109.331 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 83.3 mtp -145.4 159.09 43.6 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.144 2.177 . . . . 0.0 105.5 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.449 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 42.1 p90 -104.58 174.97 5.65 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.254 0.622 . . . . 0.0 112.573 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -143.47 152.54 41.63 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.549 2.339 . . . . 0.0 106.132 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB3' HD12 ' A' ' 56' ' ' ILE . 47.7 t -147.56 161.17 41.67 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -175.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.63 HG12 HD12 ' A' ' 10' ' ' LEU . 15.2 pt -144.33 159.2 52.83 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 123.96 0.904 . . . . 0.0 110.017 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.546 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 65.6 Cg_endo -70.88 32.59 0.23 Allowed 'Trans proline' 0 CA--C 1.547 1.174 1 C-N-CA 125.947 4.432 . . . . 0.0 115.025 -177.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -49.35 -50.44 39.83 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.032 0.933 . . . . 0.0 110.649 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -165.01 -122.92 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -152.14 154.96 33.03 Favored Pre-proline 0 C--O 1.24 0.578 0 CA-C-N 119.492 1.042 . . . . 0.0 110.39 -169.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -67.39 176.41 4.87 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.315 2.01 . . . . 0.0 106.912 166.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.92 23.36 0.7 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.236 1.398 . . . . 0.0 113.863 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -168.53 28.31 0.15 Allowed Glycine 0 CA--C 1.533 1.159 0 CA-C-N 118.75 1.275 . . . . 0.0 114.904 -174.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.4 m -144.61 169.85 17.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.696 1.748 . . . . 0.0 109.622 172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.8 m -79.61 -45.3 19.39 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.082 0.553 . . . . 0.0 111.758 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -168.98 145.24 3.47 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.433 0.693 . . . . 0.0 109.144 174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -60.99 159.66 11.14 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 167.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -88.88 -71.46 0.59 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 -168.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -151.75 -160.91 1.22 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.93 2.892 . . . . 0.0 104.34 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.31 109.1 1.46 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.2 mt -73.66 135.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 -173.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -65.19 137.49 96.94 Favored Pre-proline 0 C--O 1.235 0.314 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.02 137.9 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 N-CA-C 107.165 -1.898 . . . . 0.0 107.165 -176.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -141.19 164.49 30.11 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 5.9 mmpt? -63.62 153.12 36.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.3 tt -107.71 154.3 21.68 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.524 1.93 . . . . 0.0 110.583 -169.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.01 21.96 5.12 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.137 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -77.78 -33.42 52.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 117.723 0.762 . . . . 0.0 109.166 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -149.9 6.35 0.61 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.696 1.198 . . . . 0.0 111.79 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.601 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 4.8 mp0 -124.75 172.53 9.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.012 1.325 . . . . 0.0 111.648 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.9 m -149.55 144.03 25.98 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.988 2.115 . . . . 0.0 106.343 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 71' ' ' ILE . 9.3 pt -135.54 120.97 13.77 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 169.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -55.99 154.45 27.37 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.282 1.988 . . . . 0.0 111.181 170.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -53.43 -24.46 12.75 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.341 1.056 . . . . 0.0 111.619 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -57.13 -32.64 66.56 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.156 1.783 . . . . 0.0 114.215 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 67' ' ' ILE . 14.9 pt -117.77 -17.13 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 119.702 1.137 . . . . 0.0 110.508 -172.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -49.67 -44.85 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 128.418 2.687 . . . . 0.0 109.16 169.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.94 11.53 6.02 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.685 0.794 . . . . 0.0 112.342 -169.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.88 -177.79 29.43 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 119.577 1.08 . . . . 0.0 111.045 -174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -59.87 133.36 56.03 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.4 m -135.99 150.72 49.34 Favored 'General case' 0 CA--C 1.516 -0.362 0 O-C-N 123.812 0.695 . . . . 0.0 110.139 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -135.19 113.3 11.21 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.32 1.048 . . . . 0.0 110.111 -169.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -77.62 121.81 24.46 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 127.296 2.238 . . . . 0.0 106.963 169.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.04 159.04 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.672 -168.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.415 ' HD2' ' OD1' ' A' ' 89' ' ' ASP . 21.6 t-80 -106.95 129.04 54.82 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 167.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -75.25 110.02 9.25 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -73.54 149.21 42.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.915 -176.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.84 4.53 34.26 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.756 -1.024 . . . . 0.0 112.364 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -130.2 172.15 12.1 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.828 1.314 . . . . 0.0 111.832 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -68.22 162.78 24.22 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -168.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.4 m -65.65 -20.59 66.36 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.018 0.927 . . . . 0.0 111.589 169.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.6 m -59.44 -31.04 68.93 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.789 0.836 . . . . 0.0 112.354 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -91.85 17.56 8.97 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.801 0.84 . . . . 0.0 112.705 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.415 ' OD1' ' HD2' ' A' ' 80' ' ' HIS . 0.1 OUTLIER -64.1 106.87 1.14 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.651 -2.351 . . . . 0.0 104.651 169.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -153.87 158.07 40.23 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 108.036 -168.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.601 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -97.43 150.41 21.07 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 122.42 1.105 . . . . 0.0 109.326 167.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.89 154.44 40.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.328 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.3 168.18 30.79 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 169.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.96 -16.42 6.88 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.51 1.124 . . . . 0.0 113.297 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.48 -23.79 52.04 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.532 1.533 . . . . 0.0 112.976 169.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -123.12 -37.64 2.69 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-O 117.587 -1.197 . . . . 0.0 112.227 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 tt -95.63 157.5 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.496 1.044 . . . . 0.0 112.822 -169.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -152.81 165.24 36.01 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 129.692 3.197 . . . . 0.0 109.117 169.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . . . -99.61 155.21 17.72 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.67 1.588 . . . . 0.0 112.861 -172.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.534 ' CE2' HD11 ' A' ' 105' ' ' ILE . 29.8 t80 -67.22 109.06 2.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 122.345 1.069 . . . . 0.0 112.551 -169.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -157.74 162.45 38.53 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 125.764 1.625 . . . . 0.0 108.786 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -54.95 -33.98 62.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -168.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -63.55 -43.24 97.66 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 119.081 0.855 . . . . 0.0 110.328 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.72 -25.13 60.05 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 118.59 -0.719 . . . . 0.0 109.633 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.534 HD11 ' CE2' ' A' ' 100' ' ' TYR . 6.8 mm -73.87 -32.54 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-N 118.508 0.594 . . . . 0.0 111.382 171.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.59 96.41 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.209 0.913 . . . . 0.0 109.097 173.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.74 -51.69 68.89 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 169.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -54.42 -49.36 70.14 Favored 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 123.706 0.802 . . . . 0.0 110.462 -175.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -74.21 -44.71 52.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.368 0.531 . . . . 0.0 110.419 -173.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -32.82 55.64 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 122.966 0.506 . . . . 0.0 111.068 174.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.63 -46.52 9.45 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 118.953 0.797 . . . . 0.0 112.426 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.41 -29.95 11.34 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 111.31 171.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -65.64 -33.97 77.13 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.867 1.667 . . . . 0.0 114.292 174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -118.16 -2.72 11.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -48.19 -38.45 18.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.359 2.264 . . . . 0.0 113.417 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.15 -158.87 44.9 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.7 m -147.02 152.31 38.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.491 1.917 . . . . 0.0 106.632 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 48.6 m -64.26 154.06 36.22 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 169.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -160.01 -168.66 22.28 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.5 m -72.5 35.34 0.07 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.752 2.021 . . . . 0.0 113.663 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -138.54 149.03 61.23 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 125.858 1.663 . . . . 0.0 107.668 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.62 23.23 0.5 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.271 3.314 . . . . 0.0 113.804 -172.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.47 149.33 50.21 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.172 0.989 . . . . 0.0 111.433 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 29.5 p -134.04 -9.36 2.66 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.761 1.624 . . . . 0.0 111.697 178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.87 53.6 3.72 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 125.991 1.758 . . . . 0.0 112.105 -177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.7 -40.88 0.04 OUTLIER Glycine 0 C--O 1.219 -0.804 0 CA-C-O 117.84 -1.533 . . . . 0.0 110.96 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.9 t -146.75 134.77 15.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 120.193 1.997 . . . . 0.0 106.378 -170.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -140.79 117.91 7.83 Favored Pre-proline 0 N--CA 1.453 -0.312 0 C-N-CA 124.759 1.224 . . . . 0.0 111.123 -167.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -90.91 -5.25 4.36 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.101 2.534 . . . . 0.0 111.08 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -141.76 137.88 31.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.753 2.821 . . . . 0.0 107.535 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 127.02 153.35 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 1 C-N-CA 133.369 4.668 . . . . 0.0 107.85 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -145.98 157.6 43.88 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.772 1.229 . . . . 0.0 108.877 -170.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 . . . . . 0 C--O 1.254 1.296 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.024 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 121.072 0.463 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.46 161.4 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.515 1.126 . . . . 0.0 109.455 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -139.21 157.69 45.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.4 1.08 . . . . 0.0 109.763 -177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 tt 57.94 -52.99 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 131.503 3.921 . . . . 0.0 114.739 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -60.69 -22.57 64.06 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.807 1.243 . . . . 0.0 110.836 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -57.02 -28.49 62.55 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 129.903 3.281 . . . . 0.0 114.164 173.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -72.87 154.52 40.56 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.281 -0.887 . . . . 0.0 109.771 174.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -57.82 128.84 39.11 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 168.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.67 136.5 54.51 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -169.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.431 HD22 HG12 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -59.94 -3.62 0.59 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 116.01 1.855 . . . . 0.0 116.01 -168.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.05 30.41 0.3 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 169.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.66 -168.86 44.26 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 169.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.9 mtt85 -94.87 157.32 15.97 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 168.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.57 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.2 166.62 28.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 102.461 -3.162 . . . . 0.0 102.461 168.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.501 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.3 mm? -132.1 139.75 48.59 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 103.122 -2.918 . . . . 0.0 103.122 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.76 135.46 36.38 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -106.04 111.67 24.39 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -169.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -81.56 -35.16 30.55 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 118.622 0.646 . . . . 0.0 110.313 -171.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 164.37 -72.04 0.19 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 175.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.11 -28.54 10.78 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.188 2.592 . . . . 0.0 113.338 173.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -150.92 171.73 16.8 Favored 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 125.308 1.443 . . . . 0.0 108.622 -173.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.501 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -134.14 144.7 48.7 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 126.949 2.099 . . . . 0.0 106.605 -169.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -133.27 160.07 38.39 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.747 0.819 . . . . 0.0 109.178 -172.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -74.42 145.74 43.46 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.29 176.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.3 159.13 42.8 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 125.227 1.411 . . . . 0.0 107.952 -177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 94.55 2.13 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.896 -0.503 . . . . 0.0 110.63 -169.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 HG11 ' A' ' 14' ' ' VAL . 58.3 mt -59.11 149.85 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 128.577 2.751 . . . . 0.0 112.159 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.54 -24.62 0.05 Allowed 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 124.439 1.087 . . . . 0.0 113.356 167.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' N ' HD22 ' A' ' 28' ' ' LEU . 35.4 ttpt -125.86 139.25 53.63 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 174.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 pt -141.08 165.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -168.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.512 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.3 t-105 -149.76 154.7 38.91 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.515 -169.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.73 141.17 15.02 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.921 1.688 . . . . 0.0 109.147 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -67.19 -10.47 28.73 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.268 2.645 . . . . 0.0 112.783 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.3 m -65.11 -33.28 75.65 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.404 1.456 . . . . 0.0 111.295 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.1 p -120.24 -16.32 8.51 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.291 1.836 . . . . 0.0 110.734 175.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm 49.07 53.25 12.92 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.538 0.735 . . . . 0.0 109.095 -169.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 76.7 mtp -149.01 154.03 38.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.462 2.305 . . . . 0.0 105.533 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -100.58 174.41 6.09 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.158 0.583 . . . . 0.0 112.302 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -144.1 151.91 40.24 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 127.583 2.353 . . . . 0.0 106.34 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.447 ' HB3' HD12 ' A' ' 56' ' ' ILE . 44.7 t -147.81 161.11 41.93 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.431 HG12 HD22 ' A' ' 10' ' ' LEU . 6.9 pt -147.78 159.43 40.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.199 1.4 . . . . 0.0 110.097 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.08 94.73 0.48 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.426 3.417 . . . . 0.0 110.915 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -141.49 -4.65 1.1 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.479 0.712 . . . . 0.0 112.699 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -152.54 178.47 9.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.394 0.997 . . . . 0.0 111.001 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -144.37 69.7 15.72 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.305 2.242 . . . . 0.0 107.7 -171.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.07 -27.09 53.45 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.755 2.304 . . . . 0.0 116.761 -169.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.75 -41.84 2.1 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 119.673 1.124 . . . . 0.0 110.687 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.89 -16.82 68.79 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 123.815 0.722 . . . . 0.0 112.005 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -141.14 142.22 34.08 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 127.015 2.126 . . . . 0.0 106.534 172.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.8 m -63.57 -30.98 72.02 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.08 0.952 . . . . 0.0 111.745 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -158.77 160.43 36.29 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.496 1.918 . . . . 0.0 107.798 169.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.49 137.53 48.25 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 102.942 -2.985 . . . . 0.0 102.942 167.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.3 m -118.5 105.76 11.99 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.428 1.013 . . . . 0.0 112.154 -168.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt 54.95 -168.29 0.08 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 127.252 2.221 . . . . 0.0 112.266 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -66.37 101.96 0.81 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 40' ' ' SER . 2.7 mt -73.93 138.32 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -172.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.71 138.15 95.3 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.4 132.47 19.23 Favored 'Trans proline' 0 N--CA 1.437 -1.85 0 N-CA-C 107.18 -1.892 . . . . 0.0 107.18 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -137.16 165.28 26.48 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.623 1.169 . . . . 0.0 108.345 -170.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.41 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -66.69 153.74 42.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 62' ' ' GLY . 5.5 tt -119.83 142.68 48.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.118 1.767 . . . . 0.0 109.044 -169.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.49 ' N ' HD23 ' A' ' 61' ' ' LEU . . . 123.86 30.24 1.06 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-N 114.774 -1.103 . . . . 0.0 114.144 169.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -69.89 -39.31 76.33 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.107 1.453 . . . . 0.0 109.769 173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -152.86 -32.38 0.13 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.561 1.544 . . . . 0.0 111.043 170.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -66.73 21.1 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 129.357 3.063 . . . . 0.0 114.03 172.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.1 m -33.39 132.1 0.2 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.359 2.264 . . . . 0.0 111.263 169.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 67' ' ' ILE 0.288 7.0 tt -124.9 141.95 39.68 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -168.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.46 145.62 48.05 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.417 1.411 . . . . 0.0 110.747 -177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -56.44 -15.67 4.56 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.088 1.355 . . . . 0.0 112.901 172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.48 -26.67 68.83 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.922 1.289 . . . . 0.0 112.311 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.7 pt -122.33 -15.07 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.093 0.86 . . . . 0.0 111.223 -170.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.512 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 3.4 mm -50.75 -42.66 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 127.578 2.351 . . . . 0.0 109.507 170.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -83.21 10.76 7.67 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.708 1.203 . . . . 0.0 112.475 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -154.9 -175.78 26.37 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.85 139.52 58.35 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 175.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.9 m -133.19 149.22 52.04 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.891 0.745 . . . . 0.0 109.427 172.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -136.33 112.63 9.86 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.482 1.113 . . . . 0.0 108.616 -170.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -79.68 126.94 31.58 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 126.399 1.88 . . . . 0.0 107.511 169.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 pt -136.76 154.85 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 O-C-N 124.919 1.387 . . . . 0.0 112.491 -168.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -100.77 119.57 38.82 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 167.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.19 111.62 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 174.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -82.05 151.58 27.0 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.92 2.72 58.29 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.48 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.488 ' CH2' ' SG ' ' A' ' 128' ' ' M2L . 94.2 m95 -136.75 179.31 6.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.583 1.192 . . . . 0.0 110.991 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -77.84 160.47 28.29 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 110.858 -172.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.6 m -72.53 -13.51 61.43 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.548 0.739 . . . . 0.0 111.834 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -53.55 -31.75 47.86 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.667 1.187 . . . . 0.0 111.951 173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.455 ' CE2' ' HE ' ' A' ' 128' ' ' M2L . 41.1 m95 -89.75 7.68 35.63 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 117.911 -1.042 . . . . 0.0 113.239 -176.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -64.01 115.89 5.35 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -154.29 165.07 37.47 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.193 1.397 . . . . 0.0 108.187 -167.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.65 150.06 23.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 122.277 1.037 . . . . 0.0 110.043 168.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.17 159.99 42.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.612 175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -101.83 173.01 23.22 Favored Glycine 0 CA--C 1.524 0.596 0 C-N-CA 124.995 1.283 . . . . 0.0 110.021 169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.14 -16.85 48.91 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.125 1.37 . . . . 0.0 113.382 -177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.73 -21.42 60.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.628 1.171 . . . . 0.0 113.0 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -121.54 -39.88 2.61 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 117.283 -1.342 . . . . 0.0 112.377 171.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -94.83 157.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 119.822 1.192 . . . . 0.0 113.323 -168.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -155.04 158.05 38.53 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 129.465 3.106 . . . . 0.0 108.778 170.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.29 168.39 19.74 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 121.247 1.839 . . . . 0.0 112.971 -177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.553 ' CE2' HD11 ' A' ' 105' ' ' ILE . 25.0 t80 -67.96 117.53 9.95 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.841 -1.162 . . . . 0.0 109.84 169.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -161.03 164.15 31.12 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 125.684 1.593 . . . . 0.0 108.893 169.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -59.5 -30.43 68.55 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.444 1.098 . . . . 0.0 113.393 -169.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -65.63 -42.11 91.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.443 1.116 . . . . 0.0 109.848 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -73.39 -27.84 61.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 121.359 -0.838 . . . . 0.0 109.56 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.553 HD11 ' CE2' ' A' ' 100' ' ' TYR . 7.2 mm -70.05 -32.74 52.33 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 CA-C-N 118.751 0.705 . . . . 0.0 110.933 169.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.15 -42.18 99.41 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.52 1.055 . . . . 0.0 109.724 174.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -49.0 79.34 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 171.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -57.86 -47.12 83.64 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.529 0.732 . . . . 0.0 109.966 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -73.52 -44.51 57.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 118.524 0.602 . . . . 0.0 109.961 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.55 -32.47 50.81 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.5 173.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 44.6 mt -89.95 -44.33 9.96 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 119.282 0.947 . . . . 0.0 112.348 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.89 -28.45 9.64 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.249 1.42 . . . . 0.0 111.723 170.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -66.85 -34.68 78.33 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.928 1.691 . . . . 0.0 114.263 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -125.19 -11.42 6.99 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -169.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 51.53 18.27 0.66 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.532 2.733 . . . . 0.0 115.403 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.79 -38.4 2.68 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.996 1.76 . . . . 0.0 111.895 -175.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 75.3 m 43.79 47.32 6.73 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.333 1.453 . . . . 0.0 112.614 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.0 p -60.38 -24.06 64.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.391 1.076 . . . . 0.0 111.71 175.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -167.57 168.87 40.85 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.761 1.648 . . . . 0.0 109.164 169.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.1 m -68.52 102.94 1.55 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.843 0.857 . . . . 0.0 109.215 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.91 157.43 31.35 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 125.33 1.452 . . . . 0.0 108.907 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.45 32.7 0.38 Allowed 'Trans proline' 0 CA--C 1.548 1.198 0 C-N-CA 124.498 3.465 . . . . 0.0 112.409 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.19 9.83 2.83 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.798 1.639 . . . . 0.0 112.842 -175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 p -72.45 60.53 0.46 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.144 2.578 . . . . 0.0 112.02 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 171.74 -28.62 0.11 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.842 1.21 . . . . 0.0 111.284 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.44 137.11 3.94 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.2 p -117.56 -17.66 7.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.488 ' SG ' ' CH2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.9 mmpp? -153.91 108.57 2.5 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 121.074 -1.017 . . . . 0.0 110.712 -168.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -83.35 -9.3 10.4 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.529 2.153 . . . . 0.0 110.64 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.479 ' CG ' ' H ' ' A' ' 132' ' ' ARG . 15.3 t60 -124.04 -175.79 3.32 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.291 3.036 . . . . 0.0 107.098 -169.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.479 ' H ' ' CG ' ' A' ' 131' ' ' HIS . 29.4 mmm180 52.15 34.23 13.91 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.978 1.711 . . . . 0.0 111.097 -171.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -151.04 155.86 39.89 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.861 1.665 . . . . 0.0 107.861 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.7 ttt85 . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.404 1.482 . . . . 0.0 107.083 177.792 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.4 m -66.56 156.25 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 118.779 0.718 . . . . 0.0 110.057 174.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -156.18 -46.22 0.08 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.988 0.915 . . . . 0.0 110.426 175.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.48 -25.14 67.84 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.387 1.075 . . . . 0.0 112.171 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -55.47 -24.04 28.95 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.041 1.336 . . . . 0.0 111.768 176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -59.08 -33.64 71.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.111 1.364 . . . . 0.0 112.544 175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -96.38 161.78 13.78 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-O 121.877 0.846 . . . . 0.0 110.232 177.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -55.34 65.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 1 C-N-CA 132.95 4.5 . . . . 0.0 110.948 171.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.44 142.35 58.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.333 -1.758 . . . . 0.0 106.804 -169.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.69 -10.19 0.66 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.28 30.9 0.38 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.999 -1.64 . . . . 0.0 108.999 170.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 179.33 53.19 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 171.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -83.35 153.66 24.46 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 168.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.2 164.68 34.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 169.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.621 HD22 ' CE ' ' A' ' 22' ' ' MET . 65.9 mt -140.56 116.35 10.3 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 102.165 -3.272 . . . . 0.0 102.165 -170.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -111.5 138.71 47.66 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.328 -1.305 . . . . 0.0 108.363 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -120.59 118.57 30.52 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.199 1.4 . . . . 0.0 108.202 -169.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -98.84 -22.01 16.04 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.87 0.468 . . . . 0.0 111.449 -170.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.31 -76.57 0.23 Allowed Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -68.19 -31.56 29.01 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.107 1.871 . . . . 0.0 112.457 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.49 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -153.07 176.33 12.02 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.768 1.227 . . . . 0.0 110.743 -171.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.621 ' CE ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.07 154.6 47.29 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.809 2.444 . . . . 0.0 107.491 -173.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.481 ' CD2' HM2A ' A' ' 128' ' ' M2L . 17.3 m-85 -140.41 149.59 42.81 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.186 1.394 . . . . 0.0 108.765 -176.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.34 145.53 51.12 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.94 161.23 37.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.475 1.51 . . . . 0.0 109.02 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -148.5 104.37 3.49 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.407 -0.808 . . . . 0.0 109.777 -171.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 14' ' ' VAL . 54.7 mt -64.79 155.46 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 128.447 2.699 . . . . 0.0 112.904 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.433 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -163.79 -20.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 117.822 -1.085 . . . . 0.0 113.724 166.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' N ' HD22 ' A' ' 28' ' ' LEU . 34.7 ttpt -131.58 138.66 48.95 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 176.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.6 161.76 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -168.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.48 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.9 t-105 -144.68 154.55 42.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.384 -168.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -146.51 140.93 15.73 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 127.725 2.41 . . . . 0.0 108.881 -174.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.62 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.666 2.911 . . . . 0.0 113.549 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -66.87 -32.22 73.34 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.068 1.303 . . . . 0.0 111.571 -169.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.9 m -121.56 -11.09 8.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.647 1.179 . . . . 0.0 111.02 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt 47.09 50.41 14.1 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.058 0.943 . . . . 0.0 109.985 -171.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 53.3 mtp -150.65 154.0 36.67 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 127.365 2.266 . . . . 0.0 105.163 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.421 ' CD2' ' HD2' ' A' ' 29' ' ' LYS . 48.8 p90 -103.45 175.12 5.58 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.2 p -141.56 155.92 45.74 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 127.009 2.124 . . . . 0.0 106.847 171.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.64 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.2 m -154.06 156.66 37.72 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -169.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 pt -141.15 162.9 45.42 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 123.111 0.564 . . . . 0.0 110.58 -176.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -80.47 45.43 1.97 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.991 3.794 . . . . 0.0 111.798 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -57.26 -54.39 47.38 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.631 -0.668 . . . . 0.0 109.826 177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -166.59 171.16 11.98 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.544 1.138 . . . . 0.0 108.648 -176.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm -64.76 150.33 94.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 127.33 2.252 . . . . 0.0 111.495 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -67.2 177.84 3.47 Favored 'Trans proline' 0 CA--C 1.551 1.328 0 C-N-CA 122.65 2.233 . . . . 0.0 107.268 166.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.07 -27.42 22.46 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 120.726 -1.234 . . . . 0.0 115.635 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.51 43.97 0.55 Allowed Glycine 0 CA--C 1.529 0.913 0 CA-C-N 119.52 1.66 . . . . 0.0 113.622 -173.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.8 m -143.08 -178.11 5.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.175 0.99 . . . . 0.0 109.904 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -70.01 -177.76 1.42 Allowed 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.208 1.403 . . . . 0.0 109.131 170.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -63.29 153.02 36.16 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.563 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.01 152.04 44.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 167.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -86.7 161.51 18.39 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.754 -0.591 . . . . 0.0 110.353 -174.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.34 150.82 1.66 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.764 1.226 . . . . 0.0 108.887 168.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -21.25 97.46 0.01 OUTLIER 'General case' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 0.0 112.328 -169.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.7 mt -72.81 136.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 111.687 -2.506 . . . . 0.0 107.793 -168.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -66.93 141.84 96.99 Favored Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.98 138.54 31.33 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 N-CA-C 107.352 -1.826 . . . . 0.0 107.352 -178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -137.37 160.52 38.84 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -68.57 127.43 32.97 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 122.113 0.959 . . . . 0.0 109.017 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.1 tt -71.23 146.83 48.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.538 1.935 . . . . 0.0 111.97 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 121.7 17.83 3.76 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.697 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -81.6 -32.18 32.15 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.44 1.12 . . . . 0.0 109.845 177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -148.18 10.91 0.9 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.835 1.254 . . . . 0.0 110.893 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.49 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 15.7 mp0 -130.92 174.04 10.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.247 1.819 . . . . 0.0 109.688 -169.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.7 m -165.35 122.96 1.55 Allowed 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 100.344 -3.947 . . . . 0.0 100.344 166.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.478 HG12 HD11 ' A' ' 71' ' ' ILE 0.317 4.2 tt -123.48 129.3 24.92 Favored Pre-proline 0 N--CA 1.433 -1.277 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -167.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.47 148.86 67.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.64 1.56 . . . . 0.0 111.25 -171.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -56.32 -21.11 22.18 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.022 1.329 . . . . 0.0 112.679 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -54.86 -33.27 61.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.032 2.133 . . . . 0.0 113.524 170.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.478 HD11 HG12 ' A' ' 67' ' ' ILE . 4.6 pt -118.1 -16.13 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.422 0.689 . . . . 0.0 111.211 -169.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.48 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 2.9 mm -54.14 -42.56 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 127.948 2.499 . . . . 0.0 109.592 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -82.92 11.41 6.14 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.239 1.016 . . . . 0.0 112.661 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.97 -171.94 25.43 Favored Glycine 0 C--N 1.334 0.427 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -174.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.6 mmpp? -59.34 137.41 58.0 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 m -136.32 153.25 51.21 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 123.866 0.729 . . . . 0.0 110.936 170.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -136.73 114.81 11.51 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.514 1.126 . . . . 0.0 109.416 -170.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.12 126.03 31.55 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 126.666 1.987 . . . . 0.0 107.168 169.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.45 165.95 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-N 113.354 -1.748 . . . . 0.0 110.379 -168.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -119.63 126.94 52.38 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 165.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -78.93 125.87 29.94 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -67.38 149.62 50.04 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.089 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.97 10.19 50.16 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.497 -1.168 . . . . 0.0 113.576 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.544 ' CE2' ' HEA' ' A' ' 128' ' ' M2L . 81.6 m95 -128.04 166.28 18.71 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.11 1.455 . . . . 0.0 111.211 -176.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -61.27 168.41 2.66 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.619 1.168 . . . . 0.0 112.198 -171.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.6 m -63.34 -21.89 66.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.556 0.742 . . . . 0.0 111.711 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.5 m -60.8 -25.9 66.9 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.335 -0.853 . . . . 0.0 111.925 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.567 ' CG ' HM1A ' A' ' 128' ' ' M2L . 41.8 m95 -85.54 16.41 3.86 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.45 1.1 . . . . 0.0 112.477 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -77.73 87.71 3.99 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 167.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -146.3 166.14 27.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.084 1.353 . . . . 0.0 108.341 -167.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.49 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -104.29 152.84 21.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 122.45 1.119 . . . . 0.0 110.511 169.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.36 155.86 42.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.829 173.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.11 169.08 31.74 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 169.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.14 -18.06 22.72 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.714 1.205 . . . . 0.0 113.037 174.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.84 -19.69 18.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.272 1.429 . . . . 0.0 113.554 170.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 mtm180 -127.61 -35.48 2.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 117.39 -1.291 . . . . 0.0 111.939 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.554 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -101.87 152.83 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 120.642 1.565 . . . . 0.0 113.288 -169.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.87 160.95 41.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.28 2.632 . . . . 0.0 108.298 168.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.71 168.66 18.92 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.381 1.446 . . . . 0.0 112.273 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -77.86 109.26 11.73 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.223 -0.923 . . . . 0.0 109.105 169.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -156.42 163.33 39.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.998 1.319 . . . . 0.0 109.278 172.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -53.14 -35.85 60.18 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.665 1.586 . . . . 0.0 114.31 -169.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -62.2 -43.86 97.88 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.695 1.236 . . . . 0.0 110.006 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -78.47 -23.68 46.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 mm -69.57 -35.21 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.685 0.675 . . . . 0.0 109.859 169.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.37 -41.3 98.81 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.521 1.055 . . . . 0.0 109.435 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -46.25 89.83 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 171.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -64.45 -44.58 90.67 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.988 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.5 ptmt -72.54 -42.56 64.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 119.105 0.866 . . . . 0.0 109.504 -175.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -42.89 53.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.269 0.628 . . . . 0.0 110.419 170.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 21.7 mt -78.09 -47.73 17.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 112.398 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.23 -27.63 6.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.474 1.51 . . . . 0.0 111.605 173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -77.59 -58.07 3.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.275 1.43 . . . . 0.0 113.386 172.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -79.88 -23.31 41.95 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.68 1.127 . . . . 0.0 113.6 -170.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.93 131.35 50.61 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.328 0.651 . . . . 0.0 111.252 -169.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.47 30.78 0.26 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.437 1.018 . . . . 0.0 111.373 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 m -61.95 -22.06 65.31 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.875 1.27 . . . . 0.0 113.6 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 p -73.58 -8.85 57.6 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.4 1.08 . . . . 0.0 112.511 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 87.69 3.56 80.56 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.292 0.948 . . . . 0.0 111.812 -170.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 25.3 m -144.21 177.67 8.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.034 2.133 . . . . 0.0 107.897 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.43 138.86 96.52 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 169.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -77.9 63.76 8.16 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 124.602 3.535 . . . . 0.0 109.617 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.16 -21.77 14.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.856 1.662 . . . . 0.0 114.989 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.8 m -55.65 -38.97 70.27 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.42 1.088 . . . . 0.0 111.019 172.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 133.77 -40.98 1.52 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 107.519 -2.232 . . . . 0.0 107.519 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.08 144.51 9.78 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 104.854 -3.298 . . . . 0.0 104.854 169.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.41 137.18 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.273 0.629 . . . . 0.0 111.316 -171.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.567 HM1A ' CG ' ' A' ' 88' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.459 ' HE2' ' C ' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -161.61 97.95 1.25 Allowed Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 120.522 -1.361 . . . . 0.0 108.999 -172.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -119.12 -18.43 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.509 2.139 . . . . 0.0 113.82 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -68.82 -10.8 58.85 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 -168.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -156.12 150.58 25.75 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.027 0.931 . . . . 0.0 108.493 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -60.95 -47.14 87.81 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.493 0.717 . . . . 0.0 111.304 -176.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 . . . . . 0 C--O 1.249 1.034 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.543 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.3 m -62.56 141.98 17.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.296 0.638 . . . . 0.0 110.406 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -164.87 -39.04 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.28 1.432 . . . . 0.0 109.788 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.2 tp -52.62 -27.21 16.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.513 2.325 . . . . 0.0 113.124 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -50.8 -38.38 48.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.739 1.216 . . . . 0.0 111.197 174.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -65.09 -24.96 67.59 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.391 1.876 . . . . 0.0 113.063 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -97.57 161.34 13.82 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.362 1.065 . . . . 0.0 109.327 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.25 73.91 0.01 OUTLIER 'General case' 0 C--O 1.234 0.251 0 C-N-CA 128.935 2.894 . . . . 0.0 110.46 171.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 131.08 44.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -176.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.409 HD22 HG12 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -61.05 -4.75 1.15 Allowed 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -169.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -154.42 32.61 0.7 Allowed Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 170.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.48 -157.21 12.15 Favored Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 168.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.06 156.02 21.09 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.621 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -128.77 160.73 39.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 169.236 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.538 HD22 ' CE ' ' A' ' 22' ' ' MET . 42.7 mt -139.45 131.37 27.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 -173.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -126.21 136.81 53.27 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 -170.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -115.9 117.24 29.63 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.661 0.785 . . . . 0.0 109.19 -168.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -95.53 -21.39 18.31 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.524 0.729 . . . . 0.0 111.854 -169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.15 -73.52 0.32 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -67.63 -30.58 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.358 2.038 . . . . 0.0 112.014 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.52 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.44 178.54 10.11 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 125.254 1.422 . . . . 0.0 109.51 -170.004 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.538 ' CE ' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -133.94 154.16 51.28 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.522 2.329 . . . . 0.0 106.776 -173.347 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -137.71 152.05 48.84 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.257 1.023 . . . . 0.0 108.645 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -74.68 149.03 40.09 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 123.493 0.717 . . . . 0.0 110.604 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.37 160.48 40.18 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.081 1.352 . . . . 0.0 109.113 -176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -149.03 99.76 2.99 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.398 -0.814 . . . . 0.0 109.815 -169.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.621 HD11 HG11 ' A' ' 14' ' ' VAL . 60.3 mt -58.69 152.66 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.669 1.987 . . . . 0.0 110.647 -176.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 pp -156.72 -35.45 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.736 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 37.4 ttpt -126.0 140.1 52.88 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.09 166.66 19.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -168.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.501 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 3.7 t-105 -150.47 150.89 31.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.791 -1.095 . . . . 0.0 112.277 -168.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -147.55 142.12 16.43 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 127.531 2.332 . . . . 0.0 108.82 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.69 -8.75 24.41 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.437 2.758 . . . . 0.0 113.51 177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 56.0 m -65.66 -34.64 78.69 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 120.452 1.478 . . . . 0.0 111.248 -171.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.0 p -117.72 -18.67 9.57 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.521 1.528 . . . . 0.0 110.718 173.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 mtmm 51.33 52.14 15.43 Favored 'General case' 0 C--N 1.346 0.439 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -169.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 85.6 mtp -144.72 157.02 44.36 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.994 2.518 . . . . 0.0 105.093 178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.451 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -107.47 168.95 8.88 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.629 0.372 . . . . 0.0 111.474 -176.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.9 p -141.57 155.0 45.79 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.41 1.884 . . . . 0.0 106.647 175.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.465 ' HB3' HD12 ' A' ' 56' ' ' ILE . 32.5 t -149.95 164.23 35.99 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -176.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.409 HG12 HD22 ' A' ' 10' ' ' LEU . 6.9 pt -146.58 159.65 43.78 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.792 1.237 . . . . 0.0 109.657 -177.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.01 89.47 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 124.645 3.563 . . . . 0.0 110.575 178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -130.51 -9.54 4.1 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.279 1.032 . . . . 0.0 112.692 179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -164.45 -173.46 3.08 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.465 0.706 . . . . 0.0 109.73 -173.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 92.46 11.1 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 126.243 1.817 . . . . 0.0 107.746 171.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -48.5 164.82 0.19 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.317 2.678 . . . . 0.0 113.867 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.73 -12.48 6.75 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.308 1.432 . . . . 0.0 116.067 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -129.99 22.6 4.79 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.006 1.289 . . . . 0.0 112.732 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.4 m -135.88 141.74 44.64 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 118.57 1.185 . . . . 0.0 110.238 -173.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.6 m -69.77 -40.72 75.88 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.413 0.685 . . . . 0.0 110.531 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -167.25 158.44 11.91 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.161 2.185 . . . . 0.0 107.794 169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.41 140.12 51.98 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 166.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.3 m -122.59 105.81 10.43 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.501 1.046 . . . . 0.0 111.315 -168.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 54.09 -170.11 0.06 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 127.771 2.428 . . . . 0.0 111.81 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -65.82 107.37 1.79 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.1 mt -73.66 129.24 36.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 -173.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -67.04 139.61 95.51 Favored Pre-proline 0 C--O 1.237 0.421 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -76.05 142.11 24.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.861 1.707 . . . . 0.0 108.983 -169.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -130.38 164.19 25.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.582 0.753 . . . . 0.0 109.545 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.596 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -61.63 -16.57 49.67 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 117.52 2.415 . . . . 0.0 117.52 -168.386 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' CD1' ' CZ2' ' A' ' 91' ' ' TRP . 0.5 OUTLIER 70.91 136.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 127.597 2.359 . . . . 0.0 112.28 -171.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 134.11 7.35 2.29 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-O 118.564 -1.131 . . . . 0.0 114.949 169.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -77.16 -34.47 56.41 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.894 1.847 . . . . 0.0 111.211 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -154.74 -40.09 0.09 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.407 1.483 . . . . 0.0 109.593 174.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -66.96 137.09 56.27 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 168.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.6 m -140.46 157.38 45.6 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.469 HG23 HG12 ' A' ' 72' ' ' ILE 0.318 2.6 tt -149.82 136.55 10.9 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 -169.102 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.43 151.96 54.19 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.727 1.618 . . . . 0.0 111.346 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -56.4 -17.11 6.98 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.044 1.338 . . . . 0.0 112.832 173.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -67.18 -24.99 65.92 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.843 1.257 . . . . 0.0 111.968 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.2 pt -124.38 -12.64 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 119.35 0.977 . . . . 0.0 111.177 -171.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.501 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 1.8 mm -52.65 -44.36 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 128.097 2.559 . . . . 0.0 108.576 169.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -81.17 9.47 6.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.881 1.272 . . . . 0.0 112.82 -170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.67 -173.07 26.59 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -171.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -60.79 134.91 57.55 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 122.285 -0.538 . . . . 0.0 110.608 176.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 m -137.47 154.13 49.95 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.781 0.676 . . . . 0.0 111.278 169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -139.12 114.68 9.85 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.435 1.094 . . . . 0.0 109.836 -170.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -81.23 127.09 32.31 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 106.271 169.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 pt -138.48 154.07 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 113.776 -1.556 . . . . 0.0 112.101 -168.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -99.72 119.61 38.4 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.802 -2.666 . . . . 0.0 103.802 167.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -73.0 117.68 15.02 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -86.14 150.65 24.26 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.74 6.37 63.0 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 119.082 -0.843 . . . . 0.0 111.2 -169.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.476 ' CE2' ' HEA' ' A' ' 128' ' ' M2L . 85.2 m95 -132.84 174.03 10.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.252 1.421 . . . . 0.0 109.874 177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -67.68 174.11 3.79 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.45 1.1 . . . . 0.0 111.708 -177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 17.1 m -85.09 -6.35 59.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.237 0.615 . . . . 0.0 112.033 169.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -57.36 -31.27 65.59 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.396 -0.815 . . . . 0.0 110.979 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -89.59 20.1 4.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.616 1.166 . . . . 0.0 112.726 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.49 99.77 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 169.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -151.3 167.51 27.65 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.972 2.109 . . . . 0.0 108.111 -167.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.419 ' CZ2' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -104.23 155.26 18.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.369 0.986 . . . . 0.0 112.168 169.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.85 157.59 43.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.932 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -92.29 160.63 25.95 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 124.732 1.158 . . . . 0.0 110.346 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.1 OUTLIER -71.02 9.79 0.65 Allowed 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -179.549 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -91.92 -12.71 32.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.709 1.603 . . . . 0.0 111.223 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -125.92 -37.09 2.31 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.561 1.145 . . . . 0.0 111.3 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 14' ' ' VAL . 6.8 tt -97.35 154.46 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.412 1.005 . . . . 0.0 110.671 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 98.2 mtt180 -145.65 158.26 43.87 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.192 2.197 . . . . 0.0 109.437 169.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.88 161.41 30.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 120.247 1.385 . . . . 0.0 111.511 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.455 ' CE2' HD11 ' A' ' 105' ' ' ILE . 27.6 t80 -69.47 115.77 9.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 171.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -159.9 162.05 34.46 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.466 1.506 . . . . 0.0 108.43 172.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.0 -35.71 47.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.833 1.653 . . . . 0.0 114.364 -169.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -63.53 -44.44 94.24 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 122.554 1.168 . . . . 0.0 109.984 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -76.31 -23.91 54.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.278 -178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.7 mm -68.55 -36.17 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-N 118.781 0.719 . . . . 0.0 109.793 169.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.1 96.36 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 119.451 1.023 . . . . 0.0 110.402 175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.52 -48.2 79.91 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 170.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -63.08 -49.53 74.14 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.329 -174.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.6 pttt -75.03 -33.19 61.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 120.033 1.288 . . . . 0.0 109.854 -171.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -54.62 -53.57 52.99 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 169.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.13 -42.18 69.53 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.802 0.728 . . . . 0.0 111.628 -172.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.7 -15.54 0.74 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.434 1.494 . . . . 0.0 112.557 169.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -107.44 -50.36 3.09 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.82 1.248 . . . . 0.0 112.349 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -75.44 -23.94 56.98 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.472 1.033 . . . . 0.0 111.871 -175.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -136.83 1.92 2.57 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -168.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -79.19 35.61 1.95 Allowed Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.45 1.024 . . . . 0.0 112.743 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.1 m -62.85 -27.09 69.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.487 1.515 . . . . 0.0 113.925 -169.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.7 m -147.71 137.95 22.98 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.95 -169.4 42.12 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.1 m -129.63 11.85 5.78 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.117 0.967 . . . . 0.0 112.606 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.58 150.18 21.39 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 125.748 1.619 . . . . 0.0 107.838 171.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.94 10.56 1.06 Allowed 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.573 2.849 . . . . 0.0 114.268 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.98 6.21 2.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.105 1.762 . . . . 0.0 112.119 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 16.8 m -142.07 87.67 2.05 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -89.76 58.32 3.7 Favored Glycine 0 C--O 1.223 -0.575 0 N-CA-C 107.55 -2.22 . . . . 0.0 107.55 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.62 87.49 0.05 OUTLIER Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.152 0.882 . . . . 0.0 114.191 -169.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.9 m -92.79 -2.16 10.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.584 1.153 . . . . 0.0 112.831 173.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.699 HM2B ' SG ' ' A' ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -152.95 106.38 2.66 Favored Pre-proline 0 C--N 1.322 -0.598 0 O-C-N 119.897 -1.752 . . . . 0.0 110.426 -166.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -78.41 -25.23 7.06 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.44 2.094 . . . . 0.0 111.404 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.78 171.49 19.94 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 128.522 2.729 . . . . 0.0 105.582 -175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 62.81 13.86 6.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.282 1.833 . . . . 0.0 113.604 -177.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -66.88 -18.29 65.31 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.48 -0.762 . . . . 0.0 110.956 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 49.3 tpt85 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 127.376 2.27 . . . . 0.0 106.14 173.185 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.14 166.35 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.153 1.381 . . . . 0.0 109.049 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -150.77 165.86 32.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.012 1.725 . . . . 0.0 107.088 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 47.9 tp 65.03 -28.04 0.1 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 128.05 2.54 . . . . 0.0 114.36 -175.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -54.36 -36.03 63.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.746 1.218 . . . . 0.0 111.432 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -53.63 -36.09 61.65 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.703 2.001 . . . . 0.0 113.137 177.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -82.54 144.32 30.46 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -56.92 126.35 26.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 168.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.02 135.68 53.52 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 -170.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.37 -2.91 0.35 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 116.266 1.951 . . . . 0.0 116.266 -168.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.08 0.28 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 169.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.71 -175.16 50.65 Favored Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 106.212 -2.755 . . . . 0.0 106.212 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.443 ' HG2' HE22 ' A' ' 82' ' ' GLN . 54.1 mtt180 -87.99 156.65 19.21 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -132.22 165.9 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 N-CA-C 102.748 -3.056 . . . . 0.0 102.748 168.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.412 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.5 mm? -133.03 144.37 50.01 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 103.145 -2.909 . . . . 0.0 103.145 177.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.92 125.7 23.98 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -99.44 115.73 29.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -87.7 -25.4 23.49 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 122.958 0.503 . . . . 0.0 111.15 -172.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 149.74 -69.78 0.32 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -66.71 -41.41 11.0 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.39 2.06 . . . . 0.0 112.817 170.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 19.9 tp -148.27 179.8 7.51 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.005 1.722 . . . . 0.0 107.881 -169.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.412 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.9 OUTLIER -141.5 151.29 43.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.071 1.748 . . . . 0.0 109.178 -167.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -134.06 157.26 46.57 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.611 1.164 . . . . 0.0 108.594 -175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.28 150.21 30.07 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.75 155.2 46.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 122.895 0.478 . . . . 0.0 110.805 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -144.11 94.37 2.57 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.866 0.866 . . . . 0.0 111.397 -169.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.571 HD11 HG11 ' A' ' 14' ' ' VAL . 42.7 mt -61.94 152.09 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 127.565 2.346 . . . . 0.0 112.492 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.35 -24.8 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.776 166.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' N ' HD22 ' A' ' 28' ' ' LEU . 38.5 ttpt -127.58 139.3 52.85 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.7 pt -140.82 163.29 22.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -168.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -147.98 152.54 37.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.634 -168.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.05 139.37 14.53 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 126.62 1.968 . . . . 0.0 109.122 -171.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.19 -0.77 8.56 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.24 3.293 . . . . 0.0 113.348 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.9 m -67.55 -33.19 74.55 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.225 1.375 . . . . 0.0 110.956 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 p -129.48 -10.42 4.57 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.13 1.372 . . . . 0.0 111.618 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? 50.1 53.14 13.35 Favored 'General case' 0 C--N 1.346 0.443 0 CA-C-O 122.098 0.951 . . . . 0.0 109.632 -169.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 63.4 mtp -145.61 156.21 43.52 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.803 2.041 . . . . 0.0 106.51 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -108.88 171.43 7.43 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 p -139.49 156.71 46.76 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.63 1.972 . . . . 0.0 107.259 172.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.469 ' HB3' HD12 ' A' ' 56' ' ' ILE . 43.4 t -150.76 163.48 38.48 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.5 pt -149.88 157.87 37.62 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.746 1.618 . . . . 0.0 108.841 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 54.6 Cg_endo -78.36 56.12 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.81 3.673 . . . . 0.0 111.95 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -57.4 -57.67 11.62 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -165.22 158.99 16.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.288 1.835 . . . . 0.0 106.306 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -60.48 149.74 76.51 Favored Pre-proline 0 C--O 1.24 0.566 0 C-N-CA 123.526 0.73 . . . . 0.0 111.311 172.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -65.02 170.64 10.06 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 N-CA-C 107.494 -1.771 . . . . 0.0 107.494 166.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.97 99.81 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 120.753 -1.217 . . . . 0.0 110.188 169.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -99.59 15.29 60.01 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 117.891 -1.505 . . . . 0.0 116.319 -169.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.2 m -142.54 159.82 41.49 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.317 2.058 . . . . 0.0 109.862 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 m -65.22 -53.99 36.24 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.025 0.93 . . . . 0.0 112.081 -170.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -169.75 159.51 8.13 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.475 1.51 . . . . 0.0 108.761 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -79.45 157.49 27.5 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 167.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 p -131.21 89.33 2.71 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.135 -0.978 . . . . 0.0 111.275 -169.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt 50.9 -163.09 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.258 1.823 . . . . 0.0 110.652 -173.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -63.56 116.11 5.32 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 172.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.2 mt -81.83 135.52 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 113.478 -1.692 . . . . 0.0 106.843 -173.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -67.2 136.45 93.84 Favored Pre-proline 0 C--O 1.237 0.433 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.86 145.94 36.99 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.962 1.775 . . . . 0.0 109.568 -172.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -139.67 156.34 46.88 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.102 0.961 . . . . 0.0 109.778 -176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -62.43 -10.53 11.82 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -173.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.433 HD12 ' CZ2' ' A' ' 91' ' ' TRP 0.252 9.3 tt 71.76 151.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 114.3 -177.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 120.64 4.22 10.79 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 114.779 -1.1 . . . . 0.0 114.283 169.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.61 -22.04 60.13 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.832 1.316 . . . . 0.0 111.359 -177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -156.57 -35.11 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.797 1.239 . . . . 0.0 111.059 174.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.578 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 20.6 mp0 -66.69 165.44 14.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 174.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.4 m -147.09 141.1 25.96 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.668 1.987 . . . . 0.0 106.115 169.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.499 HG22 HD11 ' A' ' 71' ' ' ILE . 9.0 pt -136.75 125.44 15.16 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 169.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.14 156.88 22.93 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.118 1.879 . . . . 0.0 110.676 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -55.59 -15.35 2.81 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.242 1.017 . . . . 0.0 112.493 171.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -66.69 -31.33 71.93 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.385 1.474 . . . . 0.0 112.343 176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' ILE . 18.3 pt -119.31 -11.76 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 120.209 1.368 . . . . 0.0 110.757 -173.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mm -53.38 -45.88 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 127.909 2.483 . . . . 0.0 108.548 169.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -81.45 9.49 7.28 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.771 0.828 . . . . 0.0 111.732 -170.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.21 -178.41 26.87 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 119.881 1.219 . . . . 0.0 110.814 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -60.42 131.81 51.92 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 174.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.1 m -132.09 150.4 52.16 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 123.926 0.766 . . . . 0.0 110.601 173.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -135.14 112.64 10.67 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.0 1.32 . . . . 0.0 109.276 -171.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -79.55 125.0 29.03 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 126.243 1.817 . . . . 0.0 107.348 169.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.55 156.01 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 113.411 -1.722 . . . . 0.0 111.935 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -102.01 122.63 44.44 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 166.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -71.74 111.18 6.81 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 172.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.443 HE22 ' HG2' ' A' ' 13' ' ' ARG . 47.9 mt-30 -76.62 148.29 37.03 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 -177.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.41 64.05 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.928 -0.929 . . . . 0.0 113.163 -170.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.556 ' CE2' ' HEA' ' A' ' 128' ' ' M2L . 54.7 m95 -131.98 169.14 16.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.828 1.314 . . . . 0.0 110.513 176.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -65.84 171.33 4.45 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.543 1.537 . . . . 0.0 112.508 -169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.8 m -69.94 -17.15 63.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.532 1.133 . . . . 0.0 111.739 169.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.3 m -62.35 -28.82 70.03 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.686 0.794 . . . . 0.0 111.865 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -97.44 21.15 10.54 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -68.06 104.83 1.86 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -148.74 168.08 23.85 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.28 1.832 . . . . 0.0 107.866 -167.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.578 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -107.16 152.95 23.38 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 122.3 1.048 . . . . 0.0 110.402 168.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.46 161.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 113.352 -1.749 . . . . 0.0 109.773 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.53 170.67 22.38 Favored Glycine 0 C--O 1.242 0.602 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.384 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -15.27 11.16 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.225 1.41 . . . . 0.0 113.648 177.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -57.33 -23.98 52.2 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.125 1.37 . . . . 0.0 112.516 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.18 -38.76 2.28 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-O 117.52 -1.229 . . . . 0.0 112.027 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.58 HD11 HG21 ' A' ' 14' ' ' VAL . 8.2 tt -89.41 156.49 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-N 119.41 1.004 . . . . 0.0 113.441 -169.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -153.82 157.52 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 129.615 3.166 . . . . 0.0 108.594 170.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -72.7 168.88 17.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.562 1.528 . . . . 0.0 111.827 -178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.515 ' CE2' HD11 ' A' ' 105' ' ' ILE . 21.8 t80 -62.33 127.62 32.18 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 120.725 -1.234 . . . . 0.0 109.971 169.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -156.36 153.4 28.9 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 126.522 1.929 . . . . 0.0 107.866 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.82 -30.23 63.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.384 0.673 . . . . 0.0 111.184 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -65.51 -42.12 92.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.905 0.859 . . . . 0.0 110.34 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -76.63 -23.94 53.35 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.083 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.515 HD11 ' CE2' ' A' ' 100' ' ' TYR . 3.2 mm -72.51 -35.57 51.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-N 118.552 0.615 . . . . 0.0 109.654 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.96 -43.74 97.97 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.436 1.016 . . . . 0.0 109.899 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.31 -51.39 69.57 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 170.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -59.57 -43.32 93.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.733 -173.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 21.9 ttpt -74.77 -39.92 61.49 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 124.029 0.932 . . . . 0.0 110.894 -174.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -52.51 -46.33 66.62 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 118.818 0.735 . . . . 0.0 110.368 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.0 mt -80.6 -42.01 22.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 119.506 -0.283 . . . . 0.0 111.447 -171.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.28 -32.12 47.08 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.246 1.418 . . . . 0.0 110.921 170.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -76.5 -50.7 13.33 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.126 0.97 . . . . 0.0 112.293 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -66.45 -33.51 75.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 118.432 0.56 . . . . 0.0 111.655 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -141.48 98.18 3.3 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 122.734 1.254 . . . . 0.0 110.014 -168.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -177.99 50.14 0.1 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 113.672 -1.603 . . . . 0.0 110.935 -174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.7 m -133.53 24.74 4.08 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.66 1.184 . . . . 0.0 111.179 -169.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.0 p -58.97 159.52 7.01 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.324 1.45 . . . . 0.0 112.372 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -174.12 -172.06 39.03 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 125.291 1.424 . . . . 0.0 109.673 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.1 m -74.49 16.89 0.23 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.115 1.366 . . . . 0.0 114.123 -175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.15 157.69 37.15 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 126.121 1.768 . . . . 0.0 108.639 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -43.98 106.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 1 C-N-CA 126.019 4.479 . . . . 0.0 112.762 172.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -150.2 163.45 38.23 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.207 1.803 . . . . 0.0 109.303 176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.5 m 65.3 -51.6 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.848 2.459 . . . . 0.0 113.566 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 76.32 -40.47 1.51 Allowed Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.326 1.441 . . . . 0.0 113.348 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.31 46.84 2.25 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 126.138 1.828 . . . . 0.0 112.667 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 82.0 t -134.52 129.63 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -169.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.556 ' HEA' ' CE2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -158.64 122.62 2.13 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 126.157 1.783 . . . . 0.0 108.593 -168.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -73.42 -20.02 21.34 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 N-CA-C 108.488 -1.389 . . . . 0.0 108.488 168.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -51.45 -32.49 27.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.254 1.822 . . . . 0.0 112.52 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.0 mtt180 -81.56 -8.09 59.67 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.294 -0.879 . . . . 0.0 112.993 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -63.86 155.03 31.85 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.696 1.135 . . . . 0.0 110.547 -177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 125.439 1.495 . . . . 0.0 106.968 -179.837 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 tpp . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.55 158.29 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 118.885 0.766 . . . . 0.0 109.721 169.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -146.85 -27.89 0.39 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.625 0.77 . . . . 0.0 112.719 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 61.1 tp -132.58 -26.22 1.84 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.277 1.031 . . . . 0.0 111.562 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -58.13 -39.09 77.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.94 1.696 . . . . 0.0 111.21 -173.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -68.18 -18.26 64.55 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.262 1.825 . . . . 0.0 113.497 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.33 157.87 15.92 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.036 0.834 . . . . 0.0 109.775 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -62.63 66.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 130.906 3.682 . . . . 0.0 110.154 175.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.74 139.26 57.81 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 127.098 2.159 . . . . 0.0 106.587 -169.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -6.26 1.66 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 -169.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.11 28.63 0.52 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 171.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.64 -176.6 49.35 Favored Glycine 0 N--CA 1.436 -1.354 0 N-CA-C 106.223 -2.751 . . . . 0.0 106.223 168.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.42 ' HG2' HE22 ' A' ' 82' ' ' GLN . 39.6 mtt85 -87.33 151.07 23.41 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 103.347 -2.835 . . . . 0.0 103.347 168.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.921 HG11 HD11 ' A' ' 97' ' ' ILE . 2.9 p -132.8 165.8 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 169.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -139.84 128.36 22.92 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 -169.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.36 124.36 42.2 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.722 1.264 . . . . 0.0 109.641 -170.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -98.6 125.23 43.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.26 1.824 . . . . 0.0 107.383 -170.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -105.06 -17.88 14.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.762 0.825 . . . . 0.0 111.261 -175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.41 -75.17 0.29 Allowed Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.4 -25.11 21.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.331 2.021 . . . . 0.0 113.104 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -152.85 175.93 12.37 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 125.036 1.334 . . . . 0.0 109.943 -171.801 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.515 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -143.76 146.44 33.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 127.35 2.26 . . . . 0.0 106.796 -169.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -132.82 151.6 51.98 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -171.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.2 139.05 57.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' HB3' HG13 ' A' ' 14' ' ' VAL . . . -136.23 157.79 45.98 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.758 2.023 . . . . 0.0 107.598 -176.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.76 95.26 2.39 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 121.231 -0.918 . . . . 0.0 110.404 -169.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 67.0 mt -56.62 148.01 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 128.037 2.535 . . . . 0.0 112.325 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.572 HD22 ' HG2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -161.13 -31.07 0.05 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 116.707 -1.616 . . . . 0.0 111.914 166.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.572 ' HG2' HD22 ' A' ' 28' ' ' LEU . 17.5 mtmt -111.08 149.61 30.55 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 168.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 pt -145.98 161.82 11.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -149.28 153.43 37.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.499 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.45 143.77 17.79 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 109.513 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -67.99 -11.72 32.94 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.291 2.66 . . . . 0.0 113.526 176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.6 m -63.99 -33.02 74.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.834 1.197 . . . . 0.0 112.046 -170.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -122.0 -10.62 8.6 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.464 1.506 . . . . 0.0 111.243 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.3 mtmt 47.29 50.46 14.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.68 1.192 . . . . 0.0 109.533 -169.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.8 mtp -146.32 152.59 39.38 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.744 2.018 . . . . 0.0 105.896 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -101.29 173.66 6.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.114 0.566 . . . . 0.0 112.375 -176.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -138.6 161.23 37.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.717 2.007 . . . . 0.0 107.158 170.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 56' ' ' ILE . 31.4 t -154.97 162.17 41.17 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -176.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.5 pt -146.32 155.65 50.06 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.647 1.579 . . . . 0.0 109.765 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 92.5 Cg_endo -75.87 83.93 1.87 Allowed 'Trans proline' 0 CA--C 1.536 0.589 1 C-N-CA 125.482 4.121 . . . . 0.0 111.206 -174.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -141.96 13.51 2.06 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -171.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -149.36 -28.23 0.27 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 -178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 40.84 66.35 3.59 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.904 1.281 . . . . 0.0 112.735 -172.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.18 164.23 10.8 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 123.059 2.506 . . . . 0.0 111.94 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -53.55 -28.34 36.78 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.233 0.921 . . . . 0.0 114.774 -173.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.38 -5.41 65.35 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.489 -1.173 . . . . 0.0 114.066 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 m -145.8 105.97 4.04 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.358 1.579 . . . . 0.0 109.465 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -50.97 -31.87 19.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.33 1.452 . . . . 0.0 112.657 178.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -167.29 141.19 3.66 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.409 0.684 . . . . 0.0 109.542 168.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.592 ' HB1' HD11 ' A' ' 56' ' ' ILE . . . -68.67 168.46 13.11 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 166.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.8 p -124.96 85.84 2.47 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 120.854 -1.154 . . . . 0.0 112.011 -168.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt 49.67 -156.4 0.09 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.381 1.872 . . . . 0.0 110.653 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.75 103.18 0.14 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.592 HD11 ' HB1' ' A' ' 52' ' ' ALA . 3.6 mt -71.16 135.82 27.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 106.109 -1.812 . . . . 0.0 106.109 -175.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.12 136.09 93.94 Favored Pre-proline 0 C--O 1.237 0.411 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.41 136.26 30.85 Favored 'Trans proline' 0 N--CA 1.44 -1.668 0 C-N-CA 122.041 1.827 . . . . 0.0 107.706 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -140.36 162.41 35.38 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -170.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.491 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 6.2 mmpt? -63.86 152.41 39.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.9 tt -109.55 150.67 27.83 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.442 1.897 . . . . 0.0 110.527 -169.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.57 19.95 5.58 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.545 -0.752 . . . . 0.0 114.3 169.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.56 -31.63 36.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.591 1.195 . . . . 0.0 109.857 174.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -150.35 17.75 0.83 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.013 1.325 . . . . 0.0 110.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.2 mp0 -131.23 163.57 27.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.982 -172.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 m -149.2 140.56 23.23 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.723 1.209 . . . . 0.0 108.535 169.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.477 HG22 HD11 ' A' ' 71' ' ' ILE . 10.7 pt -135.91 122.55 14.26 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.99 154.51 17.35 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.245 1.963 . . . . 0.0 110.959 169.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -53.39 -22.11 7.01 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.81 0.844 . . . . 0.0 111.414 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -63.9 -27.99 69.53 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.933 1.693 . . . . 0.0 114.003 176.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.477 HD11 HG22 ' A' ' 67' ' ' ILE . 18.4 pt -119.54 -12.6 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 120.508 1.503 . . . . 0.0 110.667 -176.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mm -54.17 -45.71 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 128.141 2.576 . . . . 0.0 108.963 169.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -81.35 10.31 5.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.548 0.739 . . . . 0.0 112.12 -169.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.15 23.66 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -173.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -61.2 137.63 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.6 m -136.48 151.36 49.37 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.268 0.98 . . . . 0.0 110.378 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -139.17 113.88 9.19 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.828 1.251 . . . . 0.0 109.408 -172.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.474 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 43.8 t80 -80.11 128.7 33.81 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.382 1.473 . . . . 0.0 107.091 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 pt -139.56 152.25 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 124.882 1.273 . . . . 0.0 112.563 -168.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -97.8 125.24 42.54 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.414 ' CD2' ' HM2' ' A' ' 128' ' ' M2L . 36.5 m-85 -75.27 115.5 14.98 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 171.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.42 HE22 ' HG2' ' A' ' 13' ' ' ARG . 56.6 mt-30 -79.73 151.9 30.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 110.023 -172.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.39 6.51 34.5 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 118.837 -0.98 . . . . 0.0 111.859 -170.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.585 ' CD1' HM2B ' A' ' 128' ' ' M2L . 57.5 m95 -133.7 173.31 11.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.712 1.256 . . . . 0.0 112.069 -173.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -68.69 163.09 24.68 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.522 1.129 . . . . 0.0 112.466 -169.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -67.7 -19.38 65.15 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.154 0.982 . . . . 0.0 111.386 170.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.5 m -57.16 -31.04 64.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.156 -0.965 . . . . 0.0 111.915 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -87.92 9.29 22.63 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 117.879 -1.058 . . . . 0.0 112.912 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.78 99.64 0.34 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -152.15 166.1 32.74 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.481 1.912 . . . . 0.0 107.94 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.401 ' CD1' HG23 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -104.41 151.78 23.09 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.892 0.853 . . . . 0.0 110.671 169.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.48 HG23 HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -132.56 163.09 38.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 113.855 -1.52 . . . . 0.0 109.564 173.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.39 174.22 20.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 124.959 1.266 . . . . 0.0 110.043 169.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -15.38 33.4 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 113.948 -176.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -58.07 -24.38 58.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.312 1.045 . . . . 0.0 112.617 170.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -124.55 -36.92 2.56 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 117.807 -1.092 . . . . 0.0 112.027 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.921 HD11 HG11 ' A' ' 14' ' ' VAL . 6.4 tt -97.37 152.36 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 119.611 1.096 . . . . 0.0 112.752 -168.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -155.14 150.15 26.81 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 127.449 2.3 . . . . 0.0 111.408 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.56 158.81 34.14 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 120.016 1.28 . . . . 0.0 112.852 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.484 ' CE1' HD11 ' A' ' 105' ' ' ILE . 4.3 t80 -70.52 107.33 3.81 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.765 0.793 . . . . 0.0 110.581 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -157.25 160.5 38.69 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.254 1.422 . . . . 0.0 109.343 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -52.75 -35.96 57.02 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.454 1.502 . . . . 0.0 114.806 -168.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.21 -44.71 95.96 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 122.792 1.282 . . . . 0.0 109.808 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -77.13 -20.78 55.16 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.028 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.484 HD11 ' CE1' ' A' ' 100' ' ' TYR . 6.1 mm -73.23 -32.91 39.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.211 0 CA-C-N 119.117 0.871 . . . . 0.0 110.385 169.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.51 -41.2 96.95 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.395 0.998 . . . . 0.0 108.945 171.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.3 -50.23 74.78 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 169.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -55.48 -48.97 73.72 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 124.284 1.034 . . . . 0.0 109.916 -174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -75.82 -44.98 38.42 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.428 -172.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -57.58 -34.49 69.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.744 0.702 . . . . 0.0 110.179 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.7 mt -78.21 -50.4 11.98 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.36 -29.0 3.54 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.835 1.254 . . . . 0.0 112.275 173.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -74.15 -52.67 11.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.917 1.287 . . . . 0.0 113.539 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -86.25 -14.62 43.25 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 119.149 0.886 . . . . 0.0 113.377 -170.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.455 ' HB1' HD11 ' A' ' 21' ' ' LEU . . . -44.96 122.55 3.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.813 2.045 . . . . 0.0 114.363 -169.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.69 60.9 4.56 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.5 m -65.88 -3.62 5.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.134 1.774 . . . . 0.0 114.627 -174.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.22 139.11 36.88 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.216 1.006 . . . . 0.0 109.387 170.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -153.81 16.35 0.63 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-O 119.579 -0.567 . . . . 0.0 113.565 -170.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.4 p -144.86 15.33 1.56 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.782 1.233 . . . . 0.0 112.047 -171.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.74 167.66 13.22 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.947 2.099 . . . . 0.0 108.44 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.62 -9.26 3.66 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.911 3.074 . . . . 0.0 116.563 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.25 -2.21 23.95 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.241 1.817 . . . . 0.0 112.84 170.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 23.1 m -62.72 108.41 1.16 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.538 1.063 . . . . 0.0 108.233 173.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -159.98 28.13 0.35 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-O 118.995 -0.892 . . . . 0.0 112.866 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -158.18 7.43 0.18 Allowed Glycine 0 C--N 1.34 0.791 0 CA-C-O 117.062 -1.966 . . . . 0.0 115.561 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -155.42 149.32 11.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-N 121.782 2.791 . . . . 0.0 107.685 -169.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.585 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HA ' ' HE3' ' A' ' 129' ' ' LYS . 0.0 OUTLIER -159.92 108.74 1.43 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.951 2.1 . . . . 0.0 107.275 -168.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -84.58 -31.79 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.887 1.725 . . . . 0.0 111.832 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -57.1 -27.75 62.05 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.542 1.537 . . . . 0.0 113.179 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -74.22 -3.06 27.65 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.891 0.876 . . . . 0.0 112.638 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -128.72 28.38 5.38 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.4 1.88 . . . . 0.0 109.752 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.977 0 C-N-CA 126.209 1.804 . . . . 0.0 106.334 -176.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mpp? . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.9 m -65.16 151.37 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -151.92 -59.42 0.16 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.565 0.746 . . . . 0.0 109.055 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 64.4 tp -76.28 -39.95 52.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.317 0.508 . . . . 0.0 110.439 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -61.26 -32.32 72.13 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.533 0.733 . . . . 0.0 110.743 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -59.75 -34.55 73.11 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.045 1.738 . . . . 0.0 112.374 175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -86.92 151.7 23.08 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -57.11 122.62 12.82 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 103.672 -2.714 . . . . 0.0 103.672 168.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.06 55.77 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 102.481 -3.155 . . . . 0.0 102.481 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.02 -1.27 0.16 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -168.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.41 30.22 0.36 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 169.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.76 -174.58 49.9 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 169.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -86.76 151.69 23.16 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.56 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -130.33 163.43 35.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 168.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.433 ' HB3' ' SD ' ' A' ' 22' ' ' MET . 60.8 mt -139.91 130.4 25.55 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 102.675 -3.083 . . . . 0.0 102.675 -173.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.55 129.56 50.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.276 0.985 . . . . 0.0 108.518 -172.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -102.96 118.03 35.92 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.425 -1.695 . . . . 0.0 106.425 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -99.6 -14.44 18.99 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -169.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.57 -78.9 0.23 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -71.24 -32.58 12.63 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.387 2.058 . . . . 0.0 113.128 176.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.77 -177.17 6.31 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.821 1.648 . . . . 0.0 109.454 -169.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.499 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 11.7 tmm? -128.37 145.24 51.13 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.84 2.056 . . . . 0.0 108.306 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -130.3 146.27 51.87 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.791 0.805 . . . . 0.0 109.727 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -73.87 148.32 42.44 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 125.286 1.434 . . . . 0.0 109.845 -170.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.0 157.96 45.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.809 0.844 . . . . 0.0 110.418 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.4 ttpt -148.48 95.74 2.49 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.275 1.03 . . . . 0.0 110.78 -172.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.56 HD11 HG11 ' A' ' 14' ' ' VAL . 46.2 mt -59.72 151.25 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 128.294 2.638 . . . . 0.0 112.158 -177.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 29' ' ' LYS 0.301 0.0 OUTLIER -159.71 -28.68 0.07 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 116.802 -1.571 . . . . 0.0 111.96 166.887 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.473 ' N ' HD22 ' A' ' 28' ' ' LEU . 17.0 mtmt -113.77 150.13 33.88 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 168.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.0 166.18 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 CA-C-O 122.049 0.928 . . . . 0.0 108.693 170.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -144.18 151.76 39.95 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.514 1.526 . . . . 0.0 109.525 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -148.11 142.88 16.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 125.807 1.643 . . . . 0.0 109.563 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.57 -11.37 31.92 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.158 2.572 . . . . 0.0 113.801 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.5 m -62.15 -31.84 72.37 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 120.322 1.419 . . . . 0.0 112.312 -171.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.7 p -129.89 0.51 4.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.252 1.421 . . . . 0.0 111.219 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt 44.21 53.78 6.45 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 125.615 1.566 . . . . 0.0 110.545 -174.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 ptm -155.26 165.24 37.27 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.022 1.329 . . . . 0.0 107.703 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -110.67 172.28 6.96 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.083 0.953 . . . . 0.0 112.048 -170.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.8 p -141.0 157.3 45.53 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.67 1.988 . . . . 0.0 106.379 173.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.42 ' HB3' HD12 ' A' ' 56' ' ' ILE . 28.7 t -150.85 159.06 44.8 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 pt -149.05 157.11 40.32 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.645 1.178 . . . . 0.0 109.58 -175.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.85 55.5 1.74 Allowed 'Trans proline' 0 CA--C 1.542 0.88 1 C-N-CA 125.673 4.248 . . . . 0.0 113.594 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -59.71 -53.59 56.21 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -161.9 -112.44 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -162.66 154.8 15.85 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 126.304 1.841 . . . . 0.0 108.592 -173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.33 170.59 10.55 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.346 2.03 . . . . 0.0 108.004 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.81 4.22 1.2 Allowed Glycine 0 CA--C 1.539 1.559 0 O-C-N 120.791 -1.193 . . . . 0.0 115.138 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.75 -147.1 10.74 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.851 1.691 . . . . 0.0 110.043 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 12.3 m -126.99 24.06 6.46 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 116.375 1.991 . . . . 0.0 116.375 -168.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -141.02 115.5 9.47 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -67.97 156.12 37.98 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.821 0.448 . . . . 0.0 111.296 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.98 131.4 45.4 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 103.271 -2.863 . . . . 0.0 103.271 166.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.5 m -81.49 -58.58 2.96 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -168.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -147.48 -163.75 1.84 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.501 2.32 . . . . 0.0 106.076 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.26 109.77 2.0 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.0 mt -76.12 131.62 34.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 -173.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -66.53 138.55 95.68 Favored Pre-proline 0 C--O 1.234 0.288 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.59 137.9 31.2 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.852 1.701 . . . . 0.0 107.931 -176.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -139.05 160.06 40.67 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 130.16 42.66 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 175.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.2 tt -75.79 156.51 34.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.352 1.461 . . . . 0.0 112.31 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.21 29.38 2.15 Favored Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.262 -0.743 . . . . 0.0 114.678 169.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -79.26 -41.08 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.648 1.224 . . . . 0.0 109.041 170.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -161.96 5.0 0.06 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.347 1.059 . . . . 0.0 113.41 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.72 48.8 2.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.902 1.281 . . . . 0.0 111.603 -168.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -33.09 142.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 129.631 3.172 . . . . 0.0 113.496 168.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 71' ' ' ILE . 8.1 pt -136.88 134.47 19.23 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 107.832 169.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.97 160.1 50.85 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.18 1.92 . . . . 0.0 110.311 173.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -55.01 -23.59 20.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.973 0.909 . . . . 0.0 111.829 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.76 -33.97 67.13 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.336 1.454 . . . . 0.0 113.196 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 67' ' ' ILE . 8.2 pt -120.01 -10.06 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 119.487 1.039 . . . . 0.0 110.733 -172.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -59.31 -49.39 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 C-N-CA 127.641 2.377 . . . . 0.0 106.661 168.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -77.71 9.42 3.46 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.521 1.528 . . . . 0.0 112.088 -171.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.17 -179.19 27.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.704 1.138 . . . . 0.0 110.881 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -59.31 137.21 58.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 m -136.46 150.65 48.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 124.281 0.988 . . . . 0.0 110.456 175.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.82 114.66 12.84 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.164 -172.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -79.97 124.98 29.18 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.22 1.408 . . . . 0.0 107.374 169.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 pt -137.83 154.06 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 112.433 -168.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -96.46 124.42 40.45 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 104.201 -2.518 . . . . 0.0 104.201 166.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.471 ' CD2' ' HM1' ' A' ' 128' ' ' M2L . 16.7 m-85 -74.03 106.93 5.94 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 170.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -71.99 149.68 44.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.44 3.87 41.99 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-O 118.261 -1.299 . . . . 0.0 113.104 -169.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.5 ' CE2' ' HEA' ' A' ' 128' ' ' M2L . 63.9 m95 -126.7 168.0 14.96 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.403 1.602 . . . . 0.0 111.418 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.1 mtmt -66.69 171.35 5.26 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.341 1.056 . . . . 0.0 112.232 -169.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 m -64.08 -21.86 66.7 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.633 1.173 . . . . 0.0 111.585 169.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.4 m -63.12 -25.43 68.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.789 0.835 . . . . 0.0 112.144 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 6.8 m95 -102.23 19.15 19.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.537 0.735 . . . . 0.0 112.695 -173.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -68.66 103.52 1.75 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -149.22 168.39 23.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.708 1.603 . . . . 0.0 108.382 -167.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -105.09 152.38 22.84 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 122.12 0.962 . . . . 0.0 111.241 168.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.51 158.99 43.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.14 1.376 . . . . 0.0 110.359 173.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.74 167.2 25.5 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 169.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -19.41 21.76 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.099 1.36 . . . . 0.0 113.733 176.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -56.88 -22.88 40.42 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.676 1.191 . . . . 0.0 112.918 170.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -121.49 -38.54 2.76 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 117.324 -1.322 . . . . 0.0 111.763 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.476 HD11 HG21 ' A' ' 14' ' ' VAL . 7.4 tt -99.62 154.38 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 120.654 1.57 . . . . 0.0 113.017 -169.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -150.34 156.99 42.56 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 128.895 2.878 . . . . 0.0 108.921 169.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.39 163.63 27.32 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.602 1.161 . . . . 0.0 112.431 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.93 112.25 9.86 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 120.85 -1.156 . . . . 0.0 109.293 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -157.41 162.25 39.0 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.979 1.311 . . . . 0.0 109.63 173.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -52.94 -36.03 59.34 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.899 1.68 . . . . 0.0 113.733 -169.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -62.7 -43.86 97.73 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 122.404 1.097 . . . . 0.0 110.541 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -77.67 -22.39 50.67 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.253 -0.879 . . . . 0.0 109.519 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.4 mm -70.77 -35.16 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-N 119.153 0.888 . . . . 0.0 109.926 169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.35 -42.45 99.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 119.238 0.926 . . . . 0.0 109.319 173.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -46.8 88.3 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 172.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -63.63 -43.43 96.85 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 118.163 -0.922 . . . . 0.0 109.749 -173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -72.01 -43.77 64.51 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.371 0.987 . . . . 0.0 109.677 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -32.16 48.68 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 118.144 -0.932 . . . . 0.0 111.454 171.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.85 -45.63 10.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.053 1.297 . . . . 0.0 113.29 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.23 -23.91 9.91 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.157 1.783 . . . . 0.0 111.962 171.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -70.09 -43.65 70.68 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.342 1.857 . . . . 0.0 113.072 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -66.99 -45.89 76.22 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.445 0.641 . . . . 0.0 109.586 -175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -164.4 175.75 9.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.308 -169.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -129.59 152.05 19.45 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.386 0.993 . . . . 0.0 110.822 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.6 m -64.04 -12.07 35.18 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.965 1.706 . . . . 0.0 113.548 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m -57.31 -26.72 61.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.189 1.796 . . . . 0.0 112.708 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.35 -42.59 2.78 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.088 0.852 . . . . 0.0 111.365 -177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.7 m -75.74 14.16 0.7 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.546 1.538 . . . . 0.0 112.873 170.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -66.05 168.66 8.63 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 125.209 1.404 . . . . 0.0 110.337 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.03 5.94 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 124.81 3.673 . . . . 0.0 117.328 171.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -141.54 116.42 9.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.858 2.063 . . . . 0.0 105.528 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.2 p -89.32 56.07 3.5 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.777 1.231 . . . . 0.0 110.553 -170.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.09 -179.2 48.54 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.46 1.505 . . . . 0.0 109.724 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.59 59.0 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 119.699 -0.5 . . . . 0.0 112.345 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 m -137.4 149.4 25.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.5 ' HEA' ' CE2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -161.41 128.62 2.63 Favored Pre-proline 0 N--CA 1.445 -0.7 0 C-N-CA 127.988 2.515 . . . . 0.0 105.165 -169.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -74.19 -17.33 21.87 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.298 1.998 . . . . 0.0 109.561 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 43.89 54.18 5.87 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 127.84 2.456 . . . . 0.0 113.429 170.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 69.31 0.53 2.91 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.93 1.692 . . . . 0.0 113.875 170.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -69.31 162.3 27.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.989 1.268 . . . . 0.0 109.731 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.049 1.74 . . . . 0.0 106.949 177.651 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p -152.86 154.01 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 124.717 1.207 . . . . 0.0 108.013 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -155.25 171.96 18.96 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.92 2.088 . . . . 0.0 105.803 171.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.5 mt 56.03 30.38 16.11 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.23 1.412 . . . . 0.0 111.155 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.47 -45.07 76.98 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.955 2.102 . . . . 0.0 106.896 172.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -143.94 112.59 6.57 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 100.642 -3.836 . . . . 0.0 100.642 168.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -65.31 165.87 10.96 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 112.759 -2.018 . . . . 0.0 108.698 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.439 ' HA ' ' HB2' ' A' ' 99' ' ' ALA . 0.1 OUTLIER -57.05 130.64 46.97 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -123.85 125.39 44.58 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 102.232 -3.247 . . . . 0.0 102.232 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.433 HD22 HG12 ' A' ' 41' ' ' ILE . 1.7 mt -56.57 -9.79 0.82 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -168.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.7 34.4 0.81 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 169.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.29 -153.03 7.33 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 105.853 -2.899 . . . . 0.0 105.853 168.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -113.47 155.97 24.37 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 104.242 -2.503 . . . . 0.0 104.242 168.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.553 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.22 155.78 41.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 103.979 -2.601 . . . . 0.0 103.979 169.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 14' ' ' VAL . 7.8 mt -127.74 153.48 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.02 126.91 31.21 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -173.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -90.57 118.29 29.91 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -95.25 -14.13 24.28 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.87 0.868 . . . . 0.0 111.624 -173.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.07 -75.67 0.35 Allowed Glycine 0 C--N 1.337 0.609 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 173.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.73 -28.63 13.66 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.557 2.171 . . . . 0.0 113.135 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.493 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.5 OUTLIER -155.01 -177.12 6.3 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.933 1.693 . . . . 0.0 108.196 -170.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.493 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -146.22 147.45 31.47 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.613 1.565 . . . . 0.0 108.302 -168.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.2 170.59 15.47 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.313 1.045 . . . . 0.0 110.372 -176.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.78 147.54 25.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 123.778 0.831 . . . . 0.0 109.203 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 165.91 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.759 1.624 . . . . 0.0 108.865 -174.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -153.51 108.52 3.17 Favored 'General case' 0 C--N 1.341 0.218 0 O-C-N 121.109 -0.994 . . . . 0.0 110.487 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 14' ' ' VAL . 74.3 mt -55.4 150.09 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 128.454 2.702 . . . . 0.0 110.922 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 pp -157.1 -31.08 0.08 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.773 169.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HE2' ' CG ' ' A' ' 78' ' ' PHE . 24.0 mtmt -119.96 146.93 45.37 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 168.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.51 165.47 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -144.75 150.6 37.53 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.987 -1.46 . . . . 0.0 109.612 -170.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -150.84 142.21 15.27 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.662 1.585 . . . . 0.0 109.242 -173.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.93 -2.87 11.7 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.411 2.74 . . . . 0.0 113.652 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.3 m -63.6 -36.67 84.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 120.579 1.536 . . . . 0.0 111.46 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.9 m -134.86 12.37 3.66 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.083 0.953 . . . . 0.0 112.022 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? 42.0 55.65 3.74 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.145 1.378 . . . . 0.0 111.795 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.5 ptm -155.89 164.33 38.64 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -107.58 169.6 8.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.412 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 p -136.15 156.17 49.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.755 2.022 . . . . 0.0 106.483 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.566 ' HB2' HD12 ' A' ' 56' ' ' ILE . 20.0 m -154.21 154.63 33.82 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -169.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.433 HG12 HD22 ' A' ' 10' ' ' LEU . 3.2 pt -148.2 160.84 36.16 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.889 0.876 . . . . 0.0 110.012 -174.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.73 101.57 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.563 2.842 . . . . 0.0 110.658 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -139.76 -4.13 1.42 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.003 0.921 . . . . 0.0 112.326 174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -160.46 -175.18 4.86 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.365 1.066 . . . . 0.0 109.519 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -138.9 62.67 28.17 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 127.334 2.254 . . . . 0.0 110.45 -177.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -49.73 -29.04 18.82 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.157 3.238 . . . . 0.0 116.15 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.58 -38.7 3.2 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-N 119.403 1.001 . . . . 0.0 111.748 178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -67.63 -18.09 69.69 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.823 0.725 . . . . 0.0 112.025 170.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.0 m -136.95 135.03 37.36 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 127.101 2.16 . . . . 0.0 105.518 172.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.1 m -57.78 -51.0 71.38 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.776 0.83 . . . . 0.0 111.392 -169.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -147.45 42.34 1.08 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 118.956 -0.545 . . . . 0.0 111.991 171.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 43.15 47.37 5.3 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.467 1.603 . . . . 0.0 110.164 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -42.25 103.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 130.29 3.436 . . . . 0.0 115.206 -167.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt 58.15 -174.84 0.08 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 128.209 2.604 . . . . 0.0 111.827 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -63.55 112.89 2.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 173.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.566 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.6 mt -79.83 137.04 22.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 -175.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.38 141.98 94.05 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -72.3 138.7 30.75 Favored 'Trans proline' 0 N--CA 1.439 -1.73 0 N-CA-C 107.231 -1.873 . . . . 0.0 107.231 -178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -137.57 159.9 40.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.779 0.8 . . . . 0.0 108.952 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.44 118.82 11.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.52 153.83 41.92 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.221 1.408 . . . . 0.0 112.48 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.46 31.23 1.55 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-O 118.968 -0.907 . . . . 0.0 115.243 168.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -80.57 -40.66 25.45 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.097 1.449 . . . . 0.0 109.374 169.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -160.15 -0.41 0.07 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.06 0.944 . . . . 0.0 113.516 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.69 46.41 2.09 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.552 1.541 . . . . 0.0 111.509 -169.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 m -31.75 139.07 0.04 OUTLIER 'General case' 0 C--O 1.237 0.44 0 C-N-CA 129.776 3.23 . . . . 0.0 113.28 168.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 71' ' ' ILE . 7.6 pt -134.76 126.66 18.06 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.15 156.41 20.63 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.732 2.288 . . . . 0.0 111.128 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -55.62 -18.48 7.86 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.08 1.352 . . . . 0.0 112.758 173.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -64.04 -30.81 71.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.923 1.289 . . . . 0.0 112.338 175.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.447 HD11 HG22 ' A' ' 67' ' ' ILE . 10.1 pt -121.03 -9.49 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.835 1.198 . . . . 0.0 110.789 -173.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 mm -60.19 -49.57 83.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 127.776 2.43 . . . . 0.0 106.305 168.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.85 8.94 3.94 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.411 1.484 . . . . 0.0 111.994 -171.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.96 -178.45 24.9 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 119.27 0.941 . . . . 0.0 111.315 -174.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -63.4 136.9 57.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.2 m -139.33 152.39 47.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.246 0.966 . . . . 0.0 110.89 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.434 ' CZ ' ' CD2' ' A' ' 8' ' ' PHE . 37.5 m-85 -140.81 113.21 8.0 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.293 -170.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CG ' ' HE2' ' A' ' 29' ' ' LYS . 54.4 t80 -79.15 128.99 33.99 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 169.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 pt -139.19 153.93 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 O-C-N 124.671 1.232 . . . . 0.0 112.28 -168.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -96.38 121.53 38.28 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 167.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -71.14 112.7 7.49 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 171.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.73 149.45 31.16 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.86 53.25 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.063 -0.854 . . . . 0.0 111.902 -169.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.426 ' CD1' HM2B ' A' ' 128' ' ' M2L . 89.5 m95 -132.13 172.59 12.2 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 118.619 1.21 . . . . 0.0 111.097 -177.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.3 mtmt -72.07 158.74 35.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.331 -175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.1 m -71.63 -13.09 61.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.636 0.374 . . . . 0.0 111.778 170.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 24.9 m -54.75 -34.86 63.11 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.456 1.102 . . . . 0.0 112.357 174.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 46.7 m95 -86.98 7.94 25.37 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 118.142 -0.933 . . . . 0.0 113.109 -175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.66 118.24 9.27 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.278 7.7 tp10 -155.73 168.41 27.26 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 126.199 1.8 . . . . 0.0 107.739 -167.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -102.32 150.07 23.7 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.84 0.828 . . . . 0.0 110.652 168.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.65 153.32 31.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.764 174.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.9 157.83 28.81 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 174.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.59 8.77 0.76 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -88.19 -21.03 24.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.355 1.862 . . . . 0.0 111.557 169.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 mtm180 -117.29 -36.7 3.69 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-O 117.589 -1.196 . . . . 0.0 111.681 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.1 tt -99.07 151.0 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 120.062 1.301 . . . . 0.0 110.592 -178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.1 mtt-85 -142.62 146.23 34.3 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.596 1.558 . . . . 0.0 110.404 168.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' A' ' 8' ' ' PHE . . . -65.91 151.36 46.9 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 125.229 1.412 . . . . 0.0 109.884 174.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -59.51 123.42 16.79 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.206 1.003 . . . . 0.0 110.823 -171.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -147.85 151.32 35.74 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 127.107 2.163 . . . . 0.0 106.993 -169.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -62.66 -28.56 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.913 0.485 . . . . 0.0 110.65 173.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -64.37 -44.21 92.09 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.759 0.824 . . . . 0.0 110.302 175.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -65.52 -37.18 86.0 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.5 mm -69.67 -33.89 58.66 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-N 118.626 0.648 . . . . 0.0 109.992 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -42.45 99.28 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.287 0.949 . . . . 0.0 109.68 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -47.43 85.36 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 171.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.99 -48.02 83.42 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 118.785 -0.626 . . . . 0.0 109.579 -173.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -70.77 -44.51 66.54 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 118.32 0.509 . . . . 0.0 109.76 -175.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -27.61 33.97 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 117.991 -1.004 . . . . 0.0 112.646 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.0 mt -94.1 -45.45 7.55 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 120.441 1.473 . . . . 0.0 112.498 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -50.86 -29.15 11.12 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.47 1.508 . . . . 0.0 110.956 170.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -58.21 -42.02 85.29 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.215 1.806 . . . . 0.0 113.307 172.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -102.96 -13.8 16.75 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 119.524 1.056 . . . . 0.0 113.488 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -46.8 119.78 2.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.351 1.86 . . . . 0.0 113.373 -174.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -173.93 163.43 34.44 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.311 1.434 . . . . 0.0 110.245 169.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 44.1 m -79.01 85.3 4.95 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 172.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.7 p -58.35 -37.1 74.49 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.501 1.12 . . . . 0.0 112.736 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.63 -47.66 1.82 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.388 1.471 . . . . 0.0 113.737 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.9 m -78.48 50.95 1.0 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.664 1.986 . . . . 0.0 110.68 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.01 165.22 21.42 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.733 2.013 . . . . 0.0 108.498 -172.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.58 13.0 0.6 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.472 2.782 . . . . 0.0 114.048 176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.04 169.07 21.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 127.358 2.263 . . . . 0.0 107.154 172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.0 p -60.11 -29.03 68.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.189 0.595 . . . . 0.0 112.179 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 164.64 -173.82 40.59 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 124.888 1.232 . . . . 0.0 110.074 175.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -78.13 42.01 2.07 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.735 1.16 . . . . 0.0 111.876 174.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.8 t -141.77 119.85 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 -168.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.426 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.87 154.82 33.29 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 169.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.11 -5.45 15.81 Favored 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 121.245 1.296 . . . . 0.0 110.301 168.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -55.99 162.22 1.98 Allowed 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.502 2.721 . . . . 0.0 109.581 169.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 39.9 mtm105 61.57 -30.32 0.07 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 129.764 3.225 . . . . 0.0 114.406 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -66.67 161.2 23.92 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 120.071 1.305 . . . . 0.0 109.708 169.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? . . . . . 0 C--O 1.252 1.194 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.601 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.79 159.95 37.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 125.03 1.332 . . . . 0.0 108.145 171.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -153.77 -54.84 0.11 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.802 0.841 . . . . 0.0 109.164 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 62.9 tp -66.57 -40.18 88.85 Favored 'General case' 0 C--N 1.341 0.23 0 C-N-CA 123.485 0.714 . . . . 0.0 111.344 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -62.0 -30.61 71.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.187 0.595 . . . . 0.0 111.314 -177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -71.82 -22.96 61.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.445 1.498 . . . . 0.0 113.196 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -80.67 154.93 27.06 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -56.65 126.5 26.98 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.043 -2.576 . . . . 0.0 104.043 168.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.37 135.76 55.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 -169.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.404 HD22 HG12 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -58.9 -3.62 0.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -168.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.2 28.0 0.26 Allowed Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 169.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.89 -176.31 51.05 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 106.146 -2.782 . . . . 0.0 106.146 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 100' ' ' TYR . 87.4 mtt-85 -87.17 153.96 21.1 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.563 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -132.38 166.93 27.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 168.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -133.52 145.38 50.1 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 103.045 -2.946 . . . . 0.0 103.045 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.9 134.02 40.23 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -94.2 126.62 39.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.693 1.245 . . . . 0.0 107.649 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -103.04 -6.5 22.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.512 0.725 . . . . 0.0 111.109 -175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.53 -77.63 0.35 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 107.931 -2.067 . . . . 0.0 107.931 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.46 -34.95 4.08 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.309 2.006 . . . . 0.0 113.422 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.7 178.36 8.04 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.815 1.646 . . . . 0.0 108.131 -172.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.41 161.97 33.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -135.06 163.97 28.7 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.112 0.965 . . . . 0.0 109.132 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.13 145.59 42.07 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.302 1.041 . . . . 0.0 108.223 173.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.06 158.47 44.39 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.738 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -148.48 94.06 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.927 0.891 . . . . 0.0 109.681 -169.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.563 HD11 HG11 ' A' ' 14' ' ' VAL . 54.7 mt -58.48 150.03 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 129.62 3.168 . . . . 0.0 111.886 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.51 -19.46 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.524 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 167.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -131.03 139.77 49.99 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 173.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.9 pt -140.38 160.09 25.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -168.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -143.67 152.59 41.52 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.288 -168.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -149.63 143.6 16.95 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.653 1.581 . . . . 0.0 109.618 -172.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.24 -1.97 10.45 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.954 3.103 . . . . 0.0 113.772 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.5 m -63.22 -33.39 75.38 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 120.297 1.408 . . . . 0.0 112.014 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 p -135.74 -0.52 2.58 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.919 1.288 . . . . 0.0 111.669 -179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 48.17 52.41 13.32 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.159 0.984 . . . . 0.0 110.145 -169.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 77.9 mtp -146.19 156.7 43.59 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.393 1.877 . . . . 0.0 107.034 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -107.25 175.62 5.43 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.866 0.866 . . . . 0.0 112.365 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.3 p -141.71 152.77 44.15 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 127.041 2.136 . . . . 0.0 107.207 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.627 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.1 m -152.16 157.12 41.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -169.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.404 HG12 HD22 ' A' ' 10' ' ' LEU . 4.8 pt -148.12 160.68 36.74 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 110.009 -175.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.641 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 60.2 Cg_endo -77.98 49.31 2.93 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.958 3.772 . . . . 0.0 113.141 -176.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -61.54 -50.33 73.08 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.11 -0.994 . . . . 0.0 108.727 169.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -166.84 165.52 16.14 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.333 1.453 . . . . 0.0 108.357 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -69.46 148.15 97.03 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.484 1.514 . . . . 0.0 112.061 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -60.22 -13.88 26.31 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 124.248 3.299 . . . . 0.0 116.819 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.1 -38.08 3.48 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 119.91 1.232 . . . . 0.0 111.989 -176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -107.72 14.32 38.33 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.357 1.456 . . . . 0.0 113.124 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.7 m -136.79 159.86 40.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.262 1.825 . . . . 0.0 107.799 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.3 m -66.2 -48.35 70.92 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.959 0.504 . . . . 0.0 110.989 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -169.04 160.17 9.74 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.936 1.694 . . . . 0.0 109.082 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.641 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -72.75 159.68 33.41 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 167.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -128.77 87.31 2.56 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 121.397 -0.814 . . . . 0.0 111.486 -169.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt 53.81 -162.9 0.11 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.884 1.674 . . . . 0.0 110.305 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -62.38 112.0 2.25 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 40' ' ' SER . 4.5 mt -75.42 139.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.7 138.34 93.26 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -70.49 136.55 31.34 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 N-CA-C 107.344 -1.829 . . . . 0.0 107.344 -179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -138.72 159.58 41.76 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -170.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -64.87 131.86 47.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.9 tt -80.57 155.55 26.88 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.471 1.908 . . . . 0.0 112.199 -175.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 117.34 20.27 4.79 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.332 0.968 . . . . 0.0 112.129 177.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -78.4 -35.48 47.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.942 0.871 . . . . 0.0 109.262 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -150.97 8.94 0.57 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.703 1.201 . . . . 0.0 111.634 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.628 ' HB3' ' HE1' ' A' ' 91' ' ' TRP . 6.6 mp0 -126.72 173.5 9.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.523 1.529 . . . . 0.0 110.699 -169.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 57.7 m -153.85 140.42 18.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 169.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.499 HG22 HD11 ' A' ' 71' ' ' ILE . 12.3 pt -134.54 132.28 20.73 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 169.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.12 160.02 50.55 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.363 1.376 . . . . 0.0 109.444 172.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -56.02 -14.51 2.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.443 1.097 . . . . 0.0 112.317 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -66.93 -31.95 72.87 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.604 1.562 . . . . 0.0 112.773 176.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 67' ' ' ILE . 13.5 pt -119.34 -12.57 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 120.202 1.365 . . . . 0.0 110.686 -173.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mm -52.41 -46.92 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 128.43 2.692 . . . . 0.0 108.24 169.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -81.52 8.46 9.52 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.476 0.711 . . . . 0.0 111.923 -170.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.49 -178.35 25.29 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 119.881 1.219 . . . . 0.0 111.195 -170.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -64.13 131.84 48.67 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.3 m -136.44 152.98 51.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 124.288 0.993 . . . . 0.0 111.546 176.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -137.71 114.68 10.73 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.967 1.307 . . . . 0.0 110.006 -169.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -80.49 126.33 31.08 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 126.206 1.802 . . . . 0.0 106.791 169.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.4 pt -137.47 156.77 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 125.334 1.454 . . . . 0.0 111.488 -168.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -105.45 120.15 40.88 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 167.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -72.22 120.59 18.04 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -72.34 148.41 45.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 118.851 -1.14 . . . . 0.0 110.582 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 9.6 56.74 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.5 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.423 ' CZ2' ' HDA' ' A' ' 128' ' ' M2L . 84.4 m95 -130.76 165.01 23.86 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 118.95 1.375 . . . . 0.0 112.035 -175.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -75.26 161.62 29.16 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -170.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 6.8 m -62.17 -21.51 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.545 1.138 . . . . 0.0 111.448 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.2 m -55.59 -25.66 39.57 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.828 1.251 . . . . 0.0 112.695 174.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 40.0 m95 -101.57 1.82 38.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.216 1.006 . . . . 0.0 111.726 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.77 115.4 7.29 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 175.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.277 6.8 tp10 -156.91 169.35 24.98 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.759 1.624 . . . . 0.0 108.241 -167.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.628 ' HE1' ' HB3' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -100.08 150.46 22.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 122.229 1.014 . . . . 0.0 109.72 168.094 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.44 155.26 40.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.749 173.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -90.27 166.52 32.12 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.66 -17.48 15.02 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.83 1.252 . . . . 0.0 113.232 174.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -56.91 -22.86 40.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.767 1.227 . . . . 0.0 113.176 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -122.89 -38.98 2.55 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.431 174.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 14' ' ' VAL . 6.9 tt -95.85 156.08 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 119.767 1.167 . . . . 0.0 112.615 -169.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' HB3' HD21 ' A' ' 104' ' ' ASN . 89.0 mtt180 -155.19 155.41 33.85 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.391 2.676 . . . . 0.0 109.862 171.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -74.97 163.09 27.99 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.297 1.439 . . . . 0.0 112.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.52 ' CE2' HD11 ' A' ' 105' ' ' ILE . 35.6 t80 -66.95 115.84 7.13 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.15 -0.969 . . . . 0.0 110.392 174.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -161.69 161.89 29.61 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.482 1.513 . . . . 0.0 108.785 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -54.11 -33.25 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.798 1.639 . . . . 0.0 114.089 -169.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -64.64 -43.85 92.36 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 122.015 0.912 . . . . 0.0 110.266 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 98' ' ' ARG . 79.6 m-20 -74.3 -27.0 60.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 118.813 -0.613 . . . . 0.0 109.67 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.52 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.8 mm -67.15 -45.53 86.34 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 117.308 -1.329 . . . . 0.0 109.524 169.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.29 -44.6 79.98 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 120.796 1.634 . . . . 0.0 109.865 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -54.23 -51.79 63.36 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.225 0.61 . . . . 0.0 109.973 171.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -59.57 -48.86 80.02 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.369 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -68.26 -40.58 81.87 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 120.022 1.283 . . . . 0.0 110.276 -173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -52.47 -54.37 33.26 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt -73.71 -40.72 63.4 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.002 -0.436 . . . . 0.0 110.665 -170.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.12 -9.21 0.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.268 1.827 . . . . 0.0 113.009 169.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -114.07 -46.03 3.03 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.993 1.317 . . . . 0.0 112.284 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.51 -32.96 70.65 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 119.057 0.844 . . . . 0.0 111.632 -178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -121.41 130.2 53.45 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 122.125 0.964 . . . . 0.0 111.18 -167.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -178.85 54.82 0.09 OUTLIER Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.042 -1.436 . . . . 0.0 110.086 -174.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.7 m -125.82 39.47 3.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.446 1.498 . . . . 0.0 110.111 -169.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.89 -19.33 0.97 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 128.921 2.889 . . . . 0.0 116.095 -169.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -164.64 -172.56 32.26 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 120.912 -1.118 . . . . 0.0 110.725 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 m 56.21 36.94 28.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.727 1.211 . . . . 0.0 112.678 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.77 148.28 45.48 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 125.301 1.44 . . . . 0.0 108.824 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -79.72 36.41 0.61 Allowed 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 124.516 3.477 . . . . 0.0 112.179 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.07 -177.15 5.51 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.683 1.593 . . . . 0.0 109.238 -172.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.2 p -56.86 -34.53 67.91 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.438 0.695 . . . . 0.0 110.512 171.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 86.11 13.98 67.73 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -171.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 75.35 27.36 63.86 Favored Glycine 0 C--N 1.34 0.763 0 CA-C-O 117.856 -1.525 . . . . 0.0 112.387 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.3 m -156.53 153.57 6.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 120.236 2.018 . . . . 0.0 108.964 -169.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.423 ' HDA' ' CZ2' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.522 ' HE3' ' HD2' ' A' ' 130' ' ' PRO . 0.1 OUTLIER -164.4 91.7 1.03 Allowed Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 -167.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.522 ' HD2' ' HE3' ' A' ' 129' ' ' LYS . 93.9 Cg_endo -76.83 -41.31 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.85 1.7 . . . . 0.0 115.115 -168.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -72.06 1.75 6.86 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 115.602 1.705 . . . . 0.0 115.602 -170.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -61.38 160.4 10.91 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.985 1.266 . . . . 0.0 110.432 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -57.85 148.61 24.83 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.125 0.97 . . . . 0.0 110.833 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 C--O 1.249 1.077 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.549 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.8 m -139.93 158.9 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 125.498 1.519 . . . . 0.0 108.486 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -158.74 -34.43 0.07 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.254 1.022 . . . . 0.0 111.317 -177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 65.2 tp -53.64 -27.83 29.49 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.702 1.601 . . . . 0.0 113.337 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -59.02 -27.54 65.56 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -84.43 -17.04 40.5 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.58 1.552 . . . . 0.0 111.518 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -83.71 164.7 19.46 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 169.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.84 126.09 26.22 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.771 -2.307 . . . . 0.0 104.771 168.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.73 128.89 52.28 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -170.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.442 HD22 HG12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -59.04 -2.25 0.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 -168.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.98 32.57 0.37 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.04 -157.43 14.14 Favored Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 168.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -109.48 154.57 22.48 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 103.567 -2.753 . . . . 0.0 103.567 167.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.606 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -129.18 162.04 37.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 103.313 -2.847 . . . . 0.0 103.313 169.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 14' ' ' VAL . 35.9 mt -139.14 130.39 26.81 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 -175.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.31 139.75 51.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -108.2 115.34 29.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -96.3 -10.54 27.62 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.994 0.918 . . . . 0.0 112.065 -169.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.14 -78.69 0.31 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 173.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.62 -30.27 18.53 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.628 2.219 . . . . 0.0 112.887 175.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.445 ' CD2' ' H ' ' A' ' 22' ' ' MET . 0.4 OUTLIER -154.11 -178.43 7.1 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.577 1.551 . . . . 0.0 108.894 -169.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.445 ' H ' ' CD2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -139.17 155.14 48.04 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.613 1.565 . . . . 0.0 107.326 -172.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -138.01 167.72 21.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 109.914 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.17 144.57 36.25 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.532 1.133 . . . . 0.0 109.061 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.9 156.43 48.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.168 1.387 . . . . 0.0 108.456 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -147.55 103.65 3.55 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.576 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.606 HD11 HG11 ' A' ' 14' ' ' VAL . 74.9 mt -60.09 148.16 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 129.61 3.164 . . . . 0.0 111.428 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.27 -18.41 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 116.732 -1.604 . . . . 0.0 113.88 167.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.445 ' HE3' ' CH2' ' A' ' 91' ' ' TRP . 15.2 ttpt -124.54 139.87 53.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 169.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 pt -141.01 161.11 23.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -169.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.48 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 2.9 t-105 -149.38 152.35 35.62 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.815 0.697 . . . . 0.0 111.988 -169.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -147.21 139.51 14.08 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 127.172 2.189 . . . . 0.0 109.054 -176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.2 -9.79 26.38 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.907 3.071 . . . . 0.0 113.422 177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 53.0 m -68.48 -30.91 69.85 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.021 1.282 . . . . 0.0 111.291 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.2 m -120.1 -15.69 8.68 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.054 1.342 . . . . 0.0 110.844 174.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.4 mtmt 49.18 47.2 22.32 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 118.865 0.757 . . . . 0.0 109.914 -170.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 62.8 mtp -145.82 148.69 33.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -98.84 174.8 6.2 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.111 0.565 . . . . 0.0 112.323 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.9 p -142.28 160.07 40.97 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.529 1.932 . . . . 0.0 106.884 170.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.646 ' HB3' HD12 ' A' ' 56' ' ' ILE . 0.3 OUTLIER -147.16 165.16 30.85 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.442 HG12 HD22 ' A' ' 10' ' ' LEU . 8.5 pt -145.06 162.14 39.14 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.718 1.207 . . . . 0.0 109.113 178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.91 87.8 1.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.834 3.023 . . . . 0.0 110.208 -175.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -133.4 7.16 3.87 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.416 1.086 . . . . 0.0 111.777 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -147.12 161.2 41.35 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 120.717 -1.24 . . . . 0.0 113.042 -169.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -135.98 71.08 63.24 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 128.546 2.738 . . . . 0.0 104.963 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -60.7 123.9 13.93 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.558 2.838 . . . . 0.0 110.714 -169.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 60.74 7.25 7.69 Favored Glycine 0 CA--C 1.534 1.268 0 CA-C-O 119.45 -0.639 . . . . 0.0 114.218 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 98.54 9.37 53.14 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.782 1.182 . . . . 0.0 112.368 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 m -57.06 164.99 1.42 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.479 1.139 . . . . 0.0 110.88 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.1 m -56.01 -60.2 3.81 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.321 1.048 . . . . 0.0 112.315 -169.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -176.87 149.01 0.7 Allowed 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.105 0.962 . . . . 0.0 108.683 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.29 166.49 12.04 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -105.52 162.46 13.46 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 124.275 1.03 . . . . 0.0 111.922 -169.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -51.74 155.21 1.75 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.519 1.528 . . . . 0.0 110.126 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -23.2 98.49 0.01 OUTLIER 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.132 2.173 . . . . 0.0 112.322 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 40' ' ' SER . 4.0 mt -70.69 129.42 34.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 111.388 -2.642 . . . . 0.0 107.24 -168.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -67.12 137.12 94.21 Favored Pre-proline 0 C--O 1.236 0.344 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -173.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -72.16 131.02 17.27 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.272 1.981 . . . . 0.0 107.092 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -135.45 167.59 20.79 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.588 1.155 . . . . 0.0 108.085 -173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -65.16 151.94 44.84 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD11 ' CZ2' ' A' ' 91' ' ' TRP . 10.1 tt -108.09 147.22 31.51 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.585 1.554 . . . . 0.0 109.996 -169.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 114.87 42.73 0.77 Allowed Glycine 0 CA--C 1.527 0.787 0 O-C-N 123.906 0.754 . . . . 0.0 112.94 172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.17 -8.73 3.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.093 0.957 . . . . 0.0 112.6 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -140.73 10.81 2.24 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.144 1.378 . . . . 0.0 110.472 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.448 ' HB2' ' HE1' ' A' ' 91' ' ' TRP . 0.6 OUTLIER -161.16 -177.44 6.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 108.016 -169.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.7 m -161.52 141.92 10.77 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.651 2.78 . . . . 0.0 103.64 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 67' ' ' ILE 0.311 5.3 tt -134.01 119.6 14.74 Favored Pre-proline 0 CA--C 1.557 1.236 0 N-CA-C 104.009 -2.589 . . . . 0.0 104.009 -170.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -56.76 145.98 80.02 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.407 2.738 . . . . 0.0 113.037 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -55.8 -22.07 22.69 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.289 1.036 . . . . 0.0 112.509 172.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 -58.01 -31.3 66.83 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.792 2.037 . . . . 0.0 113.282 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 pt -117.82 -17.53 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.935 0.894 . . . . 0.0 111.014 -169.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.48 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 2.5 mm -52.87 -43.29 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 128.561 2.744 . . . . 0.0 109.656 171.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -81.91 11.75 4.72 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.972 0.909 . . . . 0.0 112.252 -169.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.59 -171.1 26.07 Favored Glycine 0 C--N 1.337 0.613 0 O-C-N 121.0 -1.063 . . . . 0.0 110.487 -174.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.5 mmpp? -57.01 136.16 56.29 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.131 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 m -137.91 151.21 47.78 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 123.927 0.767 . . . . 0.0 111.205 170.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -138.47 114.76 10.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.895 1.278 . . . . 0.0 110.294 -171.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 29' ' ' LYS . 53.5 t80 -81.48 129.23 34.57 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.0 pt -137.97 149.04 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.017 -168.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -92.83 123.83 36.38 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 102.639 -3.097 . . . . 0.0 102.639 166.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -71.3 113.41 8.31 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 169.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -73.65 149.49 41.95 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.29 15.71 52.22 Favored Glycine 0 CA--C 1.536 1.367 0 CA-C-O 119.001 -0.888 . . . . 0.0 113.063 -176.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -136.31 172.15 13.43 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.113 1.365 . . . . 0.0 110.173 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 mtmt -71.21 161.5 31.0 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-O 121.104 0.478 . . . . 0.0 110.582 -175.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.4 m -72.57 -13.47 61.4 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.759 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.9 m -55.09 -32.6 62.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.343 1.057 . . . . 0.0 112.225 175.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -87.77 2.45 51.23 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.858 0.863 . . . . 0.0 113.005 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -63.77 119.42 9.92 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.251 40.9 tt0 -158.81 153.94 25.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -167.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.448 ' HE1' ' HB2' ' A' ' 65' ' ' GLU . 0.0 OUTLIER -91.18 149.69 21.68 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.282 1.039 . . . . 0.0 109.224 168.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.44 HG11 ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -132.8 149.13 31.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 113.49 -1.686 . . . . 0.0 110.484 -177.698 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -84.74 161.93 37.07 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.552 173.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.06 10.06 0.34 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.035 1.734 . . . . 0.0 114.95 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -90.27 -34.98 15.54 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.947 1.699 . . . . 0.0 110.378 169.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.44 ' HD2' HG11 ' A' ' 92' ' ' VAL . 23.6 ttm180 -93.39 -45.11 7.95 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.759 -0.639 . . . . 0.0 110.12 175.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 14' ' ' VAL . 5.2 tt -98.61 156.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 118.564 0.62 . . . . 0.0 111.335 -171.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.455 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 99.3 mtt180 -148.23 155.25 41.13 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.771 2.029 . . . . 0.0 109.743 169.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.69 161.72 30.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 120.16 1.346 . . . . 0.0 111.427 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.416 ' CE2' HD11 ' A' ' 105' ' ' ILE . 26.4 t80 -70.12 117.9 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 173.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -162.02 161.32 28.39 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.131 1.373 . . . . 0.0 108.976 173.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.92 -36.08 47.85 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.68 1.592 . . . . 0.0 114.476 -169.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -62.19 -45.22 94.35 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 122.628 1.204 . . . . 0.0 110.476 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -76.49 -22.99 53.78 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.455 -0.783 . . . . 0.0 109.834 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.416 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.2 mm -69.01 -35.67 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 118.722 0.692 . . . . 0.0 109.772 169.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -40.9 97.23 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 118.809 0.731 . . . . 0.0 110.271 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -50.11 74.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -59.14 -48.04 83.08 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.578 -1.201 . . . . 0.0 109.6 -172.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.3 pttt -79.69 -35.98 38.29 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 119.918 1.235 . . . . 0.0 110.276 -171.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -28.19 65.24 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.243 171.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.1 mt -91.69 -45.57 8.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.262 1.392 . . . . 0.0 112.819 178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.04 16.83 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.285 1.434 . . . . 0.0 111.162 171.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -58.02 -42.32 85.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.684 1.594 . . . . 0.0 113.367 170.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -104.43 -10.01 18.02 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.336 0.971 . . . . 0.0 113.327 -177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -47.5 -45.16 26.12 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.672 1.989 . . . . 0.0 114.417 -170.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.87 -21.64 1.26 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.843 -0.976 . . . . 0.0 114.135 -177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.0 m 56.32 29.37 14.91 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.252 1.421 . . . . 0.0 112.37 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.6 p -71.32 -0.38 9.94 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.62 1.568 . . . . 0.0 113.147 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.37 -14.93 29.24 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.352 0.977 . . . . 0.0 113.728 175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.2 p -75.29 4.18 7.59 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 119.211 1.506 . . . . 0.0 113.848 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.2 170.46 10.9 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.656 2.382 . . . . 0.0 108.281 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.22 13.08 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.426 3.417 . . . . 0.0 116.951 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.83 143.35 47.88 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.05 0.94 . . . . 0.0 110.481 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 18.2 p -131.54 4.38 4.27 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.113 1.365 . . . . 0.0 111.67 -175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -60.05 -24.02 60.19 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.144 1.354 . . . . 0.0 114.53 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.7 32.38 0.19 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 118.541 1.171 . . . . 0.0 112.196 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 p -153.82 146.12 14.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 -169.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.4 mmmt -151.42 127.05 4.92 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 126.717 2.007 . . . . 0.0 106.193 -171.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.442 ' HD2' ' H ' ' A' ' 131' ' ' HIS . 23.2 Cg_endo -83.74 -27.92 1.5 Allowed 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 120.942 1.095 . . . . 0.0 110.205 169.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.442 ' H ' ' HD2' ' A' ' 130' ' ' PRO . 6.8 t-80 63.04 146.71 0.02 OUTLIER 'General case' 0 C--O 1.235 0.332 0 C-N-CA 131.017 3.727 . . . . 0.0 113.678 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -61.19 152.43 28.74 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.817 1.247 . . . . 0.0 110.851 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -66.85 -27.74 67.78 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 . . . . . 0 C--O 1.251 1.145 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.882 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.8 m -62.94 157.96 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 169.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -151.17 -50.45 0.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.128 0.571 . . . . 0.0 111.397 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 59.4 tp -86.2 -36.48 19.44 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 122.959 0.504 . . . . 0.0 109.876 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -62.45 -34.96 77.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.031 1.333 . . . . 0.0 110.592 -172.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -75.75 -16.28 60.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.684 1.594 . . . . 0.0 112.622 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -93.73 166.42 12.22 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.989 0.813 . . . . 0.0 109.646 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -55.75 63.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.364 1 C-N-CA 132.094 4.158 . . . . 0.0 111.401 169.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.33 135.81 55.78 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 127.24 2.216 . . . . 0.0 105.688 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.85 -4.92 1.11 Allowed 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -169.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.61 30.43 0.51 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 171.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.44 -165.21 34.32 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.533 -2.627 . . . . 0.0 106.533 168.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.7 mtt180 -99.74 154.75 18.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 168.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.58 HG11 HD11 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -129.39 165.88 28.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 103.15 -2.907 . . . . 0.0 103.15 168.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.411 HD12 ' CE ' ' A' ' 22' ' ' MET . 3.5 mm? -133.53 140.74 47.38 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 102.802 -3.036 . . . . 0.0 102.802 178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.92 129.8 34.89 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -177.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -104.54 114.2 28.27 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -169.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -87.64 -22.25 24.83 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.116 0.566 . . . . 0.0 110.98 -171.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.89 -72.08 0.31 Allowed Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 172.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -72.11 -32.07 11.29 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.53 2.153 . . . . 0.0 112.736 173.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.31 174.65 12.61 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.909 1.684 . . . . 0.0 109.302 -172.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.411 ' CE ' HD12 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -139.12 150.35 45.56 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.7 1.6 . . . . 0.0 108.757 -169.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -137.24 159.97 40.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.562 1.145 . . . . 0.0 109.673 -176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.99 148.87 39.54 Favored 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 123.612 0.765 . . . . 0.0 109.158 178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.56 159.33 42.36 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 124.207 1.003 . . . . 0.0 109.912 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.92 95.7 2.53 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.331 0.652 . . . . 0.0 109.457 -170.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.58 HD11 HG11 ' A' ' 14' ' ' VAL . 70.4 mt -54.77 152.56 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 128.08 2.552 . . . . 0.0 111.632 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 pp -156.02 -32.08 0.09 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.969 -0.539 . . . . 0.0 112.399 169.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 34.8 ttpt -132.2 136.81 47.29 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.65 166.28 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.7 0.762 . . . . 0.0 109.182 -172.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.462 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.9 t-105 -143.17 153.24 42.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.587 -169.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -148.6 137.48 11.96 Favored Pre-proline 0 C--O 1.242 0.678 0 C-N-CA 127.501 2.32 . . . . 0.0 108.152 -174.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.52 -10.93 28.18 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.528 2.819 . . . . 0.0 113.304 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.4 m -65.62 -31.85 73.11 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.863 1.21 . . . . 0.0 111.957 -169.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -124.51 -7.44 7.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.013 1.325 . . . . 0.0 111.163 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt 47.05 48.41 15.6 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.388 1.075 . . . . 0.0 110.65 -172.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtp -147.19 158.18 43.86 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.642 2.377 . . . . 0.0 105.98 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.434 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 52.0 p90 -108.99 174.21 5.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.788 0.835 . . . . 0.0 112.321 -174.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.5 p -147.37 149.38 32.66 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.503 1.921 . . . . 0.0 107.035 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.437 ' HB3' HD12 ' A' ' 56' ' ' ILE . 35.9 t -146.5 165.9 28.05 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -175.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.8 pt -147.92 156.73 44.13 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.141 1.377 . . . . 0.0 109.158 -176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 65.3 Cg_endo -68.77 110.01 2.25 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.422 2.748 . . . . 0.0 109.363 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -142.66 -15.17 0.73 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -166.43 -167.0 0.94 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.346 1.459 . . . . 0.0 109.811 -177.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -136.28 96.24 12.67 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 128.339 2.655 . . . . 0.0 106.654 -171.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -53.79 -21.46 20.28 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.162 2.574 . . . . 0.0 117.13 -177.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.69 -41.0 2.37 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -173.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.79 -14.87 82.11 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.539 1.066 . . . . 0.0 112.103 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 m -138.37 140.6 39.5 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.801 1.64 . . . . 0.0 108.077 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.6 m -64.92 -28.37 69.49 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.58 1.152 . . . . 0.0 112.324 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -169.45 158.61 8.05 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.037 2.135 . . . . 0.0 107.714 169.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -72.64 148.16 45.08 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 102.441 -3.17 . . . . 0.0 102.441 166.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 15.6 p -96.36 -72.0 0.65 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 118.148 2.647 . . . . 0.0 118.148 -166.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -144.42 -164.55 1.93 Allowed 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.87 2.068 . . . . 0.0 105.627 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.53 113.84 3.2 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 169.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.437 HD12 ' HB3' ' A' ' 40' ' ' SER . 3.1 mt -79.14 133.15 30.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -171.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.4 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -65.73 135.5 95.57 Favored Pre-proline 0 C--O 1.237 0.398 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -71.71 137.63 30.35 Favored 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 122.244 1.963 . . . . 0.0 108.024 -174.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -139.69 160.67 39.34 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -170.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 4.8 mmpt? -67.02 120.08 13.05 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 122.058 0.932 . . . . 0.0 108.618 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.3 tp -61.26 150.71 33.88 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.805 2.042 . . . . 0.0 112.132 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.58 25.52 3.39 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.421 -1.21 . . . . 0.0 115.751 168.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.28 -30.57 17.42 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.986 1.893 . . . . 0.0 111.023 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -152.04 -39.9 0.11 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.07 1.748 . . . . 0.0 110.272 177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.457 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 0.5 OUTLIER -71.18 159.91 33.8 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 168.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.2 m -153.93 159.31 41.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 169.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.51 HG23 HG12 ' A' ' 72' ' ' ILE 0.329 2.0 tt -144.63 126.61 8.09 Favored Pre-proline 0 CA--C 1.556 1.191 0 N-CA-C 102.347 -3.205 . . . . 0.0 102.347 -169.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -68.84 155.0 70.05 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 CA-C-N 121.155 1.448 . . . . 0.0 111.142 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -56.96 -17.6 10.31 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.788 1.235 . . . . 0.0 112.542 173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.11 -25.51 67.81 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.433 1.493 . . . . 0.0 112.332 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.2 pt -125.27 -14.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 119.229 0.922 . . . . 0.0 111.3 -170.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.51 HG12 HG23 ' A' ' 67' ' ' ILE . 1.6 mm -50.73 -42.73 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 128.587 2.755 . . . . 0.0 109.591 169.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -81.14 9.66 6.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.854 1.262 . . . . 0.0 112.768 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.01 -171.52 24.91 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 14.6 mmtt -58.66 140.4 54.63 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 122.294 -0.533 . . . . 0.0 109.658 174.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 m -138.2 149.35 45.73 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 123.933 0.771 . . . . 0.0 110.721 169.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 75' ' ' LYS . 50.0 m-85 -134.94 113.88 11.95 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 124.041 0.936 . . . . 0.0 110.763 -170.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -78.87 125.25 29.12 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 126.8 2.04 . . . . 0.0 106.479 169.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 pt -135.15 151.94 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.069 1.348 . . . . 0.0 111.435 -168.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -101.0 116.05 31.94 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 167.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -66.93 121.31 15.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -80.93 157.18 25.67 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.176 0.512 . . . . 0.0 110.031 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.35 11.11 45.64 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 119.217 -0.769 . . . . 0.0 111.731 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -135.7 167.65 20.74 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.526 1.13 . . . . 0.0 110.339 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -64.98 169.09 5.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.726 1.21 . . . . 0.0 110.659 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.2 m -82.97 -11.53 58.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.566 171.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.3 m -55.78 -33.43 64.36 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.707 1.203 . . . . 0.0 112.031 175.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.444 ' CH2' ' HD ' ' A' ' 128' ' ' M2L . 38.8 m95 -84.74 4.16 34.08 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -174.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.05 118.97 10.58 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -173.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.258 9.1 tt0 -157.23 162.02 39.25 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.589 1.556 . . . . 0.0 107.806 -167.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.435 ' CD1' HG13 ' A' ' 67' ' ' ILE . 0.0 OUTLIER -96.68 152.85 18.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 122.15 0.976 . . . . 0.0 109.497 168.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.11 155.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 113.79 -1.55 . . . . 0.0 109.441 173.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.49 167.56 28.76 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 169.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.8 -17.58 9.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.247 1.419 . . . . 0.0 113.304 176.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -56.77 -23.19 41.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 113.143 170.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -123.97 -38.56 2.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.881 173.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.517 HD11 HG21 ' A' ' 14' ' ' VAL . 7.2 tt -94.19 155.29 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 119.728 1.149 . . . . 0.0 112.451 -169.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 83.6 mtt180 -153.95 160.23 42.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 129.275 3.03 . . . . 0.0 108.765 169.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -76.21 170.78 15.67 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 120.616 1.553 . . . . 0.0 112.832 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.535 ' CE2' HD11 ' A' ' 105' ' ' ILE . 32.0 t80 -70.22 115.0 8.91 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.056 -1.027 . . . . 0.0 110.023 169.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -162.02 163.64 28.72 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.622 1.569 . . . . 0.0 109.333 170.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -54.41 -34.34 61.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.629 1.572 . . . . 0.0 113.815 -169.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -63.9 -42.07 97.53 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.096 0.95 . . . . 0.0 110.412 178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -76.16 -25.85 55.68 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.552 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.535 HD11 ' CE2' ' A' ' 100' ' ' TYR . 4.8 mm -69.59 -37.56 74.69 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.086 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.345 169.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.17 -43.6 98.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.275 0.943 . . . . 0.0 109.702 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -49.8 74.76 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 171.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.98 -51.07 69.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.759 -170.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.45 -31.98 58.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 117.63 -1.176 . . . . 0.0 110.176 -173.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -54.99 -45.72 75.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.827 1.194 . . . . 0.0 110.358 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.5 mt -77.06 -46.82 22.39 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.683 -175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.06 -29.58 30.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.022 1.329 . . . . 0.0 111.421 173.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -75.83 -48.12 22.87 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.559 1.143 . . . . 0.0 113.062 173.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -63.43 -41.73 98.69 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.366 0.53 . . . . 0.0 111.058 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.27 110.15 4.32 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.766 1.626 . . . . 0.0 108.304 -168.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -143.64 7.58 1.98 Allowed Glycine 0 CA--C 1.531 1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.919 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 51.0 m -153.05 158.05 41.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.2 m -74.78 64.92 1.31 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.4 -23.42 0.05 OUTLIER Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.864 1.697 . . . . 0.0 111.924 -169.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.7 p -116.13 -1.73 12.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.695 1.248 . . . . 0.0 112.929 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.12 151.65 93.23 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.393 1.077 . . . . 0.0 110.428 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -63.74 163.06 25.93 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.639 2.892 . . . . 0.0 111.764 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.64 -21.28 64.26 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 112.862 -1.972 . . . . 0.0 113.183 -175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.8 p -65.1 -26.62 68.29 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.717 1.207 . . . . 0.0 111.662 173.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 133.48 -46.26 1.07 Allowed Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.419 1.962 . . . . 0.0 109.269 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 61.54 4.6 5.47 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.018 1.77 . . . . 0.0 116.016 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.7 t -148.47 131.96 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 119.431 1.615 . . . . 0.0 106.983 -169.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.603 ' SG ' HM2B ' A' ' 128' ' ' M2L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? 24.75 88.8 0.07 OUTLIER Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 130.86 3.664 . . . . 0.0 114.742 167.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -90.38 -27.25 0.3 Allowed 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.744 1.63 . . . . 0.0 111.797 -172.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -34.42 77.82 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -169.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.6 mtp180 -61.49 140.22 58.11 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 118.051 0.387 . . . . 0.0 111.301 -170.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -129.71 4.6 5.03 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.754 1.622 . . . . 0.0 109.861 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 128.337 2.655 . . . . 0.0 104.484 177.115 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 18.7 m -137.95 162.27 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.987 1.315 . . . . 0.0 108.313 175.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -153.36 -42.44 0.1 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.008 0.923 . . . . 0.0 110.812 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.3 tp -63.12 -32.01 73.29 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.041 1.337 . . . . 0.0 112.01 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -56.5 -36.06 68.72 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.473 1.109 . . . . 0.0 110.816 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.94 -21.15 64.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 127.736 2.415 . . . . 0.0 113.802 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -86.93 148.01 25.53 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.057 0.844 . . . . 0.0 109.833 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.79 127.76 31.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 168.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.67 131.2 56.67 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 102.403 -3.184 . . . . 0.0 102.403 -175.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.32 -11.42 0.3 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -168.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -157.24 32.48 0.54 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 170.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.19 -170.47 36.47 Favored Glycine 0 N--CA 1.437 -1.299 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 169.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -91.16 153.25 20.17 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 103.947 -2.612 . . . . 0.0 103.947 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.874 HG11 HD11 ' A' ' 97' ' ' ILE . 2.9 p -135.92 158.35 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 169.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 14' ' ' VAL . 9.1 mt -128.28 154.66 45.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.97 129.24 31.82 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -93.18 129.05 39.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -110.19 -6.13 15.15 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.435 1.094 . . . . 0.0 111.991 -173.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.02 -80.68 0.29 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 108.318 -1.913 . . . . 0.0 108.318 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -72.42 -29.32 13.82 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.378 2.052 . . . . 0.0 113.16 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -153.65 177.83 10.52 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.782 1.633 . . . . 0.0 110.158 -169.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.431 ' CE ' HD13 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -142.75 150.85 40.6 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.042 1.737 . . . . 0.0 108.887 -168.231 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.61 175.75 9.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.938 0.895 . . . . 0.0 111.022 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.11 147.13 25.07 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.992 0.917 . . . . 0.0 109.746 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.54 ' HB3' HG13 ' A' ' 14' ' ' VAL . . . -141.34 160.29 40.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.199 1.799 . . . . 0.0 108.465 -174.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -148.41 103.47 3.43 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 120.938 -1.101 . . . . 0.0 108.882 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 14' ' ' VAL . 79.7 mt -51.64 148.11 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 127.657 2.383 . . . . 0.0 110.441 177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -153.92 -31.89 0.12 Allowed 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 123.433 0.693 . . . . 0.0 111.632 170.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HD2' ' CD1' ' A' ' 38' ' ' TYR . 33.4 ttpt -133.06 135.47 45.36 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.71 165.87 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.488 ' CZ2' HD13 ' A' ' 72' ' ' ILE . 1.7 t-105 -145.45 154.59 42.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.302 -168.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.24 141.3 14.97 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.844 2.457 . . . . 0.0 108.697 -172.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.82 -8.42 23.38 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.474 2.783 . . . . 0.0 113.356 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.7 m -66.92 -33.61 75.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.586 1.539 . . . . 0.0 110.961 -172.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.2 p -118.95 -17.39 9.07 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.733 1.613 . . . . 0.0 110.847 175.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm 48.81 52.34 14.28 Favored 'General case' 0 C--N 1.348 0.51 0 CA-C-N 119.01 0.823 . . . . 0.0 109.212 -169.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.9 mtp -148.9 156.94 43.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.476 2.71 . . . . 0.0 104.522 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CD1' ' HD2' ' A' ' 29' ' ' LYS . 53.1 p90 -106.07 170.08 8.12 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 122.602 0.361 . . . . 0.0 111.666 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 p -142.57 150.58 40.55 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 126.995 2.118 . . . . 0.0 105.647 176.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.64 ' HB2' HD12 ' A' ' 56' ' ' ILE . 2.5 m -150.79 157.99 43.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -168.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.424 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 8.0 pt -137.67 164.24 42.71 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 123.224 0.609 . . . . 0.0 109.595 -177.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 94.5 Cg_endo -75.79 33.15 0.39 Allowed 'Trans proline' 0 CA--C 1.546 1.118 1 C-N-CA 125.392 4.061 . . . . 0.0 114.415 -169.225 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -75.04 -1.38 22.56 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -147.33 169.52 19.27 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 120.237 -1.54 . . . . 0.0 112.764 -169.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -133.97 72.28 72.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.783 2.033 . . . . 0.0 106.703 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -54.65 -25.85 43.68 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.012 2.474 . . . . 0.0 117.012 -169.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.27 -42.4 1.89 Allowed Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.664 1.12 . . . . 0.0 110.806 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.14 -18.9 75.21 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.888 0.756 . . . . 0.0 112.122 170.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.7 m -140.73 141.73 34.87 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.427 1.891 . . . . 0.0 107.142 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.9 m -66.34 -23.73 66.4 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.444 1.098 . . . . 0.0 112.254 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -156.86 158.79 37.38 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.475 1.91 . . . . 0.0 107.153 169.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' A' ' 42' ' ' PRO . . . -76.38 155.7 33.84 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 168.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 m -78.95 156.98 28.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.733 -0.604 . . . . 0.0 110.966 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -54.7 160.77 1.74 Allowed 'General case' 0 C--N 1.338 0.104 0 C-N-CA 124.462 1.105 . . . . 0.0 108.993 168.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -17.24 91.64 0.01 OUTLIER 'General case' 0 C--O 1.237 0.404 0 C-N-CA 129.472 3.109 . . . . 0.0 111.127 -169.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 40' ' ' SER . 5.2 mt -72.03 136.48 25.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.121 -167.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.79 141.68 95.06 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.535 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.34 142.65 27.11 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.931 1.754 . . . . 0.0 108.822 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -129.75 165.91 20.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.817 0.847 . . . . 0.0 108.953 175.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.622 ' HA ' ' HE2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -60.37 -25.4 65.84 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 -168.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.6 tt 73.46 144.78 0.07 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.847 2.059 . . . . 0.0 112.66 -173.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 109.97 25.16 5.47 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.989 -0.895 . . . . 0.0 115.188 169.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.25 -34.6 55.81 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.062 1.431 . . . . 0.0 109.113 169.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -153.16 -24.15 0.15 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.435 1.894 . . . . 0.0 112.369 176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 34.3 mp0 -55.6 -19.51 10.54 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 129.162 2.985 . . . . 0.0 115.216 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.3 m -17.54 108.74 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.465 2.706 . . . . 0.0 111.962 -169.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.464 HG12 HD11 ' A' ' 71' ' ' ILE 0.342 4.3 tt -115.26 136.6 22.71 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 127.509 2.324 . . . . 0.0 106.764 -166.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.97 151.81 56.67 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.107 1.871 . . . . 0.0 111.578 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.61 -16.64 10.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.766 1.227 . . . . 0.0 113.339 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -64.71 -24.64 67.63 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.634 1.174 . . . . 0.0 112.367 174.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.464 HD11 HG12 ' A' ' 67' ' ' ILE . 3.6 pt -125.16 -15.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 118.706 0.684 . . . . 0.0 110.688 -170.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.488 HD13 ' CZ2' ' A' ' 31' ' ' TRP . 3.0 mm -54.67 -44.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.342 2.257 . . . . 0.0 107.158 169.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -81.15 11.31 4.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.177 1.791 . . . . 0.0 112.562 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.38 -172.26 26.29 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.636 1.107 . . . . 0.0 111.569 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -60.14 137.13 58.17 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.3 m -139.24 150.22 45.24 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 123.957 0.785 . . . . 0.0 110.465 171.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -137.04 115.58 11.96 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 124.655 1.182 . . . . 0.0 110.272 -172.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CD2' ' HE2' ' A' ' 29' ' ' LYS . 41.3 t80 -82.04 130.87 35.2 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 126.348 1.859 . . . . 0.0 106.44 169.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 pt -141.05 151.83 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-N 113.463 -1.699 . . . . 0.0 112.643 -167.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -93.62 122.96 36.61 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 103.873 -2.64 . . . . 0.0 103.873 167.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.71 115.63 11.13 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 170.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -80.49 147.99 30.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -173.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 66.11 9.16 46.8 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.885 -0.953 . . . . 0.0 112.336 -169.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.491 ' CD1' HM2B ' A' ' 128' ' ' M2L . 78.9 m95 -130.73 171.47 13.06 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.597 1.199 . . . . 0.0 111.668 -176.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -73.28 161.16 30.84 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.082 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.7 m -76.72 -13.86 60.0 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.229 172.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 14.6 m -51.1 -36.04 38.3 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.382 1.473 . . . . 0.0 111.979 171.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -88.06 2.13 52.62 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.76 -174.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -64.55 121.64 14.92 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 -172.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . 0.276 7.7 tp10 -159.13 169.19 24.73 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.894 1.278 . . . . 0.0 108.099 -167.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -101.64 153.34 19.85 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.775 0.797 . . . . 0.0 110.744 168.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.434 HG23 HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -129.24 156.3 41.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.239 172.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -88.08 161.12 31.45 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 174.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.408 ' CE1' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -69.8 7.44 0.9 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 178.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -87.43 -21.04 25.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.991 1.716 . . . . 0.0 111.115 169.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 mtm105 -117.91 -35.37 3.9 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.599 1.16 . . . . 0.0 111.813 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.874 HD11 HG11 ' A' ' 14' ' ' VAL . 4.4 tt -101.42 150.24 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.219 0.918 . . . . 0.0 110.094 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.408 ' HA ' ' CE1' ' A' ' 94' ' ' TYR . 87.4 mtt180 -147.32 143.8 28.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.094 1.358 . . . . 0.0 112.076 170.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HA ' HG23 ' A' ' 14' ' ' VAL . . . -68.18 147.81 51.74 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 126.703 2.001 . . . . 0.0 111.33 -176.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE2' HD11 ' A' ' 105' ' ' ILE . 34.4 t80 -59.52 114.68 2.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.197 0.453 . . . . 0.0 111.407 -169.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -160.53 162.23 32.92 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.272 1.029 . . . . 0.0 110.191 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -57.27 -33.74 67.93 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.118 1.367 . . . . 0.0 113.413 -169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.58 -42.99 98.27 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.598 0.713 . . . . 0.0 110.082 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.4 m-20 -67.91 -36.59 80.45 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.412 HD11 ' CE2' ' A' ' 100' ' ' TYR . 5.4 mm -67.58 -34.87 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.498 0.59 . . . . 0.0 110.804 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.7 -41.29 98.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.209 0.913 . . . . 0.0 109.955 174.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.51 -47.67 83.35 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 171.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -60.23 -48.95 79.56 Favored 'General case' 0 CA--C 1.505 -0.751 0 C-N-CA 123.732 0.813 . . . . 0.0 109.282 -173.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -71.64 -43.89 65.32 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 118.34 0.518 . . . . 0.0 109.804 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.96 -29.06 41.14 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.017 172.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.5 mt -92.96 -45.47 7.93 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 120.537 1.517 . . . . 0.0 112.341 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.0 -26.15 10.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.651 1.58 . . . . 0.0 111.491 170.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -62.72 -45.78 91.15 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.967 1.707 . . . . 0.0 112.969 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -92.36 -17.21 24.97 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.943 0.792 . . . . 0.0 112.815 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -49.55 118.07 2.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.955 1.702 . . . . 0.0 111.543 -177.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 136.34 34.98 0.22 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.956 1.741 . . . . 0.0 109.879 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.51 -36.53 78.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.657 1.183 . . . . 0.0 113.057 -169.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.1 m -141.82 33.27 1.59 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.313 0.506 . . . . 0.0 111.265 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -173.54 174.55 46.15 Favored Glycine 0 CA--C 1.525 0.682 0 O-C-N 121.197 -0.939 . . . . 0.0 111.486 172.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.9 p -83.87 17.99 2.17 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.88 1.672 . . . . 0.0 113.313 -171.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.83 151.24 45.32 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 124.877 1.271 . . . . 0.0 109.495 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.57 15.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 125.24 3.96 . . . . 0.0 117.652 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.31 22.04 3.2 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.337 1.455 . . . . 0.0 111.49 -175.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 17.4 m -136.55 110.05 7.97 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 162.0 -127.43 1.72 Allowed Glycine 0 C--N 1.332 0.352 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.28 68.37 0.69 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 168.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 47.4 t -146.93 149.15 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -167.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' M2L . . . . . 0.491 HM2B ' CD1' ' A' ' 84' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 17.11 93.65 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.826 1 C-N-CA 132.217 4.207 . . . . 0.0 115.06 168.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -95.99 -12.02 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.04 2.494 . . . . 0.0 112.344 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -60.23 -16.95 38.17 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.887 2.475 . . . . 0.0 114.991 -170.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.32 67.14 1.38 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.137 1.375 . . . . 0.0 112.084 -170.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -151.26 171.22 17.78 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.263 2.225 . . . . 0.0 108.02 175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.1 ttp-105 . . . . . 0 C--O 1.252 1.203 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.102 . . . . . . . . 0 0 . 1 stop_ save_